Citrus Sinensis ID: 013214
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 447 | 2.2.26 [Sep-21-2011] | |||||||
| P18160 | 2410 | Dual specificity protein | yes | no | 0.570 | 0.105 | 0.372 | 2e-39 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.561 | 0.390 | 0.367 | 3e-39 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.557 | 0.360 | 0.369 | 6e-38 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.532 | 0.610 | 0.375 | 7e-38 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.545 | 0.150 | 0.344 | 2e-37 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.534 | 0.144 | 0.337 | 5e-37 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.550 | 0.328 | 0.356 | 1e-36 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.568 | 0.388 | 0.338 | 1e-36 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.525 | 0.142 | 0.351 | 2e-36 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.545 | 0.266 | 0.348 | 3e-36 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 163 bits (413), Expect = 2e-39, Method: Composition-based stats.
Identities = 111/298 (37%), Positives = 154/298 (51%), Gaps = 43/298 (14%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
EYEID +EL+F + I KG F +WR VA+K + + + F++E+ +
Sbjct: 2107 EYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGI 2164
Query: 204 LQKIRHPNVVQFLGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGAL---KPSTAVRFALD 258
L K+RHPNVVQFLGA T IVTE++ G LR FL L P ++ ALD
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRD---DSGN----------LKVADFGVSKLLTV 305
IA+GMNYLH P PI+HRDL NIL D D N K++DFG+S+L
Sbjct: 2225 IAKGMNYLHGWTP-PILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKM- 2282
Query: 306 KEDRPLTCQDTSC-RYVAPEVFKNEEYDTKVDVFSFALILQEMI------EGCPPFTMKH 358
E Q C Y+APEVFK + K DV+S+ ++L E++ + P M H
Sbjct: 2283 -EQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 359 DNEVPKAYAARQRP-PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
AY + + P P +K KE++ +CW+ P RPTF+QII L+ + +
Sbjct: 2342 ----LAAYESYRPPIPLTTSSK-----WKEILTQCWDSNPDSRPTFKQIIVHLKEMED 2390
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 163 bits (412), Expect = 3e-39, Method: Compositional matrix adjust.
Identities = 103/280 (36%), Positives = 157/280 (56%), Gaps = 29/280 (10%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+ID H++ V I KG + L WRG QVAVKKL I +++ ++ F E+ L++
Sbjct: 368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 424
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
+RHPNV+QFLG+ + I TEY+P+G L + L + L+ S ++ +D A+G+
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T T C + +PE
Sbjct: 485 YLHNSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 540
Query: 325 VFKNEEYDTKVDVFSFALILQEMIE------GCPPFTMKHDNEVPKAYAARQRPPF--KA 376
V +++ Y K DV+SF +IL E G PPF + + RPP
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQV-----IFAVGREGMRPPVPQNG 595
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
P K +L+ +C NE P+ RPT Q + RLESI++S
Sbjct: 596 PPKYI-----QLLIDCLNENPSHRPTMEQCLERLESIDSS 630
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (401), Expect = 6e-38, Method: Compositional matrix adjust.
Identities = 102/276 (36%), Positives = 152/276 (55%), Gaps = 27/276 (9%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+ID ++ V I KG F L WRG QVAVKKL I +++ ++ F E+ L++
Sbjct: 385 DIDTQQIKI--GVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 441
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 264
+RHPNV+QFLG+ S + I TEY+P+G L + L K + S R +D A+G+
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGII 501
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T T C + +PE
Sbjct: 502 YLHGSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 557
Query: 325 VFKNEEYDTKVDVFSFALILQEMIE------GCPPFTMKHDNEVPKAYAARQRPPFKAPA 378
V +++ Y K DV+SF +IL E G PPF + A R + P
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPF---------QVIFAVGREGMRPPT 608
Query: 379 KLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESI 413
Y +L+++C NE P++RPT Q + LESI
Sbjct: 609 PKYGPPKYIQLLKDCLNENPSQRPTMEQCLEILESI 644
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 158 bits (400), Expect = 7e-38, Method: Compositional matrix adjust.
Identities = 96/256 (37%), Positives = 143/256 (55%), Gaps = 18/256 (7%)
Query: 172 FWRGI----QVAVKKLGEEVISDDDRVR---AFRDELALLQKIRHPNVVQFLGAVTQSSP 224
+RGI VAVK + ++ R + F+ E+ALL ++ HPN+VQF+ A +
Sbjct: 100 IYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 159
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
I+TEY+ +G+LR +L +K +L T +R ALDI+RGM YLH +IHRDL+ +
Sbjct: 160 YCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQG---VIHRDLKSN 216
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
N+L +D +KVADFG S L T + R + R++APE+ K + Y KVDV+SF +
Sbjct: 217 NLLLNDEMRVKVADFGTSCLET--QCREAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 274
Query: 343 ILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
+L E+ PF + A A + +RPP A + L LI+ CW+E P+KRP
Sbjct: 275 VLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQ---PALAHLIKRCWSENPSKRP 331
Query: 402 TFRQIITRLESINNSI 417
F I+ LE + +
Sbjct: 332 DFSNIVAVLEKYDECV 347
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 157 bits (396), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 93/270 (34%), Positives = 152/270 (56%), Gaps = 26/270 (9%)
Query: 162 EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
+I G++ + F W+G+ VAVKK ++ +S+ ++ FR E+A L +++H N+V F+GA
Sbjct: 1369 QIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSET-QLLEFRAEMAFLSELKHSNIVTFIGA 1427
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA------LDIARGMNYLHENKPV 272
+ + IVTEY+ G+LR LK P + FA A G++YLH + P+
Sbjct: 1428 CIKKPNICIVTEYMRMGNLRDVLKN-----PDIKITFANKLKLLYGAAMGIDYLHSSNPM 1482
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
I+HRD++P+NIL D+ N+K+ADFG ++ +KED + + + APEV + E+Y
Sbjct: 1483 -IVHRDIKPANILVDEHFNVKIADFGFAR---IKEDNTTMTRCGTPCWTAPEVIRGEKYC 1538
Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--PFKAPAKLYARGLKELIE 390
K DVFSF +++ E++ G PF + +V RP P P + +LI+
Sbjct: 1539 EKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDILEGGRPIIPSDCPHE-----FAKLIK 1593
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSINHK 420
+CW+ K KRPT +++ +L I +HK
Sbjct: 1594 KCWHAKAHKRPTMTEVVQQLMLITEQFDHK 1623
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 155 bits (393), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 86/255 (33%), Positives = 151/255 (59%), Gaps = 16/255 (6%)
Query: 162 EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
+I G++ + + W+ + VA+KK ++ I D++ + R+E+A L+K+ HPN++ +GA
Sbjct: 1404 QIGLGSYGVVYRGKWKNVDVAIKKFIKQKI-DENHLLGIREEIAFLKKLHHPNIITMVGA 1462
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
+ + IVTEY+ KG+LR ++ L+ ++ ++IA+G++YLH P PIIHR
Sbjct: 1463 SLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHSFDP-PIIHR 1521
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
D++PSNIL D++ N+K+ADFG ++ +KE+ + + + + APE+ +N+ YD KVDV
Sbjct: 1522 DIKPSNILIDENWNVKIADFGFAR---IKEENAIMTRCGTPCWTAPEIIRNDIYDEKVDV 1578
Query: 338 FSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--PFKAPAKLYARGLKELIEECWNE 395
FSF +++ E++ PF + ++ RP P P + +L+ +CW+
Sbjct: 1579 FSFGIVMWEVLTCKEPFIGANFMKITMDILEDVRPKIPQDCPEE-----FAKLMRKCWHA 1633
Query: 396 KPAKRPTFRQIITRL 410
K KRPT +I L
Sbjct: 1634 KSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (390), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 92/258 (35%), Positives = 139/258 (53%), Gaps = 12/258 (4%)
Query: 159 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
+ E+ GT WRGI VA+KK D+D + E ++ ++RHPN+ QFLG
Sbjct: 501 SCAEVFTGT-----WRGIIVAIKKAKLLNEDDEDFLNELAQEATIMSQLRHPNICQFLGT 555
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
++IV EY+P G L L +L ALDIA+GMNYLH P+ +IHR
Sbjct: 556 CNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKGMNYLHCCDPI-VIHR 614
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKV 335
DL+ N+L D+ +K++DFG+S D+ +T T C + APEV +N+ Y K
Sbjct: 615 DLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPC-WTAPEVLRNDPYTEKA 673
Query: 336 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395
DVFSFA++L E++ P+ ++ + + P P + LI ECW+E
Sbjct: 674 DVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQ--VSAPFTRLITECWSE 731
Query: 396 KPAKRPTFRQIITRLESI 413
P +RP+F++I+ RLE++
Sbjct: 732 DPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (390), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 93/275 (33%), Positives = 155/275 (56%), Gaps = 21/275 (7%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
E+ +EID +E+ + ++ G F + RG +VA+KKL + V +++ + F+ E
Sbjct: 161 EIIRWEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVF-EENTMNEFKKE 219
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
++L+ K+R+P+++ F+GA T + IVTE +PKG + + L+ K + A+ IA
Sbjct: 220 VSLMAKLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIA 279
Query: 261 R----GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
R GM +LH + I+H DL+P+N+L D + +KVADFG+SK + L Q
Sbjct: 280 RDTVLGMTWLHASN---ILHLDLKPANLLVDQNWVVKVADFGLSKYMKPDSKDKLLGQAG 336
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---VPKAYAARQRP- 372
S Y+APE+ N+ YD KVDVFSF+++L E++ P+ + + V + RP
Sbjct: 337 SPLYMAPEMLVNQPYDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVVNKKNRPI 396
Query: 373 -PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
P P + LK+L+ CW+ P++RP+F +I
Sbjct: 397 IPDYFPTR-----LKDLLARCWDHYPSRRPSFAEI 426
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (388), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 90/256 (35%), Positives = 148/256 (57%), Gaps = 21/256 (8%)
Query: 164 TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
+ G + W+ I VAVKK ++ I D+ ++ FR E+A L ++RHP+++ +GA +
Sbjct: 1404 SYGIVNMGKWKNINVAVKKFVKQKI-DEKQMLEFRAEIAFLSQLRHPHIILMIGACLKRP 1462
Query: 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL--DIARGMNYLHENKPVPIIHRDLEP 281
+ IVTE++ G LR +K KP ++ + A G+ YLH + P+ IIHRD++P
Sbjct: 1463 NICIVTEFMGNGSLRNVIKTT---KPEWKLKIKMLYQTALGIGYLHNSDPI-IIHRDIKP 1518
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
SNIL DDS N+K+ADFG +++ +E+ +T T C + APE+ + E+Y KVDVFSF
Sbjct: 1519 SNILVDDSMNVKIADFGFARI--KEENSVMTRCGTPC-WTAPEIIRGEKYTEKVDVFSFG 1575
Query: 342 LILQEMIEGCPPFT----MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 397
+++ E++ PF+ MK ++ + AR + P P +L+++CW+ KP
Sbjct: 1576 IVMWEVLTCKEPFSGCNFMKVSMDILE--GARPQIPSDCPID-----FTKLMKQCWHAKP 1628
Query: 398 AKRPTFRQIITRLESI 413
KRP+ +I L +
Sbjct: 1629 DKRPSMEDVIMGLNDM 1644
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 153 bits (386), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 91/261 (34%), Positives = 147/261 (56%), Gaps = 17/261 (6%)
Query: 160 SVEITKGTFILAF---WRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214
S ++ +GTF + + WRG VA+K K+ E+V ++ + FR EL +L ++RHPN+V
Sbjct: 665 SSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDV--NNQVLEEFRKELTILSRLRHPNIVL 722
Query: 215 FLGAVTQSSPMMIVTEYLPKGDLR-AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
+ A T + +TEYLP G L A +K + + A+ IA+GMNYLH +
Sbjct: 723 LMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYLHLSG--- 779
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
+IHRD++ N+L D+ N+K+ DFG+SKL + + +T S +++PE+ E+Y
Sbjct: 780 VIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTE--MTKSIGSPIWMSPELLMGEDYTE 837
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEEC 392
KVDV++F +IL E+ G P++ ++ A + RPP + L LI+ C
Sbjct: 838 KVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPI---PNAWPYQLSHLIQAC 894
Query: 393 WNEKPAKRPTFRQIITRLESI 413
W++ P KRP+F +I+ L I
Sbjct: 895 WHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 447 | ||||||
| 255562560 | 466 | protein kinase, putative [Ricinus commun | 0.948 | 0.909 | 0.800 | 0.0 | |
| 356555470 | 456 | PREDICTED: probable serine/threonine-pro | 0.944 | 0.925 | 0.8 | 0.0 | |
| 356549162 | 455 | PREDICTED: probable serine/threonine-pro | 0.941 | 0.925 | 0.795 | 0.0 | |
| 224076914 | 423 | predicted protein [Populus trichocarpa] | 0.923 | 0.976 | 0.796 | 0.0 | |
| 449459316 | 458 | PREDICTED: serine/threonine-protein kina | 0.930 | 0.908 | 0.799 | 0.0 | |
| 225443668 | 462 | PREDICTED: dual specificity protein kina | 0.950 | 0.919 | 0.778 | 0.0 | |
| 102139950 | 467 | protein kinase, putative [Musa balbisian | 0.979 | 0.937 | 0.710 | 0.0 | |
| 356499380 | 454 | PREDICTED: dual specificity protein kina | 0.928 | 0.914 | 0.754 | 0.0 | |
| 104295003 | 467 | protein kinase family protein [Musa acum | 0.979 | 0.937 | 0.708 | 0.0 | |
| 449433589 | 460 | PREDICTED: probable serine/threonine-pro | 0.939 | 0.913 | 0.756 | 1e-180 |
| >gi|255562560|ref|XP_002522286.1| protein kinase, putative [Ricinus communis] gi|223538539|gb|EEF40144.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/436 (80%), Positives = 383/436 (87%), Gaps = 12/436 (2%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEE-----------IKPEFRLMFLAN 49
ME K VR TL KQSSLAP+R R+E N ++ E+ I P RLM+ +
Sbjct: 1 MEGKSSVRFTLGKQSSLAPERSREEDVSNDQEEGSEDMSNDPEEELEDIHPGVRLMYSCH 60
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
E D++GI+ELLDSGIDVNFRDIDNRTALH+AACQG+T+VV+LLL GA+ DPKDRWGSTP
Sbjct: 61 EGDLDGIRELLDSGIDVNFRDIDNRTALHLAACQGYTDVVALLLNNGAETDPKDRWGSTP 120
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFI 169
L DAIYYKNH+VIKLLEK GAKPLMAPMHV HAREVPEYEI+PHELDFTNSVEITKGTF
Sbjct: 121 LADAIYYKNHDVIKLLEKRGAKPLMAPMHVNHAREVPEYEINPHELDFTNSVEITKGTFH 180
Query: 170 LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
LA WRGIQVAVKKLGE+VISD+D+VRAF DELALLQKIRHPNVVQFLGAVTQSSPMMIVT
Sbjct: 181 LASWRGIQVAVKKLGEDVISDEDKVRAFSDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 240
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
EYL KGDLRAFLK+KGAL+P TAVRF LDIARG+NYLHENKP PIIHRDLEPSNILRDDS
Sbjct: 241 EYLHKGDLRAFLKKKGALRPGTAVRFGLDIARGLNYLHENKP-PIIHRDLEPSNILRDDS 299
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
G+LKVADFGVSKLLTVKED+PLTCQDTSCRYVAPEVFK+EEYDTKVDVFSFALILQEMIE
Sbjct: 300 GHLKVADFGVSKLLTVKEDKPLTCQDTSCRYVAPEVFKHEEYDTKVDVFSFALILQEMIE 359
Query: 350 GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
GCPPF+ K D EVPK+YAA++RPPF+AP K Y GLK+LI+ECWNE PAKRPTFRQIIT+
Sbjct: 360 GCPPFSAKQDLEVPKSYAAKERPPFRAPTKHYPHGLKDLIQECWNENPAKRPTFRQIITK 419
Query: 410 LESINNSINHKRRWKV 425
LESI NSI HKRRWKV
Sbjct: 420 LESIYNSIGHKRRWKV 435
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555470|ref|XP_003546054.1| PREDICTED: probable serine/threonine-protein kinase drkB-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1836), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/425 (80%), Positives = 380/425 (89%), Gaps = 3/425 (0%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
ME+K P R TL KQSSLAP+R KEAEL DGE + RLM+ A E DV+GI+E L
Sbjct: 1 MESKNPARFTLGKQSSLAPERHNKEAELQ---KDGEAVDQGVRLMYSAFEGDVDGIREAL 57
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+SG+ VN++DIDNRTALHVAAC+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58 ESGVSVNYKDIDNRTALHVAACEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGAKPLMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF A WRG +VAV
Sbjct: 118 VIKLLEKHGAKPLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCSALWRGTKVAV 177
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
+KRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 238 MKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVS 297
Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360
KLL VKED+PLTCQDTSCRYVAPEVF+ EEYDTKVDVFSFALILQEMIEGCPPF+ K D+
Sbjct: 298 KLLAVKEDKPLTCQDTSCRYVAPEVFRQEEYDTKVDVFSFALILQEMIEGCPPFSAKQDD 357
Query: 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
EVPK YAA++RPPF+APAK Y+ G++ELIEECWNE PAKRPTFRQIIT+LESI N+I HK
Sbjct: 358 EVPKVYAAKERPPFQAPAKRYSHGIRELIEECWNENPAKRPTFRQIITKLESIYNTIGHK 417
Query: 421 RRWKV 425
R WKV
Sbjct: 418 RHWKV 422
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549162|ref|XP_003542966.1| PREDICTED: probable serine/threonine-protein kinase drkA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1803), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/425 (79%), Positives = 378/425 (88%), Gaps = 4/425 (0%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
ME+K P R TL KQSSLAP+R KEAEL +DGE + RLM+ A E DV+GI E L
Sbjct: 1 MESKNPARFTLGKQSSLAPERHNKEAELQ---NDGEVVDQGVRLMYSAFEGDVDGICEAL 57
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ G+ VN++DIDNRTALHVA C+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58 EFGVSVNYKDIDNRTALHVAVCEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGAK LMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF +A WRG +VAV
Sbjct: 118 VIKLLEKHGAKLLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCIALWRGTEVAV 177
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
LKRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 238 LKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVS 297
Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360
KLL VKED+PLTC DTSCRYVAPEVF+ +EYDTKVDVFSFALILQEMIEGCPPF+ K DN
Sbjct: 298 KLLAVKEDKPLTCHDTSCRYVAPEVFR-QEYDTKVDVFSFALILQEMIEGCPPFSAKQDN 356
Query: 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
EVPK YAA++RPPF+APAK Y+ G++ELIEECWNE PAKRPTFRQIITRLESI N+I+HK
Sbjct: 357 EVPKVYAAKERPPFRAPAKHYSYGIRELIEECWNENPAKRPTFRQIITRLESIYNTISHK 416
Query: 421 RRWKV 425
R WKV
Sbjct: 417 RHWKV 421
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076914|ref|XP_002305047.1| predicted protein [Populus trichocarpa] gi|222848011|gb|EEE85558.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1785), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/418 (79%), Positives = 377/418 (90%), Gaps = 5/418 (1%)
Query: 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN 67
R TL KQSSLAP+R+R+E+++ D DG + P RLM+LANE ++EGIKEL++S +DVN
Sbjct: 1 RFTLGKQSSLAPERDREESDV---DMDG--VDPGVRLMYLANEGNLEGIKELVNSDVDVN 55
Query: 68 FRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
FRDID RTALH+A+CQG T+VV LLL+ GA++DPKDRWGSTPL DAI+YKNH+VIKLLEK
Sbjct: 56 FRDIDGRTALHIASCQGLTQVVDLLLDHGAEIDPKDRWGSTPLADAIFYKNHDVIKLLEK 115
Query: 128 HGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEV 187
GAKPLMAPMHVKHAREVPEYEI+P ELDFTNSVE+TKGTF +A WRGIQVAVKKLGEEV
Sbjct: 116 RGAKPLMAPMHVKHAREVPEYEINPDELDFTNSVELTKGTFCVALWRGIQVAVKKLGEEV 175
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
+SD+D+VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE+LPKGD AFLKRKGAL
Sbjct: 176 LSDEDKVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEFLPKGDFCAFLKRKGAL 235
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
KP AVR ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG+LKVADFG+SKLLTVKE
Sbjct: 236 KPIAAVRLALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGHLKVADFGISKLLTVKE 295
Query: 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367
++PL D S RYVAPEVFKNEEYDTKVD+FSFALILQEMIEGCPPF+ K ++EVP AYA
Sbjct: 296 EKPLISLDNSWRYVAPEVFKNEEYDTKVDIFSFALILQEMIEGCPPFSAKQEHEVPSAYA 355
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKV 425
A++RPPF+AP K YA GLKELI+ECW+E PAKRPTFRQI+TRL++I NSI HKRRWKV
Sbjct: 356 AKERPPFRAPTKSYAHGLKELIQECWHENPAKRPTFRQILTRLDAIQNSIGHKRRWKV 413
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449459316|ref|XP_004147392.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/419 (79%), Positives = 371/419 (88%), Gaps = 3/419 (0%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV 66
VR L KQSS+APDR+ +EAEL +DGEEI P RLM+LANE D+EGIKELLDSGIDV
Sbjct: 11 VRFLLGKQSSMAPDRQPEEAELA---EDGEEIDPGVRLMYLANEGDLEGIKELLDSGIDV 67
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
NF DIDNRTALH+AACQG E+V LLL RGA++DPKDRWGSTPL DAI+YKNHEVIKLLE
Sbjct: 68 NFHDIDNRTALHIAACQGCNEIVDLLLRRGAEIDPKDRWGSTPLADAIFYKNHEVIKLLE 127
Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEE 186
K GAK LMAPMHVKHAREVPEYEIDP E DFTNSV +TKGTF LA WRGIQVAVK+L E+
Sbjct: 128 KRGAKHLMAPMHVKHAREVPEYEIDPKEFDFTNSVNLTKGTFHLASWRGIQVAVKELPED 187
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
VIS++D+V AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL L +KG
Sbjct: 188 VISEEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLCQLLHKKGP 247
Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
LKP AV+FALDIARGMNYLHENKP PIIHRDLEPSNILRDD+GNLKVADFGVSKLLTVK
Sbjct: 248 LKPIVAVKFALDIARGMNYLHENKPAPIIHRDLEPSNILRDDTGNLKVADFGVSKLLTVK 307
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366
ED+PLTCQDT+CRYVAPEVFKN YDTKVDVFSFALILQEMIEG PPF+ K +N + K Y
Sbjct: 308 EDKPLTCQDTACRYVAPEVFKNNGYDTKVDVFSFALILQEMIEGQPPFSNKKENAICKGY 367
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKV 425
AA RPPFKAPAK YA G+KELIE CW+E+P+KRPTFRQIITRLE+I++S++H+RRWK+
Sbjct: 368 AAGMRPPFKAPAKCYAHGIKELIEACWDERPSKRPTFRQIITRLETIHHSLSHRRRWKL 426
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225443668|ref|XP_002263226.1| PREDICTED: dual specificity protein kinase shkB [Vitis vinifera] gi|297740576|emb|CBI30758.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1778), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/429 (77%), Positives = 377/429 (87%), Gaps = 4/429 (0%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
+E+K VR TL KQSSLAP+R R EA G D E I P RLM+LANE D+EG++ELL
Sbjct: 3 VESKTAVRFTLGKQSSLAPERARDEALTEGEQGDVEGIDPRVRLMYLANEGDLEGLRELL 62
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
DSG+DVNFRDIDNRTALHVAACQGF++VV LL+ GA++D +DRWGSTPL DAI+YKNH+
Sbjct: 63 DSGMDVNFRDIDNRTALHVAACQGFSDVVEFLLKNGAEIDLEDRWGSTPLADAIHYKNHD 122
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGA+ LMAPMHV +AREVPEYEIDP ELDFTNSV+ITKGT+ +A WRGIQVAV
Sbjct: 123 VIKLLEKHGAQHLMAPMHVNNAREVPEYEIDPKELDFTNSVDITKGTYRIASWRGIQVAV 182
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
K+LG+EVI D+D+V+AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL AF
Sbjct: 183 KRLGDEVIIDEDKVKAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLHAF 242
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
LKRKGALK +TAV+FALDIARGMNYLHE++P IIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 243 LKRKGALKTATAVKFALDIARGMNYLHEHRPEAIIHRDLEPSNILRDDSGHLKVADFGVS 302
Query: 301 KLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356
KLL TVKED PL CQ+TSCRY+APEVFKNE YDTKVDVFSFALILQEMIEGCPPF+
Sbjct: 303 KLLKVANTVKEDYPLICQETSCRYLAPEVFKNEAYDTKVDVFSFALILQEMIEGCPPFSA 362
Query: 357 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
K +NEVPK YAA++RPPF+AP+KLY+ GLKELIEECWNE P KRPTF QI+TRL+ I N
Sbjct: 363 KPENEVPKVYAAQERPPFRAPSKLYSHGLKELIEECWNENPTKRPTFGQILTRLDRIYNH 422
Query: 417 INHKRRWKV 425
+ KRRWKV
Sbjct: 423 LGQKRRWKV 431
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|102139950|gb|ABF70090.1| protein kinase, putative [Musa balbisiana] | Back alignment and taxonomy information |
|---|
Score = 649 bits (1675), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/467 (71%), Positives = 373/467 (79%), Gaps = 29/467 (6%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAE-LNGLDDDG----EEIKPEFRLMFLANERDVEG 55
ME K R TL KQSSLAPDR+ E + L D DG EE+ RLM+LANE D+ G
Sbjct: 1 MEAKSTGRFTLGKQSSLAPDRDDGELQALRSGDLDGLQVPEEVDANIRLMYLANEGDLAG 60
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST------- 108
I+E L SG+DVNFRDID+RTALHVAACQGF +VV LLL+RGA VDP+DRWGST
Sbjct: 61 IEETLASGVDVNFRDIDDRTALHVAACQGFADVVQLLLDRGAQVDPEDRWGSTSNFITIA 120
Query: 109 ----PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEIT 164
PL DA++YKNHEVIKL EKHGAK + PM V++AREVPEYEIDP ELDFTNSV IT
Sbjct: 121 PAKQPLADAVHYKNHEVIKLFEKHGAKLRVTPMRVENAREVPEYEIDPSELDFTNSVNIT 180
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVVQFL 216
KGTFI+A WRGIQVAVKK ++V++D+D++ RAFRDELALLQ+IRHPNVVQFL
Sbjct: 181 KGTFIIAKWRGIQVAVKKFNDDVMADEDKLWDFFIFCRRAFRDELALLQQIRHPNVVQFL 240
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
GAVTQSSPMMIVTEYL KGDLRA+L RK L+PS+AV FALDIARGMNYLHE+KP IIH
Sbjct: 241 GAVTQSSPMMIVTEYLRKGDLRAYLNRKRTLRPSSAVLFALDIARGMNYLHEHKPEAIIH 300
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
RDLEPSNILRDDSG+LKVADFGVSKLL TVKE+RPLTC DT+CRYVAPEVF NEEYD
Sbjct: 301 RDLEPSNILRDDSGHLKVADFGVSKLLKVAKTVKEERPLTCLDTACRYVAPEVFLNEEYD 360
Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
TKVDVFSFALILQEMIEGCPPF+ K DNEVPKAY ++QRPPF+AP K YA GLKELIE C
Sbjct: 361 TKVDVFSFALILQEMIEGCPPFSYKQDNEVPKAYVSKQRPPFRAPPKQYAHGLKELIEHC 420
Query: 393 WNEKPAKRPTFRQIITRLESINNSINHKRRWKVYLFLSLSVCLHLFT 439
W+E PA RPTFR+II RL I N I KRRWKV LF + + L LF+
Sbjct: 421 WSENPADRPTFREIIDRLSKIQNHIAQKRRWKVSLF-NFYLGLQLFS 466
|
Source: Musa balbisiana Species: Musa balbisiana Genus: Musa Family: Musaceae Order: Zingiberales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499380|ref|XP_003518519.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 648 bits (1671), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/427 (75%), Positives = 360/427 (84%), Gaps = 12/427 (2%)
Query: 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDS 62
K+ R +L +QSSLAP+R G D E + P RLM+LANE D +GIKELLD+
Sbjct: 5 KLQPRFSLGRQSSLAPER-------GGCGGDASEALDPAVRLMYLANEGDSDGIKELLDA 57
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVNF DID RTALHVAACQG T+VV LLL RGADVDP+DRWGSTPL DA+YYKNH+V+
Sbjct: 58 GSDVNFTDIDGRTALHVAACQGRTDVVGLLLRRGADVDPQDRWGSTPLVDAMYYKNHDVV 117
Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
KLLEKHGA+P MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRG QVAVK
Sbjct: 118 KLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGTQVAVKT 177
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
LGEE+ +DDD+V+AF DEL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDLRA+LK
Sbjct: 178 LGEELFTDDDKVKAFHDELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLRAYLK 237
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
RKGALKP TAV+FALDIARGMNYLHE+KP IIHRDLEPSNILRDDSG+LKVADFGVSKL
Sbjct: 238 RKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKL 297
Query: 303 L----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
L TVKED+P+T DTS RYVAPEV+KNEEYDTKVDVFSFALILQEMIEGCPPF K
Sbjct: 298 LKVAKTVKEDKPVTSLDTSWRYVAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFYEKP 357
Query: 359 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418
+NEVPKAY +RPPF+A KLYA GLK+LIEECW+EKP +RPTFRQII RLE I +
Sbjct: 358 ENEVPKAYVENERPPFRASPKLYAYGLKQLIEECWDEKPYRRPTFRQIIGRLEDIYYHLA 417
Query: 419 HKRRWKV 425
KRRWKV
Sbjct: 418 QKRRWKV 424
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|104295003|gb|ABF72018.1| protein kinase family protein [Musa acuminata] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/467 (70%), Positives = 371/467 (79%), Gaps = 29/467 (6%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAE-LNGLDDDG----EEIKPEFRLMFLANERDVEG 55
ME K R TL KQSSLAPDR+ E + L D DG EE+ RLM+LANE D+ G
Sbjct: 1 MEAKSTGRFTLGKQSSLAPDRDDGELQALRSGDLDGLQVLEEVDANIRLMYLANEGDLAG 60
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST------- 108
I+E L SG+DVNFRDID+RTALHVAACQGF +VV LLL+RGA VDP+DRWGST
Sbjct: 61 IEETLASGVDVNFRDIDDRTALHVAACQGFADVVQLLLDRGALVDPEDRWGSTSNFITIA 120
Query: 109 ----PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEIT 164
PL DA++YKNHEVIKL EKHGAK + PM V++AREVPEYEIDP ELDFTNSV IT
Sbjct: 121 PAKQPLADAVHYKNHEVIKLFEKHGAKLQVTPMRVENAREVPEYEIDPSELDFTNSVNIT 180
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVVQFL 216
KGTFI+A WRGIQVAVKK ++V++D+D++ AFRDELALLQ+IRHPNVVQFL
Sbjct: 181 KGTFIIAKWRGIQVAVKKFSDDVMADEDKLWDFFIFCRSAFRDELALLQQIRHPNVVQFL 240
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
GAVTQSSPMMIVTEYL KGDLRA+L RK L+PS+AV FALDIARGMNYLHE+KP IIH
Sbjct: 241 GAVTQSSPMMIVTEYLRKGDLRAYLNRKRTLRPSSAVLFALDIARGMNYLHEHKPEAIIH 300
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
RDLEPSNILRDDSG+LKVADFGVSKLL TVKE+RPLTC DTSCRYVAPEVF NEEYD
Sbjct: 301 RDLEPSNILRDDSGHLKVADFGVSKLLKVAKTVKEERPLTCLDTSCRYVAPEVFLNEEYD 360
Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
TKVDVFSFALILQEMIEGCPPF+ K DNEVPKAY ++QRPPF+AP K Y GLKELIE C
Sbjct: 361 TKVDVFSFALILQEMIEGCPPFSYKQDNEVPKAYVSKQRPPFRAPPKQYGHGLKELIEHC 420
Query: 393 WNEKPAKRPTFRQIITRLESINNSINHKRRWKVYLFLSLSVCLHLFT 439
W+E PA RPTFR+II RL I N I KRRWKV LF + + L LF+
Sbjct: 421 WSENPADRPTFREIIDRLSKIQNHIAQKRRWKVSLF-NFYLGLQLFS 466
|
Source: Musa acuminata Species: Musa acuminata Genus: Musa Family: Musaceae Order: Zingiberales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433589|ref|XP_004134580.1| PREDICTED: probable serine/threonine-protein kinase drkD-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 636 bits (1641), Expect = e-180, Method: Compositional matrix adjust.
Identities = 320/423 (75%), Positives = 354/423 (83%), Gaps = 3/423 (0%)
Query: 6 PVRTTLLKQSSLAPDRERKEAELNGL---DDDGEEIKPEFRLMFLANERDVEGIKELLDS 62
PV+ L KQSSLAPD + +L L E I RLM+LANE D+EGI E+LDS
Sbjct: 4 PVKFKLGKQSSLAPDGDVHLEDLEELVKQHQTEEGIDSRVRLMYLANEGDLEGINEVLDS 63
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G+DVNFRDIDNRTALH+AACQGF +VV+LLLERGA+VD KDRWGSTPL DAI+YKNH+VI
Sbjct: 64 GVDVNFRDIDNRTALHIAACQGFADVVALLLERGAEVDSKDRWGSTPLRDAIHYKNHDVI 123
Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
KLLEKHGAKP +APM VK+AREVP+YEIDP ELDFTNSV ITKGTF A WRG +VAVK+
Sbjct: 124 KLLEKHGAKPPVAPMLVKNAREVPDYEIDPKELDFTNSVNITKGTFRRASWRGTEVAVKE 183
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
LGE++ +D+++VRAFRDELALLQKIRHPNVVQFLGAVTQS PMMIVTEYLPKGDL A L
Sbjct: 184 LGEDLFTDEEKVRAFRDELALLQKIRHPNVVQFLGAVTQSWPMMIVTEYLPKGDLGALLS 243
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
RK +K + VR ALDIARGMNYLHENKP PIIHR+LEPSNILRDDSG+LKVADFGVSKL
Sbjct: 244 RKREIKTMSVVRLALDIARGMNYLHENKPAPIIHRNLEPSNILRDDSGHLKVADFGVSKL 303
Query: 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
LTVKED+ TC +TS RY APEVFKNEEYDTKVDVFSFALILQEM+EGC PF K D+EV
Sbjct: 304 LTVKEDKFSTCSETSRRYQAPEVFKNEEYDTKVDVFSFALILQEMLEGCSPFPDKADSEV 363
Query: 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422
PK YAA +RPPF A K YA GLKELIEECWNEKP KRPTFRQIIT+LE I N HKRR
Sbjct: 364 PKLYAAGERPPFGALIKRYANGLKELIEECWNEKPNKRPTFRQIITQLEFIYNRFCHKRR 423
Query: 423 WKV 425
WKV
Sbjct: 424 WKV 426
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 447 | ||||||
| TAIR|locus:2117129 | 459 | AT4G18950 [Arabidopsis thalian | 0.935 | 0.910 | 0.726 | 1e-162 | |
| TAIR|locus:2098999 | 471 | AT3G58760 [Arabidopsis thalian | 0.955 | 0.906 | 0.676 | 1.1e-151 | |
| TAIR|locus:2044034 | 479 | AT2G43850 [Arabidopsis thalian | 0.930 | 0.868 | 0.483 | 1.5e-99 | |
| TAIR|locus:2045258 | 476 | AT2G31800 [Arabidopsis thalian | 0.932 | 0.876 | 0.474 | 4.1e-97 | |
| TAIR|locus:2080517 | 477 | AT3G59830 [Arabidopsis thalian | 0.935 | 0.876 | 0.474 | 3e-94 | |
| TAIR|locus:2014849 | 438 | VIK "VH1-interacting kinase" [ | 0.843 | 0.860 | 0.460 | 5.8e-82 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.691 | 0.565 | 0.354 | 5e-44 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.604 | 0.473 | 0.364 | 2.2e-43 | |
| WB|WBGene00016030 | 850 | C24A1.3 [Caenorhabditis elegan | 0.572 | 0.301 | 0.360 | 1.4e-40 | |
| DICTYBASE|DDB_G0289791 | 642 | drkA "DRK subfamily protein ki | 0.572 | 0.398 | 0.374 | 1.1e-39 |
| TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1584 (562.7 bits), Expect = 1.0e-162, P = 1.0e-162
Identities = 305/420 (72%), Positives = 354/420 (84%)
Query: 8 RTTLLKQSSLAPDR--ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
R T+ +QSS+AP++ E + +DGEEI RLM+LANE D+EGIKEL+DSGID
Sbjct: 9 RFTIGRQSSMAPEKIPEPSVHSEEEVFEDGEEIDGGVRLMYLANEGDIEGIKELIDSGID 68
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
N+RDID+RTALHVAACQG +VV LLL+R A+VDPKDRWGSTP DAI+YKN +VIK+L
Sbjct: 69 ANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPKDRWGSTPFADAIFYKNIDVIKIL 128
Query: 126 EKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGE 185
E HGAK MAPMHVK AREVPEYEI+P ELDFT S EITKGT+ +A WRGIQVAVKKL +
Sbjct: 129 EIHGAKHPMAPMHVKTAREVPEYEINPSELDFTQSKEITKGTYCMAMWRGIQVAVKKLDD 188
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG 245
EV+SDDD+VR F DELALLQ++RHPN+VQFLGAVTQS+PMMIVTEYLP+GDLR LKRKG
Sbjct: 189 EVLSDDDQVRKFHDELALLQRLRHPNIVQFLGAVTQSNPMMIVTEYLPRGDLRELLKRKG 248
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
LKP+TAVR+ALDIARGM+YLHE K PIIHRDLEPSNILRDDSG+LKVADFGVSKL+TV
Sbjct: 249 QLKPATAVRYALDIARGMSYLHEIKGDPIIHRDLEPSNILRDDSGHLKVADFGVSKLVTV 308
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
KED+P TCQD SCRY+APEVF +EEYDTK DVFSFALI+QEMIEG PF K D+E +A
Sbjct: 309 KEDKPFTCQDISCRYIAPEVFTSEEYDTKADVFSFALIVQEMIEGRMPFAEKEDSEASEA 368
Query: 366 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKV 425
YA + RP FKAP+K Y GLK LIEECW+EKPAKRPTFR+II RLESI + + HKR+W++
Sbjct: 369 YAGKHRPLFKAPSKNYPHGLKTLIEECWHEKPAKRPTFREIIKRLESILHHMGHKRQWRM 428
|
|
| TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1480 (526.0 bits), Expect = 1.1e-151, P = 1.1e-151
Identities = 297/439 (67%), Positives = 346/439 (78%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIK-------PEFRLMFLANERDV 53
++ K P R L +QSSLAP+ L +DD P RLM+LANE D+
Sbjct: 3 IKPKSPARFKLGRQSSLAPESRTPIDTLTEDEDDDLAAAATAGIGDPTIRLMYLANEGDI 62
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+GI ++LDSG +V++RDID RTALHVAACQG T+VV LLL RGA VD KDRWGSTPL DA
Sbjct: 63 DGINKMLDSGTNVDYRDIDARTALHVAACQGRTDVVELLLSRGAKVDTKDRWGSTPLADA 122
Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW 173
+YYKNH+VIKLLEKHGAKP +APMHV +EVPEYEI P ELDF+NSV+I+KGTF A W
Sbjct: 123 VYYKNHDVIKLLEKHGAKPTIAPMHVLTDKEVPEYEIHPTELDFSNSVKISKGTFNKASW 182
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
RGI VAVK GEE+ +D+D+V AFRDELALLQKIRHPNVVQFLGAVTQS+PMMIVTEYLP
Sbjct: 183 RGIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 242
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
KGDLR +L RKG L P+ AV+FAL+IARGMNYLHE+KP IIH DLEP NILRDDSG+LK
Sbjct: 243 KGDLRQYLDRKGPLMPAHAVKFALEIARGMNYLHEHKPEAIIHCDLEPPNILRDDSGHLK 302
Query: 294 VADFGVSKLL----TVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
VADFGVSKLL TVK+DRP+ TC D+S RY+APEV++NEEYDTKVDVFSFALILQEMI
Sbjct: 303 VADFGVSKLLVVKKTVKKDRPVVTCLDSSWRYMAPEVYRNEEYDTKVDVFSFALILQEMI 362
Query: 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
EGC PF D EVPKAY +RPPF AP K Y GL+ELI++CW+++ +KRPTFR II+
Sbjct: 363 EGCEPFHEIEDREVPKAYIEDERPPFNAPTKSYPFGLQELIQDCWDKEASKRPTFRVIIS 422
Query: 409 RLESINNSINHKRRWKVYL 427
LE I++ I KR WKV L
Sbjct: 423 TLELISDRIARKRSWKVML 441
|
|
| TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
Identities = 209/432 (48%), Positives = 281/432 (65%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPE-----FRLMFLANERDVEGIKELLD 61
+R + +QSSL P R ++ + DD+ PE +L+F+A++ DV GI+ELLD
Sbjct: 42 MRFSFGRQSSLDPIRRSPDSSKS--DDEPHMSVPENLDSTMQLLFMASKGDVRGIEELLD 99
Query: 62 SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
GIDVN D+D RTALH+AAC+G VV LL R A++D +DRWGST DA YY N +V
Sbjct: 100 EGIDVNSIDLDGRTALHIAACEGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDV 159
Query: 122 IKLLEKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQV 178
LL+ GAK P PM V + REVPEYE++P E+ S I+KG + +A W G +V
Sbjct: 160 YNLLKARGAKVPKTRKTPMTVSNPREVPEYELNPLEVQVRKSDGISKGAYQVAKWNGTRV 219
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
+VK L ++ SD +R+ AFR EL LL+K+RHPNV+QF+GAVTQ+ PMMIV EY PKGDL
Sbjct: 220 SVKILDKDSYSDPERINAFRHELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLS 279
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+L++KG L PS A+RFALDIARGMNYLHE KP PIIH DL+P NIL D G LK++ FG
Sbjct: 280 VYLQKKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFG 339
Query: 299 VSKLLTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
+ +L + +D+ D S Y+APEV+K+E +D +VD SF +IL E+ EG P
Sbjct: 340 MIRLSKISQDKAKVANHKAHIDLSNYYIAPEVYKDEIFDLRVDAHSFGVILYEITEGVPV 399
Query: 354 FTMKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
F + EV + +RP FK ++ Y +KELIE+CW+ + RPTF +II RL+
Sbjct: 400 FHPRPPEEVARMMCLEGKRPVFKTKSRSYPPDIKELIEKCWHPEAGIRPTFSEIIIRLDK 459
Query: 413 INNSINHKRRWK 424
I + + + WK
Sbjct: 460 IVANCSKQGWWK 471
|
|
| TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 965 (344.8 bits), Expect = 4.1e-97, P = 4.1e-97
Identities = 203/428 (47%), Positives = 275/428 (64%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLD-DDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
+R + +QSSL P R + NG + + +L+F+A DVEG+++LLD GID
Sbjct: 42 MRFSFGRQSSLDPIRRSPDGS-NGPQLAVPDNLDATMQLLFVACRGDVEGVQDLLDEGID 100
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
VN D+D RTALH+AAC+G +VV LLL R A++D +DRWGST DA YY N +V +L
Sbjct: 101 VNSIDLDGRTALHIAACEGHVDVVKLLLTRKANIDARDRWGSTAAADAKYYGNMDVFNIL 160
Query: 126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
+ GAK P PM V + REVPEYE++P EL + I+KG + +A W G +V+VK
Sbjct: 161 KARGAKVPKTKRTPMVVANPREVPEYELNPQELQVRKADGISKGIYQVAKWNGTKVSVKI 220
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
L +++ D D + AF+ EL L +K+RHPNVVQF+GAVTQ+ PMMIV+EY PKGDL ++L+
Sbjct: 221 LDKDLYKDSDTINAFKHELTLFEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQ 280
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
+KG L P+ +RFALDIARGMNYLHE KP P+IH DL+P NI+ D G+LKVA FG+
Sbjct: 281 KKGRLSPAKVLRFALDIARGMNYLHECKPEPVIHCDLKPKNIMLDSGGHLKVAGFGLISF 340
Query: 303 LTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
+ D+ D S +APEV+K+E +D VD +SF ++L EMIEG PF K
Sbjct: 341 AKLSSDKSKILNHGAHIDPSNYCMAPEVYKDEIFDRSVDSYSFGVVLYEMIEGVQPFHPK 400
Query: 358 HDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
E K +RP FKA +K + ++ELIEECW+ + RPTF +II RL+ I
Sbjct: 401 PPEEAVKLMCLEGRRPSFKAKSKSCPQEMRELIEECWDTETFVRPTFSEIIVRLDKIFVH 460
Query: 417 INHKRRWK 424
+ + WK
Sbjct: 461 CSKQGWWK 468
|
|
| TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 938 (335.3 bits), Expect = 3.0e-94, P = 3.0e-94
Identities = 203/428 (47%), Positives = 272/428 (63%)
Query: 7 VRTTLLKQSSLAPDRERKEA-ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
+R + +QSSL P R E+ E + +L+F+A++ DV G++ELL+ GID
Sbjct: 42 MRFSFGRQSSLDPIRRSPESLSCEPHMSVPENLDSTMQLLFMASKGDVNGVEELLNEGID 101
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
VN D+D RTALH+A+C+G +VV +LL R A++D +DRWGST DA YY N EV LL
Sbjct: 102 VNSIDLDGRTALHIASCEGHYDVVKVLLSRRANIDARDRWGSTAAVDAKYYGNVEVYNLL 161
Query: 126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
+ GAK P PM V + +EVPEYE++P EL I+KGT+ +A W G +V+VK
Sbjct: 162 KARGAKAPKTRKTPMTVGNPKEVPEYELNPLELQVRKVDGISKGTYQVAKWNGTRVSVKI 221
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
++ SD +RV AF +EL LL K RHPN+VQF+GAVTQ+ PMMIV E PKGDL +L+
Sbjct: 222 FDKDSYSDPERVNAFTNELTLLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQ 281
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
+KG L PS A+RFALDIARGMNYLHE KP PIIH +L P NIL D G LK++ FG+ KL
Sbjct: 282 KKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCELMPKNILLDRGGQLKISGFGLIKL 341
Query: 303 LTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
+ ED D S Y+APE++K+E +D + DV SF +IL E+ EG F K
Sbjct: 342 SKIGEDSAKVVNHEAQIDKSNYYIAPEIYKDEVFDKRADVHSFGVILYELTEGVSLFHPK 401
Query: 358 HDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
EV ++ +RP + +K Y LKELIEECW+ + + RP F +II RL+ I +
Sbjct: 402 PPEEVAESICIEGKRPTIRTKSKSYPPELKELIEECWHPEISVRPIFSEIIIRLDKIVTN 461
Query: 417 INHKRRWK 424
+ + WK
Sbjct: 462 CSKQGWWK 469
|
|
| TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 822 (294.4 bits), Expect = 5.8e-82, P = 5.8e-82
Identities = 185/402 (46%), Positives = 256/402 (63%)
Query: 44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+++ A++ D +++LL+ V+ RD D RT LHVA+ G+ +VV LLE GADV+ +
Sbjct: 41 ILWHAHQNDAAAVRKLLEEDPTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQ 100
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH--AREVP-------EYEIDPH 153
DRW +TPL DA + ++I+LL+ HG L + H + VP ++EI+P
Sbjct: 101 DRWKNTPLADAEGARKQKMIELLKSHGG--LSYGQNGSHFEPKPVPPPIPKKCDWEIEPA 158
Query: 154 ELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRV-RAFRDELALLQKIRH 209
ELDF+N+ I KG+F + A+WRG VAVK++ +SDD V + FR E+ LL K+RH
Sbjct: 159 ELDFSNAAMIGKGSFGEIVKAYWRGTPVAVKRILPS-LSDDRLVIQDFRHEVDLLVKLRH 217
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+VQFLGAVT+ P+M++TEYL GDL +LK KG L P+TAV FALDIARGM YLH N
Sbjct: 218 PNIVQFLGAVTERKPLMLITEYLRGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLH-N 276
Query: 270 KPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTVKEDRP---LTCQDTSCRYVAPE 324
+P IIHRDL+P N+L +S +LKV DFG+SKL+ V+ +T + S RY+APE
Sbjct: 277 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 336
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
VFK+ YD KVDVFSFA+IL EM+EG PPF E K + RP F++ K
Sbjct: 337 VFKHRRYDKKVDVFSFAMILYEMLEGEPPFANHEPYEAAKHVSDGHRPTFRS--KGCTPD 394
Query: 385 LKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKVY 426
L+ELI +CW+ +RP+F I+ RLE I ++ W ++
Sbjct: 395 LRELIVKCWDADMNQRPSFLDILKRLEKIKETLPSDHHWGLF 436
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 464 (168.4 bits), Expect = 5.0e-44, P = 5.0e-44
Identities = 121/341 (35%), Positives = 196/341 (57%)
Query: 98 DVDPKDRWGSTP---LGDAIYYKNHEVIKLLEKHGAKPLMAPM--HVKHARE-VPE-YEI 150
DV D W L DA+ + E++KL ++ G+K H K + E +P EI
Sbjct: 215 DVFVVDGWSQEETDGLRDAL---SKEILKLKDQPGSKQKSISFFEHDKSSNELIPACIEI 271
Query: 151 -----DPHELDFTN-SVE--ITKGTFILAFWRGI----QVAVKKLGEEVISDDDRVRAFR 198
D E+D T +E + G++ RG +VA+K L + ++++ +R F
Sbjct: 272 PTDGTDEWEIDVTQLKIEKKVASGSYG-DLHRGTYCSQEVAIKFLKPDRVNNE-MLREFS 329
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E+ +++K+RH NVVQFLGA T+S + IVTE++ +G + FL K+K A K T ++ AL
Sbjct: 330 QEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVAL 389
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
D+A+GM+YLH+N IIHRDL+ +N+L D+ G +KVADFGV+++ E +T + +
Sbjct: 390 DVAKGMSYLHQNN---IIHRDLKTANLLMDEHGLVKVADFGVARVQI--ESGVMTAETGT 444
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
R++APEV +++ Y+ K DVFS+A++L E++ G P+ + + P K P
Sbjct: 445 YRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRP-KIP 503
Query: 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418
K + + +K L+E CW++ P +RP F +II L+ I +N
Sbjct: 504 KKTHPK-VKGLLERCWHQDPEQRPLFEEIIEMLQQIMKEVN 543
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 458 (166.3 bits), Expect = 2.2e-43, P = 2.2e-43
Identities = 102/280 (36%), Positives = 166/280 (59%)
Query: 147 EYEIDPHELDFTNSVEI-TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
E+EID +L V + G + +VA+K L E ++ + +R F E+ +++
Sbjct: 284 EWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILKPERVNAE-MLREFSQEVYIMR 342
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 264
K+RH NVVQF+GA T+S + IVTE++ +G + FL K KG K + ++ ALD+++GMN
Sbjct: 343 KVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMN 402
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH+N IIHRDL+ +N+L D+ +KVADFGV+++ T E +T + + R++APE
Sbjct: 403 YLHQNN---IIHRDLKTANLLMDEHEVVKVADFGVARVQT--ESGVMTAETGTYRWMAPE 457
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
V +++ YD + DVFS+A++L E++ G P++ + + P K P + + +
Sbjct: 458 VIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRP-KIPKETHPK- 515
Query: 385 LKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWK 424
L EL+E+CW + PA RP F +II L + + R K
Sbjct: 516 LTELLEKCWQQDPALRPNFAEIIEMLNQLIREVGDDERHK 555
|
|
| WB|WBGene00016030 C24A1.3 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 376 (137.4 bits), Expect = 1.4e-40, Sum P(2) = 1.4e-40
Identities = 97/269 (36%), Positives = 143/269 (53%)
Query: 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
E++F S I G+F + +RG VAVK+ E+++L ++ HP
Sbjct: 515 EIEFQES--IGSGSFGKVYKGTYRGKLVAVKRYRAMAFGCKSETDMLCREVSILSRLAHP 572
Query: 211 NVVQFLG-AVTQSSPMMIVTEYLPKGDL--RAFLKRKG--ALKPSTAVRFALDIARGMNY 265
NVV F+G ++ S I+TE++ G L R +RK + P+ +R +LD+ARGM Y
Sbjct: 573 NVVAFVGTSLDDPSQFAIITEFVENGSLFRRENGERKNYRVMDPAFRLRISLDVARGMRY 632
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LHE+ P+IHRDL NIL G VADFG S+ + +ED LT Q + R++APEV
Sbjct: 633 LHESAAKPVIHRDLNSHNILIHADGRSVVADFGESRFVCQREDENLTKQPGNLRWMAPEV 692
Query: 326 FKNE-EYDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQRPPF-KAPAKLYA 382
F +YD KVDVFSFAL++ E+ PF+ +K + R RP P +
Sbjct: 693 FSQSGKYDRKVDVFSFALVIWEIHTAELPFSHLKPAAAAAEMTYKRGRPTLPNQPTAQFP 752
Query: 383 RGLKELIEECWNEKPAKRPTFRQIITRLE 411
+ LI + W+ + + RP F +I+ LE
Sbjct: 753 AHILSLIPQAWHPESSSRPDFVEIVALLE 781
|
|
| DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 410 (149.4 bits), Expect = 1.1e-39, Sum P(2) = 1.1e-39
Identities = 103/275 (37%), Positives = 157/275 (57%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+ID H++ V I KG + L WRG QVAVKKL I+++ ++ F E+ L++
Sbjct: 368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENI-LKEFHREINLMK 424
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMN 264
+RHPNV+QFLG+ + I TEY+P+G L + L + L+ S ++ +D A+G+
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T T C + +PE
Sbjct: 485 YLHNSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 540
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPF--KAPAKLY 381
V +++ Y K DV+SF +IL E P+ +V A RPP P K Y
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPK-Y 599
Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
+L+ +C NE P+ RPT Q + RLESI++S
Sbjct: 600 I----QLLIDCLNENPSHRPTMEQCLERLESIDSS 630
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 447 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-66 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-64 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-63 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-62 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-62 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-59 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-48 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-45 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-44 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-42 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-38 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-38 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-37 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-37 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-36 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-36 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-36 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-36 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-35 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-35 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-34 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-34 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-34 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-33 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-33 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-32 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-32 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-32 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-31 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-31 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-30 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-30 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-30 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-30 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-30 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-30 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-30 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-29 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-29 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-29 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-29 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-29 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-29 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-29 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-29 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-28 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-28 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-28 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-28 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-27 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-27 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-27 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-26 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-25 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-25 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-25 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-25 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-25 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-24 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-24 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-24 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-23 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-23 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-23 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-23 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-22 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 1e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-22 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 3e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-21 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-20 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 6e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-19 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-19 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-18 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-18 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-17 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-16 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-15 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 5e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-14 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-13 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 3e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-12 | |
| PTZ00322 | 664 | PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct | 5e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 4e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 4e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-09 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 9e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 2e-08 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 4e-08 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 4e-08 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 5e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-08 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 3e-07 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 4e-07 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 4e-07 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 5e-07 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 5e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-07 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 1e-06 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 2e-06 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 2e-06 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 5e-06 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 5e-06 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| pfam13606 | 30 | pfam13606, Ank_3, Ankyrin repeat | 6e-05 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 7e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-05 | |
| smart00248 | 30 | smart00248, ANK, ankyrin repeats | 7e-05 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 9e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 2e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 2e-04 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 8e-04 | |
| PHA02946 | 446 | PHA02946, PHA02946, ankyin-like protein; Provision | 0.001 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 0.002 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 0.002 | |
| PHA02736 | 154 | PHA02736, PHA02736, Viral ankyrin protein; Provisi | 0.002 | |
| PHA02716 | 764 | PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provi | 0.003 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.003 | |
| TIGR00870 | 743 | TIGR00870, trp, transient-receptor-potential calci | 0.003 | |
| PHA02798 | 489 | PHA02798, PHA02798, ankyrin-like protein; Provisio | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 1e-66
Identities = 82/266 (30%), Positives = 136/266 (51%), Gaps = 30/266 (11%)
Query: 162 EITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
++ +G F +G +VAVK L E + ++ F +E ++++K+ HPN+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLSHPNI 63
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKP 271
V+ LG TQ P+ IVTEY+P GDL FL++ G L ++ AL IA+GM YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN- 122
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFK 327
+HRDL N L ++ +K++DFG+S+ + + + +++APE K
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY---YRKRGGGKLPIKWMAPESLK 177
Query: 328 NEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARG 384
+ ++ +K DV+SF ++L E+ P+ + EV + R P P +LY
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELY--- 234
Query: 385 LKELIEECWNEKPAKRPTFRQIITRL 410
EL+ +CW P RPTF +++ L
Sbjct: 235 --ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 206 bits (528), Expect = 3e-64
Identities = 82/253 (32%), Positives = 129/253 (50%), Gaps = 36/253 (14%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+ ++VAVK L E+ + + ++ F E +++K+ HPNVV+ LG T+ P+ IV EY+
Sbjct: 26 KKKVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYM 83
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
GDL ++L K + L S + FAL IARGM YL IHRDL N L ++
Sbjct: 84 EGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLV 140
Query: 292 LKVADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K++DFG+S+ L + P+ R++APE K ++ +K DV+SF ++L
Sbjct: 141 VKISDFGLSRDLYDDDYYRKRGGKLPI-------RWMAPESLKEGKFTSKSDVWSFGVLL 193
Query: 345 QEMI-------EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 397
E+ G + + Y R P P +LY +L+ +CW E P
Sbjct: 194 WEIFTLGEQPYPGMSNEEVLEY--LKNGY--RLPQPPNCPPELY-----DLMLQCWAEDP 244
Query: 398 AKRPTFRQIITRL 410
RPTF +++ L
Sbjct: 245 EDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 4e-63
Identities = 86/267 (32%), Positives = 133/267 (49%), Gaps = 43/267 (16%)
Query: 166 GTFILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
G +G ++VAVK L E+ + + ++ F E +++K+ HPN+V+ LG
Sbjct: 13 GEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNIVKLLGVC 70
Query: 220 TQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
T+ P+MIV EY+P GDL +L+ R L S + FAL IARGM YL IHR
Sbjct: 71 TEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHR 127
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKNEE 330
DL N L ++ +K++DFG+S+ L + P+ R++APE K +
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI-------RWMAPESLKEGK 180
Query: 331 YDTKVDVFSFALILQEMI-------EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
+ +K DV+SF ++L E+ G + + K Y R P P +LY
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY--LKKGY--RLPKPPNCPPELY-- 234
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRL 410
+L+ +CW E P RPTF +++ L
Sbjct: 235 ---KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-62
Identities = 84/266 (31%), Positives = 134/266 (50%), Gaps = 29/266 (10%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ KG + +VAVK L E+ + ++ + F E +++K+ HPNVV+ LG T+
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE 67
Query: 222 SSPMMIVTEYLPKGDLRAFLKR---------KGALKPSTAVRFALDIARGMNYLHENKPV 272
P+ +V EY+ GDL +L++ K L + FA+ IA+GM YL K
Sbjct: 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-- 125
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFKN 328
+HRDL N L + +K++DFG+S+ + + + T R++APE K+
Sbjct: 126 -FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPIRWMAPESLKD 181
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGL 385
+ +K DV+SF ++L E+ G P+ + EV + R P P +LY
Sbjct: 182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY---- 237
Query: 386 KELIEECWNEKPAKRPTFRQIITRLE 411
EL+ CW P RPTF +++ RLE
Sbjct: 238 -ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 8e-62
Identities = 92/259 (35%), Positives = 138/259 (53%), Gaps = 14/259 (5%)
Query: 157 FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
+ ++ G+F A + G VAVK L + A R E+ +L+++ HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKP 271
+V+ + A + +V EY GDL +L R G L A + AL I RG+ YLH N
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEE 330
IIHRDL+P NIL D++G +K+ADFG++K L K LT + Y+APEV
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG---LKE 387
Y KVDV+S +IL E++ G PPF+ ++ + + PP + ++ G K+
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 388 LIEECWNEKPAKRPTFRQI 406
LI++C N+ P+KRPT +I
Sbjct: 236 LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 6e-59
Identities = 79/255 (30%), Positives = 129/255 (50%), Gaps = 22/255 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
++ +G+F LA + G VA+K + ++ I D E+ +L+K++HPN+V+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNIVRLY 63
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ +V EY GDL LK++G L A + I + YLH I+H
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVH 120
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
RDL+P NIL D+ G++K+ADFG+++ L E T Y+APEV + Y
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKL-----TTFVGTPEYMAPEVLLGKGYGK 175
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEE 391
VD++S +IL E++ G PPF D+++ + + + +PPF P + K+LI +
Sbjct: 176 AVDIWSLGVILYELLTGKPPF--PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233
Query: 392 CWNEKPAKRPTFRQI 406
+ P KR T +
Sbjct: 234 LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-52
Identities = 79/256 (30%), Positives = 118/256 (46%), Gaps = 49/256 (19%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+ +G F LA + G +VA+K + + + E+ +L+K+ HPN+V+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V EY G L+ LK L +R L I G+ YLH N IIH
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIH 115
Query: 277 RDLEPSNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTK 334
RDL+P NIL D+G +K+ADFG+SKLLT + T T Y+APEV + Y K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP-AYMAPEVLLGKGYYSEK 174
Query: 335 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394
D++S +IL E+ E LK+LI +
Sbjct: 175 SDIWSLGVILYELPE-----------------------------------LKDLIRKMLQ 199
Query: 395 EKPAKRPTFRQIITRL 410
+ P KRP+ ++I+ L
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 9e-48
Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 16/232 (6%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM--IVTEYLPKG 235
+AVK + E ++ + A E+ +L ++HPN+V++ G+ I EY+ G
Sbjct: 28 MAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
L + LK+ G L ++ I G+ YLH N I+HRD++ +NIL D G +K+A
Sbjct: 87 SLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLA 143
Query: 296 DFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
DFG +K L + + + T ++APEV + EEY D++S + EM G PP
Sbjct: 144 DFGCAKRLGDIETGEGTGSVRGTP-YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
Query: 354 FTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
++ N + Y + + P P L K+ + +C P KRPT
Sbjct: 203 WSE-LGNPMAALYKIGSSGEPPEI--PEHLSE-EAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 7e-45
Identities = 94/279 (33%), Positives = 149/279 (53%), Gaps = 36/279 (12%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+ I+ EL + I KG F +L +RG +VAVK L ++ + +AF E +++
Sbjct: 1 WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVKCLKDDSTA----AQAFLAEASVM 54
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARG 262
+RHPN+VQ LG V Q +P+ IVTEY+ KG L +L+ +G + + + FALD+ G
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CR 319
M YL E +HRDL N+L + KV+DFG++K + QD+ +
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-------QDSGKLPVK 164
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPF 374
+ APE + +++ TK DV+SF ++L E+ G P+ +V K Y R P
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY--RMEAPE 222
Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
P ++Y +++++CW PAKRPTF+Q+ +L I
Sbjct: 223 GCPPEVY-----KVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 8e-44
Identities = 95/271 (35%), Positives = 147/271 (54%), Gaps = 26/271 (9%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP EL F E+ G F L WRG I VA+K + E +S+DD F +E ++
Sbjct: 1 IDPSELTFLK--ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
K+ HPN+VQ G T+ P+ IVTEY+ G L +L+ RKG L + D+ M
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS--CRYVA 322
YL N IHRDL N L + +KV+DFG+++ V +D+ + Q T ++
Sbjct: 115 YLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAP 169
Query: 323 PEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA--RQRPPFKAPAK 379
PEVF + +K DV+SF +++ E+ EG P+ ++EV ++ +A R P AP +
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTE 229
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRL 410
+Y ++ CW+EKP RP F++++++L
Sbjct: 230 VY-----TIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 6e-42
Identities = 91/266 (34%), Positives = 139/266 (52%), Gaps = 22/266 (8%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
I+P EL F E+ G F L WR I+VA+K + E +S++D F +E ++
Sbjct: 1 INPSELTFMK--ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
K+ HP +VQ G TQ P+ IVTE++ G L +L+ R+G L + D+ GM
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL N IHRDL N L +G +KV+DFG+++ + E + ++ PE
Sbjct: 115 YLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
VF +Y +K DV+SF +++ E+ EG PF K + EV + + R P A +Y
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVY 231
Query: 382 ARGLKELIEECWNEKPAKRPTFRQII 407
E++ CW+EKP RPTF +++
Sbjct: 232 -----EVMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 9e-42
Identities = 78/259 (30%), Positives = 128/259 (49%), Gaps = 27/259 (10%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
F +I KG F A + G +VA+K + E +++ E+ +L+K +HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHEN 269
N+V++ G+ + + IV E+ G L+ LK L S ++ +G+ YLH N
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF 326
IIHRD++ +NIL G +K+ DFG+S L+ + R +T ++APEV
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-----NTMVGTPYWMAPEVI 169
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA--YAARQRPP-FKAPAKLYAR 383
+ YD K D++S + E+ EG PP+ + KA A PP + P K ++
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEK-WSD 225
Query: 384 GLKELIEECWNEKPAKRPT 402
K+ +++C + P KRPT
Sbjct: 226 EFKDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 3e-40
Identities = 85/270 (31%), Positives = 141/270 (52%), Gaps = 24/270 (8%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGI-----QVAVKKLGEEVISDDDRVRAFRDELALL 204
I P EL EI G F L W G +VA+K + E +S++D F +E ++
Sbjct: 1 IHPSELTL--VQEIGSGQFGLV-WLGYWLEKRKVAIKTIREGAMSEED----FIEEAQVM 53
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
K+ HP +VQ G T+ SP+ +V E++ G L +L+ ++G T + LD+ GM
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323
YL + +IHRDL N L ++ +KV+DFG+++ + + T ++ +P
Sbjct: 114 AYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170
Query: 324 EVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKL 380
EVF +Y +K DV+SF +++ E+ EG P+ + ++EV + A R P A +
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSV 230
Query: 381 YARGLKELIEECWNEKPAKRPTFRQIITRL 410
Y EL++ CW E+P RP+F ++ +L
Sbjct: 231 Y-----ELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 4e-38
Identities = 67/239 (28%), Positives = 119/239 (49%), Gaps = 12/239 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +K++ +S+ +R A E+ +L+K+ HPN++++ + + + IV EY
Sbjct: 25 GKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83
Query: 235 GDLRAFLKRKGALKPSTAVRFALD----IARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
GDL +K++ LD + + YLH K I+HRD++P NI +G
Sbjct: 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNG 140
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
+K+ DFG+SK+L+ D T T Y++PE+ +N+ Y+ K D++S +L E+
Sbjct: 141 LVKLGDFGISKVLSSTVDLAKTVVGTPY-YLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199
Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
PF ++ E+ Q PP + Y+ L+ L+ + P +RP+ QI+
Sbjct: 200 KHPFEGENLLELALKILKGQYPPIPSQ---YSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 8e-38
Identities = 79/244 (32%), Positives = 129/244 (52%), Gaps = 23/244 (9%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+ G +VAVK I D +AF +E A++ K+ H N+V+ LG + + + IV E +
Sbjct: 27 YTGQKVAVK-----NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80
Query: 233 PKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
KG+L FL+ +G S ++F+LD+A GM YL K ++HRDL NIL + G
Sbjct: 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDG 137
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 349
KV+DFG++++ + ++ APE K++++ +K DV+S+ ++L E+
Sbjct: 138 VAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193
Query: 350 GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
G P+ EV + R PP PA +Y L+ CW +P KRP+F ++
Sbjct: 194 GRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV-----LMTSCWETEPKKRPSFHKLR 248
Query: 408 TRLE 411
+LE
Sbjct: 249 EKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 84/258 (32%), Positives = 124/258 (48%), Gaps = 23/258 (8%)
Query: 162 EITKGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
E+ GT W G +VAVK L +S AF E +++K+RH +VQ +
Sbjct: 21 EVWMGT-----WNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+ P+ IVTEY+ KG L FLK L+ V A IA GM YL IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRD 128
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L NIL ++ K+ADFG+++L+ E ++ APE + K DV+
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 339 SFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKA--PAKLYARGLKELIEECWNE 395
SF ++L E++ G P+ + EV + R P P +LY +L+ +CW++
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY-----DLMLQCWDK 243
Query: 396 KPAKRPTFRQIITRLESI 413
P +RPTF + + LE
Sbjct: 244 DPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 5e-37
Identities = 88/257 (34%), Positives = 130/257 (50%), Gaps = 19/257 (7%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L + I VA+K L + SD R F E +++ + HPN+++ G VT+
Sbjct: 19 EVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQR-LDFLTEASIMGQFDHPNIIRLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MI+TEY+ G L FL+ G V IA GM YL E V HRDL
Sbjct: 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV---HRDLA 133
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFS 339
NIL + + KV+DFG+S+ L E T R+ APE ++ + DV+S
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWS 193
Query: 340 FALILQE-MIEGCPPFTMKHDNEVPKA----YAARQRPPFKAPAKLYARGLKELIEECWN 394
F +++ E M G P+ + +V KA Y R PP P+ LY +L+ +CW
Sbjct: 194 FGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY--RLPPPMDCPSALY-----QLMLDCWQ 246
Query: 395 EKPAKRPTFRQIITRLE 411
+ +RPTF QI++ L+
Sbjct: 247 KDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 87/270 (32%), Positives = 139/270 (51%), Gaps = 22/270 (8%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP +L F E+ G F WRG VA+K + E +S+D+ F +E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
K+ H +VQ G T+ P+ IVTEY+ G L +L+ G +PS + D+ GM
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMA 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL + IHRDL N L DD G +KV+DFG+S+ + E R+ PE
Sbjct: 115 YLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
V ++ +K DV++F +++ E+ G P+ +++E + + R P A K+Y
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY 231
Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLE 411
A ++ CW+EK +RPTF+Q+++ +E
Sbjct: 232 A-----IMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 76/253 (30%), Positives = 123/253 (48%), Gaps = 24/253 (9%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+VA+K + E S +R F +E +++++ +VV+ LG V+ P ++V E +
Sbjct: 35 PETRVAIKTVNENA-SMRER-IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMA 92
Query: 234 KGDLRAFLKRK-------GALKPSTAVRF---ALDIARGMNYLHENKPVPIIHRDLEPSN 283
KGDL+++L+ + L P T +F A +IA GM YL K +HRDL N
Sbjct: 93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARN 149
Query: 284 ILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+ + +K+ DFG+++ + + R R++APE K+ + TK DV+SF +
Sbjct: 150 CMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGV 209
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKPAK 399
+L EM P+ + EV K P P KL EL+ CW P
Sbjct: 210 VLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLL-----ELMRMCWQYNPKM 264
Query: 400 RPTFRQIITRLES 412
RPTF +I++ L+
Sbjct: 265 RPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 8e-36
Identities = 86/275 (31%), Positives = 143/275 (52%), Gaps = 30/275 (10%)
Query: 152 PHELDFTNSVEITKGTFILAF---WRG-IQVAVKKLGEEVISDDDRVRA--FRDELALLQ 205
P E +FT ++ G F + W+ ++VA+K ++ DD ++ F+ E+ L+
Sbjct: 4 PRE-EFTLERKLGSGYFGEVWEGLWKNRVRVAIK-----ILKSDDLLKQQDFQKEVQALK 57
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGM 263
++RH +++ + P+ I+TE + KG L AFL+ L ++ + A +A GM
Sbjct: 58 RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYV 321
YL E IHRDL NIL + KVADFG+++L+ KED L+ D ++
Sbjct: 118 AYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLS-SDKKIPYKWT 171
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA--RQRPPFKAPA 378
APE + + TK DV+SF ++L EM G P+ +++EV A R P K P
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQ 231
Query: 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
++Y +++ ECW +P RP+F+ + L++I
Sbjct: 232 EIY-----KIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 8e-36
Identities = 71/229 (31%), Positives = 112/229 (48%), Gaps = 14/229 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ I V E +L +I HP +V+ A + +V EY P G+L
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L ++G A +A +I + YLH II+RDL+P NIL D G++K+ DFG
Sbjct: 82 SHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFG 138
Query: 299 VSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
++K L+ + R +T C Y+APEV + Y VD +S ++L EM+ G PPF
Sbjct: 139 LAKELSSEGSRT----NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF- 193
Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
+ + + Y + P + P L + ++LI + P KR
Sbjct: 194 --YAEDRKEIYEKILKDPLRFPEFL-SPEARDLISGLLQKDPTKRLGSG 239
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 86/264 (32%), Positives = 127/264 (48%), Gaps = 44/264 (16%)
Query: 176 IQVAVKKLGE--EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VA+K L E E + FR E L+ ++HPN+V LG T+ P ++ EYL
Sbjct: 36 TSVAIKTLKENAEPKVQQE----FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91
Query: 234 KGDLRAFLKR----------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
GDL FL R K +L S + A+ IA GM YL + +HR
Sbjct: 92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHR 148
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEY 331
DL N L + +K++DFG+S+ + V+ L R++ PE ++
Sbjct: 149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-----PVRWMPPEAILYGKF 203
Query: 332 DTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKEL 388
T+ D++SF ++L E+ G P+ + EV + +RQ P PA++YA L
Sbjct: 204 TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYA-----L 258
Query: 389 IEECWNEKPAKRPTFRQIITRLES 412
+ ECWNE PA+RP F+ I TRL S
Sbjct: 259 MIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 78/255 (30%), Positives = 126/255 (49%), Gaps = 29/255 (11%)
Query: 171 AFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
W+ + VAVK L E+ + V F E A++++I+HPN+VQ LG T+ P I+
Sbjct: 25 GVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80
Query: 229 TEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
TE++ G+L +L+ + + + A I+ M YL + IHRDL N L
Sbjct: 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLV 137
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALI 343
++ +KVADFG+S+L+T T + ++ APE ++ K DV++F ++
Sbjct: 138 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 194
Query: 344 LQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
L E+ G P+ ++V K Y R P P K+Y EL+ CW P+
Sbjct: 195 LWEIATYGMSPYPGIDLSQVYELLEKGY--RMERPEGCPPKVY-----ELMRACWQWNPS 247
Query: 399 KRPTFRQIITRLESI 413
RP+F +I E++
Sbjct: 248 DRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 71/245 (28%), Positives = 122/245 (49%), Gaps = 23/245 (9%)
Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G ++AVK++ + S + + V A E+ LL+ ++H +VQ+ G + + I EY+
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
P G ++ LK GAL + ++ I G+ YLH N I+HRD++ +NILRD +GN+
Sbjct: 87 PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNV 143
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQ 345
K+ DFG SK L + + T + +++PEV E Y K DV+S +
Sbjct: 144 KLGDFGASKRL-----QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVV 198
Query: 346 EMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
EM+ PP+ + E A A Q + P+ + + + + + E KRP+
Sbjct: 199 EMLTEKPPWA---EFEAMAAIFKIATQPTNPQLPSHV-SPDARNFLRRTFVENAKKRPSA 254
Query: 404 RQIIT 408
+++
Sbjct: 255 EELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 16/266 (6%)
Query: 153 HELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
EL N + KG +++ + ++VAVK L +E I+ + F E +++ ++ HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
V+ +G V + P+M+V E P G L +LK++ + S A +A GM YL V
Sbjct: 59 VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEE 330
HRDL N+L + K++DFG+S+ L D R T ++ APE +
Sbjct: 118 ---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 331 YDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKE 387
+ +K DV+S+ + L E G P+ EV + +R P + P ++Y+
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYS----- 229
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
++ CW +P RPTF ++ +
Sbjct: 230 IMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-34
Identities = 85/263 (32%), Positives = 138/263 (52%), Gaps = 32/263 (12%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA- 218
I KG F +L +RG +VAVK I +D +AF E +++ ++RH N+VQ LG
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
V + + IVTEY+ KG L +L+ +G L ++F+LD+ M YL N +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDT 333
RDL N+L + KV+DFG++K + + QDT ++ APE + +++ T
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKFST 178
Query: 334 KVDVFSFALILQEMIE-GCPPFTMKHDNEV-PKAYAA-RQRPPFKAPAKLYARGLKELIE 390
K DV+SF ++L E+ G P+ +V P+ + P P +Y ++++
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY-----DVMK 233
Query: 391 ECWNEKPAKRPTFRQIITRLESI 413
+CW+ A RP+F Q+ +LE I
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 50/270 (18%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIV 228
G QVAVK L E+ SD F E+ +L+ + H N+V++ G + + ++
Sbjct: 33 GEQVAVKSLNHSGEEQHRSD------FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86
Query: 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
EYLP G LR +L+R + + + F+ I +GM+YL + IHRDL NIL +
Sbjct: 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVE 143
Query: 288 DSGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
+K++DFG++K+L VKE ++ + APE + ++ + DV+SF
Sbjct: 144 SEDLVKISDFGLAKVLPEDKDYYYVKEPG-----ESPIFWYAPECLRTSKFSSASDVWSF 198
Query: 341 ALILQEMIEGC-----PP--FTMKHDNEVPKAYAAR--------QR--PPFKAPAKLYAR 383
+ L E+ PP F + R +R P P ++Y
Sbjct: 199 GVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY-- 256
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
+L++ CW +P RP+F +I ++ +
Sbjct: 257 ---DLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 75/240 (31%), Positives = 115/240 (47%), Gaps = 12/240 (5%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G A+KK+ V D++ + EL L+ P VV+ GA + + IV EY+
Sbjct: 24 PTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
G L LK+ G + A I +G++YLH + IIHRD++PSN+L + G +
Sbjct: 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEV 139
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
K+ADFG+SK+L D+ T T Y++PE + E Y D++S L L E G
Sbjct: 140 KIADFGISKVLENTLDQCNTFVGT-VTYMSPERIQGESYSYAADIWSLGLTLLECALGKF 198
Query: 353 PFTMKHDNEVPK----AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
PF P A PP PA+ ++ ++ I C + P KRP+ +++
Sbjct: 199 PFL---PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 76/248 (30%), Positives = 116/248 (46%), Gaps = 25/248 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+VAVK + D R F E +L++ HPN+V+ +G Q P+ IV E +P
Sbjct: 19 NTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76
Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G L FL++K L ++ +LD A GM YL E+K IHRDL N L ++ LK
Sbjct: 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL-ESKNC--IHRDLAARNCLVGENNVLK 133
Query: 294 VADFGVSKLLTVKEDRPLTCQD----TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
++DFG+S+ +E T D ++ APE Y ++ DV+S+ ++L E
Sbjct: 134 ISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190
Query: 350 G--CPPFTMKHD---NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
P M + + Y R P P ++Y L+ +CW P RP+F
Sbjct: 191 LGDTPYPGMSNQQTRERIESGY--RMPAPQLCPEEIY-----RLMLQCWAYDPENRPSFS 243
Query: 405 QIITRLES 412
+I L+
Sbjct: 244 EIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 76/251 (30%), Positives = 116/251 (46%), Gaps = 26/251 (10%)
Query: 173 WRGI-----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
W G+ VAVK L + D F E +++K+RHP ++Q T P+ I
Sbjct: 23 WEGLWNNTTPVAVKTLKPGTMDPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78
Query: 228 VTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
VTE + G L +L+ ALK + A +A GM YL IHRDL N+L
Sbjct: 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVL 135
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
++ KVADFG+++++ ++ APE + K DV+SF ++L
Sbjct: 136 VGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLT 195
Query: 346 EMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
E++ G P+ + EV + Y R P P +LY +++ +CW E P R
Sbjct: 196 EIVTYGRMPYPGMTNAEVLQQVDQGY--RMPCPPGCPKELY-----DIMLDCWKEDPDDR 248
Query: 401 PTFRQIITRLE 411
PTF + +LE
Sbjct: 249 PTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 14/233 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K++ +S +R A +E+ +L + HPN++ + A + + IV EY P GDL
Sbjct: 29 ALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLS 87
Query: 239 AFLKRKGALK---PSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
+ ++ + P + R + + RG+ LHE K I+HRDL+ +NIL + +K+
Sbjct: 88 KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKI 144
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
D G+SK+L Q + Y+APEV+K Y K D++S +L EM PPF
Sbjct: 145 GDLGISKVLK---KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
+ ++ + PP +Y++ L+ I KP RP +I+
Sbjct: 202 EARSMQDLRYKVQRGKYPPIPP---IYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 67/186 (36%), Positives = 102/186 (54%), Gaps = 16/186 (8%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
G VA+KK+ EE I A R E++LL++++HPN+V+ L + + +V E
Sbjct: 24 GEIVALKKIRLDNEEEGIP----STALR-EISLLKELKHPNIVKLLDVIHTERKLYLVFE 78
Query: 231 YLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
Y DL+ +L KR G L P+ + RG+ Y H ++ I+HRDL+P NIL +
Sbjct: 79 YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRD 134
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMI 348
G LK+ADFG+++ + R T + + Y APE+ ++ Y T VD++S I EMI
Sbjct: 135 GVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI 193
Query: 349 EGCPPF 354
G P F
Sbjct: 194 TGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 18/234 (7%)
Query: 179 AVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
AVK E I D+D ++ DE+ +L+ ++HPN+V++ G + I EY G
Sbjct: 29 AVK---EIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L L+ L + L + G+ YLH + I+HRD++P+NI D +G +K+ D
Sbjct: 86 LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGD 142
Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTK---VDVFSFALILQEMIEG 350
FG + L + + Y+APEV + D++S ++ EM G
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202
Query: 351 CPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
P++ + DNE + A +PP +L G K+ ++ C P KRPT
Sbjct: 203 KRPWS-ELDNEFQIMFHVGAGHKPPIPDSLQLSPEG-KDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-33
Identities = 72/259 (27%), Positives = 131/259 (50%), Gaps = 21/259 (8%)
Query: 156 DFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRH 209
++ I +G F ++G+ VA+K++ E I ++ +++ E+ LL+ ++H
Sbjct: 1 NYQLGDLIGRGAFG-VVYKGLNLETGDFVAIKQISLEKIKEEA-LKSIMQEIDLLKNLKH 58
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+V+++G++ S + I+ EY G LR +K+ G S + + +G+ YLHE
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
+IHRD++ +NIL G +K+ADFGV+ L + T ++APEV +
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTP-YWMAPEVIEMS 174
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYA--ARQRPPFKAPAKLYARGLK 386
T D++S + E++ G PP+ +D N + + PP P + LK
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPY---YDLNPMAALFRIVQDDHPPL--PEGISPE-LK 228
Query: 387 ELIEECWNEKPAKRPTFRQ 405
+ + +C+ + P RPT +Q
Sbjct: 229 DFLMQCFQKDPNLRPTAKQ 247
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 84/261 (32%), Positives = 133/261 (50%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ G L R I VA+K L + + + R F E +++ + HPN++ G VT+
Sbjct: 19 EVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MIVTEY+ G L AFL++ G V IA GM YL + + +HRDL
Sbjct: 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 133
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
NIL + + KV+DFG+S++L ED P T R+ APE ++ +
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEEC 392
DV+S+ +++ E++ G P+ + +V KA R P PA L+ +L+ +C
Sbjct: 191 DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH-----QLMLDC 245
Query: 393 WNEKPAKRPTFRQIITRLESI 413
W + +RP F QI++ L+ +
Sbjct: 246 WQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 42/270 (15%)
Query: 157 FTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
FT I KG+F + + I VA+K + E +D + + E+ L + R P
Sbjct: 3 FTLLECIGKGSFGEVY-KAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSP 59
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+ ++ G+ + S + I+ EY G LK G L + ++ G+ YLHE
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEG 118
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---------YV 321
IHRD++ +NIL + G++K+ADFGVS LT T + ++
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLT----------STMSKRNTFVGTPFWM 165
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT----MKHDNEVPKAYAARQRPPFKAP 377
APEV K YD K D++S + E+ +G PP + M+ +PK P
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------NNPPSLE 219
Query: 378 AKLYARGLKELIEECWNEKPAKRPTFRQII 407
+++ K+ + C N+ P +RP+ ++++
Sbjct: 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 69/225 (30%), Positives = 119/225 (52%), Gaps = 14/225 (6%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS 250
++ V A R E+ L+ ++ HP++++ LGA + S + E++ G + L + GA K +
Sbjct: 44 EEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA 103
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKEDR 309
+ + + RG++YLHEN+ IIHRD++ +N+L D +G L++ADFG + L K
Sbjct: 104 VIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160
Query: 310 PLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVP-- 363
Q + ++APEV + E+Y DV+S ++ EM PP+ KH N +
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220
Query: 364 -KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
K +A P P L + GL+++ C +P RP R+++
Sbjct: 221 FKIASATTAPSI--PEHL-SPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 65/256 (25%), Positives = 124/256 (48%), Gaps = 15/256 (5%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
++ +G ++ I VAVK + F E ++++ HP++V+ +G +T+
Sbjct: 21 DVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78
Query: 222 SSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ P+ IV E P G+LR++L K +L ++ + ++ ++ + YL + V HRD+
Sbjct: 79 N-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV---HRDIA 134
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
N+L +K+ DFG+S+ L + + +++APE + + DV+ F
Sbjct: 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 194
Query: 341 ALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKP 397
+ + E ++ G PF +N+V +R P P LY+ L+ +CW P
Sbjct: 195 GVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-----LMTKCWAYDP 249
Query: 398 AKRPTFRQIITRLESI 413
+KRP F ++ +L I
Sbjct: 250 SKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 6e-32
Identities = 86/264 (32%), Positives = 132/264 (50%), Gaps = 30/264 (11%)
Query: 159 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
N E+ KGT VAVK E+ + + +++ F E +L++ HPN+V+ +G
Sbjct: 7 NFGEVFKGTL----KDKTPVAVKTCKED-LPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 219 VTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
TQ P+ IV E +P GD +FL K+K LK V+FALD A GM YL IHR
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC----QDTSCRYVAPEVFKNEEYDT 333
DL N L ++ LK++DFG+S+ +ED + + ++ APE Y +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 334 KVDVFSFALILQEMIE--GCPPFTMKHDN---EVPKAYAARQRPPFKAPAKLYARGLKEL 388
+ DV+S+ ++L E CP M + +V K Y R P K P +Y ++
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--RMSCPQKCPDDVY-----KV 226
Query: 389 IEECWNEKPAKRPTFRQIITRLES 412
++ CW+ KP RP F ++ L +
Sbjct: 227 MQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 77/271 (28%), Positives = 124/271 (45%), Gaps = 55/271 (20%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VAVK L ++ D + E+ +++ I +H N++ LG TQ P+ +V EY
Sbjct: 43 STVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAH 100
Query: 235 GDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
G+LR FL+ + L V FA +ARGM +L K IHRD
Sbjct: 101 GNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRD 157
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TSCR----YVAPEVFKNE 329
L N+L + +K+ADFG++ R + D T+ R ++APE +
Sbjct: 158 LAARNVLVTEDHVMKIADFGLA--------RDIHHIDYYRKTTNGRLPVKWMAPEALFDR 209
Query: 330 EYDTKVDVFSFALILQEMIE--GCPPFTMKHDNEVPKAYA-----ARQRPPFKAPAKLYA 382
Y + DV+SF ++L E+ G P + V + + R P +LY
Sbjct: 210 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VEELFKLLKEGYRMEKPQNCTQELYH 265
Query: 383 RGLKELIEECWNEKPAKRPTFRQIITRLESI 413
L+ +CW+E P++RPTF+Q++ L+ +
Sbjct: 266 -----LMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 73/236 (30%), Positives = 116/236 (49%), Gaps = 18/236 (7%)
Query: 179 AVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
AVK L ++ + + V+ E+ALL K++HPN+VQ+LG + + I E +P G
Sbjct: 29 AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L LK+ G+ + I G+ YLH+ +HRD++ +NIL D +G +K+AD
Sbjct: 89 LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLAD 145
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFT 355
FG++K V E S ++APEV + Y D++S + EM G PP+
Sbjct: 146 FGMAK--QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW- 202
Query: 356 MKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
E V K +++ PP P L K+ I +C P+ RPT +++
Sbjct: 203 --SQLEGVAAVFKIGRSKELPPI--PDHLSDEA-KDFILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 87/261 (33%), Positives = 134/261 (51%), Gaps = 22/261 (8%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSS 223
GT I + + I AVK L I+D + V F E +++ HPNV+ LG ++ S
Sbjct: 14 GTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71
Query: 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEP 281
P+ +V Y+ GDLR F+ R P+ + F L +A+GM YL K +HRDL
Sbjct: 72 PL-VVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAA 126
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
N + D+S +KVADFG+++ + KE T +++A E + +++ TK DV+
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVW 186
Query: 339 SFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395
SF ++L E M G PP+ D V R P P LY E++ CW+
Sbjct: 187 SFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLY-----EVMLSCWHP 241
Query: 396 KPAKRPTFRQIITRLESINNS 416
KP RPTF ++++R+E I ++
Sbjct: 242 KPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 68/239 (28%), Positives = 108/239 (45%), Gaps = 18/239 (7%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + + + ++V E +L + + P VV+ + + +V EYLP GDL
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ L+ G+L A + +I + YLH N IIHRDL+P NIL D +G+LK+ DF
Sbjct: 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDF 137
Query: 298 GVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
G+SK+ V+ L + + Y+APEV + + VD +S IL E + G
Sbjct: 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
Query: 351 CPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
PPF H + + + + +LI + P KR + I
Sbjct: 198 IPPF---HGETPEEIFQNILNGKIEWPEDVEVSDE--AIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-31
Identities = 71/193 (36%), Positives = 106/193 (54%), Gaps = 18/193 (9%)
Query: 175 GIQVAVKK--LGEEVISDDDRVRAFRD----ELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
G +AVK+ L S DR R+ D E+ALL++++H N+VQ+LG+ + + I
Sbjct: 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
EY+P G + A L GA + + F I +G+NYLH IIHRD++ +NIL D+
Sbjct: 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDN 141
Query: 289 SGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
G +K++DFG+SK L RP + Q S ++APEV K Y K D++S
Sbjct: 142 KGGIKISDFGISKKLEANSLSTKTNGARP-SLQG-SVFWMAPEVVKQTSYTRKADIWSLG 199
Query: 342 LILQEMIEGCPPF 354
++ EM+ G PF
Sbjct: 200 CLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 65/239 (27%), Positives = 119/239 (49%), Gaps = 18/239 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+KK + +E+ +++ +HPN+V + + + +V EY+
Sbjct: 44 GKEVAIKK----MRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99
Query: 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G L + + + ++ +G+ YLH +IHRD++ NIL G++K
Sbjct: 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVK 156
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
+ADFG + LT ++ + + T ++APEV K ++Y KVD++S ++ EM EG PP
Sbjct: 157 LADFGFAAQLTKEKSKRNSVVGTP-YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
Query: 354 FTMKHDNEVP-KA-YAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
+ E P +A + + PP K P K + K+ + +C + P KRP+ +++
Sbjct: 216 ----YLREPPLRALFLITTKGIPPLKNPEKW-SPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 81/245 (33%), Positives = 127/245 (51%), Gaps = 28/245 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K L + +S + AF E L+++++HP +V+ VTQ P+ I+TEY+ G
Sbjct: 32 KVAIKSLKQGSMSPE----AFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGS 86
Query: 237 LRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L FLK L + + A IA GM ++ IHRDL +NIL ++ K+
Sbjct: 87 LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKI 143
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
ADFG+++L+ ED T ++ + ++ APE + K DV+SF ++L E++ G
Sbjct: 144 ADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYG 200
Query: 351 CPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
P+ + EV + Y R P P +LY EL+ CW EKP +RPTF +
Sbjct: 201 RIPYPGMTNPEVIQNLERGY--RMPRPDNCPEELY-----ELMRLCWKEKPEERPTFEYL 253
Query: 407 ITRLE 411
+ LE
Sbjct: 254 RSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 77/243 (31%), Positives = 128/243 (52%), Gaps = 23/243 (9%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VAVK L +S V+AF +E L++ ++H +V+ VT+ P+ I+TEY+ KG
Sbjct: 32 KVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87
Query: 237 LRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L FLK G + + F+ IA GM Y+ IHRDL +N+L +S K+
Sbjct: 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKI 144
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
ADFG+++++ ED T ++ + ++ APE + K DV+SF ++L E++ G
Sbjct: 145 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYG 201
Query: 351 CPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
P+ +++V A R P P +LY ++++ CW EK +RPTF + +
Sbjct: 202 KIPYPGMSNSDVMSALQRGYRMPRMENCPDELY-----DIMKTCWKEKAEERPTFDYLQS 256
Query: 409 RLE 411
L+
Sbjct: 257 VLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 79/263 (30%), Positives = 114/263 (43%), Gaps = 45/263 (17%)
Query: 177 QVAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VAVK L + D R F E+ +L ++ PN+ + LG T P+ ++ EY+ G
Sbjct: 48 LVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 236 DLRAFLKR-----------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
DL FL++ +L ST + A IA GM YL V HRDL N
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV---HRDLATRNC 161
Query: 285 LRDDSGNLKVADFGVSKLLTVK-----EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
L + +K+ADFG+S+ L + R R++A E ++ TK DV++
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAP----LPIRWMAWESVLLGKFTTKSDVWA 217
Query: 340 FALILQEMIEGC--PPFTMKHDNEV----------PKAYAARQRPPFKAPAKLYARGLKE 387
F + L E++ C P+ D +V RPP P +Y E
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPP-NCPKDIY-----E 271
Query: 388 LIEECWNEKPAKRPTFRQIITRL 410
L+ ECW RPTFR+I L
Sbjct: 272 LMLECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 71/246 (28%), Positives = 127/246 (51%), Gaps = 16/246 (6%)
Query: 163 ITKGTFILAFWRGIQVAVKK-LGEEVI---SDDDRVRAFRDELALLQKIRH---PNVVQF 215
I +G + A +RG V + + ++I + DD V + E+ALL ++R PN+ ++
Sbjct: 9 IGRGAY-GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
G+ + + I+ EY G +R L + G + ++ + Y+H+ V +I
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHK---VGVI 123
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTK 334
HRD++ +NIL ++GN+K+ DFGV+ LL + T T ++APEV + YDTK
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP-YWMAPEVITEGKYYDTK 182
Query: 335 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394
D++S + + EM G PP++ D + +PP + Y++ L+E + C +
Sbjct: 183 ADIWSLGITIYEMATGNPPYS-DVDAFRAMMLIPKSKPP-RLEDNGYSKLLREFVAACLD 240
Query: 395 EKPAKR 400
E+P +R
Sbjct: 241 EEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 82/263 (31%), Positives = 130/263 (49%), Gaps = 24/263 (9%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L R I VA+K L + + + R F E +++ + HPN++ G VT+
Sbjct: 19 EVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MI+TE++ G L +FL++ G V IA GM YL E + +HRDL
Sbjct: 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLA 133
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-------RYVAPEVFKNEEYDT 333
NIL + + KV+DFG+S+ L ED TS R+ APE ++ +
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS 190
Query: 334 KVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIE 390
DV+S+ +++ E M G P+ + +V A R PP P L+ +L+
Sbjct: 191 ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALH-----QLML 245
Query: 391 ECWNEKPAKRPTFRQIITRLESI 413
+CW + RP F QI++ L+ +
Sbjct: 246 DCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 85/291 (29%), Positives = 141/291 (48%), Gaps = 31/291 (10%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALL 204
DP EL FT I KG+F F +GI VA+K + E +D + + E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVF-KGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVL 56
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
+ P V ++ G+ + + + I+ EYL G L R G +I +G++
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLD 115
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH K IHRD++ +N+L + G++K+ADFGV+ LT + + T T ++APE
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL--YA 382
V + YD+K D++S + E+ +G PP + H V P P ++
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFLIPKNNPPTLTGEFS 226
Query: 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNS---------INHKRRWK 424
+ KE I+ C N+ P+ RPT ++++ + N+ I+ +RWK
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFKRWK 277
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 8e-30
Identities = 77/256 (30%), Positives = 127/256 (49%), Gaps = 31/256 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K L + I++ + F+ E +L+ ++ HPN+V LG VTQ P+ ++ EYL +GDL
Sbjct: 37 VAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 238 RAFL-----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
FL K +L + A+ IA GM YL + +H+DL
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLA 151
Query: 281 PSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
NIL + ++K++D G+S+ + + R R++ PE ++ + D++S
Sbjct: 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 340 FALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK--APAKLYARGLKELIEECWNEK 396
F ++L E+ G P+ + EV + RQ P P ++Y+ L+ ECW E
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYS-----LMTECWQEG 266
Query: 397 PAKRPTFRQIITRLES 412
P++RP F+ I TRL S
Sbjct: 267 PSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 77/253 (30%), Positives = 110/253 (43%), Gaps = 39/253 (15%)
Query: 176 IQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
I VAVK L + +SD DD F E A++ + H N+++ G V P+M+VTE P
Sbjct: 24 IPVAVKCLKSDKLSDIMDD----FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78
Query: 234 KGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
G L L+ G ST +A+ IA GM YL + IHRDL NIL
Sbjct: 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDK 135
Query: 292 LKVADFGVSKLLTVKEDR---------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+K+ DFG+ + L ED P + APE + + DV+ F +
Sbjct: 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFA-------WCAPESLRTRTFSHASDVWMFGV 188
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAYAAR----QRPPFKAPAKLYARGLKELIEECWNEKP 397
L EM G P+ +++ K +RP P +Y ++ +CW P
Sbjct: 189 TLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA-CPQDIY-----NVMLQCWAHNP 242
Query: 398 AKRPTFRQIITRL 410
A RPTF + L
Sbjct: 243 ADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 75/250 (30%), Positives = 120/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+QVAVK L E S+ D F E ++ K H N+V+ +G + P I+ E + G
Sbjct: 37 LQVAVKTL-PESCSEQDESD-FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGG 94
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
DL++FL+ R +PS+ + A D+A+G YL EN IHRD+ N L
Sbjct: 95 DLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTC 151
Query: 289 SGN---LKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
G K+ADFG+++ + R +++ PE F + + +K DV+SF ++L
Sbjct: 152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
E+ G P+ + + EV + R PP P +Y ++ +CW P RP
Sbjct: 212 WEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVY-----RIMTDCWQHTPEDRP 266
Query: 402 TFRQIITRLE 411
F I+ R++
Sbjct: 267 NFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 85/287 (29%), Positives = 144/287 (50%), Gaps = 23/287 (8%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
DP EL FT +I KG+F F +GI +K+ I D +D + + E+ +L +
Sbjct: 1 DPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
P V ++ G+ + + + I+ EYL G L+ G L + +I +G++YL
Sbjct: 59 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYL 117
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
H K IHRD++ +N+L + G +K+ADFGV+ LT + + T T ++APEV
Sbjct: 118 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386
K YD+K D++S + E+ +G PP + H +V P + Y++ LK
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGN---YSKPLK 230
Query: 387 ELIEECWNEKPAKRPTFRQIITRLESINNS---------INHKRRWK 424
E +E C N++P+ RPT ++++ + + I+ +RWK
Sbjct: 231 EFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELIDRYKRWK 277
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 78/247 (31%), Positives = 122/247 (49%), Gaps = 23/247 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
V VK L + D++ FR EL + +K+ H NVV+ LG ++ P ++ EY GDL
Sbjct: 38 VLVKALQK--TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95
Query: 238 RAFL----KRKGALKP---STAVRFAL--DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
+ FL + LKP ST + AL IA GM++L + +HRDL N L
Sbjct: 96 KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSS 152
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+KV+ +SK + E L R++APE + +++ TK DV+SF +++ E+
Sbjct: 153 QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212
Query: 349 -EGCPPFTMKHDNEV---PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
+G PF D EV +A P P++LY +L+ CW P RP+F
Sbjct: 213 TQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY-----KLMTRCWAVNPKDRPSFS 267
Query: 405 QIITRLE 411
++++ L
Sbjct: 268 ELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G + + + VA+K L + ++ R F E +++ + H N+++ G VT+
Sbjct: 20 EVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQD-FLSEASIMGQFSHHNIIRLEGVVTK 77
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
P MI+TEY+ G L +L+ G V IA GM YL + + +HRDL
Sbjct: 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLA 134
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
NIL + + KV+DFG+S++L ED P TS R+ APE ++ +
Sbjct: 135 ARNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS 191
Query: 336 DVFSFALILQE-MIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
DV+SF +++ E M G P+ ++EV KA R P P+ +Y +L+ +C
Sbjct: 192 DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY-----QLMLQC 246
Query: 393 WNEKPAKRPTFRQIITRLESI 413
W + A+RP F I+ L+ +
Sbjct: 247 WQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 27/276 (9%)
Query: 156 DFTNSVEITKGTFILAF--WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NV 212
+ ++ +G+F + VA+K L +++ S V F E+ +L + HP N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFALDIARGMNYLHEN 269
V+ + +V EY+ G L LK RKG L S A+ I + YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 270 KPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLT-----VKEDRPLTCQDTSCRYVAP 323
IIHRD++P NIL D G +K+ DFG++KLL + + Y+AP
Sbjct: 121 G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 324 EVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA---------YAARQR 371
EV + D++S + L E++ G PPF + ++ +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
P + +L ++ +L+++ + P R + +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 14/218 (6%)
Query: 199 DELALLQKIRHPNVVQFLG--AVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTA 252
E+ +L++++HPN+V++ + + IV EY GDL +++ + ++
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107
Query: 253 VRFALDIARGMNYLH---ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
R + + H + ++HRDL+P+NI D + N+K+ DFG++K+L
Sbjct: 108 WRILTQLLLALYECHNRSDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
T T Y++PE + YD K D++S ++ E+ PPFT ++ ++
Sbjct: 167 AKTYVGTP-YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG 225
Query: 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
+ Y+ L E+I+ N P KRP+ +++
Sbjct: 226 KFRRIPY---RYSSELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 76/255 (29%), Positives = 122/255 (47%), Gaps = 25/255 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIV 228
+VAVK L ++ S D + F E A +++ HPNV++ +G +S M++
Sbjct: 27 FQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 229 TEYLPKGDLRAFL--KRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
++ GDL FL R G L T VRF +DIA GM YL IHRDL
Sbjct: 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAAR 142
Query: 283 NILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N + +++ + VADFG+S K+ + R +++A E + Y T DV++F
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG 202
Query: 342 LILQE-MIEGCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPA 398
+ + E M G P+ ++E+ R + P +Y EL+ +CW+ +P
Sbjct: 203 VTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVY-----ELMCQCWSPEPK 257
Query: 399 KRPTFRQIITRLESI 413
RP+F+ + +LE I
Sbjct: 258 CRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-29
Identities = 81/286 (28%), Positives = 132/286 (46%), Gaps = 48/286 (16%)
Query: 162 EITKGT-FILAFWRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
++ K T F L G VAVK L E + +R E LL+++ HP+V++ GA
Sbjct: 15 KVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVNHPHVIKLYGAC 72
Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPS------------------------TAVRF 255
+Q P++++ EY G LR+FL+ + PS + F
Sbjct: 73 SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
A I+RGM YL E K ++HRDL N+L + +K++DFG+S+ + ++ +
Sbjct: 133 AWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKG 189
Query: 316 -TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-------GCPPFTMKHDNEVPKAYA 367
+++A E + Y T+ DV+SF ++L E++ G P + N + Y
Sbjct: 190 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF--NLLKTGY- 246
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
R P ++Y L+ CW ++P KRPTF I LE +
Sbjct: 247 -RMERPENCSEEMYN-----LMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-29
Identities = 85/287 (29%), Positives = 141/287 (49%), Gaps = 23/287 (8%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
DP EL FT I KG+F ++GI K++ I D +D + + E+ +L +
Sbjct: 1 DPEEL-FTKLERIGKGSF-GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
P + ++ G+ + + + I+ EYL G LK G L+ + +I +G++YL
Sbjct: 59 CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYL 117
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
H + IHRD++ +N+L + G++K+ADFGV+ LT + + T T ++APEV
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386
K YD K D++S + E+ +G PP + H V P + Y++ K
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ---YSKPFK 230
Query: 387 ELIEECWNEKPAKRPTFRQI-----ITRLES----INNSINHKRRWK 424
E +E C N+ P RPT +++ ITR + I+ +RWK
Sbjct: 231 EFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWK 277
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 88/257 (34%), Positives = 132/257 (51%), Gaps = 29/257 (11%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
G + W G +VAVK L +S + +F +E +++K+RH +VQ L AV P
Sbjct: 20 GEVWMGTWNGNTKVAVKTLKPGTMSPE----SFLEEAQIMKKLRHDKLVQ-LYAVVSEEP 74
Query: 225 MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ IVTEY+ KG L FLK ALK V A +A GM Y+ + IHRDL +
Sbjct: 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSA 131
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
NIL D K+ADFG+++L+ ED T + + ++ APE + K DV+S
Sbjct: 132 NILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 340 FALILQEMI-EGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394
F ++L E++ +G P+ ++ E V + Y R P P L+ EL+ +CW
Sbjct: 189 FGILLTELVTKGRVPYPGMNNREVLEQVERGY--RMPCPQDCPISLH-----ELMLQCWK 241
Query: 395 EKPAKRPTFRQIITRLE 411
+ P +RPTF + + LE
Sbjct: 242 KDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 82/254 (32%), Positives = 125/254 (49%), Gaps = 35/254 (13%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A K+ +E S++D R F EL +L K+ HPN++ LGA + I EY P G+L
Sbjct: 32 AAIKMLKEFASENDH-RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNL 90
Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL++ L+ A ++FA D+A GM YL E + IHRDL
Sbjct: 91 LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAA 147
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N+L ++ K+ADFG+S+ V + T R++A E Y TK DV+SF
Sbjct: 148 RNVLVGENLASKIADFGLSRGEEVYVKK--TMGRLPVRWMAIESLNYSVYTTKSDVWSFG 205
Query: 342 LILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396
++L E++ G P M + ++P+ Y R P ++Y EL+ +CW ++
Sbjct: 206 VLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RMEKPRNCDDEVY-----ELMRQCWRDR 258
Query: 397 PAKRPTFRQIITRL 410
P +RP F QI +L
Sbjct: 259 PYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 62/190 (32%), Positives = 102/190 (53%), Gaps = 7/190 (3%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
G VA+KK+ + +A R E+ LQ +HP VV+ L S ++V EY+P
Sbjct: 24 TGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP 82
Query: 234 KGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL L+ + L + + + +G+ Y+H N I+HRDL+P+N+L G L
Sbjct: 83 -SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVL 138
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGC 351
K+ADFG+++L + +E R + Q + Y APE+ + +YD VD+++ I E++ G
Sbjct: 139 KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
Query: 352 PPFTMKHDNE 361
P F ++D E
Sbjct: 199 PLFPGENDIE 208
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 8e-28
Identities = 82/257 (31%), Positives = 128/257 (49%), Gaps = 36/257 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ A+K++ E DD R F EL +L K+ HPN++ LGA + + EY P
Sbjct: 35 MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92
Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
G+L FL++ L+ P+ A+ FA D+ARGM+YL + + IHRD
Sbjct: 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 149
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L NIL ++ K+ADFG+S+ V + T R++A E Y T DV+
Sbjct: 150 LAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVW 207
Query: 339 SFALILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
S+ ++L E++ G P M + ++P+ Y R P ++Y +L+ +CW
Sbjct: 208 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVY-----DLMRQCW 260
Query: 394 NEKPAKRPTFRQIITRL 410
EKP +RP+F QI+ L
Sbjct: 261 REKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-28
Identities = 67/240 (27%), Positives = 117/240 (48%), Gaps = 16/240 (6%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L EE + + DE ++ + HP+VV+ LG + SS + ++T+ +P G
Sbjct: 37 IPVAIKVLREE--TSPKANKEILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++ K + + + + IA+GM+YL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKI 150
Query: 295 ADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCP 352
DFG++KLL V E +++A E + Y K DV+S+ + + E M G
Sbjct: 151 TDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
Query: 353 PFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
P+ E+P +R P +Y ++ +CW RPTF+++I
Sbjct: 211 PYEGIPAVEIPDLLEKGERLPQPPICTIDVYM-----VLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 87/261 (33%), Positives = 133/261 (50%), Gaps = 34/261 (13%)
Query: 162 EITKGTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
E+ GT W G +VA+K L +S + AF E +++K+RH +VQ L AV
Sbjct: 21 EVWMGT-----WNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-LYAVV 70
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
P+ IVTEY+ KG L FLK + L+ V A IA GM Y+ + +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKV 335
L +NIL ++ KVADFG+++L+ ED T + + ++ APE + K
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 336 DVFSFALILQEM-IEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIE 390
DV+SF ++L E+ +G P+ + E V + Y R P + P L+ +L+
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCPPECPESLH-----DLMC 237
Query: 391 ECWNEKPAKRPTFRQIITRLE 411
+CW ++P +RPTF + LE
Sbjct: 238 QCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 6/192 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + ++ + VR +E +LQ++ HP +V + M +V + L GDLR
Sbjct: 29 AMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR 88
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L +K + +I + YLH IIHRD++P NIL D+ G++ + DF
Sbjct: 89 YHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFN 145
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
++ +T D T + Y+APEV + Y VD +S + E + G P+ H
Sbjct: 146 IATKVT--PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR-GH 202
Query: 359 DNEVPKAYAARQ 370
+ A+Q
Sbjct: 203 SRTIRDQIRAKQ 214
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 79/267 (29%), Positives = 129/267 (48%), Gaps = 50/267 (18%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---PMMIVTEYLPK 234
VAVKKL S + +R F E+ +L+ ++H N+V++ G V S+ + +V EYLP
Sbjct: 36 VAVKKLQH---STAEHLRDFEREIEILKSLQHDNIVKYKG-VCYSAGRRNLRLVMEYLPY 91
Query: 235 GDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G LR +L K + L + +A I +GM YL + +HRDL NIL + +K
Sbjct: 92 GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVK 148
Query: 294 VADFGVSKLL-------TVKE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ DFG++K+L V+E + P+ + APE ++ DV+SF ++L
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIF-------WYAPESLTESKFSVASDVWSFGVVL 201
Query: 345 QEMIEGC-----PP--FTMKHDNEVPKAYAA-----------RQRPPFKAPAKLYARGLK 386
E+ PP F N+ R P PA++YA
Sbjct: 202 YELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYA---- 257
Query: 387 ELIEECWNEKPAKRPTFRQIITRLESI 413
+++ECWN P++RP+F ++ ++E+I
Sbjct: 258 -IMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 20/223 (8%)
Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
EL + + + P +V++ GA SS + I EY G L + K+ +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 258 DIA----RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
IA +G++YLH K IIHRD++PSNIL G +K+ DFGVS L T
Sbjct: 109 KIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK----AYAAR 369
TS Y+APE + + Y DV+S L L E+ + PF + + + +Y
Sbjct: 165 -GTS-FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222
Query: 370 QRPP-FKAPAKL---YARGLKELIEECWNEKPAKRPTFRQIIT 408
P K ++ K+ I++C + P +RPT ++
Sbjct: 223 MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 82/254 (32%), Positives = 124/254 (48%), Gaps = 35/254 (13%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A K +E S DD R F EL +L K+ HPN++ LGA + + EY P G+L
Sbjct: 25 AAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 83
Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL++ L+ A + FA D+ARGM+YL + + IHRDL
Sbjct: 84 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAA 140
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
NIL ++ K+ADFG+S+ V + T R++A E Y T DV+S+
Sbjct: 141 RNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYG 198
Query: 342 LILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396
++L E++ G P M + ++P+ Y R P ++Y +L+ +CW EK
Sbjct: 199 VLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVY-----DLMRQCWREK 251
Query: 397 PAKRPTFRQIITRL 410
P +RP+F QI+ L
Sbjct: 252 PYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 74/249 (29%), Positives = 121/249 (48%), Gaps = 26/249 (10%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L + A EL ++ + H N+V LGA T P++++TEY
Sbjct: 66 MKVAVKMLKPT--AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCY 123
Query: 235 GDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL FL+RK L + F+ +A+GM +L IHRDL N+L +
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIV 180
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
K+ DFG+++ + D + + +++APE N Y + DV+S+ ++L E+
Sbjct: 181 KICDFGLAR--DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
Query: 350 --GCP----PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
P P K + + Y R P APA++Y ++++ CW+ P KRPTF
Sbjct: 239 LGSNPYPGMPVDSKFYKLIKEGY--RMAQPEHAPAEIY-----DIMKTCWDADPLKRPTF 291
Query: 404 RQIITRLES 412
+QI+ +
Sbjct: 292 KQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 72/248 (29%), Positives = 115/248 (46%), Gaps = 34/248 (13%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+VA+K++ E V R E+ + + HPNVV++ + + +V YL
Sbjct: 25 NNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82
Query: 234 KGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
G L +K G L + ++ +G+ YLH N IHRD++ NIL + G
Sbjct: 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDG 139
Query: 291 NLKVADFGVSKLLTVKEDRPL----TCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQ 345
++K+ADFGVS L DR T T C ++APEV + YD K D++SF +
Sbjct: 140 SVKIADFGVSASLADGGDRTRKVRKTFVGTPC-WMAPEVMEQVHGYDFKADIWSFGITAI 198
Query: 346 EMIEGCPPF-----------TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394
E+ G P+ T+++D P + A K Y++ +++I C
Sbjct: 199 ELATGAAPYSKYPPMKVLMLTLQND---PPSL------ETGADYKKYSKSFRKMISLCLQ 249
Query: 395 EKPAKRPT 402
+ P+KRPT
Sbjct: 250 KDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-27
Identities = 77/244 (31%), Positives = 118/244 (48%), Gaps = 23/244 (9%)
Query: 178 VAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK E + D ++A F E +L++ HPN+V+ +G TQ P+ IV E + GD
Sbjct: 23 VAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79
Query: 237 LRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
FL+ +G LK ++ + A GM YL E+K IHRDL N L + LK++
Sbjct: 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYL-ESKHC--IHRDLAARNCLVTEKNVLKIS 136
Query: 296 DFGVSKLLTVKEDRPLTC----QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
DFG+S+ +ED + ++ APE Y ++ DV+SF ++L E G
Sbjct: 137 DFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLG 193
Query: 351 CPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
P+ + + +A R P P +Y L+E CW P +RP+F +
Sbjct: 194 AVPYANLSNQQTREAIEQGVRLPCPELCPDAVY-----RLMERCWEYDPGQRPSFSTVHQ 248
Query: 409 RLES 412
L+S
Sbjct: 249 ELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 11/214 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
EL +L K P +V F GA + + I EY+ G L LK +G + + A+
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ +G+ YLHE IIHRD++PSNIL + G +K+ DFGVS L T
Sbjct: 109 VLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKT--FVGT 162
Query: 319 R-YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKHDNEVPKAYAARQRPPF 374
Y+APE + +Y K D++S L L E+ G PP D PP
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP 222
Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
+ P+ ++ ++ + C + P +RP++++++
Sbjct: 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 82/277 (29%), Positives = 135/277 (48%), Gaps = 38/277 (13%)
Query: 153 HELDFTNS---VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+E ++ + V + KGT+ + + +++A+K++ E D V+ +E+AL
Sbjct: 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALH 59
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKP--STAVRFALDIAR 261
++H N+VQ+LG+ +++ I E +P G L A L+ K G LK T + + I
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDT-SCR 319
G+ YLH+N+ I+HRD++ N+L + SG +K++DFG SK L P T T + +
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQ 174
Query: 320 YVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-------RQ 370
Y+APEV Y D++S + EM G PPF E+ + AA +
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI-----ELGEPQAAMFKVGMFKI 229
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
P P L A K I C+ P KR + ++
Sbjct: 230 HPEI--PESLSAEA-KNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 67/231 (29%), Positives = 112/231 (48%), Gaps = 15/231 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+K + V D + E+++L++ P +V++ G+ +++ + IV EY
Sbjct: 28 GQVVAIKVV--PVEEDLQEII---KEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82
Query: 235 GDLRAFLKRKGALKPSTAVRFAL---DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
G + +K K T A +G+ YLH NK IHRD++ NIL ++ G
Sbjct: 83 GSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQ 137
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
K+ADFGVS LT + T T ++APEV + Y+ K D++S + EM EG
Sbjct: 138 AKLADFGVSGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
PP++ H + P P K ++ + +++C + P +RP+
Sbjct: 197 PPYSDIHPMRAIFMIPNKPPPTLSDPEK-WSPEFNDFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 16/225 (7%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
D V+A R E+ L+ + H N+VQ+LG T + I EY+P G + + L+ G +
Sbjct: 50 DMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL 109
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
F + G+ YLH I+HRDL+ N+L D G K++DFG+SK +D
Sbjct: 110 VRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYD 163
Query: 312 TCQDTSCR----YVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPK 364
Q+ S + ++APEV + Y KVD++S ++ EM G P+ + + K
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
Query: 365 AYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
R PP L L + + C+ P RPT R+++
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVAL-DFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 54/184 (29%), Positives = 96/184 (52%), Gaps = 8/184 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK+ S+ A R E+ LL+++ HPN+++ L + +V E++ DL
Sbjct: 27 VAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDL 84
Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
+K + P + ++ + + +G+ + H + I+HRDL+P N+L + G LK+AD
Sbjct: 85 YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLAD 141
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
FG+++ RP T + Y APE+ ++ Y T VD++S I E++ P F
Sbjct: 142 FGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200
Query: 356 MKHD 359
K +
Sbjct: 201 GKSE 204
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 76/263 (28%), Positives = 118/263 (44%), Gaps = 42/263 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L EE + D F+ E AL+ + HPN+V+ LG PM ++ EY+ GDL
Sbjct: 38 VAVKMLKEE--ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95
Query: 238 RAFLKRKGALKPSTAVR----------------------FALDIARGMNYLHENKPVPII 275
FL+ + + A +A GM YL E K +
Sbjct: 96 NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FV 152
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTK 334
HRDL N L ++ +K+ADFG+S+ + + + D R++ PE Y T+
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 335 VDVFSFALILQEMIE-GCPP-FTMKHDNEVPKAYAARQ----RPPFKAPAKLYARGLKEL 388
DV+++ ++L E+ G P + M H+ + Y R P P +LY L
Sbjct: 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVI---YYVRDGNVLSCPDNCPLELYN-----L 264
Query: 389 IEECWNEKPAKRPTFRQIITRLE 411
+ CW++ P+ RP+F I L+
Sbjct: 265 MRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 7/177 (3%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L + I +V +E +LQ IRHP +V G+ S + +V EY+P G+L
Sbjct: 29 YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ L++ G A +A + + YLH I++RDL+P N+L D G +K+ DF
Sbjct: 89 FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDF 145
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G +K + + R T T Y+APE+ ++ Y VD ++ +++ EM+ G PPF
Sbjct: 146 GFAKRV---KGRTYTLCGT-PEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 74/259 (28%), Positives = 115/259 (44%), Gaps = 38/259 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VAVK L E + +D + F E LL +H N+V+F G T+ P ++V EY+ G
Sbjct: 36 ELVAVKTLKE--TASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93
Query: 236 DLRAFLKR--------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
DL FL+ G L S ++ A+ IA GM YL V HRDL
Sbjct: 94 DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV---HRDLAT 150
Query: 282 SNILRDDSGNLKVADFGVSK------LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
N L +K+ DFG+S+ V L R++ PE ++ T+
Sbjct: 151 RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML-----PIRWMPPESIMYRKFTTES 205
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEEC 392
DV+SF ++L E+ G P+ + EV + + + P P+++Y +++ C
Sbjct: 206 DVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVY-----DIMLGC 260
Query: 393 WNEKPAKRPTFRQIITRLE 411
W P +R + I RL+
Sbjct: 261 WKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 5/178 (2%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E +D + A R E+ +L+++RH N+V A + + +V EY+ + L
Sbjct: 29 VAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL 87
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
G L P + + + + Y H + IIHRD++P NIL +SG LK+ DF
Sbjct: 88 ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDF 144
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
G ++ L + PLT + Y APE+ + Y VDV++ I+ E+++G P F
Sbjct: 145 GFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 84/253 (33%), Positives = 125/253 (49%), Gaps = 21/253 (8%)
Query: 166 GTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
G + W G +VA+K L + + AF E +++K+RH +V L AV P
Sbjct: 20 GEVWMGTWNGTTKVAIKTLKPGTMMPE----AFLQEAQIMKKLRHDKLVP-LYAVVSEEP 74
Query: 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ IVTE++ KG L FLK LK V A IA GM Y+ + IHRDL +
Sbjct: 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAA 131
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
NIL D+ K+ADFG+++L+ ED T + + ++ APE + K DV+S
Sbjct: 132 NILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
F ++L E++ +G P+ + EV + R P L EL++ CW + P
Sbjct: 189 FGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC---PESLHELMKLCWKKDPD 245
Query: 399 KRPTFRQIITRLE 411
+RPTF I + LE
Sbjct: 246 ERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 69/272 (25%), Positives = 130/272 (47%), Gaps = 19/272 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRH 209
+F +I KG F + + G VA+KK+ E++ R + E+ LL+++ H
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDH 61
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAV-RFALDIARGMNY 265
PNV+++L + +++ + IV E GDL +K ++ L P + ++ + + + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
+H + I+HRD++P+N+ +G +K+ D G+ + + K + T Y++PE
Sbjct: 122 MHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSPER 177
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYAR 383
Y+ K D++S +L EM PF N + K PP PA Y+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL--PADHYSE 235
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESINN 415
L++L+ C N P KRP ++ + ++
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 70/253 (27%), Positives = 119/253 (47%), Gaps = 15/253 (5%)
Query: 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF +I KG+F + F A+K++ ++ +R A DE +L K+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
++++ + + IV EY GDL LK R L RF + I G+ +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
K I+HRD++ N+ D N+K+ D GV+KLL+ + T T Y++PE+ ++
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTP-YYLSPELCED 175
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388
+ Y+ K DV++ ++L E G PF + + PP Y++ L +L
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM---YSQQLAQL 232
Query: 389 IEECWNEKPAKRP 401
I++C + +RP
Sbjct: 233 IDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-25
Identities = 77/243 (31%), Positives = 127/243 (52%), Gaps = 24/243 (9%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VAVK + +S V AF E +++ ++H +V+ L AV P+ I+TE++ KG
Sbjct: 32 KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 86
Query: 237 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L FLK +G+ +P + F+ IA GM ++ + IHRDL +NIL S K+
Sbjct: 87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 143
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
ADFG+++++ ED T ++ + ++ APE + K DV+SF ++L E++ G
Sbjct: 144 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 200
Query: 351 CPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
P+ + EV +A R P P +LY ++ CW +P +RPTF I +
Sbjct: 201 RIPYPGMSNPEVIRALERGYRMPRPENCPEELY-----NIMMRCWKNRPEERPTFEYIQS 255
Query: 409 RLE 411
L+
Sbjct: 256 VLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 60/185 (32%), Positives = 94/185 (50%), Gaps = 17/185 (9%)
Query: 178 VAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEY 231
VA+KK + ++++ + A R E+ LLQK+RHPN+V+ VT + +V EY
Sbjct: 27 VALKK----IRMENEKEGFPITAIR-EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81
Query: 232 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
+ DL L S + + G+ YLH N I+HRD++ SNIL ++ G
Sbjct: 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDG 137
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIE 349
LK+ADFG+++ T + T + + Y PE+ Y +VD++S IL E+
Sbjct: 138 VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197
Query: 350 GCPPF 354
G P F
Sbjct: 198 GKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 60/170 (35%), Positives = 91/170 (53%), Gaps = 17/170 (10%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALKPST 251
V A E+ LL+ ++H +VQ+ G + + + I EY+P G ++ LK GAL S
Sbjct: 48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
++ I GM+YLH N I+HRD++ +NILRD +GN+K+ DFG SK L + +
Sbjct: 108 TRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTI 159
Query: 312 TCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
T R +++PEV E Y K DV+S + EM+ PP+
Sbjct: 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 69/255 (27%), Positives = 120/255 (47%), Gaps = 30/255 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K L ++ + F+ E + +++HPN+V LG VT+ P+ ++ Y DL
Sbjct: 38 VAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 238 RAFL----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL K L+P+ V IA GM +L + ++H+DL
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSF 340
N+L D N+K++D G+ + + + L R+++PE ++ D++S+
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKP 397
++L E+ G P+ + +V + RQ P PA +Y L+ ECWNE P
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYT-----LMLECWNEFP 267
Query: 398 AKRPTFRQIITRLES 412
++RP F+ I +RL +
Sbjct: 268 SRRPRFKDIHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 70/246 (28%), Positives = 112/246 (45%), Gaps = 21/246 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K++ + ++ + VR E +L + +V+ L A + + EY+P GD
Sbjct: 29 VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
R L G L A + ++ ++ LHE + IHRDL+P N L D SG++K+ DF
Sbjct: 89 RTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDF 145
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
G+SK + + + D Y+APEV + + YD VD +S +L E + G PPF+
Sbjct: 146 GLSKGIVTYANSVVGSPD----YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201
Query: 358 HDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
NE QRP + P + +LI + N+ R S+
Sbjct: 202 TPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPS----------RRFGSL 251
Query: 414 NNSINH 419
+ NH
Sbjct: 252 EDIKNH 257
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 16/220 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL ++ + R P +V F GA + + + E++ G L K+ G + + A+ +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSC 318
G+ YL+ I+HRD++PSNIL + G +K+ DFGVS +L+ D T TS
Sbjct: 113 VEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD---TFVGTST 167
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------- 369
Y++PE + +Y K DV+S + + E+ G PF + ++ +
Sbjct: 168 -YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226
Query: 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
Q PP + P+ + L++ ++ C + P +RPT +Q+
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 27/255 (10%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVT 229
++VAVK + ++ + + + F E A ++ HPNV++ +G ++S + M++
Sbjct: 28 LKVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVIL 86
Query: 230 EYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
++ GDL +FL R G L T ++F +DIA GM YL IHRDL N
Sbjct: 87 PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARN 143
Query: 284 ILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
+ + + VADFG+SK + D R +++A E + Y +K DV++F
Sbjct: 144 CMLREDMTVCVADFGLSKKI-YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 202
Query: 342 LILQE-MIEGCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
+ + E G P+ ++E+ + R + P +LY +L+ CW P
Sbjct: 203 VTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELY-----DLMYSCWRADPK 257
Query: 399 KRPTFRQIITRLESI 413
RPTF ++ LE+I
Sbjct: 258 DRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 74/261 (28%), Positives = 126/261 (48%), Gaps = 31/261 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
+ + VAVK L ++ D + E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 43 KPVTVAVKMLKDDATDKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
KG+LR +L+ + L V A +ARGM YL K IH
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
RDL N+L + +K+ADFG+++ + + + T +++APE + Y +
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 217
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEEC 392
DV+SF ++L E+ G P+ E+ K R P +LY ++ EC
Sbjct: 218 DVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYM-----IMREC 272
Query: 393 WNEKPAKRPTFRQIITRLESI 413
W+ P++RPTF+Q++ L+ +
Sbjct: 273 WHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 71/241 (29%), Positives = 112/241 (46%), Gaps = 34/241 (14%)
Query: 178 VAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K VI D + E+++L++ RHPN+V + G+ + + IV EY G
Sbjct: 31 VAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L+ + +G L + +G+ YLHE IHRD++ +NIL + G++K+
Sbjct: 86 SLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKL 142
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGC 351
ADFGVS LT + + T ++APEV E YD K D+++ + E+ E
Sbjct: 143 ADFGVSAQLTATIAKRKSFIGTP-YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
Query: 352 PP----------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
PP F + N P P K K ++ + I++C + P KRP
Sbjct: 202 PPMFDLHPMRALFLISKSNFPP--------PKLKDKEK-WSPVFHDFIKKCLTKDPKKRP 252
Query: 402 T 402
T
Sbjct: 253 T 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 66/234 (28%), Positives = 122/234 (52%), Gaps = 12/234 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
V +K++ E ++ D+R+ A ++E +L+ + HPN++++ + +MIV EY P G L
Sbjct: 28 VIIKQIPVEQMTKDERLAA-QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86
Query: 238 RAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKV 294
+++++ L T + F + I ++++H I+HRDL+ NIL D +K+
Sbjct: 87 AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKI 143
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG+SK+L+ K + T T C Y++PE+ + + Y+ K D+++ +L E+ F
Sbjct: 144 GDFGISKILSSKS-KAYTVVGTPC-YISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
+ +P F + Y+ L++LI N P+KRP QI+
Sbjct: 202 EAAN---LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 58/166 (34%), Positives = 91/166 (54%), Gaps = 7/166 (4%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
V A E+ LL+ +RH +VQ+ G + + + I EY+P G ++ LK GAL +
Sbjct: 48 VNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV--KEDR 309
R+ I +G++YLH N I+HRD++ +NILRD +GN+K+ DFG SK +
Sbjct: 108 TRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+ + +++PEV E Y K DV+S A + EM+ PP+
Sbjct: 165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 76/267 (28%), Positives = 131/267 (49%), Gaps = 44/267 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYL 232
G QVAVK L E S + + + E+ +L+ + H N+V++ G T+ + + ++ E+L
Sbjct: 33 GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 233 PKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
P G L+ +L R K + +++A+ I +GM+YL + +HRDL N+L +
Sbjct: 91 PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 147
Query: 292 LKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG++K + TVK+D D+ + APE ++ DV+SF + L
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDL-----DSPVFWYAPECLIQSKFYIASDVWSFGVTL 202
Query: 345 QEMIEGC----PPFTM-------KHDN-------EVPKAYAARQRPPFKAPAKLYARGLK 386
E++ C P T+ H V + RPP P ++Y
Sbjct: 203 YELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPP-NCPEEVY----- 256
Query: 387 ELIEECWNEKPAKRPTFRQIITRLESI 413
+L+ +CW +P+KR TF+ +I E+I
Sbjct: 257 QLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 77/279 (27%), Positives = 133/279 (47%), Gaps = 36/279 (12%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
+ + VAVK L + + D + E+ L++ I +H N++ LG TQ P+ ++ EY
Sbjct: 43 QTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100
Query: 233 PKGDLRAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIH 276
KG+LR FL+ + P V A +ARGM YL + IH
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIH 157
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
RDL N+L + +K+ADFG+++ + + + + +++APE + Y +
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
DV+SF +++ E+ G P+ E+ K R P +LY L+ EC
Sbjct: 218 DVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYM-----LMREC 272
Query: 393 WNEKPAKRPTFRQIITRLESINNSINHKRRWKVYLFLSL 431
W+ P +RPTF+Q++ L+ + +++ + YL LS+
Sbjct: 273 WHAVPTQRPTFKQLVEALDKVLAAVSEE-----YLDLSM 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 74/236 (31%), Positives = 118/236 (50%), Gaps = 11/236 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-IVTEYLP 233
G Q +KKL S +R +A E LL +++HPN+V + + ++ IV +
Sbjct: 25 GKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 234 KGDLRAFLK-RKGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
GDL LK +KG L P + V + + IA + YLHE I+HRDL+ N+ +
Sbjct: 84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNI 140
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
+KV D G++++L + D T T Y++PE+F N+ Y+ K DV++ + EM
Sbjct: 141 IKVGDLGIARVLENQCDMASTLIGTP-YYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
F K N + + PP K Y+ L ELI +++P KRP+ + I+
Sbjct: 200 HAFNAKDMNSLVYRIIEGKLPPM---PKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 72/259 (27%), Positives = 125/259 (48%), Gaps = 31/259 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ VAVK L ++ D + E+ +++ I +H N++ LGA TQ P+ ++ EY K
Sbjct: 48 VTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105
Query: 235 GDLRAFLKRKGALK----------PSTAVRF------ALDIARGMNYLHENKPVPIIHRD 278
G+LR +L+ + P + F +ARGM YL K IHRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRD 162
Query: 279 LEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
L N+L ++ +K+ADFG+++ + + + T +++APE + Y + DV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 338 FSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWN 394
+SF +++ E+ G P+ E+ K R P +LY ++ +CW+
Sbjct: 223 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCWH 277
Query: 395 EKPAKRPTFRQIITRLESI 413
P+ RPTF+Q++ L+ I
Sbjct: 278 AIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 80/270 (29%), Positives = 131/270 (48%), Gaps = 31/270 (11%)
Query: 162 EITKGTF--ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
E+ +GT IL G I+VAVK L + D + F E L+ HPN+V+ LG
Sbjct: 10 EVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGV 67
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA-------VRFALDIARGMNYLHENKP 271
+ P I+ E + GDL ++L+ + + LD+A+G YL +
Sbjct: 68 CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH- 126
Query: 272 VPIIHRDLEPSNILRDDSGN-----LKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPE 324
IHRDL N L + G +K+ DFG+++ + K D R R++APE
Sbjct: 127 --FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLPVRWMAPE 183
Query: 325 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLY 381
+ ++ T+ DV+SF +++ E++ G P+ ++ EV + A R + P P K+Y
Sbjct: 184 SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIY 243
Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLE 411
+L+ CW + P++RPTF +I L+
Sbjct: 244 -----QLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 31/261 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
R +VAVK L + D + E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 49 RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106
Query: 233 PKGDLRAFL--KRKGALK----PSTA----------VRFALDIARGMNYLHENKPVPIIH 276
KG+LR +L +R ++ P+ V A +ARGM YL K IH
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIH 163
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
RDL N+L + +K+ADFG+++ + + + T +++APE + Y +
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 223
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEEC 392
DV+SF ++L E+ G P+ E+ K R P +LY ++ +C
Sbjct: 224 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 278
Query: 393 WNEKPAKRPTFRQIITRLESI 413
W+ P++RPTF+Q++ L+ I
Sbjct: 279 WHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 65/184 (35%), Positives = 98/184 (53%), Gaps = 13/184 (7%)
Query: 175 GIQVAVKK--LGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
G VA+KK LGE + D + A R E+ LLQ+++HPN++ L S + +V E
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFT-ALR-EIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82
Query: 231 YLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
++ DL +K K L P+ + L RG+ YLH N I+HRDL+P+N+L
Sbjct: 83 FME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASD 138
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMI 348
G LK+ADFG+++ +R +T Q + Y APE+ F Y VD++S I E++
Sbjct: 139 GVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELL 197
Query: 349 EGCP 352
P
Sbjct: 198 LRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 59/186 (31%), Positives = 95/186 (51%), Gaps = 9/186 (4%)
Query: 175 GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTE 230
G ++AVK++ E V A E+ LL+ + H +VQ+ G + + I E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
++P G ++ LK GAL + ++ I G++YLH N I+HRD++ +NILRD G
Sbjct: 87 HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVG 143
Query: 291 NLKVADFGVSKLLTV--KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
N+K+ DFG SK L + + +++PEV E Y K D++S + EM+
Sbjct: 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203
Query: 349 EGCPPF 354
PP+
Sbjct: 204 TEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KG 245
I ++ + F E+ +L + +HPN+V A + + I+ E+ G L + + +G
Sbjct: 40 IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG 99
Query: 246 ALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
+P R L+ +N+LH +K +IHRDL+ NIL G++K+ADFGVS
Sbjct: 100 LTEPQIRYVCRQMLE---ALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153
Query: 304 TVKEDRPLTCQDTSCRYVAPEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
+ T T ++APEV FK+ YD K D++S + L E+ + PP +
Sbjct: 154 KSTLQKRDTFIGTP-YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212
Query: 359 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
V + P P+K ++ + ++ C + P RPT +++
Sbjct: 213 PMRVLLKILKSEPPTLDQPSK-WSSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 71/251 (28%), Positives = 112/251 (44%), Gaps = 33/251 (13%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP------MMIVTE 230
VA+K + +D ++E +L+K HPN+ F GA + +P + +V E
Sbjct: 34 VAIKIMD----IIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89
Query: 231 YLPKG---DL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
G DL + K+ LK + RG+ YLHENK +IHRD++ NIL
Sbjct: 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILL 146
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVDVFSFA 341
+ +K+ DFGVS L R T T ++APEV +E YD + DV+S
Sbjct: 147 TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY-WMAPEVIACDEQPDASYDARSDVWSLG 205
Query: 342 LILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 397
+ E+ +G PP H +P R PP + +++ + I EC +
Sbjct: 206 ITAIELADGKPPLCDMHPMRALFKIP-----RNPPPTLKSPENWSKKFNDFISECLIKNY 260
Query: 398 AKRPTFRQIIT 408
+RP +++
Sbjct: 261 EQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 3e-23
Identities = 72/254 (28%), Positives = 116/254 (45%), Gaps = 24/254 (9%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L R + VA+ L SD R R F E L + H N+V+ G +T+
Sbjct: 20 ELCRGCLKLPSKRELPVAIHTL-RAGCSDKQR-RGFLAEALTLGQFDHSNIVRLEGVITR 77
Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ MMIVTEY+ G L +FL++ +G L + +A GM YL E + +H+ L
Sbjct: 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLA 134
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKV 335
+L + K++ F ++ED+ T + APE + + +
Sbjct: 135 AHKVLVNSDLVCKISGFR-----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS 189
Query: 336 DVFSFALILQE-MIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
DV+SF +++ E M G P+ +V KA R P P L+ +L+ +C
Sbjct: 190 DVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH-----QLMLDC 244
Query: 393 WNEKPAKRPTFRQI 406
W ++ +RP F QI
Sbjct: 245 WQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 60/185 (32%), Positives = 92/185 (49%), Gaps = 5/185 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L +HP + Q + V EY+ GDL
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R G A +A +I G+ +LHE II+RDL+ N+L D G++K+ADF
Sbjct: 84 MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADF 140
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
G+ K + T T Y+APE+ + Y VD ++ ++L EM+ G PF
Sbjct: 141 GMCKEGILGGVTTSTFCGTP-DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
Query: 358 HDNEV 362
++E+
Sbjct: 200 DEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-23
Identities = 51/156 (32%), Positives = 91/156 (58%), Gaps = 7/156 (4%)
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
+E +L+++ HP +++ + ++ EY+P G+L ++L+ G ST + +A +
Sbjct: 50 NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
I + YLH + I++RDL+P NIL D G++K+ DFG +K L DR T T
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWTLCGTP- 162
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y+APEV +++ ++ VD ++ +++ EM+ G PPF
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 6e-23
Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 14/238 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
V K++ +S+ +R R +E+ +L ++HPN++ + + ++I EY G
Sbjct: 27 LVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85
Query: 237 L-RAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++KG L V + L I ++Y+H+ I+HRD++ NI +G +K+
Sbjct: 86 LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKL 142
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG+SK+L + T T Y++PE+ + +Y+ K D+++ +L E++
Sbjct: 143 GDFGISKILGSEYSMAETVVGTP-YYMSPELCQGVKYNFKSDIWALGCVLYELL--TLKR 199
Query: 355 TMKHDN--EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
T N + P + Y+ L L+ + P KRPT +++ +
Sbjct: 200 TFDATNPLNLVVKIVQGNYTPVVSV---YSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-23
Identities = 76/253 (30%), Positives = 118/253 (46%), Gaps = 23/253 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-------SPMMIV 228
++VAVK + + I + F E +++ HPNV++ +G Q+ SP++I+
Sbjct: 27 LKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVIL 85
Query: 229 TEYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
++ GDL +FL R G L V+F DIA GM YL IHRDL
Sbjct: 86 P-FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAAR 141
Query: 283 NILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N + +++ N+ VADFG+SK + + R +++A E + Y TK DV+SF
Sbjct: 142 NCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFG 201
Query: 342 LILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
+ + E+ G P+ ++E+ RQ K P GL L+ CW P R
Sbjct: 202 VTMWEIATRGQTPYPGVENSEIYDYL--RQGNRLKQPPDCL-DGLYSLMSSCWLLNPKDR 258
Query: 401 PTFRQIITRLESI 413
P+F + LE
Sbjct: 259 PSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-22
Identities = 65/244 (26%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G Q +K++ +S +R + R E+A+L ++HPN+VQ+ + ++ + IV +Y
Sbjct: 25 GKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 235 GDLRAFL-KRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL + ++G L P + + + I + ++H+ K I+HRD++ NI G +
Sbjct: 84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTI 140
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
K+ DFG++++L + TC T Y++PE+ +N Y+ K D+++ +L EM
Sbjct: 141 KLGDFGIARVLNSTVELARTCIGTP-YYLSPEICENRPYNNKSDIWALGCVLYEMC---- 195
Query: 353 PFTMKH-------DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
T+KH N V K R + + Y+ L+ L+ + + P RP+
Sbjct: 196 --TLKHAFEAGNMKNLVLKII----RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNS 249
Query: 406 IITR 409
I+ +
Sbjct: 250 ILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-22
Identities = 48/104 (46%), Positives = 64/104 (61%), Gaps = 5/104 (4%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
N D+DG L A+ +E +K LL++G DVN +D D RT LH+AA G E+
Sbjct: 1 NARDEDGRTP-----LHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEI 55
Query: 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V LLLE+GADV+ +D+ G+TPL A N +V+KLL KHGA
Sbjct: 56 VKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADV 99
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 51/166 (30%), Positives = 98/166 (59%), Gaps = 9/166 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFA 256
E++L+++++H N+V+ + + +M+V EY+ K DL+ ++ +GAL P+T F
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+ +G+ + HEN+ ++HRDL+P N+L + G LK+ADFG+++ + + + +
Sbjct: 107 YQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV 162
Query: 317 SCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
+ Y AP+V + Y T +D++S I+ EMI G P F ++ +
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 67/215 (31%), Positives = 111/215 (51%), Gaps = 11/215 (5%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPS-TAVRF 255
R E LL K++HPN+V F + + IV EY GDL +K ++G L P T +++
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
+ + G+ ++HE + ++HRD++ NI +G +K+ DFG ++LLT T
Sbjct: 106 FVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG 162
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH-DNEVPKAYAARQRPPF 374
T YV PE+++N Y+ K D++S IL E+ PF N + K +P
Sbjct: 163 TP-YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-- 219
Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
P+ Y+ L+ LI++ + P RP+ I++R
Sbjct: 220 -LPSH-YSYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 65/252 (25%), Positives = 120/252 (47%), Gaps = 24/252 (9%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+ + VAVK L +V F E+ ++ ++++PN+++ LG P+ ++TEY+
Sbjct: 43 QPVLVAVKMLRADVTKTARN--DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100
Query: 234 KGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
GDL FL ++ ++ + + A+ IA GM YL + +HRDL
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSF 340
N L + +K+ADFG+S+ L + + + R++A E ++ T DV++F
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217
Query: 341 ALILQEMIEGCP--PFTMKHDNEVPKA----YAARQRPPFKAPAKLYARGLKELIEECWN 394
+ L EM C P+++ D +V + + + R + + L + +L+ CW+
Sbjct: 218 GVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWS 277
Query: 395 EKPAKRPTFRQI 406
RPTF +I
Sbjct: 278 RDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-22
Identities = 42/89 (47%), Positives = 54/89 (60%), Gaps = 2/89 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A ++E +K LL+ G DVN D TALH+AA G E+V LLLE GADV+ KD
Sbjct: 1 LHLAAKNGNLELVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLLLEHGADVNAKD 58
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ G+T L A N E++KLL +HGA
Sbjct: 59 KDGNTALHLAARNGNLEIVKLLLEHGADI 87
|
Length = 91 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 23/200 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+ A+K L + + + +V+ ++ L + HP +++ + V EY P
Sbjct: 26 NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L ++++ G+L +A +I + YLH IIHRDL+P NIL D ++K
Sbjct: 86 NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIK 142
Query: 294 VADFGVSKLL---------------TVKEDRPLTCQDTS----CRYVAPEVFKNEEYDTK 334
+ DFG +K+L + + S YV+PE+ +
Sbjct: 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS 202
Query: 335 VDVFSFALILQEMIEGCPPF 354
D+++ I+ +M+ G PPF
Sbjct: 203 SDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 42/267 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIVTEYL 232
G VAVK L E ++ E+ +L+ + H N+V++ G ++ + ++ EY+
Sbjct: 33 GEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
P G LR +L + L + + FA I GM YLH IHRDL N+L D+ +
Sbjct: 91 PLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLV 146
Query: 293 KVADFGVSKLLT-------VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
K+ DFG++K + V+ED D+ + A E K ++ DV+SF + L
Sbjct: 147 KIGDFGLAKAVPEGHEYYRVRED-----GDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201
Query: 346 EMIEGCPPF-------------TMKHDNEVP--KAYAARQRPPF--KAPAKLYARGLKEL 388
E++ C V + R P P ++Y L
Sbjct: 202 ELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVY-----IL 256
Query: 389 IEECWNEKPAKRPTFRQIITRLESINN 415
++ CW + RPTFR +I L+ +++
Sbjct: 257 MKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 14/215 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF + + KG+F +LA +G A+K L ++VI DD V E LAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK- 59
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P + Q + V EY+ GDL +++ G K AV +A +IA G+ +LH
Sbjct: 60 -PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
II+RDL+ N++ D G++K+ADFG+ K T T Y+APE+
Sbjct: 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP-DYIAPEIIA 174
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
+ Y VD ++F ++L EM+ G PPF + ++E+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 60/182 (32%), Positives = 95/182 (52%), Gaps = 10/182 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPK 234
VA+KK+ + D + + R E+ LL +RHPN+V+ V + +V EY +
Sbjct: 34 IVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92
Query: 235 GDLRAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL + L + V+ L + RG+ YLHEN IIHRDL+ SN+L D G LK
Sbjct: 93 -DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLK 148
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
+ADFG+++ + +P+T + + Y APE+ Y T +D+++ IL E++ P
Sbjct: 149 IADFGLARTYGLP-AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207
Query: 353 PF 354
Sbjct: 208 LL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 7e-22
Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 16/220 (7%)
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL-KPSTAV 253
A + E+ LL K++HPN+V F + ++ + IV EY GDL + R +G L +
Sbjct: 45 ASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKEDRPLT 312
+ + I+ G+ ++H+ K I+HRD++ NI +G + K+ DFG+++ L + T
Sbjct: 105 SWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH---DNEVPKAYAAR 369
C T Y++PE+ +N Y+ K D++S +L E+ C T+KH N + +
Sbjct: 162 CVGTP-YYLSPEICQNRPYNNKTDIWSLGCVLYEL---C---TLKHPFEGNNLHQLVLKI 214
Query: 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
+ F + ++R L+ LI + + P RP+ I+ R
Sbjct: 215 CQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 8e-22
Identities = 60/183 (32%), Positives = 98/183 (53%), Gaps = 12/183 (6%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA-VTQSSPMMIVTEYL 232
G VA+KK+ + + R +R EL LL+ +RH N++ ++ + VTE L
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL L L+ F I RG+ Y+H ++HRDL+PSNIL +++ +L
Sbjct: 93 GT-DLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDL 147
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGC 351
K+ DFG++++ +D +T ++ Y APE+ ++YD +VD++S I EM+EG
Sbjct: 148 KICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
Query: 352 PPF 354
P F
Sbjct: 204 PLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 9e-22
Identities = 60/182 (32%), Positives = 101/182 (55%), Gaps = 13/182 (7%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+KK+ E ++D+ V A R E++LL+++ HPN+V+ L V + + +V E+L
Sbjct: 27 VALKKIRLE--TEDEGVPSTAIR-EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL- 82
Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL+ ++ L P + + +G+ Y H ++ ++HRDL+P N+L D G LK
Sbjct: 83 DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALK 139
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
+ADFG+++ V R T + + Y APE+ + +Y T VD++S I EM+ P
Sbjct: 140 LADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198
Query: 353 PF 354
F
Sbjct: 199 LF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 9e-22
Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAF---RDELALLQKIRHPNVVQFL 216
KG+F +LA +G A+K L ++V+ +DD V R LAL + HP +
Sbjct: 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE--HPFLTHLF 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ V EYL GDL ++ G + A +A +I G+ +LH+ II+
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIY 119
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
RDL+ N+L D G++K+ADFG+ K E + T C Y+APE+ K ++Y+
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK----ASTFCGTPDYIAPEILKGQKYNE 175
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEV 362
VD +SF ++L EM+ G PF + ++E+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 57/182 (31%), Positives = 96/182 (52%), Gaps = 21/182 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAF--RDELALLQKIR---HPNVVQFLG-----AVTQSSPMMI 227
VA+KK+ V ++ + R E+ALL+++ HPN+V+ L + + +
Sbjct: 27 VALKKV--RVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83
Query: 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
V E++ + DL +L + K L P T + RG+++LH ++ I+HRDL+P NIL
Sbjct: 84 VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNIL 139
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
G +K+ADFG++++ + + LT + Y APEV Y T VD++S I
Sbjct: 140 VTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197
Query: 346 EM 347
E+
Sbjct: 198 EL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 5/177 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + I + + E +L++ HP +V+ + ++ EY G+L
Sbjct: 22 ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L+ +G TA + + YLH II+RDL+P N+L D +G +K+ DFG
Sbjct: 82 TILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFG 138
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+K L + + T T YVAPE+ N+ YD VD +S ++L E++ G PPF
Sbjct: 139 FAKKLKSGQ-KTWTFCGTP-EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 63/194 (32%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
G +VA+KK+ D R R E+ LL+ +RH N++ L + SP IVT
Sbjct: 25 GRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
E + DL +K L F I RG+ YLH +IHRDL+PSNIL + +
Sbjct: 84 ELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSN 139
Query: 290 GNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEVFKN-EEYDTKVDVFSF 340
+LK+ DFG+++ + ED LT YV APE+ + Y +D++S
Sbjct: 140 CDLKICDFGLARGVDPDEDEKGFLT------EYVVTRWYRAPELLLSSSRYTKAIDIWSV 193
Query: 341 ALILQEMIEGCPPF 354
I E++ P F
Sbjct: 194 GCIFAELLTRKPLF 207
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 11/190 (5%)
Query: 174 RGIQVAVKKLG---EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
+G +AVK++ V++ + ++E+ LL+ ++H N+VQ+LG + + I E
Sbjct: 23 QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
++P G + + L R G L ++ I G+ YLH N ++HRD++ +N++ +G
Sbjct: 83 FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNG 139
Query: 291 NLKVADFGVSKLL-----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
+K+ DFG ++ L L + ++APEV Y K D++S +
Sbjct: 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199
Query: 346 EMIEGCPPFT 355
EM G PP
Sbjct: 200 EMATGKPPLA 209
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 58/185 (31%), Positives = 91/185 (49%), Gaps = 5/185 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ I + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 24 AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L+R+ + A +A +IA + YLH II+RDL+P NIL D G++ + DF
Sbjct: 84 FFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDF 140
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
G+ K T T Y+APEV + + YD VD + +L EM+ G PPF +
Sbjct: 141 GLCKEGIEHSKTTSTFCGTP-EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
Query: 358 HDNEV 362
E+
Sbjct: 200 DTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 45/211 (21%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + +++ R E +L P +V+ + + +V EY+P GDL
Sbjct: 30 AMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM 89
Query: 239 AFLKRKGALKPSTAVRF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L RK TA RF ALD + + IHRD++P NIL D G+
Sbjct: 90 NLLIRKDVFPEETA-RFYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGH 139
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDT----------------------------SCRYVAP 323
+K+ADFG+ K + +DR D+ + Y+AP
Sbjct: 140 IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199
Query: 324 EVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
EV + Y + D +S +IL EM+ G PPF
Sbjct: 200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-21
Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 18/252 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL-GAVTQSSPMMIVTEYLP 233
G +VA+K L + ++ + FR E AL ++ HPN+V L + V EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
LR L GAL R L + + H I+HRDL+P NI+
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRP 119
Query: 291 NLKVADFGVSKLLT-VKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ KV DFG+ LL V++ T T + Y APE + E D++++ LI
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRP-PFKAPAKLYARGLKELIEECWNEKPAKRP-T 402
E + G E+ + P P + L +++ + N+ P +R +
Sbjct: 180 LECLTGQRVVQGASVAEI---LYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAAS 236
Query: 403 FRQIITRLESIN 414
+ R ++
Sbjct: 237 APALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 69/218 (31%), Positives = 110/218 (50%), Gaps = 20/218 (9%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF + + KG+F +LA +G A+K L ++V+ DD V E LAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK- 59
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P + Q + V EY+ GDL +++ G K AV +A +I+ G+ +LH
Sbjct: 60 -PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPE 324
II+RDL+ N++ D G++K+ADFG+ K V T C Y+APE
Sbjct: 119 RRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIAPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
+ + Y VD +++ ++L EM+ G PPF + ++E+
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 43/235 (18%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVR-- 254
E LL + H N++ L + P ++ Y+ G+L+ FL+ R G A+
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 255 ----FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK--------L 302
A+ IA GM+YLH+ +IH+D+ N + D+ +K+ D +S+
Sbjct: 118 QLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCP-----PFT 355
L E+RP+ +++A E N+EY + DV+SF ++L E++ P PF
Sbjct: 175 LGDNENRPV-------KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227
Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
M + Y Q P P +L+A ++ CW P +RP+F Q++ L
Sbjct: 228 MAA--YLKDGYRLAQ--PINCPDELFA-----VMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 3e-21
Identities = 66/244 (27%), Positives = 117/244 (47%), Gaps = 23/244 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK ++ +D+ A +DEL ++Q++ +P +V+ +G + ++ M+V E
Sbjct: 25 VAVK-----ILKNDNNDPALKDELLREANVMQQLDNPYIVRMIG-ICEAESWMLVMELAE 78
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G L FL++ + ++ GM YL E +HRDL N+L K
Sbjct: 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAK 135
Query: 294 VADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
++DFG+SK L E+ + T ++ APE ++ +K DV+SF +++ E G
Sbjct: 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYG 195
Query: 351 CPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
P+ NEV + + +R P + P ++Y +L++ CW +RP F +
Sbjct: 196 QKPYKGMKGNEVTQMIESGERMECPQRCPPEMY-----DLMKLCWTYGVDERPGFAVVEL 250
Query: 409 RLES 412
RL +
Sbjct: 251 RLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 11/227 (4%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
G A+K L + I +V+ E ++L ++ HP +V + + + + + E++
Sbjct: 42 TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L L++ G A + ++ YLH II+RDL+P N+L D+ G++K
Sbjct: 102 GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
V DFG +K + DR T T Y+APEV +++ + VD ++ ++L E I G PP
Sbjct: 159 VTDFGFAKKVP---DRTFTLCGTP-EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
F D+ + Y K P R ++L++ KR
Sbjct: 215 F---FDDTPFRIYEKILAGRLKFPNWFDGRA-RDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 67/249 (26%), Positives = 121/249 (48%), Gaps = 21/249 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGA 218
E+ + T +L G+ VA+KK+ I D +A D E+ LL+++ HPNV+++ +
Sbjct: 17 EVYRATCLL---DGVPVALKKVQ---IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 70
Query: 219 VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPI 274
+ + + IV E GDL + F K+K + T ++ + + + ++H + +
Sbjct: 71 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---V 127
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 334
+HRD++P+N+ +G +K+ D G+ + + K + T Y++PE Y+ K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSPERIHENGYNFK 186
Query: 335 VDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
D++S +L EM PF N + K PP P+ Y+ L++L+ C
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSEELRQLVNMC 244
Query: 393 WNEKPAKRP 401
N P KRP
Sbjct: 245 INPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 23/266 (8%)
Query: 151 DPHELDFTNSVEI---TKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP N V+I + G +A + G QVAVKK+ + R +E+ +++
Sbjct: 16 DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMR 71
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+HPN+V+ + + +V E+L G L + + A L + + +++
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLAVLKALSF 130
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH +IHRD++ +IL G +K++DFG ++ + R + T ++APEV
Sbjct: 131 LHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTP-YWMAPEV 186
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR----PPFKAPAKLY 381
Y T+VD++S +++ EM++G PP+ NE P R R P K K+
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYF----NEPPLQAMKRIRDNLPPKLKNLHKVS 242
Query: 382 ARGLKELIEECWNEKPAKRPTFRQII 407
R L+ ++ PA+R T +++
Sbjct: 243 PR-LRSFLDRMLVRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 72/256 (28%), Positives = 120/256 (46%), Gaps = 30/256 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VAVK L + + D+ + F E LL ++H ++V+F G + P+++V EY+ G
Sbjct: 36 ILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 236 DLRAFLKRKGA-------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
DL FL+ G L S + A IA GM YL +HRDL
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR 149
Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N L ++ +K+ DFG+S+ + + R R++ PE ++ T+ DV+S
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 209
Query: 342 LILQEMIE-GCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEKP 397
++L E+ G P+ +NEV + QRP P ++Y +L+ CW +P
Sbjct: 210 VVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR-TCPKEVY-----DLMLGCWQREP 263
Query: 398 AKRPTFRQIITRLESI 413
R ++I + L+++
Sbjct: 264 HMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 179 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
AVK L ++ I + + + A R+ LL+ ++HP +V + + + V +Y+ G
Sbjct: 24 AVKVLQKKTILKKKEQNHIMAERN--VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
+L L+R+ A +A ++A + YLH + II+RDL+P NIL D G++ +
Sbjct: 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLT 138
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
DFG+ K E+ T T Y+APEV + E YD VD + +L EM+ G PPF
Sbjct: 139 DFGLCKEGVEPEETTSTFCGTP-EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF- 196
Query: 356 MKHDNEVPKAYAARQRPPFKAP 377
+ +V + Y P + P
Sbjct: 197 --YSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 60/236 (25%), Positives = 117/236 (49%), Gaps = 13/236 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ ++++ +HPN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + + + +LH N+ +IHRD++ NIL G++K+
Sbjct: 101 GSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG +T ++ + T T ++APEV + Y KVD++S ++ EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
Query: 355 TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
++N + Y A P + P KL A ++ + C KR + ++++
Sbjct: 216 L--NENPLRALYLIATNGTPELQNPEKLSA-IFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 68/244 (27%), Positives = 116/244 (47%), Gaps = 20/244 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+ +A+K++ E+ D+ + EL +L K P +V F GA + + EY+
Sbjct: 26 GVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83
Query: 235 GDLRAFLKRKGAL--KPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
G L A P +R + +G+ +L E IIHRD++P+N+L + +G
Sbjct: 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQ 141
Query: 292 LKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALIL 344
+K+ DFGVS L+ + CQ Y+APE K+ Y + DV+S L +
Sbjct: 142 VKLCDFGVSGNLVASLAKTNIGCQS----YMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197
Query: 345 QEMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
EM G P+ + + N + A P P+ Y+ ++ + +C N+ P +RPT+
Sbjct: 198 LEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG-YSDDAQDFVAKCLNKIPNRRPTY 256
Query: 404 RQII 407
Q++
Sbjct: 257 AQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 27/246 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +AVK++ V S + + R D ++ + P V F GA+ + + I E +
Sbjct: 26 GTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME-VMD 83
Query: 235 GDLRAFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
L F K+ KG P + + A+ I + + YLH V IHRD++PSN+L + +G
Sbjct: 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNG 141
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVF----KNEEYDTKVDVFSFALILQ 345
+K+ DFG+S L D D C+ Y+APE + YD K DV+S + +
Sbjct: 142 QVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMI 198
Query: 346 EMIEGCPPFTMKHD-----NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
E+ G P+ +V + P + PA+ ++ ++ + +C + +R
Sbjct: 199 ELATGRFPYDSWKTPFQQLKQVVEE------PSPQLPAEKFSPEFQDFVNKCLKKNYKER 252
Query: 401 PTFRQI 406
P + ++
Sbjct: 253 PNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-20
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF 215
I+KG F LA R G A+K L + + ++V + E A++ P V +
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ + +V EYL GD + +K G L A ++ ++ G+ LH+ II
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
HRD++P N+L D +G+LK+ DFG+S+ + T Y+APE D
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-----YLAPETILGVGDDKMS 174
Query: 336 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
D +S ++ E + G PPF E P A
Sbjct: 175 DWWSLGCVIFEFLFGYPPF----HAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 67/252 (26%), Positives = 125/252 (49%), Gaps = 30/252 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K + E S +R+ F +E +++++ +VV+ LG V+Q P +++ E + +GD
Sbjct: 38 RVAIKTVNEAA-SMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 95
Query: 237 LRAFLKRKGALKPSTA-------------VRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
L+++L+ +L+P ++ A +IA GM YL+ NK +HRDL N
Sbjct: 96 LKSYLR---SLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARN 149
Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+ + +K+ DFG+++ + R R+++PE K+ + T DV+SF +
Sbjct: 150 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 209
Query: 343 ILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
+L E+ P+ + +V + P P L+ EL+ CW P
Sbjct: 210 VLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKM 264
Query: 400 RPTFRQIITRLE 411
RP+F +II+ ++
Sbjct: 265 RPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 6e-20
Identities = 39/82 (47%), Positives = 50/82 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A +E +K LL+ G DVN RD D T LH+AA G +VV LLL+ GADV+ +D
Sbjct: 44 LHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADVNARD 103
Query: 104 RWGSTPLGDAIYYKNHEVIKLL 125
+ G TPL A + EV+KLL
Sbjct: 104 KDGRTPLHLAAKNGHLEVVKLL 125
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 81/295 (27%), Positives = 134/295 (45%), Gaps = 48/295 (16%)
Query: 144 EVPEYEID-PHEL---DFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
EV E+ P +L F +V KG R + VAVK L + ++ + F
Sbjct: 20 EVHLCEVVNPQDLPTLQFPFNVR--KG-------RPLLVAVKILRPD--ANKNARNDFLK 68
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------- 245
E+ +L +++ PN+++ LG P+ ++TEY+ GDL FL
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
A+ S+ + AL IA GM YL + +HRDL N L ++ +K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 301 KLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC--PPFTMK 357
+ L + + + R++A E ++ T DV++F + L E++ C P+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 358 HDNEVPKAYA------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
D +V + RQ F+ P +GL EL+ +CW+ +RP+F I
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPP--CPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 67/210 (31%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIR 208
D+T +I +GT+ + + G VA+KK+ E S+++ V A R E++LL++++
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIR-EISLLKELQ 57
Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFAL-DIARGMNY 265
HPN+V + Q S + ++ E+L DL+ +L KG + V+ L I +G+ +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
H + ++HRDL+P N+L D+ G +K+ADFG+++ + R T + + Y APEV
Sbjct: 117 CHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEV 172
Query: 326 F-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
+ Y T VD++S I EM P F
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
E LL K+ HP +V+F + + I+TEY DL L + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
+ + G++Y+H+ + I+HRDL+ NI L+++ LK+ DFGVS+LL D T
Sbjct: 112 FIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFT 166
Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374
T Y++PE K++ YD+K D++S IL EM C + N + + P
Sbjct: 167 GTP-YYMSPEALKHQGYDSKSDIWSLGCILYEMC--CLAHAFEGQNFLSVVLRIVEGPTP 223
Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
P Y+R L +++ N+ P+ RP+ +I+
Sbjct: 224 SLPET-YSRQLNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 19/233 (8%)
Query: 183 LGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYL---PKGDLR 238
G++ D + E+ ++ +++RHPN+V++ ++ + IV + + P G+
Sbjct: 41 FGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF 100
Query: 239 AFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
LK K + + + + YLH+ K I+HRDL P+NI+ + + + DF
Sbjct: 101 NSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
G++K + + LT + Y PE+ KNE Y K DV++F IL +M PPF
Sbjct: 159 GLAK--QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF--- 213
Query: 358 HDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
+ + K A P P +Y+ + ++I C RP Q+
Sbjct: 214 YSTNMLSLATKIVEAVYEP---LPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
E+ LL+++ HPNV+++L + + + + IV E GDL + F K+K + T ++
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
+ + + ++H + ++HRD++P+N+ +G +K+ D G+ + + K +
Sbjct: 112 FVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPP 373
T Y++PE Y+ K D++S +L EM PF N Q PP
Sbjct: 169 TP-YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRP 401
P + Y+ L+EL+ C P +RP
Sbjct: 228 L--PTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 17/232 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+G AVK L ++V+ DD V E +L +P + + V E+L
Sbjct: 19 KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL ++ KG A +A +I G+ +LH II+RDL+ N++ D G++
Sbjct: 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHI 135
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
K+ADFG+ K ++R T T Y+APE+ + +Y VD +SF ++L EM+ G
Sbjct: 136 KIADFGMCKENVFGDNRASTFCGTP-DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL----KELIEECWNEKPAKR 400
PF ++E+ + + R P Y R + K+++E+ + P +R
Sbjct: 195 PFHGDDEDELFE--SIRVDTPH------YPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 13/231 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ + + +E +L+K+ +V A + +V + GDL+
Sbjct: 22 ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81
Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
+ G + A+ +A I G+ +LH+ + I++RDL+P N+L DD GN++++D
Sbjct: 82 YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISD 138
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356
G++ + +K + + + + Y+APEV + E YD VD F+ L EMI G PF
Sbjct: 139 LGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196
Query: 357 ---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
K + E K + P K ++ K+L E + P KR R
Sbjct: 197 RKEKVEKEELKRRTLEM--AVEYPDK-FSPEAKDLCEALLQKDPEKRLGCR 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 57/189 (30%), Positives = 100/189 (52%), Gaps = 11/189 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + Q HP +V S + V EY+ GDL
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K + RP T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 141 GMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 355 TMKHDNEVP 363
+ ++ P
Sbjct: 197 DIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 61/254 (24%), Positives = 110/254 (43%), Gaps = 32/254 (12%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+V VK+L + D F E+ +++ HPNV+Q LG +S P ++V E+ P
Sbjct: 21 SKARVVVKEL--RASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78
Query: 234 KGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
GDL+ +L+ + R A ++A G+ +LH+ IH DL N
Sbjct: 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTA 135
Query: 289 SGNLKVADFGVSKLLTVKEDRPLT--CQDTSCRYVAPEVFKNEEYDTKV-------DVFS 339
++K+ D+G++ L ED +T C R++APE+ + D +++S
Sbjct: 136 DLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194
Query: 340 FALILQEMIE-GCPPFTMKHDNEVPKAYAARQR------PPFKAPAKLYARGLKELIEEC 392
+ + E+ P+ +E R++ P Y+ E+++ C
Sbjct: 195 LGVTMWELFTAADQPYP-DLSDEQVLKQVVREQDIKLPKPQLDLK---YSDRWYEVMQFC 250
Query: 393 WNEKPAKRPTFRQI 406
W + P RPT ++
Sbjct: 251 WLD-PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 57/186 (30%), Positives = 98/186 (52%), Gaps = 11/186 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E++ DD+ + + E + Q +P +V +S + +V EY+ GDL
Sbjct: 24 AMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A +A +I +N+LHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDY 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K + P T C Y+APE+ + EEY VD ++ +++ EM+ G PF
Sbjct: 141 GMCK----EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 355 TMKHDN 360
+ DN
Sbjct: 197 DIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 54/189 (28%), Positives = 99/189 (52%), Gaps = 11/189 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + HP +V S + V E++ GDL
Sbjct: 24 AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +N+LHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K + RP T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 141 GMCK----EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 355 TMKHDNEVP 363
+ ++ P
Sbjct: 197 DIVGMSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 163 ITKGTF---ILAFWRGIQV--AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFL 216
I KG+F +LA + + AVK L ++ I + E LL+ ++HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + + V +Y+ G+L L+R+ A +A +IA + YLH + I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVY 119
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
RDL+P NIL D G++ + DFG+ K + T C Y+APEV + YD
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEV 362
VD + +L EM+ G PPF ++ E+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 4e-19
Identities = 64/239 (26%), Positives = 113/239 (47%), Gaps = 22/239 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFR---DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
I VA+K I D + F+ D + + + H +V+ LG +S + +VT+
Sbjct: 37 IPVAIK-----TIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLS 90
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
P G L + + + +L P + + + IA+GM YL E++ ++HR+L NIL
Sbjct: 91 PLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSI 147
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 349
+++ADFGV+ LL + + + T +++A E Y + DV+S+ + + EM+
Sbjct: 148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY 207
Query: 350 GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
G P+ +EVP +R P +Y +K CW RPTF+++
Sbjct: 208 GAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVK-----CWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 62/188 (32%), Positives = 94/188 (50%), Gaps = 19/188 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S R +R EL LL+ + H NV+ L T +S + +V
Sbjct: 40 GRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRD 287
T L DL +K + L ++F + I RG+ Y+H IIHRDL+PSNI +
Sbjct: 99 TH-LMGADLNNIVKCQ-KLSDDH-IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVN 152
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQE 346
+ LK+ DFG+++ D +T + Y APE+ N Y+ VD++S I+ E
Sbjct: 153 EDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
Query: 347 MIEGCPPF 354
++ G F
Sbjct: 209 LLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFL 216
KG+F +LA +G A+K L ++VI DD V E LAL K HP +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTALH 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ V EY+ GDL ++R + +A ++ + +LH + +I+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIY 119
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+ NIL D G+ K+ADFG+ K + T T Y+APE+ + EY VD
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP-DYIAPEILQELEYGPSVD 178
Query: 337 VFSFALILQEMIEGCPPFTMKHDNE 361
++ +++ EM+ G PPF + DNE
Sbjct: 179 WWALGVLMYEMMAGQPPF--EADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 7e-19
Identities = 56/233 (24%), Positives = 115/233 (49%), Gaps = 9/233 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ +++++++PN+V FL + + +V EYL
Sbjct: 44 GQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + + + +LH N+ +IHRD++ N+L G++K+
Sbjct: 101 GSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKL 156
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG +T ++ + T T ++APEV + Y KVD++S ++ EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
++ A P + P KL + ++ + C KR + ++++
Sbjct: 216 LNENPLRALYLIATNGTPELQNPEKL-SPIFRDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 7e-19
Identities = 67/254 (26%), Positives = 123/254 (48%), Gaps = 28/254 (11%)
Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
++G V +L + D D + E+ +L+K H N+ + GA + +P
Sbjct: 23 YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82
Query: 225 -MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ +V E+ G + +K + LK +I RG+++LH++K +IHRD++
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKG 139
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEE-----YDT 333
N+L ++ +K+ DFGVS L DR + ++T + ++APEV +E YD
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF 195
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
K D++S + EM EG PP H + + + P + +K +++ + IE C
Sbjct: 196 KSDLWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPAPRLKSKKWSKKFQSFIESCL 253
Query: 394 NEKPAKRPTFRQII 407
+ ++RPT Q++
Sbjct: 254 VKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 39/243 (16%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK+ G + + + ++ +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
RG+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 163
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMK------------------- 357
Y++PE + Y + D++S L L EM G PP K
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223
Query: 358 -----HDNEVPKAYAARQ-------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
H + P+ A + PP K P+ ++ ++ +++C + P +R ++
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283
Query: 406 IIT 408
+
Sbjct: 284 LTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 57/187 (30%), Positives = 98/187 (52%), Gaps = 9/187 (4%)
Query: 179 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
AVK L ++++ + + A R+ LL+ ++HP +V + + + V +++ G
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
+L L+R+ + A +A +IA + YLH + I++RDL+P NIL D G++ +
Sbjct: 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLT 138
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
DFG+ K + D T T Y+APEV + + YD VD + +L EM+ G PPF
Sbjct: 139 DFGLCKEGIAQSDTTTTFCGTP-EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197
Query: 356 MKHDNEV 362
+ E+
Sbjct: 198 CRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 51/183 (27%), Positives = 95/183 (51%), Gaps = 18/183 (9%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + DD+ V A R E+ LL++++H N+V+ + + +V EY +
Sbjct: 28 VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ- 83
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ + G + P F + +G+ + H + ++HRDL+P N+L + +G LK+
Sbjct: 84 DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKL 140
Query: 295 ADFGVSKLLTVKEDRPLTC---QDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEG 350
ADFG+++ + P+ C + + Y P+V F + Y T +D++S I E+
Sbjct: 141 ADFGLARAFGI----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
Query: 351 CPP 353
P
Sbjct: 197 GRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 60/187 (32%), Positives = 87/187 (46%), Gaps = 8/187 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQ---KIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L + I D V + E + + RHP +V + V EY G
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
DL + +P AV +A + G+ YLHENK I++RDL+ N+L D G +K+A
Sbjct: 88 DLMMHIHTDVFSEPR-AVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIA 143
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
DFG+ K DR T T ++APEV Y VD + +++ EM+ G PF
Sbjct: 144 DFGLCKEGMGFGDRTSTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
Query: 356 MKHDNEV 362
+ EV
Sbjct: 203 GDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
G VA+KK+ D + A R E+ +L+K++HPNVV + + +
Sbjct: 33 GRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91
Query: 227 IVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
+VT Y+ DL L+ L S + L + G+NYLHEN I+HRD++ +NIL
Sbjct: 92 MVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANIL 147
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRP------LTCQDTSC---R-YVAPEVFKNE-EYDTK 334
D+ G LK+ADFG+++ P T + T+ R Y PE+ E Y T
Sbjct: 148 IDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207
Query: 335 VDVFSFALILQEMIEGCPPFTMKHD 359
VD++ + EM P K D
Sbjct: 208 VDIWGIGCVFAEMFTRRPILQGKSD 232
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 18/219 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G + AV +A +I G+ LH+ + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
+++D G++ + V E + + + + Y+APEV KNE Y D ++ +L EMI G
Sbjct: 142 RISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
Query: 353 PFTMKHD-----------NEVPKAYAARQRPPFKAPAKL 380
PF + EV + Y+ + P ++ K+
Sbjct: 200 PFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 69/221 (31%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + + KG+F +LA +G A+K L ++V+ DD V E +L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 211 NVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
+ L + Q+ + V EY+ GDL +++ G K AV +A +IA G+ +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL-----LTVKEDRPLTCQDTSC---RYV 321
II+RDL+ N++ D G++K+ADFG+ K +T K T C Y+
Sbjct: 121 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK---------TFCGTPDYI 168
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
APE+ + Y VD ++F ++L EM+ G PF + ++E+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 74/258 (28%), Positives = 120/258 (46%), Gaps = 24/258 (9%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGA 218
KG+F LA +G A+K L ++V+ DD V E +L HP +
Sbjct: 5 KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT 64
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+ V EYL GDL ++ A +A +I G+ +LH I++RD
Sbjct: 65 FQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRD 121
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L+ NIL D G++K+ADFG+ K + + + T T Y+APE+ ++Y+T VD +
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP-DYIAPEILLGQKYNTSVDWW 180
Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
SF ++L EM+ G PF + E+ + R P + R K+++ + + +P
Sbjct: 181 SFGVLLYEMLIGQSPFHGHDEEEL--FQSIRMDNPCY--PRWLTREAKDILVKLFVREPE 236
Query: 399 KR----------PTFRQI 406
+R P FR+I
Sbjct: 237 RRLGVKGDIRQHPFFREI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 10/192 (5%)
Query: 166 GTFILAFWRGIQ---VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
G ILA ++ VA+K+ + I +V E +L I HP V G+
Sbjct: 44 GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
S + +V E++ G+ FL+R +A I YL + + I++RDL+P
Sbjct: 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPE 160
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
N+L D G +K+ DFG +K++ + R T T Y+APE+ N + D ++ +
Sbjct: 161 NLLLDKDGFIKMTDFGFAKVV---DTRTYTLCGTP-EYIAPEILLNVGHGKAADWWTLGI 216
Query: 343 ILQEMIEGCPPF 354
+ E++ GCPPF
Sbjct: 217 FIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELA 202
++ DP +L FT+ EI G+F + F R ++ VA+KK+ +++ + E+
Sbjct: 19 FKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQ+I+HPN +++ G + +V EY K L+ +G
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+ YLH + +IHRD++ NIL + G +K+ADFG + + + P + ++A
Sbjct: 138 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMA 189
Query: 323 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPA 378
PEV +YD KVDV+S + E+ E PP F M N + Y Q +
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPTLQS 246
Query: 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
++ + ++ C + P RPT +++ +
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 59/184 (32%), Positives = 97/184 (52%), Gaps = 7/184 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + DRVR + E +L ++ HP +V+ A + ++ ++L GDL
Sbjct: 28 AMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 86
Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L K + V+F L ++A +++LH + II+RDL+P NIL D+ G++K+ DF
Sbjct: 87 TRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDF 142
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
G+SK E + + T Y+APEV + D +SF +++ EM+ G PF K
Sbjct: 143 GLSKESIDHEKKAYSFCGT-VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201
Query: 358 HDNE 361
E
Sbjct: 202 DRKE 205
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E +L ++ P +V + + +V ++ G+L L+R+G S A + ++
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
+ LH+ +I+RDL+P NIL D G++ + DFG+ KL +D+ +T C
Sbjct: 103 LCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK----TNTFCG 155
Query: 319 --RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
Y+APE+ Y VD ++ ++L EM+ G PPF +D V + Y + P +
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF---YDENVNEMYRKILQEPLRF 212
Query: 377 PAKLYARGLKELIEECWNEKPAKR 400
P R K+L+ + P +R
Sbjct: 213 PDGF-DRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 52/157 (33%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V + + +V EYL DL+ +L G L V+ F
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ RG++Y H+ K I+HRDL+P N+L ++ G LK+ADFG+++ +V + + + +
Sbjct: 112 LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVVTL 167
Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P+V + EY T +D++ IL EM G P F
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKP 249
++ + + E+ +L HPN+V+ L A + + I+ E+ G + A L+ + L
Sbjct: 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE 102
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
+NYLHENK IIHRDL+ NIL G++K+ADFGVS K R
Sbjct: 103 PQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTR 155
Query: 310 PLTCQDT---SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
+ +D+ + ++APEV K+ YD K DV+S + L EM + PP +
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215
Query: 362 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
V A + P P++ ++ K+ +++C + R T Q++
Sbjct: 216 VLLKIAKSEPPTLAQPSR-WSSEFKDFLKKCLEKNVDARWTTTQLL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 71/254 (27%), Positives = 123/254 (48%), Gaps = 28/254 (11%)
Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
++G V +L + D +D + E+ +L+K H N+ + GA + SP
Sbjct: 33 YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92
Query: 225 -MMIVTEYLPKGDLRAFLKR-KG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ +V E+ G + +K KG ALK +I RG+ +LH +K +IHRD++
Sbjct: 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKG 149
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEE-----YDT 333
N+L ++ +K+ DFGVS L DR + ++T + ++APEV +E YD
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDY 205
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
+ D++S + EM EG PP H + + + PP K +K +++ + IE C
Sbjct: 206 RSDIWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCL 263
Query: 394 NEKPAKRPTFRQII 407
+ RP+ Q++
Sbjct: 264 VKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 30/253 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+VAVK + E S +R+ F +E ++++ +VV+ LG V++ P ++V E + G
Sbjct: 37 TRVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94
Query: 236 DLRAFLK--------RKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
DL+++L+ G P+ ++ A +IA GM YL+ K +HRDL N +
Sbjct: 95 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 151
Query: 286 RDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG+++ + R R++APE K+ + T D++SF ++L
Sbjct: 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211
Query: 345 QEMIE-GCPPFTMKHDNEVPK-----AYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
E+ P+ + +V K Y + P P ++ +L+ CW P
Sbjct: 212 WEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ---PDNCPERVT-----DLMRMCWQFNPK 263
Query: 399 KRPTFRQIITRLE 411
RPTF +I+ L+
Sbjct: 264 MRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 27/227 (11%)
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
AF + +L+ ++ H ++V+ G V ++V EY+ G L FL R+ S +
Sbjct: 47 AFFETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKN-NVSLHWKL 104
Query: 256 --ALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGN---LKVADFGVSKLLTVK 306
A +A ++YL + K ++H ++ NIL + G +K++D G+ + +
Sbjct: 105 DVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCP-PFTMKHDNEVP 363
E+R ++APE +N + D +SF L E+ P + +E
Sbjct: 162 EERVERIP-----WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216
Query: 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
+ Y + R P A+L LI +CW P KRP+FR I+ L
Sbjct: 217 RFYQDQHRLPMPDCAELA-----NLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 21/261 (8%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L F++ EI G+F + F R ++ VA+KK+ +++ + E+ LQ
Sbjct: 12 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH + +IHRD++ NIL + G +K+ DFG + ++ P + ++APEV
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEV 182
Query: 326 ---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPAKLY 381
+YD KVDV+S + E+ E PP F M N + Y Q + +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPALQSGHW 239
Query: 382 ARGLKELIEECWNEKPAKRPT 402
+ + ++ C + P RPT
Sbjct: 240 SEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 69/267 (25%), Positives = 122/267 (45%), Gaps = 22/267 (8%)
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPN 211
EL N + KG + + + I VA+K K E D+ +R E ++ ++ +P
Sbjct: 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMR----EAEIMHQLDNPY 56
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENK 270
+V+ +G V ++ +M+V E G L FL +K + S V ++ GM YL
Sbjct: 57 IVRMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN 328
+HRDL N+L + K++DFG+SK L + + + ++ APE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGL 385
++ ++ DV+S+ + + E G P+ EV R P + P ++YA
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA--- 229
Query: 386 KELIEECWNEKPAKRPTFRQIITRLES 412
L+++CW K RP F ++ R+ +
Sbjct: 230 --LMKDCWIYKWEDRPNFAKVEERMRT 254
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 4e-18
Identities = 62/231 (26%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFAL 257
E +L+K+ P +V A + + +V + GDL+ + G L+ + ++
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
I G+ +LH + I++RD++P N+L DD GN +++D G++ + +K+ + +T + +
Sbjct: 103 QITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGT 157
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------- 369
Y+APE+ K E Y VD F+ + EM+ G PF H +V K R
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK-DHKEKVAKEELKRRTLEDEVK 216
Query: 370 -QRPPFKAPAKLYAR-GLKELIEE-----CWNEKPAKRPTFRQI-ITRLES 412
+ F +K R L + E+ N+ P K F+ I RLE+
Sbjct: 217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 5e-18
Identities = 55/233 (23%), Positives = 114/233 (48%), Gaps = 9/233 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + +++LH N+ +IHRD++ NIL G++K+
Sbjct: 101 GSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG +T ++ + T T ++APEV + Y KVD++S ++ EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
++ A P + P +L A ++ + C +R + ++++
Sbjct: 216 LNENPLRALYLIATNGTPELQNPERLSAV-FRDFLNRCLEMDVDRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 67/251 (26%), Positives = 119/251 (47%), Gaps = 23/251 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L E+ ++ + F E+ ++ +++ PN+++ L S P+ ++TEY+ GDL
Sbjct: 49 VAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 238 RAFLKRKGALKP-----------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
FL R + ST + A IA GM YL + +HRDL N L
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
+ +K+ADFG+S+ L + + + R+++ E ++ T DV++F + L
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 346 EMIEGCP--PFTMKHDNEVPKA----YAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
E++ C P++ D +V + + + R + L L +L+ CW +
Sbjct: 224 EILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKE 283
Query: 400 RPTFRQIITRL 410
RP+F++I L
Sbjct: 284 RPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 31/272 (11%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L FT+ EI G+F + F R ++ VA+KK+ +++ + E+ LQ
Sbjct: 12 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYL--PKGDLRAFLKRKGALKPSTAVRFA---LDIA 260
++RHPN +++ G + +V EY D+ K KP V A
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-----KPLQEVEIAAICHGAL 125
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
+G+ YLH ++ IHRD++ NIL + G +K+ADFG + L++ P + +
Sbjct: 126 QGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPYW 177
Query: 321 VAPEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKA 376
+APEV +YD KVDV+S + E+ E PP F M N + Y Q
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNDSPTL 234
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
+ ++ + ++ C + P RP+ +++
Sbjct: 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 7e-18
Identities = 57/233 (24%), Positives = 114/233 (48%), Gaps = 9/233 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA++++ + + +E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 45 GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + + +LH N+ +IHRD++ NIL G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG +T ++ + T T ++APEV + Y KVD++S ++ EMIEG PP+
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
++ A P + P KL A ++ + C + KR + ++++
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSAI-FRDFLNRCLDMDVEKRGSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 30/254 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L E S+ R + F+ E LL ++H ++V+F G T+ P+++V EY+ GDL
Sbjct: 38 VAVKALKE--ASESAR-QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL 94
Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
FL+ G L + A IA GM YL + +HRDL
Sbjct: 95 NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATR 151
Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N L +K+ DFG+S+ + + R R++ PE ++ T+ D++SF
Sbjct: 152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211
Query: 342 LILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKPA 398
++L E+ G P+ + E + + P P ++YA +++ CW +P
Sbjct: 212 VVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYA-----IMQGCWQREPQ 266
Query: 399 KRPTFRQIITRLES 412
+R + I +RL++
Sbjct: 267 QRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 52/161 (32%), Positives = 87/161 (54%), Gaps = 10/161 (6%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
+ E +L+ ++HP +V + A + ++ EYL G+L L+R+G TA +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
+I+ + +LH+ II+RDL+P NIL D G++K+ DFG+ K ++ E T T
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEG---TVTHTF 160
Query: 318 C---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
C Y+APE+ + VD +S ++ +M+ G PPFT
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 65/229 (28%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
+D R E+ +L+ + HPNVV+ + + ++ E++ G L A +
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THIADEQ 168
Query: 250 STAVRFALDIAR----GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
A D+AR G+ YLH I+HRD++PSN+L + + N+K+ADFGVS++L
Sbjct: 169 FLA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNE----EYDTKV-DVFSFALILQEMIEGCPPFTMKHDN 360
D P + Y++PE + YD D++S + + E G PF +
Sbjct: 221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG 279
Query: 361 EVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
+ A +PP +APA +R + I C +PAKR + Q++
Sbjct: 280 DWASLMCAICMSQPP-EAPATA-SREFRHFISCCLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 19/228 (8%)
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGAL 247
++ + + E+ +L HP +V+ LGA + I+ E+ P G + A + +G
Sbjct: 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT 108
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
+P V + + YLH K IIHRDL+ N+L G++K+ADFGVS K
Sbjct: 109 EPQIQV-ICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVS----AKN 160
Query: 308 DRPLTCQDT---SCRYVAPEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
+ L +D+ + ++APEV K+ YD K D++S + L EM + PP +
Sbjct: 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220
Query: 360 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
V A + P P+K ++ ++ ++ ++ P RP+ Q++
Sbjct: 221 MRVLLKIAKSEPPTLSQPSK-WSMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + V+ + V F +E +L P + Q A + +V EY P GDL
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ L R +F L ++ ++ +H+ + +HRD++P N+L D +G++K+ADF
Sbjct: 90 SLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADF 146
Query: 298 GVSKLLT----VKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEM 347
G + LT V P+ D Y+APEV Y + D +S +I EM
Sbjct: 147 GSAARLTANKMVNSKLPVGTPD----YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202
Query: 348 IEGCPPFT 355
I G PF
Sbjct: 203 IYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 7/182 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G AV +A +I G+ LH + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
+++D G++ + + E + + + Y+APEV KNE Y D + ++ EMIEG
Sbjct: 142 RISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
Query: 353 PF 354
PF
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 77/283 (27%), Positives = 135/283 (47%), Gaps = 56/283 (19%)
Query: 164 TKGTFILAFWR--GIQVAVKKLGEEVISDDD--RVRAFRDELALLQKI-RHPNVVQFLGA 218
T G+ LA + G VA+KK+ ++ S ++ +R E+ L+K+ HPN+V+
Sbjct: 11 TFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR----EVKSLRKLNEHPNIVKLKEV 66
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIH 276
++ + V EY+ +G+L +K RKG + +R + I +G+ ++H++ H
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFH 122
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCR-YVAPEVF-KNEEYDT 333
RDL+P N+L +K+ADFG+++ ++ P T D S R Y APE+ ++ Y +
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYT--DYVSTRWYRAPEILLRSTSYSS 178
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEV------------------PKAYA-ARQ---R 371
VD+++ I+ E+ P F +E+ P+ Y A + R
Sbjct: 179 PVDIWALGCIMAELYTLRPLF--PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236
Query: 372 PPFKAPAKLY------ARGLKELIEEC--WNEKPAKRPTFRQI 406
P AP L+ + +LI++ W+ P KRPT Q
Sbjct: 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWD--PKKRPTASQA 277
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 47/250 (18%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK+ G + + ++ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
+G+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 113 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 167
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEM-----------------IEGCPPFTMKHDNEV 362
Y++PE + Y + D++S L L EM + GCP ++E
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227
Query: 363 P----------KAYAARQRPPF---------------KAPAKLYARGLKELIEECWNEKP 397
+Y RPP K P+ ++ ++ + +C + P
Sbjct: 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNP 287
Query: 398 AKRPTFRQII 407
A+R +Q++
Sbjct: 288 AERADLKQLM 297
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 35/268 (13%)
Query: 163 ITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
I KGT+ +L G + AVK L + + D+ + A + L L HPNVV+F G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSD--HPNVVKFYG 82
Query: 218 A-----VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
V + +V E G + + FLKR ++ + G+ +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
NK IHRD++ +NIL G +K+ DFGVS LT R T T ++APEV
Sbjct: 143 NK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-WMAPEVIAC 198
Query: 329 EE-----YDTKVDVFSFALILQEMIEGCPPFT----MKHDNEVPKAYAARQRPPFKAPAK 379
E+ YD + DV+S + E+ +G PP M+ ++P R PP +
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP-----RNPPPTLHQPE 253
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQII 407
L++ + I +C + KRPT ++
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 74/251 (29%), Positives = 111/251 (44%), Gaps = 30/251 (11%)
Query: 175 GIQVAVKKLGEEVISD-DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS-----PMMI 227
G AVK L + ISD D+ + A E +LQ + HPNVV+F G ++ + +
Sbjct: 47 GSLAAVKIL--DPISDVDEEIEA---EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101
Query: 228 VTEYLPKGD----LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
V E G ++ L L + G+ +LH N+ IIHRD++ +N
Sbjct: 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNN 158
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVDVF 338
IL G +K+ DFGVS LT R T T ++APEV E+ YD + DV+
Sbjct: 159 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-WMAPEVIACEQQYDYSYDARCDVW 217
Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP--FKAPAKLYARGLKELIEECWNEK 396
S + E+ +G PP H V + + PP P K + R I +C +
Sbjct: 218 SLGITAIELGDGDPPLFDMH--PVKTLFKIPRNPPPTLLHPEK-WCRSFNHFISQCLIKD 274
Query: 397 PAKRPTFRQII 407
RP+ ++
Sbjct: 275 FEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 26/249 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEY-- 231
G +AVK++ D+ + +L ++ + P +V+F GA+ + I E
Sbjct: 29 GTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86
Query: 232 --LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
L K + K + + A+ + +NYL E + IIHRD++PSNIL D +
Sbjct: 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRN 144
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE---VFKNEEYDTKVDVFSFALILQ 345
GN+K+ DFG+S L D +D CR Y+APE + YD + DV+S + L
Sbjct: 145 GNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY 201
Query: 346 EMIEGCPPFTMKHDN------EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
E+ G P+ K ++ +V K + + ++ I C + +K
Sbjct: 202 EVATGKFPYP-KWNSVFDQLTQVVKGDPPILSN---SEEREFSPSFVNFINLCLIKDESK 257
Query: 400 RPTFRQIIT 408
RP +++++
Sbjct: 258 RPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 51/177 (28%), Positives = 96/177 (54%), Gaps = 9/177 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+KK+ + ++ A R E++LL+++ HPN+V+ L + + + +V E+L +
Sbjct: 25 GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 83
Query: 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL+ F+ + + + +G+ + H ++ ++HRDL+P N+L + G +
Sbjct: 84 -DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAI 139
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMI 348
K+ADFG+++ V R T + + Y APE+ + Y T VD++S I EM+
Sbjct: 140 KLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 10/231 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ + E +L K+ +V A + + +V + GDLR
Sbjct: 22 ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR 81
Query: 239 AFL----KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
+ + A + I G+ +LH+ + II+RDL+P N+L D+ GN+++
Sbjct: 82 YHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRI 138
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+D G++ L + + T ++APE+ + EEYD VD F+ + L EMI PF
Sbjct: 139 SDLGLAVELKDGQSKTKGYAGTP-GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
Query: 355 TMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
+ + K R P K ++ K E + P KR FR
Sbjct: 198 RARGEKVENKELKQRILNDSVTYPDK-FSPASKSFCEALLAKDPEKRLGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 69/250 (27%), Positives = 114/250 (45%), Gaps = 33/250 (13%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L + ++ + F+ E LL ++H ++V+F G P+++V EY+ GDL
Sbjct: 38 VAVKALKDPTLAAR---KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94
Query: 238 RAFLK----------------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL+ KG L S + A IA GM YL +HRDL
Sbjct: 95 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLAT 151
Query: 282 SNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
N L + +K+ DFG+S+ + + R R++ PE ++ T+ DV+SF
Sbjct: 152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEK 396
+IL E+ G P+ + EV + +RP P ++Y +++ CW +
Sbjct: 212 GVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV-CPKEVY-----DIMLGCWQRE 265
Query: 397 PAKRPTFRQI 406
P +R ++I
Sbjct: 266 PQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 51/157 (32%), Positives = 86/157 (54%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V V + +V EYL K DL+ ++ G + V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
I RG+ Y H K ++HRDL+P N+L ++ G LK+ADFG+++ +V + + + +
Sbjct: 113 ILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVVTL 168
Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P+V + EY T++D++ I EM G P F
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 4e-17
Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 25/300 (8%)
Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELD-------FTNSVEITKGTFILAFWRG 175
+ EK+ A + P K ++PE E P + T V T RG
Sbjct: 32 EAFEKYCAD--LDPEAYKKCVDLPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRG 89
Query: 176 IQVAVKKLGEEVISDDDRVRAF-RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
K + + V+ +D+R A+ R EL L H +V+ ++++ EY
Sbjct: 90 SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
GDL + LK + I ++ +H K ++HRDL+ +NI +G
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTG 206
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEM 347
+K+ DFG SK + + L + C Y+APE+++ + Y K D++S +IL E+
Sbjct: 207 IIKLGDFGFSKQYS--DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264
Query: 348 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
+ PF E+ + + PF P + G+K L++ ++ PA RPT +Q++
Sbjct: 265 LTLHRPFKGPSQREIMQQVLYGKYDPFPCPV---SSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V + + +V EYL K DL+ +L G V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ RG+NY H K ++HRDL+P N+L ++ G LK+ADFG+++ ++ + + + +
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVTL 168
Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P++ + +Y T++D++ I EM G P F
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 6e-17
Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 5/156 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E +LL+ ++H N+V + + +V EY+ + K G L P F +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
RG++Y+H+ I+HRDL+P N+L D+G LK+ADFG+++ +V + + +
Sbjct: 113 LRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLW 168
Query: 320 YVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P+V + EY T +D++ I EMI+G F
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 11/181 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI---VTEY 231
G +VA+KK+ R R EL +L+ +H N++ + V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L + DL + L F + RG+ Y+H +IHRDL+PSN+L ++
Sbjct: 89 LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCE 145
Query: 292 LKVADFGVSKLLT---VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEM 347
L++ DFG+++ L+ + +T + Y APE+ EY T +D++S I EM
Sbjct: 146 LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
Query: 348 I 348
+
Sbjct: 206 L 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 9e-17
Identities = 72/251 (28%), Positives = 120/251 (47%), Gaps = 32/251 (12%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
QV VK+L + F +E + ++H N++Q LG T+ +P ++V E+ P GD
Sbjct: 24 QVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81
Query: 237 LRAFLK--RKGAL---KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L+ +L+ RK L P+T R A +IA G+ +LH+N IH DL N L
Sbjct: 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLT 138
Query: 292 LKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKV-------DVFSFAL 342
+K+ D+G+S KED +T R++APE+ + V +V+S +
Sbjct: 139 VKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGV 197
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAYAARQ------RPPFKAPAKLYARGLKELIEECWNE 395
+ E+ E G P+ D +V Y R+ +P K P + E+++ CW
Sbjct: 198 TIWELFELGSQPYRHLSDEQV-LTYTVREQQLKLPKPRLKLP---LSDRWYEVMQFCW-L 252
Query: 396 KPAKRPTFRQI 406
+P +RP+ ++
Sbjct: 253 QPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 11/191 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L R HP + Q + V E++ GDL
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ + A +A +I + +LH+ II+RDL+ N+L D G+ K+ADF
Sbjct: 84 MFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K + T C Y+APE+ + Y VD ++ ++L EM+ G PF
Sbjct: 141 GMCK----EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
Query: 355 TMKHDNEVPKA 365
++++++ +A
Sbjct: 197 EAENEDDLFEA 207
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 56/182 (30%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 178 VAVKKLGEEVISDDDRVR--AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+KK E DD V+ A R E+ +L+++RH N+V + + + +V E++
Sbjct: 29 VAIKKFLES--EDDKMVKKIAMR-EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
L K L S ++ I RG+ + H + IIHRD++P NIL SG +K+
Sbjct: 86 VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLC 142
Query: 296 DFGVSKLLTVKEDRPLTCQD-TSCR-YVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCP 352
DFG ++ L + D + R Y APE + + +Y VD+++ ++ EM+ G P
Sbjct: 143 DFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199
Query: 353 PF 354
F
Sbjct: 200 LF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR 254
+ EL +L K P ++ F GA + + I TE++ G L + + R
Sbjct: 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGR 99
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
A+ + +G+ YL K I+HRD++PSN+L + G +K+ DFGVS L +
Sbjct: 100 IAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT 156
Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---VPKAY---AA 368
+ Y+APE E+Y DV+S + E+ G P+ N+ +P
Sbjct: 157 NA---YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV 213
Query: 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
+ PP P ++ I +C ++P +RP
Sbjct: 214 DEDPP-VLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 21/264 (7%)
Query: 148 YEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVRAFRDELA 202
Y+ DP E+ F EI G+F ++ VAVKK+ +++ + E+
Sbjct: 15 YKDDPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQ+++HPN +++ G + +V EY K L+ +G
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 133
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+ YLH + +IHRD++ NIL + G +K+ADFG + + P + ++A
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMA 185
Query: 323 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPA 378
PEV +YD KVDV+S + E+ E PP F M N + Y Q +
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNDSPTLQS 242
Query: 379 KLYARGLKELIEECWNEKPAKRPT 402
+ + ++ C + P +RP
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE 268
P +V+ G S + I E L L LKR +G + + + I + ++YL E
Sbjct: 74 PYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-- 326
V IHRD++PSNIL D SGN+K+ DFG+S L + + T Y+APE
Sbjct: 133 KHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRSAGCAAYMAPERIDP 188
Query: 327 --KNEEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
N +YD + DV+S + L E+ G P+ K + EV ++ PP P + ++
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-LTKILQEEPPSLPPNEGFSP 247
Query: 384 GLKELIEECWNEKPAKRPTFRQI-----ITRLESINNSI 417
++ C + KRP +R++ I R E+ +
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 57/181 (31%), Positives = 96/181 (53%), Gaps = 10/181 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKG 235
VA+KKL E + + + R E+ +L K++HPN+V V S+ + +V EY+ +
Sbjct: 33 VALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-EH 90
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL++ ++ K S L + G+ +LH+N I+HRDL+ SN+L ++ G LK+
Sbjct: 91 DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKI 147
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPP 353
DFG+++ +P T + Y APE+ EY T +D++S I E++ P
Sbjct: 148 CDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPL 206
Query: 354 F 354
F
Sbjct: 207 F 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 9/195 (4%)
Query: 165 KGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
KGTF IL + G A+K L +EVI D V E +LQ RHP + A
Sbjct: 5 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 64
Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
+ V EY G+L L R+ A + +I + YLH +++RD+
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDI 121
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
+ N++ D G++K+ DFG+ K T T Y+APEV ++ +Y VD +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP-EYLAPEVLEDNDYGRAVDWWG 180
Query: 340 FALILQEMIEGCPPF 354
+++ EM+ G PF
Sbjct: 181 LGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 61/235 (25%), Positives = 117/235 (49%), Gaps = 12/235 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K+L E ++ DE ++ + +P+V + LG + +S + ++T+ +P G
Sbjct: 37 IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++ K + + + + IA+GMNYL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKI 150
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCP 352
DFG++KLL E + +++A E + Y + DV+S+ + + E M G
Sbjct: 151 TDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 210
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
P+ +E+ +R P + P + + ++ +CW RP FR++I
Sbjct: 211 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 17/190 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+KK+ ++ + ++++ E +L +P VV + + +V EY+ GD
Sbjct: 30 AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
LK GAL A + + + YLH I+HRDL+P N+L G++K+ DFG
Sbjct: 90 TLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFG 146
Query: 299 VSKL----LTV--------KEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+SK+ LT K+ R + + Y+APEV + Y VD ++ +IL
Sbjct: 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206
Query: 345 QEMIEGCPPF 354
E + GC PF
Sbjct: 207 YEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK + + ++ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
RG+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 167
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKHDNEV------------PK 364
Y++PE + Y + D++S L L E+ G PP K + P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227
Query: 365 AYAARQRPPFKAPAKLY------ARGLKELIEECWNEKPAKRP 401
+ + R RPP + P + A + EL++ NE P K P
Sbjct: 228 SISPRPRPPGR-PVSGHGMDSRPAMAIFELLDYIVNEPPPKLP 269
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 3/176 (1%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 24 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L R+ A + +I ++YLH K V ++RDL+ N++ D G++K+ DFG
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFG 141
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+ K +K+ + + Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 142 LCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 20/177 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL ++ +I+H N++ + + + +V + + DL+ + RK L S L I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV-------------SKLLTVK 306
G+N LH+ +HRDL P+NI + G K+ADFG+ SK T++
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 307 EDRPLTCQDTSCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
+T + + Y APE + E+Y VD++S I E++ G P F +NE+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP--GENEI 240
|
Length = 335 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 57/253 (22%), Positives = 111/253 (43%), Gaps = 37/253 (14%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++V+ E +L + HP + + + + +V +Y P G+L
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 239 AFL-KRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L ++ G RF A ++ + YLH I++RDL+P NIL +SG++ ++D
Sbjct: 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSD 146
Query: 297 FGVSKLLTVK--------------------EDRPLTCQDT----SC----RYVAPEVFKN 328
F +SK V+ + + + S Y+APEV
Sbjct: 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL-YARGLKE 387
+ + + VD ++ ++L EM+ G PF + +E ++ + P + ++
Sbjct: 207 DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET---FSNILKKEVTFPGSPPVSSSARD 263
Query: 388 LIEECWNEKPAKR 400
LI + + P+KR
Sbjct: 264 LIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 7/182 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A K+L ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G + A+ +A +I G+ LH ++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
+++D G++ + + E + + + Y+APEV N+ Y D + ++ EMIEG
Sbjct: 142 RISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199
Query: 353 PF 354
PF
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 59/241 (24%), Positives = 117/241 (48%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L E ++ DE ++ + P V + LG + +S + +VT+ +P G
Sbjct: 37 IPVAIKVLRENTSPKANK--EILDEAYVMAGVGSPYVCRLLG-ICLTSTVQLVTQLMPYG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++ K + + + + IA+GM+YL E V ++HRDL N+L ++K+
Sbjct: 94 CLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKI 150
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
DFG+++LL + E + +++A E + + + DV+S+ + + E++ G
Sbjct: 151 TDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAK 210
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
P+ E+P +R P + P + + ++ +CW RP FR+++
Sbjct: 211 PYDGIPAREIPDLLEKGERLP-QPP--ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267
Query: 413 I 413
+
Sbjct: 268 M 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
L+ HPNVV+ T S + + +V E++ + DL +L + + + T
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 116
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+ RG+++LH ++ ++HRDL+P NIL SG +K+ADFG++++ + + LT
Sbjct: 117 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVV 171
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
+ Y APEV Y T VD++S I EM P F D
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
E +LL+ ++H N+V + + +V EYL DL+ ++ G L F
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ RG+ Y H+ + ++HRDL+P N+L + G LK+ADFG+++ +V + + + +
Sbjct: 112 LLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVVTL 167
Query: 319 RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P+V + EY T +D++ I EM G P F
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ +R P +V A + + ++ +Y+ G+L L ++ S +
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQD 315
+I +++LH+ II+RD++ NIL D G++ + DFG+SK L +E+R +
Sbjct: 112 AEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168
Query: 316 TSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---Q 370
T Y+APEV + +D VD +S ++ E++ G PFT+ + + R
Sbjct: 169 T-IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS 227
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKR 400
+PPF P + A ++ I++ + P KR
Sbjct: 228 KPPF--PKTMSAEA-RDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 4/180 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A+K L +EVI D V E +L+ RHP + + + V EY+
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L L R+ + +I ++YLH K I++RDL+ N++ D G++K+
Sbjct: 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKI 136
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG+ K + + + + Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 137 TDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 10/203 (4%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
KGTF IL + A+K L +EVI D V E +LQ RHP + +
Sbjct: 5 KGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF 64
Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
+ V EY G+L L R+ A + +I + YLH +++RDL
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDL 121
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
+ N++ D G++K+ DFG+ K T T Y+APEV ++ +Y VD +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP-EYLAPEVLEDNDYGRAVDWWG 180
Query: 340 FALILQEMIEGCPPFTMKHDNEV 362
+++ EM+ G PF + D+E
Sbjct: 181 LGVVMYEMMCGRLPFYNQ-DHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRH-PNVVQFLGA--VTQSSP---MMIVT 229
VA+KK E D++ + A R E++LLQ + +V+ L V + + + +V
Sbjct: 29 VALKKTRLE--MDEEGIPPTALR-EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85
Query: 230 EYLPKGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
EYL DL+ F+ G L T F + +G+ + H++ ++HRDL+P N+
Sbjct: 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNL 141
Query: 285 LRDDSGN-LKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEV-FKNEEYDTKVDVFS 339
L D LK+AD G+ + ++ P+ T + + Y APEV + Y T VD++S
Sbjct: 142 LVDKQKGLLKIADLGLGRAFSI----PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWS 197
Query: 340 FALILQEMIEGCPPF 354
I EM P F
Sbjct: 198 VGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 23/197 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVTQSS-----P 224
G++VA+KK IS + R R E+ +L++ +H N++ L + S
Sbjct: 29 TGVKVAIKK-----ISPFEHQTFCQRTLR-EIKILRRFKHENIIGILDIIRPPSFESFND 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+ IV E + DL +K + L F I RG+ Y+H ++HRDL+PSN+
Sbjct: 83 VYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNL 137
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFA 341
L + + +LK+ DFG++++ + D LT + Y APE+ N + Y +D++S
Sbjct: 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVG 197
Query: 342 LILQEMIEGCPPFTMKH 358
IL EM+ P F K
Sbjct: 198 CILAEMLSNRPLFPGKD 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 62/236 (26%), Positives = 112/236 (47%), Gaps = 15/236 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G QVAVKK+ + R +E+ +++ H NVV + + +V E+L
Sbjct: 47 GKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + A L + R ++YLH +IHRD++ +IL G +K+
Sbjct: 104 GALTDIVTHTRMNEEQIAT-VCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+DFG ++ + + + T ++APEV Y T+VD++S +++ EMI+G PP+
Sbjct: 160 SDFGFCAQVSKEVPKRKSLVGTP-YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
Query: 355 TMKHDNEVPKAYAARQR---PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
NE P R R PP + + L+ ++ +P++R T ++++
Sbjct: 219 F----NEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E +LL+ ++H N+V + + V EY+ + ++ G L P F +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
RG+ Y+H I+HRDL+P N+L G LK+ADFG+++ + + Q S
Sbjct: 113 LRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSE 163
Query: 320 -----YVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P+V +Y + +D++ I EM++G P F
Sbjct: 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 57/205 (27%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
VRA RD LA + +P VV+ + + + ++ EYLP GD+ L +K
Sbjct: 48 VRAERDILA---EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET- 103
Query: 254 RF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL--- 303
RF A+D + Y IHRD++P N+L D G++K++DFG+ L
Sbjct: 104 RFYIAETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154
Query: 304 -------TVKEDRPLTCQDTSCR---------------------------YVAPEVFKNE 329
+ P D + Y+APEVF
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214
Query: 330 EYDTKVDVFSFALILQEMIEGCPPF 354
Y+ + D +S +I+ EM+ G PPF
Sbjct: 215 GYNKECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 39/203 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+KK+ + + + A R E+ +L+++ H N+V IVT+ K
Sbjct: 32 GELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNL---------KEIVTD---K 78
Query: 235 GDLRAFLKRKGA--------------LKPSTAVRFALD--------IARGMNYLHENKPV 272
D F K KGA L S V F+ D + G+NY H+
Sbjct: 79 QDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN-- 136
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-Y 331
+HRD++ SNIL ++ G +K+ADFG+++L +E RP T + + Y PE+ EE Y
Sbjct: 137 -FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 195
Query: 332 DTKVDVFSFALILQEMIEGCPPF 354
+DV+S IL E+ P F
Sbjct: 196 GPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 16/165 (9%)
Query: 200 ELALLQKIR---HPNVVQFLGAVT-----QSSPMMIVTEYLPKGDLRAFLKRKGA--LKP 249
E+ALL+++ HPN+V+ + + + + +V E++ + DLR +L + L
Sbjct: 49 EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA 107
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
T RG+++LH N I+HRDL+P NIL G +K+ADFG++++ + +
Sbjct: 108 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--M 162
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
LT + Y APEV Y T VD++S I EM P F
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-15
Identities = 30/60 (50%), Positives = 39/60 (65%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A ++E +K LL+ G DVN +D D TALH+AA G E+V LLLE GAD++ KD
Sbjct: 32 LHLAARNGNLEIVKLLLEHGADVNAKDKDGNTALHLAARNGNLEIVKLLLEHGADINLKD 91
|
Length = 91 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 8/180 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L ++ I V E +L + P +V + S + +VT+Y+ G
Sbjct: 22 AMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
+L L+++G A + ++ + +LH+ I++RDL+P NIL D +G++ +
Sbjct: 82 ELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALC 138
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPF 354
DFG+SK T T+ Y+APEV +E+ Y VD +S +++ EM G PF
Sbjct: 139 DFGLSKANLTDNKTTNTFCGTT-EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 10/215 (4%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
+ E+ +++ +H N+V + G+ + + I E+ G L+ G L S +
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR 113
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
+ +G+ YLH +HRD++ +NIL D+G++K+ADFGVS +T + + T
Sbjct: 114 ETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTP 170
Query: 318 CRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV--PKAYAARQRP 372
++APEV E Y+ D+++ + E+ E PP H + Q P
Sbjct: 171 -YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229
Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
K K ++ ++ + P KRPT +++
Sbjct: 230 KLKDKMK-WSNSFHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 17/185 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
G +VA+KK+ + R FR EL +L +H NV L A+ P +
Sbjct: 25 GKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNV---LSALDILQPPHIDPFEEIY 80
Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
+VTE L + DL + L F I RG+ YLH I+HRD++P N+L
Sbjct: 81 VVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLV 136
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQ 345
+ + LK+ DFG++++ E + +T + + Y APE+ + Y + VD++S I
Sbjct: 137 NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196
Query: 346 EMIEG 350
E++
Sbjct: 197 ELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 8e-15
Identities = 60/234 (25%), Positives = 115/234 (49%), Gaps = 12/234 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L E + F DE ++ + HP++V+ LG V S + +VT+ +P G
Sbjct: 37 IPVAIKILNETTGPKANV--EFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHG 93
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L ++ + K + + + + IA+GM YL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKI 150
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
DFG+++LL E + +++A E ++ + DV+S+ + + E++ G
Sbjct: 151 TDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 210
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
P+ E+P +R P + P + + ++ +CW RP F+++
Sbjct: 211 PYDGIPTREIPDLLEKGERLP-QPP--ICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 62/253 (24%), Positives = 113/253 (44%), Gaps = 12/253 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G A+ +A ++ G+ L + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
+++D G++ + + E + + + Y+APEV NE+Y D + ++ EMI+G
Sbjct: 142 RISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
Query: 353 PFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ---IIT 408
PF K V + R+ + + ++ ++ K + + P +R R
Sbjct: 200 PFR-KRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV 258
Query: 409 RLESINNSINHKR 421
+ I +IN KR
Sbjct: 259 KQHPIFKNINFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 59/183 (32%), Positives = 96/183 (52%), Gaps = 14/183 (7%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+A+KK+ E +D+ V A R E++LL++++H N+V+ V + +V EYL
Sbjct: 30 IALKKIRLE--QEDEGVPSTAIR-EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL- 85
Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-L 292
DL+ + A P + I RG+ Y H ++ ++HRDL+P N+L D N L
Sbjct: 86 DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNAL 142
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGC 351
K+ADFG+++ + R T + + Y APE+ + Y T VD++S I EM+
Sbjct: 143 KLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
Query: 352 PPF 354
P F
Sbjct: 202 PLF 204
|
Length = 294 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 23/228 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY--- 231
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T + ++
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98
Query: 232 LP--KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
+P DL +K + L + +G+ Y+H IIHRDL+P N+ ++
Sbjct: 99 MPFMGTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNED 154
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
LK+ DFG+++ + D +T + Y APEV N Y VD++S I+ EM+
Sbjct: 155 CELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
Query: 349 EGCPPFT-MKHDNEVPKAYAARQRPPFKAPAKL-------YARGLKEL 388
G P F H +++ + P + KL Y + L
Sbjct: 211 TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF 258
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFL-KRKGALKPSTAVRFA 256
E LLQ + HP+V++ + + +V LP DL +L KR L A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
I G+ YLH + IIHRD++ NI +D + + D G ++ V L T
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLAGT 219
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
APEV ++Y++K D++S ++L EM+
Sbjct: 220 -VETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 17/173 (9%)
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
AL + F+ +A+GM++L IHRDL NIL K+ DFG+++ +
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR--DI 264
Query: 306 KEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDN 360
+ D + + +++APE N Y + DV+S+ ++L E+ G P+ M D+
Sbjct: 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
Query: 361 EVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
+ K R P AP+++Y ++++ CW+ P KRPTF+QI+ +E
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMY-----DIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 58/183 (31%), Positives = 93/183 (50%), Gaps = 17/183 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
G++VAVKKL S R +R EL LL+ ++H NV+ L T + + + +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
+L DL +K + V+F + I RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 101 THLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEM 347
LK+ DFG+++ D +T + Y APE+ N Y+ VD++S I+ E+
Sbjct: 156 DCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211
Query: 348 IEG 350
+ G
Sbjct: 212 LTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 43/123 (34%), Positives = 71/123 (57%), Gaps = 9/123 (7%)
Query: 193 RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA 252
+V+A RD LAL + P +V ++ ++ + +V EYL GD+++ L G A
Sbjct: 50 QVQAERDALAL---SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA 106
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
V++ ++A ++YLH + IIHRDL+P N+L + G++K+ DFG+SK V +R L
Sbjct: 107 VKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK---VTLNRELN 160
Query: 313 CQD 315
D
Sbjct: 161 MMD 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 46/177 (25%), Positives = 88/177 (49%), Gaps = 4/177 (2%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK + +++ + R EL +L+ ++ N+V+ A + + +V EY+ K L
Sbjct: 29 VAIKKFKDSEENEEVKETTLR-ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ + P + + + +++ H+N I+HRD++P N+L + LK+ DF
Sbjct: 88 ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDF 144
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G ++ L+ + T + Y +PE+ Y VD++S IL E+ +G P F
Sbjct: 145 GFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 64/194 (32%), Positives = 101/194 (52%), Gaps = 30/194 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM---IVTEYLP 233
VA+KK+ + + D R FR E+ LQ++ HPN+V+ L V ++ +V EY+
Sbjct: 35 VALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYM- 91
Query: 234 KGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
+ DL A + R L+ R+ + + + + Y+H +IHRDL+PSNIL + +
Sbjct: 92 ETDLHAVI-RANILED-VHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRV 146
Query: 293 KVADFGVSKLLTVKEDRP----LTCQDTSCRYVA------PEV-FKNEEYDTKVDVFSFA 341
K+ADFG+++ L+ E+ P LT YVA PE+ + Y VD++S
Sbjct: 147 KLADFGLARSLSELEENPENPVLT------DYVATRWYRAPEILLGSTRYTKGVDMWSVG 200
Query: 342 LILQEMIEGCPPFT 355
IL EM+ G P F
Sbjct: 201 CILGEMLLGKPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 69/264 (26%), Positives = 122/264 (46%), Gaps = 19/264 (7%)
Query: 151 DPHELDFTNSVEITKG-TFILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP L N ++I +G T I+ R G QVAVK + + R +E+ +++
Sbjct: 18 DPRSL-LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 73
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+H NVV+ + + ++ E+L G L + + L + + + Y
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCY 132
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY-VAPE 324
LH +IHRD++ +IL G +K++DFG + +D P Y +APE
Sbjct: 133 LHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPE 187
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP-AKLYAR 383
V Y T+VD++S +++ EM++G PP+ D+ V R PP K A +
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF--SDSPVQAMKRLRDSPPPKLKNAHKISP 245
Query: 384 GLKELIEECWNEKPAKRPTFRQII 407
L++ +E +P +R T ++++
Sbjct: 246 VLRDFLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 8/223 (3%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
D + E+ ++++ +H N+V + G+ + I EY G L+ G L
Sbjct: 48 DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
+ +G+ YLH +HRD++ +NIL D+G++K+ADFGV+ +T +
Sbjct: 108 IAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164
Query: 312 TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368
+ T ++APEV KN Y+ D+++ + E+ E PP H +
Sbjct: 165 SFIGTP-YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK 223
Query: 369 RQRPPFKAPAKL-YARGLKELIEECWNEKPAKRPTFRQIITRL 410
P K K ++ ++ + P KRPT +++T L
Sbjct: 224 SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 56/184 (30%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-----QSSPMMIVTEY 231
+VA+KK+ + D R R E+ LL+ + H NV+ + + + IV E
Sbjct: 32 KVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE- 89
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L DL ++ L F + RG+ Y+H ++HRDL+PSN+L + + +
Sbjct: 90 LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCD 146
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
LK+ DFG+++ + K D +T + Y APE+ N EY T +DV+S I E++
Sbjct: 147 LKICDFGLARTTSEKGDF-MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR 205
Query: 351 CPPF 354
P F
Sbjct: 206 KPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 27/168 (16%)
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR----- 309
++ +A+GM +L K IHRDL NIL ++ +K+ DFG+++ + D
Sbjct: 184 YSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 310 ---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDNEVPK 364
PL +++APE + Y + DV+SF ++L E+ G P+ +K D E +
Sbjct: 241 ARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 293
Query: 365 AY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
R R P ++Y L +CW+ +P++RPTF +++ L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTML-----DCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ IR P +V A + + ++ +Y+ G+L L ++ K ++
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+I + +LH+ + II+RD++ NIL D +G++ + DFG+SK E
Sbjct: 112 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168
Query: 317 SCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QR 371
+ Y+AP++ + + +D VD +S +++ E++ G PFT+ + + R
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228
Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKR 400
PP+ P ++ A K++I+ + P KR
Sbjct: 229 PPY--PQEMSALA-KDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 178 VAVKKLGEEVISDDD---RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+KK E S+DD + A R E+ +L++++HPN+V + + + +V EY
Sbjct: 29 VAIKKFVE---SEDDPVIKKIALR-EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L K + + + +N+ H++ IHRD++P NIL G +K+
Sbjct: 85 TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKL 141
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCP 352
DFG +++LT D T Y APE+ + +Y VDV++ + E++ G P
Sbjct: 142 CDFGFARILTGPGDDYTDYVATRW-YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 23/193 (11%)
Query: 232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
+++ L G+ L + F +ARGM +L V HRDL N+L
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQG 273
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+K+ DFG+++ + D + ++ +++APE + Y T DV+S+ ++L E
Sbjct: 274 KIVKICDFGLAR--DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331
Query: 347 MIE--GCPPFTMKHD----NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
+ G P M D N++ Y R P A ++Y +++ +CWN +P KR
Sbjct: 332 IFSLGGTPYPGMIVDSTFYNKIKSGY--RMAKPDHATQEVY-----DIMVKCWNSEPEKR 384
Query: 401 PTFRQIITRLESI 413
P+F + +ES+
Sbjct: 385 PSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 31 LDDDGEEIKPE---FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHV---AACQG 84
+D+ +I E + + A+ VE ++ LL +G DVNFR +T LH+ + +
Sbjct: 2 EEDESVDIIMEAALYDYLLNASNVTVEEVRRLLAAGADVNFRGEYGKTPLHLYLHYSSEK 61
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE-VIKLLEKHGA 130
++V LLLE GADV+ +R G TPL +Y VIKLL K GA
Sbjct: 62 VKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGA 108
|
Length = 471 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 58/186 (31%), Positives = 87/186 (46%), Gaps = 23/186 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
GI VAVKKL + RA+R EL LL+ + H N++ L T P + E+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT---PQKSLEEF--- 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNI 284
D+ ++ A + LD R G+ +LH IIHRDL+PSNI
Sbjct: 99 QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 154
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ LK+ DFG+++ T + +T + Y APEV Y VD++S I+
Sbjct: 155 VVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212
Query: 345 QEMIEG 350
E+++G
Sbjct: 213 GELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 27/168 (16%)
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR----- 309
++ +ARGM +L K IHRDL NIL ++ +K+ DFG+++ + D
Sbjct: 178 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 310 ---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDNEVPK 364
PL +++APE ++ Y T+ DV+SF ++L E+ G P+ ++ D E +
Sbjct: 235 ARLPL-------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287
Query: 365 AY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
R R P A ++Y+ L +CW+ P RPTF +++ L
Sbjct: 288 RLKEGTRMRAPEYATPEIYSIML-----DCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 22/196 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----MMIVT 229
G +VA+KK+ + D R R E+ LL+ +RHP++V+ + S + +V
Sbjct: 25 GEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
E L + DL +K L P F + R + Y+H + HRDL+P NIL +
Sbjct: 84 E-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANAD 139
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--------YDTKVDVFSFA 341
LK+ DFG++++ D P T YVA ++ E Y +D++S
Sbjct: 140 CKLKICDFGLARVAF--NDTPTAIFWTD--YVATRWYRAPELCGSFFSKYTPAIDIWSIG 195
Query: 342 LILQEMIEGCPPFTMK 357
I E++ G P F K
Sbjct: 196 CIFAEVLTGKPLFPGK 211
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY----- 231
+VAVKKL S R +R EL LL+ ++H NV+ L T ++ + E
Sbjct: 42 KVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L DL +K + L + RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 101 LMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCE 156
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
L++ DFG+++ + D +T + Y APE+ N Y+ VD++S I+ E+++G
Sbjct: 157 LRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 24/170 (14%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
F +E ++ P VVQ A + +V EY+P GDL + K A +
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
V ALD M + IHRD++P N+L D SG+LK+ADFG + + ++ +
Sbjct: 150 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMV 198
Query: 312 TCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
C DT+ Y++PEV K++ Y + D +S + L EM+ G PF
Sbjct: 199 RC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 26/203 (12%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF--------------LGAVTQS 222
+VAVKK+ V++D V+ E+ +++++ H N+V+ +G++T+
Sbjct: 32 RVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ + IV EY+ + DL L+ +G L A F + RG+ Y+H ++HRDL+P+
Sbjct: 89 NSVYIVQEYM-ETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143
Query: 283 NIL-RDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE-VFKNEEYDTKVDVF 338
N+ + LK+ DFG+++++ L+ + Y +P + Y +D++
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 203
Query: 339 SFALILQEMIEGCPPFTMKHDNE 361
+ I EM+ G P F H+ E
Sbjct: 204 AAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 19/161 (11%)
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
++ +ARGM +L K IHRDL NIL ++ +K+ DFG+++ + +D P +
Sbjct: 179 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR--DIYKD-PDYVR 232
Query: 315 DTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDNEVPKAY-- 366
S R ++APE ++ Y T+ DV+SF ++L E+ G P+ ++ + E +
Sbjct: 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD 292
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
R R P A ++Y ++ CW P +RPTF ++
Sbjct: 293 GTRMRAPENATPEIY-----RIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VAVKK+ + R +E+ +++ +H NVV+ + + +V E+L
Sbjct: 45 GKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + A L + + ++ LH +IHRD++ +IL G +K+
Sbjct: 102 GALTDIVTHTRMNEEQIAA-VCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 157
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+DFG ++ + R + T ++APE+ Y +VD++S +++ EM++G PP+
Sbjct: 158 SDFGFCAQVSKEVPRRKSLVGTP-YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
Query: 355 ---------TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
M DN PK + P LK ++ PA+R T +
Sbjct: 217 FNEPPLKAMKMIRDNLPPKLKNLHKVSPS----------LKGFLDRLLVRDPAQRATAAE 266
Query: 406 II 407
++
Sbjct: 267 LL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 59/188 (31%), Positives = 83/188 (44%), Gaps = 25/188 (13%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL 232
G VA+KKL + RA+R EL L++ + H N++ L T Q S YL
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPS 282
+ A L ++ LD R G+ +LH IIHRDL+PS
Sbjct: 99 VMELMDANL--------CQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS 147
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
NI+ LK+ DFG+++ T +T + Y APEV Y VD++S
Sbjct: 148 NIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 205
Query: 343 ILQEMIEG 350
I+ EMI G
Sbjct: 206 IMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 34/199 (17%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229
VA+KK+ +++++ RA R EL LL+ R H N+ M IV
Sbjct: 27 EETVAIKKITNVFSKKILAK----RALR-ELKLLRHFRGHKNITCLYD-------MDIVF 74
Query: 230 ----------EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
E L + DL ++ L + F I G+ Y+H ++HRDL
Sbjct: 75 PGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDL 131
Query: 280 EPSNILRDDSGNLKVADFGVSKLLT---VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKV 335
+P N+L + LK+ DFG+++ + + +T + Y APE+ + Y +
Sbjct: 132 KPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI 191
Query: 336 DVFSFALILQEMIEGCPPF 354
DV+S IL E++ P F
Sbjct: 192 DVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 218 AVTQSSPMMI-VTEYLP----KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
A +SS +YLP + + AL V F+ +A GM +L V
Sbjct: 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNE 329
HRDL N+L + +K+ DFG+++ + D + ++ +++APE N
Sbjct: 262 ---HRDLAARNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLPLKWMAPESIFNN 316
Query: 330 EYDTKVDVFSFALILQEM--IEGCP----PFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
Y T DV+SF ++L E+ + G P P + N + + Y R P A ++Y
Sbjct: 317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY--RMAKPAHASDEIY-- 372
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
E++++CW EK RP F Q++ + +
Sbjct: 373 ---EIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 60/279 (21%), Positives = 122/279 (43%), Gaps = 33/279 (11%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGI----QVAVKKLGEEVISDDDRVRAFRDELALLQ 205
I+ ++D SV I + + ++GI +V ++ + + +E+ L+
Sbjct: 15 IESDDIDKYTSVLIKEND-QNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLR 73
Query: 206 KIRHPNVVQFLG---AVTQSSP-MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
+I N+++ G + P + ++ EY +G LR L ++ L T + A+D +
Sbjct: 74 RIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCK 133
Query: 262 GMNYLHE--NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
G+ L++ NKP +++L + L ++ LK+ G+ K+L+ P
Sbjct: 134 GLYNLYKYTNKP----YKNLTSVSFLVTENYKLKIICHGLEKILSS----PPFKNVNFMV 185
Query: 320 YVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPF-----TMKHDNEVPKAYAARQRP 372
Y + ++ + EY K D++S ++L E+ G PF +D + K + +
Sbjct: 186 YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS--LKL 243
Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
P P +K ++E C + KRP ++I+ L
Sbjct: 244 PLDCP-----LEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 58/184 (31%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIV 228
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T + +V
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRD 287
Y+ + DL+ K G V++ + + G+ Y+H IIHRDL+P N+ +
Sbjct: 99 MPYM-QTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQE 346
+ LK+ DFG+++ D +T + Y APEV N Y+ VD++S I+ E
Sbjct: 152 EDCELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAE 207
Query: 347 MIEG 350
M+ G
Sbjct: 208 MLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF- 255
F +E ++ P VVQ A + +V EY+P GDL + P +F
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV--PEKWAKFY 147
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
++ ++ +H + +IHRD++P N+L D G+LK+ADFG + + E + C D
Sbjct: 148 TAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRC-D 201
Query: 316 TSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
T+ Y++PEV K++ Y + D +S + L EM+ G PF
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 34/191 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM---------IV 228
VA+KK+ E + + A R E+ +LQ ++H NVV L + ++ +V
Sbjct: 40 VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN-LIEICRTKATPYNRYKGSFYLV 97
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIAR-------GMNYLHENKPVPIIHRDLE 280
E+ DL L K V+F L +I + G+ Y+H NK I+HRD++
Sbjct: 98 FEFCEH-DLAGLLSNK-------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMK 146
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNE-EYDTKVD 336
+NIL G LK+ADFG+++ ++ ++ + Y PE+ E +Y +D
Sbjct: 147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPID 206
Query: 337 VFSFALILQEM 347
++ I+ EM
Sbjct: 207 MWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 24/157 (15%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMN 264
+VQ A + +V EY+P GDL + K A + V ALD M
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYV 321
+ IHRD++P N+L D SG+LK+ADFG + + + + C DT+ Y+
Sbjct: 163 F---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRC-DTAVGTPDYI 210
Query: 322 APEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
+PEV K++ Y + D +S + L EM+ G PF
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 37/82 (45%), Positives = 45/82 (54%)
Query: 47 LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
LA D G + LL G D N RD D RT LH+A G +VV +LLE GAD D+ G
Sbjct: 89 LAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDG 148
Query: 107 STPLGDAIYYKNHEVIKLLEKH 128
TPL A EV++LL +H
Sbjct: 149 KTPLELAEENGFREVVQLLSRH 170
|
Length = 664 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 37/210 (17%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + + ++V R E +L + VV+ + + ++ E+LP GD+
Sbjct: 30 AMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L +K L + + ++ +H+ + IHRD++P N+L D G++K++DFG
Sbjct: 90 TLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFG 146
Query: 299 V--------------------------------SKLLTVKEDRPLTCQDT--SCRYVAPE 324
+ K T K++R T + Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
VF Y+ D +S +I+ EM+ G PPF
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 9e-12
Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV----RFALDIARG 262
++HPN++Q LG ++ P ++V EY GDL+++L ++ + ++ + R A +IA G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---R 319
+ ++H++ +H DL N +KV D+G+ KED + +D C R
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDY-IETEDDKCVPLR 166
Query: 320 YVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV-PKAYAARQ 370
++APE+ E +V++ + L E+ E P++ D EV +Q
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ 226
Query: 371 RPPFKAPAKL-YARGLKELIEECWNEKPAKRPTFRQI 406
FK +L Y+ E+++ CW P KR T ++
Sbjct: 227 VKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 50/171 (29%), Positives = 86/171 (50%), Gaps = 27/171 (15%)
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL------TVK 306
+RF+ +A+GM++L IHRD+ N+L D K+ DFG+++ + VK
Sbjct: 215 LRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF-----TMKHDN 360
+ L +++APE + Y + DV+S+ ++L E+ G P+ K
Sbjct: 272 GNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
Query: 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
V + Y RP F AP ++Y+ +++ CWN +P +RPTF QI ++
Sbjct: 327 MVKRGYQM-SRPDF-APPEIYS-----IMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + + ++V R E +L + VV+ + + ++ E+LP GD+
Sbjct: 30 AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L +K L + + ++ +H+ + IHRD++P N+L D G++K++DFG
Sbjct: 90 TLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFG 146
Query: 299 V--------------------------------SKLLTVKEDRPLTCQDT--SCRYVAPE 324
+ K T K +R T + Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364
VF Y+ D +S +I+ EM+ G PPF + E K
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYK 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 51/209 (24%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ +R P +V A + + ++ +Y+ G++ L ++ ++
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQD 315
+I + +LH+ + I++RD++ NIL D G++ + DFG+SK L+ +++R +
Sbjct: 112 GEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG 168
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QR 371
T Y+APE+ + + K VD +S +++ E++ G PFT++ + + R
Sbjct: 169 TI-EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD 227
Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKR 400
PPF + A+ +L+ + + P KR
Sbjct: 228 PPFPSFIGPEAQ---DLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 48/203 (23%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
V+A RD LA + + VV+ + + V +Y+P GD+ + L R G + A
Sbjct: 48 VKAERDILA---EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV-------------- 299
+ ++ + +H+ + IHRD++P NIL D G++K+ DFG+
Sbjct: 105 FYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 300 ------------SKLLTVKEDRPLTC-------QDTSCR---------YVAPEVFKNEEY 331
S+ + + L Q C Y+APEV Y
Sbjct: 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221
Query: 332 DTKVDVFSFALILQEMIEGCPPF 354
D +S +IL EM+ G PPF
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 40/121 (33%), Positives = 68/121 (56%), Gaps = 7/121 (5%)
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
GDL L + G + +A +I G+ ++H N+ V ++RDL+P+NIL D+ G++++
Sbjct: 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-NRFV--VYRDLKPANILLDEHGHVRI 138
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPP 353
+D G++ + K +P T Y+APEV K YD+ D FS +L +++ G P
Sbjct: 139 SDLGLACDFSKK--KPHASVGTH-GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
Query: 354 F 354
F
Sbjct: 196 F 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 33/77 (42%), Positives = 48/77 (62%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+ IK +LD GIDVN +D + +T LH A +G E + +L E GADV+ +D G P+ A
Sbjct: 105 DMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIA 164
Query: 114 IYYKNHEVIKLLEKHGA 130
I + ++IKLL + GA
Sbjct: 165 IKHNFFDIIKLLLEKGA 181
|
Length = 434 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKGDLRAFLK-----RKGALKPSTA 252
E+ALL++++H NVV + + + + + +Y + DL +K ++ ++ PS
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLTVKED 308
I G++YLH N ++HRDL+P+NIL + G +K+ D G+++L
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPL 166
Query: 309 RPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPF 354
+PL D + Y APE+ + TK +D+++ I E++ P F
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 7/158 (4%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
R L+L+ P +V A + + + + GDL L + G +A
Sbjct: 45 RIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT 104
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
+I G+ ++H +++RDL+P+NIL D+ G+++++D G++ + K +P T
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTH 159
Query: 318 CRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y+APEV K YD+ D FS +L +++ G PF
Sbjct: 160 -GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 54/187 (28%), Positives = 94/187 (50%), Gaps = 19/187 (10%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ +V +Y GDLR +K + + A + + ++++H +IHRD++
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIK 170
Query: 281 PSNILRDDSGNLKVADFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
+NIL +G +K+ DFG SK+ TV +D T T YVAPE+++ + Y K D+F
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP-YYVAPEIWRRKPYSKKADMF 229
Query: 339 SFALILQEMIEGCPPFTMKHDNEV-PKAYAAR--QRPPFKAPAKLYARGLKELIEECWNE 395
S ++L E++ PF ++ EV K A R PP +P ++E++ +
Sbjct: 230 SLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPE------MQEIVTALLSS 283
Query: 396 KPAKRPT 402
P +RP+
Sbjct: 284 DPKRRPS 290
|
Length = 496 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 8/138 (5%)
Query: 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
G+D + ++ + + L + + D+E IK L + G DVN D + +H+A F +++
Sbjct: 114 GIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDII 173
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA------KPLMAPMH--VKH 141
LLLE+GA + KD G +PL +A Y ++ IKLL HG K P+H + H
Sbjct: 174 KLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNAIIH 233
Query: 142 AREVPEYEIDPHELDFTN 159
R E I+ ++ +
Sbjct: 234 NRSAIELLINNASINDQD 251
|
Length = 434 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFLKRKGALKPSTAVRFAL 257
E +L+ I HP+++Q G T + ++ LP K DL +L K + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL-LTVKEDRPLTCQDT 316
+ R + YLHEN+ IIHRD++ NI + G++ + DFG + + + ++ T
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
APE+ + Y VD++S ++L EM
Sbjct: 247 IATN-APELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 46/214 (21%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
E+ +L+ I H ++ + A S + M++ +Y K DL ++ R G L A+
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTYVDRSGPLPLEQAITIQRR 193
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL------T 312
+ + YLH IIHRD++ NI D+ N + DFG + L D P T
Sbjct: 194 LLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM-IEGCPPFTMK-------------- 357
+ S PE+ + Y K D++S L+L EM ++ F +
Sbjct: 251 LETNS-----PELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305
Query: 358 ---HDNEVP-----------KAYAARQRPPFKAP 377
H E P K YA RPP+ P
Sbjct: 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIP 339
|
Length = 392 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 9e-11
Identities = 56/184 (30%), Positives = 85/184 (46%), Gaps = 23/184 (12%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VA+KKL + RA+R EL L++ + H N++ L T P + E+ D
Sbjct: 51 NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT---PQKSLEEF---QD 103
Query: 237 LRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILR 286
+ ++ A ++ LD R G+ +LH IIHRDL+PSNI+
Sbjct: 104 VYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVV 159
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
LK+ DFG+++ T +T + Y APEV Y VD++S I+ E
Sbjct: 160 KSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 347 MIEG 350
MI+G
Sbjct: 218 MIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 18/190 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVKK+ + + ++ + E+ ++++HPN++ ++ + S + +V+ + G
Sbjct: 28 VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86
Query: 238 RAFLKR--KGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
LK L P A+ F L D+ ++Y+H IHR ++ S+IL G + +
Sbjct: 87 EDLLKTHFPEGL-PELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVL 142
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRY-------VAPEVFKN--EEYDTKVDVFSFALILQ 345
+ S + +K + + ++PEV + + Y+ K D++S +
Sbjct: 143 SGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC 201
Query: 346 EMIEGCPPFT 355
E+ G PF
Sbjct: 202 ELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 3e-10
Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KKL + RA+R EL L++ + H N++ L T P + E+ D+
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKSLEEF---QDV 97
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
++ A ++ LD R G+ +LH IIHRDL+PSNI+
Sbjct: 98 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 153
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
LK+ DFG+++ T +T + Y APEV Y VD++S I+ EM
Sbjct: 154 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 348 I 348
+
Sbjct: 212 V 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 52/207 (25%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
V+A RD LA + P VV + + + ++ E+LP GDL L +
Sbjct: 48 VKAERDVLA---ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS------------- 300
+ + + +H+ + IHRD++P NIL D G++K++DFG+S
Sbjct: 105 FYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 301 KLLTVKEDRP----------------LTCQDT-----------------SCRYVAPEVFK 327
KLL K ++ ++ +D + Y+APE+F
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPF 354
+ Y + D +S I+ E + G PPF
Sbjct: 222 QQGYGQECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 49/222 (22%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + + ++V + E +L + + VV+ + + V +Y+P GD+
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L R A + ++ + +H+ + IHRD++P NIL D G++K+ DFG
Sbjct: 90 SLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFG 146
Query: 299 V-------------SKLLTVKED--RPLTCQD--TSCR---------------------- 319
+ K +++D P D ++CR
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206
Query: 320 -------YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y+APEV + Y D +S +IL EM+ G PPF
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 49/222 (22%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++V + E +L + + VV+ + + V +Y+P GD+
Sbjct: 30 AMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L R G A + ++ + +H+ + IHRD++P NIL D G++K+ DFG
Sbjct: 90 SLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG 146
Query: 299 V---------SKLLT----VKEDR---------PLTC---------------QDTSC--- 318
+ SK V++D P C Q C
Sbjct: 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH 206
Query: 319 ------RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y+APEV Y D +S +IL EM+ G PPF
Sbjct: 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 38/239 (15%)
Query: 200 ELALLQKIRHPNVVQ----FLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPST 251
E+ ++++++H N+V+ FL Q + I+ E+ GDL + K G ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQK--LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119
Query: 252 AVRFALDIARGMNYLHENKPVP----IIHRDLEPSNI-----------LRDDSGNL---- 292
V + + Y H K P ++HRDL+P NI + + NL
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 293 --KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMI 348
K+ DFG+SK + + E +C T Y +PE+ +E YD K D+++ I+ E+
Sbjct: 180 IAKIGDFGLSKNIGI-ESMAHSCVGTP-YYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
G PF N + + +R P P K ++ L LI+ N +RP+ Q +
Sbjct: 238 SGKTPF--HKANNFSQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 23/232 (9%)
Query: 189 SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL 247
S D AF + +L+ ++ H ++ G + S ++V E++ G L L++ KG +
Sbjct: 55 SHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV 114
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFGVS 300
+ + A +A ++YL E+K ++H ++ NIL G +K++D GVS
Sbjct: 115 PVAWKITVAQQLASALSYL-EDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171
Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEM-IEGCPPFTMKH 358
+E+R ++APE T D +SF L E+ +G P +
Sbjct: 172 FTALSREERV-----ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226
Query: 359 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
+E + Y + R P P+ + L LI +C +P +RP+FR I+ L
Sbjct: 227 PSEKERFYEKKHRLP--EPS---CKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE-VVSLLLERGADVDPK 102
+ ++E+ + ++ LL++G DVN + T LH+ T V+ LL++ GADV+ K
Sbjct: 54 YLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAK 113
Query: 103 DRWGSTPL-----GDAIYYKNHEVIKLLEKHGAKP------LMAPMHV 139
D+ G TPL G I K VI+LL + GA M P+ V
Sbjct: 114 DKVGRTPLHVYLSGFNINPK---VIRLLLRKGADVNALDLYGMTPLAV 158
|
Length = 471 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
FR+E +L + + A + + +V +Y GDL L + P RF
Sbjct: 48 FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107
Query: 257 L-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
L ++ ++ +H+ + +HRD++P NIL D +G++++ADFG L + ED T Q
Sbjct: 108 LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDG--TVQS 160
Query: 316 T----SCRYVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKA 365
+ + Y++PE+ + E Y + D +S + + EM+ G PF + E K
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
Query: 366 YAARQRPPFKAPAKLYARGLKELI 389
++R F A + K+LI
Sbjct: 221 MNHKERFQFPAQVTDVSEDAKDLI 244
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 6e-09
Identities = 42/174 (24%), Positives = 83/174 (47%), Gaps = 10/174 (5%)
Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
+PN ++ +VT +++ +Y+ GDL LK++G L + + + +N LH+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 269 NKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
+ IIH D++ N+L D + + + D+G+ K++ +C D + Y +PE K
Sbjct: 128 HN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIK 179
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKL 380
YD D ++ ++ E++ G PF D E+ ++ RQ+ +
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV 233
|
Length = 267 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 55.6 bits (133), Expect = 9e-09
Identities = 32/77 (41%), Positives = 42/77 (54%), Gaps = 3/77 (3%)
Query: 56 IKELLDSGI--DVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
K LL++G DVN D D T LH AA G ++V LLLE GAD + ++ +G T L
Sbjct: 127 AKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYGVTALDP 186
Query: 113 AIYYKNHEVIKLLEKHG 129
A E++KLL G
Sbjct: 187 AAKNGRIELVKLLLDKG 203
|
Length = 235 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 24/180 (13%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
E+ALL++++HPNV+ S + ++ +Y + DL +K A K P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106
Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLT 304
+ V+ L I G++YLH N ++HRDL+P+NIL + G +K+AD G ++L
Sbjct: 107 RSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 305 VKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDN 360
+PL D + Y APE+ + TK +D+++ I E++ P F + ++
Sbjct: 164 -SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 29/194 (14%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV-----QFLGAVTQSSP---MMIV 228
+VA+KK V+ D + EL +++ + H N++ + ++ + +V
Sbjct: 93 KVAIKK----VLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 229 TEYLPKGDLRAFLK---RKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 284
E++P+ + ++K R P V+ ++ + R + Y+H I HRDL+P N+
Sbjct: 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNL 201
Query: 285 LRD-DSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFA 341
L D ++ LK+ DFG +K LL + C S Y APE+ Y T +D++S
Sbjct: 202 LIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC---SRFYRAPELMLGATNYTTHIDLWSLG 258
Query: 342 LILQEMIEGCPPFT 355
I+ EMI G P F+
Sbjct: 259 CIIAEMILGYPIFS 272
|
Length = 440 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 13/134 (9%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + +D + LL G +VN D N + LH A +V +LLE GA D +D
Sbjct: 172 LHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARD 231
Query: 104 RWGSTPLGDAI-YYKNHEVIKLLEKHG----AKPL---MAPMHVKHARE-----VPEYEI 150
+ G+TPL ++ Y K+++++KLL +HG AK + +H E + EY
Sbjct: 232 KCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHSSIKSERKLKLLLEYGA 291
Query: 151 DPHELDFTNSVEIT 164
D + L+ ++
Sbjct: 292 DINSLNSYKLTPLS 305
|
Length = 477 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 27/70 (38%), Positives = 41/70 (58%), Gaps = 3/70 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L + + D A EL +L + +H N+V LGA T P++++TEY
Sbjct: 69 LRVAVKML--KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY 126
Query: 235 GDLRAFLKRK 244
GDL FL++K
Sbjct: 127 GDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 18/95 (18%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAA--CQGFTEVVSLLLERGADVDPKDR--------- 104
++ LLD+G +VN ++ D LH+ + +++ LL+++G D++ K+R
Sbjct: 124 VEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRVNYLLSYGV 183
Query: 105 -------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+G TPL A+Y N E +K L GA P
Sbjct: 184 PINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANP 218
|
Length = 422 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 2/96 (2%)
Query: 32 DDDGEEIKP--EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
D+ GE P L+ +A+ + ++ELL + +D + D RT LH+AA +G+ + V
Sbjct: 515 DNGGEHDDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCV 574
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+LL+ +V +D G+T L +AI K+H++ ++L
Sbjct: 575 LVLLKHACNVHIRDANGNTALWNAISAKHHKIFRIL 610
|
Length = 823 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 51/180 (28%), Positives = 89/180 (49%), Gaps = 24/180 (13%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
E+ALL++++HPNV+ + + ++ +Y + DL +K A K P
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106
Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLT 304
V+ L I G++YLH N ++HRDL+P+NIL + G +K+AD G ++L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 305 VKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDN 360
+PL D + Y APE+ + TK +D+++ I E++ P F + ++
Sbjct: 164 -SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 27/75 (36%), Positives = 40/75 (53%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G+ +N +D+ T LH A E V LL+ GA+ + +++G TPL AI
Sbjct: 175 VNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAIL 234
Query: 116 YKNHEVIKLLEKHGA 130
N E+ KLL +G
Sbjct: 235 NNNKEIFKLLLNNGP 249
|
Length = 422 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 4e-08
Identities = 19/33 (57%), Positives = 23/33 (69%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104
D T LH+AA G EVV LLLE GADV+ +D+
Sbjct: 1 DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-08
Identities = 25/50 (50%), Positives = 30/50 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
L A +++ +K LL G DVN RD D RT LH+AA G EVV LLL
Sbjct: 77 LHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 8e-08
Identities = 50/191 (26%), Positives = 92/191 (48%), Gaps = 18/191 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--MMIVTEYLPK 234
A+K + ++ ++V R E+ L+++ HPN+++ + + + +V E L
Sbjct: 27 YAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE-LMD 83
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
+L +K RK L + + + ++++H N I HRD++P NIL D LK
Sbjct: 84 MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILK 139
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE-VFKNEEYDTKVDVFSFALILQEMIEGC 351
+ADFG + + P T + S R Y APE + + Y K+D+++ + E++
Sbjct: 140 LADFGSCR--GIYSKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196
Query: 352 PPFTMKHDNEV 362
P F NE+
Sbjct: 197 PLFPGT--NEL 205
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 31/83 (37%), Positives = 46/83 (55%), Gaps = 7/83 (8%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFT-----EVVSLLLERGADVDPKDRWGSTPL 110
+K LLD+G D+N +N T LH + + E+V LLLE GA+V+ D G TPL
Sbjct: 51 VKILLDNGADINSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPL 110
Query: 111 GDAIYYK--NHEVIKLLEKHGAK 131
AI K ++ +++ L +GA
Sbjct: 111 LYAISKKSNSYSIVEYLLDNGAN 133
|
Length = 422 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 38/140 (27%), Positives = 71/140 (50%), Gaps = 17/140 (12%)
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSN 283
+ +V +Y GDL L + P RF + ++ ++ +H+ V HRD++P N
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV---HRDIKPDN 132
Query: 284 ILRDDSGNLKVADFG----VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTK 334
+L D +G++++ADFG +++ TV+ + D Y++PE+ + E Y +
Sbjct: 133 VLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD----YISPEILQAMEDGMGKYGPE 188
Query: 335 VDVFSFALILQEMIEGCPPF 354
D +S + + EM+ G PF
Sbjct: 189 CDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 165 KGTFILAFWRGIQVAVKKLGE----EVI------SDDDRVRAFRDELALLQKIRHPNVVQ 214
+GTF F +GI+ V GE EV+ S + +F + +++ ++ H ++V
Sbjct: 5 QGTFTKIF-KGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVL 63
Query: 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-AVRFALDIARGMNYLHENKPVP 273
G ++V EY+ G L +LK+ L + + A +A +++L +
Sbjct: 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--- 120
Query: 274 IIHRDLEPSNIL-----RDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
+ H ++ N+L +GN +K++D G+S +TV L +V PE
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILL---ERIPWVPPEC 175
Query: 326 FKN-EEYDTKVDVFSFALILQEMIEGCP-PFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
+N + D +SF L E+ G P + + + Y R + PA +
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRH----QLPAPKWTE 231
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRL 410
L LI +C + +P RP+FR II L
Sbjct: 232 -LANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 18/192 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G V V+ E +++ ++A ++E+ L RHPN++ T S + +++ ++
Sbjct: 25 GTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 235 GDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
G + LK S A+ RG+NYLH+N IHR+++ S+IL G +
Sbjct: 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLV 140
Query: 293 KVADFGVSKL--LTVKEDRPLTCQD-----TSCR-YVAPEVFKNE--EYDTKVDVFSFAL 342
++ G+S L L + D TS +++PE+ + + Y+ K D++S +
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 343 ILQEMIEGCPPF 354
E+ G PF
Sbjct: 199 TACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 40/138 (28%), Positives = 72/138 (52%), Gaps = 17/138 (12%)
Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL 285
+V +Y GDL L + P RF L ++ ++ +H+ + +HRD++P N+L
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVL 134
Query: 286 RDDSGNLKVADFGVS-KLL---TVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVD 336
D +G++++ADFG +LL TV+ + + D Y++PE+ + E Y + D
Sbjct: 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD----YISPEILQAMEDGKGRYGPECD 190
Query: 337 VFSFALILQEMIEGCPPF 354
+S + + EM+ G PF
Sbjct: 191 WWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 61/245 (24%), Positives = 112/245 (45%), Gaps = 32/245 (13%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I+V +K L S D AF + ++++++ H ++V G + ++V E++ G
Sbjct: 33 IKVILKVLDP---SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89
Query: 236 DLRAFLKRKGALKPSTAVRF--ALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGN 291
L F+ RK + +T +F A +A ++YL + ++H ++ NIL R+
Sbjct: 90 PLDLFMHRKSDVL-TTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDG 145
Query: 292 -----LKVADFGVSKLLTVKEDRPLTCQDTSCR--YVAPEVFKNEE-YDTKVDVFSFALI 343
+K++D G+ +TV L+ Q+ R ++APE ++ + D +SF
Sbjct: 146 ECGPFIKLSDPGIP--ITV-----LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTT 198
Query: 344 LQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
L E+ G P K E + Y + P+ + L +L+ C N P +RP
Sbjct: 199 LWEICYNGEIPLKDKTLAEKERFYEGQCML--VTPS---CKELADLMTHCMNYDPNQRPF 253
Query: 403 FRQII 407
FR I+
Sbjct: 254 FRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 44/128 (34%), Positives = 61/128 (47%), Gaps = 4/128 (3%)
Query: 8 RTTLLKQSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLA-NERDVEGIKELLDSGI 64
+ T L +S AP R +L G D + + IK E L +A N D E I+ L+ G
Sbjct: 273 KNTPLHHASQAPSLSRLVPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGA 332
Query: 65 DVNFRDIDNRTALHVAAC-QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
DVN D T LH A+ ++V LLE GA+V+ +D TP+ A N +I
Sbjct: 333 DVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIIN 392
Query: 124 LLEKHGAK 131
L +GA
Sbjct: 393 TLLDYGAD 400
|
Length = 682 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 50.6 bits (120), Expect = 4e-07
Identities = 39/97 (40%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-----CQGFTEVVSLLLERGAD 98
L A++ D + +K LL SG DVN +D D T LH+AA +G EV LLLE GAD
Sbjct: 77 LHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGAD 136
Query: 99 VDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+D + G+TPL A + ++++LL + GA P
Sbjct: 137 LDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADP 173
|
Length = 235 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-07
Identities = 26/53 (49%), Positives = 32/53 (60%)
Query: 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
RTALH AA G E+V LLE+G D++ D G+T L A N EV+KLL
Sbjct: 1 GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLL 53
|
Length = 54 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 5e-07
Identities = 23/50 (46%), Positives = 30/50 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
L A +E +K LL+ G+D+N D D TALH+AA G EV+ LLL
Sbjct: 5 LHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-07
Identities = 20/47 (42%), Positives = 28/47 (59%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
ID+N D + T LH+AA G E+V LL+ G D++ +D G T L
Sbjct: 7 IDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTAL 53
|
Length = 56 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 28/185 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+Q VK+ I+D + + + E+A + K++HPN+V+ +G ++ EY+
Sbjct: 715 GMQFVVKE-----INDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNL 292
+L L+ L + A+ IA+ + +LH ++ +L P I+ D D +L
Sbjct: 768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+++ G L C DT C YVAPE + ++ K D++ F LIL E++
Sbjct: 825 RLSLPG------------LLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL 872
Query: 349 EGCPP 353
G P
Sbjct: 873 TGKSP 877
|
Length = 968 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 9/142 (6%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+V + + +V ++ G L + + + + R+A ++ ++ LH
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKN 328
I+ RDL P+NIL DD G++++ F E + Y APEV
Sbjct: 105 G---IVCRDLNPNNILLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGGI 156
Query: 329 EEYDTKVDVFSFALILQEMIEG 350
E D +S IL E++ G
Sbjct: 157 SEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 23/57 (40%), Positives = 32/57 (56%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
L A D+ +KELL G++V+ D TAL VA + ++V LL+ GADVD
Sbjct: 626 LCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVD 682
|
Length = 823 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 48.3 bits (114), Expect = 2e-06
Identities = 34/98 (34%), Positives = 45/98 (45%), Gaps = 5/98 (5%)
Query: 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
+ + L + + L + RD+D R LH AA +G ++V LLL GADV
Sbjct: 40 NLYLELALLPAASLSELLLKLIVDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGADV 99
Query: 100 DPKDRWGSTPLGDAIYYKN-----HEVIKLLEKHGAKP 132
+ KD G TPL A N EV KLL + GA
Sbjct: 100 NAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGADL 137
|
Length = 235 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 23/82 (28%), Positives = 42/82 (51%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ ++ +K L+ G D + + D + LH+A G + + LL++ A +D +D G TPL
Sbjct: 113 KKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPL 172
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
A+ + + K+L GA
Sbjct: 173 IIAMAKGDIAICKMLLDSGANI 194
|
Length = 413 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 1/80 (1%)
Query: 52 DVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ E K LL G D+N +D TALH A + LLL GA+V+ D+ ++PL
Sbjct: 146 EAEITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPL 205
Query: 111 GDAIYYKNHEVIKLLEKHGA 130
A+ + N ++ +L ++GA
Sbjct: 206 HHAVKHYNKPIVHILLENGA 225
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 40/104 (38%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANER---DVEGIKE-LLDSGIDVNFRDIDNRTALHV 79
KEA ++G D ++I M L ER D I E LL+ G DVN +DI T +H
Sbjct: 126 KEA-ISGNDIHYDKINESIEYMKLIKERIQQDELLIAEMLLEGGADVNAKDIYCITPIHY 184
Query: 80 AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
AA +G ++V+LLL GADV+ + L A+ KN + IK
Sbjct: 185 AAERGNAKMVNLLLSYGADVNIIALDDLSVLECAVDSKNIDTIK 228
|
Length = 682 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 23/79 (29%), Positives = 37/79 (46%), Gaps = 2/79 (2%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTE--VVSLLLERGADVDPKDRWGSTPLGDA 113
++EL+ +G D D+ T LH A + +V LL G ++ ++R+G TPL A
Sbjct: 205 VRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYA 264
Query: 114 IYYKNHEVIKLLEKHGAKP 132
+ N + L GA
Sbjct: 265 AVFNNPRACRRLIALGADI 283
|
Length = 471 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 28/163 (17%)
Query: 150 IDPHELDFTNSVEITKGTFIL-------AFWR--------------GIQVAVKKLGEEVI 188
+DP +L + ++ E+ + +L AF R ++VAVK L
Sbjct: 21 VDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR 80
Query: 189 SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
S + + A EL ++ + H N+V LGA T+ P+ I+TEY GDL +L R
Sbjct: 81 SSEKQ--ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR---- 134
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
T +++ LD R L P+ R S D G
Sbjct: 135 NKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGG 177
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 6e-05
Identities = 16/29 (55%), Positives = 20/29 (68%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVD 100
D T LH+AA G E+V LLLE GAD++
Sbjct: 1 DGNTPLHLAARNGNLELVKLLLEHGADIN 29
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 20/61 (32%), Positives = 29/61 (47%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
LL +GI +N R+ +T LH AA L+ GAD++ G+TPL + N
Sbjct: 243 LLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTPLSLMVRNNN 302
Query: 119 H 119
Sbjct: 303 G 303
|
Length = 471 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 58/262 (22%), Positives = 103/262 (39%), Gaps = 51/262 (19%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+KK+ E++ + + F E + + HP +V + P+ Y+
Sbjct: 29 RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT 88
Query: 237 LRAFLKR-------KGALKPSTAVRFALDI----ARGMNYLHENKPVPIIHRDLEPSNIL 285
L++ LK L T+V L I + Y+H ++HRDL+P NIL
Sbjct: 89 LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNIL 145
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTC---QDTSC--------------RYVAPEVFKN 328
G + + D+G + ++E+ L + C Y+APE
Sbjct: 146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPF--------TMKHDNEVPKAYAA-RQRPPF----- 374
D+++ +IL +M+ P+ + + P A R+ PPF
Sbjct: 206 VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIA 265
Query: 375 -KA----PAKLYARGLKELIEE 391
KA PA+ Y ++EL ++
Sbjct: 266 MKALAVDPAERY-SSVQELKQD 286
|
Length = 932 |
| >gnl|CDD|197603 smart00248, ANK, ankyrin repeats | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 7e-05
Identities = 17/29 (58%), Positives = 22/29 (75%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVD 100
D RT LH+AA G EVV LLL++GAD++
Sbjct: 1 DGRTPLHLAAENGNLEVVKLLLDKGADIN 29
|
Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 9/97 (9%)
Query: 44 LMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ--GFTEVVSLLLERG 96
L +L+N E +K LL+ G +VN D + T L A + +V LL+ G
Sbjct: 72 LHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNG 131
Query: 97 ADVDPKDRWGSTPLGDAIYYKNH--EVIKLLEKHGAK 131
A+V+ K+ G L + +++KLL G
Sbjct: 132 ANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVD 168
|
Length = 422 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 3/68 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK L + A EL +L + H N+V LGA T P +++TEY GD
Sbjct: 68 VAVKMLKPSAHLTERE--ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGD 125
Query: 237 LRAFLKRK 244
L FL+RK
Sbjct: 126 LLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 32/85 (37%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA---DVDPKDRWGS 107
RD E IK L+ G + + D + LH A +G + V LL+ G DV KD G
Sbjct: 46 RDSEAIKLLMKHGAIPDVKYPDIESELHDAVEEGDVKAVEELLDLGKFADDVFYKD--GM 103
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
TPL A K +++KLL GA P
Sbjct: 104 TPLHLATILKKLDIMKLLIARGADP 128
|
Length = 413 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 27/69 (39%), Positives = 39/69 (56%), Gaps = 4/69 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
VAVK L E + + + A EL +L I H NVV LGA T+ + P+M++ E+ G
Sbjct: 40 VAVKMLKEGATASEHK--ALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYG 97
Query: 236 DLRAFLKRK 244
+L FL+ K
Sbjct: 98 NLSNFLRAK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 11/106 (10%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDR-WG 106
N R+VE K +L + N + ID + E+ LLL GAD++ KDR G
Sbjct: 110 NNRNVEIFKIILTNRYK-NIQTIDLVYIDKKSKDDIIEAEITKLLLSYGADINMKDRHKG 168
Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKPLM------APMH--VKHARE 144
+T L A K+ + +LL +GA + +P+H VKH +
Sbjct: 169 NTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNK 214
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 28/73 (38%), Positives = 37/73 (50%), Gaps = 1/73 (1%)
Query: 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-CQGFTEVVSLLLERGA 97
K + L+ D+E L D+G VN D T LH A+ + +V LLERGA
Sbjct: 239 KNDLSLLKAIRNEDLETSLLLYDAGFSVNSIDDCKNTPLHHASQAPSLSRLVPKLLERGA 298
Query: 98 DVDPKDRWGSTPL 110
DV+ K+ G TPL
Sbjct: 299 DVNAKNIKGETPL 311
|
Length = 682 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 5/84 (5%)
Query: 50 ERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
E DV+ ++ELLD G DV ++D T LH+A +++ LL+ RGAD D +
Sbjct: 78 EGDVKAVEELLDLGKFADDVFYKD--GMTPLHLATILKKLDIMKLLIARGADPDIPNTDK 135
Query: 107 STPLGDAIYYKNHEVIKLLEKHGA 130
+PL A+ + + I+LL H A
Sbjct: 136 FSPLHLAVMMGDIKGIELLIDHKA 159
|
Length = 413 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK--GDLRAFL-KRKGALKPSTAVRFA 256
E LL+++ HP V+ L +V LPK DL +L R L + A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT---- 312
+ ++Y+H IIHRD++ N+L + ++ + DFG + P
Sbjct: 267 RQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 313 -CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
DT+ APEV + Y VD++S L++ E
Sbjct: 324 GTVDTN----APEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 3/69 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L S + + A EL ++ + H N+V LGA T+S P+ I+TEY
Sbjct: 68 MKVAVKMLKPTARSSEKQ--ALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFY 125
Query: 235 GDLRAFLKR 243
GDL +L +
Sbjct: 126 GDLVNYLHK 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 7/79 (8%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAA---CQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
+K L+D G +VN ++ D T LH A C+ +V+ +LL+ GADV+ + PL
Sbjct: 425 VKTLIDRGANVNSKNKDLSTPLHYACKKNCK--LDVIEMLLDNGADVNAINIQNQYPLLI 482
Query: 113 AIYYKNHEVIKLLEKHGAK 131
A+ Y H ++ +L +GA+
Sbjct: 483 ALEY--HGIVNILLHYGAE 499
|
Length = 682 |
| >gnl|CDD|165256 PHA02946, PHA02946, ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 34/89 (38%), Positives = 46/89 (51%), Gaps = 13/89 (14%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
+ER VE ELL G N D D LH+A+ +V++LL GAD + D+ T
Sbjct: 51 DERFVE---ELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKT 107
Query: 109 PLGDAIYY---KNHEVIK---LLEKHGAK 131
PL YY + EVI+ LL ++GAK
Sbjct: 108 PL----YYLSGTDDEVIERINLLVQYGAK 132
|
Length = 446 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 4/79 (5%)
Query: 52 DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
D + +K LL+ G+DVN + I TALH + + LLLE GAD++ + + TPL
Sbjct: 247 DYDILKLLLEHGVDVNAKSYILGLTALHSSIKS--ERKLKLLLEYGADINSLNSYKLTPL 304
Query: 111 GDAIY-YKNHEVIKLLEKH 128
A+ Y + ++L +
Sbjct: 305 SSAVKQYLCINIGRILISN 323
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
+R+ + + LL+ G +VN RD ++T +H AA + +++ LL+ GAD++ + T
Sbjct: 352 DRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTA 411
Query: 110 LGDAIYYKN-HEVIKLLEKHGA------KPLMAPMH 138
L A+ N + +K L GA K L P+H
Sbjct: 412 LHFALCGTNPYMSVKTLIDRGANVNSKNKDLSTPLH 447
|
Length = 682 |
| >gnl|CDD|165103 PHA02736, PHA02736, Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.002
Identities = 19/58 (32%), Positives = 34/58 (58%), Gaps = 4/58 (6%)
Query: 72 DNRTALHVAACQGFT---EVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLL 125
+ +H+ + E + LL+E GAD++ K+R +G+TPL A+Y +N+E+ L
Sbjct: 54 HGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWL 111
|
Length = 154 |
| >gnl|CDD|165089 PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 24/95 (25%), Positives = 43/95 (45%), Gaps = 4/95 (4%)
Query: 20 DRERKEAELNGLDDDGEEIKPEFRLMF--LANERDVEGIKELLDSGIDVNFRDIDNRTAL 77
+ E + LD + + P + LA D+ + L G+ ++++D RT L
Sbjct: 262 NPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCL 321
Query: 78 HVAACQGF--TEVVSLLLERGADVDPKDRWGSTPL 110
H + T+++ LL E G D++ D G+T L
Sbjct: 322 HQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVL 356
|
Length = 764 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 29/155 (18%), Positives = 53/155 (34%), Gaps = 27/155 (17%)
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
L + LH + NIL + + + G T ++ RP D
Sbjct: 23 CLQCLGALRELHRQA---------KSGNIL--LTWDGLLKLDGSVAFKTPEQSRP----D 67
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY-------AA 368
++APEV + + Y K D++S + L E ++ P+ + E+ A
Sbjct: 68 PY--FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN--EERELSAILEILLNGMPA 123
Query: 369 RQRPPFKAPAK-LYARGLKELIEECWNEKPAKRPT 402
AR ++ + C + P +R
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|233161 TIGR00870, trp, transient-receptor-potential calcium channel protein | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 25/82 (30%), Positives = 37/82 (45%), Gaps = 17/82 (20%)
Query: 68 FRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK---DRWGSTPLGDAIYY-------- 116
I TALH+AA + E+V LLLERGA V + D + + D+ Y+
Sbjct: 126 TPGI---TALHLAAHRQNYEIVKLLLERGASVPARACGDFFVKSQGVDSFYHGESPLNAA 182
Query: 117 ---KNHEVIKLLEKHGAKPLMA 135
+ ++ LL + A L A
Sbjct: 183 ACLGSPSIVALLSEDPADILTA 204
|
The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999) [Transport and binding proteins, Cations and iron carrying compounds]. Length = 743 |
| >gnl|CDD|222931 PHA02798, PHA02798, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 23/84 (27%), Positives = 44/84 (52%), Gaps = 8/84 (9%)
Query: 56 IKELLDSGIDVNFRDIDNRTAL-----HVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+K ++ G +VN D + T L ++ + ++V +L+E GAD++ K+ G TPL
Sbjct: 54 VKLFINLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPL 113
Query: 111 GDAI---YYKNHEVIKLLEKHGAK 131
+ Y N E++ + ++GA
Sbjct: 114 YCLLSNGYINNLEILLFMIENGAD 137
|
Length = 489 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 447 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.79 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.78 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.77 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.77 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.76 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.75 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.74 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.74 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.73 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.73 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.73 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.73 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.72 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.72 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.72 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.71 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.71 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.71 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.71 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.7 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.7 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.69 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.69 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.69 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.68 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.66 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.66 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.65 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.65 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.64 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.63 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.62 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.62 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.62 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.61 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.61 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.6 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.6 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.6 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.59 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.59 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.59 | |
| PF13857 | 56 | Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A | 99.58 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.58 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.57 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.57 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.56 | |
| PF13637 | 54 | Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A | 99.56 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| PHA02792 | 631 | ankyrin-like protein; Provisional | 99.54 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.54 | |
| cd00204 | 126 | ANK ankyrin repeats; ankyrin repeats mediate prote | 99.54 | |
| PTZ00322 | 664 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatas | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.52 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.52 | |
| KOG0505 | 527 | consensus Myosin phosphatase, regulatory subunit [ | 99.5 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-50 Score=388.29 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=233.6
Q ss_pred CCCCCcccCCCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeE
Q 013214 143 REVPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (447)
Q Consensus 143 ~~~~~~~i~~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 217 (447)
..+|..-.++....|...+.||+|||..+| .+|+.||+|++++..+....+.+...+|+++.+.++|||||++++
T Consensus 6 ~~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~ 85 (592)
T KOG0575|consen 6 PEIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYH 85 (592)
T ss_pred CCCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeee
Confidence 356666667777889999999999998876 479999999999888888888899999999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 218 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
+|++.+.+|++.|+|..++|..+++++++++|.++..++.||+.||.|||+++ |+|||||..|+|++++.+|||+||
T Consensus 86 ~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 86 FFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred EeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccc
Confidence 99999999999999999999999999999999999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCC
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 377 (447)
|+|..+.....+ ....+|||.|.|||++....++..+||||+||+||.|+.|++||...+-.+....+.... ..+
T Consensus 163 GLAt~le~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-Y~~--- 237 (592)
T KOG0575|consen 163 GLATQLEYDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-YSM--- 237 (592)
T ss_pred ceeeeecCcccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-ccc---
Confidence 999988755333 345789999999999999999999999999999999999999999998888877774444 222
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
|...|.+.++||.++|+.||.+|||+++++.+
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 33678999999999999999999999999975
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=378.18 Aligned_cols=269 Identities=43% Similarity=0.748 Sum_probs=231.8
Q ss_pred CCCCCcccCCCCcCcccceeeecceEEEEE---EcCeE-EEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEE
Q 013214 143 REVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (447)
Q Consensus 143 ~~~~~~~i~~~~~~~~~~~~lg~G~~~~~~---~~g~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 218 (447)
...+.+++++..+.+.. .+|.|+||.|+ |.|+. ||+|++......... .+.|.+|+.+|.+++|||||+++|+
T Consensus 31 ~~~~~~~i~~~~l~~~~--~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 31 DELPEEEIDPDELPIEE--VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred ccccceecChHHhhhhh--hcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 34456677776655544 49999999876 88999 999999876655444 7899999999999999999999999
Q ss_pred EEeCC-ceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEE
Q 013214 219 VTQSS-PMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKV 294 (447)
Q Consensus 219 ~~~~~-~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl 294 (447)
+.++. .+++||||+++|+|.+++.+ .+.++...+..++.||+.||.|||+.++ ||||||||+|||++.++ ++||
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI 185 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKI 185 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEE
Confidence 99887 79999999999999999988 5779999999999999999999999985 99999999999999997 9999
Q ss_pred eecccccccccCCCCCcccCCCCCcccCCcccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C
Q 013214 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R 371 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~ 371 (447)
+|||+++...... ...+...||+.|||||++. ...++.|+||||||+++|||+||+.||.+....+....+.... +
T Consensus 186 ~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 186 ADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR 264 (362)
T ss_pred CCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9999998765432 2334467899999999999 5689999999999999999999999999999866666664444 6
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 372 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
+.++. .+++.+..+|++||..||.+||++.+++..|+.+.+.+...
T Consensus 265 p~~p~---~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 265 PPIPK---ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred CCCCc---cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 66543 37789999999999999999999999999999998877543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=370.94 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=216.8
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHH----HHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDD----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
.|...+.||+|+||.|. .+|+.||||++.+....... ......+|+++|++++|||||+++++|...+..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 57778899999999885 58999999999875543322 2344679999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC---CCEEEeeccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLL 303 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~---~~vkl~Dfg~~~~~ 303 (447)
+||||++||+|.+.+-.++.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+..
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 99999999999999999999999999999999999999999999 9999999999999876 67999999999987
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCC---CchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHhcCCCCCCCChh
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~---~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 379 (447)
+. .......+|||.|.|||++.+..+. .++|+||+||++|-+++|.+||....... ..+++..+...-.+..+.
T Consensus 330 g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 330 GE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred cc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence 63 3445678899999999999876433 47899999999999999999999888776 667774444444456788
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++++..+||.+||..||++|||+.|++++
T Consensus 408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 408 RISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 899999999999999999999999999976
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=363.21 Aligned_cols=244 Identities=28% Similarity=0.464 Sum_probs=212.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc-eEEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~ 229 (447)
+++....||+|.-|.|+ .+++.+|+|.+... .+....+++.+|+++++..+||+||++||.|.++.. +.++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 45556789999999886 47999999999544 466777889999999999999999999999999995 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||++|+|.++++..+++++....+++.++++||.|||. ++ |+||||||+|||++..|.|||||||.+..+...
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999999998999999999999999999999996 66 999999999999999999999999999876543
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK-----HDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.-.++.||..|||||.+.+..|+.++||||||++++|+.+|+.||... ...++...+..+..|.++.. .+|+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--~fS~ 309 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--EFSP 309 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--cCCH
Confidence 335677999999999999999999999999999999999999999875 22334445544444444322 4899
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+|..||++||.+|||+.++++|
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=347.52 Aligned_cols=369 Identities=29% Similarity=0.436 Sum_probs=300.8
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~ 111 (447)
|.|.-|--|-+|||+||..|+..+++.|++.|+.+|..|.-..||||+|+..||.++|+.|++..+|+|+.|..|+||||
T Consensus 26 dln~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplh 105 (448)
T KOG0195|consen 26 DLNVGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLH 105 (448)
T ss_pred ccccccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchh
Confidence 33333444667799999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHHHHhCCCCCCCccc-----------------------ccccCCCCCc--------------------
Q 013214 112 DAIYYKNHEVIKLLEKHGAKPLMAPMH-----------------------VKHAREVPEY-------------------- 148 (447)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~a~~~~~~~~-----------------------~~~~~~~~~~-------------------- 148 (447)
|||.+|...+++-|+..|+.+++-+.. +.++..+|.-
T Consensus 106 yacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr~~ 185 (448)
T KOG0195|consen 106 YACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSRYT 185 (448)
T ss_pred hhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCccccccccccccccccccccccccc
Confidence 999999999999999999987654432 2233333311
Q ss_pred ccCCCCcCccc-ceeeecceEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 149 EIDPHELDFTN-SVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 149 ~i~~~~~~~~~-~~~lg~G~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
.|+..++++.. ..+-.+|..+.+.|+|.++++|++..... ....-++|.+|.-.|+-+.||||+.+++.|.+...+.+
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 12222222211 11224688889999999999999976543 33344779999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEe-CCCCCCCEEEcCCCCEEEe--ecccccc
Q 013214 228 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIH-RDLEPSNILRDDSGNLKVA--DFGVSKL 302 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H-~Dikp~Nill~~~~~vkl~--Dfg~~~~ 302 (447)
+..||+.|+|+..+++... .+..++.+++.+++.|+.|||+..+ ++- --+.+..+++|++.+.+|+ |--++..
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccceeeee
Confidence 9999999999999997654 6788999999999999999999884 444 4688999999998876654 4333321
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCCCCC---CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCCh
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPA 378 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~---~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 378 (447)
. ......|.||+||.+...+.+ ..+|+|||++++|||.|.+.||.+..+.+....+..++ ++.+ +
T Consensus 343 e--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i---p 411 (448)
T KOG0195|consen 343 E--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI---P 411 (448)
T ss_pred c--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC---C
Confidence 1 122346889999999776443 47999999999999999999999999999888876666 5554 5
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+..+..+.++|.-|+..||.+||.+..++..|+++.
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 678899999999999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=352.98 Aligned_cols=249 Identities=27% Similarity=0.468 Sum_probs=215.4
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeE-EEEeCCc-eEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG-AVTQSSP-MMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~-~~~~~~~-~~lv 228 (447)
+|++.++||+|+||.++ ++|..+|.|.+.-+. .+....++...|+.+|++++||||+++++ .+..+.. ++|+
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 68888999999999886 689999999998554 46677788999999999999999999998 4554444 8999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPV-PIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~-~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
||||++|+|..+++. ...+++.++|+++.|++.||.+||+.-++ .|+||||||.||+++.+|.+||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999863 34599999999999999999999994432 4899999999999999999999999999987
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.... ....+..|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+..++...+.....++++ ...||.
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p--~~~YS~ 255 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP--DEHYST 255 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--HHHhhh
Confidence 7542 3345678999999999999999999999999999999999999999999888888888666555542 367999
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.+..+|..|+..||+.||+...++.
T Consensus 256 ~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred HHHHHHHHHccCCcccCCCcchHHH
Confidence 9999999999999999999744444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=357.64 Aligned_cols=247 Identities=31% Similarity=0.536 Sum_probs=215.6
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
-+|...++||+|+|++|| .++..||||.+.+... ..+..+.+..|+.+|+.++|||||++++++..++.+|+||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 367777889999999887 4789999999987654 5667788899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC------CCEEEeeccccccc
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKLL 303 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~------~~vkl~Dfg~~~~~ 303 (447)
|||+||+|.+|+++.+.+++.++..++.||+.||++||+++ |+||||||+|||++.. -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999999999999999999999999999999999 9999999999999865 45899999999987
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
... ......+|++.|||||++..++|+.|+|+||+|+++|++++|+.||...+..++...+.... ...+..+...+.
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~-~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN-EIVPVLPAELSN 242 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc-cccCchhhhccC
Confidence 633 33355789999999999999999999999999999999999999999999988887663333 333334555667
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.+.+++...++.+|.+|.++.+...
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhh
Confidence 7889999999999999988876554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=354.86 Aligned_cols=240 Identities=30% Similarity=0.483 Sum_probs=216.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+ .+++.+|+|++++..+...+..+....|..+|..++||+||+++-.|++...+|+|+|
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld 105 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD 105 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence 68888999999999886 4789999999998887777778889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+.||.|..+|++.+.+++..+..++.+|+.||.|||+.| |+||||||+|||+|.+|+++|+|||+++..-.. ...
T Consensus 106 ~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~~ 181 (357)
T KOG0598|consen 106 YLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GDA 181 (357)
T ss_pred ccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC-CCc
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999854332 234
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
....+||+.|||||++.+..|+..+|+||||+++|+|++|.+||...+..+..+.+.....+. .+..++.+.+++++
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~---~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL---PPGYLSEEARDLLK 258 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC---CCccCCHHHHHHHH
Confidence 455789999999999999999999999999999999999999999999888877775444233 24447889999999
Q ss_pred HHcccCCCCCCC
Q 013214 391 ECWNEKPAKRPT 402 (447)
Q Consensus 391 ~cl~~dp~~Rps 402 (447)
++|..||++|..
T Consensus 259 ~LL~rdp~~RLg 270 (357)
T KOG0598|consen 259 KLLKRDPRQRLG 270 (357)
T ss_pred HHhccCHHHhcC
Confidence 999999999963
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=365.78 Aligned_cols=259 Identities=34% Similarity=0.581 Sum_probs=227.2
Q ss_pred CcccCCCCcCcccceeeecceEEEE---EEcCe-EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILA---FWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~---~~~g~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 222 (447)
.+++++.. ++..+.||+|.||.| .|+|. +||+|.++.....+ ++|.+|+++|++++|++||+++++|..+
T Consensus 200 ~wei~r~~--l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 200 PWEIPREE--LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred CeeecHHH--HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 44555544 344568999999976 47877 99999998654333 5678999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
+.++||||||+.|+|.++|+. ...+...+.+.++.|||+|++||++++ +|||||..+|||++++..+||+|||++
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccc
Confidence 899999999999999999987 455899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChh
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (447)
+...............+..|.|||.+..+.++.++||||||++||||+| |+.||..++..++.+.+..+.+.+- |.
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---P~ 427 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---PE 427 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---CC
Confidence 9655444444455566888999999999999999999999999999999 9999999999999999988887775 45
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
.+|+++.++|..||..+|++|||+..+...++++.+.-
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 68899999999999999999999999999999887643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=325.87 Aligned_cols=235 Identities=27% Similarity=0.498 Sum_probs=214.4
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+-||.|+||+|. .+|..+|+|++.+..+...++.+...+|..+|+.+.||+++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 367788899999999874 478999999999888778888899999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||++||.|.+++++.+++++..++.++.|++.|++|||+.+ |++||+||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 99999999999999999999999999999999999999999 99999999999999999999999999987652
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....+|||.|+|||++.+.+++.++|+||||+++|||+.|.+||...+...+.+.+. .+...+ |+..++.+++|+
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~-~~~v~f---P~~fs~~~kdLl 272 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL-EGKVKF---PSYFSSDAKDLL 272 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH-hCcccC---CcccCHHHHHHH
Confidence 2345789999999999999999999999999999999999999999999987777773 333443 345788999999
Q ss_pred HHHcccCCCCC
Q 013214 390 EECWNEKPAKR 400 (447)
Q Consensus 390 ~~cl~~dp~~R 400 (447)
+++|+.|-.+|
T Consensus 273 ~~LL~vD~t~R 283 (355)
T KOG0616|consen 273 KKLLQVDLTKR 283 (355)
T ss_pred HHHHhhhhHhh
Confidence 99999999999
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=349.28 Aligned_cols=248 Identities=28% Similarity=0.496 Sum_probs=219.6
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|..++.||+|+|.+|+ .++..+|||++.+..+..+..+.....|-..|.++ .||.|+++|-.|.++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 378888999999999886 47899999999888777766677788899999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
+||+++|+|.+++++-+.+++..+..++.+|+.||+|||++| ||||||||+|||+|++|++||+|||.++.++....
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999999999999999999999999999999999999 99999999999999999999999999987754321
Q ss_pred C----------Cc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 309 R----------PL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 309 ~----------~~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
. .. .++.||..|.+||++.....++.+|+|+|||++|+|+.|.+||.+.+.--+.+.+... ...|
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-~y~f-- 306 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-DYEF-- 306 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-cccC--
Confidence 1 11 4478999999999999999999999999999999999999999998887776666332 2333
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++..++.+.+||+++|..||.+|++.++|.+|
T Consensus 307 -p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 307 -PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 34567899999999999999999999888775
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=338.86 Aligned_cols=255 Identities=27% Similarity=0.499 Sum_probs=208.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC--ceE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~ 226 (447)
..++...+.||+|+||.|+. +|+..|||.+.... .. ..+.+.+|+.+|++++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--ch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 44677788999999999872 47899999887652 11 2677899999999999999999999754444 689
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeecccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT 304 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~~~~ 304 (447)
+.|||+++|+|.+++.+.+ ++++..+..+..|+++||.|||++| ++||||||+|||++. ++.+||+|||++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999999876 7999999999999999999999999 999999999999999 7999999999988665
Q ss_pred c--CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC-CCCchHHHHHhcCCCCCCCChhh
Q 013214 305 V--KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 305 ~--~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
. ..........||+.|||||++..+ ...+.+|||||||++.||+||+.||... ...+....+.... ..+..+..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~~ 247 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPDS 247 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCcc
Confidence 3 112223456789999999999853 3345999999999999999999999974 2222222222222 23345667
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+|.+.++++.+|+..||++|||+.+++++--.-.+.
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 899999999999999999999999999886554433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=353.08 Aligned_cols=244 Identities=27% Similarity=0.428 Sum_probs=214.9
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+.++-||.|+.|.|. .+|+.+|||++.+...........+.+|+-+|+.+.|||++++|++++...++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 4455679999999875 58999999999876444555667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 311 (447)
++||.|.+++.+.+++++.++.++++||+.|+.|||..+ |+|||+||+|+|++..++|||+|||+|.... +....
T Consensus 94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklL 168 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLL 168 (786)
T ss_pred cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--CCccc
Confidence 999999999999999999999999999999999999999 9999999999999999999999999998643 33455
Q ss_pred ccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
...+|+|.|.|||++.+.+|. .++||||.|++||.|++|+.||++.+...+...+..+. |.. +..+|.++++||+
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~---f~M-Ps~Is~eaQdLLr 244 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV---FEM-PSNISSEAQDLLR 244 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc---ccC-CCcCCHHHHHHHH
Confidence 667899999999999999887 58999999999999999999999776665555553333 222 3568899999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+|+.+||.+|.|+.+|++|
T Consensus 245 ~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHhccCccccccHHHHhhC
Confidence 9999999999999999987
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=345.70 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=215.0
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCC-C-HHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCce
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVIS-D-DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 225 (447)
...|...+.||+|+||.|+ .+|+.||+|++...... . ....+.+.+|+.+++++. ||||+++++++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 3478888999999999986 36899999987664222 1 134456678999999998 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-CCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~-~~vkl~Dfg~~~~~~ 304 (447)
++||||+.||+|.+++.+.+++.+..+..+++|+++|++|||++| |+||||||+|+|++.+ +++||+|||++....
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999999999999999999999999999999 9999999999999999 999999999998764
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhh-
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEE-YD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY- 381 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 381 (447)
..........||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||.+.+...+...+ ..+...++ ..+
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki-~~~~~~~p---~~~~ 247 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI-RKGEFKIP---SYLL 247 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH-hcCCccCC---CCcC
Confidence 2334456678999999999999877 76 6899999999999999999999997666665554 33333332 233
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
|++++.++++||..||.+|+++.+++ .-..++.
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 89999999999999999999999999 4455554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=321.96 Aligned_cols=248 Identities=21% Similarity=0.399 Sum_probs=205.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|.....+|+|+||+|++ +|+.||||++.... .++...+-..+|+++|++++|||+|.++++|...+.+++|+|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 466677899999999974 79999999997543 234444555889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+. ++.+-|.+. ..++.+.+.+++.|++.|+.|+|+++ ++||||||+|||++.+|.+||||||+|+.+.. +..
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 9965 555566654 45999999999999999999999999 99999999999999999999999999998774 334
Q ss_pred CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------CCC--
Q 013214 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-------------RPP-- 373 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-------------~~~-- 373 (447)
..+.+..|.+|.|||.+.+ .+|++.+||||+||++.||++|.+.|++.++-+....+...- .+-
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 5566778999999999988 489999999999999999999999999988765443332211 000
Q ss_pred ---CCC---------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 ---FKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ---~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++. ..+..+.-+.++++.||..||.+|++.++++.+
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 110 123456678999999999999999999999854
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=327.88 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=217.2
Q ss_pred CCcccCCCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE
Q 013214 146 PEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (447)
Q Consensus 146 ~~~~i~~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 220 (447)
+..++.+.-..|+...+||.|.-+.|+ -+++.||||++..+...+ .+..+++|+..++.++||||++++..|.
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 344555666789999999999887765 368999999999876533 3788999999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
.+..+|+||.||.+|++.+.++.. ..+++..+..+++++++||.|||++| .||||||+.||||+.+|.|||+|||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCce
Confidence 999999999999999999999864 34999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCC--c-ccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCC
Q 013214 299 VSKLLTVKEDRP--L-TCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (447)
Q Consensus 299 ~~~~~~~~~~~~--~-~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 373 (447)
.+..+.....+. . ....||+.|||||++... .|+.|+||||||++..||.+|..||....+....... ..+.|+
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-Lqn~pp 250 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-LQNDPP 250 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-hcCCCC
Confidence 776543322211 1 456799999999996554 7899999999999999999999999998887766555 333333
Q ss_pred CC-------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 FK-------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. .....++.+++.+|..||+.||.+|||+++++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11 1234577899999999999999999999999975
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=330.79 Aligned_cols=245 Identities=27% Similarity=0.481 Sum_probs=221.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|.+.+.||+|+||.|. ..|+.||||.++++.+.++..+-.+++|+++|..++||||+++|++|+..+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 67778899999999885 5799999999999999888888899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|..+|.|++|+.+++.+++.++..+++||.+|+.|||.++ ++|||||.+|||+|.++++||+|||++..+... ..
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~--kf 208 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK--KF 208 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc--cH
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999877643 45
Q ss_pred cccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 388 (447)
...++|+|.|.+||++.+.+|. +.+|.||||++||.|..|..||++.+...+.+++..+. +.+ .-+....-|
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP------~~PSdA~gL 282 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP------ETPSDASGL 282 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC------CCCchHHHH
Confidence 5678899999999999998775 68999999999999999999999999888888875444 222 123567789
Q ss_pred HHHHcccCCCCCCCHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
|+.||.+||++|.|..++..++.
T Consensus 283 IRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhhe
Confidence 99999999999999999999873
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=343.61 Aligned_cols=244 Identities=27% Similarity=0.505 Sum_probs=216.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||+||+ +.+.||+|.+.+... .++....+++|+++++.++||||+.+++.|+...++|+|+|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 567778899999999984 678999999987654 55677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+.| +|..++...+.++++.+..++.+++.||.|||+.+ |+|||+||+|||++..|.+|+||||+++.++.. ...
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-cee
Confidence 9965 99999999999999999999999999999999999 999999999999999999999999999987653 233
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.+...|||.|||||.+.++.|+..+|+||+||++||+++|++||....-.++.+.+....-. .+...+..+.++++
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~----~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK----PPSTASSSFVNFLQ 232 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC----CcccccHHHHHHHH
Confidence 46678999999999999999999999999999999999999999977766666665333311 23467899999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
.+|.+||.+|.+..+++.+
T Consensus 233 gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHhhcChhhcccHHHHhcC
Confidence 9999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=344.93 Aligned_cols=245 Identities=23% Similarity=0.457 Sum_probs=218.1
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|..-.+||+|.-|.|+ .+++.||+|++..... ...+-+.+|+.+|+..+|+|||.+++.|...+.+|.|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 46667789999888776 4788999999976533 234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|++||+|.+.+.. ..+++.++..++.++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 351 ym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred ecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999999998865 44999999999999999999999999 99999999999999999999999999988765443 3
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....|||.|||||++....|+++.||||||++++||+-|++||-..++-.....+...+.|.+.. +..+|+.+++++.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~-~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN-PEKLSPELKDFLD 504 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC-ccccCHHHHHHHH
Confidence 345678999999999999999999999999999999999999999988888888888888888754 5668999999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.|+++|++++++|++
T Consensus 505 ~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHhhcchhcCCCHHHHhcC
Confidence 9999999999999999975
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.51 Aligned_cols=256 Identities=20% Similarity=0.316 Sum_probs=213.5
Q ss_pred cCCCCcCcccceeeecceEEEE---EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe----C
Q 013214 150 IDPHELDFTNSVEITKGTFILA---FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----S 222 (447)
Q Consensus 150 i~~~~~~~~~~~~lg~G~~~~~---~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~ 222 (447)
+++.+++......||+|+++.+ .++|+.||+|.++..........+.+.+|+.++++++||||+++++++.+ .
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 4445555555567888888765 47899999999987654455556788899999999999999999999876 3
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
..++++|||+++|+|.+++.+...+++.....++.|++.|+.|||+. + ++||||||+||++++++.+||+|||++.
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHh
Confidence 56899999999999999999888899999999999999999999985 6 8899999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCCh
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPA 378 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 378 (447)
...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+.... ++++ +
T Consensus 172 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~ 244 (283)
T PHA02988 172 ILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL---P 244 (283)
T ss_pred hhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC---C
Confidence 654221 22356889999999876 578999999999999999999999999877666555543333 3332 2
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
..+++.+.+++.+||+.||++|||++++++.|+.++.
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 3567899999999999999999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=335.94 Aligned_cols=249 Identities=28% Similarity=0.401 Sum_probs=216.3
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|.....||+|+||.|+ .+|..+|+|++++...-..+++...+.|-++|....+|+||++|-.|++...+||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 368888899999999886 489999999999988878888899999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc----
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV---- 305 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~---- 305 (447)
||++||++..+|.+.+.|+++.+..++.+++-|+..+|+.| ++||||||+|+|||..|++||+|||++.-+..
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999999999999999999999999999999999999 99999999999999999999999999853211
Q ss_pred -----------------CCCCC-----c--------------------ccCCCCCcccCCcccCCCCCCCchhHHHHHHH
Q 013214 306 -----------------KEDRP-----L--------------------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 343 (447)
Q Consensus 306 -----------------~~~~~-----~--------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~ 343 (447)
..... . .+..|||.|+|||++.+.+|+..+|+|||||+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 00000 0 13468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHH
Q 013214 344 LQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIIT 408 (447)
Q Consensus 344 l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~ 408 (447)
+|||+.|.+||...++.++.+.+.... .-.++. ....+++..+||.+|+. ||++|.. +.||-+
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 999999999999999999888875444 233332 33467999999999999 9999975 444443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=335.12 Aligned_cols=247 Identities=29% Similarity=0.499 Sum_probs=219.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
...|+....||+|.||.||. +++.||+|++..+. ..+..+++++|+.++.+++++||.++|+.+.....++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 44677778999999999873 68899999998764 445678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||||.||++.+.++..+.+++..+..++++++.|+.|+|+++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999999988887899999999999999999999999 99999999999999999999999999988776544
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.. ....|||.|||||++.+..|+.++||||||++.+||.+|.+||....+......+.....|.+ ...+++.++++
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L---~~~~S~~~kEF 242 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRL---DGDFSPPFKEF 242 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcc---ccccCHHHHHH
Confidence 44 567899999999999988999999999999999999999999999998776655533333333 34789999999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|..||..||+.||++.+++++
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhh
Confidence 999999999999999999975
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=313.05 Aligned_cols=247 Identities=23% Similarity=0.402 Sum_probs=217.9
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+...+||+|.|+.|+ -+|+.+|+|++....+... ..+++.+|+.+-+.++||||+++.+.+.+....|+|+|
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 67777899999998764 5899999999876655443 56889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC---CEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~ 307 (447)
+++|++|..-+..+..+++..+..+++||++||.|+|.++ |+|||+||.|+++.+.. -+||+|||++..++ .
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~ 165 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D 165 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--C
Confidence 9999999877776667899999999999999999999999 99999999999997543 49999999999877 3
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCC-CChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK-APAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 386 (447)
........|||+|||||++...+|+..+|||+.|+++|-|+.|++||.+.++..+.+.+..+. ..++ ..+.+++++.+
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~-yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA-YDYPSPEWDTVTPEAK 244 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc-cCCCCcccCcCCHHHH
Confidence 455567789999999999999999999999999999999999999999999888888884443 3333 36778999999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|+++||..||.+|.|+.|.+++
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCC
Confidence 99999999999999999998865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=334.47 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=207.3
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCC-ceEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS-PMMI 227 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~-~~~l 227 (447)
.+|...++||.|+||.|+ .+|+.||||+++......++... .+|++.|++++ ||||+++.+++.+++ .+++
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n--LREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH--HHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 368888999999999987 36889999999887665443332 46999999998 999999999998887 8999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
||||| ..+|+++++.++ .+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~-- 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR-- 161 (538)
T ss_pred eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc--
Confidence 99999 579999998764 5999999999999999999999999 9999999999999988999999999999765
Q ss_pred CCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-cCCC------------
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRP------------ 372 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~~~------------ 372 (447)
...+.+.+..|.+|.|||++.. +.|+.+.|+|++||+++|+.+-++.|++.+..+....+.. -+.|
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 3456788889999999998754 5789999999999999999999999998876544333311 1121
Q ss_pred --------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --------~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+. ...++.+.++.++|.+|++.||.+|||+.+++++
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 1123477899999999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=332.32 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=210.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 227 (447)
-.|.....||+|+||.||. +|..||+|++..+...++ ...-..+|+.+|++++||||+++.+...+. ..+|+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3578888999999999884 789999999987654333 334456799999999999999999998876 68999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+|||+ -||.-++... -.+++.++..++.||+.||.|||++| |+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999995 5898888764 36999999999999999999999999 999999999999999999999999999988877
Q ss_pred CCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC--CCCC------
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP--PFKA------ 376 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~--~~~~------ 376 (447)
.....+....|.+|.|||.+.+. .|+...|+||.||+|.||++|++.|++.+..+....|.... .| .++.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 66677888889999999999876 79999999999999999999999999998877666653322 11 1110
Q ss_pred ----------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 377 ----------------PAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 377 ----------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.....+....+|+..+|..||.+|.|+.++++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 01235677889999999999999999999886
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=335.09 Aligned_cols=267 Identities=34% Similarity=0.533 Sum_probs=211.8
Q ss_pred CCCcccCCCCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE
Q 013214 145 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (447)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 220 (447)
.+..++..++.+|.....||+|+||.||. +|..||||++....... ..+|.+|+.++.+++|||+++++|+|.
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34456667777999999999999999883 56899999887543221 456999999999999999999999999
Q ss_pred eCC-ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 221 QSS-PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 221 ~~~-~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
+.+ ..+||+||+++|+|.++|.... +++|.++.+|+.++++||+|||+..+.+|+||||||+|||+|++.+.||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 988 4999999999999999998754 8999999999999999999999988778999999999999999999999999
Q ss_pred ccccccccCCCCCcccC-CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-Cc--hHH----HHHhc
Q 013214 298 GVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NE--VPK----AYAAR 369 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-~~--~~~----~~~~~ 369 (447)
|++...... ....... .||.+|+|||+...+..+.++||||||+++.|++||+.|.+.... .+ ... .+...
T Consensus 222 GLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 222 GLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred cCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 999765431 1111222 789999999999989999999999999999999999988875431 11 111 11111
Q ss_pred C-----CCCCC--CChh-hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 370 Q-----RPPFK--APAK-LYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 370 ~-----~~~~~--~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
. .+.+. .... ..-..+..+..+|++.+|.+||+|.++++.|+.+..
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 1 12221 1111 122336677789999999999999999999866543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=353.57 Aligned_cols=260 Identities=31% Similarity=0.539 Sum_probs=220.5
Q ss_pred cccCCCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeE
Q 013214 148 YEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (447)
Q Consensus 148 ~~i~~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 217 (447)
.++...++ ...++||+|.||.|+. ..+-||||.++.. .+....++|++|+.++..++|||||+++|
T Consensus 481 ~~i~r~~i--~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 481 LEIPRSDI--VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred eEechhhe--eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34444433 4456899999999873 3468999999865 35567899999999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 013214 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283 (447)
Q Consensus 218 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~N 283 (447)
+|...+.+|+|+|||..|||.++|.... +++..+.+.++.||+.|+.||-++. +|||||-.+|
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRN 633 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRN 633 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhh
Confidence 9999999999999999999999997421 2788899999999999999999999 9999999999
Q ss_pred EEEcCCCCEEEeeccccccc-ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 013214 284 ILRDDSGNLKVADFGVSKLL-TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE 361 (447)
Q Consensus 284 ill~~~~~vkl~Dfg~~~~~-~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~ 361 (447)
+||+++..|||+|||+++.. +.+..+......-+.+|||||.+..+++++++||||+||+|||+++ |+.||.+..+.|
T Consensus 634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence 99999999999999999853 2111111112234789999999999999999999999999999999 999999999999
Q ss_pred hHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 362 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+.+.+..+.-- .-+.++|.++.+||..||+.+|++||++++|-..|++.-..-
T Consensus 714 VIe~i~~g~lL---~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 VIECIRAGQLL---SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHcCCcc---cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 99988555432 236678999999999999999999999999999999876543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.68 Aligned_cols=248 Identities=27% Similarity=0.453 Sum_probs=206.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.+|+|+||.|+ .+|+.||||+++.....+.-.. ...+|++.|+.++||||+.++++|.....+.+|+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~-talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINR-TALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccH-HHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 57777899999999987 4799999999987655433333 34569999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++ .+|+..++.. ..++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+++.+.... .
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~-~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN-R 156 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC-c
Confidence 995 6999999765 46999999999999999999999999 9999999999999999999999999999887543 3
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCCC--------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPP-------------- 373 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~-------------- 373 (447)
..+....|.+|.|||.+.+. .|+...||||.||++.||+.|.+.|.+.++-+....+... +.|.
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 33334678999999988764 7999999999999999999999999988876655554222 1211
Q ss_pred ----CCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 ----FKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ----~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++. ..+..+....+++.+||..||.+|+++++++++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 110 112346678999999999999999999999985
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.40 Aligned_cols=292 Identities=27% Similarity=0.506 Sum_probs=244.3
Q ss_pred HHHHHHHHHhCCCCCCCcccccccCCCCCcccCCCCcCcccceeeecceEEEEEE-----c-C---eEEEEEEcCcccCC
Q 013214 119 HEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW-----R-G---IQVAVKKLGEEVIS 189 (447)
Q Consensus 119 ~~~~~~L~~~~a~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~lg~G~~~~~~~-----~-g---~~vavK~~~~~~~~ 189 (447)
.+++.+.......+.-......+|..-+.|++.-.++.+. +.||+|+||.|+. . + ..||+|..+.+...
T Consensus 123 ~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~ 200 (474)
T KOG0194|consen 123 SELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL 200 (474)
T ss_pred HHHHHHHHhcccceeccceeecccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccc
Confidence 3455555555555444444555666667888888877776 7999999998862 1 2 23899998865556
Q ss_pred CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHh
Q 013214 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHE 268 (447)
Q Consensus 190 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~ql~~~l~~lH~ 268 (447)
..+...++.+|++++++++||||+++||+...+..+++|||+|.||+|.++|++++. ++..+...++.+.+.||+|||+
T Consensus 201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH
Confidence 788899999999999999999999999999999999999999999999999998875 9999999999999999999999
Q ss_pred CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHH
Q 013214 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (447)
Q Consensus 269 ~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 348 (447)
++ ++||||-.+|+|++.++.+||+|||+++...... .......-+.+|+|||.+..+.++.++|||||||++||++
T Consensus 281 k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 281 KN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred CC---CcchhHhHHHheecCCCeEEeCccccccCCccee-eccccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 99 9999999999999999999999999998654211 1111224578999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 349 E-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 349 t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
+ |..||.+....++...+...+ +.+.+. ..+..+..++.+||..||++||+|.++.+.++.+......
T Consensus 357 ~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 357 ENGAEPYPGMKNYEVKAKIVKNGYRMPIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ccCCCCCCCCCHHHHHHHHHhcCccCCCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 9 899999999988888884444 555433 5578899999999999999999999999999998877654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=337.99 Aligned_cols=267 Identities=28% Similarity=0.552 Sum_probs=221.4
Q ss_pred CcccCCCCcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
+|+|.+. ++.....||+|.||+|+ |-| +||||++..+.. .++..+.|++|+.++++-+|.||+-+.|+|..+.
T Consensus 386 ~WeIp~~--ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 386 EWEIPPE--EVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccCHH--Hhhccceeccccccceeeccccc-ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 4555544 45566789999999987 444 799999998765 5568999999999999999999999999999877
Q ss_pred ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
. .||+.+|+|.+|+.+++.. .++...+.+.|++|+++|+.|||.++ |||+|||..||++.+++.|||+|||++..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 6 9999999999999999854 45899999999999999999999999 99999999999999999999999999875
Q ss_pred cccCC-CCCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCC
Q 013214 303 LTVKE-DRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAP 377 (447)
Q Consensus 303 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 377 (447)
..... ........+...|||||+++.+ +|++.+||||||+++|||++|..||.....+++.-.+..+. .+.....
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 54332 1222334567889999998754 68899999999999999999999999555554443332222 5566666
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhccc
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 421 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 421 (447)
..++++++++|+..||..++++||.+.+|+..|+.+..+..+.+
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~ 661 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN 661 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence 67788999999999999999999999999999988877654333
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=329.15 Aligned_cols=253 Identities=29% Similarity=0.474 Sum_probs=203.9
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC-
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS- 222 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~- 222 (447)
.+|+..+.||+|+||.|+. ++..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3677788999999998863 24679999987532 334456788999999999 899999999988764
Q ss_pred CceEEEEeccCCCCHHHHHHhc----------------------------------------------------------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------- 244 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 244 (447)
..++++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4589999999999999999753
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCc
Q 013214 245 ----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCR 319 (447)
Q Consensus 245 ----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~ 319 (447)
.++++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23677888899999999999999998 999999999999999999999999999765322111 1122345678
Q ss_pred ccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCC
Q 013214 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKP 397 (447)
Q Consensus 320 y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp 397 (447)
|+|||.+.+..++.++||||||+++|+|++ |..||.+....+......... .+. .+..+++.+.+++.+||+.||
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR---APENATPEIYRIMLACWQGDP 318 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCCh
Confidence 999999988889999999999999999997 999998766544332222222 222 234567889999999999999
Q ss_pred CCCCCHHHHHHHHHHHHh
Q 013214 398 AKRPTFRQIITRLESINN 415 (447)
Q Consensus 398 ~~Rps~~~~l~~l~~~~~ 415 (447)
++|||+.++++.|+++..
T Consensus 319 ~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 319 KERPTFSALVEILGDLLQ 336 (338)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.84 Aligned_cols=242 Identities=26% Similarity=0.402 Sum_probs=214.9
Q ss_pred CCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceE
Q 013214 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 226 (447)
...+|...+.||+|.||+|. .+++.+|||++++..+-..+.++..+.|.+++... +||+++.++.+|+.+.++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 33478888999999999986 37889999999999888888889999999999998 5999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+||||+.||++..+ ...+.+++..+..++..++.||+|||++| ||+||||.+|||+|.+|++||+|||+++.....
T Consensus 446 fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99999999995543 34467999999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.+ .....+|||.|||||++.+..|+..+|+|||||+||||+.|..||.+.+.+++...+... .+.+ |..+|.+..
T Consensus 522 g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-~~~y---P~~ls~ea~ 596 (694)
T KOG0694|consen 522 GD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-EVRY---PRFLSKEAI 596 (694)
T ss_pred CC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CCCC---CCcccHHHH
Confidence 33 445688999999999999999999999999999999999999999999999988887333 3333 456789999
Q ss_pred HHHHHHcccCCCCCCCH
Q 013214 387 ELIEECWNEKPAKRPTF 403 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~ 403 (447)
++|+++|..||++|..+
T Consensus 597 ~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhccCcccccCC
Confidence 99999999999999866
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=327.41 Aligned_cols=243 Identities=24% Similarity=0.409 Sum_probs=207.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|.+...........+.+.+|+.+++.++||||+++++++.+....+++||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 577788999999998862 588999999875433334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998765321
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.. ....+ +..+++.+.++|+
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~li~ 230 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA-GKLEF---PRHLDLYAKDLIK 230 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCcCC---CccCCHHHHHHHH
Confidence 1234578999999999888899999999999999999999999988776555555432 23333 3345788999999
Q ss_pred HHcccCCCCCCC-----HHHHHHH
Q 013214 391 ECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps-----~~~~l~~ 409 (447)
+||+.||.+||+ +++++++
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcC
Confidence 999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=322.62 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=203.7
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||+|+||.|+ .+|+.||+|.+.............+.+|+.+++.++|++|+++++++..++..+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 5667889999999885 36899999998755433333445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++...... .
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 9999999888643 35899999999999999999999999 999999999999999999999999998765322 1
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+...........+..++..+.+++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 22344679999999999988999999999999999999999999987665433333322222222223445788999999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 013214 390 EECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
++||+.||.+||+ +++++++
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 9999999999997 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=331.93 Aligned_cols=244 Identities=24% Similarity=0.410 Sum_probs=208.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|.+...........+.+.+|+.++++++||||+++++++..++..+++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 3688889999999998862 57899999987654334445677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+.+|+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999999999998888999999999999999999999999 999999999999999999999999998765322
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+....+....+. .....+ +..++..+.++|
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~-~~~~~~---p~~~~~~~~~li 246 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-AGRLKF---PNWFDGRARDLV 246 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh-cCCcCC---CCCCCHHHHHHH
Confidence 123467999999999998889999999999999999999999998766555544442 233333 234678899999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 013214 390 EECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
++||+.||.+||+ +.+++++
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999987 6887765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=330.39 Aligned_cols=240 Identities=25% Similarity=0.400 Sum_probs=203.9
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
.||+|+||.|+ .+|+.||+|++.............+.+|+.+++.++||||+++++.+...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 68999999887 3688999999976544344555677889999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCC
Q 013214 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (447)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 316 (447)
|.+++..++.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ........|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~g 157 (323)
T cd05571 82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceec
Confidence 9999998888999999999999999999999999 999999999999999999999999998753221 112234568
Q ss_pred CCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccC
Q 013214 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396 (447)
Q Consensus 317 t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 396 (447)
|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+. .....+ +..+++++.++|++||+.|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~~~---p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRF---PRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH-cCCCCC---CCCCCHHHHHHHHHHccCC
Confidence 999999999998889999999999999999999999998766555444442 222232 3457889999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 013214 397 PAKRP-----TFRQIITR 409 (447)
Q Consensus 397 p~~Rp-----s~~~~l~~ 409 (447)
|++|| ++.+++++
T Consensus 234 P~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 234 PKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHcCCCCCCCHHHHHcC
Confidence 99999 79988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=300.38 Aligned_cols=245 Identities=26% Similarity=0.442 Sum_probs=217.9
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|..++.||+|-||.|| .++-.||+|++.++.+......+++++|+++...++||||+++|++|.++.++|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 67788899999999887 3678899999988777666777889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~--~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|..+|+|...|. ...++++...+.++.|++.|+.|+|..+ ++||||||+|+|++..+.+|++|||-+..-+ .
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~ 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 176 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence 999999999998 5567999999999999999999999999 9999999999999999999999999886543 2
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+||..|++||...+..++..+|+|++|++.||++.|.+||......+....+... +..+ +..++.+++++
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-~~~~---p~~is~~a~dl 252 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-DLKF---PSTISGGAADL 252 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-cccC---CcccChhHHHH
Confidence 2335567899999999999999999999999999999999999999999877776666332 2232 35688999999
Q ss_pred HHHHcccCCCCCCCHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l 410 (447)
|.+|+..+|.+|.+..+++++-
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred HHHHhccCccccccHHHHhhhH
Confidence 9999999999999999998874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.35 Aligned_cols=250 Identities=35% Similarity=0.546 Sum_probs=208.1
Q ss_pred CcccCCCCcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
.|+|.++. +....-||+|+-|-|+ ..++.||||+++.- -..+++.|++++||||+.|.|+|....
T Consensus 118 ~WeiPFe~--IsELeWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEE--ISELEWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHH--hhhhhhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 44555443 2334457888777665 67899999988521 235889999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..|||||||..|-|...|+....+.......|..+|+.|+.|||.++ |||||||..||||..+..|||+|||-++..
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999999999999999999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCC-CCChhhhH
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF-KAPAKLYA 382 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 382 (447)
.... ..-.+.||..|||||++...+++.|+|||||||+||||+||..||.+-+..-+.--+ +...+ -..+..+|
T Consensus 263 ~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV---GsNsL~LpvPstcP 337 (904)
T KOG4721|consen 263 SDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV---GSNSLHLPVPSTCP 337 (904)
T ss_pred hhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec---cCCcccccCcccCc
Confidence 5442 223567999999999999999999999999999999999999999976654332111 11111 12356788
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+.+.-||+.||+..|.+|||+.+++.+|+-....
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 9999999999999999999999999999754433
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=314.03 Aligned_cols=251 Identities=26% Similarity=0.437 Sum_probs=208.8
Q ss_pred cCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
.+|+..+.||+|+||.|+. .+..||+|.++... .......+.+|+..+++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4677888999999998852 35789999997642 3444567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999774 56899999999999999999999999 99999999999999999999999998765322
Q ss_pred CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
..........++..|+|||.+.+..++.++||||||+++|++++ |+.||......+....+......+ .+..++..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 236 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---APRNCPNL 236 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHH
Confidence 11111122334678999999988899999999999999999875 999998877666555553333333 24557788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+.+++.+||+.+|.+||++.++++.|.++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=302.64 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=212.8
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCccc-----CCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCc
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV-----ISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 224 (447)
.|...+.+|.|..+.+. .+|..+|+|++.... .......++...|+.+|+++ .||+|+++.++++++..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 35566788998887653 578899999885422 11334456678899999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
+++|+|.|+.|.|.|+|.+.-.+++....++++|+.+|+.|||.++ |+||||||+|||++++.++||+|||+++.+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999998888999999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCcccCCCCCcccCCcccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCCh
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 378 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (447)
.+ ......+|||+|+|||.+.. ..|+...|+|++|++||.|+.|++||....+.-..+.+-.+...--++.+
T Consensus 175 ~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 175 PG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred Cc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 44 44566789999999998753 46888999999999999999999999977766666666343333334567
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++|.+.++||.+||+.||.+|.|++|++.+
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 8899999999999999999999999999865
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=328.53 Aligned_cols=247 Identities=29% Similarity=0.453 Sum_probs=209.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++.............+.+|+.++..++||||+++++++......+++||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 577888999999998862 578999999976544344456678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..... .
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999876432 2
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC----CCCCCCChhhhHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFKAPAKLYARGLK 386 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~ 386 (447)
.....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.... .+........+++++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 234467999999999998899999999999999999999999998877655544442221 1222111235678999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||..+|.+||++.+++++
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=311.39 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=214.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||+|..|.||. ++..+|+|++.++.....+...+.+.|.+||+.++||+++++|..|+.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 467778899999999873 458999999998877777778888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC--
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK-- 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~-- 306 (447)
||+||+|...++++. .++++.+..++.+++-||+|||..| ||.|||||+|||+.++|+|-|+||.++......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999998764 4999999999999999999999999 999999999999999999999999987543110
Q ss_pred ------------------------------CCC-----------------------CcccCCCCCcccCCcccCCCCCCC
Q 013214 307 ------------------------------EDR-----------------------PLTCQDTSCRYVAPEVFKNEEYDT 333 (447)
Q Consensus 307 ------------------------------~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~ 333 (447)
... ...+..||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 012345889999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC----HHHHHH
Q 013214 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT----FRQIIT 408 (447)
Q Consensus 334 ~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~~l~ 408 (447)
.+|+|+||+++|||+.|.-||.+.+..+....+ ....+.++..+ .++..+++||+++|.+||.+|.. +.||-+
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI-v~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI-VGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH-hcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 999999999999999999999999999988887 34444454433 67899999999999999999988 666554
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=326.03 Aligned_cols=240 Identities=25% Similarity=0.400 Sum_probs=203.5
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
.||+|+||.|+ .+|..||+|.+.............+.+|+.+++.++||||+++++++...+..|+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 68999999887 3688999999976544344556677889999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCC
Q 013214 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (447)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 316 (447)
|..++...+.+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... ........|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g 157 (323)
T cd05595 82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccC
Confidence 9999988888999999999999999999999999 999999999999999999999999998753221 112233568
Q ss_pred CCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccC
Q 013214 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396 (447)
Q Consensus 317 t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 396 (447)
|+.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+... ...+ +..+++++.++|.+||+.|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-~~~~---p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRF---PRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCC---CCCCCHHHHHHHHHHccCC
Confidence 99999999998888999999999999999999999999877665555444222 2222 3457889999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 013214 397 PAKRP-----TFRQIITR 409 (447)
Q Consensus 397 p~~Rp-----s~~~~l~~ 409 (447)
|++|| ++.+++++
T Consensus 234 P~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 234 PKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHhCCCCCCCHHHHHcC
Confidence 99998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.03 Aligned_cols=247 Identities=25% Similarity=0.461 Sum_probs=217.5
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc-eEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv 228 (447)
.+|...+.+|+|+||.++ .++..+++|.+........ ..+...+|+.+++++.||||+.+.+.|..++. ++|+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357778899999999764 4678999999987765444 44567889999999999999999999999988 9999
Q ss_pred EeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 229 TEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+||+||+|.+.+.+.+ .++++.+..|+.|++.|+.|||+++ |+|||||++|||++.++.|+|+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998654 4899999999999999999999988 999999999999999999999999999987754
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
. .......||+.|++||++.+.+|+.|+|||||||++|||++-+++|...+-..+...+.... +.+.+..++.+++
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~ 235 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---YSPLPSMYSSELR 235 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc---CCCCCccccHHHH
Confidence 3 23456789999999999999999999999999999999999999999888777766664444 3344678999999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+|+.|++.+|..||++.+++.+
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhC
Confidence 99999999999999999999976
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=327.14 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=207.3
Q ss_pred CcCcccceeeecceEEEEEE---c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 154 ELDFTNSVEITKGTFILAFW---R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~---~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
..+|...+.||+|+||.|+. . +..||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 34688889999999998762 1 25899999875544344556778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+|||+++|+|.+++.+++.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999999999998888999999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.. ....+ +..+++.+.+
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~~~~~~~ 257 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE-GIIYF---PKFLDNNCKH 257 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCHHHHH
Confidence 2334689999999999888899999999999999999999999987665544444422 22222 3446788999
Q ss_pred HHHHHcccCCCCCC-----CHHHHHHH
Q 013214 388 LIEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
+|++||+.||.+|+ ++++++++
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999999999995 88888765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=325.70 Aligned_cols=240 Identities=26% Similarity=0.411 Sum_probs=203.9
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
.||+|+||.|+ .+|+.||+|++.............+.+|+.+++.++||||+++++.+...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 58999999887 3688999999976544444556778889999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCC
Q 013214 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (447)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 316 (447)
|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...... ........|
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 9999988888999999999999999999999999 999999999999999999999999998753221 112233568
Q ss_pred CCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccC
Q 013214 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396 (447)
Q Consensus 317 t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 396 (447)
|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+. .....+ +..+++.+.++|++||+.|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~-~~~~~~---p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEDIKF---PRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc-cCCccC---CCCCCHHHHHHHHHHcCCC
Confidence 999999999988889999999999999999999999998766555444442 222222 3457789999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 013214 397 PAKRP-----TFRQIITR 409 (447)
Q Consensus 397 p~~Rp-----s~~~~l~~ 409 (447)
|.+|| ++.+++++
T Consensus 234 P~~R~~~~~~~~~~il~h 251 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 99997 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=318.27 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=203.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCC-----------HHHHHHHHHHHHHHhcCCCCcccceeEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISD-----------DDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 219 (447)
+|...+.||+|.||.|. .+++.||+|++.+..... ....+..++|+.+|++++|||||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 68889999999999886 368999999997643211 11235788899999999999999999998
Q ss_pred Ee--CCceEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 220 TQ--SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 220 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
.+ .+.+|||+|||..|.+...- ..++ +++.+++.++++++.||.|||.+| |+||||||+|+|++++|++||+|
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeec
Confidence 65 46799999999988876432 2334 999999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCC----cccCCCCCcccCCcccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh
Q 013214 297 FGVSKLLTVKEDRP----LTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 297 fg~~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 368 (447)
||.+.......... .....|||.|+|||...++. .+.+.||||+||+||+|+.|+.||-+....++...+..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 99998764332211 13357899999999987742 34689999999999999999999998877777666633
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
. ...++. .+...+.+++||.+||..||++|.+..++..+...
T Consensus 334 ~-pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 334 D-PLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred C-cccCCC-cccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 2 233332 23467899999999999999999999999877543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.70 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=205.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +++.||+|++.............+.+|..++..++||||+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 577788999999998863 578999999976543344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999998889999999999999999999999999 99999999999999999999999999875432100
Q ss_pred --------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 013214 309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (447)
Q Consensus 309 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 356 (447)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001234689999999999988999999999999999999999999988
Q ss_pred CCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcc--cCCCCCCCHHHHHHH
Q 013214 357 KHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWN--EKPAKRPTFRQIITR 409 (447)
Q Consensus 357 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~--~dp~~Rps~~~~l~~ 409 (447)
.+..+....+.... ...++. ...+++++.++|.+++. .++..||++.+++++
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 77666555553322 222322 22367889999988664 233346899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=322.72 Aligned_cols=239 Identities=25% Similarity=0.401 Sum_probs=200.3
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||+|+||.|+. +++.||+|.+.............+.+|+.++++++||||+++++.+...+..+++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 68999998862 5788999998754433445566788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCC
Q 013214 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (447)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t 317 (447)
.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .......||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 999988888999999999999999999999999 9999999999999999999999999987533221 122345689
Q ss_pred CcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCC
Q 013214 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 397 (447)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 397 (447)
+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+. .....+ +..+++.+.++|.+||+.||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL-QEPLRF---PDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH-cCCCCC---CCcCCHHHHHHHHHHcCCCH
Confidence 99999999998889999999999999999999999998766555444432 222222 34577899999999999999
Q ss_pred CCCCC---HHHHHHH
Q 013214 398 AKRPT---FRQIITR 409 (447)
Q Consensus 398 ~~Rps---~~~~l~~ 409 (447)
.+||+ +.+++.+
T Consensus 233 ~~R~~~~~~~e~l~h 247 (312)
T cd05585 233 TRRLGYNGAQEIKNH 247 (312)
T ss_pred HHcCCCCCHHHHHcC
Confidence 99975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=330.00 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=205.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|...+.||+|+||.|+. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 467778999999999873 678999999976554455566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++++||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999998753311000
Q ss_pred --------------------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHH
Q 013214 309 --------------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (447)
Q Consensus 309 --------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l 344 (447)
.......||+.|+|||.+.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001134689999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHc--ccCCCCCCCHHHHHHH
Q 013214 345 QEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECW--NEKPAKRPTFRQIITR 409 (447)
Q Consensus 345 ~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl--~~dp~~Rps~~~~l~~ 409 (447)
|+|++|+.||...+..+....+.... ...++ ....+++++.++|.+|+ ..+|..||++.+++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999998877655444442222 22221 22346789999999854 5566669999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.75 Aligned_cols=248 Identities=22% Similarity=0.395 Sum_probs=202.3
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccC-CCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 225 (447)
+|+..+.||+|+||.|+. +|+.||+|++.+... ......+.+..|..+++.+ +||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467788999999998872 578999999865322 1223445678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+++|||+++|+|.+++.++..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999999988888999999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH---HhcCCCCCCCChhhh
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQRPPFKAPAKLY 381 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 381 (447)
..........||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+ .....+.+ +..+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 234 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF---PSFI 234 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC---CCCC
Confidence 322223345689999999998765 4788999999999999999999999755433222222 12223332 3456
Q ss_pred HHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
++.+.+++.+||+.||++|| ++++++++
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 78899999999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=329.45 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=206.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++.............+.+|+.+++.++||||+++++.+.++...++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 577788999999998862 688999999976543344556678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC-
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~- 309 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++..+......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998654321100
Q ss_pred ------------------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 013214 310 ------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353 (447)
Q Consensus 310 ------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p 353 (447)
......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00123589999999999888999999999999999999999999
Q ss_pred CCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 013214 354 FTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 409 (447)
Q Consensus 354 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~~ 409 (447)
|...+..+....+.... ...++. ...+++.+.++|++|+. +|.+|++ +.+++++
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNPQETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCHHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 98777655444442222 122221 22467899999999996 9999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=329.12 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=209.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++.............+.+|..++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 577888999999998862 589999999976544343456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC---
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE--- 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~--- 307 (447)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999988888999999999999999999999998 9999999999999999999999999987654332
Q ss_pred -------------------------CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch
Q 013214 308 -------------------------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (447)
Q Consensus 308 -------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~ 362 (447)
........||+.|+|||.+.+..++.++|||||||++|+|++|+.||......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 0112334589999999999998999999999999999999999999998776555
Q ss_pred HHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC-HHHHHHH
Q 013214 363 PKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT-FRQIITR 409 (447)
Q Consensus 363 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~~l~~ 409 (447)
...+.... ...++. ...+++.+.++|.+||. ||.+||+ +.+++++
T Consensus 239 ~~~i~~~~~~~~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIINWKESLRFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhccCCcccCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 44443311 112221 22368899999999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.68 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=200.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 577788999999998762 578999999875432 23345667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|++++++..+......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9988777665555567999999999999999999999999 9999999999999999999999999998764333333
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------CC-----
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-------------RP----- 372 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-------------~~----- 372 (447)
.....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+.... .+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 334567899999999988889999999999999999999999998765433221111100 00
Q ss_pred CCCC----------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 PFKA----------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ~~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+. ....+|..+.++|++||+.||++|||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 012357789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=320.82 Aligned_cols=249 Identities=28% Similarity=0.433 Sum_probs=220.9
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 228 (447)
..|...+.||.|.||.++ .+|+.+|+|.+.+.............+|+.+|+++. ||||+++++.|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 367788899999999887 369999999998876655556678899999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC----CCEEEeecccccccc
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLLT 304 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~----~~vkl~Dfg~~~~~~ 304 (447)
||+|.||.|.+.+... .+++..+..++.|++.++.|||+.| ++|||+||+|+|+... +.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999876 4999999999999999999999999 9999999999999743 479999999999876
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
. ........||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+..+....+......--...+..++..
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred C--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 5 34456678999999999999899999999999999999999999999999988877777444432334557788999
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++|+.|+..||.+|+|+.++++|
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcC
Confidence 9999999999999999999999997
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=293.13 Aligned_cols=259 Identities=22% Similarity=0.391 Sum_probs=208.0
Q ss_pred cCCCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-
Q 013214 150 IDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 223 (447)
Q Consensus 150 i~~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 223 (447)
+...+.+|++.+.+|+|||..|+ .++..+|+|++.-. ..+..+..++|++..++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 34456789999999999998775 47889999998643 4566778889999999999999999998875443
Q ss_pred ----ceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEe
Q 013214 224 ----PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (447)
Q Consensus 224 ----~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~ 295 (447)
..|++++|...|+|.+.+.. +..+++.+.+.|+.++++||++||+..| ++.||||||.|||+++.+.+++.
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEE
Confidence 38999999999999999964 2359999999999999999999999985 79999999999999999999999
Q ss_pred ecccccccccCCCC--------CcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCC--Cch
Q 013214 296 DFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEV 362 (447)
Q Consensus 296 Dfg~~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~--~~~ 362 (447)
|||++......... .+....+|..|.|||.+.-. ..++++|||||||++|+|+.|..||...-. ..+
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 99998765432111 12334578999999998543 567899999999999999999999974322 111
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
...+ ......++...+ +|+.+.++|+.||+.||.+||+..+++..++++.
T Consensus 252 aLAv-~n~q~s~P~~~~-yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ALAV-QNAQISIPNSSR-YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEee-eccccccCCCCC-ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 122233333333 8999999999999999999999999999998764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=325.89 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=207.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++........+..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 577888999999998873 688999999986544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999876 67999999999999999999999999 999999999999999999999999999765433222
Q ss_pred CcccCCCCCcccCCcccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC-CCCCCChhhhH
Q 013214 310 PLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PPFKAPAKLYA 382 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 382 (447)
......+|+.|+|||++. ...++.++|||||||++|+|++|+.||......+....+..... ..++ ....++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~ 237 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP-EDPKVS 237 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC-CCCCCC
Confidence 223346799999999986 44677899999999999999999999987766555444433221 2222 223577
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+.+++..||+ +|.+||++.+++++
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 899999999997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=324.19 Aligned_cols=240 Identities=25% Similarity=0.404 Sum_probs=203.0
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
.||+|+||.|+ .+|+.||+|++.............+.+|..+++.++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 68999999887 3688999999976544444556677889999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
|.+++...+.+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (325)
T cd05594 82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC 157 (325)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence 99999888889999999999999999999997 67 999999999999999999999999998753221 11223346
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....+ +..+++++.++|++||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~-~~~~~~---p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRF---PRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh-cCCCCC---CCCCCHHHHHHHHHHhhc
Confidence 8999999999988889999999999999999999999998776655544442 222222 345678999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 013214 396 KPAKRP-----TFRQIITR 409 (447)
Q Consensus 396 dp~~Rp-----s~~~~l~~ 409 (447)
||++|+ ++.+++++
T Consensus 234 dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CHHHhCCCCCCCHHHHhcC
Confidence 999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=314.04 Aligned_cols=252 Identities=28% Similarity=0.463 Sum_probs=201.8
Q ss_pred cCcccceeeecceEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccc
Q 013214 155 LDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 213 (447)
.+|...+.||+|+||.|+. ++..||+|.+.... .......+.+|+.++.+++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3577788999999998863 23479999987542 345567889999999999999999
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 013214 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------------ALKPSTAVRFALDIARGMNYLHENKPVPI 274 (447)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i 274 (447)
++++++......+++|||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ +
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 99999999999999999999999999986532 3567788999999999999999999 9
Q ss_pred EeCCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--CC
Q 013214 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GC 351 (447)
Q Consensus 275 ~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t--g~ 351 (447)
+|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999998765332111 1122334778999999988889999999999999999986 56
Q ss_pred CCCCCCCCCchHHHHHhc----CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 352 PPFTMKHDNEVPKAYAAR----QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 352 ~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
.||...+..+........ ........++.++..+.+++.+||+.||++|||+.++.+.|+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 788776655443332111 111112223456788999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=316.80 Aligned_cols=248 Identities=25% Similarity=0.449 Sum_probs=205.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|+..+.||+|+||.|+. +|..+|+|.+.... .....+.+.+|+++++.++||||+++++++..++..+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 34788888999999998863 57889999987542 344567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++++|.+++.....+++..+..++.|++.||.|||+.+ .++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999999998888999999999999999999999863 2999999999999999999999999998755322
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH---------------------
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA--------------------- 367 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~--------------------- 367 (447)
......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+.
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2233467899999999998889999999999999999999999997554332221110
Q ss_pred -------------------------hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 368 -------------------------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 368 -------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
....+.. ....+++++.++|.+||+.||++|||+.+++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0001111 1224678899999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=299.89 Aligned_cols=251 Identities=28% Similarity=0.407 Sum_probs=206.3
Q ss_pred CCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--Cce
Q 013214 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 225 (447)
...+|+....|++|+||.|| .+++.||+|+++.+.-...-.... .+|+.+|.+.+|||||.+-.+.... +.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIts-LREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITS-LREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchh-HHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 33467888899999999998 368899999998765333333333 4699999999999999999887643 569
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
|+|||||+ .+|...+..-+ +++..++..++.|++.|++|||.++ |+||||||+|+|++..|.+|++|||+|+.++
T Consensus 153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 99999995 59999998765 7999999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC------CCCC
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP------PFKA 376 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~------~~~~ 376 (447)
.+ ..+.+....|.+|.|||.+.+. .|++..|+||+||++.||+++++.|.+....+....+...- .| .+..
T Consensus 229 sp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 54 4556667789999999998875 68999999999999999999999999887765554442211 11 1111
Q ss_pred C---------------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 P---------------------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ~---------------------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
. ....+..-.+|+..+|..||.+|.|+++.+++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 01145778899999999999999999998875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=329.04 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=204.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++........+..+.+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 577788999999998873 688999999875433344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++|+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999863211000
Q ss_pred -----------C---------------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHH
Q 013214 309 -----------R---------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (447)
Q Consensus 309 -----------~---------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l 344 (447)
. ......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 00123589999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCC---CCHHHHHHH
Q 013214 345 QEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKR---PTFRQIITR 409 (447)
Q Consensus 345 ~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~~l~~ 409 (447)
|+|++|+.||......+....+.... ...++ ....++.++.++|.+|+. +|.+| +++.+++.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999998776555444442221 22222 223467899999999997 77765 599998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=306.94 Aligned_cols=248 Identities=28% Similarity=0.430 Sum_probs=204.0
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-----CCceE
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-----SSPMM 226 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 226 (447)
|...+.||+|++|.|. .+|+.||+|++... +...-..++..+|+++|+.++|+||+.+.+.+.. -+.+|
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 4445789999999874 47899999999743 3455556677789999999999999999998865 24689
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|+|+| +.+|...++++..++++.+..++.|++.||+|+||.+ ++|||+||+|++++.+..+||||||+|+.....
T Consensus 103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence 999999 6799999999888999999999999999999999999 999999999999999999999999999977533
Q ss_pred C-CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh----------------
Q 013214 307 E-DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---------------- 368 (447)
Q Consensus 307 ~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---------------- 368 (447)
. ....+.+..|.+|.|||++.. ..|+...||||+||++.||++|++.|.+.+.......+..
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 1 233467788999999998755 4899999999999999999999999998875433222211
Q ss_pred ------cC-----CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 ------RQ-----RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ------~~-----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. +.++....++.++...+|+++||..||.+|+|+++++++
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 112222234677899999999999999999999999875
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=319.54 Aligned_cols=239 Identities=29% Similarity=0.485 Sum_probs=197.7
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +++.||+|.++..........+.+..|..++... +||||+++++++......++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 689999998862 5788999999765433334445556677777654 8999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .......
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 99999988888999999999999999999999998 9999999999999999999999999987543222 2223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+ ....+.+ +..++.++.+++.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i-~~~~~~~---~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI-LNDRPHF---PRWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH-HcCCCCC---CCCCCHHHHHHHHHHccC
Confidence 899999999998888999999999999999999999999987765555444 2233333 345678899999999999
Q ss_pred CCCCCCCHH-HHHH
Q 013214 396 KPAKRPTFR-QIIT 408 (447)
Q Consensus 396 dp~~Rps~~-~~l~ 408 (447)
||.+||++. ++++
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05592 234 DPTKRLGVDGDIRQ 247 (316)
T ss_pred CHHHcCCChHHHHc
Confidence 999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=322.66 Aligned_cols=253 Identities=28% Similarity=0.466 Sum_probs=205.1
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC
Q 013214 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 222 (447)
..+|+..+.||+|+||.|+. ++..||+|+++... ..+..+.+.+|+.+++.+ +||||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34688889999999998862 22479999997543 334456788999999999 899999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc----------------------------------------------------------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------- 244 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 244 (447)
+..+++|||+++|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999998642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC-c
Q 013214 245 ------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-L 311 (447)
Q Consensus 245 ------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~ 311 (447)
.++++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 13677888999999999999999998 9999999999999999999999999987654322111 1
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 389 (447)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||................ .+.. +..+++++.+++
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li 348 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR---PDFAPPEIYSIM 348 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC---CCCCCHHHHHHH
Confidence 12234567999999988889999999999999999997 999998766544333332222 2222 233578899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.+||+.||++|||+.++++.|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=320.52 Aligned_cols=234 Identities=25% Similarity=0.417 Sum_probs=197.2
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+ .+++.||+|++...........+.+..|..++... +||||+++++++...+.+++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 68999999886 25789999998765433344556677788888876 7999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (320)
T cd05590 82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFC 157 (320)
T ss_pred hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753221 11223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+.. ....+ +..++.++.++|++||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-DEVVY---PTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCHHHHHHHHHHccc
Confidence 89999999999888899999999999999999999999998776665555532 22222 334678899999999999
Q ss_pred CCCCCCCH
Q 013214 396 KPAKRPTF 403 (447)
Q Consensus 396 dp~~Rps~ 403 (447)
||.+||++
T Consensus 234 dP~~R~~~ 241 (320)
T cd05590 234 NPTMRLGS 241 (320)
T ss_pred CHHHCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=309.98 Aligned_cols=249 Identities=33% Similarity=0.557 Sum_probs=207.9
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|+..+.||+|+||.|+. ....||+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 567778899999998762 12579999987542 445567789999999999999999999999998999
Q ss_pred EEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 9999999999999999764 34778889999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 013214 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 367 (447)
+.++|+|||++........ .......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875432211 11223345788999999988889999999999999999998 999998877766655554
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
....+. .+..+++++.+++.+||+.||.+||++.+++++|+.
T Consensus 241 ~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 SRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 333332 245678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=325.88 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=206.0
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+ .+++.||+|.+.............+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 468888899999999887 368899999987543333344456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 99999999998865 45889999999999999999999999 999999999999999999999999998765432222
Q ss_pred CcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARG 384 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 384 (447)
......||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+.... ...++ ....+|.+
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~ 277 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP-DDIEISKQ 277 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC-CcCCCCHH
Confidence 22345689999999998653 47889999999999999999999999877655555553322 22222 23357889
Q ss_pred HHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
+.++|.+||+.+|.+ |+++.+++++
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcC
Confidence 999999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=321.97 Aligned_cols=249 Identities=29% Similarity=0.477 Sum_probs=202.0
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCc
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 224 (447)
+|+..+.||+|+||.|+. ++..||+|+++... .....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 677788999999998852 35689999987543 223446788899999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-----------------------------------------------------------
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------- 245 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 245 (447)
.+++|||+++|+|.+++.+..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 246 ----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 3677888999999999999999998 999999999999999999999999998765432211
Q ss_pred C-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHH
Q 013214 310 P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLK 386 (447)
Q Consensus 310 ~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 386 (447)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||................ ++.. +...+.++.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 347 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS---PECAPSEMY 347 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC---CCCCCHHHH
Confidence 1 112234667999999998899999999999999999998 899998765443322222222 2221 234567899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+++.+||+.||++|||+.++++.|++
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHh
Confidence 99999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=319.12 Aligned_cols=241 Identities=24% Similarity=0.424 Sum_probs=200.9
Q ss_pred eeeecceEEEEEE--------cCeEEEEEEcCcccC-CCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 161 ~~lg~G~~~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+.||+|+||.|+. .++.||+|.+..... ........+.+|+.+++.++||||+++++.+..++..+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4799999998862 578899999875432 1223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 311 (447)
+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCcc
Confidence 999999999998888999999999999999999999999 999999999999999999999999998643221 1122
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 391 (447)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.. ....+ +..+++.+.++|.+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~li~~ 233 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK-GKLNL---PPYLTPEARDLLKK 233 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCHHHHHHHHH
Confidence 345689999999999888889999999999999999999999987765554444422 22222 34467889999999
Q ss_pred HcccCCCCCC-----CHHHHHHH
Q 013214 392 CWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 392 cl~~dp~~Rp-----s~~~~l~~ 409 (447)
||+.||++|| ++.+++++
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcC
Confidence 9999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=327.68 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=204.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|...+.||+|+||.|+. +++.||+|++...........+.+.+|+.+++.++||||+++++.+.+...+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 467788999999998863 678999999876543344556788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC---
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE--- 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~--- 307 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999988888999999999999999999999999 9999999999999999999999999975321000
Q ss_pred -------------------------------------------CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHH
Q 013214 308 -------------------------------------------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (447)
Q Consensus 308 -------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l 344 (447)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001124589999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 013214 345 QEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 409 (447)
Q Consensus 345 ~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~~ 409 (447)
|+|++|+.||...+..+....+.... ...++ ....+++++.++|.+|+ .+|.+|++ +.+++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99999999999876655444443322 22221 23456788999998876 59999987 8877754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=312.73 Aligned_cols=243 Identities=24% Similarity=0.460 Sum_probs=211.5
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+-||+|-|..|. .+|+.||||++.+....+ -....+.+|+++|+.++|||||++|++...+..+|||+|+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 5556679999998774 699999999998876543 3446677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
-++|+|++|+-+. ..+.++.+.+++.||+.|+.|||+.. +|||||||+|+.+- .-|-|||.|||++..+..+ .
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--K 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc--c
Confidence 9999999999765 45999999999999999999999998 99999999999876 6789999999999766543 3
Q ss_pred CcccCCCCCcccCCcccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.....+|+..|-|||++.+..|+. .+||||||++||.|.+|++||+..++.+..-.+ ....... +..++.++++|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI-mDCKYtv---PshvS~eCrdL 249 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI-MDCKYTV---PSHVSKECRDL 249 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh-hcccccC---chhhhHHHHHH
Confidence 445678899999999999998884 799999999999999999999999998877666 3333332 56789999999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|..||..||++|.+.++|...
T Consensus 250 I~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHhcCchhhccHHHHhcc
Confidence 999999999999999998864
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.08 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=204.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+ .+++.||+|++.............+.+|+.+++.++||||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 57788899999999887 3578999999875433333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999753211000
Q ss_pred ----------------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHH
Q 013214 309 ----------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (447)
Q Consensus 309 ----------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 348 (447)
.......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0011246899999999999889999999999999999999
Q ss_pred hCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCC---CHHHHHHH
Q 013214 349 EGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRP---TFRQIITR 409 (447)
Q Consensus 349 tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~~l~~ 409 (447)
+|+.||......+....+.... ...+ .....+++.+.++|.+|+ .+|.+|+ ++.+++++
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHI-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccC-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999877655544442222 1111 122356788999999976 5999999 88998876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=304.71 Aligned_cols=248 Identities=29% Similarity=0.516 Sum_probs=206.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|++|.++. .++.||+|.+... ......+.+|+++++.++||||+++++++..+...+++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 466678899999987752 5789999998643 2234678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999997643 4889999999999999999999998 99999999999999999999999999886543322
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
........+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.....+. .+..++.++.+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 236 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME---RPEGCPPKVYE 236 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHH
Confidence 22222234667999999988889999999999999999998 999998766655544443322332 23457789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
++.+||+.||++||++.++++.|+.+
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=310.74 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=197.2
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||+|+||.|+ .+|+.||+|.+...........+.+..|+.+++.++||||+++.+++..+...+++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6899999886 36889999998765444444456678899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 013214 238 RAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (447)
Q Consensus 238 ~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 313 (447)
.+++.. +..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988743 345899999999999999999999999 99999999999999999999999999876543221 2233
Q ss_pred CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 013214 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393 (447)
Q Consensus 314 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 393 (447)
..+|+.|+|||.+.+..++.++|+||||+++|+|++|+.||.......................+..++..+.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 46789999999999989999999999999999999999999865543222222111111111223457889999999999
Q ss_pred ccCCCCCC-----CHHHHHHH
Q 013214 394 NEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 394 ~~dp~~Rp-----s~~~~l~~ 409 (447)
+.||++|| ++++++++
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=311.87 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=203.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +++.||+|.+.............+.+|+.+++.++||||+++++.+..+...+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 366778999999998863 578999999875443333344567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999888654 45899999999999999999999999 9999999999999999999999999987654221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.........+...........+..++..+.++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence 1223457899999999988889999999999999999999999998766544333322211111112234578889999
Q ss_pred HHHHcccCCCCCC-----CHHHHHHH
Q 013214 389 IEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
+.+||+.||.+|| ++++++++
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=318.63 Aligned_cols=241 Identities=24% Similarity=0.416 Sum_probs=198.5
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+ .+++.||+|+++............+..|..+++.+ +||||+++++++.....++++|||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 68999999886 25789999999876554555567788999999988 7999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (329)
T cd05588 82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFC 157 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998642211 11223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc--------hHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE--------VPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
||+.|+|||.+.+..++.++|+|||||++|+|++|+.||......+ ............+ +..++..+.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~ 234 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI---PRSLSVKASS 234 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC---CCCCCHHHHH
Confidence 8999999999999899999999999999999999999996432111 1111112222222 3456788999
Q ss_pred HHHHHcccCCCCCCC------HHHHHHH
Q 013214 388 LIEECWNEKPAKRPT------FRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps------~~~~l~~ 409 (447)
+|.+||+.||.+||+ +.+++++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999997 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=327.74 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=206.7
Q ss_pred CCcCcccceeeecceEEEEEE-----c-CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 153 HELDFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
....|...+.||+|++|.++. + ++.||+|.+... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 344588889999999998762 3 678999977533 3445567788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 227 IVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
+||||+++|+|.+++.. ..++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 99999999999988754 346899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhh
Q 013214 303 LTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 303 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (447)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......++ +..+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~ 295 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPV 295 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccC
Confidence 543221 112345689999999999988899999999999999999999999987766555555433333332 3456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++.++|.+||+.||++||++.+++.+
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 7899999999999999999999998753
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=319.00 Aligned_cols=240 Identities=25% Similarity=0.399 Sum_probs=201.5
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +++.||+|++........+..+.+..|..++..+ +||||+++++++...+..|+||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 589999998862 4789999999765444445556677888988866 8999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|..++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05591 82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFC 157 (321)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC-Cccccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753322 12223445
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+... ...+ +..++.++.+++.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-DVLY---PVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC---CCCCCHHHHHHHHHHhcc
Confidence 799999999998888999999999999999999999999987766655554322 2222 234678899999999999
Q ss_pred CCCCCC-------CHHHHHHH
Q 013214 396 KPAKRP-------TFRQIITR 409 (447)
Q Consensus 396 dp~~Rp-------s~~~~l~~ 409 (447)
||++|| ++.+++++
T Consensus 234 dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcC
Confidence 999999 77877765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=341.75 Aligned_cols=255 Identities=33% Similarity=0.562 Sum_probs=219.1
Q ss_pred CcccceeeecceEEEEEE------cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW------RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~------~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+.+..+.||+|.||.||. .| ..||+|.+++. .+.....+|.+|..+|+.++|||||+++|++.+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 445567899999999873 23 35899988754 5677788999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 226 MIVTEYLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
++++|||+||+|..+|++. ..++..+.+.++.|+++|+.||++++ +|||||..+|+|++....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999875 23889999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCC-CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 299 VSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 299 ~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
+|+.+-... .+......-+..|||||.+..+.++.|+|||||||++||++| |..||...++.++...+..+++.+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~-- 925 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP-- 925 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC--
Confidence 999432221 111112234678999999999999999999999999999999 9999999999998887767775553
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
+..++..+.++|..||+.+|++||++..+++.+..+.+..-
T Consensus 926 -P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 926 -PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 55678889999999999999999999999998888776653
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=302.88 Aligned_cols=245 Identities=32% Similarity=0.580 Sum_probs=202.7
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.++. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 456677899999997762 456899998764432 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++|+|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999999753 46899999999999999999999999 9999999999999999999999999987654322222
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+....++.. +...+..+.+++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~li 234 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTVYEVM 234 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHH
Confidence 223334668999999988889999999999999999999 9999987776665555544333322 233567899999
Q ss_pred HHHcccCCCCCCCHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l 410 (447)
.+||+.+|++||++.++++.|
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=317.06 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=203.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC-cccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~ 229 (447)
+|+..+.||+|+||.|+. +++.||+|++...........+.+..|..++..++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 467778999999998863 5678999999765443445566778899999999764 6888999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CC
Confidence 99999999999988888999999999999999999999999 999999999999999999999999998643221 11
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|+|||++.+..++.++|+||+||++|+|++|+.||...+..+....+. .....+ +..+++++.+++
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-~~~~~~---~~~~~~~~~~li 232 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-EHNVSY---PKSLSKEAVSIC 232 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCC---CCCCCHHHHHHH
Confidence 2234567999999999998889999999999999999999999998776655554442 223333 345678899999
Q ss_pred HHHcccCCCCCCCH-----HHHHHH
Q 013214 390 EECWNEKPAKRPTF-----RQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~-----~~~l~~ 409 (447)
.+||..||.+|++. .+++++
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999976 555543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=302.09 Aligned_cols=244 Identities=26% Similarity=0.435 Sum_probs=204.1
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
+||+|+||.|+. ++..+|+|++.... ......+.+.+|+.+++.++||||+++++++.. ...+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999988762 46889999987543 244556788999999999999999999998764 567899999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC--cc
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LT 312 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~--~~ 312 (447)
++|.+++.....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++.......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999988788999999999999999999999999 9999999999999999999999999998654332211 12
Q ss_pred cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 013214 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391 (447)
Q Consensus 313 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 391 (447)
...++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+.....++. +..+++++.++|.+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~ 233 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC---PQRCPPEMYDLMKL 233 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHHHH
Confidence 2233578999999988888999999999999999998 9999987776666666544444333 34577899999999
Q ss_pred HcccCCCCCCCHHHHHHHHHHH
Q 013214 392 CWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 392 cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
||+.||++||++.+|.+.|++.
T Consensus 234 ~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 234 CWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=302.70 Aligned_cols=253 Identities=24% Similarity=0.463 Sum_probs=208.1
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++ .+++.||+|.+........+....+.+|+.+++.++||||+++++++...+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 57778899999998775 3689999998865444456666788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988853 344889999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... +....+.....++. ....++..
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (267)
T cd08228 160 T-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL--PTEHYSEK 236 (267)
T ss_pred h-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC--ChhhcCHH
Confidence 1 1112345788899999998888899999999999999999999999755432 22222222222222 23356788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+.++|.+||+.+|++||++.++++.++.++
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=316.42 Aligned_cols=240 Identities=28% Similarity=0.450 Sum_probs=197.5
Q ss_pred eeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCC
Q 013214 161 VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 161 ~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
+.||+|+||.|+ .+|+.||+|.++..........+.+..|..++... +||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 368999999886 26789999998764332223345566777777654 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
|+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... .......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceecc
Confidence 999999988888999999999999999999999999 999999999999999999999999998643221 1222345
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
.||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+..+.+. ...+.+ +..++.++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR-VDTPHY---PRWITKESKDILEKLFE 232 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCC---CCCCCHHHHHHHHHHcc
Confidence 67999999999998899999999999999999999999998776655544442 223332 33467889999999999
Q ss_pred cCCCCCCCHH-HHHH
Q 013214 395 EKPAKRPTFR-QIIT 408 (447)
Q Consensus 395 ~dp~~Rps~~-~~l~ 408 (447)
.||++||++. ++++
T Consensus 233 ~dP~~R~~~~~~~~~ 247 (316)
T cd05620 233 RDPTRRLGVVGNIRG 247 (316)
T ss_pred CCHHHcCCChHHHHc
Confidence 9999999984 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=317.82 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=196.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 225 (447)
+|+..+.||+|+||.|+ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 46778899999999876 3689999999864322 223345678899999999999999999988543 247
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
|++|||+ +++|.+++.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999999 5799999988888999999999999999999999999 99999999999999999999999999875432
Q ss_pred CCC--CCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-------------
Q 013214 306 KED--RPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA------------- 368 (447)
Q Consensus 306 ~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~------------- 368 (447)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 211 11234568999999999865 5788999999999999999999999976553221111100
Q ss_pred --------------cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 --------------RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 --------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....++....+.+++.+.+++.+||+.||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00011111112356788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=316.38 Aligned_cols=240 Identities=28% Similarity=0.453 Sum_probs=201.0
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +++.||+|++++...........+..|..+++.+ +||||+++++++...+..+++|||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 689999998863 5789999999765433444556677888998888 7999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++....... .......
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (318)
T cd05570 82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC 157 (318)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence 99999988888999999999999999999999999 9999999999999999999999999986432211 1223345
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+. .....+ +..++..+.++|++||+.
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~-~~~~~~---~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL-EDEVRY---PRWLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCCCC---CCcCCHHHHHHHHHHccC
Confidence 7899999999998899999999999999999999999998776555544442 222222 345678999999999999
Q ss_pred CCCCCCCH-----HHHHHH
Q 013214 396 KPAKRPTF-----RQIITR 409 (447)
Q Consensus 396 dp~~Rps~-----~~~l~~ 409 (447)
||.+||++ .+++++
T Consensus 234 dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 99999999 777764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=322.67 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=203.7
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+ .+++.+|+|.+.+...........+.+|..+++.++||||+++++++..+...++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468888899999999886 257899999987543333344566788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999998654 5889999999999999999999999 999999999999999999999999999865432222
Q ss_pred CcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARG 384 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 384 (447)
......||+.|+|||++.+. .++.++|+||+||++|+|++|+.||...+.......+.... ...++ ....++..
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~ 277 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP-EDVEISKH 277 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC-CcccCCHH
Confidence 22345689999999998654 37789999999999999999999998776655555543322 22222 22346788
Q ss_pred HHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
+++++..|+..++.+ |+++.+++++
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcC
Confidence 999999999855543 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=305.49 Aligned_cols=253 Identities=28% Similarity=0.501 Sum_probs=209.7
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|...+.||+|+||.++. ++..+|+|.+... .......+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3677888999999998863 2356899988643 34456778999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG-------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~-------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
.++++||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999999997543 3899999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhc
Q 013214 292 LKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~ 369 (447)
++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+...
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875432211 11122334678999999988889999999999999999998 99999877665555555333
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 370 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
..... +..++.++.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 239 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 32222 334678899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=315.93 Aligned_cols=244 Identities=25% Similarity=0.407 Sum_probs=198.9
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH---hcCCCCcccceeEEEEeCCceEEE
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL---QKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
|...+.||+|+||.|+. +|+.||+|+++..........+.+..|..++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45667899999998863 5889999999765433344455666676655 566899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++++|..++.. +.+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 999999999988854 56999999999999999999999999 9999999999999999999999999987532221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+.. ..+.+ +..+++.+.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-~~~~~---p~~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-DEVRY---PRFLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCC---CCCCCHHHHHH
Confidence 122345689999999999988899999999999999999999999987766555544422 22222 34567889999
Q ss_pred HHHHcccCCCCCC-----CHHHHHHH
Q 013214 389 IEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
|.+||+.||.+|| ++.+++++
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 9999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=301.60 Aligned_cols=250 Identities=32% Similarity=0.529 Sum_probs=208.7
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.|+. +...||+|.++... .......+.+|+.+++.++||||+++++.+...+..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 577788999999998863 23579999987543 34456778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+++++|.+++... +.+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999764 46899999999999999999999998 999999999999999999999999999876421
Q ss_pred CCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+......+. +..++..
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 236 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---PMDCPSA 236 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHH
Confidence 111 1122334678999999988889999999999999999998 9999987766655555533323222 3456789
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+.+++.+||+.+|++||++.+++++|+++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=301.84 Aligned_cols=248 Identities=29% Similarity=0.499 Sum_probs=205.9
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|++|.++. +++.||+|.++.... ..+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 577778999999987752 567899999875432 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++++|.+++.... .+++..+..++.|++.|+.+||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999997654 6899999999999999999999998 999999999999999999999999999866532211
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.........+......+. +..++..+.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 236 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC---PPGCPKELYDI 236 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHHH
Confidence 1122223457999999988889999999999999999999 9999987766555555433323222 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+.+||+.+|++||++.++++.|+++
T Consensus 237 i~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 237 MLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHhhcCcccCCCHHHHHHHHhcC
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=303.16 Aligned_cols=248 Identities=30% Similarity=0.528 Sum_probs=206.6
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|++|.++. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+...+..++++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 577778999999998763 56789999886432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++++|.+++.+. ..++......++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999753 45888899999999999999999998 999999999999999999999999999865432222
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...........+......+. ...++.++.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 236 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR---MENCPDELYDI 236 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHH
Confidence 2223345678999999988888999999999999999998 9999987766555555533322222 23567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+.+||..+|++||+++++++.|+++
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.24 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=197.3
Q ss_pred eeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCC
Q 013214 161 VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 161 ~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
+.||+|+||.|+ .+++.||+|++.+...........+.+|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 368999999886 25789999999876544555566788899988877 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
|+|..++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... .......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccccc
Confidence 999999988888999999999999999999999999 999999999999999999999999998753221 1122345
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-----c---hHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-----E---VPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-----~---~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.||+.|+|||++.+..++.++|+||||+++|+|++|+.||...... . ............+ +..++..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---p~~~~~~~~ 233 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---PRSLSVKAA 233 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC---CCCCCHHHH
Confidence 6799999999999888999999999999999999999999632111 1 1111112222222 345678899
Q ss_pred HHHHHHcccCCCCCCC------HHHHHHH
Q 013214 387 ELIEECWNEKPAKRPT------FRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps------~~~~l~~ 409 (447)
++|.+||+.||++||+ +.+++++
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=308.56 Aligned_cols=244 Identities=37% Similarity=0.707 Sum_probs=198.6
Q ss_pred cceeeecceEEEEE---Ec------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 159 NSVEITKGTFILAF---WR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 159 ~~~~lg~G~~~~~~---~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..+.||.|.||.|+ +. +..|+||.++.. ...+....+.+|++.+++++||||++++|++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 45689999999876 34 688999999643 34555788999999999999999999999999888899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 230 e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++|++|+++||++++++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999999886 67999999999999999999999998 9999999999999999999999999988662211
Q ss_pred C-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 308 D-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 308 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
. ........+..|+|||.+....++.++||||||+++||+++ |+.||...+..+....+....+++. +..++..+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 234 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPKDI 234 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhHHH
Confidence 1 11122345678999999988889999999999999999999 7899988876666666644444333 44567889
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.++|..||+.||++|||+.++++.|
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=315.98 Aligned_cols=245 Identities=27% Similarity=0.420 Sum_probs=203.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|...+.||+|+||.|+. +++.||+|.+.............+..|..++... +||+|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 466778999999998873 5679999998765433444455667788888777 6899999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence 99999999999988888999999999999999999999999 9999999999999999999999999987533211 1
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+.. ....+ +..++.++.+++
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~~li 232 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HNVAY---PKSMSKEAVAIC 232 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCC---CCcCCHHHHHHH
Confidence 22345679999999999998999999999999999999999999988776655555432 22222 345778999999
Q ss_pred HHHcccCCCCCCCH-----HHHHH
Q 013214 390 EECWNEKPAKRPTF-----RQIIT 408 (447)
Q Consensus 390 ~~cl~~dp~~Rps~-----~~~l~ 408 (447)
.+||+.||.+|++. .++.+
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhc
Confidence 99999999999984 55554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=311.45 Aligned_cols=245 Identities=27% Similarity=0.486 Sum_probs=202.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|..+|+|.+.... .......+.+|+++++.++||||+++++++..++..+++|
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4788888999999998873 67889999887542 3445577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+.+|+|.+++...+.+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999999888899999999999999999999985 5 999999999999999999999999998754321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH---------------------
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA--------------------- 367 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~--------------------- 367 (447)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......+......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 1233457889999999988889999999999999999999999997654332211110
Q ss_pred -----------------------hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 368 -----------------------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 368 -----------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+.+ ....++.++.++|.+||+.||++|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000111 011356789999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.46 Aligned_cols=239 Identities=28% Similarity=0.451 Sum_probs=197.0
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+ .+++.||+|.++..........+.+..|..++... +||||+++++++.+.+..+++|||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 68999999886 25788999998765332233345566677777764 8999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++.+...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 99999988888999999999999999999999999 9999999999999999999999999987532211 1223345
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+.. ..+.+ +..++.++.+++.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-DNPCY---PRWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCC---CccCCHHHHHHHHHHhcc
Confidence 79999999999888899999999999999999999999987766555544422 22332 334678899999999999
Q ss_pred CCCCCCCHH-HHHH
Q 013214 396 KPAKRPTFR-QIIT 408 (447)
Q Consensus 396 dp~~Rps~~-~~l~ 408 (447)
||++||++. ++.+
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05619 234 EPERRLGVKGDIRQ 247 (316)
T ss_pred CHhhcCCChHHHHc
Confidence 999999997 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=309.40 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=196.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||.|+||.|+. +++.||+|.++.... ......+.+|+.++++++||||+++++++...+..+++||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 578888999999998873 678999999875432 1223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++ ++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~ 158 (288)
T cd07871 84 YLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K 158 (288)
T ss_pred CCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence 996 59999887654 4789999999999999999999999 9999999999999999999999999987543221 1
Q ss_pred CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C----------------
Q 013214 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R---------------- 371 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~---------------- 371 (447)
......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+.... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2233456889999998865 468899999999999999999999998766544332221110 0
Q ss_pred ----CCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ----PPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ----~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+... ...+..++++.++|++||+.||.+|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0112356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=330.53 Aligned_cols=260 Identities=32% Similarity=0.541 Sum_probs=229.2
Q ss_pred ccCCCCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 220 (447)
||++. ...+.+.||.|.||.|.. ....||||.++... .+++..+|..|..+|-+++||||+++.|+..
T Consensus 625 EId~s--~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 625 EIDPS--CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hcChh--heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 44443 455667899999998863 34789999998764 6778899999999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
....+.||+|||++|+|+.+|+++ ++++..+...+++.|+.|++||-+.+ +|||||..+|||++.+-..|++|||+
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999999875 67999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCC--CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 300 SKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
++.+..+.....+..+ -+.+|.|||.+..++++.++||||+|++|||.++ |+.||.++.+.++...+..+.+.+.
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-- 855 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-- 855 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC--
Confidence 9987655433333333 3688999999999999999999999999999998 9999999999999999877776653
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
+.++|..+.+||..||++|-.+||.+.+|+..|+++....+
T Consensus 856 -PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 856 -PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred -CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 55788999999999999999999999999999999876653
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=316.05 Aligned_cols=235 Identities=28% Similarity=0.422 Sum_probs=193.5
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+ .+|+.||+|++.............+..|.. +++.++||||+++++.+...+..+++|||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 68999999886 268999999987543323333344445544 567889999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++.+++.+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (323)
T cd05575 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFC 157 (323)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccccc
Confidence 99999998888999999999999999999999999 999999999999999999999999998753221 12223446
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+... ...+ .+.++..+.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~---~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-PLRL---KPNISVSARHLLEGLLQK 233 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCC---CCCCCHHHHHHHHHHhhc
Confidence 799999999999888999999999999999999999999877655554444222 2222 234678899999999999
Q ss_pred CCCCCCCHH
Q 013214 396 KPAKRPTFR 404 (447)
Q Consensus 396 dp~~Rps~~ 404 (447)
||.+||++.
T Consensus 234 ~p~~R~~~~ 242 (323)
T cd05575 234 DRTKRLGAK 242 (323)
T ss_pred CHHhCCCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=320.09 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=204.0
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|+..+.||+|+||.|+ .+++.+|+|++...........+.+.+|..+++.++||||+++++.+..+...++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 3578888999999999886 26789999998654333334456678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 122 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999998654 5889999999999999999999999 99999999999999999999999999986543222
Q ss_pred CCcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 383 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 383 (447)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.... ...++ ....++.
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~ 276 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP-DDNDISK 276 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC-CcCCCCH
Confidence 222345689999999998654 37789999999999999999999998776655555543322 22222 2345788
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHHH
Q 013214 384 GLKELIEECWNEKPAK--RPTFRQIITRL 410 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~--Rps~~~~l~~l 410 (447)
.+.++|..|+..++.+ |+++.+++++.
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 9999999999844433 78999988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.92 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=195.5
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|+..+.||+|+||.|+. +++.||+|.... ..+.+|+.++++++||||+++++++......++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 345799999999999998863 688999996532 245789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
++|++ +++|.+++.....+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 161 v~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 99999 5799999988888999999999999999999999999 9999999999999999999999999987543222
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-------chHHHH-HhcC---------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------EVPKAY-AARQ--------- 370 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-------~~~~~~-~~~~--------- 370 (447)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+ ...+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22223456899999999998889999999999999999999999876533210 000000 0000
Q ss_pred ------------------CCCCCC---ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ------------------RPPFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ------------------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.... .....+.++.++|.+||+.||.+|||+++++++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 111346789999999999999999999999964
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=314.63 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=203.4
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+ .+++.||+|++.+.........+.+.+|..+++.++||||+++++++..++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 57778899999999886 2578999999875433334445668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999976 456899999999999999999999999 999999999999999999999999998765432222
Q ss_pred CcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHH
Q 013214 310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 383 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 383 (447)
......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+....+.... ...++.....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2223458999999999863 356789999999999999999999998766555444443222 2333333445788
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
.++++|++|+..++++ |+++.+++++
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999988654443 7899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=304.93 Aligned_cols=242 Identities=25% Similarity=0.390 Sum_probs=193.7
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||+|+||.|+ .+|+.+|+|.+.............+..|+++++.++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6899999886 35899999998754333333334556799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 238 ~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 98886543 4888899999999999999999999 999999999999999999999999998765432 1223345
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
++..|+|||++.+..++.++|+||+||++|+|++|+.||...........+.... ..........+++++.+++.+||+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence 7889999999988889999999999999999999999997654322211211111 111222234578899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013214 395 EKPAKRPTFRQIITR 409 (447)
Q Consensus 395 ~dp~~Rps~~~~l~~ 409 (447)
.||++||++.++++.
T Consensus 236 ~~P~~R~~~~~~~~~ 250 (277)
T cd05607 236 KKPEDRLGSREKNDD 250 (277)
T ss_pred cCHhhCCCCccchhh
Confidence 999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=327.52 Aligned_cols=261 Identities=21% Similarity=0.374 Sum_probs=211.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEE-EEe-----
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGA-VTQ----- 221 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~-~~~----- 221 (447)
..++++.+.|.+|||+.||. .|..||+|++-. .++...+...+|+++|++++ |||||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 44677788999999999883 348999999854 37788899999999999995 9999999993 221
Q ss_pred -CCceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 222 -SSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 222 -~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
...++|+||||.||.|-+++.+ +..|++.++++|+.|+|+|+.+||... .||||||||.+||||+.+|+.||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 1347899999999999999975 345999999999999999999999998 479999999999999999999999999
Q ss_pred cccccccCCCCCc--------ccCCCCCcccCCccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH
Q 013214 299 VSKLLTVKEDRPL--------TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 299 ~~~~~~~~~~~~~--------~~~~~t~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~ 367 (447)
++........... -....|+.|+|||++ .+...++|+|||+|||+||-|+....||+......+
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI----- 266 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI----- 266 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE-----
Confidence 9875432221110 112358999999976 466889999999999999999999999997644322
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccchh
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWK 424 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~~ 424 (447)
..+...++. .+.|+..+.+||+.||+.||.+||+..+++.++-.+...-.+.....
T Consensus 267 lng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 267 LNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred EeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 222223332 25689999999999999999999999999999999887776554433
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=326.81 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=207.8
Q ss_pred CCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC---
Q 013214 152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--- 223 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 223 (447)
....+|...+.||+|+||.|+ .+|+.||+|++..... .......+.+|+.++..++|+|++++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344589999999999999886 2689999999876544 3455667888999999999999999988765432
Q ss_pred -----ceEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 224 -----PMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 224 -----~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
.++++|||+++|+|.++++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999998653 45899999999999999999999998 999999999999999999999
Q ss_pred eecccccccccCC-CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCC
Q 013214 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (447)
Q Consensus 295 ~Dfg~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 373 (447)
+|||+++.+.... ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+......+
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 9999987654321 112234568999999999998889999999999999999999999998776555544443333333
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+..+++++.+++.+||+.||.+||++.+++++
T Consensus 265 ---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 265 ---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 345678899999999999999999999999865
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=303.40 Aligned_cols=248 Identities=29% Similarity=0.497 Sum_probs=205.8
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|...+.||+|+||.++. ++..||+|.+.... ..+..+.+.+|+++++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 567778899999998863 23689999987542 344567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 226 MIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~--------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
+++|||+++++|.+++...+ .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997643 3778889999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhc
Q 013214 292 LKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~ 369 (447)
++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875432211 11122334678999999998899999999999999999998 99999877766655555322
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 370 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
..+. .+..++..+.+++.+||+.||++||++.++++.|+
T Consensus 241 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 241 RLLQ---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CcCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2222 23457789999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=320.98 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=204.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +++.||+|++........+....+.+|..++..++||+|+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 467778999999998863 688999999975443344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999864421100
Q ss_pred --------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 013214 309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (447)
Q Consensus 309 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 356 (447)
.......||+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001134589999999999998999999999999999999999999988
Q ss_pred CCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 013214 357 KHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR 409 (447)
Q Consensus 357 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~~l~~ 409 (447)
.+..+....+.... ...++. ...+++++.++|.+|+ .||.+|++ +.+++++
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCHHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 77666555543322 222222 2236788999999877 49999985 6666655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=302.85 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=203.2
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
..+|+..+.||+|++|.++. .+..||+|.+.... ......++.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34688889999999998762 24679999886432 3344567889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEE
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vk 293 (447)
..+++|||+++++|.+++.+.. .++...+..++.|++.||.|||+.+ ++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 9999999999999999997532 2467788899999999999999998 99999999999999999999
Q ss_pred EeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCC
Q 013214 294 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 371 (447)
|+|||++......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999998754322111 1112234678999999988889999999999999999999 7899987766555544433333
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 372 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
+.. +...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 240 ~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 240 LDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 332 3446778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=312.68 Aligned_cols=239 Identities=27% Similarity=0.431 Sum_probs=199.3
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEe
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e 230 (447)
|...+.||+|+||.|+. +|+.||+|++...........+.+..|..+++.+. ||+|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 56678999999998863 58899999987654333445566778889988885 6778889999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++|+|.+++.+.+.+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....... ..
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 9999999999988888999999999999999999999999 9999999999999999999999999987533221 12
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....||+.|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+.. ....+ +..++..+.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-~~~~~---p~~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-HNVSY---PKSLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCC---CccCCHHHHHHHH
Confidence 2334579999999999888899999999999999999999999987766555544422 22222 3456788999999
Q ss_pred HHcccCCCCCCCH
Q 013214 391 ECWNEKPAKRPTF 403 (447)
Q Consensus 391 ~cl~~dp~~Rps~ 403 (447)
+||+.||.+|++.
T Consensus 234 ~~l~~~p~~R~~~ 246 (323)
T cd05615 234 GLMTKHPSKRLGC 246 (323)
T ss_pred HHcccCHhhCCCC
Confidence 9999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=315.34 Aligned_cols=244 Identities=24% Similarity=0.388 Sum_probs=196.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++.... .......+.+|+.+++.++|+||+++++++...+.++++||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 567778899999998873 58899999986442 34456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++|+|.+. ...++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 9999998653 33567788899999999999999999 9999999999999999999999999987654321 12
Q ss_pred cccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
.....||..|+|||.+... ..+.++|||||||++|+|++|+.||......+................+..++.++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 2334679999999987432 33468999999999999999999998555444333322221111122344577899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++|.+||+.||++||++.+++++
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999986
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=316.88 Aligned_cols=236 Identities=25% Similarity=0.372 Sum_probs=197.4
Q ss_pred eeeecceEEEEE--------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 161 VEITKGTFILAF--------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 161 ~~lg~G~~~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
+.||+|+||.|+ .+|+.||+|++...... ......+.+|+.++++++||||+++++++..++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 468999999876 25789999998754322 223345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcc
Q 013214 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (447)
Q Consensus 233 ~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~ 312 (447)
++|+|.+++.+...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 99999999988888999999999999999999999999 9999999999999999999999999987643321 1223
Q ss_pred cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHH
Q 013214 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392 (447)
Q Consensus 313 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 392 (447)
...|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.. ....+ +..+++.+.++|++|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~-~~~~~---p~~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK-AKLGM---PQFLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCHHHHHHHHHH
Confidence 45679999999999888889999999999999999999999987765555444422 22222 344678899999999
Q ss_pred cccCCCCCCCHHH
Q 013214 393 WNEKPAKRPTFRQ 405 (447)
Q Consensus 393 l~~dp~~Rps~~~ 405 (447)
|+.||++||++.+
T Consensus 233 l~~~P~~R~~a~~ 245 (318)
T cd05582 233 FKRNPANRLGAGP 245 (318)
T ss_pred hhcCHhHcCCCCC
Confidence 9999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=303.28 Aligned_cols=252 Identities=28% Similarity=0.492 Sum_probs=207.9
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|...+.||+|+||.++. ++..+++|.+... .....+.+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 466678899999987762 2456899988643 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 226 MIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
+++|||+++++|.+++...+ .+++..++.++.|++.|+.|||+++ ++|+||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999997542 3788999999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 013214 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 367 (447)
+.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999999875432211 11123345778999999988889999999999999999998 999998777655555443
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
....+. .+...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 240 ~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 QGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 332222 2344678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.76 Aligned_cols=255 Identities=24% Similarity=0.483 Sum_probs=208.2
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
.+|+..+.||+|+||.|+. +|+ .||+|.+... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 4688889999999998863 333 4899998643 2345567788999999999999999999998764 57
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
++++||+++|+|.+++.+. ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 8999999999999999875 35888999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
...... ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+...........+. +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPICT 237 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCCC
Confidence 332211 122234678999999988899999999999999999998 9999987665554444433333332 34467
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..+.+++.+||..||.+||++.+++..+..+.....
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 789999999999999999999999999988876553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=302.34 Aligned_cols=249 Identities=30% Similarity=0.525 Sum_probs=204.6
Q ss_pred CcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
+|+..+.||+|+||.++. .+..||+|.+... ........+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 466678899999998863 4478999998743 23445577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 227 IVTEYLPKGDLRAFLKRKG-----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~-----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
++|||+++++|.+++.... .+++.....++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 9999999999999985322 3678888999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 013214 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 367 (447)
+.+||+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876532211 11223334677999999988889999999999999999998 999998766555555543
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
....++ .+..+++.+.+++.+||+.||.+||++.+++++|+.
T Consensus 241 ~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 333333 234567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=299.19 Aligned_cols=246 Identities=30% Similarity=0.556 Sum_probs=201.9
Q ss_pred CcccceeeecceEEEEE---E-cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAF---W-RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|...+.||+|+||.++ + .+..+|+|.+..... ....+.+|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 46677889999998875 2 234699998875432 235688899999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+.+|+|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999764 46899999999999999999999999 9999999999999999999999999987654322111
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+....++.. +...+..+.+++
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 234 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVYAIM 234 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---CCCCCHHHHHHH
Confidence 122335677999999988888999999999999999998 9999987766555555433333322 234578899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
.+||+.||.+||++.++++.++
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHcCCCcccCCCHHHHHHhhC
Confidence 9999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=298.54 Aligned_cols=245 Identities=31% Similarity=0.562 Sum_probs=202.1
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.++. .+..+|+|.+...... ...+.+|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 466778899999998763 4568999988654322 24577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++++|.+++..+ ..+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999764 46899999999999999999999999 9999999999999999999999999987654221111
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+....+... +..++..+.+++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 234 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR---PKLAPTEVYTIM 234 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHH
Confidence 112223467999999988889999999999999999999 8999987766665555533333332 234688999999
Q ss_pred HHHcccCCCCCCCHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l 410 (447)
.+||..+|++|||+.++++.|
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.28 Aligned_cols=253 Identities=25% Similarity=0.488 Sum_probs=207.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|++|.++ .+|..+|+|.+......+.....++.+|+.+++.++||||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 56777889999998775 3788999998876544455566788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++.. ...+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998864 345899999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... +....+.....++. ....+++.
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSEE 236 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC--CcccccHH
Confidence 21 122345788999999998888899999999999999999999999754432 11122211112221 23357789
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+.+++.+||+.||++|||+.++++.++++.
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=296.15 Aligned_cols=242 Identities=31% Similarity=0.545 Sum_probs=199.2
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
.||+|+||.++. +++.+|+|...... ..+....+.+|+.+++.++||||+++++++......+++|||+++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 589999988763 68899999876432 44556778999999999999999999999999999999999999999
Q ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc-ccC
Q 013214 237 LRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQ 314 (447)
Q Consensus 237 L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~-~~~ 314 (447)
|.+++.+.+ .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 999997644 5899999999999999999999999 99999999999999999999999999875432111110 111
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 393 (447)
..+..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+........ +..++..+.+++.+||
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l 233 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC---PELCPDAVYRLMERCW 233 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---cccCCHHHHHHHHHHc
Confidence 23456999999988889999999999999999998 9999987665444444433323332 3456788999999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 013214 394 NEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 394 ~~dp~~Rps~~~~l~~l~ 411 (447)
+.+|++|||+.++++.|+
T Consensus 234 ~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 234 EYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCChhhCcCHHHHHHHHh
Confidence 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.83 Aligned_cols=249 Identities=27% Similarity=0.466 Sum_probs=205.1
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+|...+.||+|++|.++ .+++.||+|.+...... .......+.+|+.++++++||||+++++++..+...+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 57778899999998776 25789999988654322 122346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
+||+++++|.+++.+.+.+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999999988888999999999999999999999999 99999999999999999999999999876533211
Q ss_pred CCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 309 RPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 309 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+......... .....+..++..+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 237 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP--TNPQLPSHVSPDAR 237 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC--CCCCCCccCCHHHH
Confidence 111 23456788999999998889999999999999999999999998665443333322221 11223445778999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||..+|++||++.+++++
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhC
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=314.54 Aligned_cols=237 Identities=27% Similarity=0.402 Sum_probs=193.5
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHH-HHHhcCCCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +++.||+|++.............+..|. .+++.++||||+++++.+...+..+++|||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 689999998862 5688999998754322222333444444 4567889999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|.+++...+.+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 157 (325)
T cd05602 82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFC 157 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753221 12223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ... ..+.++..+.+++++||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~---~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQ---LKPNITNSARHLLEGLLQK 233 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CcC---CCCCCCHHHHHHHHHHccc
Confidence 899999999999989999999999999999999999999877665554444222 112 2335678899999999999
Q ss_pred CCCCCCCHHHH
Q 013214 396 KPAKRPTFRQI 406 (447)
Q Consensus 396 dp~~Rps~~~~ 406 (447)
||.+||++.+.
T Consensus 234 ~p~~R~~~~~~ 244 (325)
T cd05602 234 DRTKRLGAKDD 244 (325)
T ss_pred CHHHCCCCCCC
Confidence 99999988743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=307.59 Aligned_cols=248 Identities=25% Similarity=0.449 Sum_probs=194.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++..... ......+.+|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3688889999999998862 688999999875432 122345678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+. ++|.+++.+. +.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 9995 6888887654 56899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-HHHH-HhcCCC------------C
Q 013214 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAY-AARQRP------------P 373 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-~~~~-~~~~~~------------~ 373 (447)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... ...+ .....+ .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22233457899999999865 4578899999999999999999999986543211 1111 000000 0
Q ss_pred CC---------CC------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 FK---------AP------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~~---------~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+. .. ...+++.+.+++.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 00 01234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=305.39 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=193.4
Q ss_pred CcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeEEEE-----e
Q 013214 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT-----Q 221 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~-----~ 221 (447)
+|+..+.||+|+||.|+. +|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 577888999999998862 36789999886543222 2223445577666655 6999999999885 2
Q ss_pred CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
....+++|||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999995 6999998754 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCC------
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP------ 373 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------ 373 (447)
+...... .......+|+.|+|||.+.+..++.++||||||+++|+|++|++||.+.+..+....+......+
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 8765432 22234567899999999988889999999999999999999999998776554433332211100
Q ss_pred ---------C--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 ---------F--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ---------~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ ....+.+++.+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 00112456788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=299.67 Aligned_cols=249 Identities=30% Similarity=0.535 Sum_probs=209.4
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+|+..+.||.|+||.++. .+..+|+|.+... .......+.+|+.+++.++||||+++++++......+++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc---chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 4677888999999988762 4788999998754 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++.+. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999753 45899999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+....+++. +..+++.+.+
T Consensus 160 ~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 235 (261)
T cd05148 160 LS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC---PAKCPQEIYK 235 (261)
T ss_pred cc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC---CCCCCHHHHH
Confidence 11 23345678999999988889999999999999999998 8999988776666555543333332 3456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
++.+||+.||++|||+.++++.|+.+
T Consensus 236 ~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 236 IMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=301.67 Aligned_cols=252 Identities=29% Similarity=0.522 Sum_probs=206.3
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|+..+.||+|+||.++. ....+++|.+.... .......+.+|+.+++.++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 356678899999998863 12468999887543 334457788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 013214 226 MIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp 281 (447)
++++||+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhh
Confidence 9999999999999998642 23778889999999999999999998 99999999
Q ss_pred CCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 013214 282 SNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 359 (447)
Q Consensus 282 ~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~ 359 (447)
+||++++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999998754322111 1122234678999999988889999999999999999998 9999987776
Q ss_pred CchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 360 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
.+...........+. +..++.++.+++.+||+.+|++||++.++++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLKTGYRMER---PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHhCCCCCCC---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 665555433333322 34567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=296.43 Aligned_cols=244 Identities=25% Similarity=0.444 Sum_probs=201.1
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.||+|+||.++. .+..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...+++|||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 489999988752 34579999987542 34455778899999999999999999998864 578999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC--Cc
Q 013214 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PL 311 (447)
Q Consensus 235 g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~ 311 (447)
++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......... ..
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999999975 456899999999999999999999998 999999999999999999999999998755432211 11
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
....++..|+|||.+....++.++|+||||+++|++++ |..||......+....+.....+.. +...++++.++|.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~ 232 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC---PAECPPEMYALMK 232 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHHH
Confidence 22233578999999988888999999999999999996 9999988776666555544444443 3456789999999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+||..||++||++.++.+.|+.+.
T Consensus 233 ~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 233 DCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHcCCChhhCcCHHHHHHHHhhhc
Confidence 999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.24 Aligned_cols=253 Identities=29% Similarity=0.467 Sum_probs=206.0
Q ss_pred CcCcccceeeecceEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc
Q 013214 154 ELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 212 (447)
..+|...+.||+|+||.++. .+..||+|.+.... .......+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCE
Confidence 44678888999999998763 23568999987543 33556788999999999999999
Q ss_pred cceeEEEEeCCceEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 013214 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281 (447)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp 281 (447)
+++++++..++..++++||+++++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++|+||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence 999999999999999999999999999998765 6899999999999999999999998 99999999
Q ss_pred CCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCC
Q 013214 282 SNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKH 358 (447)
Q Consensus 282 ~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t--g~~p~~~~~ 358 (447)
+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999875432211 11122345678999999988889999999999999999998 778887666
Q ss_pred CCchHHHHHhc----CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 359 DNEVPKAYAAR----QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 359 ~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
..+........ ........+..++.++.+++.+||+.||.+|||+.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 55544433222 111112223456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=303.26 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=200.9
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||+|+||.++. +++.||+|.+.............+.+|+.++++++|++++++++.+...+..+++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 55667899999998863 6789999998765444444445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999986543 5899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......................+..+++++.+++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 12234678999999999888899999999999999999999999987554322222111111001112345678899999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 013214 390 EECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
++||+.||++||| +.+++++
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcC
Confidence 9999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=314.43 Aligned_cols=254 Identities=26% Similarity=0.452 Sum_probs=205.0
Q ss_pred CcCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeC
Q 013214 154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 222 (447)
..+|.+.+.||+|+||.|+.. +..||+|++.... .....+.+.+|+++++++. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 346778889999999988631 2469999997542 3344567899999999995 99999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc----------------------------------------------------------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------- 244 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 244 (447)
...++|||||++|+|.+++.++
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999988643
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE
Q 013214 245 --------------------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (447)
Q Consensus 245 --------------------------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill 286 (447)
..+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 13667778899999999999999998 9999999999999
Q ss_pred cCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchH-
Q 013214 287 DDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP- 363 (447)
Q Consensus 287 ~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~- 363 (447)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 99999999999998765332211 1122345678999999988889999999999999999997 99999876544332
Q ss_pred HHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
..+....+++ .+..++..+.+++.+||+.||++||++.++.+.|+++..
T Consensus 351 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 NKIKSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHhcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 2222222222 234567889999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=316.01 Aligned_cols=244 Identities=25% Similarity=0.469 Sum_probs=215.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.-|...+.||.|+||-||+ +.+.||||++.-......+.-+++..|+.+|+++.|||++.+-|+|..+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3567778999999999874 67899999998665556666688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||| -|+-.|.+.- ..++.+-++..|+.+.++||.|||+.+ .||||||..|||+++.|.|||+|||++.....
T Consensus 106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 999 5788888864 357899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
-.++.|||.|||||++. .+.|+-++||||||+++.+|...++|+..++-.....-+..+..|.+. .+.+|..+
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~eWS~~F 254 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSDYF 254 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--CchhHHHH
Confidence 35678999999999875 458999999999999999999999999999887777777666666664 46789999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++++..||+.-|.+|||..+++.+
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhc
Confidence 999999999999999999988875
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=311.91 Aligned_cols=235 Identities=25% Similarity=0.421 Sum_probs=194.6
Q ss_pred eeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+ .+++.||+|++...........+.+.+|..++.++ +||+|+++++++.....+++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 68999999886 35789999999876554555667788999999888 6999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|..++...+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (327)
T cd05617 82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFC 157 (327)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceeccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753221 12223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC------chHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN------EVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
||+.|+|||.+.+..++.++|+||||+++|+|++|+.||...... +............+ +..++..+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~li 234 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI---PRFLSVKASHVL 234 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC---CCCCCHHHHHHH
Confidence 899999999999889999999999999999999999999643221 11112212222222 345678899999
Q ss_pred HHHcccCCCCCCCH
Q 013214 390 EECWNEKPAKRPTF 403 (447)
Q Consensus 390 ~~cl~~dp~~Rps~ 403 (447)
.+||+.||.+|+++
T Consensus 235 ~~~L~~dP~~R~~~ 248 (327)
T cd05617 235 KGFLNKDPKERLGC 248 (327)
T ss_pred HHHhccCHHHcCCC
Confidence 99999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=312.92 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=204.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +++.+|+|++.+...........+.+|..++..++||+|+++++.+.+....++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 577788999999998762 567899999865333333445568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999987 467899999999999999999999999 999999999999999999999999998754332222
Q ss_pred CcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHH
Q 013214 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 383 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 383 (447)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....+.... +..++.....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223356899999999986 3467889999999999999999999998776655555543322 3334444456788
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
++.+++++|+..++.+ |+++.+++++
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 9999999999665544 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=300.77 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=201.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.++. +++.||+|++.... ......+.+|+.+++.++||||+++++.+......+++|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 3688889999999998762 67899999986432 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++++|.+++.+++++++..+..++.|++.|+.|||+.+ ++|+|+||+||+++.++.++|+|||++....... .
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A 161 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence 99999999999988888999999999999999999999998 9999999999999999999999999987653221 1
Q ss_pred CcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGL 385 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 385 (447)
......++..|+|||.+. ...++.++|+||+|+++|+|++|+.||......+......... .++.......++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 122345788999999874 3457789999999999999999999997554333222111111 222112233567899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.++|++||+.+|++||+++++++++
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCC
Confidence 9999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=304.14 Aligned_cols=256 Identities=29% Similarity=0.518 Sum_probs=209.1
Q ss_pred cCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 221 (447)
.+|.+.+.||+|+||.|+. ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3688889999999998862 12469999987542 334456788899999999 79999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nil 285 (447)
....+++|||+++|+|.+++.... .++..++..++.|++.||+|||+.+ ++|+||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 999999999999999999997642 3788899999999999999999998 999999999999
Q ss_pred EcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchH
Q 013214 286 RDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363 (447)
Q Consensus 286 l~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~ 363 (447)
++.++.+||+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 999999999999998765422111 1122234568999999988889999999999999999998 89999876655544
Q ss_pred HHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..+....... .+...+.++.+++.+||..+|++||++.++++.|+.+.....
T Consensus 253 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 253 KLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHcCCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 4443332322 234567899999999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=295.68 Aligned_cols=245 Identities=28% Similarity=0.506 Sum_probs=202.3
Q ss_pred eeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 161 ~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
+.||+|+||.++. .+..+|+|.+...... ...+.+.+|+.+++.++||||+++++++.. ...+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 3689999998752 2368999998765432 445678899999999999999999998764 4679999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc-
Q 013214 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL- 311 (447)
Q Consensus 233 ~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~- 311 (447)
++++|.+++.....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++...........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999999988888999999999999999999999999 99999999999999999999999999886543322111
Q ss_pred -ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 312 -TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 312 -~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+......+ .+..++..+.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 231 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP---RPEECPQEIYSIM 231 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHH
Confidence 11223467999999988889999999999999999998 999998776655555543333222 2345678899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.+||..+|++||++.++++.|+++.
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=298.36 Aligned_cols=249 Identities=27% Similarity=0.487 Sum_probs=199.1
Q ss_pred cccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--Cce
Q 013214 157 FTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 225 (447)
|+..+.||+|+||.|+. ++..||+|.+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 37778999999998842 56789999987542 233456788899999999999999999987653 458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+++|||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999999764 5999999999999999999999999 99999999999999999999999999886543
Q ss_pred CCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch---------------HHHHHh
Q 013214 306 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---------------PKAYAA 368 (447)
Q Consensus 306 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~---------------~~~~~~ 368 (447)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 2211 11223456679999999888899999999999999999999999865432110 000000
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
....+ .+..++..+.+++.+||+.||++|||++++++.|+++.
T Consensus 240 ~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111 23456789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=302.71 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=202.4
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||+|+||.++. +++.||+|.+.............+.+|+.+++.++|+||+++++.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55667899999998863 5789999998765444444445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 9999999888653 35999999999999999999999999 999999999999999999999999998754322 1
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..............++..+.+++
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 22334678999999999888899999999999999999999999987655433333322221111122345678899999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 013214 390 EECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
..||+.||++||+ +.+++.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcC
Confidence 9999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=313.02 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=204.1
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+ .+++.||+|.+.............+.+|..++..++||+|+++++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 57778899999999875 3578899999875333333445668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999987 467899999999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHH
Q 013214 310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 383 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 383 (447)
......||+.|+|||++.+ +.++.++|+||||+++|+|++|+.||...+..+....+.... +.+++.....+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2233468999999999865 467889999999999999999999998776655544443322 3344444445788
Q ss_pred HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
.+.+++.+|+..++.+ |+++.+++++
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9999999999866544 4678888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=296.51 Aligned_cols=248 Identities=32% Similarity=0.518 Sum_probs=203.3
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.++. ++..||+|++...... ...+.+|+.+++.++||||+++++.+.. ...+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 578888999999987752 3457999998754321 2467889999999999999999998754 568999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++|+|.+++.+. ..+++..+..++.|++.||.|+|+.+ ++|+||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999763 34789999999999999999999998 999999999999999999999999999765433222
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||...+..++.++|+||||+++|+|++ |..||......+....+......+. ...++..+.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l 235 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPESLHDL 235 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC---ccccCHHHHHH
Confidence 2223345678999999988889999999999999999999 8999987766555544433322222 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+.+||+.||++||++.++++.|+.+.
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHccCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=313.37 Aligned_cols=236 Identities=26% Similarity=0.410 Sum_probs=194.4
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +|+.||+|++.............+..|.. +++.++||||+++++.+...+..+++|||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 589999998862 68899999987543333333445555554 567789999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|..++.+.+.+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (325)
T cd05604 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFC 157 (325)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753221 11223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+... ...+ .+..+..+.+++++|++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-PLVL---RPGASLTAWSILEELLEK 233 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-CccC---CCCCCHHHHHHHHHHhcc
Confidence 899999999999988999999999999999999999999877665554444222 2222 234678899999999999
Q ss_pred CCCCCCCHHH
Q 013214 396 KPAKRPTFRQ 405 (447)
Q Consensus 396 dp~~Rps~~~ 405 (447)
||.+||++.+
T Consensus 234 ~p~~R~~~~~ 243 (325)
T cd05604 234 DRQRRLGAKE 243 (325)
T ss_pred CHHhcCCCCC
Confidence 9999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=302.39 Aligned_cols=257 Identities=28% Similarity=0.516 Sum_probs=210.9
Q ss_pred CcCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 220 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 220 (447)
..+|...+.||+|+||.|+. ++..||+|...... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44677888999999998862 23479999887442 344567788999999999 8999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Ni 284 (447)
.....+++|||+++|+|.+++.+.. .++..++..++.|++.||.|||+++ ++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999997642 3677788999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCch
Q 013214 285 LRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 362 (447)
Q Consensus 285 ll~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~ 362 (447)
+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 9999999999999999865432211 1222345678999999988889999999999999999998 8899987766665
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
...+....+... +..++..+.+++.+||+.+|.+|||+.++++.|+++.+...
T Consensus 249 ~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 249 FKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 555533333222 34567889999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=295.31 Aligned_cols=246 Identities=27% Similarity=0.464 Sum_probs=206.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|++|.++. +|+.|++|.+..... .......+.+|+.+++.++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 356678899999987752 678999999875443 34456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999999774 46899999999999999999999998 99999999999999999999999999876543221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||++.+..++.++|+||||+++++|++|+.||...+..+....+.....+.+ +..++..+.++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV---SQMYSQQLAQL 232 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHH
Confidence 22334578899999999888889999999999999999999999987765544444433333333 33577899999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+||+.+|++||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHccCCcccCcCHHHHhhC
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=299.09 Aligned_cols=248 Identities=28% Similarity=0.495 Sum_probs=203.9
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.++...++||+|+||.++. ++..+|+|.+... .......+.+|+++++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 3566778999999998863 3568999987643 34556788999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG---------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~---------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
.+++|||+++++|.+++...+ .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCC
Confidence 999999999999999997643 3788999999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 013214 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 367 (447)
+.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 9999999999875432211 11112234678999999988889999999999999999998 999998766555544443
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
...... .+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 239 ~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 QGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 332222 23456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=305.71 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=202.9
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC-C
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-~ 223 (447)
+|+..+.||+|+||.|+. +++.||+|++.... .....+.+..|+.+++++ +||||+++++++... .
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 677888999999999873 23689999987542 334456678899999999 899999999988644 5
Q ss_pred ceEEEEeccCCCCHHHHHHhc-----------------------------------------------------------
Q 013214 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------------- 244 (447)
.+++++||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCccc
Q 013214 245 --GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYV 321 (447)
Q Consensus 245 --~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~ 321 (447)
.++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..+..... .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25788889999999999999999998 99999999999999999999999999986533221 1122334567899
Q ss_pred CCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCC
Q 013214 322 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAK 399 (447)
Q Consensus 322 aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 399 (447)
|||.+.+..++.++|||||||++|+|++ |..||.+....+......... ++.. +..+++++.+++.+||+.+|++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA---PEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC---CccCCHHHHHHHHHHccCChhh
Confidence 9999989899999999999999999998 999998755444322222222 2221 3346788999999999999999
Q ss_pred CCCHHHHHHHHHHHHh
Q 013214 400 RPTFRQIITRLESINN 415 (447)
Q Consensus 400 Rps~~~~l~~l~~~~~ 415 (447)
||++.+++++|+++..
T Consensus 320 RPs~~ell~~l~~~~~ 335 (337)
T cd05054 320 RPTFSELVEILGDLLQ 335 (337)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=310.27 Aligned_cols=249 Identities=28% Similarity=0.515 Sum_probs=216.9
Q ss_pred ccceeeecceEEEEEE-------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 158 TNSVEITKGTFILAFW-------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 158 ~~~~~lg~G~~~~~~~-------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
...+.||.|.||-||. .| --||||.-+.+. +.+..+.|..|..+|+.++||||++++|+|.+. ..|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 3456789999998762 23 358899887653 445578999999999999999999999999864 78999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||.++-|.|.++|+.+. .++......++.||+.||.|||+.+ +|||||..+|||+.+...+||+|||+++.+....
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999998765 4889999999999999999999999 9999999999999999999999999999887554
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
....+...-+..|||||-+.-+.++..+|||.||+++||+++ |..||.+-.+.++...+..+.+.+. ++++|+.+.
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~---P~nCPp~LY 622 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC---PPNCPPALY 622 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC---CCCCChHHH
Confidence 333333445778999999998999999999999999999987 9999999998888877777778876 567789999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
.++.+||+.+|.+||.+.++...|.++..
T Consensus 623 slmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999998776
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=300.54 Aligned_cols=254 Identities=32% Similarity=0.527 Sum_probs=206.3
Q ss_pred CcccceeeecceEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.++. ++ ..+++|.++.. ......+.+.+|+.+++++ +||||+++++++......++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 577778999999998762 23 34788887632 2344556788999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
++||+++++|.+++.+.. .+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence 999999999999997542 3778899999999999999999998 999999999999999999
Q ss_pred EEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC
Q 013214 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~ 370 (447)
+||+|||++...... ........+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....
T Consensus 158 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999998643211 11111223557999999988889999999999999999997 999998777665555443332
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
.+. .+..++..+.+++.+||+.+|.+||++.++++.|+.+......
T Consensus 236 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 236 RME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 222 2345778999999999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=302.54 Aligned_cols=257 Identities=28% Similarity=0.528 Sum_probs=210.1
Q ss_pred cCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 221 (447)
.+|...+.||+|+||.++. ....+|+|.+.... .......+.+|+.+++++ +||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3677888999999998763 13569999987542 344566788999999999 69999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nil 285 (447)
+...+++|||+++|+|.+++... ..++..++..++.|++.||.|||+++ ++|+||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 99999999999999999999753 23788889999999999999999998 999999999999
Q ss_pred EcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchH
Q 013214 286 RDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363 (447)
Q Consensus 286 l~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~ 363 (447)
++.++.+||+|||.+........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999976542211 11122233467999999988889999999999999999999 89999877665555
Q ss_pred HHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
..+........ +..++.++.+++.+||+.||++||++.++++.|+.+....+.
T Consensus 247 ~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 247 KLLREGHRMDK---PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred HHHHcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 55533332222 345677899999999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.37 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=200.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-----ce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~ 225 (447)
+|+..+.||+|+||.|+ .+|+.||+|.+.... ........+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 36677899999999886 368999999986532 23344567888999999999999999999998776 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+. ++|.+.+.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999995 689998888888999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc---------------
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------------- 369 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 369 (447)
..........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 322233344578899999998764 4788999999999999999999999876654332222110
Q ss_pred --------C-CCCC----CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 --------Q-RPPF----KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 --------~-~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
. .++. .......++++.++|.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 1110 00112346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=311.36 Aligned_cols=235 Identities=26% Similarity=0.396 Sum_probs=192.4
Q ss_pred eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCcccceeEEEEeCCceEEEEeccCCC
Q 013214 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 235 (447)
.||+|+||.|+. +|+.||+|++.............+..|.. +++.++||||+++++.+.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 689999998872 57899999987543323333444555554 678889999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
+|...+.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05603 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFC 157 (321)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753221 12223456
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.. ....+ +...+..+.+++.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-KPLQL---PGGKTVAACDLLVGLLHK 233 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCHHHHHHHHHHccC
Confidence 79999999999888899999999999999999999999987765444444422 22222 334677899999999999
Q ss_pred CCCCCCCHH
Q 013214 396 KPAKRPTFR 404 (447)
Q Consensus 396 dp~~Rps~~ 404 (447)
||.+||++.
T Consensus 234 ~p~~R~~~~ 242 (321)
T cd05603 234 DQRRRLGAK 242 (321)
T ss_pred CHhhcCCCC
Confidence 999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=292.05 Aligned_cols=242 Identities=31% Similarity=0.541 Sum_probs=200.3
Q ss_pred eeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 162 EITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 162 ~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
.||+|+||.++ .++..+|+|.+.... ..+....+.+|+.+++.++||||+++++++......+++|||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 58999999876 357789999987542 344556788999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCC
Q 013214 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (447)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 316 (447)
.+++... ..+++..+..++.|++.+|.|+|+.+ ++|+||||+||+++.++.+||+|||++...............+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9998754 45789999999999999999999999 9999999999999999999999999987543222111122234
Q ss_pred CCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 317 t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
+..|+|||.+.+..++.++|+||||+++|++++ |..||...........+....+... +..++..+.+++.+||+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~ 233 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC---PQKCPDDVYKVMQRCWDY 233 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHccc
Confidence 567999999988888999999999999999998 9999987766555544433323322 334678899999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 013214 396 KPAKRPTFRQIITRLE 411 (447)
Q Consensus 396 dp~~Rps~~~~l~~l~ 411 (447)
+|++||++.++++.|.
T Consensus 234 ~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 234 KPENRPKFSELQKELA 249 (250)
T ss_pred CcccCCCHHHHHHHhc
Confidence 9999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=293.71 Aligned_cols=253 Identities=26% Similarity=0.502 Sum_probs=207.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +|+.||+|.++.....+......+.+|+.++++++|+|++++++.+...+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 577888999999987752 689999998875444455556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++.. ...+++.++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999864 244889999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... +..........++. ....++..
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL--PADHYSEE 236 (267)
T ss_pred Cc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC--ChhhcCHH
Confidence 11 112334678899999998888999999999999999999999999654422 12222222222222 12357788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+.++|.+||..+|++||++.++++.|+.+.
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=300.58 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=200.7
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC----
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---- 223 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 223 (447)
..+.|...+.+|.|+||.|+. +++.||||+.-.+.. .-.+|+.+|+.+.|||||++.-+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 455788889999999999873 578999998854421 1246999999999999999988886432
Q ss_pred -ceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeec
Q 013214 224 -PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADF 297 (447)
Q Consensus 224 -~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Df 297 (447)
.+.+||||++ .+|.++++. +.+++.-.+.-+.+||++||.|||+.+ |+||||||+|+|+|. .|.+|||||
T Consensus 95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccC
Confidence 4578999996 599999974 566888899999999999999999998 999999999999995 499999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-cCCC---
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRP--- 372 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~~~--- 372 (447)
|+|+.+... .+..++.+|..|.|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+.......+.. -+.|
T Consensus 171 GSAK~L~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 171 GSAKVLVKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred CcceeeccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 999987643 445667789999999998775 799999999999999999999999999876554443322 1111
Q ss_pred ---------------CCCC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHh
Q 013214 373 ---------------PFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINN 415 (447)
Q Consensus 373 ---------------~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--l~~~~~ 415 (447)
.+.. .....+++..+++.++|..+|.+|.++.+++.+ ++.++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 1111 223567889999999999999999999999853 444443
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=300.80 Aligned_cols=249 Identities=27% Similarity=0.501 Sum_probs=204.9
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|...+.||+|+||.|+. .+..||+|.+.... .....+.+.+|..++..++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 466677899999998763 24789999997542 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
++++||+.+++|.+++... ..+++..+..++.|++.||.|+|+.+ ++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 9999999999999998532 24778889999999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHH
Q 013214 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~ 367 (447)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876532211 11122335678999999988889999999999999999998 889998776665555554
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
.....++ +..++..+.+++..||+.+|.+||++++++..|+.
T Consensus 241 ~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 4333332 44678889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=293.84 Aligned_cols=243 Identities=34% Similarity=0.617 Sum_probs=205.8
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
+|+..+.||.|++|.|+ ..|+.||+|.+.... ...+.+.+|+.+++.++||||+++++++......+++|||+
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hccceeeeecCCCceEEEEEecCcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 56777899999998876 578999999997542 14577889999999999999999999999889999999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 233 ~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
++++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999998765 6899999999999999999999999 99999999999999999999999999886532211
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
....+..|+|||.+....++.++|+||||+++|++++ |..||...+..+....+....... .+..+++.+.++|
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 232 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME---APEGCPPEVYKVM 232 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC---CccCCCHHHHHHH
Confidence 2234567999999988888999999999999999997 999998776555544443332222 2345678899999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
.+||..+|++||++.++++.|+.
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=302.08 Aligned_cols=253 Identities=30% Similarity=0.536 Sum_probs=207.7
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC
Q 013214 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 222 (447)
..+|+..+.||+|+||.++. ....+|+|.+.... .......+.+|+.+++++ +||||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34677778999999998763 12679999987542 334456788999999999 899999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill 286 (447)
+..+++|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999999642 35788899999999999999999998 9999999999999
Q ss_pred cCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 013214 287 DDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK 364 (447)
Q Consensus 287 ~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~ 364 (447)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 99999999999999865432211 1122234567999999988889999999999999999997 999998777666555
Q ss_pred HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.......+.. +...+..+.+++.+||..||++|||+.++++.|+++.
T Consensus 246 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLKEGYRMEK---PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHcCCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 5533333332 3345778999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.35 Aligned_cols=244 Identities=27% Similarity=0.446 Sum_probs=212.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
-|.+..+||+|+||.|+ .+|+.+|+|.++.+ ..++++.+|+.++++.+.|++|++||.+.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 36677889999999875 58999999998744 346889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||..|+..+.++- +.++++.++..+++..+.||+|||... -+|||||..|||++.+|..||+|||.+-.+...-.
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 9999999999974 567999999999999999999999988 79999999999999999999999999976653321
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......|||.|||||++..-.|+.++||||||++..||..|++||.+..+....-.+.....|.|. .+..+|.++.+++
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~-KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK-KPEEWSSEFNDFI 263 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC-ChHhhhhHHHHHH
Confidence 124567899999999999989999999999999999999999999988876655555344344444 4667899999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
++||..+|++|.|+.+++++
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhh
Confidence 99999999999999998876
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=295.31 Aligned_cols=246 Identities=31% Similarity=0.526 Sum_probs=203.5
Q ss_pred CcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.++ .+++.||+|.+...... ...+.+|+.++++++||||+++++++. .+..+++|||
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 56777899999999876 36789999998754432 356888999999999999999999874 4578999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+.+++|.+++.+. ..+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999998753 35889999999999999999999998 999999999999999999999999998765422222
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+..+...........+. +...+.++.++
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 235 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR---PDNCPEELYEL 235 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC---CCCCCHHHHHH
Confidence 2223345678999999988888999999999999999999 9999987776655555433323322 33467889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+.+||+.+|++||++++++..|++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=294.68 Aligned_cols=248 Identities=29% Similarity=0.468 Sum_probs=201.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc-ccceeEEEEeCC------
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSS------ 223 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~------ 223 (447)
.|...++||+|+||.|| .+|+.||+|+++.+... +-.-....+|+.+++.++|+| |+++++++....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 46666789999999987 47899999999865432 112234567999999999999 999999998877
Q ss_pred ceEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
.+++|+||+ .-+|..++...+ .++...+..++.||+.||.|||+++ |+||||||+||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 789999999 569999998765 4778899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC-----
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP----- 372 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~----- 372 (447)
|+....+. ...+...+|.+|.|||++.+. .|++..||||+||++.||+++++.|++....+....+... +.|
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99765432 334556679999999999886 7899999999999999999999999988775544444221 111
Q ss_pred -----------CCCCC--h-------hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 -----------PFKAP--A-------KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 -----------~~~~~--~-------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++.. + +..++...+++.+|++.+|.+|.|++.++.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111 1 1122478899999999999999999999987
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=298.24 Aligned_cols=248 Identities=29% Similarity=0.491 Sum_probs=205.0
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|.....||+|+||.|+. .+..||+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 567778999999998762 23689999986442 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEe
Q 013214 226 MIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~ 295 (447)
+++|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999996532 3677889999999999999999998 9999999999999999999999
Q ss_pred ecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCC
Q 013214 296 DFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (447)
Q Consensus 296 Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 373 (447)
|||+++....... .......++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+.....+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 9999876543221 11223345778999999988889999999999999999998 999998777666665554333333
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 374 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
. +..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 242 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 242 L---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred C---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 3 3345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=295.07 Aligned_cols=246 Identities=33% Similarity=0.535 Sum_probs=203.2
Q ss_pred CcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|++|.++ ..+..+|+|.+...... .+.+.+|+.++++++|||++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 57778899999999876 35678999998754332 246888999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999764 35899999999999999999999999 999999999999999999999999999765432222
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||...+..++.++|+||||+++|+|++ |..||...+..+....+.....++. +...+..+.++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 235 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC---PQDCPISLHEL 235 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHHH
Confidence 2222334667999999988889999999999999999999 9999987776665555543333332 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+.+||..+|++|||+.++.+.|++
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=295.64 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=200.5
Q ss_pred ccceeeecceEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------Cc
Q 013214 158 TNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (447)
Q Consensus 158 ~~~~~lg~G~~~~~~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 224 (447)
...+.||+|+||.|+. .+ ..+|+|.++... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3457899999998863 22 269999887643 2445567888999999999999999999987432 24
Q ss_pred eEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 225 MMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
.++++||+.+|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988742 134789999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 299 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 299 ~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
++......... .......++.|+|||...+..++.++|+||||+++|+|++ |+.||......+....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 235 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ-- 235 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence 98865432211 1122345678999999988889999999999999999999 8999987666555555544333332
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+..++..+.++|.+||+.||++|||+.++++.|+++
T Consensus 236 -~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 -PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 345678899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=294.50 Aligned_cols=250 Identities=31% Similarity=0.538 Sum_probs=205.9
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.++. .+..+|+|.+.... .......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 566778999999987752 23379999987543 34456788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+++++|.+++.+. +.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999765 45899999999999999999999999 999999999999999999999999998865432
Q ss_pred CCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 307 EDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 307 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
..... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+....+.+. +..+++
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 236 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA---PMDCPA 236 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC---CCCCCH
Confidence 22111 11223567999999988889999999999999999887 9999987766555444433323222 234678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
.+.+++.+||+.+|.+||++.++++.|+++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=295.06 Aligned_cols=250 Identities=27% Similarity=0.468 Sum_probs=203.4
Q ss_pred cccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc----
Q 013214 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---- 224 (447)
|+..+.||+|+||.++. .+..||+|.++.+.. .......+.+|+..++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 45667899999998862 236799999875432 34456778999999999999999999998865544
Q ss_pred --eEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 225 --MMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 225 --~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
.++++||+++|+|..++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECC
Confidence 79999999999999998542 25889999999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 297 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 297 fg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
||+++........ .......+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~- 235 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK- 235 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 9998765432211 1112234678999999988889999999999999999999 999998776666555553333332
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
.+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus 236 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 --QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2445778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=298.51 Aligned_cols=252 Identities=27% Similarity=0.475 Sum_probs=202.3
Q ss_pred cCcccceeeecceEEEEEE-----------------c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccce
Q 013214 155 LDFTNSVEITKGTFILAFW-----------------R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----------------~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 215 (447)
.+|+..+.||+|+||.|+. + ...||+|.+.... .......+.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 3677788999999998863 1 2358999987542 34556778999999999999999999
Q ss_pred eEEEEeCCceEEEEeccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 013214 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283 (447)
Q Consensus 216 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~N 283 (447)
++++......+++|||+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 999999999999999999999999996532 3678888999999999999999999 9999999999
Q ss_pred EEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 013214 284 ILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDN 360 (447)
Q Consensus 284 ill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t--g~~p~~~~~~~ 360 (447)
|+++.++.+||+|||++........ .......++..|+|||.+.++.++.++|+||||+++|+|++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999875432211 11122234678999999988889999999999999999988 67788776654
Q ss_pred chHHHHHh----cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 361 EVPKAYAA----RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 361 ~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
+....... .....+...++.+++.+.+++.+||+.||++|||+.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 44333211 1122222334456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=293.88 Aligned_cols=243 Identities=30% Similarity=0.565 Sum_probs=201.1
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE-eCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.++ ..|..||+|..... ...+.+.+|+.++++++|||++++++++. .....++++||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 57777899999998765 57889999988643 22456888999999999999999999764 45678999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+++++|.+++.+.. .+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999997654 3788999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.....+..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.....+. .+..+++.+.++
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 231 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPVVYDV 231 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCHHHHHH
Confidence 22234567999999988889999999999999999997 999998766555544443332222 234567899999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+.+||+.+|++|||+.++++.|+.+
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHHhcC
Confidence 9999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=301.90 Aligned_cols=253 Identities=32% Similarity=0.537 Sum_probs=203.7
Q ss_pred CcccceeeecceEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.++. ++. .+|+|.+... ........+.+|+.++.++ +||||+++++++..++..++
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 567778999999998763 343 4677776532 2345567788899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
+|||+++++|.+++.+.+ .+++.++..++.|++.|+.|||+.+ ++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997542 4788899999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC
Q 013214 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~ 370 (447)
+||+|||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.........
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 9999999986432111 1111223567999999988888999999999999999998 999998766655444442222
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
.... +...++.+.+++.+||+.+|++||++.++++.++++.....
T Consensus 241 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 241 RLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred cCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 2222 23456789999999999999999999999999988755543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=294.08 Aligned_cols=245 Identities=27% Similarity=0.452 Sum_probs=203.8
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|+||.++ .+++.+|+|.+.... .....+.+.+|+.+++.++||||+++++.+..++.+++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 46677899999998775 368899999886442 23455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++++|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 99999999988653 35889999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+......+. +..++..+.++
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHHHHH
Confidence 112234578889999999888899999999999999999999999987665444444433333332 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.||++||++.+++..
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=294.58 Aligned_cols=249 Identities=24% Similarity=0.468 Sum_probs=204.5
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+|+..+.||.|+||.++. +|+.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 466778899999998763 6788999988654221 233446688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC-
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE- 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~- 307 (447)
+||+++++|.+++.+..++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999988888999999999999999999999998 9999999999999999999999999987543211
Q ss_pred ----CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 308 ----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 308 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.. .....+..+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA-HRGLMPRLPDSFSA 236 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh-ccCCCCCCCCCCCH
Confidence 1112234578899999999888889999999999999999999999986654433222211 11222233456788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
++.++|++||+.+|.+||++.++++
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9999999999999999999999886
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=295.28 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=209.0
Q ss_pred CCcCcccceeeecceEEEEEE----c-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-C
Q 013214 153 HELDFTNSVEITKGTFILAFW----R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-S 222 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~----~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 222 (447)
...+|+..+.||+|+||.|+. . +..|++|.+... ........+.+|+.+++.++||||+++++++.. +
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 345677888999999998752 2 588999988643 345566778899999999999999999998765 4
Q ss_pred CceEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
...++++||+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEE
Confidence 6789999999999999999753 34889999999999999999999998 999999999999999999999
Q ss_pred eecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCC
Q 013214 295 ADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
+|||+++.+...... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||...+..+....+......
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL 238 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC
Confidence 999999765322111 1122345677999999988889999999999999999999 99999876655544444333222
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
.. ...+++++.+++.+||..||++|||+.++++.|+++.+.
T Consensus 239 ~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 239 AQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 22 234678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=293.00 Aligned_cols=246 Identities=33% Similarity=0.527 Sum_probs=201.3
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|...+.||+|++|.++. .+..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 467778899999988762 345799998865432 2356788999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+.+++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999997643 4788999999999999999999998 999999999999999999999999999765432222
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||...+..++.++|+||||+++|+|++ |+.||......+....+.....++. +...+..+.++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 235 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC---PQGCPESLHEL 235 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHH
Confidence 2222345678999999988889999999999999999999 9999987766555555433333332 34567899999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+.+||+.||++||++.++++.|++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=295.84 Aligned_cols=249 Identities=28% Similarity=0.483 Sum_probs=202.7
Q ss_pred cCcccceeeecceEEEEE---E-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAF---W-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|...+.||+|++|.++ . .+..||+|..... ........+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 357777899999998775 2 4578999988643 234445678889999999999999999999998889
Q ss_pred eEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC---CEEE
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKV 294 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~---~vkl 294 (447)
.+++|||+++++|.+++.+.+ .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999997653 4788999999999999999999999 99999999999998755 5999
Q ss_pred eecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCC
Q 013214 295 ADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
+|||++......... .......+..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 999998865321111 1111223567999999988889999999999999999997 99999877766655554333333
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
.. +..++..+.+++.+||+.+|++||++.+++++|+
T Consensus 241 ~~---~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 DP---PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 32 3456788999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.78 Aligned_cols=253 Identities=27% Similarity=0.462 Sum_probs=205.8
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC
Q 013214 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 222 (447)
..+|...+.||+|+||.++. .+..||+|.++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34678888999999998752 23579999887542 234456788999999999 799999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
+..+++|||+.+|+|.+++.+.. .+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999997643 3899999999999999999999998 999999999999999999999999998
Q ss_pred cccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCCh
Q 013214 301 KLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 378 (447)
Q Consensus 301 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (447)
......... ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||......+............ ..+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 266 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--AQP 266 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--CCC
Confidence 765432211 1122345678999999988889999999999999999998 999998766544333332222111 122
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
...++.+.+++.+||+.+|++||++.++++.|+++
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 34578899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=295.40 Aligned_cols=254 Identities=23% Similarity=0.477 Sum_probs=206.5
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
.+|+..+.||+|+||.++. +|+ .||+|.+.... .......+.+|..+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 3577778999999998863 344 48999987542 34455778899999999999999999999875 457
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
++++||+++|+|.+++.++ +.+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 8999999999999999774 56899999999999999999999999 9999999999999999999999999988654
Q ss_pred cCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
..... ......+++.|+|||...+..++.++||||||+++|+|++ |..||...........+.....++. +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PPICT 237 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CccCC
Confidence 32211 1112234678999999988889999999999999999998 9999987665555444433333332 34567
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 88999999999999999999999999988875544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=292.95 Aligned_cols=250 Identities=30% Similarity=0.531 Sum_probs=206.3
Q ss_pred CcccceeeecceEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.++. ++ ..+|+|.+.... .....+.+.+|+.+++.++|||++++.+++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 566778999999998762 22 379999987542 34456778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+++++|.+++.+. +.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999764 56899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 307 EDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 307 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
..... .....+..|+|||.+.+..++.++|+||||+++|++++ |+.||...+..+....+......+. +..++.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~ 237 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA---PMDCPS 237 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC---CCCCCH
Confidence 22111 11223457999999988888999999999999999997 9999987766555555543332222 234678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
.+.+++.+||+.+|++||++.++++.|+++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=293.57 Aligned_cols=247 Identities=30% Similarity=0.499 Sum_probs=203.1
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCC------HHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
|.....||+|++|.++ .+++.+|+|.+....... .+..+.+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 5566789999998775 257899999886543322 12346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999988888999999999999999999999998 99999999999999999999999999876542
Q ss_pred CCC-----CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhh
Q 013214 306 KED-----RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 306 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....+. .+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 235 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---IPSN 235 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc---CCcc
Confidence 111 11122346788999999988888999999999999999999999998765443333332222333 2345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++..+.++|++||+.||.+||++.+++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 67899999999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=292.76 Aligned_cols=242 Identities=33% Similarity=0.611 Sum_probs=204.8
Q ss_pred eeecceEEEEEE-----c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccC
Q 013214 162 EITKGTFILAFW-----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
.||+|+||.++. . +..|++|.+..... ....+.+.+|+..++.++|||++++++++......+++|||++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 589999987752 2 78899999976532 2256788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 234 KGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 234 ~g~L~~~l~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
+++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999875 67999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
.... .......++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+....... .+..++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 233 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP---KPEYCP 233 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCccCC
Confidence 3321 11233446788999999988888999999999999999999 699999887666655554433333 244568
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
..+.+++.+||..+|.+|||+.+++++|+
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 234 DELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred hHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 89999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=292.28 Aligned_cols=252 Identities=26% Similarity=0.497 Sum_probs=206.7
Q ss_pred CcccceeeecceEEEEEE----c----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|...+.||+|+||.++. + ...||+|..... ...+..+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 566778999999998763 1 236899988644 234556788999999999999999999998875 45789
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999998754 5899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
.........++..|+|||.+....++.++|+||||+++|++++ |..||......+....+....+.+. +..++..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 237 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM---PPNCPPTL 237 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHH
Confidence 2111222334567999999988888999999999999999986 9999987776655544433333332 34567899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 386 KELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
.++|.+|+..+|.+|||+.++++.|+.+...
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=295.79 Aligned_cols=247 Identities=24% Similarity=0.403 Sum_probs=201.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.++. +++.||+|.++... ......+.+|+.+++.++||||+++++.+...+..++++|
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 677888999999998762 68899999986542 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++...+.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 9999999999988888999999999999999999999999 9999999999999999999999999987554221 12
Q ss_pred cccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLK 386 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 386 (447)
.....++..|+|||.+. ...++.++|+|||||++|+|++|..||................ .++.......++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 23345788999999874 4467889999999999999999999997655433322221111 2221112224677899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||+.+|++||++.+++++
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcC
Confidence 99999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=294.37 Aligned_cols=252 Identities=24% Similarity=0.470 Sum_probs=203.4
Q ss_pred CcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
+|+..+.||+|+||.++. +|+ .+++|.+... .......++..|+..++.+.||||+++++++.. ...+
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 566778899999998762 344 4788887532 233445678888989999999999999998764 4578
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+++||+++|+|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 899999999999999764 56899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 306 KED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 306 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
... .......++..|+|||.+.+..++.++||||||+++|++++ |+.||.+....+....+.....+.. +..++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 238 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQICTI 238 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCCCCH
Confidence 221 11223446778999999988889999999999999999998 9999987765555444433333332 223567
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
.+.+++.+||..||.+|||+.++++.|..+...
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 789999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=311.30 Aligned_cols=239 Identities=25% Similarity=0.404 Sum_probs=193.4
Q ss_pred eecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeEEEEeCCceEEEEeccCC
Q 013214 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 163 lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
||+|+||.|+. +|+.||+|++................|..++... +||||+++++.+......+++|||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 68999998862 5889999998754333333344455566776655 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccCc
Confidence 999999988888999999999999999999999999 999999999999999999999999998753221 1222345
Q ss_pred CCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 013214 315 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 393 (447)
.||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+... ...++ ...+++.+.+++++||
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~--~~~~~~~~~~li~~~L 233 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-KVRFP--KNVLSDEGRQFVKGLL 233 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-CCCCC--CccCCHHHHHHHHHHc
Confidence 689999999998754 4788999999999999999999999877665554444222 22222 2346788999999999
Q ss_pred ccCCCCCC----CHHHHHH
Q 013214 394 NEKPAKRP----TFRQIIT 408 (447)
Q Consensus 394 ~~dp~~Rp----s~~~~l~ 408 (447)
+.||.+|| ++.++++
T Consensus 234 ~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 234 NRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCHHHCCCCCCCHHHHhc
Confidence 99999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=295.82 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=203.5
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|++.+.||+|+||.|+. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4677888999999998873 13479999886442 33344567889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
.+++|||+++|+|.+++.+.. ..+...+..++.|++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 2456678889999999999999999 999999999999999999999
Q ss_pred eecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCC
Q 013214 295 ADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
+|||+++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999998754322111 1112234677999999988889999999999999999998 78999876655554444333333
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.. +...++.+.+++.+||+.||++|||+.++++.|++..
T Consensus 241 ~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 241 DQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 32 3345688999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=296.98 Aligned_cols=250 Identities=30% Similarity=0.492 Sum_probs=204.6
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|+..+.||+|+||.++. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3577788999999998763 46789999987542 34455778899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~----------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~ 282 (447)
.++++||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999997432 3677888999999999999999998 999999999
Q ss_pred CEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 013214 283 NILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 360 (447)
Q Consensus 283 Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~ 360 (447)
||+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875432211 11112234667999999988889999999999999999997 88899877666
Q ss_pred chHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+....+......+. +..++.++.+++.+||+.||++|||+.++++.|++
T Consensus 240 ~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 65555433332222 33567889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.36 Aligned_cols=257 Identities=20% Similarity=0.299 Sum_probs=205.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++...........+++.+|+.+++.++||||+++++++.+++..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 677888999999998873 588999999976554455566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 231 YLPKGDLRAFLKRK-----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-----------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
|++||+|.+++... ...+...+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999998642 23456678899999999999999999 99999999999999999999999999
Q ss_pred ccccccCCC-----------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch
Q 013214 300 SKLLTVKED-----------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (447)
Q Consensus 300 ~~~~~~~~~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~ 362 (447)
+........ .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 976521110 001123589999999999988999999999999999999999999987554333
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCC-CHHHHHHHHHHHHhh
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP-TFRQIITRLESINNS 416 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~~l~~l~~~~~~ 416 (447)
.... ....+.-......+++.+.+++.+||+.||++|| +++++++.|+.+.+.
T Consensus 240 ~~~~-~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 240 SYRD-VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhh-hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 2221 1111111112345678899999999999999995 667777888776553
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=300.10 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=205.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.++ .+++.|++|.+.............+.+|+.+++.++||||+++++.+..++..+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 56777899999999876 3578999999876543344455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
|+++++|.+++...+.+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999988888999999999999999999999998 99999999999999999999999998864211100
Q ss_pred ------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 309 ------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 309 ------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+......... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCC
Confidence 00112346788999999988889999999999999999999999998776655554443322 22222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
....++..+.++|.+||+.||++||++.++.+.++.
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 233577889999999999999999996555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.60 Aligned_cols=252 Identities=28% Similarity=0.482 Sum_probs=201.9
Q ss_pred cCcccceeeecceEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccc
Q 013214 155 LDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 213 (447)
.+|+..+.||+|+||.++. ++..+|+|.+.... .......+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3578888999999998874 23469999987542 344567889999999999999999
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 013214 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (447)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~ 282 (447)
++++++...+..+++|||+++++|.+++.+.. .+++.++..++.|++.|+.|||+.+ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 99999999999999999999999999997642 2567789999999999999999999 999999999
Q ss_pred CEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCC
Q 013214 283 NILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHD 359 (447)
Q Consensus 283 Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t--g~~p~~~~~~ 359 (447)
||+++.++.++|+|||++..+..... ........++.|++||...++.++.++|+||||+++|+|++ |..||...+.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999876532211 11112233578999999888889999999999999999998 7788876655
Q ss_pred CchHHHHHh----cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 360 NEVPKAYAA----RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 360 ~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
.+....... .......+.+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 444332211 1111122223456788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=292.37 Aligned_cols=238 Identities=27% Similarity=0.397 Sum_probs=212.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|. .+|+.+|+|+++++.+-..+.+..-..|-++|+..+||++..+--.|+.++++|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 46667789999999875 4789999999999988888888888899999999999999999989999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|..||.|.-+|.+.+.+++..+..+...|+.||.|||+++ |+.||+|.+|.|+|.+|++||+|||+.+..-.. ...
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t 324 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDT 324 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc-cce
Confidence 9999999999998888999999999999999999999998 999999999999999999999999998753211 223
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
....+|||.|+|||++....|+..+|+|.+|+++|||++|+.||...+.+.+.+.+... ...| ++.++++.+.|+.
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-d~kF---Pr~ls~eAktLLs 400 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-DLKF---PRTLSPEAKTLLS 400 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-hccC---CccCCHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999988887777333 2333 5678899999999
Q ss_pred HHcccCCCCCC
Q 013214 391 ECWNEKPAKRP 401 (447)
Q Consensus 391 ~cl~~dp~~Rp 401 (447)
.+|..||.+|.
T Consensus 401 GLL~kdP~kRL 411 (516)
T KOG0690|consen 401 GLLKKDPKKRL 411 (516)
T ss_pred HHhhcChHhhc
Confidence 99999999995
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=307.73 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=194.2
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 223 (447)
.+|+..+.||+|+||.|+ .+|..||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478888999999999886 3588999999875432 3344566778999999999999999999986543
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..|++|||++ ++|.+.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 100 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCC-cCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 4799999995 56766664 34888999999999999999999999 999999999999999999999999998754
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh---------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA--------------- 368 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~--------------- 368 (447)
... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 174 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 174 CTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 321 222345678999999999988999999999999999999999999986653221111100
Q ss_pred ------cCCCCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 ------RQRPPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ------~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+.++ ......++.++++|.+||+.||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0011110 0011235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=290.69 Aligned_cols=246 Identities=22% Similarity=0.395 Sum_probs=206.9
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|+||.++ .+++.+++|.+..... ......++.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 46778899999998654 3688999999865443 33455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++.+. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999999765 45899999999999999999999998 99999999999999999999999999876543321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+......+ ....++..+.++
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---VVSVYSSELISL 232 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---CccccCHHHHHH
Confidence 2233457889999999988888899999999999999999999998776655555553333222 235567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+||..+|.+||++.+++++
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHcccCcccCCCHHHHhhC
Confidence 999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=290.62 Aligned_cols=248 Identities=29% Similarity=0.504 Sum_probs=204.1
Q ss_pred cCcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+|+..+.||+|+||.++ ..+..+|+|.+... ....+.+.+|+.+++.++|+||+++++.+.. ...+++||
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 367788899999999886 24567999988643 2345678889999999999999999999887 77899999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++.+. ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999763 34788889999999999999999998 99999999999999999999999999876543222
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......++..|+|||.+....++.++|+||||+++|++++ |+.||...+.......+......+ .....+.++.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 234 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP---RPENCPEELYN 234 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC---CcccCCHHHHH
Confidence 22222345677999999988888999999999999999998 999998776655554443332222 23456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
++.+||+.+|++||++.++.+.|+.+
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.96 Aligned_cols=251 Identities=29% Similarity=0.464 Sum_probs=203.2
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCc
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 224 (447)
++...+.||+|+||.|+. .+..||+|++.... .....+.+.+|+.++.++. ||||+++++++..+..
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 566678999999998862 23579999997543 2334457889999999997 9999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-----------------------------------------------------------
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------- 245 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 245 (447)
.++|+||+.+|+|.+++++++
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996532
Q ss_pred ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE
Q 013214 246 ---------------------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (447)
Q Consensus 246 ---------------------------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill 286 (447)
.+++.....++.|++.||.|||+.+ ++||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 2456677889999999999999998 9999999999999
Q ss_pred cCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 013214 287 DDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK 364 (447)
Q Consensus 287 ~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~ 364 (447)
++++.+||+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999999876432211 11122345788999999988889999999999999999998 899998766554433
Q ss_pred HHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 365 AYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 365 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.....+ ++.. +..++.++.+++.+||..+|.+||+++++++.|+++.
T Consensus 353 ~~~~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 NAIKRGYRMAK---PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 332222 3322 3456789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=293.74 Aligned_cols=252 Identities=26% Similarity=0.515 Sum_probs=201.0
Q ss_pred CcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--
Q 013214 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-- 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 222 (447)
...|+..+.||+|+||.++. ++..||+|.++.. ........+.+|+.+++.++|||++++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 34567888999999998852 4788999998754 2345567789999999999999999999998775
Q ss_pred CceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
...+++|||+++++|.+++.+.. .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 56899999999999999997653 5899999999999999999999999 9999999999999999999999999988
Q ss_pred ccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----------Cc-----hHH
Q 013214 302 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD----------NE-----VPK 364 (447)
Q Consensus 302 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~----------~~-----~~~ 364 (447)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++++.|+..... .+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65432211 11234466789999999888899999999999999999998766432111 00 001
Q ss_pred HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
........ ..+..++..+.+++.+||+.||++||++.++++.++.+
T Consensus 238 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111 12345788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.04 Aligned_cols=248 Identities=31% Similarity=0.517 Sum_probs=204.5
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+|...+.||+|++|.++. +++.||+|.+..... ...++.+|+.+++.++||||+++++++......+++||
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3677788999999998762 457799999875432 23568889999999999999999999998889999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++.+.. .+++..+..++.|++.|+.|||+++ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999997653 5899999999999999999999999 99999999999999999999999999876543211
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
........+..|+|||.+.+..++.++|+||||+++|++++ |+.||...........+......+. +...+..+.+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 235 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNCPEELYD 235 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHH
Confidence 11122234567999999988889999999999999999998 9999987665555544433322222 2334778999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
++.+||+.+|++||+++++++.|+.
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=301.91 Aligned_cols=262 Identities=29% Similarity=0.541 Sum_probs=211.4
Q ss_pred CCcccCCCCcCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcc
Q 013214 146 PEYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNV 212 (447)
Q Consensus 146 ~~~~i~~~~~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i 212 (447)
|.+++.. .+|.+.+.||+|+||.++. .+..||+|.+... ......+.+.+|+.+++++ +||||
T Consensus 5 ~~~~~~~--~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 5 PKWELSR--TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred cccccCH--hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence 4444443 3678888999999998752 1236899988743 2345567888999999999 79999
Q ss_pred cceeEEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 013214 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (447)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H 276 (447)
+++++++......++++||+++|+|.+++.+.. .++..++..++.|++.||.|||+.+ ++|
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH 157 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 999999999999999999999999999997532 3677888999999999999999999 999
Q ss_pred CCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 013214 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 354 (447)
Q Consensus 277 ~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~ 354 (447)
+||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999998765432111 1122334567999999988889999999999999999998 89999
Q ss_pred CCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
...+..+....+........ +..++.++.+++.+||+.+|.+||++.++++.|+.+.+.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 238 PGIPVEELFKLLKEGHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 87766555555433333332 3346778999999999999999999999999999988544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=290.08 Aligned_cols=248 Identities=29% Similarity=0.462 Sum_probs=204.7
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||.|++|.++ .+++.+++|.+.... ....+.+.+|+.++++++||||+++++++.+....+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 367778899999998775 256789999987542 235577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999999999876 77999999999999999999999998 99999999999999999999999999876543211
Q ss_pred CCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARG 384 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 384 (447)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+......... .+........++.+
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 11234567889999998776 78889999999999999999999998766544433332221 22222234567889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+++++||..+|.+||++.+++.+
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=297.95 Aligned_cols=244 Identities=26% Similarity=0.477 Sum_probs=200.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|..+|+|.+.... .......+.+|++++++++||||+++++++..++..+++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 577888999999998763 57889999887542 34455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 99999999999888889999999999999999999998 46 999999999999999999999999998754321
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--------------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------------- 369 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------------- 369 (447)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+...........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 123345788999999998888899999999999999999999999755433222111100
Q ss_pred ----------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 ----------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.. ....++.++.+++.+||..||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKL--PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccC--cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00110 112367789999999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=297.38 Aligned_cols=248 Identities=28% Similarity=0.547 Sum_probs=200.0
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||+|+||.|+. +++.+|+|.+..... .........+|+.++++++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-cccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 56678999999999873 577899999986542 222233445699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 311 (447)
+++++|.+++...+.+++..+..++.|+++||.+||+.+ ++|+||||+||++++++.++|+|||.+..... .....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~ 155 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF 155 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 998899999998888999999999999999999999999 99999999999999999999999999875411 12233
Q ss_pred ccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCC---CCChhhhHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF---KAPAKLYARGLKE 387 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 387 (447)
....++..|+|||.+. +..++.++|+||+|+++|+|++|..||.................... .......++.+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 4556789999999998 77889999999999999999999999997732222222211111110 0011122478999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.||++||++.+++++
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=293.05 Aligned_cols=251 Identities=27% Similarity=0.504 Sum_probs=198.9
Q ss_pred CcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--C
Q 013214 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--S 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 222 (447)
+..|+..+.||+|+||.++. ++..||+|.+... .....+.+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 44677788999999998863 4778999998643 34556788999999999999999999998754 3
Q ss_pred CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
...++++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 4689999999999999999764 45899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch----------------H
Q 013214 302 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV----------------P 363 (447)
Q Consensus 302 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~----------------~ 363 (447)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 65432211 11122334569999999888899999999999999999998777543321100 0
Q ss_pred HHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
......... ..+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 237 ~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011111111 12345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=296.98 Aligned_cols=243 Identities=28% Similarity=0.471 Sum_probs=205.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++ .+++.||+|.+.............+.+|++++++++||||+++++++...+..+++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 56778899999998775 2579999999876544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999999998888999999999999999999999998 999999999999999999999999998765432
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....+++.|+|||.+.+...+.++|+||||+++|+|++|+.||......+....+. .....+ +..++..+++++.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~l~~li~ 230 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-EGKVRF---PSFFSPDAKDLIR 230 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCccC---CccCCHHHHHHHH
Confidence 223457889999999988888899999999999999999999998766444444332 333333 3345788999999
Q ss_pred HHcccCCCCCC-----CHHHHHHH
Q 013214 391 ECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
+||..||.+|+ ++++++++
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcC
Confidence 99999999998 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=290.95 Aligned_cols=250 Identities=30% Similarity=0.537 Sum_probs=204.0
Q ss_pred CcccceeeecceEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
.|+..+.||+|+||.++. ++ ..||+|.+.... .......+..|+.+++.++||||+++++++..+...++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 456778999999998762 22 369999987542 45556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+++++|.+++... +.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999764 56899999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCc--ccC--CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhh
Q 013214 307 EDRPL--TCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 307 ~~~~~--~~~--~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (447)
..... ... ..+..|+|||.+.+..++.++||||||+++|++++ |..||......+....+......+. +..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~ 236 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP---PMDC 236 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC---cccC
Confidence 21111 111 12457999999988889999999999999999886 9999987665555444432222222 2356
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 78899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=305.47 Aligned_cols=253 Identities=29% Similarity=0.468 Sum_probs=211.6
Q ss_pred CcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
.....++||+|.||.+. ..+..||+|+++.+. ......+|..|+++|.+++||||++++|+|..++.+++++||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 44566789999999875 345999999998764 455578999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC-C
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-D 308 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~-~ 308 (447)
+++|+|.+++.++. .+......+++.||++|++||.+.+ ++||||.+.|+|++.++++||+|||+++.+=... .
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999998763 3456677789999999999999998 9999999999999999999999999998542221 1
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCCCchHHHHHhc----CCCCCCCChhhhH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDNEVPKAYAAR----QRPPFKAPAKLYA 382 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t--g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 382 (447)
+......-+.+|||||.+.-+++++++|+|+||+++||+++ ...||....++++.+..... ++..+..-++-++
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 11122234789999999999999999999999999999876 78999988887766554222 2333444566788
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
.++-++|.+||..|-++||+++++...|++.
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 9999999999999999999999999988764
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=300.47 Aligned_cols=253 Identities=28% Similarity=0.487 Sum_probs=201.4
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC-
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS- 222 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~- 222 (447)
.+|+..+.||+|+||.|+. +++.||+|+++... .......+.+|+.++.++ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3688889999999998862 46789999997543 334456788899999999 689999999988654
Q ss_pred CceEEEEeccCCCCHHHHHHhcC---------------------------------------------------------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKG--------------------------------------------------------- 245 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 245 (447)
...+++|||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 46799999999999999986431
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccC
Q 013214 246 ----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQ 314 (447)
Q Consensus 246 ----------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~ 314 (447)
.++...+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 2567778889999999999999998 999999999999999999999999998764322111 11122
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchH-HHHHhcCCCCCCCChhhhHHHHHHHHHHH
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP-KAYAARQRPPFKAPAKLYARGLKELIEEC 392 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~c 392 (447)
.++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.. ..+....+... +...++.+.+++..|
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~c 318 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC---CCCCCHHHHHHHHHH
Confidence 34677999999988889999999999999999997 99999876544322 22222222222 223567899999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHh
Q 013214 393 WNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 393 l~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
|+.||++|||+.+++++|+.+.+
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=288.96 Aligned_cols=245 Identities=31% Similarity=0.595 Sum_probs=201.9
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||.|+||.++. .+..+|+|.+...... ...+.+|++++++++|||++++++++......++++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 456678899999998763 4788999998754432 24678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++++|.+++... +.+++..++.++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999764 46899999999999999999999998 9999999999999999999999999987553222111
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+....+....++.. +...+..+.+++
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~ 234 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLASQSVYELM 234 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---CCCCCHHHHHHH
Confidence 222334678999999988889999999999999999998 9999987666555555433322221 233568899999
Q ss_pred HHHcccCCCCCCCHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l 410 (447)
.+||+.+|++||++.++++.|
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=288.27 Aligned_cols=246 Identities=31% Similarity=0.558 Sum_probs=195.8
Q ss_pred eeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE-eCCceEEEEecc
Q 013214 162 EITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL 232 (447)
Q Consensus 162 ~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~ 232 (447)
.||+|+||.++. .+..||+|.+... ......+.+.+|..+++.++||||+++++++. .++..++++||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 589999998762 2357999988532 23445677888999999999999999999775 455689999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC---
Q 013214 233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--- 308 (447)
Q Consensus 233 ~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~--- 308 (447)
.+|+|.+++.+. ...++.....++.|++.|+.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999999764 34677788899999999999999998 99999999999999999999999999875432111
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+.....+.. +...++.+.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 233 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPLYE 233 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHHHH
Confidence 11122345678999999988889999999999999999999 5677776555444444433222222 3345778999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
++.+||+.+|++||++.++++.|+++..
T Consensus 234 li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 234 VMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 9999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=308.52 Aligned_cols=242 Identities=29% Similarity=0.383 Sum_probs=198.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CC-----cccceeEEEEeCCc
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HP-----NVVQFLGAVTQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~iv~~~~~~~~~~~ 224 (447)
+|.+.+.||+|+||.|. .+++.||||+++. ......+...|+.+|..++ |. |+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN----~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN----KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc----ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 67888999999999875 4789999999974 3455566778999999996 43 79999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC--CEEEeecccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVS 300 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~--~vkl~Dfg~~ 300 (447)
+|||+|.+ +-+|+++++.+. .++...+..++.||+.||..||+.+ |||+||||+|||+...+ .|||+|||+|
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999 579999999875 4899999999999999999999999 99999999999998544 6999999999
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCCC------
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPP------ 373 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~------ 373 (447)
++..... ..+..+..|.|||++.+.+|+.+.|||||||++.||++|.+.|.+.+..+....+... +.|+
T Consensus 339 c~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9765432 2456678899999999999999999999999999999999999877654432222110 0000
Q ss_pred --------------------------------------------CC----C----ChhhhHHHHHHHHHHHcccCCCCCC
Q 013214 374 --------------------------------------------FK----A----PAKLYARGLKELIEECWNEKPAKRP 401 (447)
Q Consensus 374 --------------------------------------------~~----~----~~~~~~~~l~~li~~cl~~dp~~Rp 401 (447)
.+ . ........+.+++++||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 00 0 0012235689999999999999999
Q ss_pred CHHHHHHH
Q 013214 402 TFRQIITR 409 (447)
Q Consensus 402 s~~~~l~~ 409 (447)
|..++++|
T Consensus 495 tp~qal~H 502 (586)
T KOG0667|consen 495 TPAQALNH 502 (586)
T ss_pred CHHHHhcC
Confidence 99999876
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=305.70 Aligned_cols=251 Identities=27% Similarity=0.469 Sum_probs=218.8
Q ss_pred ccCCCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 149 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
........|.....||+|.|+.|. .++..||+|.+.+... +...++.+.+|+++|+.++||||++++.+.+.+.
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 334455578888899999999886 4789999999988765 3444556889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.+|+||||+.+|.+.+++.++++..+.++..++.|+.+|++|||+++ |+|||||.+|+|++.+.++||+|||++.++
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 99999999999999999999999999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhh
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLY 381 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 381 (447)
... .......|++.|.|||++.+..++ +.+|+||+|+++|.|+.|..||++.+..+......... +.++ -+
T Consensus 206 ~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~-----~m 278 (596)
T KOG0586|consen 206 DYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF-----YM 278 (596)
T ss_pred ccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc-----ee
Confidence 743 344567889999999999988665 68999999999999999999999998877766653333 4443 35
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
+.++.++|++++..+|.+|++.+++.++-
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhc
Confidence 67899999999999999999999998753
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=299.91 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=196.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +++.||+|.+..... ......+.+|+.++++++||||+++++++..++..+++||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 578888999999998873 578899999875432 1223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++ ++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 85 YLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 996 58888886654 4889999999999999999999999 99999999999999999999999999875433221
Q ss_pred CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC------------------
Q 013214 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------ 370 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------ 370 (447)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223456889999998865 467889999999999999999999998776544332221110
Q ss_pred ---CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ---RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ---~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+. ...+.+++++.++|.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 01110 0112457789999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=295.87 Aligned_cols=251 Identities=22% Similarity=0.450 Sum_probs=207.2
Q ss_pred cCCCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 150 IDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 150 i~~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
+.....+|+..+.||.|++|.++ .+|+.|++|.+.... ....+.+.+|+.+++.++|||++++++.+.....
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 34445678888999999999876 368999999886542 2234667889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.++++||+++++|.+++.+ ..+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 9999999999999998865 45899999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.....+.. ..+..+++.
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (296)
T cd06655 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSPI 244 (296)
T ss_pred cccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCccc-CCcccCCHH
Confidence 3221 12234578899999999888889999999999999999999999987765444333322222222 234457788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++|++||..||++||++.+++++
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=288.38 Aligned_cols=248 Identities=25% Similarity=0.466 Sum_probs=204.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+++.++. +++.|++|.+...... ....+.+.+|+.+++.++||||+++++.+......++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 467788999999987752 6789999998765432 4567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.+...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999988777899999999999999999999999 9999999999999999999999999988764332211
Q ss_pred c---ccCCCCCcccCCcccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHH-HHhcCCCCCCCChhhhHH
Q 013214 311 L---TCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA-YAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 311 ~---~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 383 (447)
. ....++..|+|||.+.+.. .+.++|+||||+++|++++|+.||........... +.....+.++ ....+++
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 235 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIP-DSLQLSP 235 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCC-cccccCH
Confidence 1 1345688999999987765 78899999999999999999999976543322222 2222233332 2233578
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.+.+++.+||+.+|++||++.+++.
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhc
Confidence 8999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=288.01 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=201.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-CCceEEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~ 229 (447)
+|+..+.||+|++|.++ .+++.||+|.+..... .....+.+.+|+.++++++|||++++++.+.. +..+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 46778899999998775 2578899999875432 33445678889999999999999999998764 44679999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 230 e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||+++++|.+++... ..+++.++..++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999999763 45899999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+.......+.....+. .+..+++.+.+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGE 232 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHH
Confidence 12233457889999999988888999999999999999999999998665444333332222222 24567789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||+.||++||++.+++.+
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcC
Confidence 9999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=292.75 Aligned_cols=245 Identities=28% Similarity=0.425 Sum_probs=199.8
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||.|+||.++. ++..+++|.+... .....+.+.+|+.+++.++|||++++++.+......++++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 45667899999998763 5788899988643 345567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++++|..++.+ ..++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999999998765 456899999999999999999999999 9999999999999999999999999987543221 12
Q ss_pred cccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
.....+++.|+|||.+. +..++.++|+|||||++|+|++|+.||...+..+..........+.. ..+..++.++
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSSEF 238 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCccccCHHH
Confidence 23345788999999874 33567899999999999999999999987665444333322222222 2234577899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++|.+||+.||.+||++.+++++
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.42 Aligned_cols=241 Identities=31% Similarity=0.533 Sum_probs=202.6
Q ss_pred ceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 160 ~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
...||+|+||+||. +...+|||.++.. +....+-+.+|+.+.++++|.|||+++|.+.+++.+-|.||-++|
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 44799999999983 5678999999754 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeecccccccccCCCCC
Q 013214 235 GDLRAFLKR-KGAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 235 g~L~~~l~~-~~~l--~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+|.+.++. .+++ .+.+...+..||++||.|||++. |||||||-+|+|++ -.|.+||+|||-++.+..- +..
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~ 732 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPC 732 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Ccc
Confidence 999999975 4777 78888899999999999999999 99999999999998 6789999999999876532 233
Q ss_pred cccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
...+.||..|||||++..+ .|+..+|||||||++.||.||++||......+...-. .+....-++.+...+.+.+++
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-VGmyKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-VGMYKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-hcceecCCCCcHHHHHHHHHH
Confidence 4556799999999999776 6889999999999999999999999876655432221 121222233467789999999
Q ss_pred HHHHcccCCCCCCCHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~ 408 (447)
|.+|+..||.+||++++++.
T Consensus 812 ilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHcCCCcccCccHHHhcc
Confidence 99999999999999999985
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.85 Aligned_cols=243 Identities=24% Similarity=0.362 Sum_probs=189.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------ 222 (447)
..+|+..+.||+|+||.|+. +++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 34688899999999998873 67899999885431 1234699999999999999998876432
Q ss_pred --CceEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEe
Q 013214 223 --SPMMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVA 295 (447)
Q Consensus 223 --~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~ 295 (447)
..++++|||++ ++|.+++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence 24679999996 57777664 3456899999999999999999999999 99999999999999665 69999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC-
Q 013214 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP- 372 (447)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~- 372 (447)
|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+... +.+
T Consensus 214 DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 214 DFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred ccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999998654322 22345678999999988654 6899999999999999999999999877654433332111 011
Q ss_pred --------------CCCC---------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --------------PFKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --------------~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++. .+...++++.+||.+||+.||.+|||+.+++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 112356789999999999999999999999954
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=290.38 Aligned_cols=244 Identities=29% Similarity=0.503 Sum_probs=203.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||.|+||.++. +++.||+|.+.... .......+.+|+.+++.+.||||+++++.+.++...+++||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 466677899999987752 57899999887542 23456788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.. +++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++....... ..
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence 9999999999865 56899999999999999999999998 9999999999999999999999999987654322 12
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.....+. ....++..+.+++.
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~ 234 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPT---LTGEFSKPFKEFID 234 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCC---CchhhhHHHHHHHH
Confidence 223456788999999988888999999999999999999999998766554444332222222 34567889999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.+|++||++.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHcccCcccCcCHHHHHhC
Confidence 9999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.07 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=195.5
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------C
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 223 (447)
.+|+..+.||+|+||.|+ ..++.||+|++..... .......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478888999999999885 3578999999875432 334456678899999999999999999987543 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 5799999995 578777753 4788899999999999999999999 999999999999999999999999999765
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------- 370 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 370 (447)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 177 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 422 22234567899999999999899999999999999999999999998766433322221110
Q ss_pred --------CCCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 --------RPPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 --------~~~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+. ......+..++++|.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11110 0011134578999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=294.49 Aligned_cols=248 Identities=22% Similarity=0.431 Sum_probs=203.5
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|+..+.||.|++|.++. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+......++
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 345788888999999988762 578999998875432 223667889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999999999865 45889999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.................+.. ..+..++..+.+
T Consensus 171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 248 (296)
T cd06654 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAIFRD 248 (296)
T ss_pred c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCC-CCccccCHHHHH
Confidence 1 12234578899999999888889999999999999999999999986654333222222222222 223457788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||..||++||++.+++++
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhC
Confidence 9999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=298.29 Aligned_cols=246 Identities=17% Similarity=0.358 Sum_probs=190.9
Q ss_pred ceeeecc--eEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 160 SVEITKG--TFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 160 ~~~lg~G--~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
...||+| +|+.++ .+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 3578998 556554 3689999999876543 3445567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC-
Q 013214 233 PKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (447)
Q Consensus 233 ~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~- 309 (447)
++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999653 45899999999999999999999999 999999999999999999999999865432211100
Q ss_pred -----CcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC----------
Q 013214 310 -----PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP---------- 372 (447)
Q Consensus 310 -----~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~---------- 372 (447)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.................+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0112245677999999876 35889999999999999999999999765433221111110000
Q ss_pred --------------------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --------------------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --------------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
........+++.+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0001122356789999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=289.37 Aligned_cols=255 Identities=26% Similarity=0.508 Sum_probs=209.1
Q ss_pred cCcccceeeecceEEEEEE-----cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW-----RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
.+|+..+.||+|+||.++. +| ..+|+|...... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 3567778999999998763 23 268999887553 34556778899999999999999999999987 788
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
++++||+++|+|.+++.++ ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||.+....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999999874 46899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
...... .....++..|+|||.+....++.++|+||||+++|++++ |+.||......+....+......+. +...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ---PPICT 237 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCCC
Confidence 322111 112223567999999988888999999999999999998 9999988776665555533322222 33456
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..+.+++.+||..||.+||++.++++.|+++.+...
T Consensus 238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 238 IDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 789999999999999999999999999999866443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=287.71 Aligned_cols=241 Identities=32% Similarity=0.611 Sum_probs=200.7
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
+|+..+.||+|+||.++ .+++.||+|...... ..+.+.+|+.+++.++|||++++++++..+ ..+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 57778899999999876 478899999986432 235788899999999999999999998765 479999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 233 ~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
.+++|.+++.... .+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999997643 4789999999999999999999998 999999999999999999999999998754321
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+....++. .+..++..+.+++
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 230 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME---PPEGCPADVYVLM 230 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC---CCCcCCHHHHHHH
Confidence 112234567999999988889999999999999999997 999998777655555543333332 2345678999999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
.+||+.+|++||+++++++.|++
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 231 TSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHcCCChhhCcCHHHHHHHHcc
Confidence 99999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=295.82 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=190.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeEEEEeC-----
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQS----- 222 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~----- 222 (447)
+|+..+.||+|+||.|+. +|+.||+|.++...... .....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 467778999999998863 68899999887543221 1122344566666655 799999999988642
Q ss_pred CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
...++++||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 45799999996 5899888764 34899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C--------
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R-------- 371 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~-------- 371 (447)
...... .......+|..|+|||.+.+..++.++||||+||++|+|++|++||...........+.... .
T Consensus 156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 765422 12233457889999999988889999999999999999999999997665443322221100 0
Q ss_pred ------CCC--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ------PPF--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ------~~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+ ....+.++..+.+++.+||+.||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00112456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=285.36 Aligned_cols=242 Identities=30% Similarity=0.539 Sum_probs=199.3
Q ss_pred eeecceEEEEE---E-cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 162 EITKGTFILAF---W-RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 162 ~lg~G~~~~~~---~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
.||.|++|.++ . .++.||+|.+..... .+....+.+|++++++++||||+++++++......++++||+++++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 58899888765 2 389999999876532 24567789999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc-ccCC
Q 013214 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQD 315 (447)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~-~~~~ 315 (447)
.+++.+. ..++......++.+++.|+.|||+++ ++|+||||+||+++.++.++|+|||++........... ....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9999764 46889999999999999999999999 99999999999999999999999999875442111111 1122
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
.+..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+........ +...+..+.+++.+||.
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA---PQLCPEEIYRLMLQCWA 233 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHhc
Confidence 3567999999988889999999999999999999 8999987776555554433222222 34567889999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 013214 395 EKPAKRPTFRQIITRLE 411 (447)
Q Consensus 395 ~dp~~Rps~~~~l~~l~ 411 (447)
.+|++||++.++++.|+
T Consensus 234 ~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 234 YDPENRPSFSEIYNELQ 250 (251)
T ss_pred cChhhCcCHHHHHHHhh
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=289.54 Aligned_cols=243 Identities=33% Similarity=0.559 Sum_probs=196.8
Q ss_pred eeecceEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccC
Q 013214 162 EITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 162 ~lg~G~~~~~~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
.||+|+||.++. ++ ..+++|.++.. ......+.+.+|+.+++++ +||||+++++++...+..+++|||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 589999987752 23 35788888643 2345556788999999999 89999999999999999999999999
Q ss_pred CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 234 KGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 234 ~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
+|+|.+++..+. .+++.++..++.|++.|++|||+.+ ++|+||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 999999997543 3778899999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
|++....... .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+........
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 232 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-- 232 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCC--
Confidence 9986322111 1111223567999999988889999999999999999997 9999987665555444433222222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 233 -~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 233 -PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 2345678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=286.59 Aligned_cols=245 Identities=34% Similarity=0.612 Sum_probs=203.2
Q ss_pred ccceeeecceEEEEE---Ec------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 158 TNSVEITKGTFILAF---WR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 158 ~~~~~lg~G~~~~~~---~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+..+.||.|+||.++ +. +..||+|.+.... ..+....+..|+.+++.++||||+++++.+...+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 345689999998775 22 3889999997543 233567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 229 TEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|||+++++|.+++..... +++..+..++.|++.|+.+||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999976554 899999999999999999999998 999999999999999999999999998765533
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
.........+++.|+|||.+.+..++.++|+||+|+++++|++ |+.||...+.......+.....+.. +..++..+
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 233 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPPEI 233 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence 2211112336788999999988889999999999999999998 8899987666555555544333332 34478899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.+++.+||..||++|||+.++++.|
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=289.85 Aligned_cols=250 Identities=29% Similarity=0.493 Sum_probs=204.7
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|+....||+|+||.++. ....|++|.+... ......+.+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 4677788899999998862 2467999988643 233456778999999999999999999999999899
Q ss_pred eEEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEe
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~ 295 (447)
.+++|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence 999999999999999998655 6899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
|||++...............++..|+|||.+.+..++.++|+||||+++|++++ |..||................ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~~ 238 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK-LEL 238 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC-cCC
Confidence 999986543222222233345677999999988888899999999999999998 889997666555444442222 111
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
. .+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 239 ~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 P-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1 23346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=293.14 Aligned_cols=246 Identities=26% Similarity=0.468 Sum_probs=199.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++. +|..||+|.+.... .......+.+|+.++++++||||+++++.+..++..+++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 466778899999998752 58999999886532 34445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++... ..+++..+..++.|++.|+.|||+. + ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999988763 3689999999999999999999974 6 999999999999999999999999998755322
Q ss_pred CCCCcccCCCCCcccCCcccCCCC------CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhh
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
......+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||.......................+..
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 122334678899999986543 47899999999999999999999976655444333222111112223445
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.++.++|.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 78899999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=303.59 Aligned_cols=246 Identities=25% Similarity=0.357 Sum_probs=194.3
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------C
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 223 (447)
.+|+..+.||+|+||.|+ ..++.||+|.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 478888999999999886 3588999999875432 334456777899999999999999999988643 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..+++|||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 96 ~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 4799999995 577776653 4888999999999999999999999 999999999999999999999999999764
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------- 369 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------- 369 (447)
... .......+|+.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+........
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 422 2223456789999999998888999999999999999999999999866532221111000
Q ss_pred -------CCCCC-----------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 -------QRPPF-----------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 -------~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.+ .......+..+.++|.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 00112235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=288.88 Aligned_cols=251 Identities=26% Similarity=0.517 Sum_probs=203.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|++|.++ .+++.||+|.+...... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 36677889999999876 36889999998654321 12345788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~~~~~ 306 (447)
++||+++++|.+++.+.+++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999988888999999999999999999999999 99999999999998776 5999999998765432
Q ss_pred CCC---CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCCCCCCChhhhH
Q 013214 307 EDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFKAPAKLYA 382 (447)
Q Consensus 307 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 382 (447)
... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+... .....+..+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 111 112335688999999998888899999999999999999999999765543322222111 1111222345577
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+.+++.+||..+|.+||++.+++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 899999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=291.26 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=205.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|+|+.++ .+++.||+|.+...........+.+.+|++++++++||||+++++.+......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 46778899999998765 2589999999986554454566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+.+++|.+++.+..++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 9999999999988778999999999999999999999998 9999999999999999999999999987654321 2
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+........ ..........+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-AKQETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-HHhccccccCcccCcHHHHHHHH
Confidence 23345678899999998888899999999999999999999999877653221111 11111222234457789999999
Q ss_pred HHcccCCCCCCCH--HHHHH
Q 013214 391 ECWNEKPAKRPTF--RQIIT 408 (447)
Q Consensus 391 ~cl~~dp~~Rps~--~~~l~ 408 (447)
+||+.||.+||++ +++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHccCChhHcCCccHHHHhc
Confidence 9999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.62 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=196.6
Q ss_pred cCcccceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 155 LDFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
.+|...+.||+|+||.|+. .+..||+|.+... ....+|+.+++.++||||+++++.+......++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 4688899999999998863 3478999987643 134579999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+||++ +++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 164 v~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred Eehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99999 4799999977788999999999999999999999999 9999999999999999999999999987654332
Q ss_pred CC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchH----HHHH---------------
Q 013214 308 DR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP----KAYA--------------- 367 (447)
Q Consensus 308 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~----~~~~--------------- 367 (447)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....... ..+.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 21 122456899999999999888999999999999999999999999765432211 1000
Q ss_pred ----------hcCCCCCCCC----hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 368 ----------ARQRPPFKAP----AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 368 ----------~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...++++... ...++.+++++|.+||..||++|||+.+++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0011111110 01346678999999999999999999999986
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=287.53 Aligned_cols=242 Identities=30% Similarity=0.525 Sum_probs=199.8
Q ss_pred eeecceEEEEEE------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccC
Q 013214 162 EITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 162 ~lg~G~~~~~~~------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
.||+|++|.++. .+ ..||+|.+...... ...+.+.+|+.++++++||||+++++.+.. ...++++||++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 579999987752 22 36999999876432 567789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC--
Q 013214 234 KGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-- 309 (447)
Q Consensus 234 ~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-- 309 (447)
+++|.+++.++. .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999998764 5899999999999999999999999 999999999999999999999999998876432111
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.... ... ..+..++..+.++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~l 233 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-ERL-ERPEACPQDIYNV 233 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CcC-CCCccCCHHHHHH
Confidence 1122345778999999988889999999999999999998 999998766655544443222 111 1233467889999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
+.+||+.+|++||++.++++.|.
T Consensus 234 i~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 234 MLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHCCCCcccCCCHHHHHHHhc
Confidence 99999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=290.89 Aligned_cols=245 Identities=28% Similarity=0.484 Sum_probs=204.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|++|.++. +++.||+|.+.... .......+.+|+.+++.++||||+++++++.++...++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 466778899999988762 68899999987543 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++..+ ++++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 154 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K 154 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence 99999999999765 7899999999999999999999998 99999999999999999999999999987654321 1
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....+... ...++..+.+++.
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 232 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFVS 232 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHHH
Confidence 22345678899999998888999999999999999999999999876654444443333233322 1127788999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||..+|++||++++++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 233 LCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHhhCChhhCcCHHHHhhC
Confidence 9999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=288.15 Aligned_cols=249 Identities=29% Similarity=0.503 Sum_probs=205.9
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|++|.++ .++..+|+|++...... .....+.+|+..++.++|||++++++.+......++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 57778899999998775 26788999998754332 256778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
++++++|.+++... ..+++..+..++.|++.|+.+||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999764 35899999999999999999999999 9999999999999999999999999987655432
Q ss_pred CC---CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCCh--hhh
Q 013214 308 DR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA--KLY 381 (447)
Q Consensus 308 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 381 (447)
.. ......++..|+|||.+... .++.++|+||||+++|+|++|+.||...+..+..........+.+.... ..+
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence 22 11233578899999998776 7888999999999999999999999877665544444333333332222 367
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+.+++.+||..||++||++.+++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 8899999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=289.48 Aligned_cols=233 Identities=24% Similarity=0.423 Sum_probs=187.2
Q ss_pred eeecceEEEEEEc-----------------------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc
Q 013214 162 EITKGTFILAFWR-----------------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212 (447)
Q Consensus 162 ~lg~G~~~~~~~~-----------------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 212 (447)
.||+|+||.||.. ...|++|.+... .......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 5899999887732 135899988643 23345678889999999999999
Q ss_pred cceeEEEEeCCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-
Q 013214 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290 (447)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~- 290 (447)
+++++++..+...++||||+++|+|..++.+ .+.+++..+..++.|++.||.|||+.+ ++||||||+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999999875 456899999999999999999999998 99999999999998644
Q ss_pred ------CEEEeecccccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHH-hCCCCCCCCCCCch
Q 013214 291 ------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEV 362 (447)
Q Consensus 291 ------~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~-tg~~p~~~~~~~~~ 362 (447)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|+.||......+.
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999987643211 22345778999998865 46789999999999999995 69999987665544
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
....... ..++ ...++.+.++|.+||+.+|++|||+.++++.|
T Consensus 231 ~~~~~~~--~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERFYEKK--HRLP---EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHhc--cCCC---CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 3332211 1111 12346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=287.97 Aligned_cols=244 Identities=27% Similarity=0.419 Sum_probs=190.2
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.||+|+||.|+. ++..+|+|.+.... .......+.+|+.++++++||||+++++.+.+....+++|||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 589999998763 23579999887543 233345688899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-
Q 013214 235 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (447)
Q Consensus 235 g~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~- 308 (447)
|+|.+++.... ..++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999997532 3566778889999999999999999 99999999999999999999999999865332111
Q ss_pred CCcccCCCCCcccCCcccCCC-------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCC--CCh
Q 013214 309 RPLTCQDTSCRYVAPEVFKNE-------EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK--APA 378 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 378 (447)
.......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||......+............+. ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence 111223467889999988542 35779999999999999996 99999876655543333222222221 122
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
...++.+.++++.|| .+|++|||+.+++..|.
T Consensus 237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 345678999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=287.31 Aligned_cols=246 Identities=23% Similarity=0.462 Sum_probs=205.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++. +|+.||+|.+..... ......++.+|+.+++.++||||+++++++...+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 467788999999997763 688999999875433 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+.+++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999999997643 4789999999999999999999998 99999999999999999999999999876543211
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||.+.+..++.++|+||||+++++|++|+.||......+....+.....++. +..++..+.++
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 232 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNL 232 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHH
Confidence 11223467889999999888888999999999999999999999987665555444433333332 44567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.+|.+||++.+++++
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhC
Confidence 999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=291.13 Aligned_cols=246 Identities=25% Similarity=0.419 Sum_probs=200.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||.|+||.++. ++..+++|.+... .....+.+.+|+.+++.++||||+++++.+..+...+++||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 577888999999998872 5789999998643 45566778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++++|..++.+ ...+++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 9999999988765 456899999999999999999999998 9999999999999999999999999886533211 1
Q ss_pred CcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...+..+..........+.. ..+..++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-SQPSKWSME 244 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC-CCCcccCHH
Confidence 112345678899999884 33467799999999999999999999987665443333322222222 223456788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++|.+||..||++||++.+++++
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcC
Confidence 9999999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=287.59 Aligned_cols=243 Identities=26% Similarity=0.446 Sum_probs=191.2
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
+||+|+||.|+. ....+|+|.+.... .......+.+|+..++.++||||+++++.+......+++|||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 589999998762 23578888876432 344456788899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-
Q 013214 235 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (447)
Q Consensus 235 g~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~- 308 (447)
|+|.+++.+.. ..++.....++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999997643 2467788899999999999999999 99999999999999999999999999865322111
Q ss_pred CCcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC--CCCh
Q 013214 309 RPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPA 378 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 378 (447)
.......++..|+|||++.. ..++.++||||||+++|+|++ |..||......+............+ +...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 11122335677999998643 356779999999999999999 8899987765554444433333222 2223
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
..+++.+.+++..|| .||++|||++++++.|
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 457788899999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=289.22 Aligned_cols=240 Identities=25% Similarity=0.453 Sum_probs=196.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++ .+++.||+|.+.... .....+.+.+|++++++++||||+++++.+...+..++++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 45667789999998876 367899999986542 34455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|..+ ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...... .
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 9999999754 35788899999999999999999999 999999999999999999999999998754322 2
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-------hHHHHHhcCCCCCCCChhhhHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-------VPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+ ....+.....+.. ....+++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 227 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL--PVGQFSE 227 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC--CCCcCCH
Confidence 233467889999999988889999999999999999999999997543221 1111111111111 1234678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+++.+||+.||++||++.+++++
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 89999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=285.49 Aligned_cols=247 Identities=27% Similarity=0.462 Sum_probs=204.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+|+..+.||+|++|.++. +++.|++|.+..... ...+..+.+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 356677899999988752 688999998864321 2344567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
+||+++++|.+++.+.+.+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999999988888999999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
......++..|++||.+.... ++.++|+||||+++|+|++|+.||.............. ....+..+..+++.+.+
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--SKELPPIPDHLSDEAKD 233 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--cccCCCcCCCcCHHHHH
Confidence 223455788899999987765 88999999999999999999999986654333333222 12222234557789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||+.+|.+||++.+++.+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcC
Confidence 9999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=291.04 Aligned_cols=241 Identities=26% Similarity=0.405 Sum_probs=195.6
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||+|+||.++ .+|+.||+|.+...........+.+.+|+.++++++||||+++++.+...+..|++|||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 5889998876 25889999998754433334455667899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC
Q 013214 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 238 ~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
.+++.+.. .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 99997765 6899999999999999999999999 999999999999999999999999998765431 2223345
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 395 (447)
++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+...........+..+++.+.++|.+||+.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence 67889999999888889999999999999999999999987654322222222221111122345688999999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 013214 396 KPAKRP-----TFRQIIT 408 (447)
Q Consensus 396 dp~~Rp-----s~~~~l~ 408 (447)
||.+|| ++.++++
T Consensus 236 ~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 236 DPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ChhHccCCCcccHHHHHh
Confidence 999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=295.07 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=204.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +++.||+|.+...........+.+.+|+.+++.++||||+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 577788999999998762 578999999987654444566778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+.+++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999764 46899999999999999999999998 99999999999999999999999999875432111
Q ss_pred C----------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 013214 309 R----------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (447)
Q Consensus 309 ~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 360 (447)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011234688899999998888899999999999999999999999877655
Q ss_pred chHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC----HHHHHHH
Q 013214 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT----FRQIITR 409 (447)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~~l~~ 409 (447)
.....+. .....++. ...++..+.+++.+||..||++||+ +.+++++
T Consensus 239 ~~~~~~~-~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ETFSNIL-KKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHh-cCCccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 4444332 22222222 2226789999999999999999999 7776664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=286.98 Aligned_cols=249 Identities=27% Similarity=0.484 Sum_probs=200.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCce
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 225 (447)
.+|+..+.||+|+||.++. ++..||+|.+...... .......+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3678888999999998763 5789999988654321 23345678899999999999999999998875 3568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+++++|.+++...+.+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999999988888999999999999999999999998 99999999999999999999999999875532
Q ss_pred CC--CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 306 KE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 306 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.. ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+......... ..+..+..+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP--TNPQLPSHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC--CCCCCchhcCH
Confidence 11 111123457889999999988888999999999999999999999998665443333222211 11222445677
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+++ +||..+|++||++++++.+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 888888 6888999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=312.58 Aligned_cols=246 Identities=20% Similarity=0.245 Sum_probs=189.8
Q ss_pred CCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC------CCcccceeEEEE
Q 013214 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR------HPNVVQFLGAVT 220 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~ 220 (447)
....+|+..+.||+|+||.|+. +++.||||+++.. .........|+.+++.+. |++++++++++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3456789999999999999863 5788999998632 122334555676666664 456888888887
Q ss_pred eC-CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCC--------
Q 013214 221 QS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG-------- 290 (447)
Q Consensus 221 ~~-~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~-------- 290 (447)
.. ...|++||++ +++|.+++.+.+.+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccc
Confidence 54 5689999998 78999999888889999999999999999999998 47 99999999999998765
Q ss_pred --------CEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch
Q 013214 291 --------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (447)
Q Consensus 291 --------~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~ 362 (447)
.+||+|||.+.... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 49999999876432 222345689999999999998999999999999999999999999987665433
Q ss_pred HHHHHhcC-C-------------------------CCCCC------------ChhhhHHHHHHHHHHHcccCCCCCCCHH
Q 013214 363 PKAYAARQ-R-------------------------PPFKA------------PAKLYARGLKELIEECWNEKPAKRPTFR 404 (447)
Q Consensus 363 ~~~~~~~~-~-------------------------~~~~~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ 404 (447)
...+.... . +.... .....++.+.+||.+||+.||++|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 22221110 0 00000 0001235678999999999999999999
Q ss_pred HHHHH
Q 013214 405 QIITR 409 (447)
Q Consensus 405 ~~l~~ 409 (447)
++++|
T Consensus 434 e~L~H 438 (467)
T PTZ00284 434 QMTTH 438 (467)
T ss_pred HHhcC
Confidence 99974
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=285.44 Aligned_cols=233 Identities=24% Similarity=0.416 Sum_probs=186.9
Q ss_pred eeecceEEEEEEc-----------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 162 EITKGTFILAFWR-----------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 162 ~lg~G~~~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.||+|+||.++.. ...|++|.+... .......+.+|+.+++.++||||+++++++..+..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 5899999877632 235899987643 23445678889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC-------EEEee
Q 013214 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-------LKVAD 296 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~-------vkl~D 296 (447)
.+++|||+++|+|..++.+. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. ++++|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999999998754 56899999999999999999999999 999999999999987664 89999
Q ss_pred cccccccccCCCCCcccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~-tg~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
||++...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+..... ..... .
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~~-~ 228 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQCM-L 228 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcCcc-C
Confidence 9998654321 2234678899999886 456888999999999999998 588898765544432221 11111 1
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
....++++.++|.+||+.||.+||++.++++++
T Consensus 229 ---~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 229 ---VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 122357899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=286.07 Aligned_cols=245 Identities=26% Similarity=0.463 Sum_probs=202.9
Q ss_pred cCcccceeeecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|++|.++ + +++.+++|.+... ...+++.+|+.+++.++||||+++++.+......++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 367778889999998765 2 3789999998643 22578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999999976 456899999999999999999999998 99999999999999999999999999886543321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.....+. ...+..++..+.++
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDF 232 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC-CCchhhcCHHHHHH
Confidence 2223446888999999988889999999999999999999999998765544333332211222 22344577889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.||++|||+.+++++
T Consensus 233 i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcC
Confidence 999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.84 Aligned_cols=248 Identities=26% Similarity=0.439 Sum_probs=200.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 226 (447)
+|+..+.||+|+||.++ .+|..||+|.+.... .......+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 57778899999999876 257899999875432 12334567888999999999999999999988764 4678
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
++|||+++++|.+++.+...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999999988778899999999999999999999999 999999999999999999999999998754321
Q ss_pred CC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||............. ..+..+..+..++..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 237 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA--TQPTNPVLPPHVSDH 237 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh--cCCCCCCCchhhCHH
Confidence 11 11223447888999999988888999999999999999999999998664433332221 122222334567788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+++.+|+. +|++||++++++++
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 9999999994 99999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=291.14 Aligned_cols=246 Identities=24% Similarity=0.411 Sum_probs=203.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|++.+.||.|++|.++. ++..+|+|..... .....+.+.+|+.++++++||||+++++.+..+...+++||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 577888899999987752 5789999998643 44556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 99999999998764 56999999999999999999999999 9999999999999999999999999886543221 1
Q ss_pred CcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||......+....+.....+.+ ..+..++.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 237 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWSSS 237 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCCHH
Confidence 122345788999999874 23467799999999999999999999987765554444422222222 224457889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++|.+||+.+|.+||++.+++++
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcC
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=284.27 Aligned_cols=245 Identities=26% Similarity=0.464 Sum_probs=204.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++ .+++.+|+|.+...... ......+.+|+.+++.++|||++++++.+...+..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 46778899999998776 36889999998765433 3446778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~ 307 (447)
|+++++|.+++.+. ..+++..+..++.|++.++.|||+++ ++|+||||+||++++++ .++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999999764 34889999999999999999999998 99999999999998654 57999999988654322
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+......++ +..+++.+.+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~ 231 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI---SDRYSPDLRQ 231 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC---CCCcCHHHHH
Confidence 22234568899999999888889999999999999999999999987766555444433333332 3346788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||+.||.+|||+.+++++
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhC
Confidence 9999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=287.23 Aligned_cols=251 Identities=28% Similarity=0.485 Sum_probs=201.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC-------CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
+|...+.||.|++|.++. +|+.||+|.+...... .....+.+.+|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466778999999998863 6889999987542211 1123456788999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..++++||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999988888999999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCC-CCcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCC-Ch
Q 013214 304 TVKED-RPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKA-PA 378 (447)
Q Consensus 304 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~ 378 (447)
..... .......++..|+|||.+.... ++.++|+||||+++|++++|..||......+......... .+.++. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 32211 1122345788999999987654 7889999999999999999999997554433222221111 222221 22
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..++..+.++|.+||..+|++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 4567899999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=285.85 Aligned_cols=238 Identities=26% Similarity=0.430 Sum_probs=197.7
Q ss_pred eecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||.|++|.++ . +++.+|+|.+...........+.+.+|+.+++.++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 5778887654 3 4889999999765544455567889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCC
Q 013214 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (447)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t 317 (447)
.+++.+...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 999988878999999999999999999999998 9999999999999999999999999988664332 12234568
Q ss_pred CcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--CchHHHHHh-cCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
..|++||.+.+..++.++|+||+|+++|+|++|..||..... .+....+.. .....+ +...++++.++|.+||+
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~ 232 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF---PNYIDKAAKDLIKQLLR 232 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC---CcccCHHHHHHHHHHcc
Confidence 889999999888889999999999999999999999987763 223333321 112222 33347899999999999
Q ss_pred cCCCCCCC-----HHHHHH
Q 013214 395 EKPAKRPT-----FRQIIT 408 (447)
Q Consensus 395 ~dp~~Rps-----~~~~l~ 408 (447)
.||++||+ ++++++
T Consensus 233 ~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 233 RNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CChhhCcCCcccCHHHHhc
Confidence 99999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=288.07 Aligned_cols=242 Identities=29% Similarity=0.527 Sum_probs=196.8
Q ss_pred eeecceEEEEEEc-----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 162 EITKGTFILAFWR-----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 162 ~lg~G~~~~~~~~-----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.||+|+||.|+.. +..+|+|.+.... .......+.+|+.+++.++||||+++++++......+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 5899999987621 2578999886432 23445678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-----CEEEeecc
Q 013214 231 YLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFG 298 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-----~vkl~Dfg 298 (447)
|+++++|.+++.+. ..+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999642 23788899999999999999999998 99999999999999877 89999999
Q ss_pred cccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 299 VSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 299 ~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--- 233 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ--- 233 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC---
Confidence 9875532211 11112234678999999988889999999999999999998 999998766555544443332222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
.+..+|..+.++|.+||+.+|.+||++.++++.|+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 234 KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 23456789999999999999999999999999876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=290.16 Aligned_cols=244 Identities=29% Similarity=0.502 Sum_probs=201.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||+|+||.++. +++.||+|.+.... .....+.+.+|+.+++.++||||+++++.+..+...++|+|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 355667899999988762 57899999887542 23455778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence 9999999998864 56899999999999999999999998 9999999999999999999999999987654321 11
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+. ....++.++.+++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~ 234 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT---LEGQYSKPFKEFVE 234 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC---CCcccCHHHHHHHH
Confidence 223356788999999988888999999999999999999999998665544433332222222 23356788999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.+|++||++.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHccCCcccCcCHHHHHHh
Confidence 9999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=284.16 Aligned_cols=246 Identities=28% Similarity=0.504 Sum_probs=195.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
++.....||+|+||.++. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++++|
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 444556899999998762 4678999988654 33455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKRK-GAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l--~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++... ..+ ++..+..++.|++.|+.|||+.+ ++|+||||+||+++. ++.++|+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999764 445 78888899999999999999998 999999999999986 679999999998755322
Q ss_pred CCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
........+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||............ .......+..+..++++
T Consensus 163 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 163 -NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAE 240 (268)
T ss_pred -CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHH
Confidence 1222334578899999998654 3778999999999999999999999754432221111 11111111223456788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+++.+||+.+|.+|||+.+++.+
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHhC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=293.28 Aligned_cols=247 Identities=23% Similarity=0.416 Sum_probs=195.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.++. +++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..+++||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 578888999999998863 5789999998654321 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++ ++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....... .
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 996 6899888764 45889999999999999999999999 9999999999999999999999999987543321 1
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC------------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------ 370 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------ 370 (447)
......+++.|+|||.+.+. .++.++||||||+++|+|++|++||...+..+....+....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 12233468899999988654 57789999999999999999999998765433322211100
Q ss_pred ---CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ---RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ---~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+. .....+++.+.++|.+||+.||.+|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0112457789999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.28 Aligned_cols=255 Identities=23% Similarity=0.482 Sum_probs=205.1
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
.+|+..+.||+|+||.++. +|. .||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 4567778899999998763 343 57999886542 334445688999999999999999999998754 46
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
++++||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 78999999999999997654 5889999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+......+. +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 237 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ---PPICT 237 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCC
Confidence 32211 1122334678999999988889999999999999999997 9999987665444444433333322 23456
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..+.+++.+||..+|++||++.++++.|+.+.....
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 789999999999999999999999999998765543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=321.71 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=197.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCceEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMI 227 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 227 (447)
.+|.+.+.||+|+||.|+. ++..||+|.+..... .......+..|+.+++.++||||++++++|.. ...+|+
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 3788899999999998873 578899999876543 34455778899999999999999999998854 356899
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeCCCCCCCEEEcC-----------
Q 013214 228 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP----VPIIHRDLEPSNILRDD----------- 288 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~----~~i~H~Dikp~Nill~~----------- 288 (447)
||||+++|+|.+++.. .+.+++..++.|+.||+.||.|||+.+. .+|+|+||||+|||++.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999999999999975 2569999999999999999999998531 23999999999999964
Q ss_pred ------CCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 013214 289 ------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (447)
Q Consensus 289 ------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 360 (447)
.+.+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 2348999999998654321 2233467999999999854 35788999999999999999999999865543
Q ss_pred chHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
......... .+.+ ....++..+.+||..||+.+|.+||++.+++.+
T Consensus 250 ~qli~~lk~-~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 250 SQLISELKR-GPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHHHhc-CCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 322222111 2222 123467889999999999999999999999953
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=299.95 Aligned_cols=252 Identities=30% Similarity=0.521 Sum_probs=220.8
Q ss_pred CcccceeeecceEEEEE---Ec--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
++.-..+||-|.||.|| |. ...||||.++.+. -.+++|..|..+|+.++|||+|+++|+|..+..+|||+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 45556789999998775 43 4679999998543 346889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||..|+|.+||++..+ ++.-..+.++.||.+|+.||..++ +|||||..+|+|+.++..+|++|||+++.+..+..
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 9999999999987543 677777889999999999999998 99999999999999999999999999999876655
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
........+..|.|||-+....++.|+|||+||++|||+.| |-.||.+.+..++...+....+..- +..+++.+.+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~---PeGCPpkVYe 497 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG---PEGCPPKVYE 497 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC---CCCCCHHHHH
Confidence 55555566888999999999899999999999999999998 9999999988877777766666553 5568899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
||+.||+.+|.+||++.++-+.++.+..+-
T Consensus 498 LMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 498 LMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 999999999999999999999999987654
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=287.37 Aligned_cols=253 Identities=25% Similarity=0.481 Sum_probs=201.7
Q ss_pred cCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CC
Q 013214 155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SS 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 223 (447)
..|+..+.||+|+||.++. ++..||+|.+..... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 3566778899999998762 267899999975532 2456789999999999999999999999877 55
Q ss_pred ceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 7899999999999999997754 5899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-----------HHHHH--
Q 013214 303 LTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-----------PKAYA-- 367 (447)
Q Consensus 303 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-----------~~~~~-- 367 (447)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6522111 11123345679999999888899999999999999999999999865432210 11110
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
.......+ .+..++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 01111111 1334568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=284.21 Aligned_cols=246 Identities=24% Similarity=0.447 Sum_probs=203.4
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCceEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 228 (447)
+|+..+.||.|+||.++ .+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 36667889999999876 3678999999876543 34556778899999999999999999998764 3457999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLH-----ENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH-----~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
+||+++++|.+++.. ..++++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccc
Confidence 999999999999975 356899999999999999999999 776 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChh
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (447)
+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..... +..+.
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 232 (265)
T cd08217 157 AKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF---RRIPY 232 (265)
T ss_pred cccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC---CCCcc
Confidence 887653321 12234578899999999888889999999999999999999999998765444444433222 23345
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 678899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=292.23 Aligned_cols=248 Identities=21% Similarity=0.430 Sum_probs=203.8
Q ss_pred CCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|+..+.||.|++|.++ .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 34578888999999999876 3689999999865432 233567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+|||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999999865 45888999999999999999999998 9999999999999999999999999987543321
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+.............+.. ..+..++..+.+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 247 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-QNPERLSAVFRD 247 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCC-CCccccCHHHHH
Confidence 112234578899999999888889999999999999999999999976654333222222222222 224456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||..||++||++.+++++
T Consensus 248 li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=290.32 Aligned_cols=247 Identities=24% Similarity=0.443 Sum_probs=202.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.++. +|+.||+|++.... .......+.+|+.+++.++||||+++++++......++++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3677788999999998862 48899999886542 3344577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++++|.+++.+.+.+++..+..++.+++.|+.|||+ .+ ++|+||||+||++++++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999999999888889999999999999999999997 46 999999999999999999999999998654321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-----------chHHHHHhcCCCCCCCC
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-----------EVPKAYAARQRPPFKAP 377 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~ 377 (447)
......++..|+|||.+.+..++.++|+|||||++|++++|+.||...... +..........+.+ .
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 234 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL--P 234 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC--C
Confidence 112345788999999998888899999999999999999999999865542 11111111112222 1
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
...++..+.+++.+||+.||++||++.+++++..
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 2236778999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=283.45 Aligned_cols=248 Identities=28% Similarity=0.459 Sum_probs=205.1
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|++|.++ .+++.|++|++..... ......+.+|+..+..++|||++++++++......++++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 46677889999998765 2589999999876532 2556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++++|.+++.....+++...+.++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999888889999999999999999999999 98 999999999999999999999999998865433221
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhh-hHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL-YARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l 388 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......................... ++..+.++
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 1234567889999999888889999999999999999999999987753222222211112222222334 78899999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||..+|++||++.+++++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=290.11 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=194.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +++.||+|.+..... .......+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 466778899999987763 588999999875432 22233567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|++ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 996 6898888643 45899999999999999999999999 9999999999999999999999999987554321
Q ss_pred CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-cC---------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQ--------------- 370 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~--------------- 370 (447)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.............. ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 122233457889999987654 568899999999999999999999986543221111100 00
Q ss_pred ---------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ---------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..........+++++.++|++||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000001123467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=290.07 Aligned_cols=249 Identities=23% Similarity=0.391 Sum_probs=198.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+....||+|++|.++. +|+.||+|++..... .....+.+.+|+.++++++|||++++++++......+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 467778899999987753 588999998865432 22233557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|..+......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 9999888888777677999999999999999999999998 99999999999999999999999999986543221 2
Q ss_pred cccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------------
Q 013214 311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------- 370 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------- 370 (447)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+....+....+....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 223456788999999866 457889999999999999999999998766543322221100
Q ss_pred --CCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 --RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 --~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+... .....++..+.+++.+||+.+|++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000 0012456789999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=287.43 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=199.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +|+.||+|++...... ......+.+|+.++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 467778999999987763 6889999998765432 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+ +++|.+++.. ...+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99 9999999865 456899999999999999999999999 999999999999999999999999998866543322
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC---------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP--------------- 372 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~--------------- 372 (447)
......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||......+....+.... .+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 33445678899999998654 46889999999999999999988887655433322221110 00
Q ss_pred --CC--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --PF--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+ ....+..+..+.+++.+||+.||++||++++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00112356889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=303.88 Aligned_cols=245 Identities=24% Similarity=0.413 Sum_probs=208.7
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+.+...||.|+||.||. ++...|.|++. ..+++.+++|.-|+.+|..+.||+|+++++.|..++.+|++.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 44556899999999874 34455667663 34677889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|.||.+...+-+- ..+.+.++..++.|++.||.|||+++ |||||||..|||++-+|.++|+|||.+...... ...
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qk 186 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQK 186 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-Hhh
Confidence 9999998888664 56999999999999999999999999 999999999999999999999999987643221 122
Q ss_pred cccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
..++.|||.|||||+.. ..+|+.++||||||++|.+|..+.+|....++..+...+.. ..|+.-..+..++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK-SePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh-cCCCcccCcchhhhHH
Confidence 35678999999999864 45899999999999999999999999998888877776633 3444445577899999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+++.+||..||..||++.+++++
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhC
Confidence 999999999999999999999876
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=291.74 Aligned_cols=241 Identities=23% Similarity=0.388 Sum_probs=181.7
Q ss_pred ceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCceEEEEe
Q 013214 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (447)
Q Consensus 160 ~~~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e 230 (447)
...||+|+||.|+. +++.||+|.+..... ...+.+|+.++++++||||+++++.+.. +...++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 35799999998863 457899999865432 1346789999999999999999998854 456899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE----cCCCCEEEeec
Q 013214 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 297 (447)
Q Consensus 231 ~~~~g~L~~~l~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill----~~~~~vkl~Df 297 (447)
|+ +++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||+ +..+.+||+||
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 99 56898887532 24889999999999999999999999 9999999999999 45678999999
Q ss_pred ccccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc---------hHHH
Q 013214 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---------VPKA 365 (447)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~---------~~~~ 365 (447)
|++........ .......+|+.|+|||++.+. .++.++||||+||++|+|++|++||....... ....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 99986543211 122345678999999998764 57889999999999999999999997543210 0000
Q ss_pred H-HhcCCCC------------------------CC---------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 366 Y-AARQRPP------------------------FK---------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 366 ~-~~~~~~~------------------------~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ ...+.+. .. ......+..+.++|.+||+.||.+|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0000000 00 0000123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=298.65 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=192.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------Cc
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 224 (447)
+|+..+.||+|+||.|+ .+++.||+|.+..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 67888899999999886 3578999999875432 223345677899999999999999999887533 34
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.++++|++ +++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 95 ~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecC
Confidence 78999998 789988775 456999999999999999999999999 9999999999999999999999999988654
Q ss_pred cCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C-----------
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R----------- 371 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~----------- 371 (447)
.. .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... .
T Consensus 170 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 22 233467899999999876 468889999999999999999999998655433222211100 0
Q ss_pred ----------CCCCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ----------PPFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ----------~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+..+. .....++.+.+++.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 011245568899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=286.72 Aligned_cols=245 Identities=24% Similarity=0.432 Sum_probs=201.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|...+.||+|++|.++ .+++.+++|.+... .....+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 34455689999998775 25788999988533 33344667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.. +++++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||.+........ .
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 9999999999877 67899999999999999999999999 99999999999999999999999998765432211 1
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+... .++.......++..+.+++.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHH
Confidence 12345788999999998888899999999999999999999999876655444444322 22222223346788999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.+|++||++.+++++
T Consensus 251 ~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 251 RMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHcccChhhCcCHHHHccC
Confidence 9999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=286.79 Aligned_cols=240 Identities=23% Similarity=0.352 Sum_probs=189.1
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHh---cCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ---KIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
||+|+||.|+ .+|+.+|+|.+.............+.+|..+++ ..+||+|+.+++.+...+..++||||+++
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 7999999886 257899999887654332222233344444433 34799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
++|.+++..++.+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++...... .....
T Consensus 82 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 155 (279)
T cd05633 82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (279)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccCc
Confidence 999999988888999999999999999999999999 999999999999999999999999998754322 11234
Q ss_pred CCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 013214 315 DTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393 (447)
Q Consensus 315 ~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 393 (447)
.++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||................... ...+..++..+.++|.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN-VELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCC-cCCccccCHHHHHHHHHHh
Confidence 57899999999864 467899999999999999999999997655433222111111111 1123457789999999999
Q ss_pred ccCCCCCC-----CHHHHHHH
Q 013214 394 NEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 394 ~~dp~~Rp-----s~~~~l~~ 409 (447)
..||.+|| ++++++++
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhC
Confidence 99999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=286.90 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=196.3
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEE-----e
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT-----Q 221 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~-----~ 221 (447)
...+|+..+.||+|+||.++. +++.+|+|...... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 455788889999999998763 67899999875421 2235677899999999 6999999999874 3
Q ss_pred CCceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
....+++|||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccC
Confidence 4568999999999999998753 345888999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
|++....... .......+++.|+|||.+.. ..++.++|+||+||++|+|++|+.||.................+
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 169 GVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred CceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 9987654321 12223457899999998753 34788999999999999999999999876543332222111111
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.. ..+..++..+.++|.+||+.||++|||+.+++++.
T Consensus 248 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 248 TL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11 12334567899999999999999999999998763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=286.73 Aligned_cols=246 Identities=26% Similarity=0.429 Sum_probs=195.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC-----
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----- 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~----- 222 (447)
+..|...+.||+|+||.++. +++.||+|.+.... .....+..|+.+++++ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 44577778899999998763 57899999986432 2235677899999998 799999999998753
Q ss_pred -CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 223 -SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 223 -~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
...+++|||+.+++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4589999999999999999864 35889999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
+....... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...................
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 235 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR- 235 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC-
Confidence 87653221 12233457889999999862 357789999999999999999999997655433332222211111
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....++..+.+++.+||..||.+|||+.+++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 236 -LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1233567889999999999999999999998864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=283.25 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=199.1
Q ss_pred cccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-----
Q 013214 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 223 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 223 (447)
|...+.||+|+||.++. +++.||+|.+..+.. .....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 44566899999987762 368899999876543 3445677889999999999999999999886532
Q ss_pred -ceEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 224 -PMMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 224 -~~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
..++++||+.+|+|.+++... ..++......++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECc
Confidence 247889999999999887532 14788899999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 297 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 297 fg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
||.+......... ......+++.|++||.+....++.++||||||+++|+|++ |+.||...+..+....+........
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 9998865322111 1122334678999999988888999999999999999999 8999987665544444433322221
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
+...++.+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 237 ---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 237 ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 234667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=302.18 Aligned_cols=252 Identities=25% Similarity=0.511 Sum_probs=203.8
Q ss_pred ccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCc-ccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~-~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 222 (447)
+.++...-.+....||+|+|-+||. +|..||=-.++. +....+...++|..|+.+|+.++||||+++|.+|.+.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 4444443445566899999988874 566665222211 1234566778999999999999999999999999876
Q ss_pred Cc--eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeeccc
Q 013214 223 SP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGV 299 (447)
Q Consensus 223 ~~--~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~ 299 (447)
.. +.+|+|.+..|+|..|+++.+..+......|++||+.||.|||++.| ||+|||||.+||+|+ ..|.|||+|+|+
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhH
Confidence 55 88999999999999999999999999999999999999999999995 899999999999998 678999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhcCCCCCCCCh
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPA 378 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 378 (447)
|...... ......|||.|||||++. ..|+..+||||||++++||.|+..||.--... ++.+.+..+..|.-- .
T Consensus 193 Atl~r~s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl--~ 266 (632)
T KOG0584|consen 193 ATLLRKS---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL--S 266 (632)
T ss_pred HHHhhcc---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh--h
Confidence 9876532 223468999999999986 68999999999999999999999999866554 444555344344321 1
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
..-.++++++|.+|+.. ..+|||+.++++
T Consensus 267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 KVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 12247899999999999 899999999996
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=283.62 Aligned_cols=240 Identities=26% Similarity=0.365 Sum_probs=191.8
Q ss_pred eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH-hcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 161 ~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
+.||.|++|.++. +|+.||+|.+.............+..|..++ ...+|||++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4589999988763 5789999998754332333334445555544 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 999999988888999999999999999999999998 99999999999999999999999998875432 1223
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..............+++.+.+++.+||+
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 233 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence 46788999999988778899999999999999999999998766655444442222111111233578899999999999
Q ss_pred cCCCCCCCHHHHHH
Q 013214 395 EKPAKRPTFRQIIT 408 (447)
Q Consensus 395 ~dp~~Rps~~~~l~ 408 (447)
.||++||++.++.+
T Consensus 234 ~~p~~R~~~~~~~~ 247 (260)
T cd05611 234 MDPAKRLGANGYQE 247 (260)
T ss_pred CCHHHccCCCcHHH
Confidence 99999997754444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=288.80 Aligned_cols=244 Identities=26% Similarity=0.470 Sum_probs=200.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..|...+.||+|+||.++. +|+.||+|.+........+..+.+.+|+.+++.++||||+++++++......++++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4577888999999998763 68999999987554445566677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+. |++.+.+.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9996 677777754 456899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
....+++.|+|||.+. ...++.++||||||+++|+|++|+.||...+.......+.....+.. ....++..+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 243 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--SSNDWSDYF 243 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--CchhhCHHH
Confidence 2345678899999874 34678899999999999999999999986654443333322222222 233467889
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++|.+||+.||++||++.+++.+
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcC
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=290.77 Aligned_cols=243 Identities=23% Similarity=0.427 Sum_probs=198.4
Q ss_pred ccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 158 TNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 158 ~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
.....||+|+||.++ .++..||+|.+... .....+.+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 334568999998776 25789999988643 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcc
Q 013214 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (447)
Q Consensus 233 ~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~ 312 (447)
++++|.+++.. +.+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++........ ...
T Consensus 102 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 102 EGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence 99999998754 56899999999999999999999998 99999999999999999999999999875432211 122
Q ss_pred cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHH
Q 013214 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392 (447)
Q Consensus 313 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 392 (447)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+.+ .....++..+.+++.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-KDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-ccccccCHHHHHHHHHH
Confidence 34578899999999888889999999999999999999999987655443333322212222 22334677899999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 013214 393 WNEKPAKRPTFRQIITR 409 (447)
Q Consensus 393 l~~dp~~Rps~~~~l~~ 409 (447)
|..||.+|||+.+++++
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=294.20 Aligned_cols=244 Identities=28% Similarity=0.425 Sum_probs=206.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+.-+.||+|+||.|+ .+|..+|.|.+.+..+.......-..+|-.+|.+++.++||.+--.|+..+.+|+|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 46777899999998764 6899999998876655444444556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
.|+||+|.-++.+.+ .+++..+..++.+|+.||.+||+.+ ||.||+||+|||+|+.|+++|+|+|+|..+...
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-- 340 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-- 340 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC--
Confidence 999999999997755 6999999999999999999999999 999999999999999999999999999977643
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.+.....||.+|||||++.++.|+.+.|+|||||++|+|+.|+.||.........+.+.......-...+...|++++++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL 420 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence 45566689999999999999999999999999999999999999998665433333332222222223346788999999
Q ss_pred HHHHcccCCCCCCCHH
Q 013214 389 IEECWNEKPAKRPTFR 404 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~ 404 (447)
.+.+|+.||.+|....
T Consensus 421 c~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHccCHHHhccCC
Confidence 9999999999997554
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=291.19 Aligned_cols=244 Identities=23% Similarity=0.425 Sum_probs=199.1
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|.....||+|+||.++ .+++.||+|.+.... ....+.+.+|+.+++.++|||++++++.+..+...++++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 3344578999998775 258899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 311 (447)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 999999997754 56899999999999999999999999 9999999999999999999999999986543221 112
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 391 (447)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+....+.. ..+........++..+.++|++
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-cCCCCccccCCCCHHHHHHHHH
Confidence 334578899999999888889999999999999999999999986655444333322 2222222334567889999999
Q ss_pred HcccCCCCCCCHHHHHHH
Q 013214 392 CWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 392 cl~~dp~~Rps~~~~l~~ 409 (447)
||+.+|++||++.+++++
T Consensus 254 ~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 254 MLTREPQERATAQELLDH 271 (297)
T ss_pred HhcCCcccCcCHHHHhhC
Confidence 999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=281.36 Aligned_cols=243 Identities=25% Similarity=0.406 Sum_probs=187.4
Q ss_pred eeecceEEEEEE----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKGTFILAFW----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G~~~~~~~----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.||+|+||.++. ++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++.+......+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999998863 22 345677665432 234457789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC-CC
Q 013214 235 GDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DR 309 (447)
Q Consensus 235 g~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~-~~ 309 (447)
|+|.+++.+. ...+...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999999764 23566778889999999999999998 9999999999999999999999999875422111 11
Q ss_pred CcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC--CCChh
Q 013214 310 PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPAK 379 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 379 (447)
......++..|+|||++.. ..++.++||||||+++|+|++ |..||......+....+........ +....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 1123456788999998743 235678999999999999997 6778876665444444323322211 12233
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.+++.+.+++..|| .+|++||+++++++.|
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 47788999999999 6899999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.58 Aligned_cols=244 Identities=28% Similarity=0.515 Sum_probs=199.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||.|++|.++. +++.+|+|.+.... .......+.+|+.+++.++||||+++++.+......++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 456667899999987752 58899999987643 23555778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++++|.+++... ..+++.....++.|++.|+.|||+ .+ ++|+||||+||++++++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999999876 778999999999999999999999 88 99999999999999999999999999875532211
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--CchHH---HHHhcCCCCCCCChhhhHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPK---AYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~ 383 (447)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..... .......+..+ ...++.
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP--SGKFSP 231 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC--hhhcCH
Confidence 115568889999999888899999999999999999999999976531 11111 11111122221 222788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.++|.+||..||++|||+.+++.+
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 89999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=280.69 Aligned_cols=231 Identities=27% Similarity=0.497 Sum_probs=186.4
Q ss_pred eeecceEEEEE---E--cC----------eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 162 EITKGTFILAF---W--RG----------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 162 ~lg~G~~~~~~---~--~g----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
.||+|+||.++ . ++ ..+++|.+.... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 58999998775 2 22 247888775432 115778899999999999999999999988 7789
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-------CEEEeecc
Q 013214 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFG 298 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-------~vkl~Dfg 298 (447)
++|||+++|+|.+++...+ .++...+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999998766 6899999999999999999999998 99999999999999887 79999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCC
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK 375 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 375 (447)
++..... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+...........+.
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~- 227 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM- 227 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCC-
Confidence 9876443 1223456779999998776 78889999999999999999 6888877654433333221111111
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 376 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.....+.+++.+||..+|.+||++.++++.|
T Consensus 228 ----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 228 ----PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ----CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1127889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.86 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=211.9
Q ss_pred CCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
....+.+.+..||.|.||.|| .+|+--|+|.++..... ......+.+|..++..++|||+|++||+-.+++..+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 344567778899999999998 47899999988754432 455677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|.||||++|+|.+.+...+-.++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|++|||.|..+...
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999999988777888888889999999999999999 999999999999999999999999999876543
Q ss_pred CC---CCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHhcCCCCCCCChh
Q 013214 307 ED---RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 307 ~~---~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 379 (447)
.. .......||+.|||||++.+. +...++|||||||++.||+||+.||...+.+= +...+..+..|++ |.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~---P~ 1464 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI---PE 1464 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC---ch
Confidence 21 112466799999999999764 45568999999999999999999999777653 3344445556666 44
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+|.+-+++|++||..||++|=++.+++++
T Consensus 1465 ~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1465 RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 589999999999999999999888877764
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.93 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=197.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++. +++.||+|.+....... ...+.+.+|+++++.++||||+++++++..++..++++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 466778999999988752 57899999887543322 344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|..+......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 9999999888776667999999999999999999999998 9999999999999999999999999987654322 22
Q ss_pred cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--------------------
Q 013214 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------------- 369 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------------- 369 (447)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 2334568889999998653 5678999999999999999999999765432221111100
Q ss_pred -CCCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 -QRPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 -~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+... ...+.++..+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000 0122457789999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=283.00 Aligned_cols=243 Identities=30% Similarity=0.531 Sum_probs=202.0
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||+|+||.++ .+++.||+|...... .......+.+|+.+++.++||||+++++++..+...+++|||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 5566789999999886 257899999886442 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 311 (447)
+++++|.+++.. ..+++..+..++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 999999998864 56899999999999999999999998 9999999999999999999999999987654321 112
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 391 (447)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.....+. ....++.++.+++.+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~ 235 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKEFVEA 235 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CCcccCHHHHHHHHH
Confidence 23456788999999988888899999999999999999999998766544444432222222 234567889999999
Q ss_pred HcccCCCCCCCHHHHHHH
Q 013214 392 CWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 392 cl~~dp~~Rps~~~~l~~ 409 (447)
||+.+|.+||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=299.65 Aligned_cols=246 Identities=28% Similarity=0.527 Sum_probs=212.1
Q ss_pred CcccceeeecceEEEEE---Ec-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAF---WR-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
++...+.||+|.||.|. |+ ...||||.++..... ....+|.+|+.+|.+++|||++++||+..+ ..+.+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 45566789999999875 42 357999999876432 267899999999999999999999999987 67899
Q ss_pred EEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
|||+++.|+|.+.|++ ...|.......++.||+.|+.||.+++ +|||||-.+|+++-....|||+|||+.+.++.
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999987 345888999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 306 KEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 306 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
..+.- .....-+..|+|||.+...+++.++|+|++||++|||+| |+.||.+....++.+.+..+.+.+- ++.++
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR---Pk~cs 341 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR---PKYCS 341 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC---CCCCh
Confidence 43321 223345677999999999999999999999999999999 9999999999999998876555553 45578
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
+.+.++++.||..+|++||++..|.+.+
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhH
Confidence 9999999999999999999999998543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=270.45 Aligned_cols=245 Identities=26% Similarity=0.473 Sum_probs=199.4
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEe
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+....||.|+-|.|. .+|...|||.+... .+.+...++...++++..- ..|+||+.+|+|..+..+++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 4455678999888664 46899999999865 4666677888888887766 49999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
.| ...++.++++ .+++++..+=++...+..||.||.+++ +|+|||+||+|||+|+.|++||||||.+-++-. +.
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--Sk 246 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SK 246 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec--cc
Confidence 98 4566666655 356888888889999999999999877 499999999999999999999999999977643 23
Q ss_pred CcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-CchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
..+-..|-+.|||||.+.- .+|+.++||||||++++||.||+.||.+.+. .+....+.. ..|+.-.....+|+.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCHHH
Confidence 3444556778999999854 3788899999999999999999999998654 344444433 4444433444589999
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++++..||+.|+.+||.+.+++++
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcC
Confidence 999999999999999999999875
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=287.30 Aligned_cols=249 Identities=29% Similarity=0.453 Sum_probs=197.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+|...+.||+|++|.++. +|+.||+|.+...... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 356677899999987762 5789999999765432 123345667899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|||+ +++|.+++.... .+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 899999998766 7999999999999999999999999 9999999999999999999999999998654332
Q ss_pred CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC-------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP------------- 372 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~------------- 372 (447)
. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||......+....+.... .+
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 1 2222345778999998855 357889999999999999999988887655433322221110 00
Q ss_pred --------C--CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --------P--FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --------~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ ........+..+.++|.+||+.||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 000112346789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=283.74 Aligned_cols=234 Identities=23% Similarity=0.390 Sum_probs=186.6
Q ss_pred eeecceEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 162 EITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 162 ~lg~G~~~~~~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.||+|+||.|+.. ...||+|.+... .....+.+.+|..+++.++||||+++++++......++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 5899999887631 234888877533 2344567888999999999999999999999989999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC--------EEEeecccc
Q 013214 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------LKVADFGVS 300 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~--------vkl~Dfg~~ 300 (447)
||+++|+|.+++..++ .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++. ++++|||.+
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999997654 4899999999999999999999999 999999999999987765 699999988
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHHhcCCCCCCCCh
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQRPPFKAPA 378 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (447)
..... .....++..|+|||.+.+. .++.++|+||||+++|+|++| ..||...+........ .....+ +
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~---~ 225 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--EDRHQL---P 225 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH--HccccC---C
Confidence 65432 1223467889999998764 578899999999999999998 4666654443322222 222222 2
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
...+.++.+++.+||+.||++|||++++++.|+
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 234578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=286.47 Aligned_cols=250 Identities=26% Similarity=0.438 Sum_probs=199.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +++.||+|.+..... .......+.+|++++++++||||+++++++...+..++++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 577788999999987753 578999998875432 33345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|++++.+..+..+...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9988777776666667999999999999999999999999 9999999999999999999999999988765443223
Q ss_pred cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--------------------
Q 013214 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------------- 369 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------------- 369 (447)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+........
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3345568889999999887 7889999999999999999999999865432221111000
Q ss_pred -CCCCCCC-------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 -QRPPFKA-------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 -~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.... .+..++.++.++|++||..+|++||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000 112247889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=281.60 Aligned_cols=249 Identities=23% Similarity=0.452 Sum_probs=201.3
Q ss_pred CcccceeeecceEEEEEE------cCeEEEEEEcCccc-------CCCHHHHHHHHHHHHHHhc-CCCCcccceeEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEV-------ISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ 221 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~------~g~~vavK~~~~~~-------~~~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~ 221 (447)
+|+..+.||+|+||.++. .++.+|+|.+.... ........++.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 366778899999987752 35889999875422 1233455667788888865 699999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
++..+++|||+++++|.+++.. ...+++..++.++.|++.+|.|||+ .+ ++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 3458999999999999999999996 56 99999999999999999999999
Q ss_pred cccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+......+.
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 99987654332 22344578889999999888899999999999999999999999976655444444323222222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
....+++.+.++|++||+.||++||++.++.++++
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 12346788999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=283.81 Aligned_cols=245 Identities=27% Similarity=0.503 Sum_probs=199.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~~~l 227 (447)
.|+..+.||.|+||.++ .+++.||+|.+.... .......+.+|+.+++.++ |||++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 35667789999998776 368899999987542 3344567888999999996 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+|||+++++|.+++.. +.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999999999865 47899999999999999999999999 9999999999999999999999999987665332
Q ss_pred CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.......++..|+|||.+.++ .++.++|+||||+++|+|++|+.||...........+.....+.+. ...++.++.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE--DNGYSKLLR 232 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCC--cccCCHHHH
Confidence 122334578889999988654 4688999999999999999999999876544333222111122221 122678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+||+.||++||++.+++.+
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhC
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=283.95 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=199.2
Q ss_pred ccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 222 (447)
++.....+|.....||+|+||.++. +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3444566788999999999998763 68899999886432 2235567899999998 899999999998753
Q ss_pred -----CceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEE
Q 013214 223 -----SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (447)
Q Consensus 223 -----~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vk 293 (447)
...++++||+++++|.++++. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 358999999999999998863 356899999999999999999999998 99999999999999999999
Q ss_pred EeecccccccccCCCCCcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh
Q 013214 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 368 (447)
|+|||++......... .....++..|+|||.+... .++.++|+||||+++|+|++|+.||......+....+..
T Consensus 169 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 247 (291)
T cd06639 169 LVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247 (291)
T ss_pred Eeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc
Confidence 9999998765432111 1223568889999987543 367899999999999999999999987655443333322
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+.+. .+..++..+.++|.+||+.+|++||++.+++++
T Consensus 248 ~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 2222221 233466789999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=282.33 Aligned_cols=247 Identities=27% Similarity=0.430 Sum_probs=197.8
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCC----
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS---- 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~---- 223 (447)
..+|+..+.||.|++|.++. +++.+++|++.... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 45788889999999987652 57889999986442 2346788999999999 7999999999997654
Q ss_pred --ceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 224 --PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 224 --~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
..+++|||+++++|.+++.. +..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999998865 356899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
|++....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...........+.....+
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 158 GVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred ccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 9987643221 11233457888999998753 24677899999999999999999999865544443333222222
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. ..+..++..+.++|.+||..||++|||+.+++++
T Consensus 237 ~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 237 TL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 22 2233467899999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=284.99 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=198.6
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 225 (447)
+|+..+.||.|+||.++. +|..||+|.+...... .....+.+.+|+.+++++ +||||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778899999997762 6789999998753221 223346678899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999999988888999999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh---cCCCCCCCChhh
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---RQRPPFKAPAKL 380 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 380 (447)
..........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+.. ...+++ +..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 234 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---PQE 234 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC---Ccc
Confidence 222222334578899999998653 467899999999999999999999975443322222211 122222 344
Q ss_pred hHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
+++.+.+++++||+.||++|| ++.+++++
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 678899999999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=300.95 Aligned_cols=243 Identities=20% Similarity=0.260 Sum_probs=191.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
...|.+.+.||+|+||.|+. .++.||+|.... ..+.+|++++++++||||+++++++...+..+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 44788889999999998873 578899996431 2356799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||++ .++|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9999 57898888764 46999999999999999999999999 9999999999999999999999999997654322
Q ss_pred CC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--------CchHHHHHhcCC--CCCCC
Q 013214 308 DR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--------NEVPKAYAARQR--PPFKA 376 (447)
Q Consensus 308 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~--------~~~~~~~~~~~~--~~~~~ 376 (447)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..|+..... .++...+..... ..++.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 11 12234689999999999988999999999999999999998765432211 111111111110 00000
Q ss_pred -------------------------Ch---hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 -------------------------PA---KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 -------------------------~~---~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+ ...+..+.+||.+||+.||.+|||+.|++++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 1234578999999999999999999999975
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=288.32 Aligned_cols=248 Identities=22% Similarity=0.420 Sum_probs=193.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +|+.||+|.++.... .......+.+|+.++++++||||+++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 366778899999988763 688999999875432 22233556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++ ++|.+++.+ .+.+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~ 154 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-R 154 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-C
Confidence 996 688888765 467999999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhc----------------C-
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAAR----------------Q- 370 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~----------------~- 370 (447)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|..|+...... +....+... .
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 22334568889999988664 4688999999999999999998886433322 111111000 0
Q ss_pred --CCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 --RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 --~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+. ...+.+++++.++|.+||+.||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 0112467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=285.48 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=199.5
Q ss_pred cccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceE
Q 013214 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 226 (447)
|+..+.||+|++|.++. +++.||+|.++..... .......+.+|+.++.++ +||||+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56678899999998763 4678999988653221 223345678899999999 6999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+||||+++++|.+++..+..+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999988778999999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.........++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+...........+..++..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHH
Confidence 222222345688999999987654 678999999999999999999999754332221121111111111223456788
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
+.+++.+||+.||++|||+.++.+.|+.
T Consensus 239 l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 239 ARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 9999999999999999998877766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=282.22 Aligned_cols=243 Identities=30% Similarity=0.441 Sum_probs=199.4
Q ss_pred eecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||.|+||.++ . +|+.+++|.+...........+.+.+|+.++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5778887765 2 4899999999765544445667889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-------CC
Q 013214 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-------RP 310 (447)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-------~~ 310 (447)
.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999988778999999999999999999999999 99999999999999999999999999875433211 12
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||...+...+.++|+||||+++|++++|..||......+....+.. .....+. ...++..+.+++.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-GKIEWPE-DVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCcCCCc-cccCCHHHHHHHH
Confidence 2334567889999999888888999999999999999999999987776555544433 2222221 1124788999999
Q ss_pred HHcccCCCCCCCHHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~l 410 (447)
+||+.+|.+||++..+.+.|
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHhcCCHhhcCCCccHHHHh
Confidence 99999999999995544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=283.57 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=197.6
Q ss_pred ccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe-
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ- 221 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~- 221 (447)
+.......|+..+.||.|+||.++. +++.+|+|..... ......+..|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3334445788888999999998763 6789999987543 23345678899999998 79999999999853
Q ss_pred -----CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 222 -----SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 222 -----~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
....+++|||+++|+|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 45689999999999999999753 34788889999999999999999999 999999999999999999999
Q ss_pred eecccccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc
Q 013214 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~ 369 (447)
+|||++....... .......++..|+|||.+. ...++.++|+||||+++|+|++|..||...........+..
T Consensus 163 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~- 240 (282)
T cd06636 163 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR- 240 (282)
T ss_pred eeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh-
Confidence 9999987543221 1123345788999999875 34577899999999999999999999976554332222211
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..........++..+.++|.+||+.||.+||++.+++++
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 241 -NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111122234578899999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=282.63 Aligned_cols=247 Identities=25% Similarity=0.486 Sum_probs=204.6
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
...|.....||+|++|.++. ++..|++|.+..... ..+.+.+|+..++.++|||++++++.+......+++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 34577778899999987652 588999999875422 456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+||+++++|.+++.... .++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999998876 7999999999999999999999998 9999999999999999999999999886544321
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+... ....++..+.+
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 248 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK-NPEKWSPEFKD 248 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-chhhCCHHHHH
Confidence 1 112334678899999998888899999999999999999999999876654444443333333222 23347789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.+|.+||++.+++.+
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhC
Confidence 9999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=285.57 Aligned_cols=244 Identities=26% Similarity=0.473 Sum_probs=201.6
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+.||+|+||.++ .+|..||+|.+........+....+.+|+.+++.++|||++++++++..+...+++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 7778889999998775 26789999998765444555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+. |+|.+.+.. ..++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 96 578777754 456899999999999999999999999 99999999999999999999999998865432
Q ss_pred cccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.....+++.|+|||.+. ++.++.++|+||||+++|+|++|+.||...........+.....+.. ....+++.+.+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 255 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDYFRN 255 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHHHHH
Confidence 12345688899999874 35678899999999999999999999987655544444433333332 23356788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
++.+||+.+|.+||++.+++++.-
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChh
Confidence 999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=285.19 Aligned_cols=247 Identities=22% Similarity=0.450 Sum_probs=202.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|...+.||+|+||.++. ++..||+|.+... .....+.+.+|+.+++.++||||+++++.+......++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 35788888999999998762 5788999998643 223346678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
+||+++++|.+++.+. .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999999998653 5788999999999999999999999 99999999999999999999999998875443221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+..+....+.....+.+. .+..++..+.++
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l 248 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAIFRDF 248 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCC-CccccCHHHHHH
Confidence 222345788899999998888899999999999999999999999876544332222222222222 233467789999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|++||+.+|++||++.+++.+
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=277.91 Aligned_cols=248 Identities=28% Similarity=0.477 Sum_probs=201.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 226 (447)
+|...+.||+|+||.++ .+|..||+|.+.... .........+.+|+.++++++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 67788899999998775 368899999875322 12234556788999999999999999999998764 4588
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+++||+++++|.+++.+.+.+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999999988778999999999999999999999999 999999999999999999999999998765321
Q ss_pred CC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............. .+..+..+..+++.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~ 237 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPMLPDGVSDA 237 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCCCCCcccCHH
Confidence 11 111234578899999999888889999999999999999999999986654443333221 22222335567889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+++++||+ +|.+||++.+++.+
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhcC
Confidence 9999999998 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=275.52 Aligned_cols=245 Identities=28% Similarity=0.535 Sum_probs=206.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +++.|++|.+...... ......+.+|++++++++|||++++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 466778999999987763 6789999999765432 3556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.....+++..++.++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998866543221
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||...+..++.++|+||+|+++|+|++|+.||.................+. .+..++..+.+++.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP---LPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC---CCCCCCHHHHHHHH
Confidence 223456888999999888788899999999999999999999998665433333332233333 34456789999999
Q ss_pred HHcccCCCCCCCHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~ 408 (447)
+||..+|++||++.+++.
T Consensus 233 ~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHhCChhhCcCHHHHhc
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=275.02 Aligned_cols=244 Identities=29% Similarity=0.529 Sum_probs=203.3
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+.||+|++|.++. ++..+++|++..... .....+.+|+..++.++|||++++++.+......++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 56678899999987652 488999999975432 3557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++++|.+++... ..+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999999776 57899999999999999999999998 99999999999999999999999999876654321
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..........+... ....++..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR-NPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC-cccccCHHHHHHHH
Confidence 23345788899999998888889999999999999999999999876554444333332222222 22234788999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.||++|||+.+++++
T Consensus 233 ~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=292.81 Aligned_cols=240 Identities=23% Similarity=0.329 Sum_probs=187.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +++.||+|...... ...|+.++++++||||+++++++......++++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4688899999999998863 56789999864321 245899999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+ .++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 999 5688888865 456899999999999999999999999 999999999999999999999999998753321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCCC----------chHHHHHhcC-C-CCCC
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDN----------EVPKAYAARQ-R-PPFK 375 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p-~~~~~~~----------~~~~~~~~~~-~-~~~~ 375 (447)
.......||+.|+|||++.+..++.++|||||||++|+|+++..| |...... .....+...+ . ..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 122334679999999999988999999999999999999985444 4432221 0000010000 0 0000
Q ss_pred -----------------------C----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 376 -----------------------A----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 376 -----------------------~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
. ....++..+.++|.+||+.||.+|||+.+++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 011345567789999999999999999999875
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=280.50 Aligned_cols=246 Identities=27% Similarity=0.452 Sum_probs=196.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 228 (447)
+|...+.||.|++|.++ .+++.+|+|.+.... .......+.+|++++++++||||+++++++... ..++++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 46667889999998775 367899999987542 234557788999999999999999999988653 468999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999988753 345889999999999999999999999 9999999999999999999999999987543
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-----CchHHHHHhcCCCCCCCC--
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-----NEVPKAYAARQRPPFKAP-- 377 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~-- 377 (447)
.... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....+.....+.+...
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 2211 233467889999999888899999999999999999999999986632 122222211112222111
Q ss_pred -hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 378 -AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 378 -~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+++.+.+++.+||..+|.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 12467889999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=277.87 Aligned_cols=244 Identities=28% Similarity=0.485 Sum_probs=205.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|+++.++ .+++.+|+|.+..... .......+.+|+.+++.++||||+++++.+......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 36677889999998765 2678999999876543 33445677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++.+ ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999999866 356899999999999999999999999 999999999999999999999999998766533
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.....++ .+..++.++.
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP---IPPIYSQDLQ 230 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---CchhhCHHHH
Confidence 2223456889999999988888999999999999999999999998776655544443333333 3346788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+||+.+|++||++.+++++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcC
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=279.36 Aligned_cols=246 Identities=24% Similarity=0.450 Sum_probs=201.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.++ .+|..+|+|.+...... ....+.+.+|+.+++.++||||+++++.+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 46677889999998776 26788999998754332 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC-EEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~-vkl~Dfg~~~~~~~~~ 307 (447)
|+++++|.+++.+.. .+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++. ++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999997643 4789999999999999999999998 999999999999998764 6999999987654322
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
. ......+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+............ ..+.++..+.+
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDLRS 232 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHHHH
Confidence 1 1123457888999999988888999999999999999999999998666544444332222222 23456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||..+|++|||+.+++++
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhC
Confidence 9999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=285.29 Aligned_cols=240 Identities=29% Similarity=0.445 Sum_probs=210.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|.....||+|+||.|.. +.+.+|||+++++.+-..+.++--..|-++|... +-|+++++..+|+..+++|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 566677899999999863 4578999999998877666677777888999888 5778999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+.||+|--++++-+++.+..+..++..|+-||.+||++| |+.||||.+|||++.+|++||+|||++..-- ....
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~~~ 505 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FDGV 505 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc-cCCc
Confidence 99999999999999999999999999999999999999999 9999999999999999999999999987522 2234
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......|||.|+|||++..++|+.++|+||+|++||||+.|++||++.+..++...+ ......+ +...|.+..++.
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI-~ehnvsy---PKslSkEAv~ic 581 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI-MEHNVSY---PKSLSKEAVAIC 581 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HHccCcC---cccccHHHHHHH
Confidence 456788999999999999999999999999999999999999999999998888877 3333333 566789999999
Q ss_pred HHHcccCCCCCCCH
Q 013214 390 EECWNEKPAKRPTF 403 (447)
Q Consensus 390 ~~cl~~dp~~Rps~ 403 (447)
+..|...|.+|...
T Consensus 582 kg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGC 595 (683)
T ss_pred HHHhhcCCccccCC
Confidence 99999999999643
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=274.74 Aligned_cols=249 Identities=28% Similarity=0.500 Sum_probs=205.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 228 (447)
+|+..+.||+|++|.++. ++..|++|++..... .....+.+.+|+..+++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 366678899999987763 588999999876543 245667889999999999999999999999988 889999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
+||+++++|.+++.+...+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999999988878999999999999999999999998 99999999999999999999999999887654322
Q ss_pred C-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 R-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
. ......++..|+|||.+.+...+.++|+||||+++|+|++|..||....... ...............+...+..+.+
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-AALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHhccccCCCcCCCcccCHHHHH
Confidence 1 1233457889999999988888999999999999999999999998766211 1111111112222334456789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+|++.||++||++.+++.+
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhhC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=280.72 Aligned_cols=244 Identities=25% Similarity=0.482 Sum_probs=190.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHH-HhcCCCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|+..+.||+|+||.++. +|+.||+|.+..... .... ..+..|... ++..+||||+++++++..+...+++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 567778999999998863 689999999876532 2222 334445554 66679999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 230 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
||++ |+|.+++.. +..+++..++.++.|++.|+.|||++ + ++|+||||+||+++.++.+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9995 788888754 24589999999999999999999997 7 9999999999999999999999999987653
Q ss_pred cCCCCCcccCCCCCcccCCcccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhcCCCCCCCChh
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 379 (447)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... +..........+.+ ...
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 231 (283)
T cd06617 156 DS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL--PAE 231 (283)
T ss_pred cc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC--Ccc
Confidence 22 11122346788999998865 34678999999999999999999999754322 22222222222222 223
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+|.++.++|.+||..+|++||++.+++++
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 477899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=283.57 Aligned_cols=247 Identities=25% Similarity=0.472 Sum_probs=205.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|...+.||.|++|.++. +|+.||+|++.............+.+|..+++++. ||||+++++.+...+..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 577778999999988762 68999999987654444555677889999999998 999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~- 308 (447)
||+++++|.+++.+.+.+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999998888999999999999999999999999 99999999999999999999999999876543221
Q ss_pred ------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC
Q 013214 309 ------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 309 ------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~ 370 (447)
.......++..|+|||.+....++.++|+||||++++++++|+.||............. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-KL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-hc
Confidence 11123346788999999988888899999999999999999999999776444333332 22
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCH----HHHHHH
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTF----RQIITR 409 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~~~l~~ 409 (447)
...+ +..+++.+.+++++||+.+|.+||++ .+++++
T Consensus 238 ~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 238 EYSF---PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CCCC---CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 2222 33457889999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=285.50 Aligned_cols=241 Identities=24% Similarity=0.404 Sum_probs=180.8
Q ss_pred ceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCceEEEEe
Q 013214 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (447)
Q Consensus 160 ~~~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e 230 (447)
...||+|+||.|+. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 35799999998863 346899998865422 2356789999999999999999998853 567899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE----cCCCCEEEeec
Q 013214 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 297 (447)
Q Consensus 231 ~~~~g~L~~~l~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill----~~~~~vkl~Df 297 (447)
|+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 995 6888877521 24788899999999999999999999 9999999999999 46678999999
Q ss_pred ccccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch----------HH
Q 013214 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV----------PK 364 (447)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~----------~~ 364 (447)
|++........ .......+|+.|+|||.+.+. .++.++||||||+++|+|++|++||........ ..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 99986543211 122344678999999998764 578899999999999999999999975432110 00
Q ss_pred HHHhcC------------CCCCC---------------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 365 AYAARQ------------RPPFK---------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 365 ~~~~~~------------~~~~~---------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....+ .+.+. ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 00000 0001124568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=275.22 Aligned_cols=246 Identities=26% Similarity=0.476 Sum_probs=206.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||.|++|.++ .++..|++|++..... .......+.+|+++++.++|||++++.+.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 46677889999998765 2588999999876543 33556678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++.+. ..+++..+..++.+++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999764 66999999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
. .......+++.|+|||...+..++.++|+||+|+++++|++|+.||......+..........++ .+..++..+.
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELR 232 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence 2 11223456888999999988888999999999999999999999998776555544443333333 2346778999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+||..+|++||++.+++++
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=282.52 Aligned_cols=248 Identities=24% Similarity=0.455 Sum_probs=194.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|++|.++. +|+.||+|.+..... .......+.+|++++++++||||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 367778899999987752 688999999875432 22334568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 995 6899888653 45899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC--------------
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP-------------- 372 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~-------------- 372 (447)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||............... ..+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 1222334578899999886643 578899999999999999999999765533222111111 000
Q ss_pred --CC--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --PF--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+ ....+.+++++.++|.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 00112356788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=278.58 Aligned_cols=230 Identities=23% Similarity=0.407 Sum_probs=184.8
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
+|+|+||.++ .++..+|+|.......... |......+ +||||+++++.+..++..+++|||+++++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 6999999876 3678899999865432211 22222222 79999999999999999999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccccccCCCCCcccCC
Q 013214 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
|.+++.++..+++.++..++.|+++|+.|||+.+ ++|+||||+||+++.++ .++|+|||++...... ....
T Consensus 96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~ 167 (267)
T PHA03390 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYD 167 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCC
Confidence 9999988888999999999999999999999999 99999999999999988 9999999998765422 2235
Q ss_pred CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchH-HHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 316 ~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......... .......... ...+..+++.+.++|.+||+
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~ 246 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK-LPFIKNVSKNANDFVQSMLK 246 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc-CCcccccCHHHHHHHHHHhc
Confidence 788999999998888999999999999999999999999865543321 1111111111 12234678899999999999
Q ss_pred cCCCCCCC-HHHHHHH
Q 013214 395 EKPAKRPT-FRQIITR 409 (447)
Q Consensus 395 ~dp~~Rps-~~~~l~~ 409 (447)
.+|.+||+ +++++++
T Consensus 247 ~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 247 YNINYRLTNYNEIIKH 262 (267)
T ss_pred cChhhCCchHHHHhcC
Confidence 99999996 6888753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=272.70 Aligned_cols=240 Identities=26% Similarity=0.400 Sum_probs=195.8
Q ss_pred Ccccc-eeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe----CCc
Q 013214 156 DFTNS-VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----SSP 224 (447)
Q Consensus 156 ~~~~~-~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~----~~~ 224 (447)
+|++. ..||-|--|.|. .+|+.+|+|++... +..++|+++--+. .|||||+++++|+. ...
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34443 357888777663 58999999998632 3456688775555 69999999998864 356
Q ss_pred eEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeeccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg~ 299 (447)
+.+|||.++||.|.+.+++++. +++.++..|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 7899999999999999998765 999999999999999999999999 999999999999974 45699999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC----chHHHHHhcCCCCCC
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN----EVPKAYAARQRPPFK 375 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~ 375 (447)
++.-.. .........||.|.|||++...+|+...|+||+||++|-|++|.+||...... .....+ ..+...|+
T Consensus 211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI-~~gqy~FP 287 (400)
T KOG0604|consen 211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI-RTGQYEFP 287 (400)
T ss_pred ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh-hccCccCC
Confidence 986442 23334456799999999999999999999999999999999999999876542 334444 33344443
Q ss_pred -CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 376 -APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 376 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+..+|+..+++|+.+|..+|.+|.|..+++++
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 4567889999999999999999999999999876
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=279.88 Aligned_cols=238 Identities=22% Similarity=0.374 Sum_probs=188.6
Q ss_pred eecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHH---HHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 163 ITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 163 lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
||+|+||.|+ .+++.||+|.+.............+..| ...++...||+|+++++++...+..+++|||+.|
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 7899999876 3578999999876443322222223333 3445556899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
++|.+++...+.+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...... .....
T Consensus 82 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~ 155 (278)
T cd05606 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (278)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCcCc
Confidence 999999988888999999999999999999999998 999999999999999999999999998754322 11234
Q ss_pred CCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHH--HHhcCCCCCCCChhhhHHHHHHHHHH
Q 013214 315 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA--YAARQRPPFKAPAKLYARGLKELIEE 391 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~ 391 (447)
.++..|+|||.+.++ .++.++|+||+|+++|+|++|+.||........... ......+.+ +..++..+.+++.+
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~ 232 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---PDSFSPELRSLLEG 232 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC---CCcCCHHHHHHHHH
Confidence 578999999998754 578999999999999999999999987643222111 111112222 33467899999999
Q ss_pred HcccCCCCCC-----CHHHHHHH
Q 013214 392 CWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 392 cl~~dp~~Rp-----s~~~~l~~ 409 (447)
||..+|.+|| ++.+++++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhC
Confidence 9999999999 99998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=290.44 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=194.6
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------C
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 223 (447)
.+|+..+.||+|+||.++ .+|+.||+|.+..... .......+.+|+.++++++||||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 468888999999999875 3789999999875432 334445677899999999999999999988644 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..+++|||+. ++|.+.+... ++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 5799999995 6888888654 889999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------- 369 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------- 369 (447)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 169 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 4321 122345688899999999889999999999999999999999999765532221111000
Q ss_pred -------CCCCC--------------C----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 -------QRPPF--------------K----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 -------~~~~~--------------~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++.. + ......++.+.++|.+||+.||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0 0012346678999999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=280.60 Aligned_cols=242 Identities=26% Similarity=0.464 Sum_probs=198.2
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|.....||+|+||.++. +|+.|++|.+...........+.+.+|+.+++.++|||++++++++.+....+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44456799999988763 6889999998765444555667788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+. |++.+++.. ..++++.++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 688887765 456899999999999999999999999 99999999999999999999999998864321
Q ss_pred cccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.....++..|+|||.+. ...++.++|+||||+++|+|++|..||...+.......+.....+.. ....++..+.+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 251 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--QSNEWTDSFRG 251 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CccccCHHHHH
Confidence 12345688899999974 35678899999999999999999999987765444444323322222 12346678999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+||+.+|.+||++.+++.+
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=288.96 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=198.1
Q ss_pred CCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 227 (447)
....|++.+.||+||-..|+. +.+-+|+|++.... .+......|.+|+..|.++ .|.+|+++|+|-..++.+|+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 344788999999999988873 44778888877654 3667889999999999999 59999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRKGAL-KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l-~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
||||= ..+|.++|++.... +.-.+..+..|++.|+.++|..| |||.||||.|+|+- .|.+||+|||.|..+..+
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 99986 57999999876553 33577889999999999999999 99999999999986 579999999999877654
Q ss_pred CCC-CcccCCCCCcccCCcccCCC-----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHHhc-CCC
Q 013214 307 EDR-PLTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAAR-QRP 372 (447)
Q Consensus 307 ~~~-~~~~~~~t~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-~~~~~~~-~~~ 372 (447)
... ......||+.||+||.+... +.++++|||||||+||+|+.|+.||........ ...+..- ...
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 322 22456799999999988532 366899999999999999999999985442211 1111111 122
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|+..+..+ ++.++++.||+.||++||+..+++++
T Consensus 593 efp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 593 EFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 454444433 38999999999999999999999975
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=282.72 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=195.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 228 (447)
+|+..+.||.|++|.++. +++.+|+|.++..... ......+.+|+.++++++||||+++++++... ...+++
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 677788999999988763 5789999998754332 22334566799999999999999999998877 889999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99996 59999887644 5899999999999999999999999 9999999999999999999999999988655432
Q ss_pred CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC---------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR--------------- 371 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--------------- 371 (447)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.....
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 122334467889999998764 468899999999999999999999987654433222211100
Q ss_pred --------CCC---CCChhh--hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 --------PPF---KAPAKL--YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 --------~~~---~~~~~~--~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
... ....+. +++.+.++|++||+.||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 000111 47789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=281.39 Aligned_cols=244 Identities=28% Similarity=0.465 Sum_probs=192.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|...+.||+|+||.|+. +|+.||+|.+..... ......+.+|+.++.++. ||||+++++++..+...+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 445567899999998862 678999999875432 244567888999999995 999999999999989999999
Q ss_pred eccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 230 e~~~~g~L~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
||+. +++.++.. ....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.++|+|||++...
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9985 56655432 235689999999999999999999985 6 999999999999999999999999998754
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh---cCCCCCC-C
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---RQRPPFK-A 376 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---~~~~~~~-~ 376 (447)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..... ....+.. ...+.+. .
T Consensus 159 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd06616 159 VDS--IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILSNS 234 (288)
T ss_pred ccC--CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCCCc
Confidence 322 111233568889999998765 688899999999999999999999986542 2222211 1112221 1
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....++..+.++|.+||+.||++|||+.+++.+
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123478899999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=280.16 Aligned_cols=247 Identities=27% Similarity=0.465 Sum_probs=195.1
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+..+.||.|++|.++. +|..||+|++..+.. .......+.+|+.+++.++|||++++++++.+.+..++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 45667899999987763 689999999875532 222335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
+ +++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~ 154 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-R 154 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-c
Confidence 9 479999998765 6899999999999999999999998 9999999999999999999999999987654321 1
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC------------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------ 370 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------ 370 (447)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 12223457889999987654 56889999999999999999999997654322211111100
Q ss_pred -------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 -------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 -------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+......+.++..+.++|.+||+.||.+||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011111223466789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=279.97 Aligned_cols=248 Identities=29% Similarity=0.421 Sum_probs=196.5
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEEEE
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT 229 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 229 (447)
|+..+.||.|++|.++. +|+.+|+|.+.... ........+.+|+.+++.++|||++++++++... +..++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 45667899999987763 57899999998653 2333446678899999999999999999999888 8899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9996 5899888765 57999999999999999999999998 99999999999999999999999999987654332
Q ss_pred CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC-C------CCCC----
Q 013214 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-P------PFKA---- 376 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~------~~~~---- 376 (447)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+..... + .+..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 22333456788999998765 3578899999999999999999999987665433333211110 0 0000
Q ss_pred ---------------Chhh-hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 ---------------PAKL-YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ---------------~~~~-~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.... +++.+.+++++||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0011 26788999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=281.89 Aligned_cols=249 Identities=18% Similarity=0.330 Sum_probs=194.1
Q ss_pred cccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccC
Q 013214 157 FTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
+...+.+|.|+++.++ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++..+...+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 3344555666665443 4789999999876532 34566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC---
Q 013214 234 KGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--- 308 (447)
Q Consensus 234 ~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~--- 308 (447)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+|++|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999763 45889999999999999999999999 99999999999999999999999998865432111
Q ss_pred ---CCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC-----------
Q 013214 309 ---RPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP----------- 372 (447)
Q Consensus 309 ---~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------- 372 (447)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.................+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 011233467789999998663 5788999999999999999999999865433221111110000
Q ss_pred -------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 -------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 -------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.-......++..+.+++.+||+.||++|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0011123456789999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=280.26 Aligned_cols=241 Identities=22% Similarity=0.406 Sum_probs=197.3
Q ss_pred ceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 160 ~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
...||+|+||.++ .+|+.||+|.+... .......+.+|+.+++.++|||++++++.+...+..+++|||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 3568999998775 26889999987533 233456688899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
++|.+++. .+.+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......
T Consensus 102 ~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 102 GALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 99999775 456899999999999999999999999 9999999999999999999999999887554321 112334
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
.+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......+....+.....+.+. ....++..+.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLK-NLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccC-CcccCCHHHHHHHHHHHh
Confidence 5788899999998888899999999999999999999999876554443333222222221 233467789999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013214 395 EKPAKRPTFRQIITR 409 (447)
Q Consensus 395 ~dp~~Rps~~~~l~~ 409 (447)
.||.+||++.+++.+
T Consensus 256 ~~P~~R~~~~~ll~~ 270 (292)
T cd06657 256 RDPAQRATAAELLKH 270 (292)
T ss_pred CCcccCcCHHHHhcC
Confidence 999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.37 Aligned_cols=251 Identities=16% Similarity=0.225 Sum_probs=184.4
Q ss_pred cCcccceeeecceEEEEEE------cCeEEEEE--------------EcCcccCCCHHHHHHHHHHHHHHhcCCCCcccc
Q 013214 155 LDFTNSVEITKGTFILAFW------RGIQVAVK--------------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~------~g~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 214 (447)
.+|+..+.||+|+||.|+. .+..++.| .+.+...........+.+|+.++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 3688899999999998873 11112222 111111122334566889999999999999999
Q ss_pred eeEEEEeCCceEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC
Q 013214 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (447)
Q Consensus 215 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~ 289 (447)
+++++...+..++++|++ +++|.+++... .......+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 999999999999999999 56888777542 22345677889999999999999999 9999999999999999
Q ss_pred CCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCCCc---hHHH
Q 013214 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNE---VPKA 365 (447)
Q Consensus 290 ~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p-~~~~~~~~---~~~~ 365 (447)
+.+||+|||++..+............||..|+|||++.+..++.++|||||||++|+|++|..+ |....... ....
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 9999999999987653322222345689999999999998999999999999999999998754 44332221 1111
Q ss_pred HHhcC--CCCCCCC-------------------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 366 YAARQ--RPPFKAP-------------------------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 366 ~~~~~--~~~~~~~-------------------------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.... ...++.. ....+..+.++|.+||+.||.+|||+.+++++
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11000 0000000 01234567788999999999999999999874
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=283.85 Aligned_cols=249 Identities=29% Similarity=0.421 Sum_probs=194.9
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 227 (447)
.+|+..+.||.|+||.++ .+|+.||+|.++...... .....+.+|+.++++++||||+++++++... +..++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367888899999999876 258899999986543222 2223456799999999999999999998755 46899
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||+. ++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999995 5898888753 56899999999999999999999999 999999999999999999999999998865432
Q ss_pred CCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC-------------
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP------------- 372 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~------------- 372 (447)
. .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 A-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred c-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 2 12222334778999999865 45788999999999999999999999877655444333221100
Q ss_pred -----CCCC--------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 -----PFKA--------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 -----~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.... .....++.+.++|.+||+.||++|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 011247788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=278.94 Aligned_cols=247 Identities=25% Similarity=0.481 Sum_probs=195.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||.|++|.++. +|+.||+|.+..... ......+.+|+.++++++||||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 467788999999987762 588999999875432 2223556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|++ ++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 997 58988886543 5899999999999999999999999 9999999999999999999999999987554321
Q ss_pred CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC---------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR--------------- 371 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~--------------- 371 (447)
. ......++..|++||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.....
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 12233467889999988654 568899999999999999999999987765443332211110
Q ss_pred --CCCCC--------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 --PPFKA--------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 --~~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..++. ..+..+..+.+++.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 012346788999999999999999999998863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=270.37 Aligned_cols=242 Identities=24% Similarity=0.389 Sum_probs=199.0
Q ss_pred ceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccC
Q 013214 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 160 ~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
...||+|+++.|. .+|..+|||++.+. +.-.+.+..+|++++.+. .|+||++++++|+++.++|||||-|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 4578999998763 68999999999764 334456677899999999 59999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC---EEEeecccccccccCC--C
Q 013214 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVKE--D 308 (447)
Q Consensus 234 ~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~---vkl~Dfg~~~~~~~~~--~ 308 (447)
||+|..+++++..+++.++..+..+|+.||.+||.+| |.|||+||+|||-.+... +|||||.+...+.... .
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999999999999999999999999999999999999 999999999999875543 8999998765432111 1
Q ss_pred ----CCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-------Cc--------hHH
Q 013214 309 ----RPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-------NE--------VPK 364 (447)
Q Consensus 309 ----~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-------~~--------~~~ 364 (447)
.......|+..|||||+.. ...|+.+.|.||||+++|-|++|.+||.+.-. .+ +.+
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 1123456788999999753 23688999999999999999999999976533 22 122
Q ss_pred HHHhcCCCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 365 AYAARQRPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 365 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.+ ..+...|+ +.+..+|.+..+++..++..|+.+|.++.++++
T Consensus 317 sI-QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SI-QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HH-hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 23 33444443 467789999999999999999999999999987
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=281.59 Aligned_cols=245 Identities=26% Similarity=0.454 Sum_probs=200.0
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||+|++|.++ .+++.+|+|.+...........+++.+|+.+++.++|||++++++++......++++|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 46677789999998775 2578899998865433444556678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+. |+|.+.+.. ..++++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 995 688887754 456899999999999999999999998 999999999999999999999999998754321
Q ss_pred CcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
....+++.|+|||.+. ...++.++||||||+++|+|++|..||......+....+.....+.. ....++..+.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 244 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFR 244 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHHHH
Confidence 2335688899999874 34578899999999999999999999987655444444433333332 2335778899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
++|++||+.+|++||++.+++.+-.
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCcc
Confidence 9999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=272.87 Aligned_cols=235 Identities=30% Similarity=0.467 Sum_probs=197.2
Q ss_pred eecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||.|++|.++ . +++.+|+|.+.............+.+|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 5788888665 2 4889999998876555555677889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCC
Q 013214 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (447)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t 317 (447)
.+++.....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 999988888999999999999999999999998 9999999999999999999999999987654321 122334568
Q ss_pred CcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCC
Q 013214 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 397 (447)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 397 (447)
..|+|||.+.+...+.++|+||||+++|++++|..||...+..+....+.. ....+ +...+..+.+++++||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRF---PEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCHHHHHHHHHHhcCCH
Confidence 889999999888888999999999999999999999976665443333322 22222 33447889999999999999
Q ss_pred CCCCCHHH
Q 013214 398 AKRPTFRQ 405 (447)
Q Consensus 398 ~~Rps~~~ 405 (447)
++||++.+
T Consensus 233 ~~R~~~~~ 240 (250)
T cd05123 233 TKRLGSGG 240 (250)
T ss_pred hhCCCccc
Confidence 99999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=279.20 Aligned_cols=248 Identities=26% Similarity=0.431 Sum_probs=192.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +|+.||+|.+..... .......+.+|++++++++||||+++++++.+....++|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 577788999999987752 678999999865432 22334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~ 307 (447)
|++ ++|.+++..... +++..+..++.|++.||.|||+++ ++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 688888865443 577888899999999999999998 999999999999985 5579999999987654321
Q ss_pred CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC-------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP------------- 372 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~------------- 372 (447)
.......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+....+... ..+
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 112233467889999988664 5788999999999999999999999876543322221110 000
Q ss_pred ------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ------~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+. ...+.+++.+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0113456789999999999999999999999874
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=278.40 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=190.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|.+...... .....+.+|+.+++.++|+||+++++++..+...++++
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4688888999999998863 5889999998654321 22235668999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 677777654 355788889999999999999999998 99999999999999999999999999875432211
Q ss_pred CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHh-cC------------CCC
Q 013214 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAA-RQ------------RPP 373 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~-~~------------~~~ 373 (447)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||....... ....... .+ .+.
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 11233468889999998654 57889999999999999999999997654321 1111000 00 000
Q ss_pred C---------CCC------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 F---------KAP------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~---------~~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ ... ....+..+.+++.+|+..||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 000 00124678999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=279.54 Aligned_cols=247 Identities=25% Similarity=0.422 Sum_probs=190.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|++|.++. +++.||+|.+...... .....+.+|+.++++++||||+++++++......++|||
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 577888999999998762 6789999998654321 122345679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+. ++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 996 5999988764 46899999999999999999999999 99999999999999999999999999875432211
Q ss_pred CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhc-CCC--------------
Q 013214 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAAR-QRP-------------- 372 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~-~~~-------------- 372 (447)
......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...... +....+... ..+
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122235788999998865 45788999999999999999999999765521 111111000 000
Q ss_pred ------CCC-----CChhhhH--HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ------PFK-----APAKLYA--RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ------~~~-----~~~~~~~--~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
... ......+ ..+.+++.+||+.+|++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0001122 678899999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=287.75 Aligned_cols=241 Identities=24% Similarity=0.396 Sum_probs=206.2
Q ss_pred ceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 160 ~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.+.||+|.||+|| .+|++||||++.+..+.. +....+++|+.+|+++.||.||.+.-.|+..++++.|||-+ .
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 4679999999987 589999999999887754 44488999999999999999999999999999999999999 5
Q ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC---CEEEeecccccccccCCCC
Q 013214 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 235 g~L~~~l~--~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++.+++- +.+++++.....++.||+.||.|||-++ |+|+||||+|||+.+.. .+||||||+++.++.. .
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 67777664 4578999999999999999999999999 99999999999998654 6999999999998754 3
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
...+..|||.|+|||++....|+.+-|+||.|+++|.-++|..||.. ++++..++......-.+.++..++.+..++|
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHH
Confidence 34567899999999999999999999999999999999999999974 4445555533333333345778899999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+|+..=.+|-|....+.+
T Consensus 800 n~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHhcchHhhccc
Confidence 99999999999999877654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=286.44 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=192.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cc
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 224 (447)
.+|+..+.||+|++|.++. +|+.||+|.+... ........+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3688889999999998763 6899999998642 2233456678899999999999999999887644 35
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.++++||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 799999995 588887743 56999999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCC--CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-----------
Q 013214 305 VKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----------- 370 (447)
Q Consensus 305 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----------- 370 (447)
..... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+.......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 32211 1123457889999998654 467889999999999999999999997654322111110000
Q ss_pred ----------CCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ----------RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ----------~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.. ...+.+++.+.++|.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0112356789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=287.93 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=196.6
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe----CCce
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 225 (447)
.+|+..+.||.|++|.++ .+|+.||+|++..... .......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 467778899999998775 3689999999875432 22345667789999999999999999988753 3468
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+. ++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999995 699999987778999999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCC---cccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc------------
Q 013214 306 KEDRP---LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR------------ 369 (447)
Q Consensus 306 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~------------ 369 (447)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 22111 123457888999998765 46788999999999999999999999776543221111100
Q ss_pred ------------C-CCCC--CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 ------------Q-RPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ------------~-~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
. .... ....+..+..+.++|.+||+.+|++||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 0010 00113457889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=279.29 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=191.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCc-----
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~----- 224 (447)
+|+..+.||+|+||.++. +|+.||+|....... .......+.+|+.+++.+ +||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 577788999999998763 688999998865432 222335677899999999 46999999999887665
Q ss_pred eEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeecc
Q 013214 225 MMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFG 298 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg 298 (447)
.+++|||++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 899999997 4898888643 34799999999999999999999999 999999999999998 8899999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CC-----
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QR----- 371 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~----- 371 (447)
++....... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+... ..
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 987653321 11222345788999998865 45788999999999999999999999876543322221110 00
Q ss_pred -------------CCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 -------------PPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 -------------~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+. ...+.++..+.++|.+||..||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0112467889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=286.91 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=198.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 225 (447)
+|...+.||+|+||.++ .+|+.||+|.+..... .......+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 68888899999999876 3688999999875432 223345667899999999999999999987644 347
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++++||+. ++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999994 799999988888999999999999999999999999 99999999999999999999999999886543
Q ss_pred CCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc---------------
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------------- 369 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 369 (447)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+...
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 KG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred Cc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 22 12233456888999998765 46889999999999999999999999765432211111000
Q ss_pred ------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHH
Q 013214 370 ------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESI 413 (447)
Q Consensus 370 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--l~~~ 413 (447)
..+.+....+.+++.+.++|++||+.||++|||+.+++++ ++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0011111123467889999999999999999999999987 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=280.67 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=192.2
Q ss_pred CcccceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceE
Q 013214 156 DFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 226 (447)
+|...+.||+|++|.++. .++.||+|.+...........+.+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 366778899999997762 5789999999864322233345677899999999999999999999988 7899
Q ss_pred EEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC----CCCEEEeec
Q 013214 227 IVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD----SGNLKVADF 297 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~----~~~vkl~Df 297 (447)
+||||++ ++|.+.+... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 5777776432 25889999999999999999999999 999999999999999 899999999
Q ss_pred ccccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch---------HHH
Q 013214 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---------PKA 365 (447)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~---------~~~ 365 (447)
|++........ .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543222 112234568889999987664 578899999999999999999999986654320 000
Q ss_pred H-H------------------------hcCCCCCCC--Ch------hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 366 Y-A------------------------ARQRPPFKA--PA------KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 366 ~-~------------------------~~~~~~~~~--~~------~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ . ......++. .. ...+..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0 000111110 00 0345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=276.48 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=189.3
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC--CceEEE
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMMIV 228 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv 228 (447)
|+..+.||+|+||.++. +++.||+|.++.... ..... ...+|+.+++++ +|||++++++++.++ +..+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 45567899999987753 688999999875432 22222 334688888888 499999999999987 889999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+||++ ++|.+.+... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99996 5888888764 56899999999999999999999999 999999999999999 999999999987654321
Q ss_pred CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC---------------C
Q 013214 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---------------R 371 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---------------~ 371 (447)
......++..|+|||.+.. ..++.++|+|||||++|+|++|..||...+..+......... .
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 --PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred --CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2223456889999997654 456889999999999999999999998765433222221100 0
Q ss_pred CC--CC--------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 PP--FK--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ~~--~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. ++ .....++..+.++|.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 00 0112467899999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=276.45 Aligned_cols=251 Identities=16% Similarity=0.160 Sum_probs=185.4
Q ss_pred CcCcccceeeecceEEEEEE-----c---CeEEEEEEcCcccCCC--HH-H-----HHHHHHHHHHHhcCCCCcccceeE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----R---GIQVAVKKLGEEVISD--DD-R-----VRAFRDELALLQKIRHPNVVQFLG 217 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~---g~~vavK~~~~~~~~~--~~-~-----~~~~~~E~~~l~~l~hp~iv~~~~ 217 (447)
..+|++.+.||+|+||.|+. + +..+|+|+........ +. . ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788999999999999873 2 3466777543322110 00 0 011223344556678999999999
Q ss_pred EEEeCC----ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEE
Q 013214 218 AVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (447)
Q Consensus 218 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vk 293 (447)
++.... ..++++|++ ..++.+.+......++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEE
Confidence 765443 347888887 4578877776666788889999999999999999998 99999999999999999999
Q ss_pred EeecccccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-HHHH
Q 013214 294 VADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAY 366 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-~~~~ 366 (447)
|+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ ....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999999976532111 111234689999999999998999999999999999999999999987743321 1111
Q ss_pred H----hc-CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 367 A----AR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 367 ~----~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
. .. ..... ..+..++.+.++++.||..+|++||++.++++.+
T Consensus 247 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 247 KCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 00 11111 1234578899999999999999999999999865
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=280.31 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=191.0
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-----
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 223 (447)
..+|+..+.||+|+||.++ .+++.||+|.+....... .....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3468888999999999876 268899999886543221 22234567999999999999999999887654
Q ss_pred ---ceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 224 ---PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 224 ---~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
..+++|||+. ++|.+.+.... .+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 3599999995 68888886543 6899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCC---CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C--C
Q 013214 300 SKLLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R--P 372 (447)
Q Consensus 300 ~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~--~ 372 (447)
+......... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+.... . +
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 8765432211 11233467889999988664 46789999999999999999999998665433222211100 0 0
Q ss_pred ---------------CCCCC----------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ---------------PFKAP----------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ---------------~~~~~----------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++.. ....++.+.++|.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 00124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=248.38 Aligned_cols=248 Identities=24% Similarity=0.439 Sum_probs=202.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...++||+|++|+|+. +++.||+|.++.+.- ++-.-....+|+.+++.++|.|||++++...++..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 456667899999999974 678999999986542 22233556779999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|| ..+|..+..+ ++.++.+.+..++.|++.||.++|+++ ++|||+||+|.+|+.+|.+|++|||+++.++.+. +
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-r 156 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-R 156 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-E
Confidence 99 5699999876 577999999999999999999999999 9999999999999999999999999999876542 3
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhc-CCC------------CC
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR-QRP------------PF 374 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~-~~~------------~~ 374 (447)
..+....|.+|.+|.++.+. -|+++.|+||-||++.|+.. |++.|++.+..+....+... +.+ .+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 34445569999999998876 58889999999999999986 88889988766655554221 111 11
Q ss_pred ---CCC---------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 375 ---KAP---------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 375 ---~~~---------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.. .+..+..-++++++++.-+|.+|.++++.+++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111 12344567899999999999999999988764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.05 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=213.8
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
.-+|.+.+.||+|+||-|. .+++.+|+|++.+..........-|..|-++|..-+.+-|++++-.|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 3478888999999999663 47889999999875444444457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||++||+|-.++.+.+++++..+..++..++-||..+|+.| +|||||||+|||+|..|++||+|||.+-.+.....
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 999999999999998889999999999999999999999999 99999999999999999999999999887765544
Q ss_pred CCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhH
Q 013214 309 RPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYA 382 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 382 (447)
.......|||.|.+||++.. +.|++.+|+||+||++|||+.|..||...+..+....|-... .-.|| ....+|
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP-~~~~VS 309 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP-DETDVS 309 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC-cccccC
Confidence 44566789999999999853 468899999999999999999999999888777766663332 44554 234589
Q ss_pred HHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPT---FRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps---~~~~l~~ 409 (447)
++.++||.+.+ -+|+.|.. +.++..|
T Consensus 310 eeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 310 EEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 99999999887 56778877 7777654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=289.44 Aligned_cols=239 Identities=24% Similarity=0.363 Sum_probs=213.6
Q ss_pred CcccceeeecceEEEE---EEcCeE--EEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILA---FWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~---~~~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
++....-||-|+||.| ...++. +|+|++++.++.+.++.+....|-++|...+.|+||++|-.|.++..+|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3445556899999976 345555 89999999888888888999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
-|-||.|+..+++++.+++.++..++..+++|+.|||+++ |+.|||||+|.+++.+|.+||.|||+++.+... ..
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~K 575 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RK 575 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC--Cc
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999987653 34
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 389 (447)
...++|||.|.|||++....++.++|.||||+++|||++|.+||.+.++......+..+. ... .|+.++....+||
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~---~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE---FPRRITKTATDLI 652 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh---cccccchhHHHHH
Confidence 456789999999999999999999999999999999999999999999888777764443 222 2467888999999
Q ss_pred HHHcccCCCCCCC
Q 013214 390 EECWNEKPAKRPT 402 (447)
Q Consensus 390 ~~cl~~dp~~Rps 402 (447)
+++...+|.+|..
T Consensus 653 k~LCr~~P~ERLG 665 (732)
T KOG0614|consen 653 KKLCRDNPTERLG 665 (732)
T ss_pred HHHHhcCcHhhhc
Confidence 9999999999976
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.14 Aligned_cols=244 Identities=21% Similarity=0.415 Sum_probs=188.5
Q ss_pred eeecc--eEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKG--TFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G--~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.||.| +|+.|+ .+|+.||+|++..... ..+..+.+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 45655 777664 2689999999875533 345567889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC--
Q 013214 235 GDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-- 310 (447)
Q Consensus 235 g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-- 310 (447)
++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998764 34889999999999999999999998 9999999999999999999999998543221110000
Q ss_pred ----cccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC-----------
Q 013214 311 ----LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP----------- 372 (447)
Q Consensus 311 ----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~----------- 372 (447)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+......... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0112345679999998764 47789999999999999999999998665433221111100 00
Q ss_pred ------------------------------CC-CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ------------------------------PF-KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ------------------------------~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. ......+++.+.++|++||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 01123467789999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=284.53 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=203.8
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-----ce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~ 225 (447)
+|+..+.||.|++|.++ .+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 46777899999998775 247899999987542 22344567888999999999999999999988765 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+++|||+. ++|.+++.+..++++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999996 689999988788999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC-C--------
Q 013214 306 KED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP-P-------- 373 (447)
Q Consensus 306 ~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~-------- 373 (447)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+...... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 321 122334568889999999887 7889999999999999999999999877654333322111100 0
Q ss_pred ------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHh
Q 013214 374 ------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINN 415 (447)
Q Consensus 374 ------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--l~~~~~ 415 (447)
+....+..+..+.++|.+||+.+|.+||++.+++.+ ++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000112356789999999999999999999999975 444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=275.21 Aligned_cols=246 Identities=28% Similarity=0.483 Sum_probs=191.6
Q ss_pred cCcccceeeecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|...+.||+|++|.++ + +++.||+|.++.... ......+..|+.++... .||||+++++++......+++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 467778899999998775 3 389999999875432 22344555677666666 599999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|||+ ++++.+.+.. ...+++..+..++.|++.|+.|||+ .+ ++|+||+|+||++++++.+||+|||++......
T Consensus 93 ~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9998 4678877765 4568999999999999999999998 46 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhcCCCCCCCChhhh
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 381 (447)
.. .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... +....+.....+..+ ....+
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 245 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-PNEGF 245 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC-CCCCC
Confidence 11 12234677899999987543 778999999999999999999999764332 222222222222222 22246
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++.+++.+||+.||++||++.+++.+
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 7889999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.74 Aligned_cols=258 Identities=30% Similarity=0.526 Sum_probs=214.1
Q ss_pred CcccCCCCcCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCccc
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVV 213 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv 213 (447)
.++++...+.+. +.+|+|.||.+.+ ....||||.++.... ....+.+..|+++|+.+ +||||+
T Consensus 290 ~~e~~~~~l~~~--~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLG--KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhcccc--ceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchh
Confidence 567776665444 4899999997752 146899999987653 36678899999999999 699999
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 013214 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (447)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~ 277 (447)
.++|+|..++.+++++||+..|+|.++++.++ .++..+.+.++.||+.|++||++.. ++||
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 99999999999999999999999999998765 3888899999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCC--CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 013214 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 354 (447)
Q Consensus 278 Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~ 354 (447)
||-.+|||+.++..+||+|||+++.............. -+..|||||.+....++.++||||||+++||++| |..||
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 99999999999999999999999854332222111111 3566999999999999999999999999999999 99999
Q ss_pred CCCC-CCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 355 TMKH-DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 355 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
.+.. ..++.+.+..+.+... |..+++++.++|+.||+.+|++||++.++.+.++...
T Consensus 523 p~~~~~~~l~~~l~~G~r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 523 PGIPPTEELLEFLKEGNRMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCCCcHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 9865 4445454544445554 4456789999999999999999999999999999854
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.88 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=197.7
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+.||.|++|.++. +|+.+++|.+...... ......+.+|+.++++++||||+++++++..+...++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 45567899999987753 6889999998765432 23446778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
++ ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 80 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 80 MD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred cC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 96 588888866 457899999999999999999999999 9999999999999999999999999987665432 12
Q ss_pred cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C-----------------
Q 013214 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R----------------- 371 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~----------------- 371 (447)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.... .
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334567889999998776 78889999999999999999999998766533322221110 0
Q ss_pred --------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 --------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.......+.++..+.++|.+||+.||.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00011123467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=273.08 Aligned_cols=246 Identities=27% Similarity=0.436 Sum_probs=193.0
Q ss_pred cccceeeecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeEEEEeCCc----
Q 013214 157 FTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSP---- 224 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~~---- 224 (447)
|+..+.||.|+||.++ . +++.||+|++..... .......+.+|+.+++++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 4566789999998775 2 478999999975433 222334566677777666 59999999999988776
Q ss_pred -eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 225 -MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 225 -~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
.+++|||+. ++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999996 58999887643 4899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC----------
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---------- 371 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---------- 371 (447)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|++||......+....+.....
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 156 IYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 654321 11223467889999999888889999999999999999999999987665443333311100
Q ss_pred -------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 -------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 -------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.......+..++.+.++|.+||+.||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00011122456788999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=268.28 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=195.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+.+....||.|+||.|. ..|+..|||+++.... +...+++..|.+...+- +.||||++||.+..++..|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 55566789999999885 4799999999986643 45566777788775555 7999999999999999999999
Q ss_pred eccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 230 e~~~~g~L~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
|.| .-||..+-+ ++..+++...-.+......||.||-..- .|+|||+||+|||++..|.+||||||.+-.+.
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999 467765543 3456899888889999999999998765 39999999999999999999999999987553
Q ss_pred cCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhcCCCCC---CCCh
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPF---KAPA 378 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~---~~~~ 378 (447)
.. ...+.-.|-..|||||.+... .|+.++|+||||++|||+.||+.||...+.. +....+ ..+.++. +...
T Consensus 220 ~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V-v~gdpp~l~~~~~~ 296 (361)
T KOG1006|consen 220 DS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV-VIGDPPILLFDKEC 296 (361)
T ss_pred HH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH-HcCCCCeecCcccc
Confidence 22 222333455679999998643 5889999999999999999999999988752 222233 3333332 2233
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..++..+..+|..|+..|-..||++.++.++
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 4588999999999999999999999998753
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=279.11 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=194.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 223 (447)
.+|+..+.||+|+||.++. +|+.||+|.+..... .......+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 3677788999999988762 578999999875432 1222345678999999999999999999887654
Q ss_pred ----ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 224 ----PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 224 ----~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
..++++||+++ ++.+.+.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999965 777777654 46899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC----
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP---- 372 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~---- 372 (447)
.+...............++..|+|||.+.+. .++.++||||||+++|+|++|++||......+....+.... .+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 9886654332222333457789999987653 56889999999999999999999998655433332221111 00
Q ss_pred --CC-------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --PF-------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --~~-------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+ ......++..+.+++.+||+.||.+||++.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00112357889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=282.19 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=195.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC--CceE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~ 226 (447)
.+|+..+.||+|+||.++. +|+.+|+|++..... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 3677888999999987752 578999998865322 233445677899999999 999999999998654 3589
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
++|||+. ++|..++.++ .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999996 6999988765 7888999999999999999999998 999999999999999999999999998765432
Q ss_pred CC----CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc------------
Q 013214 307 ED----RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR------------ 369 (447)
Q Consensus 307 ~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~------------ 369 (447)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 12223457889999998755 45778999999999999999999999765543322221111
Q ss_pred ---------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 ---------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ---------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+....+.++.++.++|.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0111111223367889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=286.54 Aligned_cols=233 Identities=27% Similarity=0.429 Sum_probs=194.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|.....+|.|+|+.+. .+++..++|++.+.. .+..+|..++... +||||+++.+.+.+....|+||
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 56666779999998764 468899999997652 1234577666666 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE-cCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-DDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill-~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|++.|+-+.+.+...+... ..+..|+.+|+.|+.|||++| ++|||+||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999998888887766555 788889999999999999999 9999999999999 69999999999999876543
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.....-|..|.|||++....+++.+|+||||++||+|++|+.||...... ++... ...+++. ..+|.+.++
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~---i~~~~~s---~~vS~~AKd 541 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR---IQMPKFS---ECVSDEAKD 541 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh---hcCCccc---cccCHHHHH
Confidence 11223478899999999999999999999999999999999999987766 22222 2233332 568999999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
|+..||+.||.+||++.++..+
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHHhccCChhhCcChhhhccC
Confidence 9999999999999999999875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=278.54 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=193.8
Q ss_pred cceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHH-----------HHHHHHHHHHHHhcCCCCcccceeEEEEeC
Q 013214 159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD-----------RVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (447)
Q Consensus 159 ~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 222 (447)
..+.||.|+||.++. +++.||+|.+......... ....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 456799999998763 6889999988654322110 012467899999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
+..+++|||+. |+|.+++.....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceee
Confidence 99999999995 699999988788999999999999999999999999 99999999999999999999999999876
Q ss_pred cccCC-------------CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh
Q 013214 303 LTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 303 ~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 368 (447)
..... ........+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 54111 1111223457789999998764 468899999999999999999999987765443332211
Q ss_pred cC-CCC---C--------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 RQ-RPP---F--------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ~~-~~~---~--------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. .+. + .......+..+.++|.+||+.+|++||++.+++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11 000 0 00012346789999999999999999999999863
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=269.30 Aligned_cols=246 Identities=27% Similarity=0.445 Sum_probs=194.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+|...+.||+|+||.++. .+..+++|.++..... .......+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 467778999999998862 3445666665432211 112234566789999999999999999999998999999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
+||+++++|.+++.+ ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 356899999999999999999999998 999999999999975 579999999987653
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.................+. .+..++.+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 232 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETYSRQ 232 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---CcchhcHH
Confidence 3221 1223456788999999988888899999999999999999999997655443333332222222 34567789
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++|.+||..||++||++.+++++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhC
Confidence 9999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=299.21 Aligned_cols=144 Identities=29% Similarity=0.516 Sum_probs=131.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|.+.+.||+|+||.|+. +++.||+|++.............+..|+.+++.++||||+++++.+......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 4678889999999998862 48899999997655555666678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
||+.+++|.+++...+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999988888999999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=277.45 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=192.0
Q ss_pred CcccceeeecceEEEEEE-----c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeC----C
Q 013214 156 DFTNSVEITKGTFILAFW-----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----S 223 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~----~ 223 (447)
+|...+.||+|+||.++. + +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 366778899999998752 3 6789999987432 2333456678899999999 599999999875432 4
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..++++||+. ++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 5789999984 799999988888999999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCC---CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc----------
Q 013214 304 TVKED---RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---------- 369 (447)
Q Consensus 304 ~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---------- 369 (447)
..... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+.......+...
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43211 11123457889999998765 46789999999999999999999999865532221111000
Q ss_pred -----------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 -----------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 -----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+....+..+..+.+++.+||+.||.+|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0111111122346789999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=279.72 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=194.1
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 223 (447)
.+|.....||+|++|.++ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367778899999998775 3689999999875432 2233456788999999999999999999987543
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..++++||+. .+|.++. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 4699999995 5777765 346899999999999999999999999 999999999999999999999999998754
Q ss_pred ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------ 370 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------ 370 (447)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+....
T Consensus 168 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 168 DA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 32 1223456788999999866 467889999999999999999999998765332222211100
Q ss_pred ----------CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHh
Q 013214 371 ----------RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINN 415 (447)
Q Consensus 371 ----------~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--l~~~~~ 415 (447)
.+..+ ...+..+..+.++|++||+.||++||++.+++.+ ++.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00010 0112356778999999999999999999999966 666654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=271.40 Aligned_cols=247 Identities=28% Similarity=0.485 Sum_probs=196.0
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|+....||+|++|.++. +++.||+|.+.... ......+.+..|+.+++.++|||++++++++.+....++++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 34556789999987763 58999999987653 2233345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
++ ++|.+++.+. ..+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~ 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RT 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc-cc
Confidence 96 6999999876 57999999999999999999999999 9999999999999999999999999987654322 12
Q ss_pred cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------------
Q 013214 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------- 370 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------- 370 (447)
......+..|+|||.+.+. .++.++|+||||+++|++++|+.||......+....+....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2233456789999998776 78889999999999999999999998765433222211100
Q ss_pred -CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 -RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 -~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+. ...+..+..+.++|++||..||++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00100 1112346789999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=268.37 Aligned_cols=245 Identities=24% Similarity=0.395 Sum_probs=191.3
Q ss_pred cccceeeecceEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEe
Q 013214 157 FTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e 230 (447)
|+..+.||.|++|.++ . +++.|++|.+...... .......+|+..+++++ |||++++++++..++..+++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 4566789999998775 2 5788999998754322 11223456899999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+ +|+|.+++.... .+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 99 789999998764 6899999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC---------------
Q 013214 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--------------- 372 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------------- 372 (447)
......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||......+...........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2233456888999998754 45788999999999999999999999766543322211110000
Q ss_pred ---CC--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ---PF--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ---~~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+ ....+..+..+.+++++||+.||++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00 00011225779999999999999999999998764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=277.41 Aligned_cols=243 Identities=24% Similarity=0.383 Sum_probs=192.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------c
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------P 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------~ 224 (447)
+|+..+.||+|+||.++. +|..||+|++.... ........+.+|+.+++.++||||+++++++.... .
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 688888999999998752 68899999986543 23334556788999999999999999999987654 3
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.+++|||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999999 7899888764 56899999999999999999999999 9999999999999999999999999987643
Q ss_pred cCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C-----------
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R----------- 371 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~----------- 371 (447)
.. .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||...+.......+.... .
T Consensus 170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 170 SE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred cC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 21 123356888999998866 357889999999999999999999998655322211111100 0
Q ss_pred ----------C-----CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 372 ----------P-----PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 372 ----------~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
+ .+......+++.+.++|.+|++.||.+|||+.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000111245677999999999999999999999995
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=275.28 Aligned_cols=246 Identities=28% Similarity=0.440 Sum_probs=193.3
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-CCceEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMI 227 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 227 (447)
..+|+..+.||.|+||.++. +|+.||+|++..... .....+.+..|+.+++.++||||+++++++.. ....++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 34688889999999998763 688999998865432 23344667789999999999999999999875 457899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
++||+ +++|.++++. .++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 99999 6789888764 45888889999999999999999999 99999999999999999999999999875432
Q ss_pred CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH-------------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA------------------- 367 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~------------------- 367 (447)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+.
T Consensus 161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 1123456788999998765 468899999999999999999999997654311110000
Q ss_pred -----h-cCCC--CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 368 -----A-RQRP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 368 -----~-~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
. .... +.....+.++..+.++|.+||+.+|++||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000 1111112456889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.96 Aligned_cols=243 Identities=30% Similarity=0.484 Sum_probs=186.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe---------
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 221 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--------- 221 (447)
+|.....||+||||.|+ .+|+.+|||+++... .......+.+|+.++.+++|||||++|..+.+
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 56677789999999876 489999999998764 55666788899999999999999999843200
Q ss_pred --------------------------------------------------------------------------------
Q 013214 222 -------------------------------------------------------------------------------- 221 (447)
Q Consensus 222 -------------------------------------------------------------------------------- 221 (447)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CceEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 013214 222 ----------------------S--------SPMMIVTEYLPKGDLRAFLKRKGAL-KPSTAVRFALDIARGMNYLHENK 270 (447)
Q Consensus 222 ----------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~l-~~~~~~~i~~ql~~~l~~lH~~~ 270 (447)
+ ..+||-||||+...|.++++++... .....|+++++|++||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 1268999999887777777766544 57889999999999999999999
Q ss_pred CCCeEeCCCCCCCEEEcCCCCEEEeecccccccc-----------------cCCCCCcccCCCCCcccCCcccCCCC---
Q 013214 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT-----------------VKEDRPLTCQDTSCRYVAPEVFKNEE--- 330 (447)
Q Consensus 271 ~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~-----------------~~~~~~~~~~~~t~~y~aPE~~~~~~--- 330 (447)
+|||||||.||+++++..|||+|||++.... .......+...||.-|+|||++.+..
T Consensus 718 ---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 718 ---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred ---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999998721 01112346678999999999997654
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCC---hhhhHHHHHHHHHHHcccCCCCCCCHHHHH
Q 013214 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP---AKLYARGLKELIEECWNEKPAKRPTFRQII 407 (447)
Q Consensus 331 ~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 407 (447)
|+.|+|+||||++++||+. ||.+. .|-...+..-....++.. ...--+.-..+|+.|++.||.+|||+.+++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 9999999999999999984 45532 222222211112222222 111123456899999999999999999998
Q ss_pred H
Q 013214 408 T 408 (447)
Q Consensus 408 ~ 408 (447)
+
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 6
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=276.44 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=192.4
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------ 222 (447)
..+|...+.||+|+||.++ .+|+.||+|++..... .....+.+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 3468888899999999875 3688999999875422 233345677899999999999999999988643
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3468888887 7899887764 46899999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C---------
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R--------- 371 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~--------- 371 (447)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+.... .
T Consensus 170 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 170 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 432 2233456888999998866 467889999999999999999999997655433222211100 0
Q ss_pred -----------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 -----------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 -----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.......++.+.++|.+||+.||.+||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000111246788999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=262.73 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=190.6
Q ss_pred CcccceeeecceEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-CCce
Q 013214 156 DFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 225 (447)
.|.....||+|++|.||.. ...+|+|+++.+...+.-. ....+|+.+++.++|||++.+..++.. +..+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 5777889999999999842 3479999997653222222 345679999999999999999998877 7889
Q ss_pred EEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC----CCEEEee
Q 013214 226 MIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVAD 296 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~----~~vkl~D 296 (447)
++++||.+ -+|++.++- ...++...+..+++||+.|+.|||++. |+||||||+|||+..+ |.|||+|
T Consensus 104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 99999995 599999863 245899999999999999999999999 9999999999999877 8999999
Q ss_pred cccccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCC-------C---chH
Q 013214 297 FGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD-------N---EVP 363 (447)
Q Consensus 297 fg~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-------~---~~~ 363 (447)
||+++.+...-. ........|.+|.|||.+.+. .|++..|||++||++.||++-++.|.+... . ++.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999998764321 122334568999999998876 688899999999999999999888764321 1 111
Q ss_pred HHHHhcCCCCC---------CCC-----------------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 364 KAYAARQRPPF---------KAP-----------------------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 364 ~~~~~~~~~~~---------~~~-----------------------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+....-+.|.- +.. ...-++..-+|+.++|..||.+|.|+++.+++
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 11111111110 000 00112347789999999999999999998875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=280.25 Aligned_cols=245 Identities=27% Similarity=0.378 Sum_probs=194.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc-----
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----- 224 (447)
.+|.....||+|++|.++. +++.||+|++..... .......+.+|+.+++.++|||++++.+++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 3688889999999998762 578999999865432 23344567789999999999999999988766554
Q ss_pred -eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 -~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.++++||+ +++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 6799998865 56999999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC-----------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR----------- 371 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----------- 371 (447)
... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+.....
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 422 2334568889999987653 678899999999999999999999986654433222211110
Q ss_pred ----------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ----------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+......+++.+.++|++||+.||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00111112357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=274.03 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=190.8
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-----
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 223 (447)
..+|+..+.||.|++|.++. +++.+|+|.+......+ .....+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 34788889999999998762 57899999886543222 12234678999999999999999999875433
Q ss_pred ---ceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 224 ---PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 224 ---~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
.+++++||+. ++|...+.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 4699999995 577777764 346999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCC----------cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh
Q 013214 300 SKLLTVKEDRP----------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 300 ~~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 368 (447)
+.......... .....+++.|+|||.+.+. .++.++||||||+++|+|++|++||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 87654322111 1223457789999987654 578899999999999999999999987665433332211
Q ss_pred cCCC----------------------CCCC----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 RQRP----------------------PFKA----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ~~~~----------------------~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.... ..+. ....+++.+.+++.+||+.||.+|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1100 0000 001234678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=283.54 Aligned_cols=255 Identities=24% Similarity=0.481 Sum_probs=219.8
Q ss_pred cCcccceeeecceEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
......+.||+|+||+|+.. .-+||+|++... ...+.-.++..|+-.|.++.|||++++++++..+. +
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 35566778999999998742 257999988754 34555678899999999999999999999998765 8
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.||++|++.|+|.++++.+ +++-....+.|..||++||.|||.++ ++||||-.+|||+.+-.++|+.|||+++...
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 8999999999999999865 56889999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
..... ......-.+.|||-|.+....++.++|||||||++||++| |..||.+....++...+....+.+ .++.++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs---qPpiCt 926 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS---QPPICT 926 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC---CCCCcc
Confidence 54332 2233445678999999999999999999999999999999 999999999999988887777644 355678
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..+.-++.+||..|+..||+++++..++.++.+...
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 899999999999999999999999999988776554
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=277.32 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=189.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-------
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------- 222 (447)
.+|...+.||.|+||.++. +|..||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 5788889999999998862 588999998865432 3446678899999999999999999876543
Q ss_pred -------CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEE
Q 013214 223 -------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKV 294 (447)
Q Consensus 223 -------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl 294 (447)
...++++||++ ++|.+++.. +.+++..+..++.|++.||.|||+.+ ++|+||||+||+++. ++.++|
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 689888754 46899999999999999999999999 999999999999984 557899
Q ss_pred eecccccccccCCCC--CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--
Q 013214 295 ADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-- 369 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-- 369 (447)
+|||.+......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+..+........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999998765322111 1122346788999998654 46778999999999999999999999766543222211110
Q ss_pred ---------------------CCCC---CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 ---------------------QRPP---FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ---------------------~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.... .....+.++.++.++|.+||+.||.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 000112356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=260.61 Aligned_cols=215 Identities=19% Similarity=0.251 Sum_probs=172.9
Q ss_pred ceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCHHHH
Q 013214 166 GTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240 (447)
Q Consensus 166 G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 240 (447)
|.++.|+ .+|+.+|+|.++... ...+|...+....||||+++++++......+++|||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 5555544 478999999987542 122344455556799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcc
Q 013214 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320 (447)
Q Consensus 241 l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y 320 (447)
+.+...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+...... .....++..|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 988778999999999999999999999998 999999999999999999999999987654322 1223346779
Q ss_pred cCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCC
Q 013214 321 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400 (447)
Q Consensus 321 ~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 400 (447)
+|||...+..++.++|+||+|+++|+|++|+.|+...... ........ .+..+++.+.++|++||+.||++|
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLN---IPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccC---CcccCCHHHHHHHHHHccCCHHHh
Confidence 9999998888899999999999999999999887643221 00001111 234467889999999999999999
Q ss_pred CCH
Q 013214 401 PTF 403 (447)
Q Consensus 401 ps~ 403 (447)
|++
T Consensus 221 ~~~ 223 (237)
T cd05576 221 LGA 223 (237)
T ss_pred cCC
Confidence 996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=258.35 Aligned_cols=240 Identities=24% Similarity=0.404 Sum_probs=202.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|...+.||+|++..|. .+.+.+|+|+++++.+.+++...=.+.|-.+..+- +||++|-+..+|..+.++++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 57778899999998663 57889999999998887777777677888888777 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||++||+|--+++++++++++.+..+...|+-||.|||++| |+.||+|.+|+|++..|++||+|+|+.+..-.+ ..
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~-gd 406 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GD 406 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCC-Cc
Confidence 99999999999999999999999999999999999999999 999999999999999999999999998753322 23
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC--C-CC----CchHHHHHhcCCCCCCCChhhhH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM--K-HD----NEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~--~-~~----~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
..+...|||.|.|||++.+..|..++|+|+||++++||+.|+.||+. + ++ ++..-++.......+ ++..|
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri---prsls 483 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI---PRSLS 483 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---cceee
Confidence 34567899999999999999999999999999999999999999962 1 12 122222223332222 45566
Q ss_pred HHHHHHHHHHcccCCCCCCC
Q 013214 383 RGLKELIEECWNEKPAKRPT 402 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps 402 (447)
.....+++..|+.||.+|..
T Consensus 484 vkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 484 VKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hhhHHHHHHhhcCCcHHhcC
Confidence 77788999999999999954
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=261.99 Aligned_cols=256 Identities=30% Similarity=0.487 Sum_probs=199.7
Q ss_pred CcCcccceeeecceEEEE---EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCcccceeEEEEeCC----c
Q 013214 154 ELDFTNSVEITKGTFILA---FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----P 224 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~---~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~~~~~~~~~~----~ 224 (447)
..+....+.||+|.||.| .|.|+.||||++... .+ +.+.+|.++.+.. +|+||+.+++.-..+. .
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr--dE----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR--DE----RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEeccc--ch----hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 346677789999999865 699999999999632 11 4556677766654 9999999998765432 5
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-----NKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-----~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
+|||++|-+.|||+|||.+ ..++.+...+++..++.||+|||. +|+..|.|||||+.|||+.+++...|+|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 8999999999999999987 669999999999999999999994 6777799999999999999999999999999
Q ss_pred ccccccCC---CCCcccCCCCCcccCCcccCCCC----C--CCchhHHHHHHHHHHHHhC----------CCCCCCCCC-
Q 013214 300 SKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEE----Y--DTKVDVFSFALILQEMIEG----------CPPFTMKHD- 359 (447)
Q Consensus 300 ~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~----~--~~~~Di~slG~~l~~l~tg----------~~p~~~~~~- 359 (447)
|....... +.+.....||.+|||||++...- + -..+||||||.++||+..+ ++||.+.-+
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 97655432 23446678999999999986541 1 1369999999999999753 468865433
Q ss_pred ----CchHHHHHhc-CCCCCCCChhhhH--HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 360 ----NEVPKAYAAR-QRPPFKAPAKLYA--RGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 360 ----~~~~~~~~~~-~~~~~~~~~~~~~--~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
++..+.+... .+|.++..+...+ ..+.++|+.||..||.-|.|+-.+-+.|.++.+.
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 2233333222 3666654444333 4678899999999999999999999999888763
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=280.06 Aligned_cols=245 Identities=27% Similarity=0.422 Sum_probs=204.7
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe-----CCc
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-----SSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-----~~~ 224 (447)
.+.+...||.|++|.|+ .+|+.+|+|+....... .+++..|.++++.+ .|||++.+|+++.- .+.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 45566789999998876 47889999998765422 24677799999999 69999999999853 467
Q ss_pred eEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
+|||||||.+||..|+++. ..++.++.+..|+..++.|+.|||.+. ++|||||=.|||++.++.|||+|||.+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 9999999999999999975 356899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCC
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 377 (447)
+.....+. ....|||.|||||++... .|+.++|+||||++..||.-|.+|+.++.+....-.+.....| -...
T Consensus 173 ldsT~grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP-kLkr 250 (953)
T KOG0587|consen 173 LDSTVGRR-NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP-KLKR 250 (953)
T ss_pred eecccccc-cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc-cccc
Confidence 76543333 446789999999998653 4677999999999999999999999988887665555222222 2334
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+..++.++.++|..||..|.++||++.+++++
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 67899999999999999999999999998864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=304.23 Aligned_cols=246 Identities=23% Similarity=0.372 Sum_probs=189.5
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+.....||+|+||.|| .+|..||+|++..... ....|++.+++++||||+++++++.+....++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 35566789999999886 3678999999864321 11246888999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++|+|.++++. +++.++..++.|++.|++|||...+.+++||||||+||+++.++..++. ||.+.....
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 9999999999963 8899999999999999999995533349999999999999998887775 665443211
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--chHHHHHh---c------CCCCCC---C
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAA---R------QRPPFK---A 376 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~--~~~~~~~~---~------~~~~~~---~ 376 (447)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ . ..+... .
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence 11235688999999999889999999999999999999999998643221 11111100 0 011111 1
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
.......++.+++.+||+.||++||++.++++.|+.+.+..
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 12233456788999999999999999999999999876643
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=276.76 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=197.2
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------Cce
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SPM 225 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~~ 225 (447)
+...+.||+|+||.|+ .+|+.||||.+.... .....+...+|++++++++|||||++++.-+.. +..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4455689999999886 479999999998654 345567788999999999999999999876543 346
Q ss_pred EEEEeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc--CCC--CEEEeecc
Q 013214 226 MIVTEYLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSG--NLKVADFG 298 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~--~~~--~vkl~Dfg 298 (447)
.++||||.||||...+.+. ..+++.+.+.++.+++.||.|||++| |+||||||.||++- .+| .-||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 8999999999999999753 45999999999999999999999999 99999999999975 334 37999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc----hHHHHHhcCC--
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQR-- 371 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~----~~~~~~~~~~-- 371 (447)
.|+.++.. ....+..||..|++||.+.. ..|+..+|.|||||++|++.||..||....... +.-.+..+..
T Consensus 170 ~Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 170 AARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99987654 35567889999999999984 788999999999999999999999997555432 2211111110
Q ss_pred ----------------CCCCCChhh----hHHHHHHHHHHHcccCCCCCC--CHHHHHHHHHHHHhh
Q 013214 372 ----------------PPFKAPAKL----YARGLKELIEECWNEKPAKRP--TFRQIITRLESINNS 416 (447)
Q Consensus 372 ----------------~~~~~~~~~----~~~~l~~li~~cl~~dp~~Rp--s~~~~l~~l~~~~~~ 416 (447)
..++. +.. .-..+..++..+|..+|++|- .+.+....+.++.+.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeEeeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 01111 112 223466778889999999998 777777777765543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=260.82 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=201.5
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCcccceeEEEEeCC----ceE
Q 013214 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~~~~~~~~~~----~~~ 226 (447)
..+....+|+|.||.|+ .+++.||||+++ ....+.|++|-++.+.. +|+||++++++-.... ..+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34455678999999887 478999999985 34567899999998876 7999999999865444 789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK------PVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~------~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
||+||.+.|+|.++|+.+ .+++....+++..+++||+|||+.. +.+|+|||||+.|||+.++++..|+|||+|
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999999764 5899999999999999999999754 337999999999999999999999999999
Q ss_pred cccccCC-CCCcccCCCCCcccCCcccCCC-CCC-----CchhHHHHHHHHHHHHhCCCCCCC-C---------------
Q 013214 301 KLLTVKE-DRPLTCQDTSCRYVAPEVFKNE-EYD-----TKVDVFSFALILQEMIEGCPPFTM-K--------------- 357 (447)
Q Consensus 301 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~-----~~~Di~slG~~l~~l~tg~~p~~~-~--------------- 357 (447)
..+.... ..+.....||.+|||||++.+. .+. .+.||||+|.++||++++..-+.. .
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 8876442 2333456799999999998764 222 369999999999999986543321 0
Q ss_pred -CCCchHHHH-HhcCCCCCCCChh--hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 358 -HDNEVPKAY-AARQRPPFKAPAK--LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 358 -~~~~~~~~~-~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..++....+ ..+.||.++..+. .....+++.++.||+.||+-|.|+.=+-+.+..+...-+
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 112233333 3344777655433 234678999999999999999999999888888776554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=261.91 Aligned_cols=243 Identities=26% Similarity=0.319 Sum_probs=193.6
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CCc----ccceeEEEEeC
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPN----VVQFLGAVTQS 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~----iv~~~~~~~~~ 222 (447)
.-+|.+...+|+|+||.|. .++..||||+++. -....++.+-|+++++++. .|+ ++++.++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 4478888899999999875 3578999999873 3455566778999999993 333 78888889999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-----------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----------- 289 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~----------- 289 (447)
++.|+|+|.+ |-|+.+++++++ +++...+..++.|+++++++||+.+ ++|-||||+|||+.+.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999 779999999875 4889999999999999999999999 9999999999997532
Q ss_pred ---------CCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 013214 290 ---------GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (447)
Q Consensus 290 ---------~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 360 (447)
-.|+++|||+|.+-... ......|..|.|||++.+-+++.++||||+||+|+|+++|...|++.++.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 25899999999875432 24456788999999999999999999999999999999999999988765
Q ss_pred chH---HHHHhcCCC------------------CCCC---------------Ch-------hhhHHHHHHHHHHHcccCC
Q 013214 361 EVP---KAYAARQRP------------------PFKA---------------PA-------KLYARGLKELIEECWNEKP 397 (447)
Q Consensus 361 ~~~---~~~~~~~~~------------------~~~~---------------~~-------~~~~~~l~~li~~cl~~dp 397 (447)
|-. +.+ .+..| ..+. +. ..--..+-+||++||..||
T Consensus 316 EHLaMMerI-lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 316 EHLAMMERI-LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHh-hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 521 111 11000 0000 00 0112358899999999999
Q ss_pred CCCCCHHHHHHH
Q 013214 398 AKRPTFRQIITR 409 (447)
Q Consensus 398 ~~Rps~~~~l~~ 409 (447)
.+|+|+.|++++
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=264.65 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=200.6
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHH----HHHHHHHHHHHHhcCCCCcccceeEEEE-eCCce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDD----RVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~ 225 (447)
+|.....||+|||..|+ ...+.||+|+-....-+.++ ......+|.++-+.+.||.||++|++|. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 56677789999997664 46789999987655433332 3345678999999999999999999986 45678
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeecccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKL 302 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg~~~~ 302 (447)
|.|+|||+|.+|.-+|+.+.-+++.++..|+.||+.||.||.+.. .||+|-||||.|||+-+ .|.+||+|||++..
T Consensus 544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999999999999999999999999999999999999987 57999999999999863 57899999999998
Q ss_pred cccCCCCC------cccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hH-HHHHhcC
Q 013214 303 LTVKEDRP------LTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VP-KAYAARQ 370 (447)
Q Consensus 303 ~~~~~~~~------~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~-~~~~~~~ 370 (447)
+....... .....||.+|++||.+.-+ +.+.++||||+||++|+++.|+.||....... +. +......
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 86543321 2456789999999987533 67789999999999999999999998654322 11 1111111
Q ss_pred -CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 371 -RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 371 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
.-.|+ .-+.++++.+.+|++||+.--++|....++..
T Consensus 703 tEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 703 TEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred eeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 12232 24567899999999999999999999888764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=249.62 Aligned_cols=237 Identities=34% Similarity=0.540 Sum_probs=193.2
Q ss_pred cceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCHHHHHH
Q 013214 165 KGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242 (447)
Q Consensus 165 ~G~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 242 (447)
.|..+.+.. +|+.+++|++........ .+.+.+|+..+++++|+|++++++.+......++++||+++++|.+++.
T Consensus 2 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 2 FGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred ceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 355555554 469999999875533221 5788899999999999999999999999899999999999889999998
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccC
Q 013214 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322 (447)
Q Consensus 243 ~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~a 322 (447)
....++...++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++++|||.+....... ......++..|++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 7766899999999999999999999998 9999999999999999999999999998765432 2233456788999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 013214 323 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402 (447)
Q Consensus 323 PE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 402 (447)
||.+.+..++.++|+||||++++++++|..||......+...................++..+.+++.+||..+|++||+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 99998888899999999999999999999999874333332222222222222222226788999999999999999999
Q ss_pred HHHHHH
Q 013214 403 FRQIIT 408 (447)
Q Consensus 403 ~~~~l~ 408 (447)
+.++++
T Consensus 235 ~~~~~~ 240 (244)
T smart00220 235 AEEALQ 240 (244)
T ss_pred HHHHhh
Confidence 999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=268.27 Aligned_cols=240 Identities=24% Similarity=0.362 Sum_probs=198.8
Q ss_pred cccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+-||-|+||.|. .+...+|.|.+.+...-..++....+.|-+||..-..+-||++|-.|.+.+.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 5556789999999774 35567899988776555666777788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC--
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-- 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-- 309 (447)
++||++-.+|-+-+-+.++.+..++.++..|+++.|..| +|||||||+|||||.+|+|||+|||+..-+....+.
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999999999999999999999999999999999999999 999999999999999999999999997543211000
Q ss_pred -------------C--------------------------cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC
Q 013214 310 -------------P--------------------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350 (447)
Q Consensus 310 -------------~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg 350 (447)
. .....||+.|+|||++....++..+|+||.|++||+|+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 0 0234589999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchHHHHHhcCCCCC-CCChhhhHHHHHHHHHHHcccCCCCCC
Q 013214 351 CPPFTMKHDNEVPKAYAARQRPPF-KAPAKLYARGLKELIEECWNEKPAKRP 401 (447)
Q Consensus 351 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rp 401 (447)
++||-..++.+....+.... ..+ .....++|+++.++|.++. .+++.|.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~-~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWR-NFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred CCCccCCCCCcceeeeeehh-hccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 99999998888766653332 222 1235678889999987644 4566664
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=249.55 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=191.4
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--------
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-------- 221 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------- 221 (447)
..|.....||+|+||.|+ .+|+.||+|++-.+.....-. ....+|+++|..++|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-italreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 356667789999999664 578889999775432222222 234569999999999999999887743
Q ss_pred CCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
...+|+||++|+ .+|.-.+... -+++..++.+++.++..||.|+|+.. |+|||+|++|+||+.+|.+||+|||++
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 234899999995 5898888655 56999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC---CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC---CCC
Q 013214 301 KLLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---RPP 373 (447)
Q Consensus 301 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~ 373 (447)
+.+...... ..+....|.+|++||.+.+. .++++.|+|.-||++.+|++|.+.+.+.+.......+.... .+.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 766543222 13445569999999998876 78999999999999999999999988766544333321110 111
Q ss_pred CCCC---------------h-------h------hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 FKAP---------------A-------K------LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~~~~---------------~-------~------~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++. + + .-.++..+|++.+|..||.+|+++++++++
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1100 0 0 012467899999999999999999998875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-33 Score=280.18 Aligned_cols=240 Identities=26% Similarity=0.394 Sum_probs=186.0
Q ss_pred cccceeeecceEEE----EEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFIL----AFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~----~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+.+|.|+-|+ +.+.|+.||||++-.+. ..-..+|+..|+.- .||||+++|+.-.+++..||..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 44455677776654 45789999999986432 24557899999999 699999999999999999999999
Q ss_pred cCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---C--CCEEEeecccccc
Q 013214 232 LPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---S--GNLKVADFGVSKL 302 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~----l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~--~~vkl~Dfg~~~~ 302 (447)
| ..+|.+++...+. ......+.++.|+++||+|||+.+ |+||||||+||||+. + .+++|+|||+++.
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9 5799999987411 122455788999999999999998 999999999999986 3 4689999999998
Q ss_pred cccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChh
Q 013214 303 LTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 303 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (447)
+..+... ......||.+|+|||++....-+..+||||+||++|+.++ |.+||.+.-..+. .+.... ..+....+
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~-~~L~~L~~ 737 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGN-YTLVHLEP 737 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCc-cceeeecc
Confidence 8755432 2356678999999999999888889999999999999998 5999996654432 221221 11111111
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+..+||.+|++.+|..||++.+++.|
T Consensus 738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 738 LPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred CchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111288999999999999999999999754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=227.50 Aligned_cols=212 Identities=26% Similarity=0.440 Sum_probs=168.5
Q ss_pred CcccceeeecceEEEE-----EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILA-----FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~-----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
......+||+|++|.+ ..+|+..|+|+++... +.....+..+|+++..+. .+|++|.+||.......+++.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3445568999999976 3689999999998653 334455667788887666 7999999999999999999999
Q ss_pred eccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 230 EYLPKGDLRAFL----KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 230 e~~~~g~L~~~l----~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
|.|+ -||..+- ++++.+++...=+++..+.+||.|||++- .++|||+||+|||++..|++|+||||.+-.+..
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9994 5886654 34667899999999999999999999975 599999999999999999999999999876543
Q ss_pred CCCCCcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCC-CchHHHHHhcCCCCC
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRPPF 374 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~ 374 (447)
. ...+...|-..|||||.+..+ .|+.++||||||+++.||.+++.||+.... .+..+++.....|.+
T Consensus 202 S--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~L 273 (282)
T KOG0984|consen 202 S--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQL 273 (282)
T ss_pred h--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCC
Confidence 2 222223345679999988543 688899999999999999999999997764 345555544444444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=255.98 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=194.8
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC------CCcccceeEEEEeCCc
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR------HPNVVQFLGAVTQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~~ 224 (447)
.|.+....|+|.|+.|. ..|+.||||++..+.... ..=..|+.+|+.++ --|+++++-.|...++
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 57777778999999875 468899999998554332 33356999999995 2379999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVS 300 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~ 300 (447)
+|||+|.+ .-+|.++|++-+ .|....+..++.|+.-||..|-..+ |+|+||||+|||+++.. .+||||||+|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999999 579999998755 4888999999999999999999998 99999999999999654 5899999999
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-cC-C-------
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQ-R------- 371 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~-~------- 371 (447)
...+... .+.+..+..|.|||++.+-.|+...|+||+||+||||+||+..|++.+........-. .+ .
T Consensus 585 ~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 585 SFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 8765432 2334456679999999999999999999999999999999999998887665433211 00 0
Q ss_pred -----------------------------------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHH
Q 013214 372 -----------------------------------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404 (447)
Q Consensus 372 -----------------------------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 404 (447)
+.++...+..-..+.+|+..||..||++|.|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 001111222335699999999999999999999
Q ss_pred HHHHH
Q 013214 405 QIITR 409 (447)
Q Consensus 405 ~~l~~ 409 (447)
+++.+
T Consensus 742 qAL~H 746 (752)
T KOG0670|consen 742 QALKH 746 (752)
T ss_pred HHhcC
Confidence 98864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=256.11 Aligned_cols=250 Identities=18% Similarity=0.211 Sum_probs=177.0
Q ss_pred CCcCcccceeeecceEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHH--------------H
Q 013214 153 HELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRA--------------F 197 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~---------------------~g~~vavK~~~~~~~~~~~~~~~--------------~ 197 (447)
...+|...+.||+|+||.||. .++.||||++.... ....++ .
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~---~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR---QGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc---hhhHHHHHhhhhhhhcccchh
Confidence 345788999999999999873 34679999986432 111222 2
Q ss_pred HHHHHHHhcCCCCc-----ccceeEEEEe--------CCceEEEEeccCCCCHHHHHHhcC-------------------
Q 013214 198 RDELALLQKIRHPN-----VVQFLGAVTQ--------SSPMMIVTEYLPKGDLRAFLKRKG------------------- 245 (447)
Q Consensus 198 ~~E~~~l~~l~hp~-----iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~------------------- 245 (447)
..|+.++.+++|.+ +++++++|.. .+..++|+||+++++|.++++...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 34666677776554 3667777653 356899999999999999986421
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcc
Q 013214 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320 (447)
Q Consensus 246 -----~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y 320 (447)
.+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++...............+++.|
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y 376 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence 1345678889999999999999998 99999999999999999999999999875543222222223347899
Q ss_pred cCCcccCCCC--------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCCCCc--------hHHHH--H
Q 013214 321 VAPEVFKNEE--------------------Y--DTKVDVFSFALILQEMIEGCP-PFTMKHDNE--------VPKAY--A 367 (447)
Q Consensus 321 ~aPE~~~~~~--------------------~--~~~~Di~slG~~l~~l~tg~~-p~~~~~~~~--------~~~~~--~ 367 (447)
+|||.+.... + ..+.|+||+||++|+|++|.. ||....... ..... .
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 9999875432 1 124799999999999999875 665322111 00000 0
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCC---CCCCCHHHHHHH
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKP---AKRPTFRQIITR 409 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~~~l~~ 409 (447)
......++ .....++...+++.+||..+| .+|+|++++++|
T Consensus 457 ~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11122332 234467889999999999766 689999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=265.62 Aligned_cols=246 Identities=19% Similarity=0.225 Sum_probs=162.8
Q ss_pred CCcCcccceeeecceEEEEEE-----c----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEE-----
Q 013214 153 HELDFTNSVEITKGTFILAFW-----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----- 218 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~----- 218 (447)
...+|...+.||+|+||.||. + +..||+|++..... . +...+| .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--V---EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--h---HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 344788899999999999873 3 78999998764321 1 111111 1122222222222211
Q ss_pred -EEeCCceEEEEeccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 013214 219 -VTQSSPMMIVTEYLPKGDLRAFLKRKGA--------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (447)
Q Consensus 219 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~ 277 (447)
.......++++||+.+++|.+++..... .....+..++.|++.||.|||+.+ |+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 2455678999999999999999875421 112345679999999999999998 9999
Q ss_pred CCCCCCEEEcC-CCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCC----------------------CCCCc
Q 013214 278 DLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE----------------------EYDTK 334 (447)
Q Consensus 278 Dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~ 334 (447)
||||+|||++. ++.+||+|||++...............+++.|+|||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999995 67999999999986544333333456678999999965322 23345
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC----------CCCCCCC-------hhhhHHHHHHHHHHHcccCC
Q 013214 335 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----------RPPFKAP-------AKLYARGLKELIEECWNEKP 397 (447)
Q Consensus 335 ~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~-------~~~~~~~l~~li~~cl~~dp 397 (447)
+|||||||++|+|+++..|+..... .....+.... .+..... ....+....+||.+||+.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 6999999999999997766442110 0001110000 0000000 00012235589999999999
Q ss_pred CCCCCHHHHHHH
Q 013214 398 AKRPTFRQIITR 409 (447)
Q Consensus 398 ~~Rps~~~~l~~ 409 (447)
++|||+.+++++
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=239.72 Aligned_cols=250 Identities=24% Similarity=0.414 Sum_probs=198.2
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cce
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 225 (447)
+.+-.+.||.|+||.|. .+|+.||+|++.. .+..--....+.+|++++..++|.|++..++...-. ..+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 44556789999999876 4799999999864 333444556777899999999999999988876533 246
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
|.++|.+ ..+|...+.+...++.+.+.-++.||++||+|||+.+ |+||||||.|.|++++..+||||||+++....
T Consensus 133 YV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 8899999 5789998888888999999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC-----------
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP----------- 372 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~----------- 372 (447)
......+....|-.|.|||++.+. .|+...||||.||++.||+.++..|...++.+..+.+... +.|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 555555555568889999999875 7889999999999999999999999877765544433111 111
Q ss_pred -------------CCCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 013214 373 -------------PFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 373 -------------~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l 410 (447)
.++. .+..-..+...++..++..||++|.+..+.+.++
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1110 0112233566788899999999999999988765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=237.04 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=209.7
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-Cc
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~ 224 (447)
+++....+-+|+||.++. +.+.|-+|.++.. .++-+...+..|.-.+....|||+.++.+++..+ ..
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 344555678899998763 2456777877654 3455667788899899999999999999987654 56
Q ss_pred eEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 225 MMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
.+.++.++.-|+|..++... ..++..+...++.|++.|+.|||+++ ++|.||..+|.+|++.-++||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEecc
Confidence 78899999999999999732 12667788889999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCc-ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 297 FGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 297 fg~~~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
=.+++.+-....... ...-.+..||+||.+....|+..+|+||||+++|||+| |+.||..-++.|....+..+.+..-
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 999987643322111 22234778999999999999999999999999999999 9999999999998877766665543
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
|-++|+++-.+|.-||+.+|++||+++++..-|.+...++.
T Consensus 520 ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 520 ---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred ---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 45788999999999999999999999999999998877654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=233.19 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=191.6
Q ss_pred CcCcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------C
Q 013214 154 ELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 223 (447)
..+|...+.+|.|.-..+. ..+++||+|++..+.. ....-++..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCceEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 3456666677777663222 4689999999877633 333334556799999999999999999998644 3
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..|+|||+| ..+|...+. -.++-.+...++.|++.|++|||+.| |+||||||+||++..++.+|+.|||+++..
T Consensus 95 e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 479999999 579988887 45778899999999999999999999 999999999999999999999999999864
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH-hcCC-----------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQR----------- 371 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~-~~~~----------- 371 (447)
... ...+.+..|..|.|||++.+..+.+.+||||+||++.||++|+..|.+.+.-+...++. .-+.
T Consensus 169 ~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 169 DTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred Ccc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 432 34466778889999999999889999999999999999999999998765422211110 0000
Q ss_pred ---------CC---------CC--------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ---------PP---------FK--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ---------~~---------~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+. ++ ...+.-+..+++++.+||..||++|.|+.+++.|
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 00 0111234568899999999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=218.17 Aligned_cols=241 Identities=20% Similarity=0.392 Sum_probs=187.0
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeC--CceE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~~~ 226 (447)
.+|++.+++|+|.++.|+ .+.+.++||+++.- ....+.+|+.+|+.+. ||||+++++...++ ....
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 468888999999997664 57889999999743 2367889999999995 99999999988654 5678
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeeccccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTV 305 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~~~~~ 305 (447)
+++||+++.+....- ..++...+..++.+++.||.||||.| |.|||+||.|++||. .-.++|+|+|+|.++..
T Consensus 112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999999877766544 34788889999999999999999999 999999999999994 45699999999999875
Q ss_pred CCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCC-CCCCchHHHHHhc--------------
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYAAR-------------- 369 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~-~~~~~~~~~~~~~-------------- 369 (447)
.. .......+..|.-||.+.. +.|+.+-|+|||||++..|+..+.||-. .++.+....+...
T Consensus 186 ~~--eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 GK--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred Cc--eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 43 2333445667889998765 4688999999999999999998888753 3332222221110
Q ss_pred --CCCCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 --QRPPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 --~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
-.|.+. .....++++..+++.++|..|-++|+|++|.+.+
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 001110 1112356899999999999999999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=253.29 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=208.4
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|.....+|+|++|-|+ .+++..|+|+++.+ ..+...-++.|+-+++-.+||||+.+++.+.....++++||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45666789999999886 36889999999865 33445667789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
||.||+|++.-+-.+++++.++..+.+..+++++|||+.| =+|||||=.||++++.|.+|++|||.+..+...- ..
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 9999999998888899999999999999999999999999 7999999999999999999999999987665432 22
Q ss_pred cccCCCCCcccCCccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-cCCCCCCCChhhhHHHHH
Q 013214 311 LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~ 386 (447)
...+.||+.|||||+- +.+.|+..+|+|++|++..|+-.-++|..+..+.+.....-. ...++-......+++.+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 3567899999999975 456789999999999999999888888666555554444322 235555556677899999
Q ss_pred HHHHHHcccCCCCCCCHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~ 408 (447)
++++.++..+|++||+++.++.
T Consensus 249 ~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHhcCCCccCCChhhhee
Confidence 9999999999999999998876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=215.17 Aligned_cols=206 Identities=37% Similarity=0.650 Sum_probs=176.0
Q ss_pred eecceEEEEE---Ec--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 163 ITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 163 lg~G~~~~~~---~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
||+|.+|.++ .. |+.+++|+........ ..+.+.+|+..++.++|++++++++++......++++||+.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 4677776554 33 8999999987553211 456788999999999999999999999998999999999998999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeecccccccccCCCCCcccCC
Q 013214 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQD 315 (447)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 315 (447)
.+++... ..++...++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 9999875 56899999999999999999999998 999999999999999 89999999999876543321 122344
Q ss_pred CCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 316 TSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 316 ~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
+...|++||.+... ..+.++|+|++|++++++ ..+.+++..|++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence 67789999999877 778899999999999999 567899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013214 395 EKPAKRPTFRQIITR 409 (447)
Q Consensus 395 ~dp~~Rps~~~~l~~ 409 (447)
.||.+||++.+++++
T Consensus 200 ~~p~~R~~~~~l~~~ 214 (215)
T cd00180 200 KDPEKRPSAKEILEH 214 (215)
T ss_pred CCcccCcCHHHHhhC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-29 Score=237.86 Aligned_cols=195 Identities=24% Similarity=0.394 Sum_probs=170.3
Q ss_pred CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHH-----HHHHHHHHhcCC---CCcccceeEEEEeC
Q 013214 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRA-----FRDELALLQKIR---HPNVVQFLGAVTQS 222 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~-----~~~E~~~l~~l~---hp~iv~~~~~~~~~ 222 (447)
+|...+.+|+|+||.|. .+...|++|.+.++.+-.+..+++ .-.|+++|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 58888899999999874 356789999998876544443332 446999999996 99999999999999
Q ss_pred CceEEEEecc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 223 SPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 223 ~~~~lv~e~~-~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
+..||+||-- +|-+|.+++...+.+++.++..|++|++.|+++||+.| |+|||||-+|+.++.+|-+||+|||++.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchh
Confidence 9999999986 45699999999999999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCC
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTM 356 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~ 356 (447)
... +.+...+.||..|.|||++.+.+|- ..-|||++|+++|.+...+.||..
T Consensus 719 ~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 654 3455667899999999999988765 468999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=213.79 Aligned_cols=199 Identities=33% Similarity=0.564 Sum_probs=168.1
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|.....||.|+++.++. +++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 34567889999887652 4789999999765322 2567888999999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~-l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++++|.+++..... +++.....++.+++.++.+||+.+ ++|+|++|.||+++.++.++|+|||.+..........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999999999988766 899999999999999999999998 9999999999999999999999999988765432112
Q ss_pred cccCCCCCcccCCccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCCC
Q 013214 311 LTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDN 360 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~tg~~p~~~-~~~~ 360 (447)
.....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 2334567789999998 666778899999999999999999999976 4443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=214.53 Aligned_cols=252 Identities=18% Similarity=0.322 Sum_probs=191.7
Q ss_pred CCCcccCCCCc--CcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCccccee
Q 013214 145 VPEYEIDPHEL--DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFL 216 (447)
Q Consensus 145 ~~~~~i~~~~~--~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~ 216 (447)
++..++...++ .|.+.+.+|+|.||... .+.+.+++|.++.+ .....+|.+|...--.+ .|.||+..|
T Consensus 12 I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY 87 (378)
T KOG1345|consen 12 IPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTY 87 (378)
T ss_pred cccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHH
Confidence 45555554443 58888899999999764 46789999998754 34567899999876666 589999887
Q ss_pred EE-EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC--CCCEE
Q 013214 217 GA-VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLK 293 (447)
Q Consensus 217 ~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~--~~~vk 293 (447)
+. |+..+..++++||++.|+|.+-+.. ..+.+.....++.|+++|+.|||+++ +||||||.+||||-. ..++|
T Consensus 88 ~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 88 EVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred HHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEE
Confidence 64 6777888999999999999987754 34778888999999999999999999 999999999999863 34899
Q ss_pred EeecccccccccCCCCCcccCCCCCcccCCcccCC---C--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch----HH
Q 013214 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN---E--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV----PK 364 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~----~~ 364 (447)
|||||.++..+..... ..-+..|.+||.... + ...+.+|+|.||+++|.++||++||+....... ..
T Consensus 164 lcDFG~t~k~g~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~ 239 (378)
T KOG1345|consen 164 LCDFGLTRKVGTTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE 239 (378)
T ss_pred eeecccccccCceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence 9999998865432211 123566889987532 2 567889999999999999999999985443221 12
Q ss_pred HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
....+..+..+......++.+..+.++-+..+|++|-...+..+
T Consensus 240 ~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 240 QWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred HHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 22233355555566678889999999999999999944444433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=204.10 Aligned_cols=165 Identities=18% Similarity=0.280 Sum_probs=131.3
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 013214 235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (447)
Q Consensus 235 g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 313 (447)
|+|.+++.++ ..+++.+++.++.|++.||.|||+.+ ||+||+++.++.+|+ ||++...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------~ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------Q 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------c
Confidence 6899999874 45999999999999999999999875 999999999999999 9998765432 1
Q ss_pred CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHhcCCCC---CCCChhhhHH--HHHH
Q 013214 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPP---FKAPAKLYAR--GLKE 387 (447)
Q Consensus 314 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~--~l~~ 387 (447)
..+|+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.....+. -......++. .+.+
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD 143 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence 246899999999999999999999999999999999999997654322 222222221111 1112334454 6999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+|.+||+.||.+||++.++++++..+..+
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 99999999999999999999998776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=217.80 Aligned_cols=129 Identities=29% Similarity=0.380 Sum_probs=107.0
Q ss_pred CCCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----CC---cccceeEE
Q 013214 152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HP---NVVQFLGA 218 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp---~iv~~~~~ 218 (447)
+...+|...++||.|-|++|. ...+.||+|+.+. .+-..+....|+.+|+++. |+ +||++++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 334578999999999998875 3568999999873 2334566678999999983 33 59999999
Q ss_pred EEeC----CceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc
Q 013214 219 VTQS----SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (447)
Q Consensus 219 ~~~~----~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~ 287 (447)
|... .++|+|+|++ |.+|..++... +.++...+..|++|++.||.|||+.. +|||-||||+|||+.
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 9753 5799999999 78999999865 45999999999999999999999976 599999999999984
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=256.25 Aligned_cols=195 Identities=16% Similarity=0.209 Sum_probs=140.6
Q ss_pred cCCC-CcccceeEEE-------EeCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 013214 206 KIRH-PNVVQFLGAV-------TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (447)
Q Consensus 206 ~l~h-p~iv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H 276 (447)
.++| +||++++++| .....++.++||+ +++|.+++... ..+++.++..++.||+.||.|||++| |+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 3445 5777777776 2334678889988 67999999753 45999999999999999999999999 999
Q ss_pred CCCCCCCEEEcCCC-------------------CEEEeecccccccccCCC---------------CCcccCCCCCcccC
Q 013214 277 RDLEPSNILRDDSG-------------------NLKVADFGVSKLLTVKED---------------RPLTCQDTSCRYVA 322 (447)
Q Consensus 277 ~Dikp~Nill~~~~-------------------~vkl~Dfg~~~~~~~~~~---------------~~~~~~~~t~~y~a 322 (447)
|||||+|||++..+ .+|++|||+++....... .......+|+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996544 455666666543211000 00011347888999
Q ss_pred CcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 013214 323 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402 (447)
Q Consensus 323 PE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 402 (447)
||++.+..++.++|||||||++|||++|..|+.... .....+.....++. .....+...+++.+||+.+|.+||+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQ---ILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChh---hhhcCHHHHHHHHHhCCCChhhCcC
Confidence 999999899999999999999999999988865322 11112211111111 1111345668889999999999999
Q ss_pred HHHHHHH
Q 013214 403 FRQIITR 409 (447)
Q Consensus 403 ~~~~l~~ 409 (447)
+.+++++
T Consensus 259 ~~eil~h 265 (793)
T PLN00181 259 MSELLQS 265 (793)
T ss_pred hHHHhhc
Confidence 9999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=203.53 Aligned_cols=258 Identities=15% Similarity=0.254 Sum_probs=213.5
Q ss_pred CCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceE
Q 013214 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 226 (447)
.-..|.++++||+|+||..+ .++++||||.-+.... ..++..|....+.+ ..++|+..|-+.....+..
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 34579999999999998754 6899999997764432 24677899999988 5899999999888888889
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-----CEEEeecccc
Q 013214 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGVS 300 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-----~vkl~Dfg~~ 300 (447)
||+|++ |.||+|++.-. +.++..++..++.|++.-++++|++. +|.|||||+|+||...+ .|.++|||++
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999999 88999998744 56999999999999999999999999 99999999999998654 4899999999
Q ss_pred cccccCCCCC------cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC----
Q 013214 301 KLLTVKEDRP------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---- 370 (447)
Q Consensus 301 ~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---- 370 (447)
+.+..+.... ..+..||.+||+-..+.+...+.+.|+-|||-++.+.+.|..||.+..-....+....-+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 9876543322 245679999999999999999999999999999999999999999877655444432222
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
..++...+.++|.++...++-.-..+-.+-|..+-+...+.++......
T Consensus 257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 2233334567889999999998899999999999999999888877643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=212.38 Aligned_cols=244 Identities=21% Similarity=0.360 Sum_probs=186.6
Q ss_pred cCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 225 (447)
..|....+||+|+|+.|+. ..+.||+|.+..... . ..+.+|+++|..+ .+.||+++.+++..++..
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--P---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--c---hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3567778999999998862 578999999875432 2 4578899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~~~~~~ 304 (447)
++|+||++.....++... ++..++..+++.++.||.++|.+| |+||||||+|++.+ ..+.-.|+|||++....
T Consensus 111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999998888887754 678899999999999999999999 99999999999998 56778999999987221
Q ss_pred cCC--------------C-----------------------------CCcccCCCCCcccCCcccCC-CCCCCchhHHHH
Q 013214 305 VKE--------------D-----------------------------RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSF 340 (447)
Q Consensus 305 ~~~--------------~-----------------------------~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~sl 340 (447)
... . .......||++|.|||++.. +..+++.||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0 00023458999999999765 467789999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCc--------------hHHHHHhcCC------------------------CCCC-------
Q 013214 341 ALILQEMIEGCPPFTMKHDNE--------------VPKAYAARQR------------------------PPFK------- 375 (447)
Q Consensus 341 G~~l~~l~tg~~p~~~~~~~~--------------~~~~~~~~~~------------------------~~~~------- 375 (447)
|+++..+++++.||-.....- +.+.-...++ ..+.
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 999999999999985433210 0000000000 0000
Q ss_pred ---CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 376 ---APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 376 ---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....++..+-+++++|+..||.+|.|+++.+++
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0011234578899999999999999999999875
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=186.69 Aligned_cols=259 Identities=17% Similarity=0.228 Sum_probs=208.0
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 228 (447)
..|...++||+|+||-.+ .+|+.||+|.-+..... .++.-|..+.+.++ ...|+.+..+..+...-.+|
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 468889999999998655 58999999987654432 35667889999995 56788888888888889999
Q ss_pred EeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeecccccccc
Q 013214 229 TEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLT 304 (447)
Q Consensus 229 ~e~~~~g~L~~~l~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg~~~~~~ 304 (447)
||.+ |.+|++.+. ..+.++..+++-++-|++.-++|+|.++ ++||||||+|+|+.- ...+.++|||+|+.+.
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999 889999886 3466999999999999999999999999 999999999999873 3469999999998764
Q ss_pred cCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHH---HHhcC-CCCC
Q 013214 305 VKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA---YAARQ-RPPF 374 (447)
Q Consensus 305 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~---~~~~~-~~~~ 374 (447)
..... ......||.+|.+-....+-..+.+.|+-|+|.++.++..|..||++.......+. +.... ..+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 32211 12345689999998888777788999999999999999999999998876543333 22221 2222
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccc
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 422 (447)
...+..+|.++.-.+.-|-..--++-|....+.+.+..+....+....
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d 293 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYD 293 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCC
Confidence 234556788999999999999999999999999999999988877643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-23 Score=202.34 Aligned_cols=255 Identities=20% Similarity=0.307 Sum_probs=197.3
Q ss_pred CcccceeeecceEEEEEE----c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC----CCcccceeEEE-EeCCc
Q 013214 156 DFTNSVEITKGTFILAFW----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAV-TQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----hp~iv~~~~~~-~~~~~ 224 (447)
+|...+.||+|+||.++. . ...+|+|.......... ..+..|..++..+. .+++.++++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 788999999999998873 1 24789998765422111 14667888888886 26899999998 47778
Q ss_pred eEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-----CCEEEeec
Q 013214 225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-----GNLKVADF 297 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~-----~~vkl~Df 297 (447)
.++||+.+ |.+|.++.... +.++..++..++.|++.+|.++|+.| ++||||||+|+++... ..++|.||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 89999999 88999988654 46999999999999999999999999 9999999999999865 35999999
Q ss_pred ccccccc--cCC------CCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh
Q 013214 298 GVSKLLT--VKE------DRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 298 g~~~~~~--~~~------~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 368 (447)
|+++... ... ... .....||.+|.++..+.+...+++.|+||++.++.++..|..||..............
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998322 111 111 1235589999999999999999999999999999999999999987665433333322
Q ss_pred cCCCCCCC-ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 369 RQRPPFKA-PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 369 ~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
........ .....+.++.++...+-..+...+|....+...++......
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 22111111 12334577888888888899999999999999988876654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-21 Score=188.75 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=198.2
Q ss_pred cccceeeecceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC-cccceeEEEEeCCceEEEEeccC
Q 013214 157 FTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
|.....||.|+|+.++. ....+++|.+.............+.+|..++..+.|+ +++++.+.+......+++++++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 45667899999987763 2367899999876554444677889999999999888 79999999977777899999999
Q ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccccccCCCC
Q 013214 234 KGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 234 ~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~~ 309 (447)
++++.+++.... .++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999998877665 7899999999999999999999999 99999999999999988 6999999998755433221
Q ss_pred -----CcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----CchHHHHHhcCCC-CCCC
Q 013214 310 -----PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKAYAARQRP-PFKA 376 (447)
Q Consensus 310 -----~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~----~~~~~~~~~~~~~-~~~~ 376 (447)
......++..|++||.+.+ ...+...|+||+|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2355678999999999987 5788899999999999999999999876664 2333333222222 1111
Q ss_pred Chh----hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 PAK----LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ~~~----~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
... .....+.+++..++..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111 113578899999999999999999887765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-24 Score=220.95 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=185.2
Q ss_pred cceeeecceEEEEEE-----cCeEEEEEEcCc---ccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 159 NSVEITKGTFILAFW-----RGIQVAVKKLGE---EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 159 ~~~~lg~G~~~~~~~-----~g~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
..+.+|.|.+|.++. ....++.|.... ...........+..|+.+-..++|||++.....+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 455778888883331 122233332221 111122222236678888888999999887777666555555699
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-- 308 (447)
||++ +|..++.+.+.+...++..++.|++.|+.|+|+.| +.|||+|++|+++..+|.+||+|||.+.....+-.
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9998 99999998888999999999999999999999999 99999999999999999999999999876554332
Q ss_pred -CCcccCCCCCcccCCcccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCCCchH--HHHHhcCC---CCCCCChhhh
Q 013214 309 -RPLTCQDTSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVP--KAYAARQR---PPFKAPAKLY 381 (447)
Q Consensus 309 -~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~tg~~p~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~ 381 (447)
.......|+..|+|||.+.+..|++ ..||||.|+++..|.+|+.||......+.. ......++ .........+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 2335567899999999999999987 589999999999999999999866654432 11111111 1111234567
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
+...+.+|.+||+.||.+|.|+++|++
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhh
Confidence 788999999999999999999999987
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=194.60 Aligned_cols=168 Identities=21% Similarity=0.227 Sum_probs=126.7
Q ss_pred cccCCCCcCcccceeeecceEEEEEE------cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHhcCCCCcccc-eeEE
Q 013214 148 YEIDPHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQ-FLGA 218 (447)
Q Consensus 148 ~~i~~~~~~~~~~~~lg~G~~~~~~~------~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~-~~~~ 218 (447)
..+.+...+|...+.||+|+||.|+. +++.||||++..... ......+.+.+|++++++++|+|+++ +++.
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 34445556799999999999998872 467789998753311 13345567899999999999999985 4432
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEEcCCCCEEEeec
Q 013214 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADF 297 (447)
Q Consensus 219 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Di-kp~Nill~~~~~vkl~Df 297 (447)
+..+++|||++|++|... .. .. ...++.|++++|.|||+.| |+|||| ||+|||++.++.+||+||
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 457999999999999732 11 11 1467899999999999999 999999 999999999999999999
Q ss_pred ccccccccCCCC-------CcccCCCCCcccCCcccCCC
Q 013214 298 GVSKLLTVKEDR-------PLTCQDTSCRYVAPEVFKNE 329 (447)
Q Consensus 298 g~~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~ 329 (447)
|+++.+...... ......+++.|+|||.+...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999866433211 11234567789999988543
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-23 Score=168.98 Aligned_cols=103 Identities=35% Similarity=0.352 Sum_probs=53.2
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHc-CCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~-g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~ 115 (447)
|-.||||||.||..|+.++++.|+.. |+|+|..+..|+||||||+..|+.+++++|+++|+.++.+|..|.||||-|+.
T Consensus 69 DdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAa 148 (226)
T KOG4412|consen 69 DDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAA 148 (226)
T ss_pred cccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHHHh
Confidence 33445555555555555555555544 55555555555555555555555555555555555555555555555555555
Q ss_pred cchHHHHHHHHHhCCCCCCCcccc
Q 013214 116 YKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 116 ~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
.|+.+++++|+..|+.+++.+..+
T Consensus 149 vGklkvie~Li~~~a~~n~qDk~G 172 (226)
T KOG4412|consen 149 VGKLKVIEYLISQGAPLNTQDKYG 172 (226)
T ss_pred ccchhhHHHHHhcCCCCCcccccC
Confidence 555555555555555544444333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-23 Score=210.80 Aligned_cols=244 Identities=20% Similarity=0.291 Sum_probs=174.0
Q ss_pred CcccceeeecceEEEEE---E-cCeEEEEEEcCccc-CCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAF---W-RGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~-~g~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
++...+.+|++.|-++. . .|. |.||++.+.. .-+-....+-.+|++ ...+++||++++.-....++..|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 46677789999996543 2 344 8999886432 111122222233444 566699999999888778888899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|. ..+|+|.+..++.+..-+...++.|++.|+.-+|..| |+|||||.+|||+++-..+.|+||..-+..=.+.+.+
T Consensus 102 yv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99 5699999998888889999999999999999999999 9999999999999999999999998765332222222
Q ss_pred --cc----cCCCCCcccCCcccCCC-----------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCC
Q 013214 311 --LT----CQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 311 --~~----~~~~t~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
.. ....-..|.|||.+... ..+++.||||+||++.||++ |++||.-. ++.... .+..-
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aYr-~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAYR-SGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhHh-ccCcc
Confidence 11 12233469999988541 15678999999999999998 89988611 111110 11000
Q ss_pred CCCCChh-hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 PFKAPAK-LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ~~~~~~~-~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....... --+..++++|..|++.||.+|.|+++.++.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000000 012368899999999999999999999886
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-22 Score=164.06 Aligned_cols=109 Identities=28% Similarity=0.378 Sum_probs=102.0
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|+|..+..|.|+|||||..|+.+++++|+++|+.++.+|..|+||||.|+..|...++++|+..||.+|.+|+.|+||
T Consensus 96 ~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~Tp 175 (226)
T KOG4412|consen 96 GADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTP 175 (226)
T ss_pred CCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCcccccCccH
Confidence 56667777788889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~ 138 (447)
||.|...|+.+...+|+++||++...+..
T Consensus 176 L~~al~e~~~d~a~lLV~~gAd~~~edke 204 (226)
T KOG4412|consen 176 LHHALAEGHPDVAVLLVRAGADTDREDKE 204 (226)
T ss_pred HHHHHhccCchHHHHHHHhccceeecccc
Confidence 99998889999999999999998776553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=199.15 Aligned_cols=222 Identities=22% Similarity=0.325 Sum_probs=184.4
Q ss_pred eecceEEEEE--------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEeccC
Q 013214 163 ITKGTFILAF--------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 163 lg~G~~~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
+|.|.||.|+ ..|.-+|+|++++......... ....|-.++...+ ||+++++.-.++.+...+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 5788888764 3567788998876544333222 5567888888886 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCccc
Q 013214 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (447)
Q Consensus 234 ~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 313 (447)
||+|...+.+...+.+.....+...++-++.++|+.+ ++|+|+|++||+++.+|++++.|||+++..-.. ..
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~-----~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE-----KI 152 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh-----hh
Confidence 9999999988888899999999999999999999999 999999999999999999999999999864322 11
Q ss_pred CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 013214 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393 (447)
Q Consensus 314 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 393 (447)
.+||..|||||++. .....+|.||||+++++|++|..||.. ++...+ .+.... .+...+...++++..++
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I-l~~~~~---~p~~l~~~a~~~~~~l~ 222 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI-LKAELE---MPRELSAEARSLFRQLF 222 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH-hhhccC---CchhhhHHHHHHHHHHH
Confidence 27899999999997 567889999999999999999999997 444444 222222 25667889999999999
Q ss_pred ccCCCCCCCH
Q 013214 394 NEKPAKRPTF 403 (447)
Q Consensus 394 ~~dp~~Rps~ 403 (447)
..+|.+|...
T Consensus 223 ~r~p~nrLg~ 232 (612)
T KOG0603|consen 223 KRNPENRLGA 232 (612)
T ss_pred hhCHHHHhcc
Confidence 9999999755
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-21 Score=172.31 Aligned_cols=170 Identities=10% Similarity=0.164 Sum_probs=131.7
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHH------HHHHHHHHhcCCCCcccceeEEEEeC--
Q 013214 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRA------FRDELALLQKIRHPNVVQFLGAVTQS-- 222 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~hp~iv~~~~~~~~~-- 222 (447)
+.+|+..+.+|.|+||.|+ .++..+|+|.+.......+...+. +.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 4478888999999999876 356789999998765555444444 57899999999999999999886543
Q ss_pred ------CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 223 ------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 223 ------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
...+++|||++|.+|.++.. +++ ....+++.++..+|+.| ++|||+||+||+++++| ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEE
Confidence 35789999999999988632 333 34569999999999999 99999999999999988 99999
Q ss_pred cccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHH
Q 013214 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (447)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 348 (447)
||........ ... ..++....++.++|+||||+++..+.
T Consensus 178 fg~~~~~~e~--~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQR--KAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccch--hhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 9987643211 100 01344455677999999999987664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=182.14 Aligned_cols=212 Identities=30% Similarity=0.503 Sum_probs=165.9
Q ss_pred HhcCCCCcccceeEEEEeCCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EeCCCCC
Q 013214 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPI-IHRDLEP 281 (447)
Q Consensus 204 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i-~H~Dikp 281 (447)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. .-.++......++++++.||.|+|..- + .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence 3577899999999999999999999999999999999987 345888888899999999999999975 4 9999999
Q ss_pred CCEEEcCCCCEEEeeccccccccc-CCCCCcccCCCCCcccCCcccCCCC-------CCCchhHHHHHHHHHHHHhCCCC
Q 013214 282 SNILRDDSGNLKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEVFKNEE-------YDTKVDVFSFALILQEMIEGCPP 353 (447)
Q Consensus 282 ~Nill~~~~~vkl~Dfg~~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~l~tg~~p 353 (447)
.|.+++....+||+|||+...... .............-|.|||.+.... .+.+.|+||+|++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 999999999999999999876532 1111111222345699999987641 35679999999999999999999
Q ss_pred CCCCCCC----chHHHHHhcCCCCCCCChh---hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 354 FTMKHDN----EVPKAYAARQRPPFKAPAK---LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 354 ~~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
|...... ++...+...+..++.+... ..++++..+++.||..+|.+||+++.+...++.+.....
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~ 229 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGS 229 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccccc
Confidence 9864432 3333433323333322111 345578999999999999999999999998888776543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=165.71 Aligned_cols=137 Identities=20% Similarity=0.234 Sum_probs=105.7
Q ss_pred eeeecceEEEEEE----cCeEEEEEEcCcccCCCHHH-----------------------HHHHHHHHHHHhcCCCCccc
Q 013214 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDR-----------------------VRAFRDELALLQKIRHPNVV 213 (447)
Q Consensus 161 ~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~hp~iv 213 (447)
..||+|++|.|+. +|+.||+|+++......... ......|+.++.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4699999998863 68999999997543211110 11234599999999888775
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeCCCCCCCEEEcCCCCE
Q 013214 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL-HENKPVPIIHRDLEPSNILRDDSGNL 292 (447)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~l-H~~~~~~i~H~Dikp~Nill~~~~~v 292 (447)
........ ..++||||++|+++.....+..+++..++..++.|++.+|.++ |+.| ++||||||+||+++ ++.+
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcE
Confidence 44433222 2389999998887766544556799999999999999999999 6888 99999999999998 4789
Q ss_pred EEeeccccccc
Q 013214 293 KVADFGVSKLL 303 (447)
Q Consensus 293 kl~Dfg~~~~~ 303 (447)
+|+|||++...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=174.76 Aligned_cols=231 Identities=19% Similarity=0.305 Sum_probs=149.2
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC----------CcccceeEE
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH----------PNVVQFLGA 218 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------p~iv~~~~~ 218 (447)
..++.....||.|+++.++ .+|+++|+|+............+++++|.-....+.+ -.++..++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 3356677889999999876 3689999998866554555567778777755555422 123333332
Q ss_pred EEe---------C---C-----ceEEEEeccCCCCHHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 013214 219 VTQ---------S---S-----PMMIVTEYLPKGDLRAFLKR---KGA----LKPSTAVRFALDIARGMNYLHENKPVPI 274 (447)
Q Consensus 219 ~~~---------~---~-----~~~lv~e~~~~g~L~~~l~~---~~~----l~~~~~~~i~~ql~~~l~~lH~~~~~~i 274 (447)
..- . . ..+++|+-+ .++|.+++.. ... +.......+..|+++.+++||+.| +
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---L 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence 211 1 1 246788888 5799888642 222 222334456689999999999999 9
Q ss_pred EeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCC--------CCCCchhHHHHHHHHHH
Q 013214 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--------EYDTKVDVFSFALILQE 346 (447)
Q Consensus 275 ~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~Di~slG~~l~~ 346 (447)
+|+||||+|++++.+|.++|+||+.....+... .....+..|.|||..... .++.+.|.|+||+++|.
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999999998776544221 112335678999976432 46788999999999999
Q ss_pred HHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCC
Q 013214 347 MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400 (447)
Q Consensus 347 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 400 (447)
|++|+.||........... .+. .+.++|+.++.||+.+|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-------~f~-~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-------DFS-RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-------GGT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-------cch-hcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999986654332211 111 233678999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-19 Score=157.15 Aligned_cols=186 Identities=13% Similarity=0.067 Sum_probs=134.1
Q ss_pred cceeeecceEEEEEE---cCeEEEEEEcCcccCCCHH-HHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEeccC
Q 013214 159 NSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDD-RVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 159 ~~~~lg~G~~~~~~~---~g~~vavK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
....|++|+||.+++ .+.+++.+.+......... ....+.+|+++|++++ |+++++++++ ...+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 345789999998875 4567776666543221111 1225789999999994 5889999886 34699999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEEcCCCCEEEeecccccccccCCCC---
Q 013214 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFGVSKLLTVKEDR--- 309 (447)
Q Consensus 234 ~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Di-kp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--- 309 (447)
|.+|.+.... ....++.|++.++.++|+.| |+|||| ||+||+++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9998764321 12357789999999999999 999999 799999999999999999999854432210
Q ss_pred -C--------cccCCCCCcccCCcccCCC-CCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 013214 310 -P--------LTCQDTSCRYVAPEVFKNE-EYD-TKVDVFSFALILQEMIEGCPPFTMKH 358 (447)
Q Consensus 310 -~--------~~~~~~t~~y~aPE~~~~~-~~~-~~~Di~slG~~l~~l~tg~~p~~~~~ 358 (447)
. ......++.+++|+...-- ..+ ...+.++.|.-+|.++|+..|..+.+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0011246677777643211 223 56788999999999999998876544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=157.60 Aligned_cols=139 Identities=19% Similarity=0.175 Sum_probs=107.7
Q ss_pred ceeeecceEEEEEE----cCeEEEEEEcCcccCCCH----------------------H-HHHHHHHHHHHHhcCCCCcc
Q 013214 160 SVEITKGTFILAFW----RGIQVAVKKLGEEVISDD----------------------D-RVRAFRDELALLQKIRHPNV 212 (447)
Q Consensus 160 ~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~----------------------~-~~~~~~~E~~~l~~l~hp~i 212 (447)
...||+|++|.|+. +|+.||||+++....... . ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999998863 589999999876521100 0 01234679999999999988
Q ss_pred cceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCC
Q 013214 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 213 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
.....+.... .++||||++|+++........+++......++.|++.++.++|+ .| ++||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence 6554443332 48999999887654443344668888999999999999999999 88 99999999999999 889
Q ss_pred EEEeecccccccc
Q 013214 292 LKVADFGVSKLLT 304 (447)
Q Consensus 292 vkl~Dfg~~~~~~ 304 (447)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=165.43 Aligned_cols=196 Identities=21% Similarity=0.287 Sum_probs=144.3
Q ss_pred CCCcccceeEEEEe---------------------------CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 013214 208 RHPNVVQFLGAVTQ---------------------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260 (447)
Q Consensus 208 ~hp~iv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~ 260 (447)
+||||+++.++|.+ ...+|+||..+ ..+|..++..+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 69999999887743 23589999998 469999997654 46667778899999
Q ss_pred HHHHHHHhCCCCCeEeCCCCCCCEEEc--CCC--CEEEeeccccccccc-----CCCCCcccCCCCCcccCCcccCCCC-
Q 013214 261 RGMNYLHENKPVPIIHRDLEPSNILRD--DSG--NLKVADFGVSKLLTV-----KEDRPLTCQDTSCRYVAPEVFKNEE- 330 (447)
Q Consensus 261 ~~l~~lH~~~~~~i~H~Dikp~Nill~--~~~--~vkl~Dfg~~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~- 330 (447)
+|+.|||.+| +.|||+|++|||+. +++ .+.++|||.+-.-.. +-....-..+|....||||+....+
T Consensus 352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999 99999999999985 333 478999997642111 1111122345777899999975431
Q ss_pred ----CC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHH
Q 013214 331 ----YD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405 (447)
Q Consensus 331 ----~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 405 (447)
.+ .|+|.|+.|.+.||++....||.......+. ........++..+..+++.+++++...|+.||.+|+|..-
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheec--hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 22 4899999999999999999999874332221 1112223344456678899999999999999999998765
Q ss_pred HHHHH
Q 013214 406 IITRL 410 (447)
Q Consensus 406 ~l~~l 410 (447)
..+.|
T Consensus 507 AANvl 511 (598)
T KOG4158|consen 507 AANVL 511 (598)
T ss_pred HHhHH
Confidence 54443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-19 Score=158.56 Aligned_cols=135 Identities=17% Similarity=0.274 Sum_probs=104.1
Q ss_pred CcccceeeecceEEEEEE---cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-----CCCcccceeEEEEeCC---c
Q 013214 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-----RHPNVVQFLGAVTQSS---P 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~---~ 224 (447)
++.....||+|+++.||. ++.. +||++.... ....+.+.+|+.+++.+ .||||++++++++++. .
T Consensus 3 ~L~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 3 RLSEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred ecCCcceecCCCceEEEECCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 345567899999999984 2333 577775432 22346789999999999 5799999999998874 3
Q ss_pred eE-EEEec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeCCCCCCCEEEcCC----CCEEEee
Q 013214 225 MM-IVTEY--LPKGDLRAFLKRKGALKPSTAVRFALDIARGM-NYLHENKPVPIIHRDLEPSNILRDDS----GNLKVAD 296 (447)
Q Consensus 225 ~~-lv~e~--~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l-~~lH~~~~~~i~H~Dikp~Nill~~~----~~vkl~D 296 (447)
++ +|+|| +.+++|.+++++. .+++. ..++.|++.++ .|||+++ |+||||||+||+++.. +.++|+|
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 33 78999 5579999999764 46655 35678888777 9999999 9999999999999743 3799999
Q ss_pred cccc
Q 013214 297 FGVS 300 (447)
Q Consensus 297 fg~~ 300 (447)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.5e-19 Score=183.76 Aligned_cols=258 Identities=19% Similarity=0.228 Sum_probs=188.6
Q ss_pred CCcccCCCCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCcccceeEE
Q 013214 146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGA 218 (447)
Q Consensus 146 ~~~~i~~~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~ 218 (447)
+..++......|.+.++||+|+||.||+ +|+.||+|+-+.....+--- =.+++.+++ -+.|..+..+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHHHHH
Confidence 3445555566899999999999999985 68999999887654332111 122333443 2345555555
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-------CC
Q 013214 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-------GN 291 (447)
Q Consensus 219 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~-------~~ 291 (447)
..-.+.-++|+||.+.|+|.+++..++.+++..+..+..|++..+.+||..+ |||+||||+|.++... --
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred HccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccc
Confidence 5666777999999999999999998888999999999999999999999999 9999999999998632 24
Q ss_pred EEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC
Q 013214 292 LKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~ 370 (447)
++|+|||.+..+....+. .......|-.+-++|+..+..++..+|.|.|+.+++.|+.|+..= ...+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~ 908 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGS 908 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCc
Confidence 999999999877654443 345566788899999999999999999999999999999996542 10111
Q ss_pred CCCCCC-ChhhhH-HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccch
Q 013214 371 RPPFKA-PAKLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRW 423 (447)
Q Consensus 371 ~~~~~~-~~~~~~-~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~ 423 (447)
.-.... .++.+. +-..++...+|..|-..=|...++...++.....-...-++
T Consensus 909 ~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~~~~~ 963 (974)
T KOG1166|consen 909 SWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFTGLRE 963 (974)
T ss_pred ceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHHHHHH
Confidence 000000 011111 23557788888855555588888888888766655543333
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=155.52 Aligned_cols=107 Identities=20% Similarity=0.157 Sum_probs=95.6
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHH---HHHHHHcCCCCCCCC-CCCCCHHHHHHHcCcHHHHHHHHH-cCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEG---IKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDR 104 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~---~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~-~ga~~~~~d~ 104 (447)
+.+.+.+|..|+||||+||..|+.+. +++|++.|+++|.+| ..|+||||+|+..|+.+++++|++ .|++++.+|.
T Consensus 47 g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~ 126 (166)
T PHA02743 47 GHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINY 126 (166)
T ss_pred chhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCC
Confidence 44455666678899999999988654 899999999999998 589999999999999999999995 7999999999
Q ss_pred CCCCccccccccchHHHHHHHHHhCCCCCCCc
Q 013214 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
.|.||||+|+..++.+++++|+++|++++...
T Consensus 127 ~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~ 158 (166)
T PHA02743 127 QHETAYHIAYKMRDRRMMEILRANGAVCDDPL 158 (166)
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999999999986543
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-19 Score=160.79 Aligned_cols=135 Identities=19% Similarity=0.184 Sum_probs=91.5
Q ss_pred cccceeeeec---ccCCCCccccchhcccCCCCCCCccchhhHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCCHH
Q 013214 4 KVPVRTTLLK---QSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTAL 77 (447)
Q Consensus 4 ~~~~~~~~~~---~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~---~~~~~~~~Ll~~g~d~n~~d~~g~t~L 77 (447)
.+|+..++.+ ...+.....+.|||+|..+. ..|+||||+|+.. ++.+++++|+++|+|+|.+|.+|.|||
T Consensus 52 ~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~----~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpL 127 (209)
T PHA02859 52 ETPIFSCLEKDKVNVEILKFLIENGADVNFKTR----DNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLL 127 (209)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCC----CCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence 3455555432 22344444555666655431 2466778877653 367888888888888888888888888
Q ss_pred HHHHH--cCcHHHHHHHHHcCCCCCCCCCCCCCcccc-ccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 78 HVAAC--QGFTEVVSLLLERGADVDPKDRWGSTPLGD-AIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 78 h~A~~--~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~-a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|+|+. .++.+++++|++.|++++.+|..|.||||. |+..++.+++++|+++|+++...+..+.++
T Consensus 128 h~a~~~~~~~~~iv~~Li~~gadin~~d~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~~d~~g~tp 195 (209)
T PHA02859 128 HMYMCNFNVRINVIKLLIDSGVSFLNKDFDNNNILYSYILFHSDKKIFDFLTSLGIDINETNKSGYNC 195 (209)
T ss_pred HHHHHhccCCHHHHHHHHHcCCCcccccCCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence 88765 357788888888888888888888888874 555677788888888888777665544443
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.3e-19 Score=172.56 Aligned_cols=113 Identities=28% Similarity=0.322 Sum_probs=106.0
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
+.+.+..|.+|-|+||+||.+|+.+++++|+++|||||..+ .-|.||||+|+++|+..+|.+|+++|||++.+|..|.|
T Consensus 68 g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~ 147 (600)
T KOG0509|consen 68 GESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLT 147 (600)
T ss_pred CcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCc
Confidence 77788888889999999999999999999999999999998 77899999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|+|.|++.++.-++-+|+.+|++++..+..+.++
T Consensus 148 ~lHla~~~~~~~~vayll~~~~d~d~~D~~grTp 181 (600)
T KOG0509|consen 148 PLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTP 181 (600)
T ss_pred HHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCH
Confidence 9999999999999999999999998887766555
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.8e-19 Score=180.13 Aligned_cols=225 Identities=27% Similarity=0.409 Sum_probs=159.4
Q ss_pred cccccccCCCCCcccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC
Q 013214 136 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210 (447)
Q Consensus 136 ~~~~~~~~~~~~~~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 210 (447)
++...++..-......+.+.+|...+.|..|++|.||. +.+++|+|+=+...+ +++ ++..-..|
T Consensus 64 p~~~~s~~~~~as~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li--------lRn---ilt~a~np 132 (1205)
T KOG0606|consen 64 PMTDESPESRGASRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI--------LRN---ILTFAGNP 132 (1205)
T ss_pred CCCCCCcccccccccCCCccccceeEeeccCCCCceeeeeccccccchhhcccccchh--------hhc---cccccCCc
Confidence 44444443322334456677888888999999987763 367788843221110 111 33333444
Q ss_pred cccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC
Q 013214 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (447)
Q Consensus 211 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~ 290 (447)
++| |+=...++.-++++.+. +.+++|+|+.+ |+|||+||+|.+|+.-|
T Consensus 133 fvv---------------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mG 180 (1205)
T KOG0606|consen 133 FVV---------------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMG 180 (1205)
T ss_pred cee---------------------chhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecc
Confidence 444 44444455545555433 77899999999 99999999999999999
Q ss_pred CEEEeecccccccccCCCC--------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 013214 291 NLKVADFGVSKLLTVKEDR--------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (447)
Q Consensus 291 ~vkl~Dfg~~~~~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 356 (447)
++|+.|||+++........ ......|||.|.|||++..+.|...+|+|++|+++|+.+-|+.||.+
T Consensus 181 hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG 260 (1205)
T KOG0606|consen 181 HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 260 (1205)
T ss_pred cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC
Confidence 9999999998754221100 01345789999999999999999999999999999999999999999
Q ss_pred CCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHH
Q 013214 357 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404 (447)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 404 (447)
.+++++...+.... ..++..-..+++++++++.++|+.+|..|--..
T Consensus 261 dtpeelfg~visd~-i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 261 DTPEELFGQVISDD-IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred CCHHHHHhhhhhhh-ccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 99988877664333 222222344678999999999999999995433
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-19 Score=174.83 Aligned_cols=126 Identities=29% Similarity=0.350 Sum_probs=112.3
Q ss_pred cccCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHH
Q 013214 13 KQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLL 92 (447)
Q Consensus 13 ~~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~L 92 (447)
|.-++.-...++|||+|..+.+ -+.|||||||++|++.++.+|+++|||++.+|.+|.||||+||..|+.-+|-+|
T Consensus 89 Nrl~v~r~li~~gadvn~~gG~----l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayl 164 (600)
T KOG0509|consen 89 NRLDVARYLISHGADVNAIGGV----LGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYL 164 (600)
T ss_pred CcHHHHHHHHHcCCCccccCCC----CCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHH
Confidence 3444555667889999988864 367899999999999999999999999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCc-cccccc
Q 013214 93 LERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP-MHVKHA 142 (447)
Q Consensus 93 l~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~-~~~~~~ 142 (447)
+..|+|+|.+|.+|+||||||+++|....+..|++.|+.+...+ .++.++
T Consensus 165 l~~~~d~d~~D~~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d~~~g~Tp 215 (600)
T KOG0509|consen 165 LSKGADIDLRDNNGRTPLMWAAYKGFALFVRRLLKFGASLLLTDDNHGNTP 215 (600)
T ss_pred HHhcccCCCcCCCCCCHHHHHHHhcccHHHHHHHHhcccccccccccCCch
Confidence 99999999999999999999999998877999999999998776 555544
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=133.67 Aligned_cols=88 Identities=43% Similarity=0.574 Sum_probs=83.0
Q ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHH
Q 013214 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123 (447)
Q Consensus 44 lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~ 123 (447)
||+||..|+.+++++|++.+.+++. |+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+.+|+.++++
T Consensus 1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~ 76 (89)
T PF12796_consen 1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK 76 (89)
T ss_dssp HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence 7999999999999999999999987 899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCC
Q 013214 124 LLEKHGAKPLMA 135 (447)
Q Consensus 124 ~L~~~~a~~~~~ 135 (447)
+|+++|++++.+
T Consensus 77 ~Ll~~g~~~~~~ 88 (89)
T PF12796_consen 77 LLLEHGADVNIR 88 (89)
T ss_dssp HHHHTTT-TTSS
T ss_pred HHHHcCCCCCCc
Confidence 999999998764
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=160.86 Aligned_cols=107 Identities=15% Similarity=0.091 Sum_probs=82.1
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCC-CHHHHHHHcCcHHHHHHHHHcCCCCCCCC-CCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPKD-RWGS 107 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~-t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d-~~g~ 107 (447)
|.|.+.+|..|+||||+||..|+.+++++|+++|+++|.++..|+ ||||+|+..|+.++|++|+++|.+. .| ..|.
T Consensus 84 Gadvn~~d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~~~~--~d~~~g~ 161 (284)
T PHA02791 84 GMDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST--FDLAILL 161 (284)
T ss_pred CCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcCCcc--cccccCc
Confidence 444455566778888888888888888888888888888877774 7888888888888888888776543 22 2478
Q ss_pred CccccccccchHHHHHHHHHhCCCCCCCccc
Q 013214 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (447)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~ 138 (447)
||||+|+..|+.+++++|+++|++++..+..
T Consensus 162 TpLh~Aa~~g~~eiv~lLL~~gAd~n~~d~~ 192 (284)
T PHA02791 162 SCIHITIKNGHVDMMILLLDYMTSTNTNNSL 192 (284)
T ss_pred cHHHHHHHcCCHHHHHHHHHCCCCCCcccCC
Confidence 8888888888888888888888888776543
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.8e-18 Score=158.51 Aligned_cols=100 Identities=26% Similarity=0.272 Sum_probs=93.6
Q ss_pred CCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 013214 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (447)
Q Consensus 34 ~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a 113 (447)
+..|.+|+||||+|+..|+.+++++|++.|+++|..| |+||||+|+..|+.+++++|++.|++++.+|..|+||||+|
T Consensus 24 ~~~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~A 101 (284)
T PHA02791 24 FKADVHGHSALYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYA 101 (284)
T ss_pred CCCCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence 3567789999999999999999999999999999875 78999999999999999999999999999999999999999
Q ss_pred cccchHHHHHHHHHhCCCCCCC
Q 013214 114 IYYKNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 114 ~~~~~~~~~~~L~~~~a~~~~~ 135 (447)
+..|+.+++++|+++|++++..
T Consensus 102 a~~g~~eivk~Ll~~gadin~~ 123 (284)
T PHA02791 102 VDSGNMQTVKLFVKKNWRLMFY 123 (284)
T ss_pred HHcCCHHHHHHHHHCCCCcCcc
Confidence 9999999999999999987554
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.2e-18 Score=148.47 Aligned_cols=102 Identities=21% Similarity=0.274 Sum_probs=92.9
Q ss_pred CCCCCCCccchhhHHHHHHHcCC----HHHHHHHHHcCCCCCCCCC-CCCCHHHHHHHcCcHHHHHHHHH-cCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLE-RGADVDPKD 103 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~----~~~~~~Ll~~g~d~n~~d~-~g~t~Lh~A~~~g~~~~v~~Ll~-~ga~~~~~d 103 (447)
+.+.+.+|..|+||||+|+..|+ .+++++|++.|+|+|.+|. +|+||||+|+..++.+++++|++ .|++++.+|
T Consensus 50 ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n 129 (169)
T PHA02741 50 AAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCN 129 (169)
T ss_pred hhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCC
Confidence 34455666678899999999999 5899999999999999985 99999999999999999999998 599999999
Q ss_pred CCCCCccccccccchHHHHHHHHHhCCC
Q 013214 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (447)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~~~~a~ 131 (447)
..|.||||+|...++.+++++|+++++.
T Consensus 130 ~~g~tpL~~A~~~~~~~iv~~L~~~~~~ 157 (169)
T PHA02741 130 ADNKSPFELAIDNEDVAMMQILREIVAT 157 (169)
T ss_pred CCCCCHHHHHHHCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999998765
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=149.83 Aligned_cols=100 Identities=20% Similarity=0.218 Sum_probs=92.4
Q ss_pred CCCccchhhHHHHHHHcCCH---HHHHHHHHcCCCCCCCC-CCCCCHHHHHHHcCcHHHHHHHHH-cCCCCCCCCCCCCC
Q 013214 34 DGEEIKPEFRLMFLANERDV---EGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGST 108 (447)
Q Consensus 34 ~~~~~~g~t~lh~a~~~~~~---~~~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~-~ga~~~~~d~~g~t 108 (447)
+..|.+|+||||+||..|+. +++++|++.|+|+|.+| .+|+||||+|+..|+.+++++|++ .|++++.+|..|.|
T Consensus 49 ~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~t 128 (154)
T PHA02736 49 LEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKT 128 (154)
T ss_pred HHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCC
Confidence 45577899999999999986 46889999999999998 599999999999999999999998 49999999999999
Q ss_pred ccccccccchHHHHHHHHHhCCCCC
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~~ 133 (447)
|||+|+..|+.+++++|+++|+++.
T Consensus 129 pL~~A~~~~~~~i~~~Ll~~ga~~~ 153 (154)
T PHA02736 129 PYYVACERHDAKMMNILRAKGAQCK 153 (154)
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCC
Confidence 9999999999999999999998864
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.6e-18 Score=147.19 Aligned_cols=110 Identities=20% Similarity=0.176 Sum_probs=96.2
Q ss_pred CCCCccchhhHHHHHHHcCCHHHHHHHHH------cCCCCCCCCCCCCCHHHHHHHcCc----HHHHHHHHHcCCCCCCC
Q 013214 33 DDGEEIKPEFRLMFLANERDVEGIKELLD------SGIDVNFRDIDNRTALHVAACQGF----TEVVSLLLERGADVDPK 102 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~------~g~d~n~~d~~g~t~Lh~A~~~g~----~~~v~~Ll~~ga~~~~~ 102 (447)
.+.++..|+||||+||..|+.++++.|+. .|+++|.+|..|+||||+|+..|+ .+++++|+++|+++|.+
T Consensus 14 ~~~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~ 93 (169)
T PHA02741 14 IAEKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQ 93 (169)
T ss_pred hhccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCC
Confidence 34556678899999999999999999854 369999999999999999999998 58999999999999999
Q ss_pred CC-CCCCccccccccchHHHHHHHHH-hCCCCCCCccccccc
Q 013214 103 DR-WGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKHA 142 (447)
Q Consensus 103 d~-~g~tpl~~a~~~~~~~~~~~L~~-~~a~~~~~~~~~~~~ 142 (447)
|. .|+||||+|+..++.+++++|++ .|+++...+....++
T Consensus 94 ~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tp 135 (169)
T PHA02741 94 EMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSP 135 (169)
T ss_pred CcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCH
Confidence 85 99999999999999999999997 589887765544433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-16 Score=144.95 Aligned_cols=134 Identities=23% Similarity=0.378 Sum_probs=111.0
Q ss_pred eeeecceEEEEE---EcCeEEEEEEcCcccCCCHH-----HHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 161 VEITKGTFILAF---WRGIQVAVKKLGEEVISDDD-----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 161 ~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
+.||+|++|.++ +.|..+++|........... ....+.+|+.++..+.|+++.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 468999998775 57899999986543322221 2345778999999999999888777777778889999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 233 ~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
+|++|.+.+..... ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999865432 77889999999999999999 99999999999999 78899999998763
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-18 Score=167.47 Aligned_cols=130 Identities=23% Similarity=0.125 Sum_probs=107.1
Q ss_pred ccceeee-ecccCCCCccccchhc-ccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHH
Q 013214 5 VPVRTTL-LKQSSLAPDRERKEAE-LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82 (447)
Q Consensus 5 ~~~~~~~-~~~~~~~~~~~~~~a~-~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~ 82 (447)
+|+..+. .+...+..+..+.||+ .|..+.+..+..|.|++|.|+..++.+++++|+++|||+|.+|.+|+||||+|+.
T Consensus 151 t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~ 230 (437)
T PHA02795 151 NAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIY 230 (437)
T ss_pred CHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHH
Confidence 3444444 2456666677777763 3333333444567889999999999999999999999999999999999999999
Q ss_pred cCcHHHHHHHHHcCCCCCCCCCCCCCccccccccc--------hHHHHHHHHHhCCCCCC
Q 013214 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK--------NHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 83 ~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~--------~~~~~~~L~~~~a~~~~ 134 (447)
.|+.+++++|+++||++|.+|..|.||||+|+..| +.+++++|+++|+++..
T Consensus 231 ~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g~~~~~~~~~~eIvelLL~~gadI~~ 290 (437)
T PHA02795 231 AGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDRGSVIARRETHLKILEILLREPLSIDC 290 (437)
T ss_pred cCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCCcccccccHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999999999999988 46899999999988754
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=170.19 Aligned_cols=108 Identities=31% Similarity=0.436 Sum_probs=99.1
Q ss_pred cCCCCCCCccc-hhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIK-PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (447)
Q Consensus 29 n~~d~~~~~~~-g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~ 107 (447)
+|.|.+..+.. |+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|++.|++++.+|..|.
T Consensus 156 ~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~ 235 (477)
T PHA02878 156 YGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGN 235 (477)
T ss_pred cCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCC
Confidence 35555556666 89999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc-chHHHHHHHHHhCCCCCCCc
Q 013214 108 TPLGDAIYY-KNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 108 tpl~~a~~~-~~~~~~~~L~~~~a~~~~~~ 136 (447)
||||+|+.. ++.+++++|+++|++++...
T Consensus 236 TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~ 265 (477)
T PHA02878 236 TPLHISVGYCKDYDILKLLLEHGVDVNAKS 265 (477)
T ss_pred CHHHHHHHhcCCHHHHHHHHHcCCCCCccC
Confidence 999999975 68999999999999987643
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=149.62 Aligned_cols=109 Identities=25% Similarity=0.269 Sum_probs=94.7
Q ss_pred CCCCccchhhHHHHHHHcC--CHHHHHHHHHcCCCCCCCC-CCCCCHHHHHHHc---CcHHHHHHHHHcCCCCCCCCCCC
Q 013214 33 DDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWG 106 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~~~--~~~~~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~---g~~~~v~~Ll~~ga~~~~~d~~g 106 (447)
.+..+..|.||||+|+..+ +.+++++|+++|+|+|.++ ..|+||||+|+.. ++.+++++|+++|+++|.+|..|
T Consensus 44 ~n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G 123 (209)
T PHA02859 44 VNDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDG 123 (209)
T ss_pred hhccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCC
Confidence 3445677899999999855 8999999999999999997 5899999998864 47999999999999999999999
Q ss_pred CCccccccc--cchHHHHHHHHHhCCCCCCCcccccc
Q 013214 107 STPLGDAIY--YKNHEVIKLLEKHGAKPLMAPMHVKH 141 (447)
Q Consensus 107 ~tpl~~a~~--~~~~~~~~~L~~~~a~~~~~~~~~~~ 141 (447)
.||||+|+. .++.+++++|+++|++++..+..+.+
T Consensus 124 ~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d~~g~t 160 (209)
T PHA02859 124 KNLLHMYMCNFNVRINVIKLLIDSGVSFLNKDFDNNN 160 (209)
T ss_pred CCHHHHHHHhccCCHHHHHHHHHcCCCcccccCCCCc
Confidence 999999876 46899999999999999876554433
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=167.00 Aligned_cols=107 Identities=33% Similarity=0.491 Sum_probs=101.0
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
|.|.+.++..|.||||+||..|+.+++++|++.|+|+|.+|.+|.||||+|+..|+.+++++|+++|++++..|..|.||
T Consensus 114 g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~tp 193 (434)
T PHA02874 114 GIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESP 193 (434)
T ss_pred cCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 55667778889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
||+|+..|+.+++++|+++|+++....
T Consensus 194 L~~A~~~g~~~iv~~Ll~~g~~i~~~~ 220 (434)
T PHA02874 194 LHNAAEYGDYACIKLLIDHGNHIMNKC 220 (434)
T ss_pred HHHHHHcCCHHHHHHHHhCCCCCcCCC
Confidence 999999999999999999999876544
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-18 Score=160.94 Aligned_cols=104 Identities=29% Similarity=0.381 Sum_probs=94.7
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
|++.|..+....|||-.||..|+.+++++|+++|+|++..|..|.|.||+||+.||.+|+++|++.|||+|.++..|+|+
T Consensus 107 ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNTA 186 (615)
T KOG0508|consen 107 GASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNTA 186 (615)
T ss_pred cCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCchH
Confidence 34555555666789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCC
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~ 133 (447)
||.|+..|+.+++++|+++|+.+.
T Consensus 187 LH~caEsG~vdivq~Ll~~ga~i~ 210 (615)
T KOG0508|consen 187 LHDCAESGSVDIVQLLLKHGAKID 210 (615)
T ss_pred HHhhhhcccHHHHHHHHhCCceee
Confidence 999999999999999999988763
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=136.17 Aligned_cols=94 Identities=35% Similarity=0.435 Sum_probs=88.0
Q ss_pred hHHHHHHHcCCHHHHHHHHHcCCC-CCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHH
Q 013214 42 FRLMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120 (447)
Q Consensus 42 t~lh~a~~~~~~~~~~~Ll~~g~d-~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~ 120 (447)
-.+.+|+..+....|+.|++..+| +|.+|.+|.||||.|+++|+.+||+.|+..||+++++...|+||||-||.+.+.+
T Consensus 65 rl~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~ 144 (228)
T KOG0512|consen 65 RLLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFE 144 (228)
T ss_pred HHHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchh
Confidence 347899999999999999988777 9999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 013214 121 VIKLLEKHGAKPLMA 135 (447)
Q Consensus 121 ~~~~L~~~~a~~~~~ 135 (447)
++..|+++|++++..
T Consensus 145 va~~LLqhgaDVnA~ 159 (228)
T KOG0512|consen 145 VAGRLLQHGADVNAQ 159 (228)
T ss_pred HHHHHHhccCccccc
Confidence 999999999998654
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=136.86 Aligned_cols=95 Identities=27% Similarity=0.244 Sum_probs=87.3
Q ss_pred CCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 013214 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 112 (447)
.|.+|.+|.||||-|+++|+.+++..|+..|||++++...||||||-||.+++.+++.+||++|||+|+..+...||||+
T Consensus 90 vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t~g~ltpLhl 169 (228)
T KOG0512|consen 90 VNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQTKGLLTPLHL 169 (228)
T ss_pred ccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCcccccccccchhhHH
Confidence 57888899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchH-HHHHHHHH
Q 013214 113 AIYYKNH-EVIKLLEK 127 (447)
Q Consensus 113 a~~~~~~-~~~~~L~~ 127 (447)
|+...+. ..+.+|+.
T Consensus 170 aa~~rn~r~t~~~Ll~ 185 (228)
T KOG0512|consen 170 AAGNRNSRDTLELLLH 185 (228)
T ss_pred hhcccchHHHHHHHhh
Confidence 9987654 45555553
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-17 Score=164.35 Aligned_cols=100 Identities=24% Similarity=0.239 Sum_probs=89.6
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~ 116 (447)
+.+|+||||+||..|+.+++++|+++|+|+|.+|.+|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..
T Consensus 99 ~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~ 178 (413)
T PHA02875 99 YKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAK 178 (413)
T ss_pred cCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHc
Confidence 45688999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred chHHHHHHHHHhCCCCCCCc
Q 013214 117 KNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 117 ~~~~~~~~L~~~~a~~~~~~ 136 (447)
|+.+++++|+++|++++...
T Consensus 179 g~~eiv~~Ll~~ga~~n~~~ 198 (413)
T PHA02875 179 GDIAICKMLLDSGANIDYFG 198 (413)
T ss_pred CCHHHHHHHHhCCCCCCcCC
Confidence 99999999999999887643
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.7e-17 Score=177.30 Aligned_cols=111 Identities=27% Similarity=0.282 Sum_probs=97.5
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHH--------------------------
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC-------------------------- 82 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~-------------------------- 82 (447)
+|.|+|..|.+|+||||+||..|+.++++.|+++|+|+|.+|.+|+||||+|+.
T Consensus 547 ~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~~~~~~~~~L 626 (823)
T PLN03192 547 AKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPHAAGDLL 626 (823)
T ss_pred CCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcccCcccCchHH
Confidence 455566677788999999999999999999999999999999999999886554
Q ss_pred -----cCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCcccc
Q 013214 83 -----QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 83 -----~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
+|+.+++++|+++|+|+|.+|.+|.||||+|+..|+.+++++|+++|++++..+.+.
T Consensus 627 ~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g 688 (823)
T PLN03192 627 CTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDD 688 (823)
T ss_pred HHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCC
Confidence 555566777888999999999999999999999999999999999999998765544
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-17 Score=144.07 Aligned_cols=113 Identities=19% Similarity=0.191 Sum_probs=93.9
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCH----HHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHH---HHHHHHcCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV---VSLLLERGADVDP 101 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~----~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~---v~~Ll~~ga~~~~ 101 (447)
|+.|.+..+.++.++||+||..|+. +++++|++.|+++|.+|.+|+||||+|+..|+.+. +++|++.|+++|.
T Consensus 9 ~~~~~~~~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~ 88 (166)
T PHA02743 9 NNLGAVEIDEDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINA 88 (166)
T ss_pred cchHHhhhccCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCC
Confidence 3444444444555679999999998 66667888999999999999999999999988654 8999999999999
Q ss_pred CC-CCCCCccccccccchHHHHHHHHH-hCCCCCCCcccccc
Q 013214 102 KD-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKH 141 (447)
Q Consensus 102 ~d-~~g~tpl~~a~~~~~~~~~~~L~~-~~a~~~~~~~~~~~ 141 (447)
+| ..|.||||+|+..++.+++++|+. .|+++........+
T Consensus 89 ~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~t 130 (166)
T PHA02743 89 RELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINYQHET 130 (166)
T ss_pred CCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCCCCCC
Confidence 98 589999999999999999999995 89998766544433
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.5e-17 Score=152.52 Aligned_cols=99 Identities=19% Similarity=0.113 Sum_probs=79.4
Q ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCCCC----CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCC-CCCCCCccccccccc
Q 013214 43 RLMFLANERDVEGIKELLDSGIDVNFRD----IDNRTALHVAACQGFTEVVSLLLERGADVDPK-DRWGSTPLGDAIYYK 117 (447)
Q Consensus 43 ~lh~a~~~~~~~~~~~Ll~~g~d~n~~d----~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~-d~~g~tpl~~a~~~~ 117 (447)
+||.|+..|+.+++++|+++|||+|.++ ..|.||||+|+..|+.+++++|+++|||+|.+ +..|.||||+|+..+
T Consensus 36 lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~ 115 (300)
T PHA02884 36 ILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHG 115 (300)
T ss_pred HHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcC
Confidence 4566777788888888888888888874 57888888888888888888888888888876 457888888888888
Q ss_pred hHHHHHHHHHhCCCCCCCcccccc
Q 013214 118 NHEVIKLLEKHGAKPLMAPMHVKH 141 (447)
Q Consensus 118 ~~~~~~~L~~~~a~~~~~~~~~~~ 141 (447)
+.+++++|+++|++++.....+.+
T Consensus 116 ~~eivklLL~~GAdin~kd~~G~T 139 (300)
T PHA02884 116 CLKCLEILLSYGADINIQTNDMVT 139 (300)
T ss_pred CHHHHHHHHHCCCCCCCCCCCCCC
Confidence 888888888888888766544433
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.9e-17 Score=163.69 Aligned_cols=112 Identities=21% Similarity=0.245 Sum_probs=96.4
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC--cHHHHHHHHHcCCCCCC-CCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDP-KDRW 105 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g--~~~~v~~Ll~~ga~~~~-~d~~ 105 (447)
+|.|++.++.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..+ ..+++++|+++|++++. .|..
T Consensus 61 ~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~ 140 (446)
T PHA02946 61 RGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEE 140 (446)
T ss_pred CcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCC
Confidence 44555566667889999999999999999999999999999999999999998876 48899999999999995 6899
Q ss_pred CCCccccccccchHHHHHHHHHhCCCCCCCcccccc
Q 013214 106 GSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (447)
Q Consensus 106 g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~ 141 (447)
|.|||+ |+..++.+++++|++.|++++..+..+.+
T Consensus 141 g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G~t 175 (446)
T PHA02946 141 GCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFGKN 175 (446)
T ss_pred CCcHHH-HHHCCChHHHHHHHhccccccccCCCCCC
Confidence 999997 66778999999999999998776554433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.4e-18 Score=166.07 Aligned_cols=170 Identities=27% Similarity=0.404 Sum_probs=127.2
Q ss_pred ceEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
.+++.|++|...+|.+++..+. ..+......+..|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999997543 36777888999999999999 66 999999999999999999999999998
Q ss_pred cccccCC-----CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCC
Q 013214 301 KLLTVKE-----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (447)
Q Consensus 301 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 374 (447)
....... ....+...||..||+||.+.+..|+.++||||||++++|++. -.-++.... ....+..+..|+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---TLTDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhhhcCCCChH
Confidence 7665443 122345678999999999999999999999999999999997 222222111 1111112222210
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 405 (447)
...++ +.-..|+.+++...|.+||++.+
T Consensus 481 --~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 481 --FLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred --HhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 11122 23347899999999999994443
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.8e-17 Score=162.18 Aligned_cols=107 Identities=25% Similarity=0.320 Sum_probs=98.8
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCC-
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS- 107 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~- 107 (447)
.|.|++..+.+|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+..|.
T Consensus 124 ~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~~~~~ 203 (413)
T PHA02875 124 RGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGKNGCV 203 (413)
T ss_pred CCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCc
Confidence 3455566667789999999999999999999999999999999999999999999999999999999999999998886
Q ss_pred CccccccccchHHHHHHHHHhCCCCCCC
Q 013214 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~~a~~~~~ 135 (447)
||+|+|+..|+.+++++|+++|++++..
T Consensus 204 t~l~~A~~~~~~~iv~~Ll~~gad~n~~ 231 (413)
T PHA02875 204 AALCYAIENNKIDIVRLFIKRGADCNIM 231 (413)
T ss_pred hHHHHHHHcCCHHHHHHHHHCCcCcchH
Confidence 7899999999999999999999998753
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.4e-17 Score=169.00 Aligned_cols=107 Identities=20% Similarity=0.171 Sum_probs=65.1
Q ss_pred CCCCCCccchhhHHHHHHHcCC--HHHHHHHHHcCCCCCCCCCCCCCHHHHH----------------------------
Q 013214 31 LDDDGEEIKPEFRLMFLANERD--VEGIKELLDSGIDVNFRDIDNRTALHVA---------------------------- 80 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~~--~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A---------------------------- 80 (447)
.|.+.+|..|+||||+|+..|+ .+++++|+++|||+|.+|..|+||||+|
T Consensus 203 ADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~~~ 282 (764)
T PHA02716 203 VNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKNIP 282 (764)
T ss_pred CCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhccccccccch
Confidence 3333444455666666666663 3666666666666666666666666653
Q ss_pred ---------HHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccc--cchHHHHHHHHHhCCCCCCCcc
Q 013214 81 ---------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 81 ---------~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~--~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
+..|+.+++++|+++|++++.+|..|+||||+|+. .++.+++++|+++|++++..+.
T Consensus 283 ~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~ 350 (764)
T PHA02716 283 MILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDN 350 (764)
T ss_pred hhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCC
Confidence 23355666666666666666666666666666543 3456666666666666655443
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.9e-17 Score=164.52 Aligned_cols=111 Identities=29% Similarity=0.332 Sum_probs=99.1
Q ss_pred CCCCCCCccchhhHHHHHHHcC---CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC-cHHHHHHHHHcCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRW 105 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~---~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g-~~~~v~~Ll~~ga~~~~~d~~ 105 (447)
|.|.+.++..|.||||+|+..+ +.+++++|++.|+|+|.+|..|+||||+|+..| +.+++++|+++|++++.+|..
T Consensus 37 ga~vn~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in~~~~~ 116 (471)
T PHA03095 37 GADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDKV 116 (471)
T ss_pred CCCcccCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCCCCCCC
Confidence 4444555566788999999999 999999999999999999999999999999999 599999999999999999999
Q ss_pred CCCcccccc--ccchHHHHHHHHHhCCCCCCCccccc
Q 013214 106 GSTPLGDAI--YYKNHEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 106 g~tpl~~a~--~~~~~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
|.||||+|+ ..++.+++++|+++|++++..+..+.
T Consensus 117 g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~~g~ 153 (471)
T PHA03095 117 GRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYGM 153 (471)
T ss_pred CCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 999999999 56789999999999999877655443
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.1e-17 Score=138.75 Aligned_cols=104 Identities=27% Similarity=0.288 Sum_probs=97.6
Q ss_pred CCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 013214 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (447)
Q Consensus 34 ~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a 113 (447)
|.-|..|.|||+||+.+|+++++++|++.|||++...+...|+|.+|++.|..++|++|+.++.|+|.-|.+|-|||-||
T Consensus 154 N~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyA 233 (296)
T KOG0502|consen 154 NACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYA 233 (296)
T ss_pred cCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeeee
Confidence 44556788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccchHHHHHHHHHhCCCCCCCcc
Q 013214 114 IYYKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 114 ~~~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
++.++.++++.|+..||++.....
T Consensus 234 vrgnhvkcve~Ll~sGAd~t~e~d 257 (296)
T KOG0502|consen 234 VRGNHVKCVESLLNSGADVTQEDD 257 (296)
T ss_pred ecCChHHHHHHHHhcCCCcccccc
Confidence 999999999999999999876543
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.2e-17 Score=163.55 Aligned_cols=111 Identities=24% Similarity=0.255 Sum_probs=99.0
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc-CcHHHHHHHHHcCCCCCCCCC-CCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GFTEVVSLLLERGADVDPKDR-WGS 107 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~-g~~~~v~~Ll~~ga~~~~~d~-~g~ 107 (447)
|.|.+..+..|+||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+.. ++.+++++|+++|+++|.++. .|.
T Consensus 191 gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~~~g~ 270 (477)
T PHA02878 191 GANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGL 270 (477)
T ss_pred CCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCCCCCC
Confidence 344555667789999999999999999999999999999999999999999976 789999999999999999986 899
Q ss_pred CccccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
||||+| .++.+++++|+++|++++..+..+.++
T Consensus 271 TpLh~A--~~~~~~v~~Ll~~gadin~~d~~g~Tp 303 (477)
T PHA02878 271 TALHSS--IKSERKLKLLLEYGADINSLNSYKLTP 303 (477)
T ss_pred CHHHHH--ccCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 999999 467899999999999998876655544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.4e-16 Score=140.39 Aligned_cols=129 Identities=26% Similarity=0.374 Sum_probs=104.5
Q ss_pred eecceEEEEE---EcCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 163 lg~G~~~~~~---~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
||+|++|.++ ++|..|++|.......... .....+.+|+++++.+.|+++.....++......+++|||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 7899998776 6788999998654322221 1235677899999999988766665556666778999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
++|.+.+..... .++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998765321 78899999999999999 99999999999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=9e-17 Score=150.49 Aligned_cols=112 Identities=19% Similarity=0.167 Sum_probs=96.8
Q ss_pred ccCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCC-CCCCCCHHHHHHHcCcHHHHHHH
Q 013214 14 QSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLL 92 (447)
Q Consensus 14 ~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~-d~~g~t~Lh~A~~~g~~~~v~~L 92 (447)
...+.....+.|||+|..+. ..+..|.||||+|+..|+.+++++|+++|||+|.+ +..|.||||+|+..|+.+++++|
T Consensus 45 ~~eivk~LL~~GAdiN~~~~-~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklL 123 (300)
T PHA02884 45 YTDIIDAILKLGADPEAPFP-LSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEIL 123 (300)
T ss_pred CHHHHHHHHHCCCCccccCc-ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHH
Confidence 34455556778888877653 12346899999999999999999999999999986 46899999999999999999999
Q ss_pred HHcCCCCCCCCCCCCCccccccccchHHHHHHHH
Q 013214 93 LERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126 (447)
Q Consensus 93 l~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~ 126 (447)
+++||+++.+|..|.||+|+|+..++.+++.++.
T Consensus 124 L~~GAdin~kd~~G~TpL~~A~~~~~~~~~~~~~ 157 (300)
T PHA02884 124 LSYGADINIQTNDMVTPIELALMICNNFLAFMIC 157 (300)
T ss_pred HHCCCCCCCCCCCCCCHHHHHHHhCChhHHHHhc
Confidence 9999999999999999999999988888876664
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.8e-17 Score=164.92 Aligned_cols=107 Identities=25% Similarity=0.306 Sum_probs=95.4
Q ss_pred cCCCCCCCccchhhHHHHHHHc-----CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC---cHHHHHHHHHcCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADVD 100 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~-----~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g---~~~~v~~Ll~~ga~~~ 100 (447)
+|.|.+..+..|.||||.|+.+ +..+++++|+++|+|+|.+|.+|+||||+|+.++ +.+++++|+++||+++
T Consensus 60 ~Gadvn~~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn 139 (489)
T PHA02798 60 LGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTT 139 (489)
T ss_pred CCCCCCCCCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCcc
Confidence 3444455556778889998864 6799999999999999999999999999999876 7899999999999999
Q ss_pred CCCCCCCCccccccccch---HHHHHHHHHhCCCCCCC
Q 013214 101 PKDRWGSTPLGDAIYYKN---HEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 101 ~~d~~g~tpl~~a~~~~~---~~~~~~L~~~~a~~~~~ 135 (447)
.+|..|.||||+|+..++ .+++++|+++|++++..
T Consensus 140 ~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~ 177 (489)
T PHA02798 140 LLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH 177 (489)
T ss_pred ccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence 999999999999999887 99999999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=144.96 Aligned_cols=141 Identities=20% Similarity=0.139 Sum_probs=106.8
Q ss_pred cccceeeecceEEEEE------EcCeEEEEEEcCcccCCC-------------------H--HHHHHHHHHHHHHhcCCC
Q 013214 157 FTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISD-------------------D--DRVRAFRDELALLQKIRH 209 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~------~~g~~vavK~~~~~~~~~-------------------~--~~~~~~~~E~~~l~~l~h 209 (447)
|...+.||+|++|.++ .+|+.||+|+++...... . .....+..|+.+++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5566789999998774 368999999887542110 0 012345689999999975
Q ss_pred C--cccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc
Q 013214 210 P--NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (447)
Q Consensus 210 p--~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~ 287 (447)
. .++++++. ...++||||++|++|.........+...+...++.|++.++.+||+.+ .++|+||||+||+++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~ 183 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH 183 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE
Confidence 3 34444443 235899999998888776544455677777899999999999999987 399999999999999
Q ss_pred CCCCEEEeecccccccc
Q 013214 288 DSGNLKVADFGVSKLLT 304 (447)
Q Consensus 288 ~~~~vkl~Dfg~~~~~~ 304 (447)
++.++|+|||.+....
T Consensus 184 -~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -DGKVVIIDVSQSVELD 199 (237)
T ss_pred -CCCEEEEEChhhhccC
Confidence 8899999999987543
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-16 Score=163.06 Aligned_cols=101 Identities=23% Similarity=0.262 Sum_probs=51.6
Q ss_pred CCCCCccchhhHHHHHHHcCCH--HHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 32 DDDGEEIKPEFRLMFLANERDV--EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~--~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
|++.+|..|+||||+||..|+. ..++.|++.|+|+|.+|..|+||||+|+..|+.+++++|+++||+++.+|..|.||
T Consensus 214 ~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~~d~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~~g~tp 293 (471)
T PHA03095 214 DPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTP 293 (471)
T ss_pred CCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence 3333444445555555554442 34444555555555555555555555555555555555555555555555555555
Q ss_pred cccccccchHHHHHHHHHhCCCC
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~ 132 (447)
||+|+..|+.++++.|++.++++
T Consensus 294 l~~A~~~~~~~~v~~LL~~~~~~ 316 (471)
T PHA03095 294 LSLMVRNNNGRAVRAALAKNPSA 316 (471)
T ss_pred HHHHHHhCCHHHHHHHHHhCCCH
Confidence 55555555555555555554443
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.5e-16 Score=162.33 Aligned_cols=101 Identities=30% Similarity=0.412 Sum_probs=53.3
Q ss_pred CccchhhHHHHHHHcC--CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCC------C
Q 013214 36 EEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG------S 107 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~~--~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g------~ 107 (447)
.+..|.||||+|+..| +.+++++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|++++..+..| .
T Consensus 137 ~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~ 216 (480)
T PHA03100 137 KNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGDIETLLFTIFE 216 (480)
T ss_pred cCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHH
Confidence 3334445555555555 5555555555555555555555555555555555555555555555555555444 4
Q ss_pred Cccccccccch--HHHHHHHHHhCCCCCCCc
Q 013214 108 TPLGDAIYYKN--HEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 108 tpl~~a~~~~~--~~~~~~L~~~~a~~~~~~ 136 (447)
||+|+|+..++ .+++++|+++|++++..+
T Consensus 217 t~l~~a~~~~~~~~~iv~~Ll~~g~din~~d 247 (480)
T PHA03100 217 TPLHIAACYNEITLEVVNYLLSYGVPINIKD 247 (480)
T ss_pred hHHHHHHHhCcCcHHHHHHHHHcCCCCCCCC
Confidence 55555555554 555555555555544433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-15 Score=157.05 Aligned_cols=134 Identities=24% Similarity=0.239 Sum_probs=108.7
Q ss_pred cccceeeecceEEEEEE---cCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 157 FTNSVEITKGTFILAFW---RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~---~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
|...+.||+|+||.|+. .+..+++|+....... .....+.+.+|+++++.++|++++....++......+++
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 45577899999999874 5556666643222111 112235688999999999999999888877777788999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
|||++|++|.+++. ....++.+++.+|.+||+.+ ++|||+||+||++ .++.++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999885 34678999999999999999 9999999999999 678999999999874
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-16 Score=163.53 Aligned_cols=109 Identities=20% Similarity=0.172 Sum_probs=90.6
Q ss_pred CCCCCC-ccchhhHHHHHHHc--CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCc--HHHHHHHHHcCCCCCCCCCC
Q 013214 31 LDDDGE-EIKPEFRLMFLANE--RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF--TEVVSLLLERGADVDPKDRW 105 (447)
Q Consensus 31 ~d~~~~-~~~g~t~lh~a~~~--~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~--~~~v~~Ll~~ga~~~~~d~~ 105 (447)
.|.+.+ +..|+||||+|+.. ++.+++++|+++|+|+|.+|.+|+||||+|+..|+ .++|++|+++|||+|.+|..
T Consensus 167 ADIN~~~d~~G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~ 246 (764)
T PHA02716 167 VNLNYVCKKTGYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVN 246 (764)
T ss_pred CCcccccCCCCCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 444444 56688999998654 67899999999999999999999999999999995 59999999999999999999
Q ss_pred CCCcccccc-------------------------------------ccchHHHHHHHHHhCCCCCCCcccc
Q 013214 106 GSTPLGDAI-------------------------------------YYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 106 g~tpl~~a~-------------------------------------~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
|+||||+|+ ..|+.+++++|+++|++++..+..+
T Consensus 247 G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G 317 (764)
T PHA02716 247 GMSPIMTYIINIDNINPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAG 317 (764)
T ss_pred CCCHHHHHHHhhhccCHHHHHHHHHhccccccccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCC
Confidence 999999753 3456777888888888776655443
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.5e-16 Score=160.73 Aligned_cols=105 Identities=24% Similarity=0.325 Sum_probs=80.3
Q ss_pred CCCCCCCccchhhHHHHHHHcC---CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCc---HHHHHHHHHcCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVDPKD 103 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~---~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~---~~~v~~Ll~~ga~~~~~d 103 (447)
|.|.|..+.+|+||||+|+.++ +.+++++|+++|+|+|.+|.+|.||||+|+..|+ .+++++|+++|++++.++
T Consensus 99 GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~~ 178 (489)
T PHA02798 99 GADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTHN 178 (489)
T ss_pred CCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCccccc
Confidence 3444445556788899999875 6899999999999999999999999999999887 899999999888887764
Q ss_pred -CCCCCcccccccc----chHHHHHHHHHhCCCCCC
Q 013214 104 -RWGSTPLGDAIYY----KNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 104 -~~g~tpl~~a~~~----~~~~~~~~L~~~~a~~~~ 134 (447)
..|.||+|.++.. ++.+++++|+++|+++..
T Consensus 179 ~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~Ga~i~~ 214 (489)
T PHA02798 179 NKEKYDTLHCYFKYNIDRIDADILKLFVDNGFIINK 214 (489)
T ss_pred CcCCCcHHHHHHHhccccCCHHHHHHHHHCCCCccc
Confidence 4566777665443 356677777776665543
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=160.31 Aligned_cols=95 Identities=29% Similarity=0.456 Sum_probs=48.2
Q ss_pred chhhHHHHHH--HcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC--cHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 013214 39 KPEFRLMFLA--NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (447)
Q Consensus 39 ~g~t~lh~a~--~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g--~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~ 114 (447)
.|.||||+|+ ..|+.+++++|+++|+|+|.+|..|.||||+|+..| +.+++++|+++|++++.+|..|.||||+|+
T Consensus 105 ~g~tpL~~A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL~~A~ 184 (480)
T PHA03100 105 NGITPLLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRYGYTPLHIAV 184 (480)
T ss_pred CCCchhhHHHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccCCCCCHHHHHH
Confidence 3444455555 555555555555555555555555555555555555 455555555555555555555555555555
Q ss_pred ccchHHHHHHHHHhCCCCC
Q 013214 115 YYKNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 115 ~~~~~~~~~~L~~~~a~~~ 133 (447)
..|+.+++++|+++|+++.
T Consensus 185 ~~~~~~iv~~Ll~~ga~~~ 203 (480)
T PHA03100 185 EKGNIDVIKFLLDNGADIN 203 (480)
T ss_pred HhCCHHHHHHHHHcCCCcc
Confidence 5555555555555554443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-17 Score=171.57 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=193.1
Q ss_pred CcCcccceeeecceEEEEE------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceE
Q 013214 154 ELDFTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~ 226 (447)
...|...+.||+|.|+.+. .....+|+|.+.... ...........|..+-+.+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 4466667779999998654 234556777665443 23444556667888888886 999999999999999999
Q ss_pred EEEeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccc
Q 013214 227 IVTEYLPKGDLRAFL-KRKG-ALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKL 302 (447)
Q Consensus 227 lv~e~~~~g~L~~~l-~~~~-~l~~~~~~~i~~ql~~~l~~lH-~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~ 302 (447)
+.++|..|+++.+.+ .... ..+...+..++.|+..++.|+| ..+ +.|+|+||+|.+++..+ .++++|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999999988 5444 5777888899999999999999 887 99999999999999999 999999999987
Q ss_pred ccc--CCCCCcccCCC-CCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC-CCCCCC
Q 013214 303 LTV--KEDRPLTCQDT-SCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PPFKAP 377 (447)
Q Consensus 303 ~~~--~~~~~~~~~~~-t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 377 (447)
+.. ..........| ++.|+|||...+. ...+..|+||.|+++..+++|..||................+ ......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 765 22223334456 9999999999884 445789999999999999999999986655432211111111 111223
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
+...+....+++.+++..+|..|.+.+++-.
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccc
Confidence 4556778889999999999999999888754
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.2e-16 Score=155.65 Aligned_cols=69 Identities=38% Similarity=0.474 Sum_probs=37.6
Q ss_pred CCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCC
Q 013214 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 66 ~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~ 134 (447)
+|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++.+++++|+++|++++.
T Consensus 117 ~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~ 185 (434)
T PHA02874 117 VNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANV 185 (434)
T ss_pred CCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCC
Confidence 344455555555555555555555555555555555555555555555555555555555555555443
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-16 Score=168.21 Aligned_cols=108 Identities=34% Similarity=0.344 Sum_probs=102.9
Q ss_pred hhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCC
Q 013214 25 EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (447)
Q Consensus 25 ~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~ 104 (447)
..--.|++.+-++..|.||||.||..|++++|++|+++|+|+|.+|+.|+||||.||..|+.+|+++|+++||++|+.|.
T Consensus 525 ~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d~ 604 (1143)
T KOG4177|consen 525 ILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAADL 604 (1143)
T ss_pred HHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCcccc
Confidence 33446888899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCccccccccchHHHHHHHHHhCCCC
Q 013214 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~~a~~ 132 (447)
+|.|||++|...|+.++++.+...++++
T Consensus 605 ~g~TpL~iA~~lg~~~~~k~l~~~~~~~ 632 (1143)
T KOG4177|consen 605 DGFTPLHIAVRLGYLSVVKLLKVVTATP 632 (1143)
T ss_pred cCcchhHHHHHhcccchhhHHHhccCcc
Confidence 9999999999999999999999999983
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.1e-16 Score=164.94 Aligned_cols=113 Identities=28% Similarity=0.325 Sum_probs=94.7
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCc-HHHHHHHHHcCCCCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~-~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
|.|.+.++..|+||||+|+..|+.+++++|++.|+|++..+..|.||||+|+..++ ..++++|+++|+++|.+|..|+|
T Consensus 365 gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~~G~T 444 (682)
T PHA02876 365 GANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNKDLST 444 (682)
T ss_pred CCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCCCCCh
Confidence 44555566678888999999999999999999999999999889999999987665 56789999999999999999999
Q ss_pred ccccccccc-hHHHHHHHHHhCCCCCCCccccccc
Q 013214 109 PLGDAIYYK-NHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 109 pl~~a~~~~-~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|||+|+..+ +.+++++|+++|++++..+..+.++
T Consensus 445 pLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~~g~tp 479 (682)
T PHA02876 445 PLHYACKKNCKLDVIEMLLDNGADVNAINIQNQYP 479 (682)
T ss_pred HHHHHHHhCCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 999998866 6899999999999988776655544
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.6e-16 Score=145.68 Aligned_cols=112 Identities=30% Similarity=0.325 Sum_probs=105.8
Q ss_pred CCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcc
Q 013214 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl 110 (447)
+.-++.+..|-+||..|+..|+.++++.|+++|++||.......|||--||.-|+.++|++|+++|||++..|..|.|.|
T Consensus 75 V~FDge~IegappLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcL 154 (615)
T KOG0508|consen 75 VRFDGETIEGAPPLWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCL 154 (615)
T ss_pred EEeCCcccCCCchhhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeE
Confidence 34578888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
++|++.|+.+++++|++.|+|++.+..++.++
T Consensus 155 mIa~ykGh~~I~qyLle~gADvn~ks~kGNTA 186 (615)
T KOG0508|consen 155 MIACYKGHVDIAQYLLEQGADVNAKSYKGNTA 186 (615)
T ss_pred EeeeccCchHHHHHHHHhCCCcchhcccCchH
Confidence 99999999999999999999999988776655
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.4e-15 Score=136.51 Aligned_cols=138 Identities=20% Similarity=0.211 Sum_probs=105.4
Q ss_pred cccceeeecceEEEEEEcCeEEEEEEcCcccC----------CCHHHHHHHHHHHHHHhcCCCCcc--cceeEEEEeCCc
Q 013214 157 FTNSVEITKGTFILAFWRGIQVAVKKLGEEVI----------SDDDRVRAFRDELALLQKIRHPNV--VQFLGAVTQSSP 224 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~~g~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~i--v~~~~~~~~~~~ 224 (447)
+...+..|.|+++.+...+..++||....... .+......+.+|+.++.++.|+++ ++.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 33445678888888888999999998753211 112234567889999999988775 667776443322
Q ss_pred ----eEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 225 ----MMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 225 ----~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
.++|||+++| .+|.+++.. .++++. .+.+++.++.+||+.| |+|+||||.|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 3599999987 689988865 345544 3568999999999999 99999999999999988999999998
Q ss_pred ccc
Q 013214 300 SKL 302 (447)
Q Consensus 300 ~~~ 302 (447)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=135.44 Aligned_cols=135 Identities=21% Similarity=0.107 Sum_probs=102.6
Q ss_pred cccceeeecceEEEEE---E-cCeEEEEEEcCcccCCCH-------------------HHHHHHHHHHHHHhcCCCC--c
Q 013214 157 FTNSVEITKGTFILAF---W-RGIQVAVKKLGEEVISDD-------------------DRVRAFRDELALLQKIRHP--N 211 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~---~-~g~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~hp--~ 211 (447)
|...+.||+|+||.++ . +|+.||||++........ ........|..++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5556789999999886 2 589999998764321000 0112356789999998777 4
Q ss_pred ccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 212 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
+++.++ ....+++|||++|++|..... ......++.+++.++.++|+.+ ++|+||||+||++++++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCc
Confidence 455544 245589999999999876532 1345678899999999999998 999999999999999999
Q ss_pred EEEeecccccccc
Q 013214 292 LKVADFGVSKLLT 304 (447)
Q Consensus 292 vkl~Dfg~~~~~~ 304 (447)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.3e-16 Score=155.19 Aligned_cols=99 Identities=28% Similarity=0.332 Sum_probs=48.3
Q ss_pred CCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHH-c-CCCCCCCCCCCCCccc
Q 013214 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-R-GADVDPKDRWGSTPLG 111 (447)
Q Consensus 34 ~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~-~-ga~~~~~d~~g~tpl~ 111 (447)
+.+|.+|.||||+||+.|+.+.++.|+..|+++|.++.++.||||.||..|+.++|+-||+ . -..+|..|..|.||||
T Consensus 267 ~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLH 346 (929)
T KOG0510|consen 267 NDEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLH 346 (929)
T ss_pred hcccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchh
Confidence 3344444555555555555555555555555555555555555555555555544444444 2 2234444444444444
Q ss_pred cccccchHHHHHHHHHhCCCC
Q 013214 112 DAIYYKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~a~~ 132 (447)
.|+..|+.+++++|++.||..
T Consensus 347 laa~~gH~~v~qlLl~~GA~~ 367 (929)
T KOG0510|consen 347 LAAKSGHDRVVQLLLNKGALF 367 (929)
T ss_pred hhhhcCHHHHHHHHHhcChhh
Confidence 444444444444444444443
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1e-15 Score=156.09 Aligned_cols=114 Identities=15% Similarity=0.104 Sum_probs=96.5
Q ss_pred CCccccchhcccCCCCCCCccchhhHHHHHHHcCC----HHHHHHHHHcCC--CCCCCCCCCCCHHHH---HHHcC----
Q 013214 18 APDRERKEAELNGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGI--DVNFRDIDNRTALHV---AACQG---- 84 (447)
Q Consensus 18 ~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~----~~~~~~Ll~~g~--d~n~~d~~g~t~Lh~---A~~~g---- 84 (447)
..++.+.|||+|. . ..|+||||+||..++ .+++++|+++|+ |+|.+|.+|+||||. |...+
T Consensus 362 velLIs~GAdIN~-----k-~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~ 435 (672)
T PHA02730 362 LRCMLDNGATMDK-----T-TDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYH 435 (672)
T ss_pred HHHHHHCCCCCCc-----C-CCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhcccccc
Confidence 3445667888774 2 468899999998875 899999999997 699999999999994 33332
Q ss_pred -----cHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCcc
Q 013214 85 -----FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 85 -----~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
..+++++|+++||++|.+|..|.||||+|+..++.+++++|+++||+++....
T Consensus 436 ~~e~~~~~ivk~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d~ 493 (672)
T PHA02730 436 CYETILIDVFDILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTSR 493 (672)
T ss_pred ccchhHHHHHHHHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCCC
Confidence 23579999999999999999999999999999999999999999999977653
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.9e-16 Score=113.93 Aligned_cols=92 Identities=28% Similarity=0.504 Sum_probs=68.3
Q ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHH
Q 013214 43 RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122 (447)
Q Consensus 43 ~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~ 122 (447)
.+.|++.+|..+-++..+..|.|||..- .|+||||+|+..|..+++++|+..||+++.+|+.|-|||--|++.|+.+++
T Consensus 5 ~~~W~vkNG~~DeVk~~v~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cV 83 (117)
T KOG4214|consen 5 SVAWNVKNGEIDEVKQSVNEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCV 83 (117)
T ss_pred hHhhhhccCcHHHHHHHHHccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHH
Confidence 3567777777777777777777776554 677777777777777777777777777777777777777777777777777
Q ss_pred HHHHHhCCCCCCC
Q 013214 123 KLLEKHGAKPLMA 135 (447)
Q Consensus 123 ~~L~~~~a~~~~~ 135 (447)
++|++.||+-.+.
T Consensus 84 klLL~~GAdrt~~ 96 (117)
T KOG4214|consen 84 KLLLQNGADRTIH 96 (117)
T ss_pred HHHHHcCccccee
Confidence 7777777775443
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=148.76 Aligned_cols=121 Identities=16% Similarity=0.057 Sum_probs=102.0
Q ss_pred cCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCC-CC-----CCCCCCHHHHHHHcCcHHH
Q 013214 15 SSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN-FR-----DIDNRTALHVAACQGFTEV 88 (447)
Q Consensus 15 ~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n-~~-----d~~g~t~Lh~A~~~g~~~~ 88 (447)
..+.......|||+|..+ +.||+|+|+..|+.+++++|+++|++.+ .. +..|.||+|.|+..++.++
T Consensus 131 ~eiV~~LI~~GADIn~~~-------~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eI 203 (437)
T PHA02795 131 IDIVDFMVDHGAVIYKIE-------CLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEI 203 (437)
T ss_pred HHHHHHHHHCCCCCCCCC-------CCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHH
Confidence 334455567788887643 3689999999999999999999998543 22 2348899999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 89 v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
+++|+++||++|.+|..|.||||+|+..|+.+++++|+++|++++.....+.++
T Consensus 204 ve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~Tp 257 (437)
T PHA02795 204 YKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTC 257 (437)
T ss_pred HHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 999999999999999999999999999999999999999999998776554443
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.9e-16 Score=133.39 Aligned_cols=107 Identities=26% Similarity=0.334 Sum_probs=85.9
Q ss_pred CCCCccchhhHHHHHHHcCCHHHHHHHHHcCC--C-----CCCCCCCCCCHHHHHHHcCcH---HHHHHHHHcCCCCCCC
Q 013214 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGI--D-----VNFRDIDNRTALHVAACQGFT---EVVSLLLERGADVDPK 102 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~--d-----~n~~d~~g~t~Lh~A~~~g~~---~~v~~Ll~~ga~~~~~ 102 (447)
.+..|.+|+||||+||..|+. ++++...+. + ++.+|.+|+||||+|+..|+. +++++|++.|++++.+
T Consensus 10 ~~~~d~~g~tpLh~A~~~g~~--~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~ 87 (154)
T PHA02736 10 ASEPDIEGENILHYLCRNGGV--TDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGK 87 (154)
T ss_pred HHhcCCCCCCHHHHHHHhCCH--HHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCcccc
Confidence 455667799999999999984 333333322 2 345789999999999999987 4689999999999999
Q ss_pred C-CCCCCccccccccchHHHHHHHHH-hCCCCCCCcccccc
Q 013214 103 D-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKH 141 (447)
Q Consensus 103 d-~~g~tpl~~a~~~~~~~~~~~L~~-~~a~~~~~~~~~~~ 141 (447)
| ..|+||||+|+..++.+++++|++ .|++++..+..+.+
T Consensus 88 ~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~t 128 (154)
T PHA02736 88 ERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKT 128 (154)
T ss_pred CCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCC
Confidence 8 499999999999999999999998 48888766544433
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=154.52 Aligned_cols=107 Identities=21% Similarity=0.258 Sum_probs=85.7
Q ss_pred cCCCCCCCccchhhHHHHHHHc---CCHHHHHHHHHcCCCC-CCCCCCCCCHHHHHHHc--CcHHHHHHHHHcCCCCCC-
Q 013214 29 NGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDV-NFRDIDNRTALHVAACQ--GFTEVVSLLLERGADVDP- 101 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~---~~~~~~~~Ll~~g~d~-n~~d~~g~t~Lh~A~~~--g~~~~v~~Ll~~ga~~~~- 101 (447)
+|.|.+.++..|+||||.|+.. |+.+++++|+++|||+ +.+|..|+||||+|+.. ++.+++++|+++|++++.
T Consensus 97 ~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~ 176 (494)
T PHA02989 97 FGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEK 176 (494)
T ss_pred CCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccc
Confidence 4444555566678889987755 6789999999999999 78899999999998754 578999999999999888
Q ss_pred CCCCCCCcccccccc----chHHHHHHHHHhCCCCCCC
Q 013214 102 KDRWGSTPLGDAIYY----KNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 102 ~d~~g~tpl~~a~~~----~~~~~~~~L~~~~a~~~~~ 135 (447)
.+..|.||||+|+.. ++.+++++|+++|++++..
T Consensus 177 ~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn~~ 214 (494)
T PHA02989 177 TSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIETN 214 (494)
T ss_pred ccccCCChHHHHHhcccccccHHHHHHHHhCCCCcccc
Confidence 678888998887665 4788899999988887644
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-15 Score=153.65 Aligned_cols=113 Identities=20% Similarity=0.229 Sum_probs=98.1
Q ss_pred CCCCccccchhcccCCCCCCCccchhhHHHHHHH------cCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc---CcH
Q 013214 16 SLAPDRERKEAELNGLDDDGEEIKPEFRLMFLAN------ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ---GFT 86 (447)
Q Consensus 16 ~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~------~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~---g~~ 86 (447)
.+...+.+.|||+|..+ .+.||||.|+. .++.+++++|+++|||+|.+|.+|+||||.|+.. |+.
T Consensus 51 ~iv~~Ll~~GAdvn~~~------~~~tpL~~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~ 124 (494)
T PHA02989 51 KIVKLLIDNGADVNYKG------YIETPLCAVLRNREITSNKIKKIVKLLLKFGADINLKTFNGVSPIVCFIYNSNINNC 124 (494)
T ss_pred HHHHHHHHcCCCccCCC------CCCCcHHHHHhccCcchhhHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcH
Confidence 34555667788887653 35799999875 5789999999999999999999999999998865 679
Q ss_pred HHHHHHHHcCCCC-CCCCCCCCCcccccccc--chHHHHHHHHHhCCCCCC
Q 013214 87 EVVSLLLERGADV-DPKDRWGSTPLGDAIYY--KNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 87 ~~v~~Ll~~ga~~-~~~d~~g~tpl~~a~~~--~~~~~~~~L~~~~a~~~~ 134 (447)
+++++|+++|||+ +.+|..|.||||+|+.. ++.+++++|+++|++++.
T Consensus 125 eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~ 175 (494)
T PHA02989 125 DMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE 175 (494)
T ss_pred HHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence 9999999999999 89999999999998754 689999999999999876
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.4e-15 Score=156.78 Aligned_cols=108 Identities=20% Similarity=0.184 Sum_probs=92.4
Q ss_pred cCCCCCCCccchhhHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC---------------------
Q 013214 29 NGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--------------------- 84 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~---~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g--------------------- 84 (447)
++.+.+.+|.+|+||||+||.. |+.+++++|++.|+|++.+|.+|+||||+|+..|
T Consensus 21 ~~~~~~~~d~~g~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n~ 100 (661)
T PHA02917 21 DRDPNDTRNQFKNNALHAYLFNEHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSNI 100 (661)
T ss_pred ccCcccccCCCCCcHHHHHHHhhhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCCC
Confidence 4555566677888999997665 8899999999999999999999999999887644
Q ss_pred --------------cHHHHHHHHHcCCCCCCCCCCCCCccccc--cccchHHHHHHHHHhCCCCCCCc
Q 013214 85 --------------FTEVVSLLLERGADVDPKDRWGSTPLGDA--IYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 85 --------------~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a--~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
+.++|++|+++|||+|.+|..|.||||+| +..|+.+++++|+++|++++...
T Consensus 101 ~~~~~~~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d 168 (661)
T PHA02917 101 NDFNIFSYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYED 168 (661)
T ss_pred CCcchHHHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccc
Confidence 45789999999999999999999999954 45789999999999999997543
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.6e-16 Score=113.36 Aligned_cols=85 Identities=22% Similarity=0.258 Sum_probs=75.4
Q ss_pred ccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCC
Q 013214 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (447)
Q Consensus 28 ~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~ 107 (447)
..|.|.|. ...|+|||||||..|..+++++|+..|||++.+|+.|.|||--|++.||.++|++|++.||+-..+..+|.
T Consensus 23 ~~g~nVn~-~~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~~GAdrt~~~PdG~ 101 (117)
T KOG4214|consen 23 NEGLNVNE-IYGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQNGADRTIHAPDGT 101 (117)
T ss_pred HccccHHH-HhCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHHcCcccceeCCCch
Confidence 34445553 34799999999999999999999999999999999999999999999999999999999999999988998
Q ss_pred Cccccc
Q 013214 108 TPLGDA 113 (447)
Q Consensus 108 tpl~~a 113 (447)
+.+..+
T Consensus 102 ~~~eat 107 (117)
T KOG4214|consen 102 ALIEAT 107 (117)
T ss_pred hHHhhc
Confidence 777543
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.3e-15 Score=150.78 Aligned_cols=118 Identities=31% Similarity=0.291 Sum_probs=103.2
Q ss_pred ccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHH-cC-CCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCC
Q 013214 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99 (447)
Q Consensus 22 ~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~-~g-~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~ 99 (447)
.+.||++|.++ .++.||||.||..|+.++++.|++ .| ..+|..|..|.||||+|+.+||..++++|++.||+.
T Consensus 293 l~~Ga~I~~kn-----~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~ 367 (929)
T KOG0510|consen 293 LGFGASINSKN-----KDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALF 367 (929)
T ss_pred HHcCCcccccC-----CCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhh
Confidence 45666666655 556677999999999999999998 54 679999999999999999999999999999999998
Q ss_pred C---CCCCCCCCccccccccchHHHHHHHHHhCCCCCCCcccccccCC
Q 013214 100 D---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144 (447)
Q Consensus 100 ~---~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~~~ 144 (447)
. ..|.+|.||||.|+..|+..++++|+.+||++...+..+.++-.
T Consensus 368 ~~~~e~D~dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~~n~~g~SA~~ 415 (929)
T KOG0510|consen 368 LNMSEADSDGNTALHLAAKYGNTSAVQKLISHGADIGVKNKKGKSAFD 415 (929)
T ss_pred hcccccccCCchhhhHHHHhccHHHHHHHHHcCCceeecccccccccc
Confidence 8 56999999999999999999999999999999887766655543
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.9e-16 Score=140.79 Aligned_cols=107 Identities=29% Similarity=0.326 Sum_probs=81.9
Q ss_pred CccchhhHHHHHHHcCCHHHHHHHHHcC-CCCCCCCCCCCC--------------------------------------H
Q 013214 36 EEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRT--------------------------------------A 76 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~~~~~~~~~Ll~~g-~d~n~~d~~g~t--------------------------------------~ 76 (447)
-|.+|+|+||||+..+|.++|+.||+.| +|+|.+|.-|+| +
T Consensus 264 aDsNGNTALHYsVSHaNF~VV~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mgnVNaKAsQ~gQTA 343 (452)
T KOG0514|consen 264 ADSNGNTALHYAVSHANFDVVSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMGDVNAKASQHGQTA 343 (452)
T ss_pred hcCCCCeeeeeeecccchHHHHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhccCcchhhhhhcchh
Confidence 3445566688888888888888888776 677766555544 4
Q ss_pred HHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHh-CCCCCCCccccccc
Q 013214 77 LHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH-GAKPLMAPMHVKHA 142 (447)
Q Consensus 77 Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~-~a~~~~~~~~~~~~ 142 (447)
|++|+.+|+.++|+.||..|||+|.+|.+|.|+|+.|+.+|++|++++|+.. ++++...+..++++
T Consensus 344 LMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTA 410 (452)
T KOG0514|consen 344 LMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTA 410 (452)
T ss_pred hhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchh
Confidence 6677888888999999999999999999999999999999999999988864 34554444444444
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.9e-15 Score=149.32 Aligned_cols=112 Identities=18% Similarity=0.243 Sum_probs=89.6
Q ss_pred CCCCCCCccchhhHHHHHHHcC--CHHHHHHHHHcCCCCCC-CCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNF-RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~--~~~~~~~Ll~~g~d~n~-~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g 106 (447)
|.|++.+|.+|+||||+|+..+ ..+++++|+++|+|+|. .|.+|.|||| ||..|+.+++++|++.|++++.+|..|
T Consensus 95 GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G 173 (446)
T PHA02946 95 GADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFG 173 (446)
T ss_pred cCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCCCCcHHH-HHHCCChHHHHHHHhccccccccCCCC
Confidence 3344445666788899988766 47889999999999995 6888999997 666788999999999999999999999
Q ss_pred CCccccccccc--hHHHHHHHHHhCCCCCCCccccccc
Q 013214 107 STPLGDAIYYK--NHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 107 ~tpl~~a~~~~--~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
+||||+|+..+ +.+++++|+++|++++..+..+.++
T Consensus 174 ~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~d~~G~Tp 211 (446)
T PHA02946 174 KNHIHRHLMSDNPKASTISWMMKLGISPSKPDHDGNTP 211 (446)
T ss_pred CCHHHHHHHhcCCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence 99999887654 4688999999999988766554443
|
|
| >PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.7e-16 Score=107.15 Aligned_cols=55 Identities=53% Similarity=0.668 Sum_probs=32.2
Q ss_pred HHHcC-CCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 013214 59 LLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (447)
Q Consensus 59 Ll~~g-~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a 113 (447)
||++| +|+|.+|..|.||||+||..|+.+++++|++.|+|++.+|..|+||+|+|
T Consensus 1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 57788 89999999999999999999999999999999999999999999999987
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.7e-15 Score=114.24 Aligned_cols=64 Identities=42% Similarity=0.587 Sum_probs=59.7
Q ss_pred hhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCC
Q 013214 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (447)
Q Consensus 40 g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d 103 (447)
|+||||+||..|+.+++++|++.|+|+|.+|.+|+||||+|+.+|+.+++++|+++|++++.+|
T Consensus 26 ~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~n 89 (89)
T PF12796_consen 26 GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLLLEHGADVNIRN 89 (89)
T ss_dssp SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHHHHTTT-TTSS-
T ss_pred CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 7789999999999999999999999999999999999999999999999999999999999876
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=7e-15 Score=156.31 Aligned_cols=106 Identities=33% Similarity=0.355 Sum_probs=76.5
Q ss_pred CCCCCCccchhhHHHHHHHcC-CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 31 LDDDGEEIKPEFRLMFLANER-DVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~-~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~-g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
.|.+..+.+|+||||+|+..| +.+.++.|++.|+|+|.+|..|+||||+|+.. ++.+++++|++.|+++|.+|..|.|
T Consensus 298 adin~~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~~G~T 377 (682)
T PHA02876 298 ADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKT 377 (682)
T ss_pred CCCCCcCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCCcHHHHHHHHHcCCCCccCCCCCCC
Confidence 334444555667777777777 47777777777777777777777777777764 3577777777777777777777778
Q ss_pred ccccccccchHHHHHHHHHhCCCCCCCc
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
|||+|+..|+.+++++|+++|+++....
T Consensus 378 pLh~Aa~~~~~~iv~~Ll~~gad~~~~~ 405 (682)
T PHA02876 378 PIHYAAVRNNVVIINTLLDYGADIEALS 405 (682)
T ss_pred HHHHHHHcCCHHHHHHHHHCCCCccccC
Confidence 8887777777778888887777765443
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.2e-15 Score=153.69 Aligned_cols=104 Identities=30% Similarity=0.252 Sum_probs=92.0
Q ss_pred CCCCCCCccchhhHHHHHHHcC-----------------------CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcH
Q 013214 30 GLDDDGEEIKPEFRLMFLANER-----------------------DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT 86 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~-----------------------~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~ 86 (447)
|.+.+..+.+|+||||.||+.+ ..++++.|+++|||+|.+|..|+||||+|+..++.
T Consensus 386 ga~~~~~~~~G~TpL~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~~~~ 465 (661)
T PHA02917 386 GGDAVNHLDDGEIPIGHLCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRYNKQ 465 (661)
T ss_pred CCCccccCCCCCChhHHHHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHcCCH
Confidence 3444444556999999988543 35678999999999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCccccccc-cchHHHHHHHHHhCCCCC
Q 013214 87 EVVSLLLERGADVDPKDRWGSTPLGDAIY-YKNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 87 ~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~-~~~~~~~~~L~~~~a~~~ 133 (447)
+++++|+++|++++.+|..|.||||+|+. .++.+++++|+.+|+++.
T Consensus 466 ~~v~~Ll~~GAdin~~d~~G~T~L~~A~~~~~~~~iv~~LL~~ga~i~ 513 (661)
T PHA02917 466 SLVSLLLESGSDVNIRSNNGYTCIAIAINESRNIELLKMLLCHKPTLD 513 (661)
T ss_pred HHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCCCHHHHHHHHHcCCChh
Confidence 99999999999999999999999999996 678999999999998875
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=8.8e-15 Score=149.28 Aligned_cols=100 Identities=16% Similarity=0.178 Sum_probs=87.9
Q ss_pred CCccchhhHHHHHHHcC---CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC--cHHHHHHHHHcCC--CCCCCCCCCC
Q 013214 35 GEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGA--DVDPKDRWGS 107 (447)
Q Consensus 35 ~~~~~g~t~lh~a~~~~---~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g--~~~~v~~Ll~~ga--~~~~~d~~g~ 107 (447)
.+|.+|+||||+|+..| +.+++++|+++|||+|.+|.+|+||||+|+..+ +.++|++|++.|+ +++..++.++
T Consensus 36 ~kd~~G~TaLh~A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~~~~~~d 115 (672)
T PHA02730 36 HIDRRGNNALHCYVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNELTSNIND 115 (672)
T ss_pred hcCCCCCcHHHHHHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCcccccccCC
Confidence 55667889999999997 599999999999999999999999999999977 7999999999955 5588888899
Q ss_pred Cccccccc--cchHHHHHHHHH-hCCCCCC
Q 013214 108 TPLGDAIY--YKNHEVIKLLEK-HGAKPLM 134 (447)
Q Consensus 108 tpl~~a~~--~~~~~~~~~L~~-~~a~~~~ 134 (447)
+|++.++. +++.+++++|++ .++++..
T Consensus 116 ~~l~~y~~s~n~~~~~vk~Li~~~~~~~~~ 145 (672)
T PHA02730 116 FDLYSYMSSDNIDLRLLKYLIVDKRIRPSK 145 (672)
T ss_pred chHHHHHHhcCCcHHHHHHHHHhcCCChhh
Confidence 99998877 889999999997 5566653
|
|
| >PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.6e-15 Score=102.14 Aligned_cols=54 Identities=39% Similarity=0.524 Sum_probs=45.5
Q ss_pred hhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHH
Q 013214 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93 (447)
Q Consensus 40 g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll 93 (447)
|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|++.|+.+++++|+
T Consensus 1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll 54 (54)
T PF13637_consen 1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL 54 (54)
T ss_dssp SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence 689999999999999999999999999999999999999999999999999986
|
... |
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.3e-15 Score=134.95 Aligned_cols=90 Identities=37% Similarity=0.441 Sum_probs=86.1
Q ss_pred chhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHc-CCCCCCCCCCCCCccccccccc
Q 013214 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYK 117 (447)
Q Consensus 39 ~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~-ga~~~~~d~~g~tpl~~a~~~~ 117 (447)
-|.|+|++|+..|++++++.||..|||||.+|.+|.|+|++||.+||.+++++||.. ++|+...|.+|.|+|.+|...|
T Consensus 339 ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTAl~IAleag 418 (452)
T KOG0514|consen 339 HGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTALSIALEAG 418 (452)
T ss_pred hcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchhhhhHHhcC
Confidence 588999999999999999999999999999999999999999999999999999986 8999999999999999999999
Q ss_pred hHHHHHHHHHh
Q 013214 118 NHEVIKLLEKH 128 (447)
Q Consensus 118 ~~~~~~~L~~~ 128 (447)
+.||.-+|-.+
T Consensus 419 h~eIa~mlYa~ 429 (452)
T KOG0514|consen 419 HREIAVMLYAH 429 (452)
T ss_pred chHHHHHHHHH
Confidence 99999887654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.3e-14 Score=126.12 Aligned_cols=134 Identities=23% Similarity=0.221 Sum_probs=93.7
Q ss_pred eeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHH---------------------HHHHHHHHhcCCCC--ccc
Q 013214 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRA---------------------FRDELALLQKIRHP--NVV 213 (447)
Q Consensus 161 ~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~hp--~iv 213 (447)
+.||+|+||.++. +|+.||+|++............. ...|...+..+.+. .+.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 5689999998863 58999999886543221111111 13566666666433 355
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCC
Q 013214 214 QFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
+.++. ...+++|||++++.+.. .+.... . ...+..++.+++.++.++|+ .+ ++|+||||+||+++ ++.
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGK 152 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCc
Confidence 55543 24589999998854321 111111 1 16678899999999999999 88 99999999999999 899
Q ss_pred EEEeecccccccc
Q 013214 292 LKVADFGVSKLLT 304 (447)
Q Consensus 292 vkl~Dfg~~~~~~ 304 (447)
++++|||++....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PHA02792 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.9e-15 Score=148.51 Aligned_cols=113 Identities=16% Similarity=0.104 Sum_probs=71.1
Q ss_pred CCCccccchhcccCCCCCCCccchhhHHHHHHHcCCH---HHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHH
Q 013214 17 LAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDV---EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93 (447)
Q Consensus 17 ~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~---~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll 93 (447)
+...+.+.|||+|..|.++ .+.||||+|+..+.. +++++|+++|||+|.+|..|+||||+|+..++.+++++|+
T Consensus 354 IVelLIs~GADIN~kD~~g---~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~n~eivelLL 430 (631)
T PHA02792 354 VVEYILKNGNVVVEDDDNI---INIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESHSVSLVEWLI 430 (631)
T ss_pred HHHHHHHcCCchhhhcCCC---CChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcCCHHHHHHHH
Confidence 3344455566666555443 234667766655543 3466667777777777777777777777777777777777
Q ss_pred HcCCCCCCCCCCCCCccccccc----------cchHHHHHHHHHhCCCC
Q 013214 94 ERGADVDPKDRWGSTPLGDAIY----------YKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 94 ~~ga~~~~~d~~g~tpl~~a~~----------~~~~~~~~~L~~~~a~~ 132 (447)
++||+++.+|..|.|||++|+. ....++++.|+++|.++
T Consensus 431 s~GADIN~kD~~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i 479 (631)
T PHA02792 431 DNGADINITTKYGSTCIGICVILAHACIPEIAELYIKILEIILSKLPTI 479 (631)
T ss_pred HCCCCCCCcCCCCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCCh
Confidence 7777777777777777777654 11244566666666544
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=2e-14 Score=155.22 Aligned_cols=96 Identities=28% Similarity=0.452 Sum_probs=88.6
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~ 116 (447)
+.++.++||.||..|+.++++.|++.|+|+|.+|.+|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..
T Consensus 522 ~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~ 601 (823)
T PLN03192 522 DPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISA 601 (823)
T ss_pred CccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHh
Confidence 33567889999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred chHHHHHHHHHhCCCC
Q 013214 117 KNHEVIKLLEKHGAKP 132 (447)
Q Consensus 117 ~~~~~~~~L~~~~a~~ 132 (447)
|+.+++++|++.++..
T Consensus 602 g~~~iv~~L~~~~~~~ 617 (823)
T PLN03192 602 KHHKIFRILYHFASIS 617 (823)
T ss_pred CCHHHHHHHHhcCccc
Confidence 8888888887766543
|
|
| >cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.6e-14 Score=115.78 Aligned_cols=101 Identities=44% Similarity=0.565 Sum_probs=93.9
Q ss_pred CccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 013214 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~ 115 (447)
++.+|.||||+|+..++.++++.|++.|++++..+..|.||||+|+..++.+++++|++.|++++..+..|.||+|+|+.
T Consensus 3 ~~~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~ 82 (126)
T cd00204 3 RDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAAR 82 (126)
T ss_pred cCcCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHH
Confidence 34678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHHhCCCCCCCc
Q 013214 116 YKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 116 ~~~~~~~~~L~~~~a~~~~~~ 136 (447)
.++.+++++|++.+.++....
T Consensus 83 ~~~~~~~~~L~~~~~~~~~~~ 103 (126)
T cd00204 83 NGNLDVVKLLLKHGADVNARD 103 (126)
T ss_pred cCcHHHHHHHHHcCCCCcccC
Confidence 999999999999986655543
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. |
| >PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.4e-14 Score=148.22 Aligned_cols=96 Identities=42% Similarity=0.529 Sum_probs=90.1
Q ss_pred hHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHH
Q 013214 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (447)
Q Consensus 42 t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~ 121 (447)
+.|+.||..|+.+.++.|++.|+|+|.+|.+|+||||+||.+|+.+++++|+++|++++.+|..|.||||+|+..|+.++
T Consensus 84 ~~L~~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~i 163 (664)
T PTZ00322 84 VELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREV 163 (664)
T ss_pred HHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHH
Confidence 46899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHh-------CCCCCCCcc
Q 013214 122 IKLLEKH-------GAKPLMAPM 137 (447)
Q Consensus 122 ~~~L~~~-------~a~~~~~~~ 137 (447)
+++|+++ |+++.....
T Consensus 164 v~~Ll~~~~~~~~~ga~~~~~~~ 186 (664)
T PTZ00322 164 VQLLSRHSQCHFELGANAKPDSF 186 (664)
T ss_pred HHHHHhCCCcccccCCCCCcccc
Confidence 9999999 666655443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-13 Score=117.67 Aligned_cols=131 Identities=19% Similarity=0.182 Sum_probs=106.5
Q ss_pred ceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC--CcccceeEEEEeCCceEEEEeccCC
Q 013214 160 SVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 160 ~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.+.||.|.++.++ ..+..+++|....... ...+.+|...++.+.+ +++++++.+....+..++++||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 3568888887665 4567899999865432 3567889999999976 5899999988887889999999988
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 235 g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
+++..+ +......++.++++++.++|.....+++|+|++|.||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 4566677889999999999986323499999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.7e-14 Score=126.88 Aligned_cols=111 Identities=26% Similarity=0.364 Sum_probs=94.0
Q ss_pred cccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCC
Q 013214 21 RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100 (447)
Q Consensus 21 ~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~ 100 (447)
+.+.||-+|..+ ....||||.||..|+.++++.|++..+|+|+.|+.|+|||||||.+|...+++-|++.||.++
T Consensus 53 ll~rgarvn~tn-----mgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyacfwgydqiaedli~~ga~v~ 127 (448)
T KOG0195|consen 53 LLSRGARVNSTN-----MGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQIAEDLISCGAAVN 127 (448)
T ss_pred HHhccccccccc-----CCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHHHHHHHhccceee
Confidence 345555555544 445678999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccccchHHHHHHHHHhCCCCCCCc
Q 013214 101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 101 ~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
..|++|.||+..|.-.-...+.+.-.++|..++.-+
T Consensus 128 icnk~g~tpldkakp~l~~~l~e~aek~gq~~nrip 163 (448)
T KOG0195|consen 128 ICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIP 163 (448)
T ss_pred ecccCCCCchhhhchHHHHHHHHHHHHhCCCCCccc
Confidence 999999999998866555566777777887765433
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.4e-14 Score=151.75 Aligned_cols=107 Identities=36% Similarity=0.436 Sum_probs=97.7
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~ 116 (447)
...|-|++|.|+..+.+.+++.+++.|++++.++.+|+||||.||..|+.++|++|+++|||++.+|+.|+||||.|+..
T Consensus 504 ~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~ 583 (1143)
T KOG4177|consen 504 AKKGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQ 583 (1143)
T ss_pred chhccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHc
Confidence 34567778888888888888888888999999999999999999999999999999999999999999999999999999
Q ss_pred chHHHHHHHHHhCCCCCCCcccccccC
Q 013214 117 KNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (447)
Q Consensus 117 ~~~~~~~~L~~~~a~~~~~~~~~~~~~ 143 (447)
|+.+++++|+++|++++.......++.
T Consensus 584 G~~~i~~LLlk~GA~vna~d~~g~TpL 610 (1143)
T KOG4177|consen 584 GHNDIAELLLKHGASVNAADLDGFTPL 610 (1143)
T ss_pred ChHHHHHHHHHcCCCCCcccccCcchh
Confidence 999999999999999998877766654
|
|
| >KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-14 Score=138.03 Aligned_cols=114 Identities=31% Similarity=0.345 Sum_probs=80.6
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCC----------------------------------------
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNF---------------------------------------- 68 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~---------------------------------------- 68 (447)
+++++|..|..||||||.|+..|+..++++|+++|+++-.
T Consensus 95 ~ga~Vn~~d~e~wtPlhaaascg~~~i~~~li~~gA~~~avNsdg~~P~dl~e~ea~~~~l~~~~~r~gi~iea~R~~~e 174 (527)
T KOG0505|consen 95 NGANVNAQDNEGWTPLHAAASCGYLNIVEYLIQHGANLLAVNSDGNMPYDLAEDEATLDVLETEMARQGIDIEAARKAEE 174 (527)
T ss_pred hcCCccccccccCCcchhhcccccHHHHHHHHHhhhhhhhccCCCCCccccccCcchhHHHHHHHHHhcccHHHHhhhhH
Confidence 4444555555566677777777777777777776654221
Q ss_pred -------------------CCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhC
Q 013214 69 -------------------RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (447)
Q Consensus 69 -------------------~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~ 129 (447)
++..|-|+||.|+.+|..+++++|+++|.+++.+|.+|+||||.|+.+|..+++++|+++|
T Consensus 175 ~~ml~D~~q~l~~G~~~d~~~~rG~T~lHvAaa~Gy~e~~~lLl~ag~~~~~~D~dgWtPlHAAA~Wg~~~~~elL~~~g 254 (527)
T KOG0505|consen 175 QTMLDDARQWLNAGAELDARHARGATALHVAAANGYTEVAALLLQAGYSVNIKDYDGWTPLHAAAHWGQEDACELLVEHG 254 (527)
T ss_pred HHHHHHHHHHHhccccccccccccchHHHHHHhhhHHHHHHHHHHhccCcccccccCCCcccHHHHhhhHhHHHHHHHhh
Confidence 2233566677777777778888888888888888888888888888888888888888888
Q ss_pred CCCCCCccccccc
Q 013214 130 AKPLMAPMHVKHA 142 (447)
Q Consensus 130 a~~~~~~~~~~~~ 142 (447)
+++.+.......+
T Consensus 255 a~~d~~t~~g~~p 267 (527)
T KOG0505|consen 255 ADMDAKTKMGETP 267 (527)
T ss_pred cccchhhhcCCCC
Confidence 8876654444443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 447 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-36 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-36 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-32 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-32 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-31 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-31 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-31 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-31 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-31 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-29 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-29 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-29 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-29 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-29 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-29 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-29 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-29 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-29 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-29 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-28 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-28 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-28 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-28 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-28 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-28 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-28 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-28 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-28 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-27 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-27 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-27 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-27 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-27 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-27 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-27 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-27 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-27 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-27 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-27 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-26 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-26 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-26 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-26 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-26 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-26 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-26 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-26 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-26 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-26 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-26 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-26 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-26 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-26 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-26 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-26 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-26 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-26 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-26 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-26 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-26 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-26 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-26 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-26 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-26 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-26 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-26 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-26 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-26 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-26 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-26 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-26 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-26 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-26 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-26 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-26 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-26 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-26 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-26 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-25 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-25 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-25 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-25 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-25 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-25 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-25 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-25 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-25 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-25 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-25 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-25 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-25 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-25 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-25 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-25 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-25 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-25 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-25 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-25 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-25 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-25 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-25 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-25 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-25 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-25 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-25 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-25 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-25 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-25 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-25 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-25 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-24 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-24 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-24 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-24 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-24 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-24 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-24 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-24 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-24 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-24 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-24 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-24 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-24 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-24 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-24 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-24 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-24 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-24 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-24 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-23 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-23 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-23 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-23 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-23 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-23 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-23 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-23 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-23 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-23 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-23 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-23 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-23 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-23 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-23 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-23 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-22 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-22 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-22 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-22 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-22 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-22 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-22 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-22 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-22 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-22 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-22 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-22 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-22 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-22 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-22 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-22 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-22 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-22 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-22 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-22 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-22 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-21 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-21 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-21 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-21 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-21 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-21 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-21 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-21 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-21 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-21 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-21 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-21 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-21 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-21 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-21 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-21 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-21 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-20 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-20 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-20 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-20 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-20 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-20 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-20 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-20 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-19 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-19 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-19 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-19 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-19 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-19 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-19 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-19 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-19 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-19 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-19 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-19 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-19 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-19 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-18 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-18 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-18 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-18 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-18 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-18 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-17 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-17 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-16 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-16 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-16 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-16 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-16 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-15 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-15 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-15 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-15 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-15 | ||
| 4hqd_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 6e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-14 | ||
| 4gpm_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 9e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-13 | ||
| 4gmr_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 2e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 1n0r_A | 126 | 4ank: A Designed Ankyrin Repeat Protein With Four I | 2e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-13 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-13 | ||
| 1n0q_A | 93 | 3ank: A Designed Ankyrin Repeat Protein With Three | 5e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-13 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-12 | ||
| 4hb5_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 1e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 4dui_A | 169 | Darpin D1 Binding To Tubulin Beta Chain (not In Com | 2e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-12 | ||
| 4drx_E | 169 | Gtp-Tubulin In Complex With A Darpin Length = 169 | 3e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-12 | ||
| 2l6b_A | 115 | Nrc Consensus Ankyrin Repeat Protein Solution Struc | 4e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-12 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-12 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 2y0b_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4_ | 4e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-12 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-12 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-12 | ||
| 4atz_D | 154 | Ad5 Knob In Complex With A Designed Ankyrin Repeat | 5e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-11 | ||
| 1mj0_A | 166 | Sank E3_5: An Artificial Ankyrin Repeat Protein Len | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 2xzd_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4 | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-11 | ||
| 2xeh_A | 157 | Structural Determinants For Improved Thermal Stabil | 4e-11 | ||
| 2xee_A | 157 | Structural Determinants For Improved Thermal Stabil | 4e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-11 | ||
| 2qyj_A | 166 | Crystal Structure Of A Designed Full Consensus Anky | 8e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-11 | ||
| 3zu7_B | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 3q9u_C | 158 | In Silico And In Vitro Co-Evolution Of A High Affin | 9e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-10 | ||
| 2v4h_C | 136 | Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 13 | 1e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 2bkg_A | 166 | Crystal Structure Of E3_19 An Designed Ankyrin Repe | 1e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-10 | ||
| 1svx_A | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-10 | ||
| 2xzt_G | 136 | Caspase-3 In Complex With Darpin-3.4_i78s Length = | 1e-10 | ||
| 4f6r_D | 169 | Tubulin:stathmin-Like Domain Complex Length = 169 | 1e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-10 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169 | Back alignment and structure |
|
| >pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2V4H|C Chain C, Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 136 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2BKG|A Chain A, Crystal Structure Of E3_19 An Designed Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1SVX|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Maltose Binding Protein Length = 169 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136 | Back alignment and structure |
|
| >pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 1e-93
Identities = 81/280 (28%), Positives = 132/280 (47%), Gaps = 25/280 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ ID E++ + +G F A WR VA+K++ + +AF EL
Sbjct: 2 LHMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQI-----ESESERKAFIVELRQ 54
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIA 260
L ++ HPN+V+ GA P+ +V EY G L L + + A+ + L +
Sbjct: 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKEDRPLTCQDTSCR 319
+G+ YLH +P +IHRDL+P N+L G LK+ DFG + + +T S
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAA 168
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKAP 377
++APEVF+ Y K DVFS+ +IL E+I PF +A RPP
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--- 225
Query: 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
K + ++ L+ CW++ P++RP+ +I+ + +
Sbjct: 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 2e-93
Identities = 99/296 (33%), Positives = 153/296 (51%), Gaps = 19/296 (6%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
P ++ + A + + +I +L+ +I G+F A W G VAVK L E+
Sbjct: 14 DIPTTENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDVAVKILMEQ 71
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
+ RV F E+A+++++RHPN+V F+GAVTQ + IVTEYL +G L L + GA
Sbjct: 72 DFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 247 ---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
L + A D+A+GMNYLH P PI+HR+L+ N+L D +KV DFG+S+L
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
+ ++APEV ++E + K DV+SF +IL E+ P+ + +V
Sbjct: 190 A-STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV 248
Query: 364 KAYAAR-QRP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
A + +R P + + +IE CW +P KRP+F I+ L + S
Sbjct: 249 AAVGFKCKRLEIPRNLNPQ-----VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 3e-89
Identities = 87/280 (31%), Positives = 126/280 (45%), Gaps = 26/280 (9%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISD-DDRVRAFRDELALL 204
EID EL I G F AFW G +VAVK + D + R E L
Sbjct: 3 EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
++HPN++ G + + +V E+ G L L K + P V +A+ IARGMN
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSG--------NLKVADFGVSKLLTVKEDRPLTCQDT 316
YLH+ VPIIHRDL+ SNIL LK+ DFG+++
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAG 176
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP--P 373
+ ++APEV + + DV+S+ ++L E++ G PF V A + P
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
P +L+E+CWN P RP+F I+ +L +I
Sbjct: 237 STCPEPFA-----KLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 9e-86
Identities = 81/287 (28%), Positives = 130/287 (45%), Gaps = 32/287 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFW--RGIQVAVKKLGEEVISDD----DRVRAF 197
+ +E+++ +I KG F VA+K L + ++ + F
Sbjct: 13 LPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFA 256
+ E+ ++ + HPN+V+ G + P +V E++P GDL L + +K S +R
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGVSKLLTVKEDRPL 311
LDIA G+ Y+ P PI+HRDL NI KVADFG+S+ +
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSV 183
Query: 312 TCQDTSCRYVAPEVF--KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
+ + +++APE + E Y K D +SFA+IL ++ G PF ++ R
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
Query: 370 Q---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ RP P R L+ +IE CW+ P KRP F I+ L +
Sbjct: 244 EEGLRPTI--PEDCPPR-LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 3e-84
Identities = 68/284 (23%), Positives = 127/284 (44%), Gaps = 27/284 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
E++I +L+ I KG F W G +VA++ + E ++D+++AF+ E+
Sbjct: 27 EWDIPFEQLEIGE--LIGKGRFGQVYHGRWHG-EVAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
++ RH NVV F+GA + I+T L + + K L + + A +I +G
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV----KEDRPLTCQDTSC 318
M YLH I+H+DL+ N+ D+ G + + DFG+ + V + + L Q+
Sbjct: 143 MGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 319 RYVAPEVFKNEE---------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
++APE+ + + DVF+ I E+ PF + +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258
Query: 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+P + + +++ CW + +RPTF +++ LE +
Sbjct: 259 MKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 9e-84
Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 24/280 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
ID +L+F ++ + W+G + VK L S + R F +E
Sbjct: 4 HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPR 60
Query: 204 LQKIRHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFALDI 259
L+ HPNV+ LGA + ++T ++P G L L + S AV+FALD+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
ARGM +LH +P I L +++ D+ +++ V +
Sbjct: 121 ARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM------YAPA 173
Query: 320 YVAPEVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK 375
+VAPE + + DT D++SFA++L E++ PF + E+ A RP
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI- 232
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
P + + + +L++ C NE PAKRP F I+ LE + +
Sbjct: 233 -PPGI-SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 1e-80
Identities = 85/299 (28%), Positives = 135/299 (45%), Gaps = 40/299 (13%)
Query: 145 VPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRD 199
+P P +L + KG F I R G + +K+L D++ R F
Sbjct: 2 MPHRIFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLK 56
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALD 258
E+ +++ + HPNV++F+G + + + +TEY+ G LR +K S V FA D
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 316
IA GM YLH IIHRDL N L ++ N+ VADFG+++L+ ++ +P +
Sbjct: 117 IASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 317 -----------SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI------EGCPPFTMKHD 359
+ ++APE+ YD KVDVFSF ++L E+I P TM
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 360 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418
V + P P + + C + P KRP+F ++ LE++ +
Sbjct: 234 LNVRGFL--DRYCPPNCPPSFF-----PITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 6e-80
Identities = 73/277 (26%), Positives = 137/277 (49%), Gaps = 18/277 (6%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++EI ++ I G+F W G VAVK L +++AF++E+ +
Sbjct: 18 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-TPQQLQAFKNEVGV 73
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L+K RH N++ F+G T + IVT++ L L + + + A ARG
Sbjct: 74 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYV 321
M+YLH IIHRDL+ +NI + +K+ DFG++ + Q + S ++
Sbjct: 133 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 322 APEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQRPPFKAP 377
APEV + ++ Y + DV++F ++L E++ G P++ + + +++ + P +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 378 AKLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ + +K L+ EC +K +RP+F +I+ +E +
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-77
Identities = 69/313 (22%), Positives = 123/313 (39%), Gaps = 46/313 (14%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++ +I KG + + WRG +VAVK + ++ E+
Sbjct: 31 VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVF----FTTEEASWFRETEIYQ 84
Query: 204 LQKIRHPNVVQFLGAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
+RH N++ F+ A + + + ++T+Y G L +LK L + ++ A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143
Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
G+ +LH I HRDL+ NIL +G +AD G++ +
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 315 DTSC---RYVAPEV------FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
+T RY+ PEV + + D++SF LIL E+ C + + ++P
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 366 YAA----------------RQRP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
+ RP P + + R + +L+ ECW PA R T ++
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
Query: 408 TRLESINNSINHK 420
L ++ S + K
Sbjct: 324 KTLAKMSESQDIK 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-73
Identities = 70/291 (24%), Positives = 116/291 (39%), Gaps = 44/291 (15%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
+ KG + W+G VAVK R EL +RH N++ F+ +
Sbjct: 16 VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRET----ELYNTVMLRHENILGFIASD 71
Query: 220 TQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV--- 272
S + ++T Y G L +L+ L + +R L IA G+ +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 273 --PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK 327
I HRDL+ NIL +G +AD G++ + + ++ + RY+APEV
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 328 NE------EYDTKVDVFSFALILQEMIEGCPPFTMKHD------NEVPKAYAA------- 368
+ +VD+++F L+L E+ + D + VP +
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250
Query: 369 ---RQRPPFKAPAKLYA--RGLKELIEECWNEKPAKRPTFRQIITRLESIN 414
+QRP L +L++ECW + P+ R T +I L I+
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-72
Identities = 68/313 (21%), Positives = 115/313 (36%), Gaps = 46/313 (14%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ I KG F WRG +VAVK R E+
Sbjct: 36 VQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA----EIYQ 89
Query: 204 LQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
+RH N++ F+ A + + + +V++Y G L +L R + ++ AL
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALST 148
Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
A G+ +LH I HRDL+ NIL +G +AD G++ D
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 315 DTSC---RYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGC------PPFTMKHD 359
+ RY+APEV + E + D+++ L+ E+ C + + +
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268
Query: 360 NEVPKAYAA----------RQRPPFKAPAKL--YARGLKELIEECWNEKPAKRPTFRQII 407
+ VP + + RP + R + +++ ECW A R T +I
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
Query: 408 TRLESINNSINHK 420
L ++ K
Sbjct: 329 KTLSQLSQQEGIK 341
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-68
Identities = 68/312 (21%), Positives = 116/312 (37%), Gaps = 46/312 (14%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
L +G F A VAVK + D + E+
Sbjct: 17 ENLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVY 70
Query: 203 LLQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
L ++H N++QF+GA + + + ++T + KG L FLK + + A
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAET 129
Query: 259 IARGMNYLHENKPV-------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
+ARG+ YLHE+ P I HRD++ N+L ++ +ADFG++ +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 312 TCQDT-SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
T + RY+APEV + ++D+++ L+L E+ C D +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 366 YAA-----------------RQRPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQI 406
++RP + L E IEECW+ R + +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 407 ITRLESINNSIN 418
R+ + N
Sbjct: 310 GERITQMQRLTN 321
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-66
Identities = 79/328 (24%), Positives = 119/328 (36%), Gaps = 61/328 (18%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
E +D L I +G + VAVK S +R + F +E
Sbjct: 4 AASEPSLDLDNLKLLEL--IGRGRYGAVYKGSLDERPVAVKVF-----SFANR-QNFINE 55
Query: 201 LA--LLQKIRHPNVVQFLGA-----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
+ + H N+ +F+ ++V EY P G L +L ++
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114
Query: 254 RFALDIARGMNYLHENKPV------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
R A + RG+ YLH P I HRDL N+L + G ++DFG+S LT
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 308 DRPLTCQDTSC-------RYVAPEVFKN-------EEYDTKVDVFSFALILQEMIEGC-- 351
+D + RY+APEV + E +VD+++ LI E+ C
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 352 -------PPFTMKHDNEVPKAYAA----------RQRPPFK---APAKLYARGLKELIEE 391
P + M EV +QRP F L R LKE IE+
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 392 CWNEKPAKRPTFRQIITRLESINNSINH 419
CW++ R T + R+ +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-61
Identities = 77/309 (24%), Positives = 143/309 (46%), Gaps = 24/309 (7%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
+ + + + A P + ++E++ ++ + ++ G +
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH--KLGGGQYGEVYEG 239
Query: 172 FWRG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
W+ + VAVK L E+ + ++ F E A++++I+HPN+VQ LG T+ P I+T
Sbjct: 240 VWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295
Query: 230 EYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
E++ G+L +L+ + + + A I+ M YL + IHR+L N L
Sbjct: 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVG 352
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
++ +KVADFG+S+L+T ++ APE ++ K DV++F ++L E+
Sbjct: 353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
Query: 348 I-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
G P+ ++V + R P P K+Y EL+ CW P+ RP+F
Sbjct: 413 ATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFA 467
Query: 405 QIITRLESI 413
+I E++
Sbjct: 468 EIHQAFETM 476
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 7e-60
Identities = 84/302 (27%), Positives = 129/302 (42%), Gaps = 30/302 (9%)
Query: 127 KHGAKPLMAPMHVKHAREVP--EYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVA 179
+PL V R VP ++ ++ +L +I +G F R VA
Sbjct: 86 LSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVA 143
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
VK E + D F E +L++ HPN+V+ +G TQ P+ IV E + GD
Sbjct: 144 VKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201
Query: 240 FLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
FL+ L+ T ++ D A GM YL IHRDL N L + LK++DFG
Sbjct: 202 FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFG 258
Query: 299 VSKLLTVKEDRPLTCQDTSC----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 353
+S+ D ++ APE Y ++ DV+SF ++L E G P
Sbjct: 259 MSREE---ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
Query: 354 FTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
+ + + + R P P ++ L+E+CW +P +RP+F I L+
Sbjct: 316 YPNLSNQQTREFVEKGGRLPCPELCPDAVF-----RLMEQCWAYEPGQRPSFSTIYQELQ 370
Query: 412 SI 413
SI
Sbjct: 371 SI 372
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-59
Identities = 76/278 (27%), Positives = 136/278 (48%), Gaps = 24/278 (8%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVAVKKLGEEVISDDDRVRAFRDE 200
++E++ ++ + ++ G + W+ + VAVK L E+ + ++ F E
Sbjct: 6 DKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKE 59
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALD 258
A++++I+HPN+VQ LG T+ P I+TE++ G+L +L+ + + + A
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
I+ M YL + IHRDL N L ++ +KVADFG+S+L+T
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 375
++ APE ++ K DV++F ++L E+ G P+ ++V + R P
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
P K+Y EL+ CW P+ RP+F +I E++
Sbjct: 237 CPEKVY-----ELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-59
Identities = 85/278 (30%), Positives = 145/278 (52%), Gaps = 28/278 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
++ IDP EL F EI G F L +W +VA+K + E +S++D F +E
Sbjct: 2 KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 55
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
++ K+ HP +VQ G + +P+ +VTE++ G L +L+ ++G T + LD+
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 318
GM YL E +IHRDL N L ++ +KV+DFG+++ + D T +
Sbjct: 116 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPV 169
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 375
++ +PEVF Y +K DV+SF +++ E+ EG P+ + ++EV + + R P
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 229
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
A +Y +++ CW E+P RP F +++ +L I
Sbjct: 230 ASTHVY-----QIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-59
Identities = 82/286 (28%), Positives = 138/286 (48%), Gaps = 34/286 (11%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
+ ++ EL I KG F +L +RG +VAVK + + + F E +
Sbjct: 14 SGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-----FLAEAS 66
Query: 203 LLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
++ ++RH N+VQ LG + + + IVTEY+ KG L +L+ + L ++F+LD+
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR---PLTCQDT 316
M YL N +HRDL N+L + KV+DFG++K + +D P+
Sbjct: 127 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV----- 178
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PP 373
++ APE + +++ TK DV+SF ++L E+ G P+ +V + P
Sbjct: 179 --KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 236
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419
P +Y E+++ CW+ A RP+F Q+ +LE I H
Sbjct: 237 DGCPPAVY-----EVMKNCWHLDAAMRPSFLQLREQLEHIKTHELH 277
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-59
Identities = 83/321 (25%), Positives = 141/321 (43%), Gaps = 31/321 (9%)
Query: 114 IYYKNH--EVIKLLEKHGAKPLMAPMHVKHAREVPEY-------EIDPHELDFTNSV--- 161
+++ +H + L G P H E P EI+ + +
Sbjct: 1 MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60
Query: 162 ---EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
E+ G + R + VA+K L + + R F E +++ + HPN+++ G
Sbjct: 61 DSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGV 118
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
VT+ MIVTEY+ G L FL+ G V + GM YL + +HR
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHR 175
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKV 335
DL N+L D + KV+DFG+S++L D T R+ APE + +
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSAS 235
Query: 336 DVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEEC 392
DV+SF +++ E++ G P+ + +V + R P P L+ +L+ +C
Sbjct: 236 DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH-----QLMLDC 290
Query: 393 WNEKPAKRPTFRQIITRLESI 413
W++ A+RP F QI++ L+++
Sbjct: 291 WHKDRAQRPRFSQIVSVLDAL 311
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-58
Identities = 83/276 (30%), Positives = 140/276 (50%), Gaps = 28/276 (10%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALL 204
E+ E+ E+ G F L W+G VAVK + E +S+D+ F E +
Sbjct: 4 ELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTM 57
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
K+ HP +V+F G ++ P+ IVTEY+ G L +L+ L+PS + D+ GM
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRY 320
+L ++ IHRDL N L D +KV+DFG+++ + D + ++
Sbjct: 118 AFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKW 171
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAP 377
APEVF +Y +K DV++F +++ E+ G P+ + ++EV + R P A
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLAS 231
Query: 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+Y +++ CW+E P KRPTF+Q+++ +E +
Sbjct: 232 DTIY-----QIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-58
Identities = 79/278 (28%), Positives = 136/278 (48%), Gaps = 28/278 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
+EIDP +L F E+ G F WRG VA+K + E +S+D+ F +E
Sbjct: 18 SWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAK 71
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
++ + H +VQ G T+ P+ I+TEY+ G L +L+ + + + D+
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 318
M YL + +HRDL N L +D G +KV+DFG+S+ + D T S
Sbjct: 132 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPV 185
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 375
R+ PEV ++ +K D+++F +++ E+ G P+ ++E + A R P
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL 245
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
A K+Y ++ CW+EK +RPTF+ +++ + +
Sbjct: 246 ASEKVY-----TIMYSCWHEKADERPTFKILLSNILDV 278
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-57
Identities = 87/302 (28%), Positives = 145/302 (48%), Gaps = 34/302 (11%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
K + + + + ++ EL I KG F +L +RG +VAVK
Sbjct: 170 PKVMEGTVAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK----- 222
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLKRKG 245
I +D +AF E +++ ++RH N+VQ LG + + + IVTEY+ KG L +L+ +G
Sbjct: 223 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282
Query: 246 --ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
L ++F+LD+ M YL N +HRDL N+L + KV+DFG++K
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339
Query: 304 TVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHD 359
+ +D P+ ++ APE + +++ TK DV+SF ++L E+ G P+
Sbjct: 340 SSTQDTGKLPV-------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392
Query: 360 NEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
+V + P P +Y ++++ CW+ A RPTF Q+ +LE I
Sbjct: 393 KDVVPRVEKGYKMDAPDGCPPAVY-----DVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447
Query: 418 NH 419
H
Sbjct: 448 LH 449
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-57
Identities = 87/308 (28%), Positives = 135/308 (43%), Gaps = 26/308 (8%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
YY H L +EI L ++ +G F +
Sbjct: 148 YYSKHA--DGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMG 203
Query: 172 FWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
W G +VA+K L +S + F E +++K+RH +VQ V++ P+ IVTE
Sbjct: 204 TWNGTTRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTE 258
Query: 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
Y+ KG L FLK + L+ V A IA GM Y+ +HRDL +NIL +
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGE 315
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+ KVADFG+++L+ E ++ APE + K DV+SF ++L E+
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
Query: 349 -EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
+G P+ + EV R P + P L+ +L+ +CW ++P +RPTF
Sbjct: 376 TKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-----DLMCQCWRKEPEERPTFEY 430
Query: 406 IITRLESI 413
+ LE
Sbjct: 431 LQAFLEDY 438
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 7e-57
Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 37/295 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRD 199
E +D L + E+ G F +++ VAVK L E +D
Sbjct: 10 EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLA 67
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E ++Q++ +P +V+ +G M+V E G L +L++ +K + +
Sbjct: 68 EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR---------P 310
+ GM YL E+ +HRDL N+L K++DFG+SK L E+ P
Sbjct: 127 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAAR 369
+ ++ APE ++ +K DV+SF +++ E G P+ +EV
Sbjct: 184 V-------KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
Query: 370 QR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422
+R P P ++Y +L+ CW RP F + RL + + ++
Sbjct: 237 ERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 7e-57
Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 27/282 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
EI P + I G F + + VA+K L ++ R F
Sbjct: 38 TTEIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQR-VDF 93
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
E ++ + H N+++ G +++ PMMI+TEY+ G L FL+ + G V
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
IA GM YL +HRDL NIL + + KV+DFG+S++L + T
Sbjct: 154 RGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 317 SC--RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR-- 371
R+ APE ++ + DV+SF +++ E++ G P+ ++EV KA R
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270
Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
P P+ +Y +L+ +CW ++ A+RP F I++ L+ +
Sbjct: 271 TPMDCPSAIY-----QLMMQCWQQERARRPKFADIVSILDKL 307
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 7e-57
Identities = 83/276 (30%), Positives = 131/276 (47%), Gaps = 24/276 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
+EI L ++ +G F + W G +VA+K L +S + F E
Sbjct: 261 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 314
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIA 260
+++K+RH +VQ V++ P+ IVTEY+ KG L FLK + L+ V A IA
Sbjct: 315 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
GM Y+ +HRDL +NIL ++ KVADFG+++L+ E ++
Sbjct: 374 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAP 377
APE + K DV+SF ++L E+ +G P+ + EV R P + P
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 490
Query: 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
L+ +L+ +CW ++P +RPTF + LE
Sbjct: 491 ESLH-----DLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-56
Identities = 83/277 (29%), Positives = 133/277 (48%), Gaps = 22/277 (7%)
Query: 149 EIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
E+D + V E+ G L + I VA+K L + + R F E +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEAS 98
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIAR 261
++ + HPN+++ G VT+S P+MIVTEY+ G L +FL K V IA
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--R 319
GM YL + +HRDL NIL + + KV+DFG+ ++L + T + R
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKA 376
+ +PE ++ + DV+S+ ++L E++ G P+ + +V KA R PP
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
PA LY +L+ +CW + RP F QI++ L+ +
Sbjct: 276 PAALY-----QLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-56
Identities = 72/304 (23%), Positives = 135/304 (44%), Gaps = 45/304 (14%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
+ + L F ++ KG F + + VAVKKL S ++ +R F
Sbjct: 4 PTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDF 58
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
E+ +L+ ++H N+V++ G + + ++ EYLP G LR +L++ K + ++
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLT 312
+ I +GM YL + IHRDL NIL ++ +K+ DFG++K+L ++ +
Sbjct: 119 YTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPPFTM 356
++ + APE ++ DV+SF ++L E+ G
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235
Query: 357 KHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414
+ + R P P ++Y ++ ECWN +RP+FR + R++ I
Sbjct: 236 MIVFHLIELLKNNGRLPRPDGCPDEIY-----MIMTECWNNNVNQRPSFRDLALRVDQIR 290
Query: 415 NSIN 418
+++
Sbjct: 291 DNMA 294
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-56
Identities = 75/336 (22%), Positives = 142/336 (42%), Gaps = 47/336 (13%)
Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---IL 170
++ +H + A R+ + + L F ++ KG F +
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMGSAFEDRD--PTQFEERHLKFLQ--QLGKGNFGSVEM 59
Query: 171 AFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 223
+ VAVKKL S ++ +R F E+ +L+ ++H N+V++ G +
Sbjct: 60 CRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116
Query: 224 -PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ ++ EYLP G LR +L++ K + +++ I +GM YL + IHRDL
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLAT 173
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
NIL ++ +K+ DFG++K+L ++ + ++ + APE ++ DV+S
Sbjct: 174 RNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWS 233
Query: 340 FALILQEMI----------------EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
F ++L E+ G + + R P P ++Y
Sbjct: 234 FGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY 293
Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
++ ECWN +RP+FR + R++ I + +
Sbjct: 294 -----MIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-56
Identities = 73/285 (25%), Positives = 119/285 (41%), Gaps = 26/285 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVRAFR 198
I +L ++ G+F W + VAVK L +V+S + + F
Sbjct: 12 TCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL 257
E+ + + H N+++ G V PM +VTE P G L L+ +G T R+A+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT- 316
+A GM YL + IHRDL N+L +K+ DFG+ + L +D + +
Sbjct: 129 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 317 -SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKA-YAARQR-- 371
+ APE K + D + F + L EM G P+ + +++ +R
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
P P +Y ++ +CW KP RPTF + L +
Sbjct: 246 RPEDCPQDIY-----NVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-55
Identities = 86/280 (30%), Positives = 137/280 (48%), Gaps = 30/280 (10%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDEL 201
E+E+ L + G F + ++ G +VAVK L + +S D F E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
L+++++H +V+ VTQ P+ I+TEY+ G L FLK L + + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-- 317
A GM ++ E IHRDL +NIL D+ + K+ADFG+++L+ ED T ++ +
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKF 172
Query: 318 -CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PP 373
++ APE + K DV+SF ++L E++ G P+ + EV + R P
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
P +LY +L+ CW E+P RPTF + + LE
Sbjct: 233 DNCPEELY-----QLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-55
Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 39/293 (13%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 2 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 58
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E ++ ++ +P +V+ +G + +M+V E G L FL ++ + S
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-------- 309
++ GM YL E +HRDL N+L + K++DFG+SK L +
Sbjct: 118 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 310 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYA 367
PL ++ APE ++ ++ DV+S+ + + E + G P+ EV
Sbjct: 175 WPL-------KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
Query: 368 ARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418
+R P + P +LY L+ +CW K RP F + R+ + S+
Sbjct: 228 QGKRMECPPECPPELY-----ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-55
Identities = 67/283 (23%), Positives = 133/283 (46%), Gaps = 27/283 (9%)
Query: 144 EVPEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAF 197
+YEI ++ + ++ +G ++ + VA+K + D F
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKF 63
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL+ RK +L ++ + +A
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
++ + YL + +HRD+ N+L + +K+ DFG+S+ + ED
Sbjct: 123 YQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASK 176
Query: 317 S---CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR- 371
+++APE + + DV+ F + + E++ G PF +N+V +R
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236
Query: 372 -PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
P P LY L+ +CW P++RP F ++ +L +I
Sbjct: 237 PMPPNCPPTLY-----SLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 8e-55
Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 27/281 (9%)
Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
P+Y I ++ + E+ +G + I VAVK ++ D F
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMS 62
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
E +++ + HP++V+ +G + + P I+ E P G+L +L+R K +LK T V ++L
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS- 317
I + M YL +HRD+ NIL +K+ DFG+S+ + ED +
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTR 175
Query: 318 --CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--P 372
++++PE + T DV+ FA+ + E++ G PF + +V R
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 235
Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
P P LY L+ CW+ P+ RP F +++ L +
Sbjct: 236 PDLCPPVLY-----TLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 8e-55
Identities = 63/262 (24%), Positives = 122/262 (46%), Gaps = 31/262 (11%)
Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
KG +I + I VA+K+L E + + DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ ++T+ +P G L ++ + K + + + + IA+GMNYL + + ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEYDTK 334
N+L ++K+ DFG++KLL +E P+ +++A E + Y +
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-------KWMALESILHRIYTHQ 199
Query: 335 VDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEE 391
DV+S+ + + E++ G P+ +E+ +R P +Y ++ +
Sbjct: 200 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY-----MIMRK 254
Query: 392 CWNEKPAKRPTFRQIITRLESI 413
CW RP FR++I +
Sbjct: 255 CWMIDADSRPKFRELIIEFSKM 276
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-54
Identities = 70/302 (23%), Positives = 135/302 (44%), Gaps = 45/302 (14%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRV 194
EV + L ++ +G F L + G QVAVK L E S + +
Sbjct: 12 EVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHI 67
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKR-KGALKPST 251
+ E+ +L+ + H N+V++ G T+ + + ++ E+LP G L+ +L + K +
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
+++A+ I +GM+YL + +HRDL N+L + +K+ DFG++K + ++
Sbjct: 128 QLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 184
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPP 353
+D+ + APE ++ DV+SF + L E++ G
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
Query: 354 FTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
M + +R P P ++Y +L+ +CW +P+ R +F+ +I E
Sbjct: 245 GQMTV-TRLVNTLKEGKRLPCPPNCPDEVY-----QLMRKCWEFQPSNRTSFQNLIEGFE 298
Query: 412 SI 413
++
Sbjct: 299 AL 300
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-54
Identities = 78/298 (26%), Positives = 139/298 (46%), Gaps = 30/298 (10%)
Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGE 185
++ ++ + + V I P L + I +G F I AVK L
Sbjct: 4 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFL-KR 243
I+D V F E +++ HPNV+ LG +S ++V Y+ GDLR F+
Sbjct: 64 --ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
+ F L +A+GM YL K +HRDL N + D+ +KVADFG+++
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD- 177
Query: 304 TVKEDRPLTCQDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMK 357
+ + + + + +++A E + +++ TK DV+SF ++L E++ G PP+
Sbjct: 178 -MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236
Query: 358 HDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ ++ +R P P LY E++ +CW+ K RP+F ++++R+ +I
Sbjct: 237 NTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-54
Identities = 76/299 (25%), Positives = 132/299 (44%), Gaps = 46/299 (15%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
+ L + + ++ KG F L + VAVK+L S D+ R F
Sbjct: 17 PTIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDF 71
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVR 254
+ E+ +L+ + +V++ G + +V EYLP G LR FL + + L S +
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLT 312
++ I +GM YL + +HRDL NIL + ++K+ADFG++KLL + +D
Sbjct: 132 YSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPPFTM 356
+ + APE + + + DV+SF ++L E+ GC
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
Query: 357 KHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ + + QR P PA+++ EL++ CW P RP+F + +L+ +
Sbjct: 249 AL-SRLLELLEEGQRLPAPPACPAEVH-----ELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-54
Identities = 78/316 (24%), Positives = 142/316 (44%), Gaps = 30/316 (9%)
Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAF 172
E + + ++ ++ + + V I P L + I +G F
Sbjct: 50 KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGT 109
Query: 173 WRG-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMM 226
I AVK L I+D V F E +++ HPNV+ LG +S +
Sbjct: 110 LLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167
Query: 227 IVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
+V Y+ GDLR F+ + F L +A+GM +L K +HRDL N +
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCM 224
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-----RYVAPEVFKNEEYDTKVDVFSF 340
D+ +KVADFG+++ + + + + + +++A E + +++ TK DV+SF
Sbjct: 225 LDEKFTVKVADFGLARD--MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282
Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKP 397
++L E++ G PP+ + ++ +R P P LY E++ +CW+ K
Sbjct: 283 GVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKCWHPKA 337
Query: 398 AKRPTFRQIITRLESI 413
RP+F ++++R+ +I
Sbjct: 338 EMRPSFSELVSRISAI 353
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-54
Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 31/303 (10%)
Query: 127 KHGAKPLM-------APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG- 175
K G L + E +EI L ++ G F +A +
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKH 212
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+VAVK + +S + F E +++ ++H +V+ VT+ P+ I+TE++ KG
Sbjct: 213 TKVAVKTMKPGSMSVEA----FLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKG 267
Query: 236 DLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
L FLK + F+ IA GM ++ + IHRDL +NIL S K
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCK 324
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCP 352
+ADFG+++++ E ++ APE + K DV+SF ++L E++ G
Sbjct: 325 IADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384
Query: 353 PFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
P+ + EV +A R P P +LY ++ CW +P +RPTF I + L
Sbjct: 385 PYPGMSNPEVIRALERGYRMPRPENCPEELY-----NIMMRCWKNRPEERPTFEYIQSVL 439
Query: 411 ESI 413
+
Sbjct: 440 DDF 442
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-53
Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 30/288 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
EV + I + + I KG F + IQ A+K L I++ +V
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVE 67
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLK-RKGALKPSTAV 253
AF E L++ + HPNV+ +G + + ++ Y+ GDL F++ + +
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
F L +ARGM YL E K +HRDL N + D+S +KVADFG+++ + + +
Sbjct: 128 SFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSV 182
Query: 314 QDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367
Q ++ A E + + TK DV+SF ++L E++ G PP+ ++ A
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242
Query: 368 ARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+R P P LY +++++CW PA RPTFR ++ +E I
Sbjct: 243 QGRRLPQPEYCPDSLY-----QVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-53
Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 27/279 (9%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
EL + G F W I V +K + ++ S +A D
Sbjct: 9 IFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTD 64
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALD 258
+ + + H ++V+ LG S + +VT+YLP G L ++ +GAL P + + +
Sbjct: 65 HMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTS 317
IA+GM YL E+ ++HR+L N+L ++VADFGV+ LL + + T
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPF 374
+++A E +Y + DV+S+ + + E++ G P+ EVP +R P
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240
Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+Y ++ +CW RPTF+++ +
Sbjct: 241 ICTIDVY-----MVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-53
Identities = 75/313 (23%), Positives = 130/313 (41%), Gaps = 40/313 (12%)
Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQV 178
H + L+ + ++ + ID + L + +G F + + ++V
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTEYLP 233
AVK + + S + F E A ++ HPNV++ LG + S M++ ++
Sbjct: 66 AVKTMKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 234 KGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
GDL +L + T ++F +DIA GM YL +HRDL N +
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFKNEEYDTKVDVFSFALI 343
D + VADFG+SK + Q +++A E + Y +K DV++F +
Sbjct: 182 DDMTVCVADFGLSKKI---YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238
Query: 344 LQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKR 400
+ E+ G P+ ++E+ R P +LY E++ CW P R
Sbjct: 239 MWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELY-----EIMYSCWRTDPLDR 293
Query: 401 PTFRQIITRLESI 413
PTF + +LE +
Sbjct: 294 PTFSVLRLQLEKL 306
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-53
Identities = 71/296 (23%), Positives = 128/296 (43%), Gaps = 45/296 (15%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
L ++ +G F L + VAVK L + + ++
Sbjct: 27 VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQ 82
Query: 200 ELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
E+ +L+ + H +++++ G + + + +V EY+P G LR +L + ++ + + FA
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQ 141
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQD 315
I GM YLH IHRDL N+L D+ +K+ DFG++K + + R D
Sbjct: 142 QICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPPFTMKHD 359
+ + APE K ++ DV+SF + L E++ G M
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV- 257
Query: 360 NEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ + +R P K PA++Y L++ CW + + RPTF +I L+++
Sbjct: 258 LRLTELLERGERLPRPDKCPAEVY-----HLMKNCWETEASFRPTFENLIPILKTV 308
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-53
Identities = 87/309 (28%), Positives = 133/309 (43%), Gaps = 60/309 (19%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A G+ VAVK L +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL +L + H N+V LGA T P +++TEY GDL FL+RK
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 245 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
AL + F+ +A+GM +L IHRDL NIL K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 297 FGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
FG+++ + VK + P+ +++APE N Y + DV+S+ + L E+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPV-------KWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 349 E--GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
P M D++ K R P APA++Y ++++ CW+ P KRPTF+
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY-----DIMKTCWDADPLKRPTFK 296
Query: 405 QIITRLESI 413
QI+ +E
Sbjct: 297 QIVQLIEKQ 305
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-53
Identities = 66/294 (22%), Positives = 120/294 (40%), Gaps = 45/294 (15%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRG---------IQVAVKKLGEEVISDDDRVR 195
++I +L F + +GTF R +V +K L + + +
Sbjct: 3 HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK---AHRNYSE 57
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
+F + +++ K+ H ++V G ++V E++ G L +LK+ K + +
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNIL--------RDDSGNLKVADFGVSKLLTVK 306
A +A M++L EN +IH ++ NIL + +K++D G+S + K
Sbjct: 118 VAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 307 E--DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEV 362
+ + +V PE +N + + D +SF L E+ G P +
Sbjct: 175 DILQERI-------PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227
Query: 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
+ Y R + P A+L LI C + +P RP+FR II L S+
Sbjct: 228 LQFYEDRHQLPAPKAAELA-----NLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-52
Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 51/302 (16%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
++ + I + + KG F A + ++VAVK L ++I+ D
Sbjct: 14 KLEDVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI-E 70
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLKR------ 243
F E A +++ HP+V + +G +S M++ ++ GDL AFL
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
L T VRF +DIA GM YL IHRDL N + + + VADFG+S
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLS--- 184
Query: 304 TVKEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 353
R + D +++A E + Y DV++F + + E++ G P
Sbjct: 185 -----RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
Query: 354 FTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
+ + E+ R P + ++Y +L+ +CW+ P +RP+F + LE
Sbjct: 240 YAGIENAEIYNYLIGGNRLKQPPECMEEVY-----DLMYQCWSADPKQRPSFTCLRMELE 294
Query: 412 SI 413
+I
Sbjct: 295 NI 296
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-52
Identities = 73/303 (24%), Positives = 135/303 (44%), Gaps = 58/303 (19%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
E+E+ ++ + E+ +G+F +G+ +VA+K + E S +R
Sbjct: 18 DEWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRER-I 73
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------G 245
F +E +++++ +VV+ LG V+Q P +++ E + +GDL+++L+
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
S ++ A +IA GM YL+ NK +HRDL N + + +K+ DFG++
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT----- 185
Query: 306 KEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
R + D Y +PE K+ + T DV+SF ++L E+
Sbjct: 186 ---RDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239
Query: 353 PFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
P+ + +V + P P L+ EL+ CW P RP+F +II+ +
Sbjct: 240 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSI 294
Query: 411 ESI 413
+
Sbjct: 295 KEE 297
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-52
Identities = 87/339 (25%), Positives = 136/339 (40%), Gaps = 72/339 (21%)
Query: 124 LLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---- 176
LL++ P+ M + ++ E + +++ +I +G F A G+
Sbjct: 18 LLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYE 75
Query: 177 ---QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK L EE S D + F+ E AL+ + +PN+V+ LG PM ++ EY+
Sbjct: 76 PFTMVAVKMLKEEA-SADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133
Query: 234 KGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHEN 269
GDL FL+ L + + A +A GM YL E
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV-------- 321
K +HRDL N L ++ +K+ADFG+S R + D Y
Sbjct: 194 K---FVHRDLATRNCLVGENMVVKIADFGLS--------RNIYSADY---YKADGNDAIP 239
Query: 322 ----APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPF 374
PE Y T+ DV+++ ++L E+ G P+ EV P
Sbjct: 240 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE 299
Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
P +LY L+ CW++ PA RP+F I L+ +
Sbjct: 300 NCPLELY-----NLMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 7e-52
Identities = 84/302 (27%), Positives = 132/302 (43%), Gaps = 52/302 (17%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
EI + F E+ + F G VA+K L ++ R FR
Sbjct: 5 EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLR-EEFR 60
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--------------- 243
E L +++HPNVV LG VT+ P+ ++ Y GDL FL
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 244 -KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
K AL+P V IA GM YL + ++H+DL N+L D N+K++D G+ +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 303 L------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT 355
+ + + L R++APE ++ D++S+ ++L E+ G P+
Sbjct: 178 VYAADYYKLLGNSLL-----PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 356 MKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ +V + RQ P PA +Y L+ ECWNE P++RP F+ I +RL +
Sbjct: 233 GYSNQDVVEMIRNRQVLPCPDDCPAWVY-----ALMIECWNEFPSRRPRFKDIHSRLRAW 287
Query: 414 NN 415
N
Sbjct: 288 GN 289
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 7e-52
Identities = 79/314 (25%), Positives = 131/314 (41%), Gaps = 59/314 (18%)
Query: 141 HAREVPEY-------EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKL 183
H E P+Y I ++ E+ +G F LA + VAVK L
Sbjct: 22 HIIENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL 79
Query: 184 GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243
E S+ R + F+ E LL ++H ++V+F G T+ P+++V EY+ GDL FL+
Sbjct: 80 KEA--SESAR-QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRS 136
Query: 244 ---------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
G L + A +A GM YL +HRDL N L
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193
Query: 289 SGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+K+ DFG+S+ + V L R++ PE ++ T+ DV+SF +
Sbjct: 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTML-----PIRWMPPESILYRKFTTESDVWSFGV 248
Query: 343 ILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAK 399
+L E+ G P+ + E + P P ++Y ++ CW +P +
Sbjct: 249 VLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVY-----AIMRGCWQREPQQ 303
Query: 400 RPTFRQIITRLESI 413
R + + + RL+++
Sbjct: 304 RHSIKDVHARLQAL 317
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-52
Identities = 62/259 (23%), Positives = 120/259 (46%), Gaps = 25/259 (9%)
Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
KG +I + I VA+K+L E + + DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ ++T+ +P G L ++ + K + + + + IA+GMNYL + + ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKVDV 337
N+L ++K+ DFG++KLL +E +++A E + Y + DV
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDV 202
Query: 338 FSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWN 394
+S+ + + E++ G P+ +E+ +R P +Y ++ +CW
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY-----MIMVKCWM 257
Query: 395 EKPAKRPTFRQIITRLESI 413
RP FR++I +
Sbjct: 258 IDADSRPKFRELIIEFSKM 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 9e-52
Identities = 88/312 (28%), Positives = 143/312 (45%), Gaps = 55/312 (17%)
Query: 138 HVKHAREVPEY----EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEE 186
H H + P+ +D +++ F + I +G F + A + + A+K++ E
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63
Query: 187 VISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK- 244
S DD R F EL +L K+ HPN++ LGA + + EY P G+L FL++
Sbjct: 64 A-SKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121
Query: 245 ---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
L + FA D+ARGM+YL + + IHRDL NIL ++
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 178
Query: 290 GNLKVADFGVSKLLTVKEDR-----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
K+ADFG+S+ V + P+ R++A E Y T DV+S+ ++L
Sbjct: 179 YVAKIADFGLSRGQEVYVKKTMGRLPV-------RWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 345 QEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRP 401
E++ G P+ E+ + R P ++Y +L+ +CW EKP +RP
Sbjct: 232 WEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVY-----DLMRQCWREKPYERP 286
Query: 402 TFRQIITRLESI 413
+F QI+ L +
Sbjct: 287 SFAQILVSLNRM 298
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-51
Identities = 77/303 (25%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A G+ +VAVK L + D
Sbjct: 39 EKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKE 94
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
A EL ++ + +H N+V LGA T P++++TEY GDL FL+RK
Sbjct: 95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
+ F+ +A+GM +L IHRD+ N+L + K+ DFG++
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 301 KLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCP 352
+ + VK + L +++APE + Y + DV+S+ ++L E+ P
Sbjct: 212 RDIMNDSNYIVKGNARLP-----VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 353 PFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
+ +++ K + P AP +Y +++ CW +P RPTF+QI + L
Sbjct: 267 YPGILVNSKFYKLVKDGYQMAQPAFAPKNIY-----SIMQACWALEPTHRPTFQQICSFL 321
Query: 411 ESI 413
+
Sbjct: 322 QEQ 324
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-51
Identities = 77/306 (25%), Positives = 124/306 (40%), Gaps = 65/306 (21%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
I ++ E+ +G F LA + VAVK L + + R + F+
Sbjct: 11 HIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR-KDFQ 65
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---------------- 242
E LL ++H ++V+F G P+++V EY+ GDL FL+
Sbjct: 66 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
KG L S + A IA GM YL +HRDL N L + +K+ DFG+S
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS-- 180
Query: 303 LTVKEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFSFALILQEMI-E 349
R + D Y PE ++ T+ DV+SF +IL E+
Sbjct: 181 ------RDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231
Query: 350 GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
G P+ + EV + + P P ++Y +++ CW +P +R ++I
Sbjct: 232 GKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY-----DVMLGCWQREPQQRLNIKEIY 286
Query: 408 TRLESI 413
L ++
Sbjct: 287 KILHAL 292
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-51
Identities = 81/314 (25%), Positives = 133/314 (42%), Gaps = 66/314 (21%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
P++E L + +G F + A + VAVK L E + +R
Sbjct: 16 PKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELR 71
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------- 244
E +L+++ HP+V++ GA +Q P++++ EY G LR FL+
Sbjct: 72 DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
AL + FA I++GM YL E K ++HRDL NIL +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRK 188
Query: 292 LKVADFGVSKLLTVKEDRPLTCQD----TSC-----RYVAPEVFKNEEYDTKVDVFSFAL 342
+K++DFG+S R + +D S +++A E + Y T+ DV+SF +
Sbjct: 189 MKISDFGLS--------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAK 399
+L E++ G P+ + R P ++Y L+ +CW ++P K
Sbjct: 241 LLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY-----RLMLQCWKQEPDK 295
Query: 400 RPTFRQIITRLESI 413
RP F I LE +
Sbjct: 296 RPVFADISKDLEKM 309
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-51
Identities = 86/339 (25%), Positives = 150/339 (44%), Gaps = 59/339 (17%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
++ + I E + ++A + E P +E+ L + +G F +LA
Sbjct: 31 HHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK--PLGEGAFGQVVLA 88
Query: 172 FWRGI---------QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221
G+ +VAVK L + ++ D E+ +++ I +H N++ LGA TQ
Sbjct: 89 EAIGLDKDKPNRVTKVAVKMLKSDA-TEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQ 146
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNY 265
P+ ++ EY KG+LR +L+ + L V A +ARGM Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTS 317
L K IHRDL N+L + +K+ADFG+++ + + P+
Sbjct: 207 LASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV------ 257
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPF 374
+++APE + Y + DV+SF ++L E+ G P+ E+ K R P
Sbjct: 258 -KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 316
Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+LY ++ +CW+ P++RPTF+Q++ L+ I
Sbjct: 317 NCTNELY-----MMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-51
Identities = 67/267 (25%), Positives = 128/267 (47%), Gaps = 17/267 (6%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ +EI +G+F ++VA +L + ++ +R + F++E +
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEM 78
Query: 204 LQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
L+ ++HPN+V+F + V +++VTE + G L+ +LKR +K + I
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+G+ +LH P PIIHRDL+ NI +G++K+ D G++ L + T
Sbjct: 139 LKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPE 195
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 378
++APE+++ E+YD VDV++F + + EM P++ + P +
Sbjct: 196 -FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFD 252
Query: 379 KLYARGLKELIEECWNEKPAKRPTFRQ 405
K+ +KE+IE C + +R + +
Sbjct: 253 KVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-51
Identities = 78/315 (24%), Positives = 126/315 (40%), Gaps = 67/315 (21%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E L+F + G F + A GI QVAVK L E+ +D
Sbjct: 38 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 93
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL ++ ++ H N+V LGA T S P+ ++ EY GDL +L+ K
Sbjct: 94 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L + FA +A+GM +L +HRDL N+L
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKV 210
Query: 292 LKVADFGVSKLLTVKEDRPLTCQD-----TSC----RYVAPEVFKNEEYDTKVDVFSFAL 342
+K+ DFG++ R + + +++APE Y K DV+S+ +
Sbjct: 211 VKICDFGLA--------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
Query: 343 ILQEMIE-GCPPF-TMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPA 398
+L E+ G P+ + D K + PF A ++Y +++ CW
Sbjct: 263 LLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY-----IIMQSCWAFDSR 317
Query: 399 KRPTFRQIITRLESI 413
KRP+F + + L
Sbjct: 318 KRPSFPNLTSFLGCQ 332
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-51
Identities = 82/323 (25%), Positives = 146/323 (45%), Gaps = 59/323 (18%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------QV 178
P++A + E P++E +L + +G F ++A GI V
Sbjct: 13 DPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTV 70
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ ++ D E+ +++ I +H N++ LGA TQ P+ ++ EY KG+L
Sbjct: 71 AVKMLKDDA-TEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 238 RAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
R +L+ + + V +ARGM YL K IHRDL
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 185
Query: 282 SNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDT 333
N+L ++ +K+ADFG+++ + + P+ +++APE + Y
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYTH 238
Query: 334 KVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIE 390
+ DV+SF +++ E+ G P+ E+ K R P +LY ++
Sbjct: 239 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY-----MMMR 293
Query: 391 ECWNEKPAKRPTFRQIITRLESI 413
+CW+ P++RPTF+Q++ L+ I
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRI 316
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 7e-51
Identities = 81/298 (27%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
E+ + + G F G+ QVAVK L E S+ D
Sbjct: 24 LKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-LD 79
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALKP 249
F E ++ K H N+V+ +G QS P I+ E + GDL++FL+ +L
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLL--- 303
+ A DIA G YL EN IHRD+ N L G K+ DFG+++ +
Sbjct: 140 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 304 --TVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMK 357
K P+ +++ PE F + +K D +SF ++L E+ G P+ K
Sbjct: 197 SYYRKGGCAMLPV-------KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 358 HDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ EV + + R PP P +Y ++ +CW +P RP F I+ R+E
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-50
Identities = 81/324 (25%), Positives = 146/324 (45%), Gaps = 59/324 (18%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------Q 177
P++A + E P++E +L + +G F ++A GI
Sbjct: 58 DTPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVT 115
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK L ++ + + + E+ +++ I +H N++ LGA TQ P+ ++ EY KG+
Sbjct: 116 VAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173
Query: 237 LRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
LR +L+ + + V +ARGM YL K IHRDL
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 230
Query: 281 PSNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYD 332
N+L ++ +K+ADFG+++ + + P+ +++APE + Y
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYT 283
Query: 333 TKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELI 389
+ DV+SF +++ E+ G P+ E+ K R P +LY ++
Sbjct: 284 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY-----MMM 338
Query: 390 EECWNEKPAKRPTFRQIITRLESI 413
+CW+ P++RPTF+Q++ L+ I
Sbjct: 339 RDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 2e-50
Identities = 67/285 (23%), Positives = 133/285 (46%), Gaps = 35/285 (12%)
Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
+YEI ++ + ++ +G ++ + VA+K + D F
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQ 440
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL RK +L ++ + +A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL-------TVKEDRPL 311
++ + YL + +HRD+ N+L + +K+ DFG+S+ + K P+
Sbjct: 500 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQ 370
+++APE + + DV+ F + + E++ G PF +N+V +
Sbjct: 557 -------KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609
Query: 371 R--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
R P P LY L+ +CW P++RP F ++ +L +I
Sbjct: 610 RLPMPPNCPPTLY-----SLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-50
Identities = 80/300 (26%), Positives = 122/300 (40%), Gaps = 52/300 (17%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
E+ + + G F G+ QVAVK L E S+ D
Sbjct: 64 DLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-L 119
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALK 248
F E ++ K H N+V+ +G QS P I+ E + GDL++FL+ +L
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 249 PSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV 305
+ A DIA G YL EN IHRD+ N L G K+ DFG++
Sbjct: 180 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA----- 231
Query: 306 KEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFT 355
R + +++ PE F + +K D +SF ++L E+ G P+
Sbjct: 232 ---RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288
Query: 356 MKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
K + EV + + R PP P +Y ++ +CW +P RP F I+ R+E
Sbjct: 289 SKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 83/307 (27%), Positives = 136/307 (44%), Gaps = 59/307 (19%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
++E L + +G F I A GI VAVK L E + RA
Sbjct: 21 KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 76
Query: 197 FRDELALLQKI-RHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKR----------- 243
EL +L I H NVV LGA T+ P+M++ E+ G+L +L+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 244 -----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
K L + ++ +A+GM +L K IHRDL NIL + +K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFG 193
Query: 299 VSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 349
+++ + K D PL +++APE + Y + DV+SF ++L E+
Sbjct: 194 LARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 350 GCPPF-TMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
G P+ +K D E + R P ++Y + + +CW+ +P++RPTF ++
Sbjct: 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-----QTMLDCWHGEPSQRPTFSEL 301
Query: 407 ITRLESI 413
+ L ++
Sbjct: 302 VEHLGNL 308
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 65/288 (22%), Positives = 120/288 (41%), Gaps = 25/288 (8%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 328 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 384
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E ++ ++ +P +V+ +G + +M+V E G L FL ++ + S
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
++ GM YL E +HR+L N+L + K++DFG+SK L +
Sbjct: 444 QVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 318 --CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--P 372
++ APE ++ ++ DV+S+ + + E + G P+ EV +R
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 560
Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
P + P +LY L+ +CW K RP F + R+ + S+ K
Sbjct: 561 PPECPPELY-----ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-48
Identities = 55/237 (23%), Positives = 113/237 (47%), Gaps = 10/237 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G Q +K++ +S +R + R E+A+L ++HPN+VQ+ + ++ + IV +Y
Sbjct: 49 GRQYVIKEINISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 235 GDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL + + + + + I + ++H+ K I+HRD++ NI G +
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTV 164
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
++ DFG++++L + C T Y++PE+ +N+ Y+ K D+++ +L E+
Sbjct: 165 QLGDFGIARVLNSTVELARACIGTPY-YLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
F + + PP Y+ L+ L+ + + P RP+ I+ +
Sbjct: 224 AFEAGSMKNLVLKIISGSFPPV--SLH-YSYDLRSLVSQLFKRNPRDRPSVNSILEK 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-48
Identities = 61/254 (24%), Positives = 113/254 (44%), Gaps = 13/254 (5%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +G F A G+ VA+KK+ + D E+ LL+++ HPNV+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPV 272
+ + + + IV E GDL +K + T ++ + + + ++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
++HRD++P+N+ +G +K+ D G+ + + K + T Y++PE Y+
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPERIHENGYN 214
Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
K D++S +L EM PF N Q P+ Y+ L++L+ C
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274
Query: 393 WNEKPAKRPTFRQI 406
N P KRP +
Sbjct: 275 INPDPEKRPDVTYV 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-48
Identities = 53/257 (20%), Positives = 90/257 (35%), Gaps = 18/257 (7%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
F + G++ + G AVK+ DR R + + + +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHEN 269
V+ A + + + TE L+ + GA L + + D + +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
++H D++P+NI G K+ DFG+ L + RY+APE+
Sbjct: 177 G---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGD-PRYMAPELL-QG 230
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389
Y T DVFS L + E+ + P F A + L+ ++
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELP--HGGEGWQQLRQGYLPPEFTAG---LSSELRSVL 285
Query: 390 EECWNEKPAKRPTFRQI 406
P R T +
Sbjct: 286 VMMLEPDPKLRATAEAL 302
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 9e-48
Identities = 59/241 (24%), Positives = 111/241 (46%), Gaps = 13/241 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTEYL 232
G + K+L +++ ++ E+ LL++++HPN+V++ + ++ + IV EY
Sbjct: 31 GKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 233 PKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVP--IIHRDLEPSNILR 286
GDL + + + + L +R + + H ++HRDL+P+N+
Sbjct: 90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
D N+K+ DFG++++L T T Y++PE Y+ K D++S +L E
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFVGTPY-YMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 347 MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
+ PPFT E+ + P + Y+ L E+I N K RP+ +I
Sbjct: 209 LCALMPPFTAFSQKELAGKIREGKFRRI--PYR-YSDELNEIITRMLNLKDYHRPSVEEI 265
Query: 407 I 407
+
Sbjct: 266 L 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-46
Identities = 71/303 (23%), Positives = 127/303 (41%), Gaps = 50/303 (16%)
Query: 147 EYEIDPHEL-DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
+ +D DF I G F A R G +K++ + +A R E
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAER-E 54
Query: 201 LALLQKIRHPNVVQFLGA----------------VTQSSPMMIVTEYLPKGDLRAFLKRK 244
+ L K+ H N+V + G +++ + I E+ KG L +++++
Sbjct: 55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 245 GA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
L A+ I +G++Y+H K +I+RDL+PSNI D+ +K+ DFG+
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 303 LTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
L R S RY++PE +++Y +VD+++ LIL E++ C
Sbjct: 172 LKNDGKR-----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA----- 221
Query: 360 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419
E K + + ++ + K L+++ ++KP RP +I+ L S
Sbjct: 222 FETSKFFTDLRDGIIS---DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278
Query: 420 KRR 422
R
Sbjct: 279 NER 281
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-45
Identities = 67/288 (23%), Positives = 110/288 (38%), Gaps = 48/288 (16%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + +G F + A A+KK+ +++ E+ LL + H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILS-EVMLLASLNHQ 62
Query: 211 NVVQFLGA-------------VTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFA 256
VV++ A V + S + I EY G L + + + R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD- 315
I ++Y+H IIHRDL+P NI D+S N+K+ DFG++K + D
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 316 ---------TSC---RYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
++ YVA EV Y+ K+D++S +I EMI P T +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237
Query: 363 PKAYAARQRPPFKAPAKL---YARGLKELIEECWNEKPAKRPTFRQII 407
+ + P + K++I + P KRP R ++
Sbjct: 238 ---LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-45
Identities = 56/259 (21%), Positives = 99/259 (38%), Gaps = 36/259 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA------------VTQS 222
A+K++ + R + R E+ L K+ HP +V++ A +
Sbjct: 30 DCNYAIKRIRLPN-RELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDL 279
+ I + K +L+ ++ + ++ S + L IA + +LH ++HRDL
Sbjct: 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDL 144
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----------CRYVAPEVFKN 328
+PSNI +KV DFG+ + E+ Y++PE
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388
Y KVD+FS LIL E++ P T E + + F +
Sbjct: 205 NSYSHKVDIFSLGLILFELL--YPFST---QMERVRTLTDVRNLKFPPLFTQKYPCEYVM 259
Query: 389 IEECWNEKPAKRPTFRQII 407
+++ + P +RP II
Sbjct: 260 VQDMLSPSPMERPEAINII 278
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-44
Identities = 66/275 (24%), Positives = 121/275 (44%), Gaps = 20/275 (7%)
Query: 142 AREVPEYEIDPHEL-DFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVR 195
A+E+PE +DP + + KG F I A K + + ++ +
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
E+++ + + H +VV F G + + +V E + L KR+ AL A +
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
I G YLH N+ +IHRDL+ N+ ++ +K+ DFG++ + +R +
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER----KK 173
Query: 316 TSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372
C Y+APEV + + +VDV+S I+ ++ G PPF + + + Y ++
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKN 230
Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
+ P + LI++ P RPT +++
Sbjct: 231 EYSIPKHI-NPVAASLIQKMLQTDPTARPTINELL 264
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 57/280 (20%), Positives = 105/280 (37%), Gaps = 43/280 (15%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
+F +I G F R G A+K+ + + D A R+ A +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYL 266
+VV++ A + M+I EY G L + K + L + RG+ Y+
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNL-------------------KVADFGVSKLLTVKE 307
H ++H D++PSNI + K+ D G ++
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--- 185
Query: 308 DRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366
P + R++A EV + N + K D+F+ AL + P ++ ++ +
Sbjct: 186 -SPQVEEGD-SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP--RNGDQW---H 238
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
RQ + P ++ EL++ + P +RP+ +
Sbjct: 239 EIRQGRLPRIPQV-LSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 60/236 (25%), Positives = 110/236 (46%), Gaps = 16/236 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+A+K L + + R E+ + +RHPN+++ G ++ + ++ EY P
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G + L++ + ++A ++Y H + +IHRD++P N+L +G LK+
Sbjct: 94 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKI 150
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
ADFG S P + + C Y+ PE+ + +D KVD++S ++ E + G
Sbjct: 151 ADFGWSVHA------PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
PPF N + Y R F P + G ++LI P++RP R+++
Sbjct: 205 PPF---EANTYQETYKRISRVEFTFPDFV-TEGARDLISRLLKHNPSQRPMLREVL 256
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 66/269 (24%), Positives = 107/269 (39%), Gaps = 26/269 (9%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
+YE T+ + +G+F + G Q AVKK+ EV + E
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------E 100
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
L + P +V GAV + + I E L G L +K+ G L A+ +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKEDRPLTCQDTSCR 319
G+ YLH + I+H D++ N+L G+ + DFG + L
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 320 ----YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPP 373
++APEV + D KVD++S ++ M+ GC P+T P A+ P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT--QYFRGPLCLKIASEPPPI 275
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPT 402
+ P A + I+E ++P R +
Sbjct: 276 REIPPSC-APLTAQAIQEGLRKEPVHRAS 303
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-44
Identities = 52/261 (19%), Positives = 102/261 (39%), Gaps = 26/261 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----IVTE 230
G A+K++ + + + E + + HPN+++ + + ++
Sbjct: 54 GHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
+ +G L ++R L + L I RG+ +H HRDL+P+NIL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILL 167
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTC--------QDTSCRYVAPEVFKNEEY---DTKV 335
D G + D G + + Q + Y APE+F + + D +
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
Query: 336 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395
DV+S +L M+ G P+ M A A + + + ++ L +L+
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR-HSSALWQLLNSMMTV 286
Query: 396 KPAKRPTFRQIITRLESINNS 416
P +RP ++++LE++
Sbjct: 287 DPHQRPHIPLLLSQLEALQPP 307
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-44
Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 14/236 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
A K + + ++ + E+++ + + H +VV F G + + +V E +
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L KR+ AL A + I G YLH N+ +IHRDL+ N+ ++ +K+
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKI 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
DFG++ + +R + C Y+APEV + + +VDV+S I+ ++ G
Sbjct: 183 GDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
PPF + + + Y ++ + P + LI++ P RPT +++
Sbjct: 239 PPF---ETSCLKETYLRIKKNEYSIPKHI-NPVAASLIQKMLQTDPTARPTINELL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 55/249 (22%), Positives = 113/249 (45%), Gaps = 27/249 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 33 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 90
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 91 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 146
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 147 KLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKP 397
S IL M G PF + N++ K +A + P + L+++++ C P
Sbjct: 205 SLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQDVLKCCLKRDP 262
Query: 398 AKRPTFRQI 406
+R + ++
Sbjct: 263 KQRISIPEL 271
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-43
Identities = 60/235 (25%), Positives = 108/235 (45%), Gaps = 16/235 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+A+K L + + + R E+ + +RHPN+++ + ++ E+ P+
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L L++ G + F ++A ++Y HE K +IHRD++P N+L G LK+
Sbjct: 99 GELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKI 155
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
ADFG S P + T C Y+ PE+ + + +D KVD++ ++ E + G
Sbjct: 156 ADFGWSVH------APSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
PPF + + K P L + G K+LI + P +R + +
Sbjct: 210 PPF---DSPSHTETHRRIVNVDLKFPPFL-SDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-43
Identities = 55/249 (22%), Positives = 113/249 (45%), Gaps = 27/249 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 52 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 109
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 110 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 165
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 166 KLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKP 397
S IL M G PF + N++ K +A + P + L+++++ C P
Sbjct: 224 SLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQDVLKCCLKRDP 281
Query: 398 AKRPTFRQI 406
+R + ++
Sbjct: 282 KQRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-43
Identities = 55/249 (22%), Positives = 113/249 (45%), Gaps = 27/249 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 80 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 137
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 138 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 193
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 194 KLIDFGIANQM--QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKP 397
S IL M G PF + N++ K +A + P + L+++++ C P
Sbjct: 252 SLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQDVLKCCLKRDP 309
Query: 398 AKRPTFRQI 406
+R + ++
Sbjct: 310 KQRISIPEL 318
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-42
Identities = 74/255 (29%), Positives = 118/255 (46%), Gaps = 27/255 (10%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ KGT+ +++A+K E+ D + +E+AL + ++H N+VQ+L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIK----EIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAV--RFALDIARGMNYLHENKPVP 273
G+ +++ + I E +P G L A L+ K G LK + + I G+ YLH+N+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 274 IIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-- 330
I+HRD++ N+L + SG LK++DFG SK L T T Y+APE+
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ-YMAPEIIDKGPRG 201
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP---KAYAARQRPPFKAPAKLYARGLKE 387
Y D++S + EM G PPF + K + P P + A K
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFY-ELGEPQAAMFKVGMFKVHPEI--PESMSAEA-KA 257
Query: 388 LIEECWNEKPAKRPT 402
I +C+ P KR
Sbjct: 258 FILKCFEPDPDKRAC 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 64/237 (27%), Positives = 113/237 (47%), Gaps = 17/237 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K + + ++ + FR E+ +++ + HPN+V+ + + ++ EY
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G++ +L G +K A I + Y H+ + I+HRDL+ N+L D N+K+
Sbjct: 99 GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKI 155
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEG 350
ADFG S L D C Y APE+F+ ++YD +VDV+S +IL ++ G
Sbjct: 156 ADFGFSNE--FTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
PF + + R ++ P + + + L++ P KR T QI+
Sbjct: 211 SLPF---DGQNLKELRERVLRGKYRIPFYM-STDCENLLKRFLVLNPIKRGTLEQIM 263
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 4e-41
Identities = 59/237 (24%), Positives = 115/237 (48%), Gaps = 15/237 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++VA+K + ++ + V+ ++E+ + +++HP++++ S+ + +V E
Sbjct: 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G++ +LK R + A F I GM YLH + I+HRDL SN+L + N+K
Sbjct: 96 GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIK 152
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
+ADFG++ L + ++ T C Y++PE+ + + DV+S + ++ G
Sbjct: 153 IADFGLATQLKMPHEK----HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
PPF + V ++ P+ L + K+LI + PA R + ++
Sbjct: 209 RPPF---DTDTVKNTLNKVVLADYEMPSFL-SIEAKDLIHQLLRRNPADRLSLSSVL 261
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 61/269 (22%), Positives = 111/269 (41%), Gaps = 35/269 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--------M 225
G + A+K+L + +++++ RA E+ ++K+ HPN+VQF A +
Sbjct: 53 GREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 226 MIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
+++TE + K +G L T ++ R + ++H KP PIIHRDL+ N
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVEN 168
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----------TSCRYVAPEVF---KNE 329
+L + G +K+ DFG + ++ D + Q T+ Y PE+ N
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389
K D+++ IL + PF D + + P LI
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPF---EDGAKLRIVNGKYSIPPHDT---QYTVFHSLI 282
Query: 390 EECWNEKPAKRPTFRQIITRLESINNSIN 418
P +R + +++ +L+ I + N
Sbjct: 283 RAMLQVNPEERLSIAEVVHQLQEIAAARN 311
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 71/237 (29%), Positives = 114/237 (48%), Gaps = 16/237 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VAVK L + I D V + E+ L+ RHP++++ ++ + +V EY+
Sbjct: 36 GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L ++ + G ++ A R I ++Y H + ++HRDL+P N+L D N K+
Sbjct: 96 GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 152
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEG 350
ADFG+S ++ + L TSC Y APEV Y +VD++S +IL ++ G
Sbjct: 153 ADFGLSNMM--SDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
PF D VP + + F P L R + L+ P KR T + I
Sbjct: 208 TLPF---DDEHVPTLFKKIRGGVFYIPEYL-NRSVATLLMHMLQVDPLKRATIKDIR 260
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 54/289 (18%), Positives = 95/289 (32%), Gaps = 55/289 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
G A+K V E +L+K+ H N+V+ +++ + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 286
P G L L+ L S + D+ GMN+L EN I+HR+++P NI+R
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148
Query: 287 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK--------NEEYDTK 334
D K+ DFG ++ L +D + Y+ P++++ ++Y
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 335 VDVFSFALILQEMIEGCPPF----------------TMKHDNEVPKAYAARQRPPFKAPA 378
VD++S + G PF + + P
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263
Query: 379 KLYARG---------LKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418
+ L ++ K F Q I + N
Sbjct: 264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 53/286 (18%), Positives = 93/286 (32%), Gaps = 55/286 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
G A+K V E +L+K+ H N+V+ +++ + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 286
P G L L+ L S + D+ GMN+L EN I+HR+++P NI+R
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148
Query: 287 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK--------NEEYDTK 334
D K+ DFG ++ L +D + Y+ P++++ ++Y
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 335 VDVFSFALILQEMIEGCPPFTMKHDNE----------------VPKAYAARQRPPFKAPA 378
VD++S + G PF + P
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263
Query: 379 KL---------YARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
+ L ++ K F Q I +
Sbjct: 264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 5e-38
Identities = 49/242 (20%), Positives = 90/242 (37%), Gaps = 22/242 (9%)
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
+ + +S + A ++ + N V L + + I + K +L+
Sbjct: 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150
Query: 240 FLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
++ R+ +L+ + + IA + +LH ++HRDL+PSNI +KV D
Sbjct: 151 WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 207
Query: 297 FGVSKLLTVKEDRPLTCQDTSCR-----------YVAPEVFKNEEYDTKVDVFSFALILQ 345
FG+ + E+ Y++PE Y KVD+FS LIL
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
Query: 346 EMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
E++ T E + + F ++++ + P +RP
Sbjct: 268 ELL--YSFST---QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322
Query: 406 II 407
II
Sbjct: 323 II 324
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-38
Identities = 88/311 (28%), Positives = 142/311 (45%), Gaps = 36/311 (11%)
Query: 134 MAPMHVKHA-REVPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV 187
MA V+ + + DP EL FT +I KG+F F VA+K + E
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE- 58
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
+D + + E+ +L + P V ++ G+ + + + I+ EYL G L+
Sbjct: 59 -EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD 117
Query: 248 KPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
+ A R L +G++YLH K IHRD++ +N+L + G +K+ADFGV+ LT
Sbjct: 118 ETQIATILREIL---KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
+ + T T ++APEV K YD+K D++S + E+ G PP + H
Sbjct: 172 TQIKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------P 224
Query: 366 YAARQRPPFKAPAKL---YARGLKELIEECWNEKPAKRPT---------FRQIITRLESI 413
P P L Y++ LKE +E C N++P+ RPT + + +
Sbjct: 225 MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYL 284
Query: 414 NNSINHKRRWK 424
I+ +RWK
Sbjct: 285 TELIDRYKRWK 295
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 7e-38
Identities = 67/266 (25%), Positives = 107/266 (40%), Gaps = 29/266 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL------GAVTQSSPMMIV 228
G QVA+K+ + +S +R R E+ +++K+ HPNVV + + ++
Sbjct: 39 GEQVAIKQC-RQELSPKNRERWCL-EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 229 TEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
EY GDLR +L + LK DI+ + YLHEN+ IIHRDL+P NI+
Sbjct: 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIV 153
Query: 286 RDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFS 339
K+ D G +K L + T +Y+APE+ + ++Y VD +S
Sbjct: 154 LQPGPQRLIHKIIDLGYAKEL--DQGELCT---EFVGTLQYLAPELLEQKKYTVTVDYWS 208
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
F + E I G PF N P + + R +Y + P
Sbjct: 209 FGTLAFECITGFRPF---LPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNH 265
Query: 400 RPTFRQI-ITRLESINNSINHKRRWK 424
+ R + ++R
Sbjct: 266 LSGILAGKLERWLQCMLMWHQRQRGT 291
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 66/287 (22%), Positives = 127/287 (44%), Gaps = 23/287 (8%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP + +T +I +G + G +VA++++ + + +E+ +++
Sbjct: 17 DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+ ++PN+V +L + + +V EYL G L + + A + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH N+ +IHRD++ NIL G++K+ DFG +T ++ + T T ++APEV
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEV 187
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
+ Y KVD++S ++ EMIEG PP+ ++ A P + P K +
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK-LSAIF 246
Query: 386 KELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWK 424
++ + C KR + F +I L S+ I +
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 69/237 (29%), Positives = 118/237 (49%), Gaps = 17/237 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+VA+K + +++ D E++ L+ +RHP++++ +T + +++V EY
Sbjct: 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L ++ K + RF I + Y H +K I+HRDL+P N+L DD+ N+K+
Sbjct: 93 GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKI 149
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEG 350
ADFG+S ++ + L TSC Y APEV + Y +VDV+S ++L M+ G
Sbjct: 150 ADFGLSNIM--TDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204
Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
PF D +P + + P L + G + LI P +R T ++I
Sbjct: 205 RLPF---DDEFIPNLFKKVNSCVYVMPDFL-SPGAQSLIRRMIVADPMQRITIQEIR 257
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 18/240 (7%)
Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK + + + + ++ + E+ + + + H NVV+F G + + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L ++ + A RF + G+ YLH I HRD++P N+L D+ NLK
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145
Query: 294 VADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMI 348
++DFG++ + +R L + C YVAPE+ K E+ VDV+S ++L M+
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQII 407
G P+ D+ + Y+ + L+ + E P+ R T I
Sbjct: 203 AGELPWDQPSDS--CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 59/290 (20%), Positives = 107/290 (36%), Gaps = 58/290 (20%)
Query: 165 KGTF---ILAFWRGIQVAVKKL--------------GEEVISDDDRVRAFRDELALLQKI 207
+G F IL A+KK + IS + F++EL ++ I
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR------ 261
++ + G +T + I+ EY+ + F + L + + + +
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160
Query: 262 --GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
+Y+H K I HRD++PSNIL D +G +K++DFG S+ + D+ + S
Sbjct: 161 LNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIK---GSRG 212
Query: 319 --RYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374
++ PE F NE KVD++S + L M PF + + + +
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF--SLKISLVELFNNIRTKNI 270
Query: 375 KAPAKLYAR------------------GLKELIEECWNEKPAKRPTFRQI 406
+ P + ++ + PA+R T
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 65/287 (22%), Positives = 119/287 (41%), Gaps = 23/287 (8%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP L + V+I +G+ + G QVAVK + + R +E+ +++
Sbjct: 42 DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 97
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+H NVV+ + + ++ E+L G L + + L + + + Y
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAY 156
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH +IHRD++ +IL G +K++DFG ++ + + T ++APEV
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-WMAPEV 212
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
Y T+VD++S +++ EM++G PP+ + K P K K + L
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHK-VSPVL 271
Query: 386 KELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWK 424
++ +E P +R T F E + I R+
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYRKQT 318
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-36
Identities = 55/243 (22%), Positives = 99/243 (40%), Gaps = 28/243 (11%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+V VK K+ E+ +D ++ E+A+L ++ H N+++ L +V
Sbjct: 49 NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108
Query: 230 E-YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + DL AF+ R L A + + YL IIHRD++ NI+ +
Sbjct: 109 EKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAE 165
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 344
+K+ DFG + ++ + T C Y APEV Y +++++S + L
Sbjct: 166 DFTIKLIDFGSAAY--LERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
++ PF E+ + A PP+ L L+ P +R T
Sbjct: 221 YTLVFEENPF-----CELEETVEAAIHPPYLVSK-----ELMSLVSGLLQPVPERRTTLE 270
Query: 405 QII 407
+++
Sbjct: 271 KLV 273
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 82/282 (29%), Positives = 128/282 (45%), Gaps = 26/282 (9%)
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
PM K + I + L T + GTF + G +VAVK L + I
Sbjct: 1 GPMAEKQKHDGRVK-IGHYILGDT----LGVGTFGKVKVGKHELTGHKVAVKILNRQKIR 55
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
D V R E+ L+ RHP++++ ++ S + +V EY+ G+L ++ + G L
Sbjct: 56 SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE 115
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
+ R I G++Y H + ++HRDL+P N+L D N K+ADFG+S ++ +
Sbjct: 116 KESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGE 170
Query: 310 PLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
L TSC Y APEV Y +VD++S +IL ++ G PF D+ VP
Sbjct: 171 FL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTL 224
Query: 366 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
+ F P L + L++ P KR T + I
Sbjct: 225 FKKICDGIFYTPQYL-NPSVISLLKHMLQVDPMKRATIKDIR 265
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-36
Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 32/245 (13%)
Query: 175 GIQVAVKKLGEEVISD----DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIV 228
+ VA+K + ++ ISD + R E+ LL+K+ V++ L + +++
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126
Query: 229 TEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
E P DL F+ +GAL+ A F + + + H ++HRD++ NIL D
Sbjct: 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 183
Query: 288 -DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFAL 342
+ G LK+ DFG LL D Y PE + Y V+S +
Sbjct: 184 LNRGELKLIDFGSGALLK---DTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 343 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
+L +M+ G PF +E + + + + + LI C +P+ RPT
Sbjct: 238 LLYDMVCGDIPF---EHDE--EIIRGQVFFRQRVSS-----ECQHLIRWCLALRPSDRPT 287
Query: 403 FRQII 407
F +I
Sbjct: 288 FEEIQ 292
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 46/271 (16%)
Query: 175 GIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVKKL V + + F E+ ++ K +H N+V+ LG + + +V Y+P
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113
Query: 234 KGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
G L L P + A A G+N+LHEN IHRD++ +NIL D++
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAF 170
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCR------YVAPEVFKNEEYDT-----KVDVFS 339
K++DFG+++ + R Y+AP E K D++S
Sbjct: 171 TAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAP------EALRGEITPKSDIYS 219
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL-----------YARGLKEL 388
F ++L E+I G P + ++ + + ++ +
Sbjct: 220 FGVVLLEIITGLPAVDEHREPQLLLDIK---EEIEDEEKTIEDYIDKKMNDADSTSVEAM 276
Query: 389 IE---ECWNEKPAKRPTFRQIITRLESINNS 416
+C +EK KRP +++ L+ + S
Sbjct: 277 YSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 14/231 (6%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K + ++ ++ F E+ ++ H N+V + + +V EY+
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L +++ G L TA+ F I G+ + H+ + I+HRD++P NIL D + LK+ D
Sbjct: 98 LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD 154
Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
FG++K L+ + LT + + +Y +PE K E D D++S ++L EM+ G PP
Sbjct: 155 FGIAKALS---ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLKELIEECWNEKPAKRP 401
F + V A Q + L +I + A R
Sbjct: 212 FN--GETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 200 ELALLQKIRHPNVVQF---LGAVTQSSPMMIVTEYLPKGDLRAF-LKRKGALKPSTAVRF 255
E+A+L+K+ HPNVV+ L + + +V E + +G + + L A +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPV--MEVPTLKPLSEDQARFY 142
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
D+ +G+ YLH K IIHRD++PSN+L + G++K+ADFGVS D L+
Sbjct: 143 FQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLS--- 195
Query: 316 TSC---RYVAPEVFKNE--EYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
+ ++APE + +DV++ + L + G PF D + ++
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF---MDERIMCLHSKI 252
Query: 370 QRPPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQI 406
+ + P + A LK+LI ++ P R +I
Sbjct: 253 KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 22/242 (9%)
Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK + + + + ++ + E+ + + + H NVV+F G + + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L ++ + A RF + G+ YLH I HRD++P N+L D+ NLK
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145
Query: 294 VADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMI 348
++DFG++ + +R L + C YVAPE+ K E+ VDV+S ++L M+
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 349 EGCPPFTMKHDNEVP---KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
G P+ D+ P+K L+ + E P+ R T
Sbjct: 203 AGELPWDQPSDSCQEYSDWKEKKTYLNPWKK----IDSAPLALLHKILVENPSARITIPD 258
Query: 406 II 407
I
Sbjct: 259 IK 260
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 16/197 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VA+K + E + SD + E +++ P+VV + + + D
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L A L+R+G L P AV I ++ H HRD++P NIL + D
Sbjct: 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVD 177
Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
FG++ T D LT + Y+APE F + D+++ +L E + G PP
Sbjct: 178 FGIASATT---DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
Query: 354 FT-------MKHDNEVP 363
+ H N+
Sbjct: 235 YQGDQLSVMGAHINQAI 251
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-34
Identities = 66/272 (24%), Positives = 110/272 (40%), Gaps = 31/272 (11%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
D+ I G + + +VA+K++ E + E+ + + HP
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHHP 73
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA-LDIA-------RG 262
N+V + + + +V + L G + +K A + IA G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TS 317
+ YLH+N IHRD++ NIL + G++++ADFGVS L D T
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 318 CRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
C ++APEV + YD K D++SF + E+ G P+ +V P +
Sbjct: 191 C-WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 377 PA------KLYARGLKELIEECWNEKPAKRPT 402
K Y + +++I C + P KRPT
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 67/247 (27%), Positives = 101/247 (40%), Gaps = 34/247 (13%)
Query: 175 GIQVAVKKLG----EEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAVTQSSPMM 226
+QVA+K + D V E+ALL K+ HP V++ L M
Sbjct: 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114
Query: 227 IVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
+V E LP DL ++ KG L + F + + + H ++HRD++ NIL
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENIL 171
Query: 286 RD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSF 340
D G K+ DFG LL D P Y PE +Y V+S
Sbjct: 172 IDLRRGCAKLIDFGSGALL---HDEPY---TDFDGTRVYSPPEWISRHQYHALPATVWSL 225
Query: 341 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
++L +M+ G PF + D E+ +A PA + + LI C KP+ R
Sbjct: 226 GILLYDMVCGDIPF--ERDQEILEA-------ELHFPAHV-SPDCCALIRRCLAPKPSSR 275
Query: 401 PTFRQII 407
P+ +I+
Sbjct: 276 PSLEEIL 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 66/279 (23%), Positives = 111/279 (39%), Gaps = 63/279 (22%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+ +A K + E I R + R EL +L + P +V F GA + I E++
Sbjct: 58 GLVMARKLIHLE-IKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L LK+ G + + ++ + +G+ YL E I+HRD++PSNIL + G +K+
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKL 173
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEM 347
DFGVS L D+ Y++PE + Y + D++S L L EM
Sbjct: 174 CDFGVSGQLI----------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
Query: 348 IEGCPPFTMKHDNEVPKAYAA--------------------------------------- 368
G P E+ +
Sbjct: 224 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283
Query: 369 --RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
+ PP K P+ +++ ++ + +C + PA+R +Q
Sbjct: 284 IVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 57/272 (20%), Positives = 115/272 (42%), Gaps = 24/272 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
E+ +L+ E+ +G + + G +AVK++ V + ++ R D
Sbjct: 2 MEVKADDLEPIM--ELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDI 58
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFALDI 259
++ + P V F GA+ + + I E + + + + + + A+ I
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
+ + +LH +IHRD++PSN+L + G +K+ DFG+S L + D C+
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173
Query: 320 -YVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRPP 373
Y+APE E Y K D++S + + E+ P+ + + + P
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQVVEEPS 231
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
+ PA ++ + +C + +RPT+ +
Sbjct: 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 60/270 (22%), Positives = 117/270 (43%), Gaps = 19/270 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
Y+ + ++L+ E+ GT + G +AVK++ + ++ R D
Sbjct: 19 RYQAEINDLENLG--EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLD 75
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
+L+ P +VQ G ++ + I E + + + +G + + + I +
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-Y 320
+ YL E +IHRD++PSNIL D+ G +K+ DFG+S L + + + C Y
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAY 190
Query: 321 VAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
+APE + YD + DV+S + L E+ G P+ + ++ PP
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQ 405
++ + +++C + KRP + +
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 74/288 (25%), Positives = 114/288 (39%), Gaps = 40/288 (13%)
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
P+ + + Y+ +I G F L + VAVK +
Sbjct: 9 GPLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIERGAA- 58
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
D+ V+ R E+ + +RHPN+V+F + + + I+ EY G+L + G
Sbjct: 59 IDENVQ--R-EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE 115
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 307
A F + G++Y H + I HRDL+ N L D S LK+ DFG SK
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VL 170
Query: 308 DRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
++ Y+APEV +EYD DV+S + L M+ G PF D E P
Sbjct: 171 HSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF---EDPEEP 224
Query: 364 KAYAAR----QRPPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQI 406
+ Y + P + + LI + PA R + +I
Sbjct: 225 RDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-34
Identities = 68/288 (23%), Positives = 127/288 (44%), Gaps = 25/288 (8%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
P E+ F ++ +G++ + G VA+K + + ++ E++++Q
Sbjct: 26 QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQ 79
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
+ P+VV++ G+ +++ + IV EY G + ++ R L +G+
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH + IHRD++ NIL + G+ K+ADFGV+ LT + T T ++APE
Sbjct: 140 YLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPE 195
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
V + Y+ D++S + EM EG PP+ H P F+ P ++
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL-WSDN 254
Query: 385 LKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWK 424
+ +++C + P +R T F + + + + IN K
Sbjct: 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVK 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 61/266 (22%), Positives = 107/266 (40%), Gaps = 42/266 (15%)
Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G +VA+K+ + + + F E+ L RHP++V +G + + M+++ +Y+
Sbjct: 63 GAKVALKRR-----TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 233 PKGDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
G+L+ L + + ARG++YLH IIHRD++ NIL D+
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNEEYDTKVDVFSF 340
+ K+ DFG+SK T + T S Y+ PE F K DV+SF
Sbjct: 175 NFVPKITDFGISKKGTELD-------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 341 ALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKA------PAKLYARGLK---E 387
++L E++ E A + + K+ L+ +
Sbjct: 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD 287
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
+C RP+ ++ +LE
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 28/249 (11%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+VA++ K + D E+ +L+K+ HP +++ + IV
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 286
E + G+L + LK +T + + + YLHEN IIHRDL+P N+L +
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 275
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSF 340
++ +K+ DFG SK+ + E + T C Y+APEV + Y+ VD +S
Sbjct: 276 EEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 341 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLKELIEECWNEKP 397
+IL + G PPF+ + +++A +L+++ P
Sbjct: 331 GVILFICLSGYPPFS--EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 388
Query: 398 AKRPTFRQI 406
R T +
Sbjct: 389 KARFTTEEA 397
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 22/244 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTE 230
+ AVK L ++ + + E+ LL+++RH NV+Q + + + V E
Sbjct: 30 LCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88
Query: 231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
Y G + A + + G+ YLH I+H+D++P N+L
Sbjct: 89 YCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTG 145
Query: 290 GNLKVADFGVSKLL-TVKEDRPLTCQDTSC---RYVAPEVFKNEE-YD-TKVDVFSFALI 343
G LK++ GV++ L D TS + PE+ + + KVD++S +
Sbjct: 146 GTLKISALGVAEALHPFAADDTC---RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVT 202
Query: 344 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
L + G PF + + K + + + P L +L++ +PAKR +
Sbjct: 203 LYNITTGLYPF---EGDNIYKLFENIGKGSYAIPGDC-GPPLSDLLKGMLEYEPAKRFSI 258
Query: 404 RQII 407
RQI
Sbjct: 259 RQIR 262
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 27/240 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL--GAVTQSSPMM--IVTEYL 232
VAVK L ++ D FR E + HP +V G + + IV EY+
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
LR + +G + P A+ D + +N+ H+N IIHRD++P+NI+ + +
Sbjct: 99 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 155
Query: 293 KVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
KV DFG+++ + +T + +Y++PE + + D + DV+S +L E++
Sbjct: 156 KVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 350 GCPPFT--------MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
G PPFT +H E P P A + + L ++ + + P R
Sbjct: 215 GEPPFTGDSPVSVAYQHVREDP--------IPPSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 63/258 (24%), Positives = 101/258 (39%), Gaps = 31/258 (12%)
Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
GT + + VAVK++ E S DR E+ LL++ HPNV+++
Sbjct: 38 GTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHPNVIRYFCTEKDRQ 91
Query: 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
I E L+ ++++K A + G+ +LH I+HRDL+P
Sbjct: 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPH 147
Query: 283 NILRDDSGN-----LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK---NEEY 331
NIL ++DFG+ K L + + ++APE+ E
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLA-VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 332 DTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKA--PAKLYARGLKEL 388
VD+FS + +I EG PF + +A P K +EL
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPF---GKSLQRQANILLGACSLDCLHPEKHEDVIAREL 263
Query: 389 IEECWNEKPAKRPTFRQI 406
IE+ P KRP+ + +
Sbjct: 264 IEKMIAMDPQKRPSAKHV 281
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 62/236 (26%), Positives = 112/236 (47%), Gaps = 11/236 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G + AVK + + + + E+ LL+++ HPN+++ +V E
Sbjct: 51 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + + A R + G+ Y+H+NK I+HRDL+P N+L + N
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 167
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
+++ DFG+S + + + + + Y+APEV YD K DV+S +IL ++ GC
Sbjct: 168 IRIIDFGLSTH--FEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 406
PPF ++ ++ K + + F+ P K + K+LI + P+ R + R
Sbjct: 225 PPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+VA+K K + D E+ +L+K+ HP +++ + IV
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 286
E + G+L + LK +T + + + YLHEN IIHRDL+P N+L +
Sbjct: 94 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 150
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSF 340
++ +K+ DFG SK+ + E + T C Y+APEV + Y+ VD +S
Sbjct: 151 EEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 205
Query: 341 ALILQEMIEGCPPF 354
+IL + G PPF
Sbjct: 206 GVILFICLSGYPPF 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 29/245 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++ A K + + +S D + E + +K++HPN+V+ ++ + S +V + +
Sbjct: 31 GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + + + A I + Y H N I+HR+L+P N+L +
Sbjct: 90 GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 146
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+K+ADFG++ V + Y++PEV K + Y VD+++ +IL ++
Sbjct: 147 VKLADFGLAIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
Query: 349 EGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPAKRP 401
G PPF + + + A P + A K LI+ P KR
Sbjct: 202 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-------KSLIDSMLTVNPKKRI 254
Query: 402 TFRQI 406
T Q
Sbjct: 255 TADQA 259
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 59/236 (25%), Positives = 117/236 (49%), Gaps = 12/236 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++ A+K + + +S + +E+A+L+ + HPN+++ +V E
Sbjct: 62 HVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + + A + G+ YLH++ I+HRDL+P N+L ++
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDAL 177
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
+K+ DFG+S + + + + + + Y+APEV + ++YD K DV+S +IL ++ G
Sbjct: 178 IKIVDFGLSAV--FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY 234
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 406
PPF + D E+ + + + F +P K + G K+LI++ +R + +Q
Sbjct: 235 PPFGGQTDQEILRK-VEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 37/263 (14%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G F L R G A+K + + D + +E+A+L+KI+H N+V
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
++ +V + + G+L + +G A + + YLHEN I+H
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 330
RDL+P N+L +++ + + DFG+SK+ ++ ++ T+C YVAPEV +
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMS---TACGTPGYVAPEVLAQKP 183
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYAR 383
Y VD +S +I ++ G PPF + ++++ + P + A
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA----- 238
Query: 384 GLKELIEECWNEKPAKRPTFRQI 406
K+ I + P +R T +
Sbjct: 239 --KDFICHLLEKDPNERYTCEKA 259
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 66/301 (21%), Positives = 124/301 (41%), Gaps = 40/301 (13%)
Query: 149 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++DP+E+ + E+ G F + G A K + ++ + + E+ +
Sbjct: 14 DLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEI 69
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARG 262
L HP +V+ LGA + I+ E+ P G + A + ++ +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV- 321
+N+LH + IIHRDL+ N+L G++++ADFGVS + + ++
Sbjct: 130 LNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-------FIG 179
Query: 322 -----APEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
APEV K+ YD K D++S + L EM + PP + V A
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239
Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRW 423
P P+K ++ ++ ++ ++ P RP+ F IT +++ + +
Sbjct: 240 PTLLTPSK-WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAE 298
Query: 424 K 424
Sbjct: 299 V 299
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 68/276 (24%), Positives = 119/276 (43%), Gaps = 26/276 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
++ +L EI +G + ++ G +AVK++ V + ++ + D
Sbjct: 16 HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLD 72
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-----AVRFA 256
+++ P +VQF GA+ + I E + F K ++ +
Sbjct: 73 VVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
L + +N+L EN IIHRD++PSNIL D SGN+K+ DFG+S L D +D
Sbjct: 132 LATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDA 186
Query: 317 SCR-YVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
CR Y+APE YD + DV+S + L E+ G P+ + +
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246
Query: 372 PP--FKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
PP + + ++ + C + +KRP +++
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-31
Identities = 54/335 (16%), Positives = 104/335 (31%), Gaps = 68/335 (20%)
Query: 134 MAPMHVKHAREVPEYEI----DPHELDFTNSVEITKGTFILAF-WRGIQ------VAVKK 182
MA H H + + + I KG L V V++
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGG-CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRR 59
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
+ E S++ V + EL + + HPN+V + + + +VT ++ G + +
Sbjct: 60 INLEACSNEM-VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 243 --RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
+ + + ++Y+H +HR ++ S+IL G + ++ +
Sbjct: 119 THFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 175
Query: 301 KLLTVKEDRPLTCQDTSCRYV------APEVFK--NEEYDTKVDVFSFALILQEMIEGCP 352
+ R D V +PEV + + YD K D++S + E+ G
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
Query: 353 PF---------TMKHDNEVPK---------------------------------AYAARQ 370
PF K + VP +
Sbjct: 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 295
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
P + ++ +E+C P RP+
Sbjct: 296 DSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 57/239 (23%), Positives = 103/239 (43%), Gaps = 20/239 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
I+ A KK+ + + D DR + E+ +++ + HPN+++ ++ + +V E
Sbjct: 34 RIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + K + S A R D+ + Y H+ + HRDL+P N L
Sbjct: 91 GELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSP 147
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
LK+ DFG++ K + + T YV+P+V + Y + D +S +++ ++
Sbjct: 148 LKLIDFGLAAR--FKPGKMMR---TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLL 201
Query: 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 406
G PPF+ D+EV F + + LI + P +R T Q
Sbjct: 202 CGYPPFSAPTDSEVMLK-IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 57/242 (23%), Positives = 106/242 (43%), Gaps = 22/242 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++ +K + ++ + E+ +L+ + HPN+++ M IV E
Sbjct: 47 GLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RD 287
G+L + R AL + + Y H ++H+DL+P NIL
Sbjct: 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTS 161
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG+++L K D T + Y+APEVFK + K D++S +++
Sbjct: 162 PHSPIKIIDFGLAEL--FKSDEHST---NAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
++ GC PFT EV + A + P + + +L+++ + P +RP+
Sbjct: 216 YFLLTGCLPFTGTSLEEVQQK-ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAA 274
Query: 405 QI 406
Q+
Sbjct: 275 QV 276
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 12/236 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ AVK + + + D E+ LL+K+ HPN+++ + SS IV E
Sbjct: 47 QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + ++ A R + G+ Y+H++ I+HRDL+P NIL ++ +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
+K+ DFG+S +++ + + + Y+APEV + YD K DV+S +IL ++ G
Sbjct: 163 IKIIDFGLSTC--FQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT 219
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 406
PPF K++ ++ K + F P + + K+LI + P+ R T Q
Sbjct: 220 PPFYGKNEYDILKR-VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 54/228 (23%), Positives = 107/228 (46%), Gaps = 15/228 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + ++ + + VR EL ++Q + HP +V + M +V + L GDLR
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L++ K T F ++ ++YL + IIHRD++P NIL D+ G++ + DF
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCP 352
++ + + + +T T Y+APE+F + + Y VD +S + E++ G
Sbjct: 161 IAAM--LPRETQIT---TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
P+ ++ + + P+ ++ + L+++ P +R
Sbjct: 216 PYHIRSSTSSKEIVHTFETTVVTYPSAW-SQEMVSLLKKLLEPNPDQR 262
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 56/286 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VAVK+L EE + F+ E+ ++ H N+++ G + ++V Y+
Sbjct: 54 GTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 235 GDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
G + + L+ + +P R AL ARG+ YLH++ IIHRD++ +NIL D+
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNEEYDTKVDVFSFAL 342
V DFG++KL+ K DT + ++APE + K DVF + +
Sbjct: 172 EAVVGDFGLAKLMDYK--------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 223
Query: 343 ILQEMIEGCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARG-LKELI--------- 389
+L E+I G F + + L L+ L+
Sbjct: 224 MLLELITGQRAFDLARLANDDDVMLLDWVK---------GLLKEKKLEALVDVDLQGNYK 274
Query: 390 -EE----------CWNEKPAKRPTFRQIITRLESINNSINHKRRWK 424
EE C P +RP +++ LE + W+
Sbjct: 275 DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG-DGLAERWEEWQ 319
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-31
Identities = 65/297 (21%), Positives = 120/297 (40%), Gaps = 38/297 (12%)
Query: 132 PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKK 182
P MA M + F+++ ++ + G F + G++ A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
+ + +S D + E + +K++HPN+V+ ++ + S +V + + G+L +
Sbjct: 62 INTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGV 299
+ + A I + Y H N I+HR+L+P N+L + +K+ADFG+
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 300 SKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356
+ V + Y++PEV K + Y VD+++ +IL ++ G PPF
Sbjct: 178 AIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232
Query: 357 KHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPAKRPTFRQI 406
+ + + A P + A K LI+ P KR T Q
Sbjct: 233 EDQHRLYAQIKAGAYDYPSPEWDTVTPEA-------KSLIDSMLTVNPKKRITADQA 282
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 20/185 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E + A R E+ +L++++HPN+V L + + +V EY +
Sbjct: 31 VAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TV 88
Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L R P V+ + +N+ H++ IHRD++P NIL +K+ D
Sbjct: 89 LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCD 145
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFALILQEMIE 349
FG ++LLT V +PE+ + +Y VDV++ + E++
Sbjct: 146 FGFARLLTG-PSDYYDD------EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198
Query: 350 GCPPF 354
G P +
Sbjct: 199 GVPLW 203
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 50/278 (17%)
Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
GT + ++G VAVK++ D E+ LL + HPNV+++ + T
Sbjct: 29 GTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR 82
Query: 224 PMMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ I E +L+ ++ K K + IA G+ +LH K IIH
Sbjct: 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIH 138
Query: 277 RDLEPSNIL-------------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RY 320
RDL+P NIL ++ + ++DFG+ K L + T + +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198
Query: 321 VAPEVFKNEE-------YDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRP 372
APE+ + +D+FS + ++ +G PF D ++ R
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF---GDKYSRESNIIRGIF 255
Query: 373 PFKAPAKLYARGL----KELIEECWNEKPAKRPTFRQI 406
L+ R L +LI + + P KRPT ++
Sbjct: 256 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 66/246 (26%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ AVK + + + D E+ LL+K+ HPN+++ + SS IV E
Sbjct: 47 QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + ++ A R + G+ Y+H++ I+HRDL+P NIL ++ +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+K+ DFG+S +++ + Y+APEV + YD K DV+S +IL ++
Sbjct: 163 IKIIDFGLSTC--FQQNTKMK---DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILL 216
Query: 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAP--------AKLYARGLKELIEECWNEKPAKR 400
G PPF K++ ++ K + F P A K+LI + P+ R
Sbjct: 217 SGTPPFYGKNEYDILKR-VETGKYAFDLPQWRTISDDA-------KDLIRKMLTFHPSLR 268
Query: 401 PTFRQI 406
T Q
Sbjct: 269 ITATQC 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 50/226 (22%), Positives = 103/226 (45%), Gaps = 14/226 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + I +++V E ++ ++ HP V+ + Y G+L
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++++ G+ + RF +I + YLH IIHRDL+P NIL ++ ++++ DF
Sbjct: 119 KYIRKIGSFDETCT-RFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 174
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G +K+L+ + + + +YV+PE+ + D+++ I+ +++ G PPF
Sbjct: 175 GTAKVLSPESKQARAN--SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
+ + + P K + + ++L+E+ KR
Sbjct: 233 ---RAGNEYLIFQKIIKLEYDFPEKFFPKA-RDLVEKLLVLDATKR 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 40/297 (13%), Positives = 90/297 (30%), Gaps = 43/297 (14%)
Query: 138 HVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEV 187
+ + E+++ + + + +G F A + +K
Sbjct: 50 KLPAIKPKTEFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA- 246
+ + L+ ++F A + ++V E G L +
Sbjct: 108 PWEFYIGT---QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164
Query: 247 ----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----------RDDSGN 291
+ + FA+ + + +H+ + IIH D++P N + D S
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 292 LKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
L + D G S + + + T + + + E+ N+ ++ ++D F A + M+ G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
E + F+ L E N ++
Sbjct: 282 TYMKVKNEGGEC------KPEGLFRRLPHLDM--WNEFFHVMLNIPDCHHLPSLDLL 330
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 28/271 (10%), Positives = 53/271 (19%), Gaps = 46/271 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT----- 229
A+K + + + ++ + + P V
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 230 --------------------EYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARG 262
DL +G + R
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
L ++H P N+ G L + D K Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL----WKVGTRGPASSVPVTYAP 259
Query: 323 PEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
E + ++ + L + + PF + R P
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAF 319
Query: 381 YAR-----GLKELIEECWNEKPAKRPTFRQI 406
+ +K LI N +R +
Sbjct: 320 GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 61/242 (25%), Positives = 104/242 (42%), Gaps = 23/242 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++ AVK I D + + LL+ +HPN++ + +VTE +
Sbjct: 47 NMEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSG 290
G+L + R+ A I + + YLH ++HRDL+PSNIL +
Sbjct: 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEM 347
++++ DFG +K L E+ L T C +VAPEV + + YD D++S ++L M
Sbjct: 158 SIRICDFGFAKQLR-AENGLLM---TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM 213
Query: 348 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLKELIEECWNEKPAKRPTFR 404
+ G PF D+ + A F + K+L+ + + P +R T
Sbjct: 214 LTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273
Query: 405 QI 406
+
Sbjct: 274 LV 275
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 58/181 (32%), Positives = 104/181 (57%), Gaps = 12/181 (6%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + ++D+ + A R E++LL+++ HPN+V + + + +V E++ K
Sbjct: 48 VALKRIRLD--AEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ L K L+ S + + RG+ + H+++ I+HRDL+P N+L + G LK+
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKL 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 353
ADFG+++ + R T + + Y AP+V +++Y T VD++S I EMI G P
Sbjct: 161 ADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219
Query: 354 F 354
F
Sbjct: 220 F 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-30
Identities = 56/181 (30%), Positives = 103/181 (56%), Gaps = 12/181 (6%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+KK+ E +D+ + R E+++L++++H N+V+ + +++V E+L +
Sbjct: 29 FALKKIRLE--KEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ L +G L+ TA F L + G+ Y H+ + ++HRDL+P N+L + G LK+
Sbjct: 85 DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKI 141
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 353
ADFG+++ + R T + + Y AP+V +++Y T +D++S I EM+ G P
Sbjct: 142 ADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
Query: 354 F 354
F
Sbjct: 201 F 201
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 62/246 (25%), Positives = 114/246 (46%), Gaps = 21/246 (8%)
Query: 175 GIQVAVK----------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
+ A+K + ++ + + +E++LL+ + HPN+++
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+VTE+ G+L + + A I G+ YLH++ I+HRD++P NI
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENI 177
Query: 285 L---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
L ++ N+K+ DFG+S +D L + + Y+APEV K ++Y+ K DV+S
Sbjct: 178 LLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCG 234
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKR 400
+I+ ++ G PPF ++D ++ K + + F K + KELI+ KR
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKK-VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKR 293
Query: 401 PTFRQI 406
T +
Sbjct: 294 CTAEEA 299
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 23/195 (11%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228
G + AVK ++ A R E +L+++ HP+++ + + SS M +V
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
+ + KG+L +L K AL + +++LH N I+HRDL+P NIL DD
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDD 235
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE------YDTKVDVFS 339
+ ++++DFG S ++ L C Y+APE+ K Y +VD+++
Sbjct: 236 NMQIRLSDFGFSCH--LEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWA 290
Query: 340 FALILQEMIEGCPPF 354
+IL ++ G PPF
Sbjct: 291 CGVILFTLLAGSPPF 305
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 61/182 (33%), Positives = 96/182 (52%), Gaps = 11/182 (6%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+KK+ D A R E+ LLQ++ HPN++ L A S + +V +++
Sbjct: 38 VAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL +K L PS + L +G+ YLH++ I+HRDL+P+N+L D++G LK
Sbjct: 97 -DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK 152
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
+ADFG++K +R T Q + Y APE+ F Y VD+++ IL E++ P
Sbjct: 153 LADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211
Query: 353 PF 354
Sbjct: 212 FL 213
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 30/247 (12%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G++ A K + E+++L+++ H NV+ + ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL +K +L A F I G+NYLH K I H DL+P NI+
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
++K+ DFG++ + ++ + +VAPE+ E + D++S +I
Sbjct: 152 NIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 346 EMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPA 398
++ G PF E + F A K+ I + ++
Sbjct: 210 ILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA-------KDFIRKLLVKETR 262
Query: 399 KRPTFRQ 405
KR T ++
Sbjct: 263 KRLTIQE 269
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 24/196 (12%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVR-AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227
+ AVK G + +R A E+ +L+K+ HPN++Q ++ +
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
V + + KG+L +L K L + + + LH+ I+HRDL+P NIL D
Sbjct: 102 VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 158
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE------YDTKVDVF 338
D N+K+ DFG S + L C Y+APE+ + Y +VD++
Sbjct: 159 DDMNIKLTDFGFSCQ--LDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 213
Query: 339 SFALILQEMIEGCPPF 354
S +I+ ++ G PPF
Sbjct: 214 STGVIMYTLLAGSPPF 229
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 57/250 (22%), Positives = 99/250 (39%), Gaps = 36/250 (14%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G + A K +L E+ +L++IRHPN++ + ++++
Sbjct: 30 GKEYAAKFIKKRRLSSSRRGVS--REEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL K +L A +F I G++YLH + I H DL+P NI+
Sbjct: 88 ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDK 144
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFAL 342
+ +K+ DFG++ + + +VAPE+ E + D++S +
Sbjct: 145 NVPNPRIKLIDFGIAHKI--EAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
Query: 343 ILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNE 395
I ++ G PF + E +A F A K+ I +
Sbjct: 200 ITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA-------KDFIRRLLVK 252
Query: 396 KPAKRPTFRQ 405
P +R T Q
Sbjct: 253 DPKRRMTIAQ 262
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 71/295 (24%), Positives = 116/295 (39%), Gaps = 37/295 (12%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L F++ EI G+F + VA+KK+ +++ + E+ LQ
Sbjct: 51 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED---RPLTCQDTSCRYVA 322
LH + +IHRD++ NIL + G +K+ DFG + ++ P ++A
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY--------WMA 218
Query: 323 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KA-YAARQRPPFKAP 377
PEV +YD KVDV+S + E+ E PP N A Y Q
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----LFNMNAMSALYHIAQNESPALQ 274
Query: 378 AKLYARGLKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWK 424
+ ++ + ++ C + P RPT F I + I +
Sbjct: 275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 329
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 8/179 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E + A R E+ LL+++RH N+V L + +V E++ +
Sbjct: 53 VAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TI 110
Query: 238 RAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L+ L ++ I G+ + H + IIHRD++P NIL SG +K+ D
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCD 167
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
FG ++ L + + Y APE+ + +Y VDV++ ++ EM G P F
Sbjct: 168 FGFARTLAAP-GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 57/257 (22%), Positives = 101/257 (39%), Gaps = 49/257 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
AVK +IS + E+ L+ HPN+V+ +V E L
Sbjct: 36 NQAFAVK-----IISKRMEANTQK-EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
G+L +K+K + A + ++++H+ ++HRDL+P N+L +D+
Sbjct: 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNL 146
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEM 347
+K+ DFG ++L +++PL T C Y APE+ YD D++S +IL M
Sbjct: 147 EIKIIDFGFARLKPP-DNQPLK---TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTM 202
Query: 348 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL------------------KELI 389
+ G PF + + + ++ + K+LI
Sbjct: 203 LSGQVPF-----------QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI 251
Query: 390 EECWNEKPAKRPTFRQI 406
+ P KR +
Sbjct: 252 QGLLTVDPNKRLKMSGL 268
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 60/285 (21%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
A+K K+ + D +R++ E+ L++K+ HPN+ + + +V
Sbjct: 51 RAIRAIKIMNKNKIRQINPKDVERIK---TEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107
Query: 230 EYLPKGDLRAFLKRKGALKPST-------------------------------------- 251
E G L L
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167
Query: 252 --AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 307
I ++YLH I HRD++P N L + S +K+ DFG+SK
Sbjct: 168 KLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224
Query: 308 DRPLTCQDTSC---RYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
+ T +VAPEV NE Y K D +S ++L ++ G PF +D +
Sbjct: 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT 284
Query: 363 PKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 406
++ F+ P + + ++L+ N +R +
Sbjct: 285 ISQ-VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 58/247 (23%), Positives = 97/247 (39%), Gaps = 30/247 (12%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G+Q A K + E+++L++I+HPNV+ + ++++
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVS--REDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL K +L A F I G+ YLH + I H DL+P NI+
Sbjct: 94 ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDR 150
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
+K+ DFG++ + + +VAPE+ E + D++S +I
Sbjct: 151 NVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 346 EMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPA 398
++ G PF E +A F A A K+ I + P
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA-------KDFIRRLLVKDPK 261
Query: 399 KRPTFRQ 405
KR T +
Sbjct: 262 KRMTIQD 268
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 3e-29
Identities = 49/181 (27%), Positives = 93/181 (51%), Gaps = 12/181 (6%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + DD+ V A R E+ LL++++H N+V+ + + +V E+ +
Sbjct: 30 VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ + G L P F + +G+ + H ++HRDL+P N+L + +G LK+
Sbjct: 86 DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKL 142
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 353
A+FG+++ + R + + + Y P+V F + Y T +D++S I E+ P
Sbjct: 143 ANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
Query: 354 F 354
Sbjct: 202 L 202
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 53/182 (29%), Positives = 93/182 (51%), Gaps = 15/182 (8%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+K++ EE A R E++LL+ ++H N+V + + +V EYL K
Sbjct: 30 VALKEIRLEHEEGAP----CTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84
Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL+ +L G + F + RG+ Y H K ++HRDL+P N+L ++ G LK
Sbjct: 85 -DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELK 140
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
+ADFG+++ ++ + + + Y P++ + +Y T++D++ I EM G P
Sbjct: 141 LADFGLARAKSI-PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
Query: 353 PF 354
F
Sbjct: 200 LF 201
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 29/229 (12%)
Query: 142 AREVPEYEIDPHELDFTNSV-----EITKGTF---ILAFWR--GIQVAVKKLGEEVISDD 191
A VP+Y ID D + E+ +G + A+K V+
Sbjct: 35 ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK-----VLKKT 89
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
+ R E+ +L ++ HPN+++ + + +V E + G+L + KG
Sbjct: 90 VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD 149
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKED 308
A I + YLHEN I+HRDL+P N+L LK+ADFG+SK+ V+
Sbjct: 150 AADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQ 204
Query: 309 RPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+ T C Y APE+ + Y +VD++S +I ++ G PF
Sbjct: 205 VLMK---TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 36/274 (13%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP + F + GT+ + G A+K + +V D++ + E+ +L+
Sbjct: 21 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEE--EIKQEINMLK 75
Query: 206 KI-RHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFA 256
K H N+ + GA + +P + +V E+ G + +K + LK
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+I RG+++LH++K +IHRD++ N+L ++ +K+ DFGVS L R T T
Sbjct: 136 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 317 SCRYVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAYA--A 368
++APEV +E YD K D++S + EM EG PP H P +A
Sbjct: 193 PY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH----PMRALFLIP 247
Query: 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
R P K +++ + IE C + ++RP
Sbjct: 248 RNPAPRLKSKK-WSKKFQSFIESCLVKNHSQRPA 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 53/264 (20%), Positives = 111/264 (42%), Gaps = 35/264 (13%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ KG F G + A + + +S D + E + + ++HPN+V+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLH 76
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
++++ ++ + + G+L + + + A I + + H+ ++H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVH 133
Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 330
R+L+P N+L + +K+ADFG++ + E + Y++PEV + +
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWF---GFAGTPGYLSPEVLRKDP 189
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP--------AKLYA 382
Y VD+++ +IL ++ G PPF + + + + F +P A
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ-IKAGAYDFPSPEWDTVTPEA---- 244
Query: 383 RGLKELIEECWNEKPAKRPTFRQI 406
K+LI + P+KR T +
Sbjct: 245 ---KDLINKMLTINPSKRITAAEA 265
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 16/230 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL- 237
A KKL ++ + + E +L K+ +V A + + +V + GD+
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 238 ---RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
+ + A+ + I G+ +LH+ II+RDL+P N+L DD GN+++
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRI 330
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
+D G++ L + + ++APE+ EEYD VD F+ + L EMI
Sbjct: 331 SDLGLAVELKAGQTKT----KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
Query: 352 PPFTM-KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
PF E + P K + K+ E + P KR
Sbjct: 387 GPFRARGEKVENKELKQRVLEQAVTYPDKF-SPASKDFCEALLQKDPEKR 435
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 48/185 (25%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ E +++ V A R E++LL++++H N+++ + + + ++ EY
Sbjct: 62 VAIKRIRLE--HEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----RDDSG 290
DL+ ++ + + F + G+N+ H + +HRDL+P N+L ++
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETP 174
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIE 349
LK+ DFG+++ + R T + + Y PE+ + Y T VD++S A I EM+
Sbjct: 175 VLKIGDFGLARAFGI-PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
Query: 350 GCPPF 354
P F
Sbjct: 234 KTPLF 238
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 25/195 (12%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G Q AVK K + ++ E ++ ++HP++V+ L + + +V
Sbjct: 49 GQQFAVKIVDVAKFTSSPGLSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVF 105
Query: 230 EYLPKGDLRAFLKRKGALKPS----TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
E++ DL + ++ A + I + Y H+N IIHRD++P +L
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVL 162
Query: 286 ---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFS 339
+++S +K+ FGV+ L + ++APEV K E Y VDV+
Sbjct: 163 LASKENSAPVKLGGFGVAIQLG-ESGLVAG---GRVGTPHFMAPEVVKREPYGKPVDVWG 218
Query: 340 FALILQEMIEGCPPF 354
+IL ++ GC PF
Sbjct: 219 CGVILFILLSGCLPF 233
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 16/189 (8%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G++ A K + E+++L+++ HPN++ + ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVC--REEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL +K +L A F I G+NYLH K I H DL+P NI+
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
++K+ DFG++ +++ + +VAPE+ E + D++S +I
Sbjct: 152 NIPIPHIKLIDFGLAHE--IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 346 EMIEGCPPF 354
++ G PF
Sbjct: 210 ILLSGASPF 218
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 56/304 (18%)
Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITK-----GTF---ILAFWR--GIQVAVKKLGE 185
H EV +P + T+ +++K G + F R G + A+K L
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-- 62
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFL 241
D +A ++ Q P++V L ++I+ E + G+L + +
Sbjct: 63 -----YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117
Query: 242 KRKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVAD 296
+ +G + A DI + +LH + I HRD++P N+L ++ LK+ D
Sbjct: 118 QERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTD 174
Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
FG +K L T C YVAPEV E+YD D++S +I+ ++ G PP
Sbjct: 175 FGFAKET---TQNALQ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
Query: 354 FTMKHDNEVPKAYAARQR---PPFKAP--------AKLYARGLKELIEECWNEKPAKRPT 402
F + R R F P A K+LI P +R T
Sbjct: 229 FYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA-------KQLIRLLLKTDPTERLT 281
Query: 403 FRQI 406
Q
Sbjct: 282 ITQF 285
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-28
Identities = 53/187 (28%), Positives = 97/187 (51%), Gaps = 20/187 (10%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+K++ EE A R E++L+++++H N+V+ + + + +V E++
Sbjct: 33 VALKEVKLDSEEGTP----STAIR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87
Query: 235 GDLRAFLK------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
DL+ ++ L+ + F + +G+ + HENK I+HRDL+P N+L +
Sbjct: 88 -DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINK 143
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEM 347
G LK+ DFG+++ + + + + Y AP+V + Y T +D++S IL EM
Sbjct: 144 RGQLKLGDFGLARAFGI-PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM 202
Query: 348 IEGCPPF 354
I G P F
Sbjct: 203 ITGKPLF 209
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 32/247 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
G + A K L + D R E+A+L+ + P V+ +S ++++ EY
Sbjct: 54 GQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112
Query: 234 KGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDD 288
G++ + + + +R I G+ YLH+N I+H DL+P NIL
Sbjct: 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQ 345
G++K+ DFG+S+ + L Y+APE+ + T D+++ +I
Sbjct: 170 LGDIKIVDFGMSRKI--GHACELR---EIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224
Query: 346 EMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPA 398
++ PF + + E + F A + I+ + P
Sbjct: 225 MLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA-------TDFIQSLLVKNPE 277
Query: 399 KRPTFRQ 405
KRPT
Sbjct: 278 KRPTAEI 284
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-28
Identities = 52/229 (22%), Positives = 98/229 (42%), Gaps = 17/229 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L ++ I +E L+L+ P +V A + + + + G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
DL L + G + +A +I G+ ++H +++RDL+P+NIL D+ G+++++
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334
Query: 296 DFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGC 351
D G++ + +P S Y+APEV K YD+ D FS +L +++ G
Sbjct: 335 DLGLACD--FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
PF + + + P + L+ L+E +R
Sbjct: 389 SPFRQHKTKDKHEIDRMTLTMAVELPDSF-SPELRSLLEGLLQRDVNRR 436
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 44/235 (18%), Positives = 82/235 (34%), Gaps = 39/235 (16%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVTEY 231
V +K L D + E L ++ HP++VQ V + IV EY
Sbjct: 108 PVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
+ L+ L + A+ + L+I ++YLH +++ DL+P NI+ +
Sbjct: 166 VGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEEQ- 219
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
LK+ D G + + + APE+ + D+++ L
Sbjct: 220 LKLIDLGAVSRIN----------SFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAA 268
Query: 347 MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
+ P ++ + +P P K L+ + P +R
Sbjct: 269 LTLDLPTRNGRYVDGLP-----EDDPVLKTYDSYGR-----LLRRAIDPDPRQRF 313
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 39/193 (20%), Positives = 85/193 (44%), Gaps = 15/193 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G K + D V+ +E++++ ++ HP ++ A M+++ E+L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
G+L F + + + + G+ ++HE+ I+H D++P NI+ +
Sbjct: 133 GEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKA 187
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
++K+ DFG++ L D + + + APE+ E D+++ ++ ++
Sbjct: 188 SSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
Query: 350 GCPPFTMKHDNEV 362
G PF + D E
Sbjct: 246 GLSPFAGEDDLET 258
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ I +E +L+K+ VV A + +V + GDL+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
+ G + AV +A +I G+ LH + I++RDL+P NIL DD G+++++D
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329
Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
G++ V E + + Y+APEV KNE Y D ++ +L EMI G P
Sbjct: 330 LGLAV--HVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
Query: 354 FT-MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
F K + + + P + + + + L + + PA+R
Sbjct: 385 FQQRKKKIKREEVERLVKEVPEEYSERF-SPQARSLCSQLLCKDPAER 431
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 17/225 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++ +E +LQ + P +V+ + +S + +V EY+ G++
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L+R G A +A I YLH +I+RDL+P N+L D G ++V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+ K + T T C +APE+ ++ Y+ VD ++ +++ EM G PPF
Sbjct: 187 FA-----KRVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF- 238
Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
++ + Y + P+ + LK+L+ KR
Sbjct: 239 --FADQPIQIYEKIVSGKVRFPSHF-SSDLKDLLRNLLQVDLTKR 280
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 10/187 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + A + V EY G+L
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L R+ A + +I + YLH +++RD++ N++ D G++K+ DFG
Sbjct: 94 FHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+ K T C Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 151 LCKEGISDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
Query: 356 MKHDNEV 362
+ +
Sbjct: 207 NQDHERL 213
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 43/243 (17%), Positives = 91/243 (37%), Gaps = 30/243 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
K + + + E+++L RH N++ + ++++ E++
Sbjct: 30 KKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
D+ F L V + + + +LH + I H D+ P NI+ S
Sbjct: 86 LDI--FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRS 140
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
+K+ +FG ++ L K T+ Y APEV +++ T D++S ++ ++
Sbjct: 141 STIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 350 GCPPFTMKHDNE----VPKAYAARQRPPFK---APAKLYARGLKELIEECWNEKPAKRPT 402
G PF + + + + A FK A + ++ ++ R T
Sbjct: 199 GINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA-------MDFVDRLLVKERKSRMT 251
Query: 403 FRQ 405
+
Sbjct: 252 ASE 254
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 23/181 (12%)
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
K L + ++ +A+GM +L K IHRDL NIL + +K+ DFG+++
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 303 L------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF- 354
+ K D L +++APE + Y + DV+SF ++L E+ G P+
Sbjct: 243 IYKDPDYVRKGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297
Query: 355 TMKHDNEVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
+K D E + R R P ++Y + + +CW+ +P++RPTF +++ L +
Sbjct: 298 GVKIDEEFCRRLKEGTRMRAPDYTTPEMY-----QTMLDCWHGEPSQRPTFSELVEHLGN 352
Query: 413 I 413
+
Sbjct: 353 L 353
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 13/225 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L R+ A + +I ++YLH K +++RDL+ N++ D G++K+ DFG
Sbjct: 237 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFG 294
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+ K T C Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 295 LCKEGIKDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350
Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
+ ++ + + P L K L+ + P +R
Sbjct: 351 NQDHEKL---FELILMEEIRFPRTL-GPEAKSLLSGLLKKDPKQR 391
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 15/193 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A K + SD + VR E+ + +RHP +V A + M+++ E++
Sbjct: 182 GNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
G+L F + AV + + +G+ ++HEN +H DL+P NI+ S
Sbjct: 239 GEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRS 293
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
LK+ DFG++ L + + + + APEV + + D++S ++ ++
Sbjct: 294 NELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
Query: 350 GCPPFTMKHDNEV 362
G PF ++D+E
Sbjct: 352 GLSPFGGENDDET 364
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 41/246 (16%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGI----------QVAV 180
PL P V + E+ +TN I G+F G+ +VA+
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSF------GVVFQAKLVESDEVAI 69
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPK 234
KK + D R R EL +++ ++HPNVV + +V EY+P+
Sbjct: 70 KK-----VLQDKR-FKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DS 289
+ R + K K + + + R + Y+H I HRD++P N+L D S
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPS 178
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMI 348
G LK+ DFG +K+L P S Y APE+ F Y T +D++S ++ E++
Sbjct: 179 GVLKLIDFGSAKILI--AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236
Query: 349 EGCPPF 354
+G P F
Sbjct: 237 QGQPLF 242
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 34/240 (14%), Positives = 70/240 (29%), Gaps = 44/240 (18%)
Query: 172 FWRGI------QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
FW+ + QVA+ + + + DD ++ L +I P V + L V +
Sbjct: 47 FWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106
Query: 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
++V E++ G L+ + P A+R +A + H + PS +
Sbjct: 107 LVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVR 161
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
G++ +A + + + D+ L
Sbjct: 162 VSIDGDVVLAYPA---------------------TMPDA-------NPQDDIRGIGASLY 193
Query: 346 EMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKLYA---RGLKELIEECWNEKPAKRP 401
++ P + + A P PA + + + R
Sbjct: 194 ALLVNRWPLPEAGVRSGLAPAERDTAGQP-IEPADIDRDIPFQISAVAARSVQGDGGIRS 252
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 26/279 (9%)
Query: 95 RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVP---EYEID 151
R + K+ W + L + + K+ L A P + A++ Y +
Sbjct: 33 RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
E + G F G+++A K + + D + V+ +E++++ +
Sbjct: 93 KTE-------ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQ 142
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNY 265
+ H N++Q A + +++V EY+ G+L + L + F I G+ +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRH 202
Query: 266 LHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323
+H+ I+H DL+P NIL D+ +K+ DFG+++ K L + ++AP
Sbjct: 203 MHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAP 257
Query: 324 EVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
EV + D++S +I ++ G PF +D E
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 55/265 (20%), Positives = 99/265 (37%), Gaps = 42/265 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
+ AVK + ++ RV E+ +L + + H NV++ + + +V E +
Sbjct: 38 SQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
G + + + ++ A D+A +++LH I HRDL+P NIL +
Sbjct: 95 GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVS 151
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQD---TSC---RYVAPEVFK-----NEEYDTKVDVFS 339
+K+ DF + + + D T C Y+APEV + YD + D++S
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL-------------- 385
+IL ++ G PPF R L+
Sbjct: 212 LGVILYILLSGYPPF---VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI 268
Query: 386 ----KELIEECWNEKPAKRPTFRQI 406
K+LI + +R + Q+
Sbjct: 269 SCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 56/192 (29%), Positives = 89/192 (46%), Gaps = 25/192 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G VA+KK + D R R EL +++K+ H N+V+ S +V
Sbjct: 79 GELVAIKK-----VLQDKR-FKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 229 TEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+Y+P+ + R + + K L + + R + Y+H I HRD++P N+
Sbjct: 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNL 187
Query: 285 LRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFAL 342
L D D+ LK+ DFG +K L P S Y APE+ F +Y + +DV+S
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 245
Query: 343 ILQEMIEGCPPF 354
+L E++ G P F
Sbjct: 246 VLAELLLGQPIF 257
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 58/188 (30%), Positives = 92/188 (48%), Gaps = 11/188 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++V+ DD V E L + P + Q + V EY+ GDL
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ G K AV +A +IA G+ +L II+RDL+ N++ D G++K+ADF
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 486
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K T C Y+APE+ + Y VD ++F ++L EM+ G PF
Sbjct: 487 GMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542
Query: 355 TMKHDNEV 362
+ ++E+
Sbjct: 543 EGEDEDEL 550
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 60/225 (26%), Positives = 109/225 (48%), Gaps = 17/225 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +E++ +V DE +L + HP +++ G + + ++ +Y+ G+L
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L++ A +A ++ + YLH II+RDL+P NIL D +G++K+ DFG
Sbjct: 95 SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG 151
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+ K +T T C Y+APEV + Y+ +D +SF +++ EM+ G PF
Sbjct: 152 FA-----KYVPDVT--YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF- 203
Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
+D+ K Y + P +K+L+ ++R
Sbjct: 204 --YDSNTMKTYEKILNAELRFPPFF-NEDVKDLLSRLITRDLSQR 245
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 11/188 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++V+ DD V E +L + P + Q + V EY+ GDL
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ G K AV +A +IA G+ +L II+RDL+ N++ D G++K+ADF
Sbjct: 109 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 165
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K T C Y+APE+ + Y VD ++F ++L EM+ G PF
Sbjct: 166 GMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221
Query: 355 TMKHDNEV 362
+ ++E+
Sbjct: 222 EGEDEDEL 229
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 11/188 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L ++V+ DD V E +L HP + + V EYL GDL
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++ S A +A +I G+ +LH I++RDL+ NIL D G++K+ADF
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF 162
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K + + + +T C Y+APE+ ++Y+ VD +SF ++L EM+ G PF
Sbjct: 163 GMCKENMLGDAKT----NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218
Query: 355 TMKHDNEV 362
+ + E+
Sbjct: 219 HGQDEEEL 226
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 17/188 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + + V FR+E +L + Q A + + +V EY GDL
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L + G P+ RF +I ++ +H +HRD++P NIL D G++++ADF
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-------YDTKVDVFSFALILQEM 347
G L + Y++PE+ + Y + D ++ + EM
Sbjct: 207 GSCLKLRADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263
Query: 348 IEGCPPFT 355
G PF
Sbjct: 264 FYGQTPFY 271
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 56/191 (29%), Positives = 100/191 (52%), Gaps = 11/191 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + ++ HP +V S + V EY+ GDL
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 98 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K D T T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 155 GMCKEGLRPGDT--T--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210
Query: 355 TMKHDNEVPKA 365
+ ++ P
Sbjct: 211 DIVGSSDNPDQ 221
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 65/256 (25%), Positives = 100/256 (39%), Gaps = 47/256 (18%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
+ A+K ++ D + R E+ L + + P++V+ + ++IV
Sbjct: 87 QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138
Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
E L G+L R + A A I + YLH I HRD++P N+L
Sbjct: 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 195
Query: 286 -RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFA 341
+ + LK+ DFG +K LT T C YVAPEV E+YD D++S
Sbjct: 196 SKRPNAILKLTDFGFAKE--TTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQR---PPFKAP--------AKLYARGLKELIE 390
+I+ ++ G PPF H + R R F P K LI
Sbjct: 251 VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV-------KMLIR 303
Query: 391 ECWNEKPAKRPTFRQI 406
+P +R T +
Sbjct: 304 NLLKTEPTQRMTITEF 319
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 32/271 (11%), Positives = 72/271 (26%), Gaps = 49/271 (18%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----------------------HPNV 212
G V + ++ ++E+ L+ +R P
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 213 VQFLGAVTQSSPMMIVTEYLPK-----------GDLRAFLKRKGALKPSTAVRFALDIAR 261
+ + M +++ + L + +L ++ L + R
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
+ LH ++H L P +I+ D G + + F P+
Sbjct: 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETT 279
Query: 322 APEVFKNEEYDTK-----VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
A + ++ D ++ L + + P D+ R
Sbjct: 280 AERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN---TDDAALGGSEWIFRSCKNI 336
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQII 407
P + ++ L+E R Q +
Sbjct: 337 P-----QPVRALLEGFLRYPKEDRLLPLQAM 362
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 55/191 (28%), Positives = 100/191 (52%), Gaps = 11/191 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A++ + +E+++DD+ + + E + ++ HP +V S + V EY+ GDL
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 141 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K D T T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 198 GMCKEGLRPGDT--T--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253
Query: 355 TMKHDNEVPKA 365
+ ++ P
Sbjct: 254 DIVGSSDNPDQ 264
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 32/277 (11%), Positives = 73/277 (26%), Gaps = 60/277 (21%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-------------------------H 209
G V + ++ ++E+ L+ +R
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 210 PNVVQFLGAVTQSSPMMIVTEY-LPKGD-------LRAFLKRKGALKPSTAVRFALDIAR 261
+++ + Y + + L + +L ++ L + R
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
+ LH ++H L P +I+ D G + + F V++ + S +
Sbjct: 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL----VRDGARVVS-SVSRGFE 269
Query: 322 APEVFKNEE-----------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370
PE+ D ++ L++ + P +
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI---TKDAALGGSEWIF 326
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
R P ++ L+E R Q +
Sbjct: 327 RSCKNIPQ-----PVRALLEGFLRYPKEDRLLPLQAM 358
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 59/190 (31%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MM 226
VA+K + + R E+ALL+++ HPNVV+ + S +
Sbjct: 37 VALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95
Query: 227 IVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+V E++ + DLR +L + L T RG+++LH N I+HRDL+P NI
Sbjct: 96 LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENI 151
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
L G +K+ADFG++++ + LT + Y APEV Y T VD++S I
Sbjct: 152 LVTSGGTVKLADFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 209
Query: 345 QEMIEGCPPF 354
EM P F
Sbjct: 210 AEMFRRKPLF 219
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 11/188 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L HP + Q + V E++ GDL
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ + A +A +I + +LH+ II+RDL+ N+L D G+ K+ADF
Sbjct: 112 MFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K T T C Y+APE+ + Y VD ++ ++L EM+ G PF
Sbjct: 169 GMCKEGICNGVT--T--ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF 224
Query: 355 TMKHDNEV 362
++++++
Sbjct: 225 EAENEDDL 232
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 11/187 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + DRVR + E +L ++ HP +V+ A + ++ ++L GDL
Sbjct: 56 AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L ++ + ++A +++LH II+RDL+P NIL D+ G++K+ DFG
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+SK E + + C Y+APEV + D +SF +++ EM+ G PF
Sbjct: 172 LSKESIDHEKK----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227
Query: 356 MKHDNEV 362
K E
Sbjct: 228 GKDRKET 234
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 21/189 (11%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MMI 227
VA+K++ + + ++ + R E+A+L+ + HPNVV+ T S + +
Sbjct: 40 VALKRVRVQ--TGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 228 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
V E++ + DL +L + + T + RG+++LH ++ ++HRDL+P NIL
Sbjct: 97 VFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 152
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
SG +K+ADFG++++ + LT + Y APEV Y T VD++S I
Sbjct: 153 VTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 346 EMIEGCPPF 354
EM P F
Sbjct: 211 EMFRRKPLF 219
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 97.5 bits (244), Expect = 4e-24
Identities = 21/87 (24%), Positives = 37/87 (42%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ LA + ++ + ++ +N D + T L AA G VV LL+ GAD
Sbjct: 7 VHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLG 66
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + L A +++K+L G
Sbjct: 67 KGRESALSLACSKGYTDIVKMLLDCGV 93
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 94.0 bits (235), Expect = 6e-23
Identities = 29/106 (27%), Positives = 44/106 (41%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ L E L ++ + +K LLD G+DVN D + T L A
Sbjct: 60 ADPQLLGKGRE--SA---LSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNH 114
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ V +LLE GAD + G + A+ V +++E H K
Sbjct: 115 VKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLK 160
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 92.8 bits (232), Expect = 2e-22
Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 5/107 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+E +N D++G P LM+ A + ++ LL +G D +AL +A +
Sbjct: 25 QENVINHTDEEGF--TP---LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSK 79
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+T++V +LL+ G DV+ D G TPL A++ + + +K+L + GA
Sbjct: 80 GYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGA 126
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 75.9 bits (188), Expect = 1e-16
Identities = 17/61 (27%), Positives = 30/61 (49%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
N ++H A QG ++ +E+ ++ D G TPL A + V++ L ++GA
Sbjct: 2 ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGAD 61
Query: 132 P 132
P
Sbjct: 62 P 62
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 67.0 bits (165), Expect = 2e-13
Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 5/79 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D +G P L++ + V+ +K LL+SG D ++ +A G+
Sbjct: 93 VDVNEYDWNGG--TP---LLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLAVALGY 147
Query: 86 TEVVSLLLERGADVDPKDR 104
V ++ + +
Sbjct: 148 RSVQQVIESHLLKLLQNIK 166
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 15/186 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
VA+KKL + RA+R EL L++ + H N++ L T + IV
Sbjct: 50 ERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + +L ++ + L + G+ +LH IIHRDL+PSNI+
Sbjct: 109 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
LK+ DFG+++ T +T + Y APEV Y VD++S I+ EMI
Sbjct: 163 DCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220
Query: 349 EGCPPF 354
+G F
Sbjct: 221 KGGVLF 226
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 96.3 bits (241), Expect = 4e-24
Identities = 29/89 (32%), Positives = 45/89 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + D+ ++ LL +G D N +D T LH A G +VV LLL+ A V+
Sbjct: 14 LHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTG 73
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+PL DA + +++KLL +GA
Sbjct: 74 YQNDSPLHDAAKNGHVDIVKLLLSYGASR 102
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 7e-24
Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 5/105 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ N D G P L N ++ ++ LL VN N + LH AA G
Sbjct: 34 SDPNVKDHAGW--TP---LHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGH 88
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
++V LLL GA + + +G P+ ++ L EK+ +
Sbjct: 89 VDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNES 133
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 85.9 bits (214), Expect = 2e-20
Identities = 25/68 (36%), Positives = 39/68 (57%), Gaps = 1/68 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
GID + T LH+A+ +G V LL+ G+D + KD G TPL +A + + +V+
Sbjct: 1 GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVV 59
Query: 123 KLLEKHGA 130
+LL +H A
Sbjct: 60 ELLLQHKA 67
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 49.7 bits (120), Expect = 1e-07
Identities = 13/73 (17%), Positives = 24/73 (32%), Gaps = 5/73 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N + P L A V+ +K LL G N +I + +
Sbjct: 67 ALVNTTGYQND--SP---LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESM 121
Query: 86 TEVVSLLLERGAD 98
++ L + +
Sbjct: 122 KSLLLLPEKNESS 134
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 38.9 bits (92), Expect = 6e-04
Identities = 9/37 (24%), Positives = 16/37 (43%), Gaps = 1/37 (2%)
Query: 96 GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G D + G T L A + ++ L ++G+ P
Sbjct: 1 GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDP 36
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 44/186 (23%), Positives = 79/186 (42%), Gaps = 15/186 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + FR+E +L + A + + +V +Y GDL
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L + P RF ++ ++ +H+ +HRD++P NIL D +G++++ADF
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-----YDTKVDVFSFALILQEMIE 349
G L + Y++PE+ + E Y + D +S + + EM+
Sbjct: 220 GSCLKLMEDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 350 GCPPFT 355
G PF
Sbjct: 277 GETPFY 282
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 95.5 bits (239), Expect = 6e-24
Identities = 30/89 (33%), Positives = 45/89 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
M+ D++ +K+ + G DVN R LH AA G E++ LL +GAD++ D
Sbjct: 11 FMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPD 70
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ TPL A+Y + +KLL GA
Sbjct: 71 KHHITPLLSAVYEGHVSCVKLLLSKGADK 99
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 77.8 bits (193), Expect = 1e-17
Identities = 28/100 (28%), Positives = 43/100 (43%), Gaps = 5/100 (5%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K ++N + G KP L + A+ +E ++ LL G D+N D + T L A +
Sbjct: 29 KGEDVNRTLEGGR--KP---LHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE 83
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
G V LLL +GAD K G T +++
Sbjct: 84 GHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKALLQ 123
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 72.0 bits (178), Expect = 1e-15
Identities = 14/59 (23%), Positives = 21/59 (35%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
A G + V + +G DV+ G PL A E+++ L GA
Sbjct: 6 MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGA 64
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 15/226 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ I + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L+R+ A +A +IA + YLH I++RDL+P NIL D G++ + DF
Sbjct: 127 FYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K T T C Y+APEV + YD VD + +L EM+ G PPF
Sbjct: 184 GLCKENIEHNST--T--STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
++ E+ Y P + + + L+E + KR
Sbjct: 240 YSRNTAEM---YDNILNKPLQLKPNI-TNSARHLLEGLLQKDRTKR 281
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 51/188 (27%), Positives = 95/188 (50%), Gaps = 11/188 (5%)
Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L ++ + + E +L++++HP +V + A + ++ EYL G+L
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L+R+G TA + +I+ + +LH+ II+RDL+P NI+ + G++K+ DF
Sbjct: 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF 165
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K T C Y+APE+ ++ VD +S ++ +M+ G PPF
Sbjct: 166 GLCKESIHDGTV----THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221
Query: 355 TMKHDNEV 362
T ++ +
Sbjct: 222 TGENRKKT 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 48/190 (25%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MMIVT 229
VA+KK+ E + + A R E+ +LQ ++H NVV + + + +V
Sbjct: 45 VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103
Query: 230 EYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
++ DL L S R + G+ Y+H NK I+HRD++ +N+L
Sbjct: 104 DFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITR 159
Query: 289 SGNLKVADFGVSKLLTV---KEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALIL 344
G LK+ADFG+++ ++ + T + + Y PE+ +Y +D++ I+
Sbjct: 160 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 219
Query: 345 QEMIEGCPPF 354
EM P
Sbjct: 220 AEMWTRSPIM 229
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 1e-23
Identities = 25/89 (28%), Positives = 39/89 (43%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ A ++ L+ G VN D+ + LH A G V +LL+ GA V+
Sbjct: 63 MHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVT 122
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
TPL +A + + + LL +HGA
Sbjct: 123 ADWHTPLFNACVSGSWDCVNLLLQHGASV 151
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 25/105 (23%), Positives = 41/105 (39%), Gaps = 7/105 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ P L + +K+LL+SG DVN + + LH
Sbjct: 181 GNIDHKISHLG--TP---LYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVRTAS 234
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E+ LL++ GAD K+ G P+ ++ LE+ GA
Sbjct: 235 EELACLLMDFGADTQAKNAEGKRPVELVP-PESPLAQLFLEREGA 278
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 5e-20
Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ L+ G +++ + T L++A V LLE GADV+ + + +PL +
Sbjct: 173 VNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVR 231
Query: 116 YKNHEVIKLLEKHGAKP 132
+ E+ LL GA
Sbjct: 232 TASEELACLLMDFGADT 248
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 4e-19
Identities = 28/107 (26%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+N + D P L + +K LL G VN D T L A G
Sbjct: 83 WAVNIITADHV--SP---LHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGS 137
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V+LLL+ GA V P+ ++P+ +A + E + L +G
Sbjct: 138 WDCVNLLLQHGASVQPESD-LASPIHEAARRGHVECVNSLIAYGGNI 183
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 82.5 bits (205), Expect = 8e-18
Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++NG+ D P L + + LL G V + D + +H AA +G
Sbjct: 116 AQVNGVTADWH--TP---LFNACVSGSWDCVNLLLQHGASVQ-PESDLASPIHEAARRGH 169
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E V+ L+ G ++D K TPL A + +K L + GA
Sbjct: 170 VECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADV 216
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 22/84 (26%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
RD GI+ LL + + + + + + +H AA G + L+ +G V+ +
Sbjct: 38 GPRDFPGIR-LLSNPLMGD--AVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVS 94
Query: 109 PLGDAIYYKNHEVIKLLEKHGAKP 132
PL +A + +K+L KHGA+
Sbjct: 95 PLHEACLGGHLSCVKILLKHGAQV 118
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 3e-09
Identities = 12/80 (15%), Positives = 22/80 (27%), Gaps = 12/80 (15%)
Query: 56 IKELLDSGIDVNFRD-----IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
L+ G + D +D G LL D +P+
Sbjct: 11 SSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPGI-----RLLSNPLMGDAVS--DWSPM 63
Query: 111 GDAIYYKNHEVIKLLEKHGA 130
+A + + ++ L G
Sbjct: 64 HEAAIHGHQLSLRNLISQGW 83
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 53.6 bits (130), Expect = 4e-08
Identities = 7/45 (15%), Positives = 17/45 (37%), Gaps = 1/45 (2%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
L+D G D ++ + + + + + + L GA +
Sbjct: 238 ACLLMDFGADTQAKNAEGKRPVELVPPESPLAQL-FLEREGASLP 281
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 25/195 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD--ELALLQKIRHPNVVQFLGAVTQSSP-------M 225
G+ VA+KK+ D R+ + L + HPN+VQ +
Sbjct: 48 GMSVAIKKV------IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101
Query: 226 MIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+V EY+P L R + +R+ A P F + R + LH V + HRD++P
Sbjct: 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKP 159
Query: 282 SNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFS 339
N+L + G LK+ DFG +K L+ P S Y APE+ F N+ Y T VD++S
Sbjct: 160 HNVLVNEADGTLKLCDFGSAKKLS--PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWS 217
Query: 340 FALILQEMIEGCPPF 354
I EM+ G P F
Sbjct: 218 VGCIFAEMMLGEPIF 232
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 33/198 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKG 235
A+K++ IS A R E+ALL++++HPNV+ + + + +Y
Sbjct: 51 YALKQIEGTGISMS----ACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104
Query: 236 DLRAFLK---------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 285
DL +K + L I G++YLH N ++HRDL+P+NIL
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILV 161
Query: 286 ---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-----YVAPEV-FKNEEYDTKVD 336
+ G +K+AD G ++L +PL D Y APE+ Y +D
Sbjct: 162 MGEGPERGRVKIADMGFARLFNS-PLKPLA--DLDPVVVTFWYRAPELLLGARHYTKAID 218
Query: 337 VFSFALILQEMIEGCPPF 354
+++ I E++ P F
Sbjct: 219 IWAIGCIFAELLTSEPIF 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 14/183 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + F +E ++ P VVQ A + +V EY+P GDL
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L + A + ++ ++ +H IHRD++P N+L D SG+LK+ADFG
Sbjct: 157 VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGC 351
+ + DT+ Y++PEV K++ Y + D +S + L EM+ G
Sbjct: 214 TCMKMNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
Query: 352 PPF 354
PF
Sbjct: 271 TPF 273
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 30/193 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T +S + +V
Sbjct: 49 GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
++ DL+ + K + +G+ Y+H ++HRDL+P N+ ++
Sbjct: 108 MPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNE 161
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFA 341
LK+ DFG+++ D +T YV APEV Y+ VD++S
Sbjct: 162 DCELKILDFGLAR----HADAEMT------GYVVTRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 342 LILQEMIEGCPPF 354
I+ EM+ G F
Sbjct: 212 CIMAEMLTGKTLF 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 35/203 (17%)
Query: 174 RGIQVAVKKLGEEVISDDDRV---------RAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
GI VA+K++ V R R E+ LL HPN++
Sbjct: 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFHHPNILGLRDIFVHFEE 103
Query: 225 MM-----IVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+VTE + DL + ++ + P F I G++ LHE ++HRD
Sbjct: 104 PAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEY 331
L P NIL D+ ++ + DF +++ D T YV APE+ + + +
Sbjct: 160 LHPGNILLADNNDITICDFNLAR--EDTADANKT------HYVTHRWYRAPELVMQFKGF 211
Query: 332 DTKVDVFSFALILQEMIEGCPPF 354
VD++S ++ EM F
Sbjct: 212 TKLVDMWSAGCVMAEMFNRKALF 234
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 4e-23
Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 4/105 (3%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N +++G P L + ++ LL G D R + T +AA G
Sbjct: 29 ANVNFQEEEGGWT-P---LHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGS 84
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+++ L L +GADV+ D +G T +A Y + +K L K GA
Sbjct: 85 VKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGA 129
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 8e-22
Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPK 102
L+ DV+ +++LL+ G +VNF++ + T LH A ++V LLL GAD +
Sbjct: 9 LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G+TP A + +++KL GA
Sbjct: 69 KKNGATPFLLAAIAGSVKLLKLFLSKGA 96
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 4e-21
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 10/112 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE----LLDSGIDVNFRDIDNRTALHVAA 81
A++N D+ G L+ D ++ LLD G DVN R +T L +A
Sbjct: 173 ADVNACDNMGR--NA---LIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227
Query: 82 CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +V LLE+ +++ D G T L A+ K ++ +LL K GA
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 2e-18
Identities = 34/116 (29%), Positives = 51/116 (43%), Gaps = 16/116 (13%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ +G P + A V+ +K L G DVN D TA AA G
Sbjct: 63 ADPVLRKKNGA--TP---FLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGK 117
Query: 86 TEVVSLLLERGADVDPKD----------RWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
+ + L +RGA+V+ + + G+T L DA + EV+K LL++ GA
Sbjct: 118 VKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGA 173
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 1e-15
Identities = 37/120 (30%), Positives = 49/120 (40%), Gaps = 20/120 (16%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN----------RT 75
A++N D G M A V+ +K L G +VN R T
Sbjct: 96 ADVNECDFYGF--TA---FMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGAT 150
Query: 76 ALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLLEKHGA 130
AL AA +G EV+ +LL E GADV+ D G L A+ + + LL HGA
Sbjct: 151 ALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGA 210
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 1e-15
Identities = 19/62 (30%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKH 128
+++ L A ++V LLE GA+V+ ++ G TPL +A+ ++++LL +H
Sbjct: 2 AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 6e-13
Identities = 22/79 (27%), Positives = 40/79 (50%), Gaps = 6/79 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A++N + G+ P L+ ++ + ++ LL+ I++N D D +TAL +A
Sbjct: 210 ADVNVRGERGK--TP---LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264
Query: 85 FTEVVSLLLERGADVDPKD 103
++ LL +RGA D D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 92.8 bits (232), Expect = 4e-23
Identities = 38/87 (43%), Positives = 51/87 (58%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E +K+LL G DVN R D T LH+AA G E+V LLL +GADV+ +
Sbjct: 13 LHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARS 72
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G+TP A +HE++KLL+ GA
Sbjct: 73 KDGNTPEHLAKKNGHHEIVKLLDAKGA 99
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 79.0 bits (196), Expect = 4e-18
Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 2/68 (2%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G D T LH AA G E V LL +GADV+ + + G+TPL A + E++
Sbjct: 1 GHMWG--SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIV 58
Query: 123 KLLEKHGA 130
KLL GA
Sbjct: 59 KLLLAKGA 66
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 74.3 bits (184), Expect = 1e-16
Identities = 30/85 (35%), Positives = 38/85 (44%), Gaps = 5/85 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N DG P L A E +K LL G DVN R D T H+A G
Sbjct: 33 ADVNARSKDGN--TP---LHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGH 87
Query: 86 TEVVSLLLERGADVDPKDRWGSTPL 110
E+V LL +GADV+ + S
Sbjct: 88 HEIVKLLDAKGADVNARSWGSSHHH 112
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 4e-23
Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A+ + ++ L+ A + E + LL ++ + D T LH+AA
Sbjct: 15 AKAVLTGEYKKDE-----LLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYN 69
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+V LLL+ GADV KD+ G PL +A Y ++EV +LL KHGA
Sbjct: 70 RVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGA 115
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 35/89 (39%), Positives = 42/89 (47%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V ++ LL G DV+ +D LH A G EV LLL+ GA V+ D
Sbjct: 62 LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMD 121
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
W TPL +A EV LL HGA P
Sbjct: 122 LWQFTPLHEAASKNRVEVCSLLLSHGADP 150
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 25/77 (32%), Positives = 41/77 (53%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G +VN ++ D T LHVAA + +V+ +L + GA ++ D G T L A
Sbjct: 230 AELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAAL 289
Query: 116 YKNHEVIKLLEKHGAKP 132
+ + +LL +G+ P
Sbjct: 290 AGHLQTCRLLLSYGSDP 306
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 9e-21
Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 6/110 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+++ D G P L + E + LL G VN D+ T LH AA +
Sbjct: 82 ADVHAKDKGGL--VP---LHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNR 136
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
EV SLLL GAD + G + + A + E + K + L A
Sbjct: 137 VEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHS-LLQA 185
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 1e-20
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVD 100
L+ A E D+ +K+ L I + + TALH A +V LLL +GA+V+
Sbjct: 182 LLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVN 241
Query: 101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
K++ TPL A +++V+++L KHGAK
Sbjct: 242 EKNKDFMTPLHVAAERAHNDVMEVLHKHGAKM 273
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 8e-19
Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+L D + L AA G ++++LL + D STPL A
Sbjct: 7 ALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAA 66
Query: 115 YYKNHEVIKLLEKHGA 130
Y +++LL +HGA
Sbjct: 67 GYNRVRIVQLLLQHGA 82
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 82.9 bits (206), Expect = 1e-17
Identities = 19/77 (24%), Positives = 29/77 (37%), Gaps = 5/77 (6%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
++ L G +N D +TALH AA G + LLL G+D G T
Sbjct: 263 MEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMG-- 320
Query: 116 YKNHEVIKLLEKHGAKP 132
+E ++ +
Sbjct: 321 ---NEAVQQILSESTPM 334
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 26/131 (19%), Positives = 43/131 (32%), Gaps = 29/131 (22%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA----- 80
A +N +D P L A++ VE LL G D + ++A+ +A
Sbjct: 115 ACVNAMDLWQF--TP---LHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPEL 169
Query: 81 ----------------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA---IYYKNHEV 121
A + V L + + T L A ++ K +V
Sbjct: 170 RERLTYEFKGHSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQV 229
Query: 122 IKLLEKHGAKP 132
+LL + GA
Sbjct: 230 AELLLRKGANV 240
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 61.7 bits (151), Expect = 1e-10
Identities = 17/83 (20%), Positives = 28/83 (33%), Gaps = 10/83 (12%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N LD G+ L A ++ + LL G D + + TA +
Sbjct: 271 AKMNALDSLGQTA-----LHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN---- 321
Query: 86 TEVVSLLLERGADVDPKDRWGST 108
E V +L + D
Sbjct: 322 -EAVQQILSESTPMRTSDVDYRL 343
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 9/60 (15%), Positives = 17/60 (28%), Gaps = 14/60 (23%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGA 130
++AL L + A + L +A N +++ LL
Sbjct: 3 FGKSALD-------------LADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNV 49
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 94.4 bits (236), Expect = 4e-23
Identities = 27/107 (25%), Positives = 46/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ + L + E L + + + LL+ +D+N D + T L A
Sbjct: 60 ADPHILAKERE--SA---LSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNH 114
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V LL RGAD+ + G TP+ A+ +V +++E H K
Sbjct: 115 VKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKL 161
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 4e-22
Identities = 27/87 (31%), Positives = 50/87 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L++ + ++E ++ LL+ G D + + +AL +A+ G+T++V LLLER D++ D
Sbjct: 40 LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A+ + + ++ L GA
Sbjct: 100 WNGGTPLLYAVRGNHVKCVEALLARGA 126
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 1e-21
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+ LA + +++ +KE L G + VN D T L A+ G E V LLE GAD
Sbjct: 6 IHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHIL 65
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ + L A +++ LL +
Sbjct: 66 AKERESALSLASTGGYTDIVGLLLERDVDI 95
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 76.7 bits (190), Expect = 1e-16
Identities = 15/84 (17%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D +G P L++ V+ ++ LL G D+ T + +A G+
Sbjct: 93 VDINIYDWNGG--TP---LLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLAVALGY 147
Query: 86 TEVVSLLLERGADVDPKDRWGSTP 109
+V ++ + + + P
Sbjct: 148 RKVQQVIENHILKLFQSNLVPADP 171
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 5e-14
Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 1/61 (1%)
Query: 73 NRTALHVAACQGFTEVVSLLLERGAD-VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ ++H A QG + + L +G + V+ D G TPL A + E ++ L + GA
Sbjct: 2 DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGAD 61
Query: 132 P 132
P
Sbjct: 62 P 62
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 6e-23
Identities = 53/192 (27%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
VA+KKL + RA+R EL L++ + H N++ L T + +V
Sbjct: 87 DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + +L ++ + L + G+ +LH IIHRDL+PSNI+
Sbjct: 146 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 199
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEVFKNEEYDTKVDVFSFAL 342
LK+ DFG+++ T +T YV APEV Y VD++S
Sbjct: 200 DCTLKILDFGLAR--TAGTSFMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
Query: 343 ILQEMIEGCPPF 354
I+ EM+ F
Sbjct: 252 IMGEMVRHKILF 263
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 6e-23
Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
G + G P L + + +K LL G N ++ T LH+AA G
Sbjct: 5 ISGGGGGESGL--TP---LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGH 59
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
TEV LL+ A V+ K + TPL A + ++KLL ++ A P
Sbjct: 60 TEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANP 106
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 2e-22
Identities = 32/107 (29%), Positives = 45/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
N G P L A E E + LL + N + T LH+ A +G
Sbjct: 236 GSANAESVQGV--TP---LHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGH 290
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V +L++ G VD R G TPL A +Y N +++K L +H A
Sbjct: 291 VPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADV 337
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 2e-22
Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K+A N + G P L +A E V L+ G+ V+ T LHVA+
Sbjct: 267 KQANGNLGNKSGL--TP---LHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHY 321
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G ++V LL+ ADV+ K + G +PL A + +++ LL K+GA P
Sbjct: 322 GNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASP 370
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 2e-22
Identities = 36/107 (33%), Positives = 46/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N G P L A E VE + LL+ T LHVAA G
Sbjct: 104 ANPNLATTAGH--TP---LHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGK 158
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V LLLER A + + G TPL A+++ N +++KLL G P
Sbjct: 159 VRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSP 205
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 29/109 (26%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
++A N +G P L + +++ +K LL G + + T LH+AA Q
Sbjct: 168 RDAHPNAAGKNGL--TP---LHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQ 222
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
EV LL+ G + + G TPL A + E++ LL A
Sbjct: 223 NQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANG 271
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 6e-22
Identities = 33/110 (30%), Positives = 48/110 (43%), Gaps = 5/110 (4%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
+ +A++N D + P L A +K LL++ + N T LH+AA
Sbjct: 68 QNKAKVNAKAKDDQT--P---LHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAR 122
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+G E V LLE+ A + G TPL A Y V +LL + A P
Sbjct: 123 EGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHP 172
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 6e-22
Identities = 31/109 (28%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
KEA + G P L A V + LL+ N + T LHVA
Sbjct: 135 KEASQACMTKKGF--TP---LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHH 189
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
++V LLL RG G TPL A EV + L ++G
Sbjct: 190 NNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSA 238
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.0 bits (240), Expect = 1e-21
Identities = 34/109 (31%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ A N + E P L A E K LL + VN + D++T LH AA
Sbjct: 36 RGASPNVSNVKVE--TP---LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARI 90
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G T +V LLLE A+ + G TPL A + E + L + A
Sbjct: 91 GHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQ 139
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 1e-21
Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ G P L ++ +++ +K LL DVN + + LH AA QG
Sbjct: 302 VMVDATTRMGY--TP---LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGH 356
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
T++V+LLL+ GA + G+TPL A V +L+ +
Sbjct: 357 TDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDE 402
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 6e-21
Identities = 31/107 (28%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ +G P L A + VE + LL G N + T LH+AA +G
Sbjct: 203 GSPHSPAWNGY--TP---LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGH 257
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E+V+LLL + A+ + ++ G TPL + V +L KHG
Sbjct: 258 AEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMV 304
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 24/70 (34%), Positives = 32/70 (45%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
GI T LHVA+ G +V LL+RGA + + TPL A + EV
Sbjct: 4 GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVA 63
Query: 123 KLLEKHGAKP 132
K L ++ AK
Sbjct: 64 KYLLQNKAKV 73
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 11/38 (28%), Positives = 16/38 (42%)
Query: 95 RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G G TPL A + + ++K L + GA P
Sbjct: 3 PGISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASP 40
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 7e-23
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 17/141 (12%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ DDG + + D E + LL+ G D+N+ ++D TALH A
Sbjct: 32 KKTKVKFDDGAV------FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDN 85
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLMA 135
++V L+E GA+++ D G PL A ++ + L GA PL
Sbjct: 86 VDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDI 145
Query: 136 PMHVKHAREVPEYEIDPHELD 156
E+ + E++ +D
Sbjct: 146 AEEEAM-EELLQNEVNRQGVD 165
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 8e-21
Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 1/78 (1%)
Query: 56 IKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
++ L+S I+ TALHVAA +G+TEV+ LL++ DV+ KD G TPL A
Sbjct: 181 ARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAA 240
Query: 115 YYKNHEVIKLLEKHGAKP 132
++ E ++L ++
Sbjct: 241 HWGKEEACRILVENLCDM 258
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 4e-20
Identities = 22/76 (28%), Positives = 35/76 (46%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K L+ + DVN +D D T LH AA G E +L+E D++ ++ G T A
Sbjct: 215 LKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADE 274
Query: 116 YKNHEVIKLLEKHGAK 131
+ +L +K
Sbjct: 275 DILGYLEELQKKQNLL 290
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 2e-16
Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 1/77 (1%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
++ + + D+ A G TE V LLERGAD++ + G T L A
Sbjct: 22 TDLEPPVVKRKKTKVKF-DDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQA 80
Query: 114 IYYKNHEVIKLLEKHGA 130
N +++K L ++GA
Sbjct: 81 CIDDNVDMVKFLVENGA 97
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 4e-13
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 11/105 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + ++ +G+ P L E E ++ ++ +D A
Sbjct: 130 AHVGAVNSEGD--TP---LDIAEEEAMEELLQNEVNRQ------GVDIEAARKEEERIML 178
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ L + + G T L A EV+KLL +
Sbjct: 179 RDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARY 223
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 6e-12
Identities = 10/67 (14%), Positives = 20/67 (29%), Gaps = 1/67 (1%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ D + + G + + + K G+ L A + E + L
Sbjct: 1 MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFL-AACSSGDTEEVLRL 59
Query: 126 EKHGAKP 132
+ GA
Sbjct: 60 LERGADI 66
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 51.7 bits (125), Expect = 2e-07
Identities = 16/78 (20%), Positives = 29/78 (37%), Gaps = 5/78 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D DG P L A+ E + L+++ D+ + +TA VA
Sbjct: 223 YDVNIKDYDGWT--P---LHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDIL 277
Query: 86 TEVVSLLLERGADVDPKD 103
+ L ++ K
Sbjct: 278 GYLEELQKKQNLLHSEKR 295
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 95.2 bits (238), Expect = 8e-23
Identities = 28/113 (24%), Positives = 54/113 (47%), Gaps = 6/113 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +DD G+ L + A +V+ LL +G + + ++ T L +AA +G
Sbjct: 116 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 170
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
E +LL+ A+ D D P A +H++++LL+++ +H
Sbjct: 171 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRS-PQLH 222
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 91.3 bits (228), Expect = 2e-21
Identities = 27/87 (31%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A +++L++S DVN D ++ALH AA + +LL+ GA+ D ++
Sbjct: 96 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 155
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A ++E K+L H A
Sbjct: 156 NREETPLFLAAREGSYETAKVLLDHFA 182
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 86.3 bits (215), Expect = 1e-19
Identities = 25/90 (27%), Positives = 37/90 (41%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
L A + K LL++ D N +D RT LH A V +L+ A D+D +
Sbjct: 29 LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 88
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G+TPL A +++ L A
Sbjct: 89 MHDGTTPLILAARLAVEGMLEDLINSHADV 118
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 85.5 bits (213), Expect = 2e-19
Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
I + + G + N D TALH+AA ++ LLE AD + +D G TPL A+
Sbjct: 7 ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66
Query: 115 YYKNHEVIKLLEKHGAK 131
V ++L ++ A
Sbjct: 67 SADAQGVFQILIRNRAT 83
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 83.6 bits (208), Expect = 1e-18
Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A+ N D+ G P L + + L+ + D++ R D T L +AA
Sbjct: 49 ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 103
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
++ L+ ADV+ D G + L A N + +L K+GA
Sbjct: 104 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 149
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 50.9 bits (123), Expect = 2e-07
Identities = 14/48 (29%), Positives = 21/48 (43%), Gaps = 1/48 (2%)
Query: 84 GFTEVVSLLLERGADV-DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
V+S + +GA + + DR G T L A Y + K L + A
Sbjct: 2 DAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASA 49
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 2/108 (1%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
RK P L+ A ++E +++ + D + + + TALH A C
Sbjct: 6 RKAGSPRKARRARLN--PLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAIC 63
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+V L+ GA+V+ D G TPL A + + L +HGA
Sbjct: 64 GANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGA 111
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-18
Identities = 20/109 (18%), Positives = 37/109 (33%), Gaps = 8/109 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + +++G L + + L+ +G +VN D T LH AA
Sbjct: 45 NDPSQPNEEGI--TA---LHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCND 99
Query: 86 TEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKN--HEVIKLLEKHGAK 131
T + L++ GA + G+T Y+ + L
Sbjct: 100 TVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQS 148
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 10/67 (14%), Positives = 18/67 (26%), Gaps = 1/67 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
L D + + AL + F + +S V +D T A
Sbjct: 139 ATYLADVEQSMGLMNSGAVYALWDYS-AEFGDELSFREGESVTVLRRDGPEETDWWWAAL 197
Query: 116 YKNHEVI 122
+ +
Sbjct: 198 HGQEGYV 204
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 11/88 (12%), Positives = 21/88 (23%), Gaps = 7/88 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
E + ++ ++ + + + + V RD T AA
Sbjct: 145 VEQSMGLMNSGAVY------ALWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALH 198
Query: 84 GFTEVV-SLLLERGADVDPKDRWGSTPL 110
G V V P+
Sbjct: 199 GQEGYVPRNYFGLFPRVKPQRSKVKHHH 226
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 9/47 (19%), Positives = 14/47 (29%), Gaps = 3/47 (6%)
Query: 89 VSLLLERGADVDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +L + R L DA EV++ K P
Sbjct: 1 MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDP 47
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 1e-22
Identities = 27/105 (25%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +DD G+ L + A +V+ LL +G + + ++ T L +AA +G
Sbjct: 148 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 202
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E +LL+ A+ D D P A +H++++LL+
Sbjct: 203 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDLEHH 247
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-21
Identities = 27/87 (31%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A +++L++S DVN D ++ALH AA + +LL+ GA+ D ++
Sbjct: 128 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 187
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A ++E K+L H A
Sbjct: 188 NREETPLFLAAREGSYETAKVLLDHFA 214
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 87.1 bits (217), Expect = 1e-19
Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A+ N D+ G P L + + L+ + D++ R D T L +AA
Sbjct: 81 ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 135
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
++ L+ ADV+ D G + L A N + +L K+GA
Sbjct: 136 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 181
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-19
Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
L A + K LL++ D N +D RT LH A V +L+ A D+D +
Sbjct: 61 LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 120
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+TPL A +++ L A
Sbjct: 121 MHDGTTPLILAARLAVEGMLEDLINSHA 148
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 82.9 bits (206), Expect = 3e-18
Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
I + + G + N D TALH+AA ++ LLE AD + +D G TPL A+
Sbjct: 39 ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 98
Query: 115 YYKNHEVIKLLEKHGAK 131
V ++L ++ A
Sbjct: 99 SADAQGVFQILIRNRAT 115
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 72.5 bits (179), Expect = 1e-14
Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 14/83 (16%)
Query: 64 IDVNFRDIDNRTALHVAACQGFT-------------EVVSLLLERGADV-DPKDRWGSTP 109
+DVN R D T L +A+C G V+S + +GA + + DR G T
Sbjct: 1 MDVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETA 60
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A Y + K L + A
Sbjct: 61 LHLAARYSRSDAAKRLLEASADA 83
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 56.3 bits (137), Expect = 4e-09
Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 5/77 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + ++ E P L A E E K LLD + + D +R +A +
Sbjct: 181 ANKDMQNNREE--TP---LFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMH 235
Query: 86 TEVVSLLLERGADVDPK 102
++V LL
Sbjct: 236 HDIVRLLDLEHHHHHHH 252
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 90.5 bits (226), Expect = 1e-22
Identities = 40/74 (54%), Positives = 50/74 (67%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 19 KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78
Query: 117 KNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 79 GHLEVVKLLLEAGA 92
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 75.1 bits (186), Expect = 4e-17
Identities = 32/59 (54%), Positives = 39/59 (66%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ RT LH+AA G EVV LLLE GADV+ KD+ G TPL A + EV+KLL + GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 53.5 bits (130), Expect = 2e-09
Identities = 32/74 (43%), Positives = 42/74 (56%), Gaps = 5/74 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
A++N D +G P L A +E +K LL++G DVN +D + RT LH+AA
Sbjct: 24 AGADVNAKDKNGR--TP---LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78
Query: 84 GFTEVVSLLLERGA 97
G EVV LLLE GA
Sbjct: 79 GHLEVVKLLLEAGA 92
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 92.9 bits (232), Expect = 2e-22
Identities = 20/85 (23%), Positives = 33/85 (38%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+++LL D+N + LH A G +V L+ GA V +++G P+ A
Sbjct: 88 VQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKA 147
Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVK 140
+ + EK G P
Sbjct: 148 PLRELLRERAEKMGQNLNRIPYKDT 172
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 2e-21
Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 5/111 (4%)
Query: 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
+ E +LN DD G P L + E ++ L+ G +N + + T LH+AA
Sbjct: 26 DNTENDLNQGDDHGF--SP---LHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAA 80
Query: 82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G ++V LL+ AD++ + G+ PL A ++ +V + L +GA
Sbjct: 81 SHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALV 131
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 68.6 bits (169), Expect = 8e-14
Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 1/62 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ + +G V L L+ D++ D G +PL A V+++L
Sbjct: 2 SPEFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMR 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-22
Identities = 19/120 (15%), Positives = 36/120 (30%), Gaps = 18/120 (15%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANE------RDVEGIKELLDSGIDVNFRDIDNRTALHV 79
A++ +G L E K L+ G D+ + +
Sbjct: 66 ADIKSRTKEGT--TL---FFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFK 120
Query: 80 AACQGFTEVVS-------LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
F + + + G + KD+WG T L + +K++E + K
Sbjct: 121 NIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKY 180
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-16
Identities = 16/96 (16%), Positives = 34/96 (35%), Gaps = 9/96 (9%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN---RTALHVAACQGFTEVVSLLLERGADVD 100
+ A E EL + G + + + L + ++ L+ +GAD+
Sbjct: 10 VSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIK 69
Query: 101 PKDRWGSTPLGDAIYYKNH------EVIKLLEKHGA 130
+ + G+T + E+ K+ + GA
Sbjct: 70 SRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGA 105
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-12
Identities = 10/85 (11%), Positives = 25/85 (29%), Gaps = 12/85 (14%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE-------LLDSGIDVNFRDIDNRTALH 78
A++ L + + V+ + SG+ + +D TAL
Sbjct: 105 ADITALYKPYK--IV---VFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALE 159
Query: 79 VAACQGFTEVVSLLLERGADVDPKD 103
+ ++ + + K+
Sbjct: 160 FVKRCQKPIALKMMEDYIKKYNLKE 184
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 12/63 (19%), Positives = 20/63 (31%), Gaps = 3/63 (4%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
+ + AA G E L E+G + K L + +++ L
Sbjct: 4 MSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLIN 63
Query: 128 HGA 130
GA
Sbjct: 64 KGA 66
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 2e-22
Identities = 32/87 (36%), Positives = 48/87 (55%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + LL +G+ + R +RT LH+AA +G +V +LL+ GADV+ KD
Sbjct: 38 LHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKD 97
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
T L A + + EV++LL K+GA
Sbjct: 98 MLKMTALHWATEHNHQEVVELLIKYGA 124
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 87.1 bits (217), Expect = 1e-20
Identities = 28/83 (33%), Positives = 44/83 (53%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A+E ++ LL G DVN +D+ TALH A EVV LL++ GADV +
Sbjct: 71 LHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQS 130
Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
++ T +I N ++ ++L+
Sbjct: 131 KFCKTAFDISIDNGNEDLAEILQ 153
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 2e-20
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 1/87 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G D + LH+AA G +LL G D +
Sbjct: 6 LLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDART 64
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ TPL A + ++++L KHGA
Sbjct: 65 KVDRTPLHMAASEGHANIVEVLLKHGA 91
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 70.5 bits (174), Expect = 8e-15
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 1/59 (1%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D L AA G + V +L+ GA D G++PL A Y + ++L + G
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGV 58
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 29/193 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S+ RA+R EL LL+ +RH NV+ L T + +V
Sbjct: 50 GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
++ DL +K + L + +G+ Y+H IIHRDL+P N+ ++
Sbjct: 109 MPFMGT-DLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNE 163
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFA 341
LK+ DFG+++ + D +T YV APEV Y VD++S
Sbjct: 164 DCELKILDFGLAR----QADSEMT------GYVVTRWYRAPEVILNWMRYTQTVDIWSVG 213
Query: 342 LILQEMIEGCPPF 354
I+ EMI G F
Sbjct: 214 CIMAEMITGKTLF 226
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-22
Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)
Query: 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
+ +DG+ L + + LL ++ ++ +TALH+AA G
Sbjct: 2 FGYVTEDGD--TA---LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V L GA V +R G T L A + H +L +
Sbjct: 57 EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 5e-22
Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQG 84
+L + DG P L +D E ++ L D+G D+N + RT LH+A
Sbjct: 149 LQLEAENYDGH--TP---LHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQ 203
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V+ LLL+ GAD + G TPLG A+ N + +LL HGA
Sbjct: 204 AASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPE 251
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 30/115 (26%), Positives = 47/115 (40%), Gaps = 1/115 (0%)
Query: 19 PDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALH 78
R+ + L D + + + E D + + + D T LH
Sbjct: 104 HPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLH 163
Query: 79 VAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
VA E+V LL + GAD++ + G TPL A+ + V++LL K GA P
Sbjct: 164 VAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADP 218
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 2e-18
Identities = 14/74 (18%), Positives = 26/74 (35%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
++ LL +G D R RT L A + + LL GA +P +
Sbjct: 208 LELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSGS 267
Query: 116 YKNHEVIKLLEKHG 129
+ + +++
Sbjct: 268 DSDSDNRDEGDEYD 281
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 14/101 (13%), Positives = 24/101 (23%), Gaps = 14/101 (13%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + +++L +G V + TALH+A +LL+
Sbjct: 49 LHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDA 108
Query: 104 RWGSTPLGDAIYYKN--------------HEVIKLLEKHGA 130
+E E
Sbjct: 109 SDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRL 149
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 3e-22
Identities = 21/76 (27%), Positives = 34/76 (44%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ LL G + N D T +H AA +GF + + +L GA +D D WG P+ A
Sbjct: 60 AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAE 119
Query: 115 YYKNHEVIKLLEKHGA 130
+ ++ + L
Sbjct: 120 EQGHRDIARYLHAATG 135
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 1e-21
Identities = 27/106 (25%), Positives = 45/106 (42%), Gaps = 7/106 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ L + L A VE +++LL++G D N + R + V G
Sbjct: 3 PGIHMLGGSSD--AG---LATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM-MGS 56
Query: 86 TEVVSLLLERGADVDPKDRWGST-PLGDAIYYKNHEVIKLLEKHGA 130
+V LLL GA+ + D T P+ DA + + +L + GA
Sbjct: 57 AQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGA 102
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 2e-20
Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EV 121
++ + L AA +G E V LLE GAD + +R+G P+ + +V
Sbjct: 2 SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM--GSAQV 59
Query: 122 IKLLEKHGAKP 132
+LL HGA+P
Sbjct: 60 AELLLLHGAEP 70
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 60.5 bits (148), Expect = 2e-11
Identities = 16/73 (21%), Positives = 28/73 (38%), Gaps = 4/73 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
AE N D +P + A E ++ + L +G ++ D R + +A QG
Sbjct: 68 AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGH 123
Query: 86 TEVVSLLLERGAD 98
++ L D
Sbjct: 124 RDIARYLHAATGD 136
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 94.0 bits (235), Expect = 3e-22
Identities = 30/88 (34%), Positives = 43/88 (48%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V+ L+ +G +++ D RT L AA E V L++ GA VDPKD
Sbjct: 15 LHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKD 74
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
GST L A ++EV++ L +G
Sbjct: 75 AEGSTCLHLAAKKGHYEVVQYLLSNGQM 102
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 1e-20
Identities = 21/75 (28%), Positives = 34/75 (45%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL + D++ +I + LH+AA + + V L L R +DV K++ G TPL A
Sbjct: 160 AEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASL 219
Query: 116 YKNHEVIKLLEKHGA 130
+ K
Sbjct: 220 NSQVWSALQMSKALQ 234
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 1e-20
Identities = 21/75 (28%), Positives = 34/75 (45%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K LL G D+N RD + LH AA G ++ +LL D+ + G +PL A
Sbjct: 127 VKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAAR 186
Query: 116 YKNHEVIKLLEKHGA 130
++ + L +
Sbjct: 187 ENRYDCVVLFLSRDS 201
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 88.6 bits (221), Expect = 2e-20
Identities = 20/67 (29%), Positives = 34/67 (50%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
++ + R+ LH AA G ++ +L++ GA++D TPL +A + E +K
Sbjct: 2 MNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVK 61
Query: 124 LLEKHGA 130
L K GA
Sbjct: 62 YLIKAGA 68
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 88.2 bits (220), Expect = 3e-20
Identities = 25/108 (23%), Positives = 48/108 (44%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A ++ D +G L A + E ++ LL +G +DVN +D T + A
Sbjct: 68 ALVDPKDAEGS--TC---LHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYK 122
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
++V LLL +G+D++ +D + L A + ++ ++L
Sbjct: 123 HVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDL 170
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 54.3 bits (132), Expect = 1e-08
Identities = 13/75 (17%), Positives = 27/75 (36%), Gaps = 5/75 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ +L+ ++ G+ P L A E + + L DV ++ + T L A+
Sbjct: 166 AKCDLHAVNIHGD--SP---LHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLN 220
Query: 84 GFTEVVSLLLERGAD 98
+ + D
Sbjct: 221 SQVWSALQMSKALQD 235
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 3e-22
Identities = 26/77 (33%), Positives = 39/77 (50%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
E + LL G + + +D +H AA GF + + LLE ADV+ +D G+ PL A
Sbjct: 51 EIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLA 110
Query: 114 IYYKNHEVIKLLEKHGA 130
+ V++ L KH A
Sbjct: 111 AKEGHLRVVEFLVKHTA 127
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 87.4 bits (218), Expect = 1e-20
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 1/87 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A D+E + LL + ++VN ++ RTAL V G E+ LL RGA+ D KD
Sbjct: 9 LASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKD 67
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
R G + DA + ++ L + A
Sbjct: 68 RTGFAVIHDAARAGFLDTLQTLLEFQA 94
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 87.4 bits (218), Expect = 1e-20
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + D G + A ++ ++ LL+ DVN D + LH+AA +G
Sbjct: 61 ANPDLKDRTGF--AV---IHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGH 115
Query: 86 TEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
VV L++ A +V ++ G T A Y +EV+ L++ +GA
Sbjct: 116 LRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGA 161
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 70.9 bits (175), Expect = 8e-15
Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 1/61 (1%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
L AA +G E ++ LL+ +V+ ++ +G T L N E+ + L GA
Sbjct: 4 PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGAN 62
Query: 132 P 132
P
Sbjct: 63 P 63
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQG 84
+++ +D++G L+F+A + ++ L ++G D++ RD+ TALH+AA
Sbjct: 68 RDVDAVDENGR--TA---LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYV 122
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EVV L+E GAD++ +D G T L A + G +
Sbjct: 123 RPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 169
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-21
Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
A + D + + +LL DV+ D + RTAL A G + V LL E GAD+D +D
Sbjct: 49 WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 107
Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
R G T L A Y EV++ L + GA
Sbjct: 108 MRGGLTALHMAAGYVRPEVVEALVELGADI 137
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 18/87 (20%), Positives = 35/87 (40%), Gaps = 3/87 (3%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E ++ L++ G D+ D TAL +A T ++ G + +
Sbjct: 115 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 174
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + ++ EV +++EK G
Sbjct: 175 ---VINVLEGQVFEYAEVDEIVEKRGK 198
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 9/69 (13%), Positives = 17/69 (24%), Gaps = 4/69 (5%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
I + + + G + ADV + TP A + + +
Sbjct: 6 IIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQALS 62
Query: 124 LLEKHGAKP 132
L
Sbjct: 63 QL-LEDRDV 70
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 12/106 (11%), Positives = 27/106 (25%), Gaps = 16/106 (15%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++ D+ G L + G + + + +
Sbjct: 135 ADIEVEDERGL--TA---LELAREILKTTPKGNPMQFGRRIGLEKV---INVLEGQVFEY 186
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EV ++ +RG G + + + H A+
Sbjct: 187 AEVDEIVEKRGK--------GKDVEYLVRWKDGGDCEWVKGVHVAE 224
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 4/48 (8%), Positives = 14/48 (29%), Gaps = 2/48 (4%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
++ + + ++ + + + A+ KD L
Sbjct: 189 VDEIVEKRGKGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD--YEDGL 234
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 91.3 bits (228), Expect = 4e-22
Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L A DV+ ++ LL + + + +TAL V G T + LL++GA + +
Sbjct: 6 LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQ 64
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D G++P+ DA + +K+L +HGA
Sbjct: 65 DTSGTSPVHDAARTGFLDTLKVLVEHGA 92
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 1e-21
Identities = 23/73 (31%), Positives = 36/73 (49%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
ELL G N +D + +H AA GF + + +L+E GADV+ D G+ P+ A+
Sbjct: 51 ALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQ 110
Query: 116 YKNHEVIKLLEKH 128
+ V+ L
Sbjct: 111 EGHTAVVSFLAAE 123
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 85.5 bits (213), Expect = 5e-20
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N D G P + A ++ +K L++ G DVN D +H+A +G
Sbjct: 59 ASPNVQDTSGT--SP---VHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGH 113
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
T VVS L +D+ +D G TPL A+ +++ +L+ H
Sbjct: 114 TAVVSFLAA-ESDLHRRDARGLTPLELALQRGAQDLVDILQGH 155
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 63.6 bits (156), Expect = 2e-12
Identities = 17/60 (28%), Positives = 24/60 (40%), Gaps = 4/60 (6%)
Query: 75 TALHVAACQGFTEVV-SLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGAKP 132
L AA +G + V LL D +R+G T L ++ + L K GA P
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMF--GSTAIALELLKQGASP 61
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 4e-22
Identities = 35/89 (39%), Positives = 46/89 (51%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L F A V ++ LL G DV+ +D LH A G EV LL++ GA V+ D
Sbjct: 46 LHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVAD 105
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
W TPL +A +E+ KLL +HGA P
Sbjct: 106 LWKFTPLHEAAAKGKYEICKLLLQHGADP 134
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 85.5 bits (213), Expect = 7e-20
Identities = 28/72 (38%), Positives = 39/72 (54%), Gaps = 1/72 (1%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
L+ G VN D+ T LH AA +G E+ LLL+ GAD K+R G+TPL D + +
Sbjct: 94 LVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPL-DLVKDGD 152
Query: 119 HEVIKLLEKHGA 130
++ LL A
Sbjct: 153 TDIQDLLRGDAA 164
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 84.7 bits (211), Expect = 1e-19
Identities = 35/88 (39%), Positives = 47/88 (53%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ A DVE +K+L ++ + T LH AA VV LL+ GADV K
Sbjct: 12 LLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAK 71
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D+ G PL +A Y ++EV +LL KHGA
Sbjct: 72 DKGGLVPLHNACSYGHYEVAELLVKHGA 99
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 4e-14
Identities = 20/69 (28%), Positives = 26/69 (37%), Gaps = 4/69 (5%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEV 121
G N + L AA G E V L + + STPL A Y V
Sbjct: 1 GAMGN---SEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSV 57
Query: 122 IKLLEKHGA 130
++ L +HGA
Sbjct: 58 VEYLLQHGA 66
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 47.0 bits (113), Expect = 2e-06
Identities = 20/72 (27%), Positives = 27/72 (37%), Gaps = 6/72 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N D P L A + E K LL G D ++ D T L + G
Sbjct: 99 AVVNVADLWKF--TP---LHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVK-DGD 152
Query: 86 TEVVSLLLERGA 97
T++ LL A
Sbjct: 153 TDIQDLLRGDAA 164
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 92.5 bits (231), Expect = 5e-22
Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ AN+RD + +KE+L V+ D + T L++A E+ L++RGAD++ +
Sbjct: 9 LLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQ 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ +P A E++ + KH
Sbjct: 69 NSISDSPYLYAGAQGRTEILAYMLKHAT 96
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 81.7 bits (203), Expect = 3e-18
Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 44 LMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAAC-----QGFTEVVSLLLERGA 97
L+ A + ++ +K LL+ G D++F++ TAL A Q + ++V LL+E GA
Sbjct: 110 LIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGA 169
Query: 98 DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
D KD G T + A E+ K+L ++
Sbjct: 170 DQSIKDNSGRTAMDYANQKGYTEISKILAQY 200
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 4e-17
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 7/82 (8%)
Query: 56 IKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPLGDA 113
+ +L D+N + AL AA +G + V LLLE G D+D ++ +G T L +A
Sbjct: 88 LAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEA 147
Query: 114 IYY----KNH-EVIKLLEKHGA 130
+ + + +++KLL ++GA
Sbjct: 148 VGLREGNQLYQDIVKLLMENGA 169
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 76.7 bits (190), Expect = 2e-16
Identities = 17/62 (27%), Positives = 28/62 (45%)
Query: 69 RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ + L A + +V +L + VD D G+TPL A++ + E+ K L
Sbjct: 2 KTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 5e-22
Identities = 33/87 (37%), Positives = 51/87 (58%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DVN D T LH+AA G E+V +LL+ GADV+ D
Sbjct: 18 LLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVD 77
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A + + E++++L K+GA
Sbjct: 78 HAGMTPLRLAALFGHLEIVEVLLKNGA 104
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 90.9 bits (227), Expect = 9e-22
Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N D G P L A +E ++ LL +G DVN D T L +AA G
Sbjct: 38 ADVNAEDASGW--TP---LHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGH 92
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E+V +LL+ GADV+ D G TPL A + + E++++L K+GA
Sbjct: 93 LEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGA 137
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 89.3 bits (223), Expect = 3e-21
Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 5/103 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +D G P L A +E ++ LL +G DVN D++ T LH+AA G
Sbjct: 71 ADVNAVDHAGM--TP---LRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGH 125
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
E+V +LL+ GADV+ +D++G T +I N ++ ++L+K
Sbjct: 126 LEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKL 168
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 74.7 bits (185), Expect = 5e-16
Identities = 22/61 (36%), Positives = 34/61 (55%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
D L AA G + V +L+ GADV+ +D G TPL A + + E++++L K+G
Sbjct: 11 GSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNG 70
Query: 130 A 130
A
Sbjct: 71 A 71
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 69/246 (28%), Positives = 107/246 (43%), Gaps = 41/246 (16%)
Query: 134 MAPMHVKHAREVPEY---EIDPHELDFTNSVEITK-------GTFILAFWR--GIQVAVK 181
MA H H++E P + E++ + + G+ AF G++VAVK
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 182 KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPKG 235
KL S R +R EL LL+ ++H NV+ L T + + +VT +
Sbjct: 61 KLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA- 118
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
DL +K + L I RG+ Y+H IIHRDL+PSN+ ++ LK+
Sbjct: 119 DLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 174
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFALILQEMI 348
DFG++ R + T YV APE+ Y+ VD++S I+ E++
Sbjct: 175 DFGLA--------RHTADEMTG--YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 349 EGCPPF 354
G F
Sbjct: 225 TGRTLF 230
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 6e-22
Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
A + D + + +LL DV+ D + RTAL A G + V LL E GAD+D +D
Sbjct: 48 WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 106
Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
R G T L A Y EV++ L + GA
Sbjct: 107 MRGGLTALHMAAGYVRPEVVEALVELGADI 136
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 2e-21
Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 26 AELNGLDDDGEEIKPEFR--LMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAAC 82
+++ +D++G R L+F+A + ++ L ++G D++ RD+ TALH+AA
Sbjct: 67 RDVDAVDENG-------RTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 119
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EVV L+E GAD++ +D G T L A + G +
Sbjct: 120 YVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 168
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 8e-12
Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 17/85 (20%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E ++ L++ G D+ D TAL +A T ++ G + +
Sbjct: 114 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 173
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKH 128
VI +LE
Sbjct: 174 -----------------VINVLEGQ 181
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 7e-11
Identities = 9/69 (13%), Positives = 18/69 (26%), Gaps = 4/69 (5%)
Query: 62 SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+ I + + + G + ADV + TP A + +
Sbjct: 3 NKIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQA 59
Query: 122 IKLLEKHGA 130
+ L
Sbjct: 60 LSQL-LEDR 67
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 8e-22
Identities = 32/87 (36%), Positives = 50/87 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DVN +D T L++A G E+V +LL+ GADV+ D
Sbjct: 18 LLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVD 77
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A + + E+ ++L KHGA
Sbjct: 78 AIGFTPLHLAAFIGHLEIAEVLLKHGA 104
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 85.5 bits (213), Expect = 3e-20
Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 5/103 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N D+ G P L +E ++ LL +G DVN D T LH+AA G
Sbjct: 38 ADVNAKDEYGL--TP---LYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGH 92
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
E+ +LL+ GADV+ +D++G T +I N ++ ++L+K
Sbjct: 93 LEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQKL 135
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 72.0 bits (178), Expect = 2e-15
Identities = 23/59 (38%), Positives = 35/59 (59%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D L AA G + V +L+ GADV+ KD +G TPL A + + E++++L K+GA
Sbjct: 13 DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGA 71
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 8e-22
Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 32/216 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
VA+KK+ D R R E+ +L +++ +++ + + IV
Sbjct: 51 EKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
E DL+ K L ++ G N++HE+ IIHRDL+P+N L +
Sbjct: 110 EIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQD 165
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR---------------YV------APEV-FK 327
++KV DFG+++ + ++D + +V APE+
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
E Y +D++S I E++ N P
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 92.9 bits (232), Expect = 9e-22
Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
++ E +EL+++G DV D +N T LH AA ++V + +GA VD
Sbjct: 13 IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 72
Query: 104 R-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
STPL A + ++ L K+GA P
Sbjct: 73 GDLNSTPLHWATRQGHLSMVVQLMKYGADP 102
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 8e-21
Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 49 NERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
+ D + LL + VN D TALH A G T V+SLLLE GA+VD ++ G
Sbjct: 154 HSVDP--TRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGE 211
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAK 131
+ L A KN +I L++
Sbjct: 212 SALDLAKQRKNVWMINHLQEARQA 235
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 1e-19
Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ +L+ G D + D + + +H+AA G T +V+ L+ +G DVD D+ G TPL A Y
Sbjct: 92 VVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAY 151
Query: 116 YKNH-EVIKLLEKHGA 130
+ + +LL
Sbjct: 152 RTHSVDPTRLLLTFNV 167
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 1e-19
Identities = 28/134 (20%), Positives = 49/134 (36%), Gaps = 16/134 (11%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQG 84
++ D + L + A ++ +K + G V+ D N T LH A QG
Sbjct: 33 YDVRQPDKENV--TL---LHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQG 87
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLM 134
+V L++ GAD D G + + A + + ++ L G PLM
Sbjct: 88 HLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLM 147
Query: 135 APMHVKHAREVPEY 148
+ H+ +
Sbjct: 148 WAAYRTHSVDPTRL 161
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 84.8 bits (211), Expect = 5e-19
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 7/107 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ + +D +G + A + L+ G DV+ D + T L AA +
Sbjct: 100 ADPSLIDGEGC--SC---IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTH 154
Query: 86 T-EVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + LLL V+ D++ +T L A+ N VI LL + GA
Sbjct: 155 SVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGA 201
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 79.4 bits (197), Expect = 5e-17
Identities = 16/65 (24%), Positives = 24/65 (36%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ D + + A G E L+E G DV D+ T L A +++K
Sbjct: 2 MTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYY 61
Query: 126 EKHGA 130
GA
Sbjct: 62 ISKGA 66
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 58.2 bits (142), Expect = 8e-10
Identities = 12/60 (20%), Positives = 27/60 (45%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + I LL++G +V+ ++I +AL +A + +++ L E +
Sbjct: 181 LHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEARQAKGYDN 240
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 89.3 bits (223), Expect = 1e-21
Identities = 40/75 (53%), Positives = 51/75 (68%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 18 VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAAR 77
Query: 116 YKNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 78 NGHLEVVKLLLEAGA 92
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 88.9 bits (222), Expect = 1e-21
Identities = 40/74 (54%), Positives = 50/74 (67%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 52 KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 111
Query: 117 KNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 112 GHLEVVKLLLEAGA 125
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 75.5 bits (187), Expect = 8e-17
Identities = 32/59 (54%), Positives = 39/59 (66%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ RT LH+AA G EVV LLLE GADV+ KD+ G TPL A + EV+KLL + GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 54.7 bits (133), Expect = 2e-09
Identities = 24/42 (57%), Positives = 30/42 (71%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA 97
+K LL++G DVN +D + RT LH+AA G EVV LLLE GA
Sbjct: 84 VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 125
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 92.5 bits (231), Expect = 1e-21
Identities = 21/105 (20%), Positives = 36/105 (34%), Gaps = 19/105 (18%)
Query: 47 LANERDVEG-------------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87
+A D +G + G +++ + +T LH+A
Sbjct: 1 MATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPS 60
Query: 88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
VV LL+ GA DR G T A +++ ++ L A
Sbjct: 61 VVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPG 105
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 6e-21
Identities = 22/87 (25%), Positives = 39/87 (44%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ + ++ LL G +VN + +ALH A+ +G +V L+ GAD K+
Sbjct: 154 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 213
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A + ++++ A
Sbjct: 214 CHNDTPLMVARSRRVIDILRGKATRPA 240
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 87.5 bits (218), Expect = 5e-20
Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 1/78 (1%)
Query: 56 IKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
++ LL+ G D++ DI + R+ L A +V LLL+ GA+V+ + GS+ L A
Sbjct: 132 VQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSAS 191
Query: 115 YYKNHEVIKLLEKHGAKP 132
+++ L + GA
Sbjct: 192 GRGLLPLVRTLVRSGADS 209
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 84.8 bits (211), Expect = 5e-19
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 9/109 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
EL+ ++ + P L ++ L+ +G D +TA H+A
Sbjct: 37 RELDIYNNLRQ--TP---LHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRS 91
Query: 86 TEVVSLLLERGA----DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ LL+ A D++ ++ G T L A+ + E ++LL + GA
Sbjct: 92 PTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGA 140
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 84.8 bits (211), Expect = 5e-19
Identities = 39/110 (35%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG----IDVNFRDIDNRTALHVAA 81
A LD G+ R ++ LLDS +D+ R+ D TALHVA
Sbjct: 70 ASPMALDRHGQ--TA---AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAV 124
Query: 82 CQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGA 130
E V LLLERGAD+D D G +PL A+ + +++LL +HGA
Sbjct: 125 NTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGA 174
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 2/87 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + +V + LL++G N + N LH AA T++V +LL G D D
Sbjct: 35 SYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFD 92
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+T L A+ N + +KL K
Sbjct: 93 DKGNTALYYAVDSGNMQTVKLFVKKNW 119
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-20
Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 3/85 (3%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
N + +K L S D D+ +A + A +V LL GA + +
Sbjct: 7 INTWKSKQLKSFL-SSKDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NE 63
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
PL A ++ +++K+L G
Sbjct: 64 FPLHQAATLEDTKIVKILLFSGLDD 88
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-20
Identities = 20/88 (22%), Positives = 35/88 (39%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A D + +K LL SG+D + D TAL+ A G + V L +++ +
Sbjct: 66 LHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYG 125
Query: 104 RWG-STPLGDAIYYKNHEVIKLLEKHGA 130
+ G T A+ + ++
Sbjct: 126 KTGWKTSFYHAVMLNDVSIVSYFLSEIP 153
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 8e-18
Identities = 18/106 (16%), Positives = 35/106 (33%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
L G + DV + L F + +H+ G
Sbjct: 119 WRLMFYGKTGWKT-S---FYHAVMLNDVSIVSYFLSEI-PSTFDLAILLSCIHITIKNGH 173
Query: 86 TEVVSLLLERGADVDPKDRWGSTP-LGDAIYYKNHEVIKLLEKHGA 130
+++ LLL+ + + P + AI K+ E+++ L K+
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDI 219
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 2e-16
Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 8/81 (9%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111
V+ + LLD N + + +A E++ L + ++ +
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIY-------SANL 226
Query: 112 DAIYYKNHEVIKLLEKHGAKP 132
+ + + E+ K++ + +
Sbjct: 227 ENVLLDDAEIAKMIIEKHVEY 247
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 8e-11
Identities = 11/97 (11%), Positives = 29/97 (29%), Gaps = 13/97 (13%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
N + + + +D+E ++ L I++ +A
Sbjct: 185 TSTNTNNSLLFIPD----IKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDD 233
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
E+ +++E+ + + K E+I
Sbjct: 234 AEIAKMIIEKHVEYKSDSYTKDLDI--VKNNKLDEII 268
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-21
Identities = 22/76 (28%), Positives = 35/76 (46%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ LL G + N D T +H AA +GF + + +L GA +D +D WG P+ A
Sbjct: 60 AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAE 119
Query: 115 YYKNHEVIKLLEKHGA 130
+ +V + L
Sbjct: 120 ELGHRDVARYLRAAAG 135
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 4e-20
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A VE ++ LL++G + N + R + V G V LLL GA+ + D
Sbjct: 16 LATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCAD 74
Query: 104 RWGST-PLGDAIYYKNHEVIKLLEKHGAKP 132
T P+ DA + + +L + GA+
Sbjct: 75 PATLTRPVHDAAREGFLDTLVVLHRAGARL 104
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 76.7 bits (190), Expect = 6e-17
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 5/74 (6%)
Query: 60 LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
++ + + L AA +G E V LLE GA+ + + +G P+ +
Sbjct: 1 MEPAAGSS--MEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMM--GS 56
Query: 120 -EVIKLLEKHGAKP 132
V +LL HGA+P
Sbjct: 57 ARVAELLLLHGAEP 70
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 9e-14
Identities = 18/96 (18%), Positives = 31/96 (32%), Gaps = 9/96 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
AE N D +P + A E ++ + L +G ++ RD R + +A G
Sbjct: 68 AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGH 123
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+V L GS ++
Sbjct: 124 RDVARYLRAAAGGTR-----GSNHARIDAAEGPSDI 154
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 28/87 (32%), Positives = 46/87 (52%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ + E + + ++ ++ D + + + TALH A C G TE+V L++ G +V+ D
Sbjct: 41 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A N +V K L + GA
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFLVESGA 127
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-19
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 8/110 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + +D+G I L E +K L+ G++VN D D T LH AA
Sbjct: 61 DDPSLPNDEG--ITA---LHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNN 115
Query: 86 TEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+V L+E GA V D + + + + + L K
Sbjct: 116 VQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 165
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 16/77 (20%), Positives = 33/77 (42%), Gaps = 1/77 (1%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+ E + G+ V F L ++ +G ++V ++ D + G T L +A
Sbjct: 19 KTGSERIAHGMRVKFNP-LPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNA 77
Query: 114 IYYKNHEVIKLLEKHGA 130
+ + E++K L + G
Sbjct: 78 VCAGHTEIVKFLVQFGV 94
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 8/63 (12%), Positives = 19/63 (30%), Gaps = 1/63 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
+I + +L + S + G V L D+ ++++ +
Sbjct: 2 EITGQVSLPPGKRTNLRKTGSERIAHGMRVKFNPL-PLALLLDSSLEGEFDLVQRIIYEV 60
Query: 130 AKP 132
P
Sbjct: 61 DDP 63
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 25/124 (20%), Positives = 44/124 (35%), Gaps = 13/124 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN---FRDIDNRTALHVAAC 82
+N D DG P L A+ +V+ K L++SG V + D+
Sbjct: 94 VNVNAADSDGW--TP---LHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEME 148
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142
+G+T+ L + ++ L Y+ +L K G M +H +
Sbjct: 149 EGYTQCSQFLYGVQEKMGIMNKGVIYAL---WDYEPQNDDELPMKEGDC--MTIIHREDE 203
Query: 143 REVP 146
E+
Sbjct: 204 DEIE 207
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 37/221 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
VA+KK+ D R R E+A+L ++ H +VV+ L V +V
Sbjct: 78 KRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
E D + + L ++ G+ Y+H I+HRDL+P+N L +
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQD 192
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR--------------------YV------AP 323
++KV DFG+++ + E+ + +V AP
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252
Query: 324 EV-FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
E+ E Y +DV+S I E++ H + P
Sbjct: 253 ELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 26/108 (24%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SGIDVNFRDIDNRTALHVAACQG 84
+NGLD G L + + + ++ L I++N ++ TALH AA +G
Sbjct: 97 VGVNGLDKAGS--TA---LYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKG 151
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ ++V LLL +GA D ++ A ++K + A
Sbjct: 152 YADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVR 199
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-18
Identities = 18/108 (16%), Positives = 39/108 (36%), Gaps = 11/108 (10%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+E ++ + D + ++ + L V + LH AA +
Sbjct: 34 EEGDIIYITDMSDT-----NWWKGTSK-----GRTGLIPSNYVAEQAESIDNPLHEAAKR 83
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
G + L+ V+ D+ GST L A + + ++++ L +
Sbjct: 84 GNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNI 131
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 11/89 (12%), Positives = 24/89 (26%), Gaps = 5/89 (5%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + EL D+ + + T +G T ++ V +
Sbjct: 16 VFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLI-----PSNYVAEQA 70
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
PL +A N ++ +
Sbjct: 71 ESIDNPLHEAAKRGNLSWLRECLDNRVGV 99
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 9/58 (15%), Positives = 20/58 (34%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
++ LL G + R+I+ + A +A ++ A + D+
Sbjct: 156 VQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDS 213
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-08
Identities = 7/66 (10%), Positives = 12/66 (18%), Gaps = 5/66 (7%)
Query: 74 RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL-----EKH 128
+ + A L D+ T +I +
Sbjct: 13 QVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLIPSNYVAEQAES 72
Query: 129 GAKPLM 134
PL
Sbjct: 73 IDNPLH 78
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 24/196 (12%)
Query: 175 GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IV 228
G VA+KK+ E +R R E+ +L+ +H N++ S I+
Sbjct: 36 GEIVAIKKI--EPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + DL + + L F R + LH + +IHRDL+PSN+L +
Sbjct: 93 QELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINS 147
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YV------APEV-FKNEEYDTKVDVF 338
+ +LKV DFG+++++ +V APEV + +Y +DV+
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVW 207
Query: 339 SFALILQEMIEGCPPF 354
S IL E+ P F
Sbjct: 208 SCGCILAELFLRRPIF 223
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-21
Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 6/93 (6%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP- 101
L+ A E DV+ + +LL G +V+ R TALH+AA E +L+E ++
Sbjct: 7 LLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFE 66
Query: 102 ----KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G T L A+ +N +++ L GA
Sbjct: 67 PMTSELYEGQTALHIAVINQNVNLVRALLARGA 99
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 28/105 (26%), Positives = 40/105 (38%), Gaps = 17/105 (16%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-------------RTALHVAACQGFTEVVS 90
L ++V ++ LL G V+ R + L AAC G E+V
Sbjct: 79 LHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVR 138
Query: 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEV----IKLLEKHGAK 131
LL+E GAD+ +D G+T L I N LL +
Sbjct: 139 LLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGG 183
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 29/123 (23%), Positives = 49/123 (39%), Gaps = 23/123 (18%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVA 80
E++ GE L A ++E L+++ ++ + +TALH+A
Sbjct: 28 CEVHQRGAMGETA-----LHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIA 82
Query: 81 ACQGFTEVVSLLLERGADVDPKDR-------------WGSTPLGDAIYYKNHEVIKLLEK 127
+V LL RGA V + +G PL A + E+++LL +
Sbjct: 83 VINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIE 142
Query: 128 HGA 130
HGA
Sbjct: 143 HGA 145
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-16
Identities = 22/97 (22%), Positives = 33/97 (34%), Gaps = 10/97 (10%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS----LLLERGADV 99
L F A E ++ L++ G D+ +D T LH+ Q LLL
Sbjct: 125 LSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD 184
Query: 100 DPK------DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
K + G TP A N + + L +
Sbjct: 185 HLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRK 221
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-13
Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 1/67 (1%)
Query: 75 TALHVAACQGFTEVVS-LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
+ L +AA + + +S LL G +V + G T L A Y N E +L + + +
Sbjct: 5 SPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELV 64
Query: 134 MAPMHVK 140
PM +
Sbjct: 65 FEPMTSE 71
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 19/191 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI--VTEY 231
+V VK + + + R E+ +L+ +R PN++ V V E+
Sbjct: 61 NEKVVVKI-----LKPVKKKKIKR-EIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSG 290
+ D + + L + +I + ++Y H I+HRD++P N++ D +
Sbjct: 115 VNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 168
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIE 349
L++ D+G+++ + + S + PE+ + + YD +D++S +L MI
Sbjct: 169 KLRLIDWGLAE--FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
Query: 350 GCPPFTMKHDN 360
PF HDN
Sbjct: 227 RKEPFFHGHDN 237
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 4e-21
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 46 FLANERDVEG---------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS 90
FL N RD I +L+++ + +DI+ TAL A +
Sbjct: 26 FLRNYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAE 85
Query: 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
LL +G++V+ KD G TPL +I + E+ L +HGA
Sbjct: 86 KLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGA 125
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 89.0 bits (222), Expect = 7e-21
Identities = 28/87 (32%), Positives = 47/87 (54%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L++ + ++LL G +VN +D +T L + G++E+ LLE GA+V+ ++
Sbjct: 72 LIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRN 131
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A Y E++K L + GA
Sbjct: 132 LEGETPLIVASKYGRSEIVKKLLELGA 158
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 87.1 bits (217), Expect = 3e-20
Identities = 30/87 (34%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
LM+ E LL+ G +VN R+++ T L VA+ G +E+V LLE GAD+ +D
Sbjct: 105 LMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARD 164
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G T A + EVIK+ +
Sbjct: 165 LTGLTAEASARIFGRQEVIKIFTEVRR 191
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 51.6 bits (125), Expect = 7e-08
Identities = 9/64 (14%), Positives = 19/64 (29%), Gaps = 6/64 (9%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+ D + + + + + L +D + TPL A I L
Sbjct: 2 SHMDKNGEIVEKIKDEKSINQNLDFLRNY------RDSYNRTPLMVACMLGMENAIDKLV 55
Query: 127 KHGA 130
++
Sbjct: 56 ENFD 59
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 57/224 (25%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-------- 226
G + A+KK + D R R EL +++ + H N+++ + +
Sbjct: 32 GKRFALKK-----VLQDPR-YKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84
Query: 227 ------------------------------IVTEYLPKGDL----RAFLKRKGALKPSTA 252
++ EY+P L ++F++ ++ +
Sbjct: 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLI 143
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPL 311
+ + R + ++H I HRD++P N+L + LK+ DFG +K L P
Sbjct: 144 SIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI--PSEPS 198
Query: 312 TCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
S Y APE+ EY +D++S + E+I G P F
Sbjct: 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 31/196 (15%)
Query: 175 GIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----I 227
++VA+KK+ E R R E+ +L + RH N++ + + I
Sbjct: 52 KVRVAIKKISPFEHQT---YCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
V + + DL L + L F I RG+ Y+H ++HRDL+PSN+L +
Sbjct: 108 VQDLMET-DLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162
Query: 288 DSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEV-FKNEEYDTKVDVF 338
+ +LK+ DFG++++ D LT YV APE+ ++ Y +D++
Sbjct: 163 TTCDLKICDFGLARVADPDHDHTGFLT------EYVATRWYRAPEIMLNSKGYTKSIDIW 216
Query: 339 SFALILQEMIEGCPPF 354
S IL EM+ P F
Sbjct: 217 SVGCILAEMLSNRPIF 232
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 54/230 (23%), Positives = 105/230 (45%), Gaps = 15/230 (6%)
Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGD 236
A+K L ++ R E +L+ IR P +V A + + ++ +Y+ G+
Sbjct: 86 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L L ++ + +I + +LH+ II+RD++ NIL D +G++ + D
Sbjct: 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 202
Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGC 351
FG+SK V ++ C Y+AP++ + + +D VD +S +++ E++ G
Sbjct: 203 FGLSK-EFVADETERA--YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
Query: 352 PPFTMK-HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
PFT+ N + + P ++ + K+LI+ + P KR
Sbjct: 260 SPFTVDGEKNSQAEISRRILKSEPPYPQEM-SALAKDLIQRLLMKDPKKR 308
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-20
Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 1/91 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
L + + ++ L+ G DVN ++ N RTALH+A ++VSLLL+ GADV+
Sbjct: 121 LHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRV 180
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
G +P + + + L + + L
Sbjct: 181 TYQGYSPYQLTWGRPSTRIQQQLGQLTLENL 211
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-20
Identities = 21/87 (24%), Positives = 38/87 (43%)
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
+E I+++ +NF++ +T LH+A E+ LL G D + +D G+TP
Sbjct: 22 ALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTP 81
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136
L A + +L + P +
Sbjct: 82 LHLACEQGCLASVGVLTQSCTTPHLHS 108
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 12/114 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHV 79
+ D G P L + + + L S + + + T LH+
Sbjct: 69 CDPELRDFRGN--TP---LHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHL 123
Query: 80 AACQGFTEVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
A+ G+ +V LL+ GADV+ ++ G T L A+ +N +++ LL K GA
Sbjct: 124 ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADV 177
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 1e-12
Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 70 DIDNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
D + LH+A EV+ + A ++ ++ TPL A+ E+ + L
Sbjct: 5 TEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEAL 64
Query: 126 EKHGAKP 132
G P
Sbjct: 65 LGAGCDP 71
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 9/66 (13%), Positives = 17/66 (25%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G DVN + + + T + L + +
Sbjct: 167 VSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESEDEESYDTE 226
Query: 116 YKNHEV 121
+ E
Sbjct: 227 SEFTEF 232
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 1/78 (1%)
Query: 55 GIKELLD-SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
G + D ++ D +N +HVAA +G T+ V L+E G ++R+G T L A
Sbjct: 1 GPGSMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLA 60
Query: 114 IYYKNHEVIKLLEKHGAK 131
+ + K L G
Sbjct: 61 CKFGCVDTAKYLASVGEV 78
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 20/111 (18%), Positives = 41/111 (36%), Gaps = 5/111 (4%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ A + + ++ L+++G+ ++ TALH+A G + L G
Sbjct: 24 IHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWH 83
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV---KHAREVPEYEID 151
G P+ A+ +++ L + + P + REV E
Sbjct: 84 --GQKPIHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNEIGSH 132
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 24/125 (19%), Positives = 47/125 (37%), Gaps = 10/125 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-----GIDVNFRDIDNRTALHVA 80
A D E P LM R+ E + ++D+ + +++ + + LH A
Sbjct: 164 ASPTAKDKADE--TP---LMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWA 218
Query: 81 ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
+ +V +E G DV+ +D + PL ++ + K L + L+
Sbjct: 219 ILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYH 278
Query: 141 HAREV 145
+ V
Sbjct: 279 NGTTV 283
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 14/86 (16%), Positives = 23/86 (26%)
Query: 47 LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
L +G V + + AA EV+ LL E+ +V G
Sbjct: 264 LQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTG 323
Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V ++ A
Sbjct: 324 AGGAVKRKKKAAPAVKRMKLAPSAPV 349
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 5/82 (6%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-----GADVDPKDRWGSTPL 110
IK L+ G +D + T L A E + L+++ +D ++ G++ L
Sbjct: 156 IKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHL 215
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
AI +V + G
Sbjct: 216 HWAILINWEDVAMRFVEMGIDV 237
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 20/75 (26%), Positives = 35/75 (46%), Gaps = 7/75 (9%)
Query: 63 GIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
I + + +TALH G + E++ +L++ GA KD+ TPL A+ ++N E
Sbjct: 128 EIGSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNRE 187
Query: 121 VIKLL-----EKHGA 130
+ L+ K
Sbjct: 188 ALDLMMDTVPSKSSL 202
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 13/100 (13%), Positives = 29/100 (29%), Gaps = 2/100 (2%)
Query: 11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
LL+++ + NG + + + A+ E ++ L + +V
Sbjct: 263 LLQKT--DVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSL 320
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ V + L A V + R +
Sbjct: 321 NTGAGGAVKRKKKAAPAVKRMKLAPSAPVRTRSRSRARSS 360
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 7e-09
Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 14/91 (15%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + + L++ + + + EV K
Sbjct: 88 IHLAVMANKTDLVVALVEGAKE------RGQMPESLLNECDEREVN------EIGSHVKH 135
Query: 104 RWGSTPLGDAIYY-KNH-EVIKLLEKHGAKP 132
G T L + + E+IK+L + GA P
Sbjct: 136 CKGQTALHWCVGLGPEYLEMIKILVQLGASP 166
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 6/43 (13%), Positives = 13/43 (30%)
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
S+ + D + A + ++ L + G P
Sbjct: 4 SMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSP 46
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 40/205 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----- 226
+VA+KK I D A R E+ +++++ H N+V+ + S +
Sbjct: 36 DKRVAIKK-----IVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89
Query: 227 ---------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
IV EY+ DL L +G L A F + RG+ Y+H ++HR
Sbjct: 90 SLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHR 144
Query: 278 DLEPSNILRDDSG-NLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNE 329
DL+P+N+ + LK+ DFG+++ + + + +P +
Sbjct: 145 DLKPANLFINTEDLVLKIGDFGLAR--IMDPHYSHKGHLSE--GLVTKWYRSPRLLLSPN 200
Query: 330 EYDTKVDVFSFALILQEMIEGCPPF 354
Y +D+++ I EM+ G F
Sbjct: 201 NYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 60/284 (21%), Positives = 98/284 (34%), Gaps = 75/284 (26%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
+ A+K ++ D + R E+ L + + P++V+ + ++IV
Sbjct: 43 QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94
Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
E L G+L R + A A I + YLH I HRD++P N+L
Sbjct: 95 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 151
Query: 286 -RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ + LK+ DFG A E E+YD D++S +I+
Sbjct: 152 SKRPNAILKLTDFG----------------------FAKETTG-EKYDKSCDMWSLGVIM 188
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAAR---QRPPFKAP--------AKLYARGLKELIEECW 393
++ G PPF H + R + F P K LI
Sbjct: 189 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV-------KMLIRNLL 241
Query: 394 NEKPAKRPTFRQII-------------TRLESINNSINHKRRWK 424
+P +R T + + T L + K RW+
Sbjct: 242 KTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 285
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-20
Identities = 28/75 (37%), Positives = 37/75 (49%), Gaps = 3/75 (4%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
L+ G + D L AA G + V +L+ GADV KD+ GSTPL A
Sbjct: 10 SSGLVPRGSHMG---SDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAAR 66
Query: 116 YKNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 67 NGHLEVVKLLLEAGA 81
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-19
Identities = 30/83 (36%), Positives = 48/83 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DV +D + T LH+AA G EVV LLLE GADV +D
Sbjct: 28 LLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQD 87
Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
++G T +I N ++ ++L+
Sbjct: 88 KFGKTAFDISIDNGNEDLAEILQ 110
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 8e-10
Identities = 9/51 (17%), Positives = 19/51 (37%), Gaps = 3/51 (5%)
Query: 80 AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ S L+ RG+ + L +A + +++L +GA
Sbjct: 1 GSSHHHHHHSSGLVPRGSHMGSD---LGKKLLEAARAGQDDEVRILMANGA 48
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 4e-20
Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 4/93 (4%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV--- 99
L E + ++ELL S + +D D R LH + E+ S LL + +V
Sbjct: 6 LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 65
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D D G TP A N EV+K L KP
Sbjct: 66 DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKP 98
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 2e-19
Identities = 23/76 (30%), Positives = 35/76 (46%), Gaps = 3/76 (3%)
Query: 58 ELL---DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ L D+N T LH+A + + EV L+E GA V KD++ PL A
Sbjct: 89 KSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAA 148
Query: 115 YYKNHEVIKLLEKHGA 130
+ ++I+LL G
Sbjct: 149 SVGSLKLIELLCGLGK 164
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 2e-19
Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 7/109 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+LN + + G L ++ E + L+++G V +D N+ LH AA G
Sbjct: 98 PDLNKITNQGV--TC---LHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGS 152
Query: 86 TEVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKNHEVIKLL-EKHGAKP 132
+++ LL G + V+ +D+ G TPL A+ + + LL EK+GA+
Sbjct: 153 LKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEY 201
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 82.5 bits (205), Expect = 3e-18
Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 10/110 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI---DNRTALHVAAC 82
+ L D DG P L + + + E LL +VN D T H+A
Sbjct: 27 SLLLQKDQDGR--IP---LHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACS 81
Query: 83 QGFTEVVSLLLER--GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G EVV L +R D++ G T L A+ K EV + L ++GA
Sbjct: 82 VGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGA 131
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 6e-15
Identities = 26/105 (24%), Positives = 42/105 (40%), Gaps = 10/105 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQG 84
A + D + P L A+ ++ I+ L G VN++D T L A +G
Sbjct: 131 ASVRIKDKFNQ--IP---LHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEG 185
Query: 85 FTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ LL+E+ GA+ D D G+ N +V K +
Sbjct: 186 HGDAAVLLVEKYGAEYDLVDNKGAKAE---DVALNEQVKKFFLNN 227
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-14
Identities = 15/59 (25%), Positives = 27/59 (45%), Gaps = 1/59 (1%)
Query: 73 NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ LH A + F +V LL + + + KD+ G PL ++ ++ HE+ L
Sbjct: 2 SNYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKME 60
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 4e-20
Identities = 44/183 (24%), Positives = 67/183 (36%), Gaps = 11/183 (6%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+ LA ++ +KE + + D D+RTALH A G TE+V LL+ G V+ K
Sbjct: 10 ICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 69
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL------MAPMHV---KHAREVPEYEIDPH 153
D G +PL A E++K L GA P+H K+ E+ ++
Sbjct: 70 DDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLE-G 128
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
+ A +G V L S + + L L
Sbjct: 129 GANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEA 188
Query: 214 QFL 216
+FL
Sbjct: 189 KFL 191
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 11/60 (18%), Positives = 23/60 (38%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ N ++A E+ +L + D+ T L A + E+++ L + G
Sbjct: 5 VSNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGV 64
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N ++ +G L + A++ E LL+ G + + +D + TA+H AA +G
Sbjct: 97 AHVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGN 151
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
++V +LL A + +D G+TPL A + E K L GA
Sbjct: 152 LKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGAS 197
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 2e-14
Identities = 21/107 (19%), Positives = 40/107 (37%), Gaps = 7/107 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + D + A + +++ + LL N +D + T LH+A +
Sbjct: 130 ANPDAKDHYDATA-----MHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEER 184
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E L+ +GA + +++ TPL A +I G +
Sbjct: 185 VEEAKFLVTQGASIYIENKEEKTPLQVA--KGGLGLILKRLAEGEEA 229
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 18/75 (24%), Positives = 28/75 (37%), Gaps = 7/75 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N D +G L +E VE K L+ G + + + +T L VA G
Sbjct: 163 ASTNIQDTEGNTP-----LHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK--GG 215
Query: 86 TEVVSLLLERGADVD 100
++ L G +
Sbjct: 216 LGLILKRLAEGEEAS 230
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 23/110 (20%), Positives = 53/110 (48%), Gaps = 4/110 (3%)
Query: 26 AELNGLDDDGEEIKPEFR---LMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAA 81
A+++ ++ + L + A ++ +K L+ + G + + +D D +T + +AA
Sbjct: 262 AKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAA 321
Query: 82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+G EVV L+++GA V+ D T A +H ++ + ++ +
Sbjct: 322 QEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPE 371
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 18/72 (25%), Positives = 33/72 (45%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
KE + +G DVN D D T L +A +V+ L++ GAD ++ + L A
Sbjct: 147 HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 206
Query: 114 IYYKNHEVIKLL 125
++ ++ +
Sbjct: 207 AANRDFGMMVYM 218
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 11/124 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +D D P LM R + L+ +G D + R+ALH AA
Sbjct: 157 ADVNAMDCDEN--TP---LMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRD 211
Query: 86 TEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKNHEVI---KLLEKHGAKPLMAPMHV 139
++ +L D++ DR G T L + + + + KLL + GAK
Sbjct: 212 FGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAAR 271
Query: 140 KHAR 143
K +
Sbjct: 272 KDSE 275
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 9/87 (10%)
Query: 53 VEGIKELLDSGIDVNFR--------DIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKD 103
V K L++ G V++ RTALH AA +V L+ E+G++ D +D
Sbjct: 251 VASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQD 310
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TP+ A EV+ L + GA
Sbjct: 311 EDGKTPIMLAAQEGRIEVVMYLIQQGA 337
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 9/83 (10%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL--------ERGADVDPKDRWGS 107
+ + +++ NRT LH A E L+ GADV+ D +
Sbjct: 109 TEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDEN 167
Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
TPL A+ + ++ L K GA
Sbjct: 168 TPLMLAVLARRRRLVAYLMKAGA 190
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 14/111 (12%), Positives = 29/111 (26%), Gaps = 7/111 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ + N L + + + + ++ LH A
Sbjct: 50 IKRQRNELQHYSL-----YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEA-A 103
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
G + + ++ R T L + E + L H AK +
Sbjct: 104 GSYAITEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECI 153
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 9/116 (7%), Positives = 26/116 (22%), Gaps = 5/116 (4%)
Query: 19 PDRERKEAELNGL----DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR 74
+R RK +N + EE + +++ + N +
Sbjct: 3 GNRTRKRRMINASVWMPPMENEEKNRKNHQSITSSQHSLLEASYDGYIKRQRNELQHYSL 62
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G + + L ++ + + + +
Sbjct: 63 YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEAAG-SYAITEPITRESV 117
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 16/75 (21%), Positives = 30/75 (40%), Gaps = 5/75 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + D+DG+ P +M A E +E + L+ G V D + TA +A
Sbjct: 304 SNKDKQDEDGK--TP---IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNH 358
Query: 86 TEVVSLLLERGADVD 100
+V + + +
Sbjct: 359 HNIVDIFDRCRPERE 373
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 6/72 (8%), Positives = 18/72 (25%), Gaps = 9/72 (12%)
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ + ++ +L A+ G+ + + + P N
Sbjct: 25 EKNRKNHQSITSSQHSLLEASYDGYIKRQ---------RNELQHYSLYPNPQGYGNGNDF 75
Query: 121 VIKLLEKHGAKP 132
+ + P
Sbjct: 76 LGDFNHTNLQIP 87
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM----IVT 229
G VAVKK+ + + D R FR E+ +L ++ H N+V L + + +V
Sbjct: 34 GEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLR--ADNDRDVYLVF 90
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
+Y+ DL A + R L+P + + + YLH ++HRD++PSNIL +
Sbjct: 91 DYMET-DLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAE 145
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR--------------YV------APEV-FKN 328
++KVADFG+S+ + YV APE+ +
Sbjct: 146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS 205
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPF 354
+Y +D++S IL E++ G P F
Sbjct: 206 TKYTKGIDMWSLGCILGEILCGKPIF 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 41/219 (18%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIR---------- 208
G F LA VA+K ++ D A DE+ LLQ++
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 209 -HPNVVQFLGAVTQSSPMM----IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIAR 261
++++ L P +V E L +L A +K+ P V+ + +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKLLTVKEDRPLTCQD 315
G++Y+H IIH D++P N+L + +K+AD G + D T
Sbjct: 143 GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSI 196
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+ Y +PEV + D++S A ++ E+I G F
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH------PNV 212
KG+F + A+ VA+K ++ ++ R R +E+ +L+ +R NV
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP--STAVR-FALDIARGMNYLHEN 269
+ L T + + + E L +L +K K + VR FA I + ++ LH+N
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIK-KNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 270 KPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
+ IIH DL+P NIL + +KV DFG S E + + S Y APEV
Sbjct: 220 R---IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRFYRAPEVIL 272
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
Y +D++S IL E++ G P + + +
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 21/127 (16%), Positives = 35/127 (27%), Gaps = 2/127 (1%)
Query: 11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
LL +R K+ + + F ++ + LL S V
Sbjct: 66 LLCLYYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQ 125
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGDAIYYKNHEVIKLLEKH 128
+N A +AA G V++ L E A + V+ L +
Sbjct: 126 AENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCEL 185
Query: 129 GAKPLMA 135
A
Sbjct: 186 APTEATA 192
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 17/87 (19%), Positives = 24/87 (27%), Gaps = 5/87 (5%)
Query: 57 KELLDSGIDVNFRDI--DNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGD 112
L + I +N A +AA G V++ L E
Sbjct: 145 NRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRW 204
Query: 113 AIYYKNH-EVIKLLEKHGAKPLMAPMH 138
A + H VI L A +H
Sbjct: 205 AAVGRGHHNVINFLLDCPVMLAYAEIH 231
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 15/118 (12%), Positives = 33/118 (27%), Gaps = 14/118 (11%)
Query: 24 KEAELNGLDD--DGEEIKPEFRLMFLANERDVEGIKELL---------DSGIDVNFRDID 72
K + +G+ D E F ++ R+ E + + + + D
Sbjct: 259 KLSNPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGD 318
Query: 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
L +A G +LLL + + ++ + +H
Sbjct: 319 ANELLRLALRLGNQGACALLLSIPSVLALTKA---NNYYINETGGRLDLRAVALEHHH 373
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 12/91 (13%)
Query: 56 IKELLDSGIDVNFRDI--DNRTALHVAACQ-GFTEVVSLLLERGADVDPKDRWGSTPLGD 112
+ L + I +N A AA G V++ LL+ + +
Sbjct: 179 LNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFE---- 234
Query: 113 AIYYKNHEVIKLLEKHGA--KPLMAPMHVKH 141
Y V + +H K + + +
Sbjct: 235 ---YGEKYVNPFIARHVNRLKEMHDAFKLSN 262
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 22/199 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMM 226
VA+K +I + + E+ LL+ + +V + +
Sbjct: 78 EQEWVAIK-----IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132
Query: 227 IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+V E L +L L+ R FA + + +L + + IIH DL+P NI
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENI 190
Query: 285 L--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
L +K+ DFG S + + + S Y +PEV YD +D++S
Sbjct: 191 LLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246
Query: 343 ILQEMIEGCPPFTMKHDNE 361
IL EM G P F+ ++ +
Sbjct: 247 ILVEMHTGEPLFSGANEVD 265
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 21/125 (16%), Positives = 48/125 (38%), Gaps = 8/125 (6%)
Query: 14 QSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNF-R 69
Q L P+ + L + + + E + ++ + ++ + + ++ +++N
Sbjct: 68 QRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPV 127
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLL 125
D T LH E+V L++ G++ D G + L A+ N+ LL
Sbjct: 128 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALL 187
Query: 126 EKHGA 130
+
Sbjct: 188 DYLYP 192
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 18/87 (20%), Positives = 33/87 (37%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K+ E+ + +E + +N +D + T L++AA
Sbjct: 234 KKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARL 293
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPL 110
G +V LL+ GAD ++ G P+
Sbjct: 294 GNISIVDALLDYGADPFIANKSGLRPV 320
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 21/158 (13%), Positives = 50/158 (31%), Gaps = 27/158 (17%)
Query: 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG------ 84
+D+ G L +L + ++E +K L+ G + + D + L A
Sbjct: 127 VDEHGNTP-----LHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSG 181
Query: 85 -FTEVVSLLLERGADVDPKDRWGSTPL------------GDAIYYKNHEVIKLLEKHGAK 131
F ++ L + +D T L A Y ++ + K +
Sbjct: 182 TFEALLDYL---YPCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNR 238
Query: 132 PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFI 169
P+ + + K ++ + + ++ +
Sbjct: 239 PIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANML 276
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 12/83 (14%), Positives = 25/83 (30%), Gaps = 4/83 (4%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAA----CQGFTEVVSLLLERGADVDPKDRWGSTP 109
+ ++ + + + E + L ++ +D G T
Sbjct: 227 ILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTC 286
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A N ++ L +GA P
Sbjct: 287 LNIAARLGNISIVDALLDYGADP 309
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 16/121 (13%), Positives = 30/121 (24%), Gaps = 21/121 (17%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLA---NERDVEGIKELLDSGI-DVNFRDIDNRTALHVAA 81
+ D+ GE L+ N D + LLD + D NRT LH
Sbjct: 155 SNRLYGDNMGE--SC---LVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHII 209
Query: 82 CQGFTE------------VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
++ ++++ + + + I
Sbjct: 210 ITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLK 269
Query: 130 A 130
Sbjct: 270 W 270
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 8e-15
Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 21/121 (17%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A LN + + I + L R + +K+ + +TALH+A +
Sbjct: 61 AMLNLHNGQNDTIA-----LLLDVARKTDSLKQFV--NASYTDSYYKGQTALHIAIERRN 113
Query: 86 TEVVSLLLERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+V+LL+E GADV +G PL A ++K L ++ +
Sbjct: 114 MTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQ 173
Query: 132 P 132
P
Sbjct: 174 P 174
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 25/112 (22%), Positives = 38/112 (33%), Gaps = 22/112 (19%)
Query: 44 LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
L A + +K LL + D++ RD T LH T + +
Sbjct: 152 LSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNE 211
Query: 92 LLERGADVDP-------KDRWGSTPLGDAIYYKNHEVIKLL---EKHGAKPL 133
+L GA + P +R G TPL A V+ + E H +
Sbjct: 212 ILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECR 263
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 11/64 (17%), Positives = 22/64 (34%), Gaps = 8/64 (12%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
+L + + T L +AA G V++ +L+R A ++
Sbjct: 217 AKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIH-------EPECRHAAAHH 269
Query: 117 KNHE 120
+H
Sbjct: 270 -HHH 272
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 18/88 (20%), Positives = 29/88 (32%), Gaps = 11/88 (12%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-------RGADVDPKDR-WGSTPLGDA- 113
+ +R ++ A Q + + LL R D + KD G T L A
Sbjct: 3 SAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAM 62
Query: 114 --IYYKNHEVIKLLEKHGAKPLMAPMHV 139
++ ++ I LL K V
Sbjct: 63 LNLHNGQNDTIALLLDVARKTDSLKQFV 90
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 27/93 (29%), Positives = 44/93 (47%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
AN+ + + ++ +G ++ + D TALH AA + + LLL+ A V + G
Sbjct: 201 ANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGE 260
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
T L A + E +LLE+ A P+HV
Sbjct: 261 TALDIARKKHHKECEELLEQAQAGTFAFPLHVD 293
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 49 NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQGF---TEVVSLLLERGADV 99
RD+ + E +G D LH+A +V +++ G +
Sbjct: 160 CNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHL 219
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D K G+T L A Y + +KLL K A
Sbjct: 220 DAKAADGNTALHYAALYNQPDCLKLLLKGRALV 252
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 27/142 (19%), Positives = 46/142 (32%), Gaps = 37/142 (26%)
Query: 21 RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN------- 73
+ A+ G L +R ++ +K L+++G DV+ R
Sbjct: 76 KPLVNAQCTDEFYQGH--SA---LHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQG 130
Query: 74 ------RTALHVAACQGFTEVVSLLLERG---ADVDPKDRWGSTPL------GD------ 112
L +AAC +VV+ LLE A ++ D G+T L D
Sbjct: 131 TCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENS 190
Query: 113 ----AIYYKNHEVIKLLEKHGA 130
+Y ++ L
Sbjct: 191 ALVIHMYDGLLQMGARLCPTVQ 212
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 21/91 (23%), Positives = 34/91 (37%), Gaps = 15/91 (16%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-------------WGSTP 109
+ALH+A + + V LL+E GADV + +G P
Sbjct: 80 NAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELP 139
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
L A K +V+ L ++ +P A +
Sbjct: 140 LSLAACTKQWDVVTYLLENPHQP--ASLEAT 168
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 13/76 (17%), Positives = 26/76 (34%), Gaps = 1/76 (1%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ + +AL + G ++ + L + + G TPL A E+ + +
Sbjct: 181 MIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHI 240
Query: 126 EKHGAKPLMAPMHVKH 141
+ A H H
Sbjct: 241 LQREFSG-AAAHHHHH 255
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 22/110 (20%)
Query: 43 RLMFLANERDVEGIKELLDS--------GIDVNFRDIDNRTALHVAAC---QGFTEVVSL 91
RL + + E + LL+ +T L A G +
Sbjct: 5 RLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACIMP 64
Query: 92 LLERG-----------ADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
LL+ A + G + L AI ++ + +KLL ++GA
Sbjct: 65 LLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGA 114
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 9/48 (18%), Positives = 18/48 (37%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
++ L + + T L +AA +G E+ +L+R
Sbjct: 201 LQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGA 248
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 13/71 (18%), Positives = 20/71 (28%), Gaps = 11/71 (15%)
Query: 73 NRTALHVAACQGFTEVVSLLLE--------RGADVDPKDRWGSTPLGDAIY--YKNH-EV 121
+R L +G E ++ LLE + G T L A+
Sbjct: 2 DRDRLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNAC 61
Query: 122 IKLLEKHGAKP 132
I L +
Sbjct: 62 IMPLLQIDKDS 72
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 26/114 (22%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN--------------RTALHVAACQGFTEVV 89
L R ++ L++ G DV+ + L +AAC +V
Sbjct: 97 LHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIV 156
Query: 90 SLLLERG---ADVDPKDRWGSTPLGDAIYYKNH---------EVIKLLEKHGAK 131
L E G AD+ +D G+T L + ++ ++ LL AK
Sbjct: 157 HYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAK 210
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 25/113 (22%)
Query: 45 MFLANERDVEGIKELLDSG---------IDVNFRDIDNR--TALHVAACQGFTEVVSLLL 93
+ + + I LLD I+ FRD+ R TALH+A + V LL+
Sbjct: 54 LLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLV 113
Query: 94 ERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E+GADV + R +G PL A ++ L ++G K
Sbjct: 114 EKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQ 166
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 22/105 (20%)
Query: 48 ANERDVEGIKE----LLDSGIDVNFRDIDN----RTALHVAA---CQGFTEVVSLLLERG 96
+ +G++ LL + + +T L A G + + +LL+
Sbjct: 13 VSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDTIPILLDIA 72
Query: 97 ADVDP-----------KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G T L AI + ++LL + GA
Sbjct: 73 EKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGA 117
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 19/107 (17%), Positives = 34/107 (31%), Gaps = 19/107 (17%)
Query: 44 LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
L A + L ++G D+ +D T LH T++ L
Sbjct: 144 LSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDL 203
Query: 92 LLERGADVDPK-------DRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
LL + A + P + G +PL A + + + +
Sbjct: 204 LLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIA 250
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 14/70 (20%), Positives = 23/70 (32%), Gaps = 11/70 (15%)
Query: 73 NRTALHVAA----CQGFTEVVSLLLERGADVDPKDRW----GSTPLGDA---IYYKNHEV 121
NR L G ++S LL + ++ G T L A + ++
Sbjct: 5 NRPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDT 64
Query: 122 IKLLEKHGAK 131
I +L K
Sbjct: 65 IPILLDIAEK 74
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 8/59 (13%), Positives = 17/59 (28%), Gaps = 7/59 (11%)
Query: 49 NERDVEGIKELLDSGIDVN-------FRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
+ + LL + + D + L +AA G + ++ R
Sbjct: 194 TKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADA 252
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 20/93 (21%), Positives = 40/93 (43%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
+ + + L+ + +++ + TALH E + LLL A ++ + G
Sbjct: 180 VDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGE 239
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
TPL A K+ +LL + + + +HV+
Sbjct: 240 TPLDIAKRLKHEHCEELLTQALSGRFNSHVHVE 272
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 9/93 (9%)
Query: 49 NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQG---FTEVVSLLLERGADV 99
RD+ G+ + G+D+ + TALH+A +V L++ ++
Sbjct: 139 KTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNL 198
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D + GST L N E +KLL + A
Sbjct: 199 DKQTGKGSTALHYCCLTDNAECLKLLLRGKASI 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 52/234 (22%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRH-----PNVV 213
GTF +L AVK V+ + + + + E +L+KI++ N+V
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKP 271
++ G M ++ E L L + R ++ + ++I + +NYL +
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS- 157
Query: 272 VPIIHRDLEPSNIL-------------------------RDDSGNLKVADFGVSKLLTVK 306
+ H DL+P NIL R S +K+ DFG +
Sbjct: 158 --LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----TF 211
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360
+ + +Y APEV N +D D++SF +L E+ G F H++
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR-THEH 264
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 55/213 (25%), Positives = 80/213 (37%), Gaps = 41/213 (19%)
Query: 177 QVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVT 229
QVA+K +I + + R A R E+ +L+KI+ V M I
Sbjct: 47 QVALK-----IIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101
Query: 230 EYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
E L K + FLK P VR A + + +LHEN+ + H DL+P NIL
Sbjct: 102 ELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFV 157
Query: 286 -----------------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
+ +++VADFG + + T + Y PEV
Sbjct: 158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTTIVATRHYRPPEVILE 213
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
+ DV+S IL E G F + E
Sbjct: 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 52/207 (25%), Positives = 77/207 (37%), Gaps = 34/207 (16%)
Query: 178 VAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVTE 230
VAVK ++ + DR A R E+ +L+ + VQ L + IV E
Sbjct: 43 VAVK-----IVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97
Query: 231 YLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
L F+K G L +R A I + +N+LH NK + H DL+P NIL
Sbjct: 98 LLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQ 153
Query: 289 SGNLKVADFGVSKLLTVKEDRPL-------TC--QDTSCRYV------APEVFKNEEYDT 333
S + + + + + + + V APEV +
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQ 213
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDN 360
DV+S IL E G F HD+
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFP-THDS 239
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 26/99 (26%), Positives = 38/99 (38%), Gaps = 9/99 (9%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVN------FRDIDNRTALHVA---ACQGFTEVVSLLL 93
RL RD+ + E +G D LH+A A Q +V ++
Sbjct: 135 RLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFII 194
Query: 94 ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ G +D K G+T L A Y + +KLL K A
Sbjct: 195 QNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALV 233
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 52/256 (20%), Positives = 83/256 (32%), Gaps = 76/256 (29%)
Query: 164 TKGTFILA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPN---VV 213
T L+ VA+K V S + DE+ LL+ +R PN VV
Sbjct: 49 HFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 214 QFLGAVTQSSP----MMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLH 267
Q L S + +V E L L ++ + L + + +G++YLH
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163
Query: 268 ENKPVPIIHRDLEPSNIL------------------------------------------ 285
IIH D++P NIL
Sbjct: 164 TK--CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 286 -------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
+ +K+AD G + + T + +Y + EV Y+T D++
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277
Query: 339 SFALILQEMIEGCPPF 354
S A + E+ G F
Sbjct: 278 STACMAFELATGDYLF 293
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 3e-10
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 3/101 (2%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N ++ + P L+ + + LL +G +VN D R LH A G
Sbjct: 224 ADVNWVNGGQDNATP---LIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGH 280
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
T + L L+RGAD+ +D G PL A+ N +++ LL
Sbjct: 281 TGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLR 321
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 6e-10
Identities = 24/87 (27%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 48 ANERDVEGIKELLDSGIDVNFR--DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW 105
+ + + + L G DVN+ DN T L A LL+ GA+V+ D
Sbjct: 208 GHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSA 267
Query: 106 GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G PL A + + L K GA
Sbjct: 268 GRGPLHHATILGHTGLACLFLKRGADL 294
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 4e-06
Identities = 55/474 (11%), Positives = 135/474 (28%), Gaps = 166/474 (35%)
Query: 19 PDRER---KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT 75
D + + E++ + + + RL + + E +++ ++ + +N+
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY------- 91
Query: 76 ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
F L+ + + T + Y + + + + + A
Sbjct: 92 --------KF------LMSPIKT-EQRQPSMMTRM----YIEQRDRL-----YNDNQVFA 127
Query: 136 PMHVKHAREVPE-----YEIDPHELDFTNSVEIT----KGTFILAFWRGIQVAVKKLGEE 186
+V + + E+ P + + G+ G + +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKN-------VLIDGVLGS-------GKTW----VALD 169
Query: 187 VISDDDRVRAF---------------RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
V L +LQK+ + + SS + +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH- 228
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DS 289
++A L+R L ++KP L +L + ++
Sbjct: 229 ----SIQAELRR----------------------LLKSKPYE---NCLL---VLLNVQNA 256
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS-------FAL 342
+ LLT + + +T +++ + D +
Sbjct: 257 KAWNAFNLSCKILLTTR-FKQVT------DFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 343 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
L C P ++P+ P + + A +++ + W+
Sbjct: 310 YL-----DCRPQ------DLPR--EVLTTNPRR--LSIIAESIRDGLAT-WD-------N 346
Query: 403 FRQI-ITRLES-INNSINH-----KRRWKVYLFLSLSVCLHLF---TWISIIII 446
++ + +L + I +S+N R+ +F LSV F I I++
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRK----MFDRLSV----FPPSAHIPTILL 392
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 32/249 (12%), Positives = 70/249 (28%), Gaps = 72/249 (28%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
+ + D + + L ++ E + +++ ++N ALH
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK-VKLENEYALH---------- 446
Query: 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEY 148
+++ D P Y+ +H H H+K+
Sbjct: 447 -RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG------H---------HLKNIEHPERM 490
Query: 149 EIDPHE-LDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
+ LDF F L +++ D A L LQ++
Sbjct: 491 TLFRMVFLDF-------------RF----------LEQKIRHDSTAWNASGSILNTLQQL 527
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL----KPSTAVRFALDIARGM 263
+ + + + P + + FL + K + +R AL
Sbjct: 528 K-----FYKPYICDNDPKY--ERLV--NAILDFLPKIEENLICSKYTDLLRIAL------ 572
Query: 264 NYLHENKPV 272
+ E++ +
Sbjct: 573 --MAEDEAI 579
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 27/133 (20%), Positives = 54/133 (40%), Gaps = 16/133 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
+VA+K E + + E + + ++ + + ++V + L
Sbjct: 32 NEEVAIKL---E--NVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG 86
Query: 234 K--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDD 288
DL F RK +LK T + A + + ++H +HRD++P N L
Sbjct: 87 PSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRR 141
Query: 289 SGNLKVADFGVSK 301
+ + + DFG++K
Sbjct: 142 ANQVYIIDFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 21/77 (27%), Positives = 41/77 (53%), Gaps = 6/77 (7%)
Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 285
+V E L DL+ + G K ST ++ + + + Y+HEN+ +H D++ +N+L
Sbjct: 129 MVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184
Query: 286 -RDDSGNLKVADFGVSK 301
+ + +AD+G+S
Sbjct: 185 GYKNPDQVYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 30/135 (22%), Positives = 50/135 (37%), Gaps = 18/135 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
VA+K + R E +++ + Q +V E L
Sbjct: 34 NEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLG 88
Query: 234 K--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
DL R +LK T + A+ + M Y+H +I+RD++P N L R +
Sbjct: 89 PSLEDLFDLCDRTFSLK--TVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGN 143
Query: 290 GNLKVA---DFGVSK 301
+V DF ++K
Sbjct: 144 KTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 8/69 (11%)
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNL 292
DL F RK +LK T + A + + Y+H IHRD++P N L +
Sbjct: 93 DLFNFCSRKFSLK--TVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 147
Query: 293 KVADFGVSK 301
+ DFG++K
Sbjct: 148 YIIDFGLAK 156
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 2e-04
Identities = 29/202 (14%), Positives = 52/202 (25%), Gaps = 52/202 (25%)
Query: 152 PHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDD-----RVRAFRDELAL 203
+I +G F VA+K + E + E+ +
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 204 LQKI---------RHPNVVQFLGA--VTQSSP---------------------------- 224
+++ R + V S P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 225 MMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
+ IV E+ G DL + +TA + + + + HRDL N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGN 192
Query: 284 ILRDDSGNLKVADFGVSKLLTV 305
+L + K+ K T+
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 21/82 (25%), Positives = 37/82 (45%), Gaps = 12/82 (14%)
Query: 227 IVTEYLPK--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+V + L DL RK ++K T A + + +HE +++RD++P N
Sbjct: 83 LVIDLLGPSLEDLLDLCGRKFSVK--TVAMAAKQMLARVQSIHEKS---LVYRDIKPDNF 137
Query: 285 L-----RDDSGNLKVADFGVSK 301
L ++ + V DFG+ K
Sbjct: 138 LIGRPNSKNANMIYVVDFGMVK 159
|
| >3agd_A Salt-tolerant glutaminase; glutaminase super family, hydrolase; 2.20A {Micrococcus luteus} PDB: 3age_A* 3if5_A 3ih8_A 3ih9_A 3iha_A* 3ihb_A 2dfw_A Length = 456 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 6e-04
Identities = 6/85 (7%), Positives = 17/85 (20%), Gaps = 2/85 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ F E ++ + +L A + +
Sbjct: 335 IRFGGAEAVLDALTDLRTGAEKPGTGWDAAVYPRWQEAAADRAALSAATGGGAVHEAAAA 394
Query: 104 RWGSTPLGD--AIYYKNHEVIKLLE 126
G + V ++ +
Sbjct: 395 AARDENDGPIRTVVLNLARVDRIDD 419
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 14/68 (20%), Positives = 35/68 (51%), Gaps = 7/68 (10%)
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 293
+ ++ + K T ++ +L I + Y+HE++ +H D++ SN+L + +
Sbjct: 140 KIYEANAKRFSRK--TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVY 194
Query: 294 VADFGVSK 301
+ D+G++
Sbjct: 195 LVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 12/68 (17%), Positives = 28/68 (41%), Gaps = 6/68 (8%)
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 293
+ L + ++ A + + +LHEN+ +H ++ NI +D +
Sbjct: 146 SALDVSPKH-VLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVT 201
Query: 294 VADFGVSK 301
+A +G +
Sbjct: 202 LAGYGFAF 209
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 447 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.91 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.9 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.9 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.85 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.85 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.85 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.85 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.85 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.85 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.84 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.84 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.84 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.84 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.84 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.83 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.83 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.83 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.83 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.83 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.83 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.83 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.82 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.82 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.82 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.82 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.82 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.82 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.82 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.82 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.82 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.82 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.81 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.81 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.81 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.81 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.81 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.8 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.8 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.8 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.8 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.8 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.8 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.8 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.8 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.8 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.8 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.8 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.79 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.79 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.79 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.79 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.79 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.79 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.79 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.79 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.79 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.79 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.79 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.78 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.78 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.78 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.78 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.78 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.77 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.77 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.77 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.77 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.77 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.77 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.77 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.76 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.76 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.76 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.76 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.76 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.76 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.76 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.76 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.76 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.76 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.76 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.75 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.75 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.75 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.75 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.75 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.75 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.75 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.75 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.75 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.74 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.74 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.74 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.73 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.73 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.73 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.72 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.72 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.7 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.69 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.69 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.68 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.68 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.66 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.65 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.65 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.62 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.6 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.56 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.51 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.45 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.36 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.1 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.07 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.76 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.71 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.67 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.47 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.15 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.12 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.57 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.72 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.67 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.6 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.51 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.38 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.79 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.48 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 82.59 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=414.73 Aligned_cols=267 Identities=27% Similarity=0.470 Sum_probs=218.6
Q ss_pred CcccCCCCcCcccceeeecceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.|+|++.+ +...+.||+|+||.||. ....||||+++... ...+..+.|.+|+.++++++|||||++++++.+ +.
T Consensus 30 ~Wei~~~~--l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 30 YWEIEASE--VMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CCBCCTTS--CCEEEECCCCSSSEEEEEESSSEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CcEEcHHH--eEEeeEEeeCCCcEEEEEEECCcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 46777764 45567899999999884 34579999997544 355667889999999999999999999998864 57
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
+++|||||++|+|.+++... +++++.++..++.|++.||.|||+++ |+||||||+|||+++++++||+|||+|+..
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 89999999999999999764 57999999999999999999999998 999999999999999999999999999875
Q ss_pred ccCC-CCCcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC--CCCCCCC
Q 013214 304 TVKE-DRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKAP 377 (447)
Q Consensus 304 ~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 377 (447)
.... ........||+.|||||++.+ +.++.++|||||||++|||+||+.||.+.+............ .|..+..
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 4322 222345678999999999864 358899999999999999999999999877655444333333 3444555
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
+..+|+++.++|.+||+.||++|||+.+++++|+.++.++.+.
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk~ 305 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKI 305 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC-
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCCC
Confidence 6678899999999999999999999999999999998876543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=417.24 Aligned_cols=252 Identities=28% Similarity=0.486 Sum_probs=217.8
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|...+.||+|+||.|+. ++..||||+++.. ..+..++|.+|++++++++|||||+++++|.+++.+
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 577788999999998863 3678999999743 456678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCE
Q 013214 226 MIVTEYLPKGDLRAFLKRK-------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~v 292 (447)
++|||||++|+|.+++++. ..+++.++..++.|++.||.|||+++ |+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence 9999999999999999764 35899999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC
Q 013214 293 KVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 293 kl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~ 370 (447)
||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+....
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999865432221 1123357999999999999999999999999999999999 999999988877777776555
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+++. +..+|+++.++|.+||+.||++|||++++.+.|+++.+.
T Consensus 248 ~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 248 VLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 5554 456789999999999999999999999999999988764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-55 Score=416.63 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=218.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..|...++||+|+||.|+. +|+.||||+++.+... .+|+.+++.++|||||++++++.+++.+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3577788999999999873 5899999999765432 35999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+||+|.+++++.+.+++.++..++.|++.||.|||+++ |+||||||+|||++.+| ++||+|||+|+.......
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999999999899999999999999999999999999 99999999999999987 699999999987653221
Q ss_pred C----CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 309 R----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 309 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
. ......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..++...+... .+++...++.+|+.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE-PPPIREIPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-CCGGGGSCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-CCCchhcCccCCHH
Confidence 1 123356999999999999999999999999999999999999999988888777776443 33333445678899
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
+.++|.+||+.||.+|||+.|++++|.........
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 99999999999999999999999999887776643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=416.35 Aligned_cols=252 Identities=27% Similarity=0.491 Sum_probs=213.3
Q ss_pred CcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
++...++||+|+||.||. +++.||||+++.. .....++|.+|++++++++|||||+++++|.+.+.+
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 566778999999999873 3788999999743 556678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC
Q 013214 226 MIVTEYLPKGDLRAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~ 290 (447)
++|||||++|+|.+++++. +++++.++..++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence 9999999999999999753 35899999999999999999999998 99999999999999999
Q ss_pred CEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHh
Q 013214 291 NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 291 ~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~ 368 (447)
.+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||...+..+....+..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999986543322 22234568999999999999999999999999999999999 9999998887777777755
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
..+++. +..+|+++.++|.+||+.||++|||+.+++++|+.+.+.
T Consensus 276 g~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 GRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TCCCCC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCC---cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 555554 346789999999999999999999999999999998765
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=417.65 Aligned_cols=247 Identities=21% Similarity=0.402 Sum_probs=216.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++.+......+..+.+.+|++++++++||||+++++++.+++.+|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 688999999999999973 689999999976543333445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-C
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~ 309 (447)
||+||+|.+++.+.+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++++||+|||+|+.+..... .
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999999999999999999999999999999 99999999999999999999999999987653322 2
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+.. ....+ +..+|+++++||
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~dli 265 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK-LEYDF---PEKFFPKARDLV 265 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCC---CTTCCHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCC---CcccCHHHHHHH
Confidence 33456899999999999999999999999999999999999999998877776666633 33444 345788999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+||+.||++|||+.|++.+
T Consensus 266 ~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHHSCSSGGGSTTSGGGTCH
T ss_pred HHHccCCHhHCcChHHHcCC
Confidence 99999999999999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-55 Score=419.82 Aligned_cols=246 Identities=22% Similarity=0.450 Sum_probs=210.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||||++..... .....+.+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999998873 589999999987654 44557889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+||+|.+++...+ .+++.+++.++.|++.||.|||+++ |+||||||+|||++.+|++||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 999999999997643 4789999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+.....++. +..+|+++.+|
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~l 256 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV---SLHYSYDLRSL 256 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSCHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---CccCCHHHHHH
Confidence 112345689999999999999999999999999999999999999998887777766655544443 45678999999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.||++|||+.+++++
T Consensus 257 i~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=404.10 Aligned_cols=244 Identities=27% Similarity=0.452 Sum_probs=199.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++.+......+....+.+|++++++++||||+++++++.+++.+|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 688899999999998873 689999999987665555566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|| +|+|.+++.+++++++.++..++.|++.||.|||+++ |+||||||+|||+++++++||+|||+|+..... ..
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~ 167 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NF 167 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC--Cc
Confidence 99 7899999999999999999999999999999999999 999999999999999999999999999865432 22
Q ss_pred cccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....||+.|||||++.+..+ +.++||||+||++|+|++|+.||.+.+..+....+. ...+.+ +..+|++++++|
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~-~~~~~~---p~~~s~~~~~li 243 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS-NGVYTL---PKFLSPGAAGLI 243 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCC---CTTSCHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-cCCCCC---CCCCCHHHHHHH
Confidence 345679999999999988776 579999999999999999999999877666655553 333343 345789999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+||+.||++|||+.+++++
T Consensus 244 ~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHC
T ss_pred HHHccCChhHCcCHHHHHcC
Confidence 99999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-55 Score=414.60 Aligned_cols=255 Identities=30% Similarity=0.519 Sum_probs=217.1
Q ss_pred ccCCCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEE
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 218 (447)
++...+ ++..++||+|+||.||. +++.||||+++... .....++|.+|+.++++++|||||+++|+
T Consensus 22 ei~~~~--~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 22 EISLSA--VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp BCCGGG--EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCHHH--CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 444443 44457899999999873 45789999997543 33445789999999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 013214 219 VTQSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (447)
Q Consensus 219 ~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~ 282 (447)
|.+++.+++|||||++|+|.++|... ..+++.++..++.|++.||.|||+++ |+||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCcccc
Confidence 99999999999999999999999653 35889999999999999999999999 999999999
Q ss_pred CEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 013214 283 NILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 360 (447)
Q Consensus 283 Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~ 360 (447)
|||+++++++||+|||+++....... .......||+.|||||++.++.++.++|||||||++|||+| |+.||.+.+..
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986643322 22344568999999999999999999999999999999998 89999998887
Q ss_pred chHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
++...+....+++. +..+|+.+.++|.+||+.||++|||+++|+++|+.+
T Consensus 255 ~~~~~i~~~~~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVEMIRNRQVLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHcCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 77777766555554 456788999999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=413.81 Aligned_cols=246 Identities=22% Similarity=0.380 Sum_probs=214.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..|+..+.||+|+||.|+. +|+.||||++....... .+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3588888999999999873 68999999997543322 356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|||+||+|.+++.+ +++++.++..++.|++.||.|||+++ |+||||||+|||++.+|++||+|||+|+.+.... .
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 225 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 225 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-C
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-C
Confidence 99999999999876 56999999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.....+.+ ..+..+|+++.+||
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~dli 304 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-KNLHKVSPSLKGFL 304 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-SCGGGSCHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-CccccCCHHHHHHH
Confidence 23456799999999999999999999999999999999999999998877666666644333333 34567899999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+||+.||++|||+.|++++
T Consensus 305 ~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 305 DRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=399.86 Aligned_cols=246 Identities=26% Similarity=0.497 Sum_probs=204.5
Q ss_pred cccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe----CCceEE
Q 013214 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMI 227 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~l 227 (447)
|+..++||+|+||.|+. ++..||+|++..... .....+.+.+|+.++++++|||||+++++|.+ +..+|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 35667899999999973 588999999976544 44556789999999999999999999999875 345899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~~~~~~~~ 306 (447)
|||||+||+|.+++++.+.+++..+..++.|++.||.|||++++ +|+||||||+|||++ .++.+||+|||+|+....
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 99999999999999998999999999999999999999999873 599999999999998 479999999999975432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.......||+.|||||++.+ .++.++|||||||++|+|+||+.||..................+ ...+..+++++.
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~ 260 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFDKVAIPEVK 260 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-GGGGGCCCHHHH
T ss_pred --CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-CCCCccCCHHHH
Confidence 23345679999999999865 69999999999999999999999998665443332222222211 122445678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+||.+||+.||++|||+.+++++
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=414.18 Aligned_cols=246 Identities=22% Similarity=0.387 Sum_probs=214.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..|+..++||+|+||.|+. +|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 3588889999999999873 6899999999754322 2356789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|||+||+|.++++. +.+++.++..++.|++.||.|||+++ |+||||||+|||++.+|++||+|||+|..+.... .
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 302 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 302 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence 99999999999865 56999999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.....+.+ ..+..+|+++.+||
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~dli 381 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-KNLHKVSPSLKGFL 381 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SCTTSSCHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-cccccCCHHHHHHH
Confidence 23456789999999999999999999999999999999999999998877776666644433333 33456889999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+||+.||++|||+.|++++
T Consensus 382 ~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-54 Score=405.92 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=204.6
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.|+. +++.||+|++++...... ....+.+|+.++++++||||+++++++.+++.+|+
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 689999999999999873 467899999976433221 12357789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|||||+||+|.+++.+.+.+++.++..++.|++.||.|||+++ |+||||||+|||++.+|++||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999999999999999999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..++...+.. ..+++ +..+|+++.+
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~~ 255 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK-AKLGM---PQFLSPEAQS 255 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCC---CTTSCHHHHH
T ss_pred -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc-CCCCC---CCcCCHHHHH
Confidence 223456799999999999999999999999999999999999999998877776666633 33333 3457899999
Q ss_pred HHHHHcccCCCCCCCH-----HHHHHH
Q 013214 388 LIEECWNEKPAKRPTF-----RQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~-----~~~l~~ 409 (447)
||.+||+.||++|||+ ++++++
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 9999999999999984 566653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=404.32 Aligned_cols=259 Identities=27% Similarity=0.485 Sum_probs=216.5
Q ss_pred cccCCCCcCcccceeeecceEEEEEE---c-------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-Cccccee
Q 013214 148 YEIDPHELDFTNSVEITKGTFILAFW---R-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFL 216 (447)
Q Consensus 148 ~~i~~~~~~~~~~~~lg~G~~~~~~~---~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~ 216 (447)
|||+.. +|+..+.||+|+||.|+. . ++.||||++.... .....+.+.+|+.+++++.| ||||+++
T Consensus 59 wEi~~~--~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 59 WEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HBCCGG--GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cEecHH--HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 555554 677788999999999874 1 3679999997543 44556789999999999965 9999999
Q ss_pred EEEEeC-CceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Q 013214 217 GAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279 (447)
Q Consensus 217 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Di 279 (447)
++|..+ ..+++|||||++|+|.++|++. ..+++.++..++.|++.||.|||+++ |+||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999764 5689999999999999999753 23789999999999999999999999 999999
Q ss_pred CCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 013214 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMK 357 (447)
Q Consensus 280 kp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~ 357 (447)
||+|||+++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543222 2234467999999999999999999999999999999998 99999987
Q ss_pred CCCchH-HHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 358 HDNEVP-KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 358 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
...+.. ..+....+++. +..+++++.++|.+||+.||++|||+.+++++|+++.++
T Consensus 292 ~~~~~~~~~i~~g~~~~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 292 KIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 765543 44434445554 345788999999999999999999999999999998654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=385.32 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=197.2
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC----ceEEE
Q 013214 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~lv 228 (447)
+|...+.||+|+||.|+ ++|+.||||++.... ........|+..+.+++||||+++++++.+++ .+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 56677899999999876 689999999986431 22222345666677889999999999998654 57999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-----PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-----~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
||||++|+|.+++++ .+++++.+..++.|++.||.|||++. ..+|+||||||+|||++.++++||+|||+++..
T Consensus 80 ~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999999976 46899999999999999999999871 113999999999999999999999999999876
Q ss_pred ccCCCC---CcccCCCCCcccCCcccCCC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--------------
Q 013214 304 TVKEDR---PLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------------- 360 (447)
Q Consensus 304 ~~~~~~---~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-------------- 360 (447)
...... ......||+.|||||++.+. .++.++|||||||++|||+||+.||......
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 543221 12345689999999998754 3667999999999999999998766432211
Q ss_pred -chHHHHHhcC-CCCCCCCh--hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 361 -EVPKAYAARQ-RPPFKAPA--KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 361 -~~~~~~~~~~-~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+....+.... +|.++... ...++.+.++|.+||+.||++|||+.++++.|+++.++
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1112221222 44444322 23557899999999999999999999999999988764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=382.20 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=189.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-------
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 223 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------- 223 (447)
+|+..+.||+|+||.|+. +|+.||||+++.. ......+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC--SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 577888999999999873 5899999998754 24556678899999999999999999999987544
Q ss_pred -----ceEEEEeccCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEe
Q 013214 224 -----PMMIVTEYLPKGDLRAFLKRKGAL---KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (447)
Q Consensus 224 -----~~~lv~e~~~~g~L~~~l~~~~~l---~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~ 295 (447)
.+|++||||++|+|.+++...+.+ ++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 379999999999999999876553 45668899999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCC-----------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHH
Q 013214 296 DFGVSKLLTVKEDR-----------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364 (447)
Q Consensus 296 Dfg~~~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~ 364 (447)
|||+|+........ ..+...||+.|||||++.+..|+.++|||||||++|||++ ||.+.. +...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 99999876543211 1133569999999999999999999999999999999996 775422 1112
Q ss_pred HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.......+++.....++.+.++|.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 221212233333345566778899999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=386.44 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=206.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe------CCc
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~ 224 (447)
+|+..+.||+|+||.|+. +|+.||||+++.... .....+.+.+|+.+|+.++||||+++++++.. .+.
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 688999999999999873 689999999976543 44556778899999999999999999998764 367
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
+|+|||||+ |+|.+++.+++++++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999995 789999998899999999999999999999999999 9999999999999999999999999998764
Q ss_pred cCC---CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCC------
Q 013214 305 VKE---DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP------ 373 (447)
Q Consensus 305 ~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~------ 373 (447)
... ........||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+....+.... .++
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 321 2233457899999999998775 56899999999999999999999999877665555443221 111
Q ss_pred ---------------CCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 ---------------FKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ---------------~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
... ..+..++++.+||.+||..||.+|||+.++++|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 012457889999999999999999999999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=397.91 Aligned_cols=246 Identities=22% Similarity=0.359 Sum_probs=205.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccC---CCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
.+|...+.||+|+||.|+. +|+.||+|++.+... .........+.++.+++.++||||++++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 3688999999999999973 689999999965432 12222333445577788889999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+|||||+||+|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||+|||++.+|++||+|||+|......
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 99999999999999999999999999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH--HhcCCCCCCCChhhhHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYAR 383 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 383 (447)
......||+.|||||++.+ ..|+.++|+|||||++|+|++|+.||.+.+........ .......+ +..+|+
T Consensus 346 ---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~---p~~~S~ 419 (689)
T 3v5w_A 346 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---PDSFSP 419 (689)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC---CTTSCH
T ss_pred ---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC---CccCCH
Confidence 2244679999999999964 57999999999999999999999999876544432222 12223333 456789
Q ss_pred HHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
++++||.+||+.||.+|++ +.++++|
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 9999999999999999998 6777764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=394.70 Aligned_cols=246 Identities=22% Similarity=0.377 Sum_probs=213.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|.+.+.||+|+||.|+. +|+.||+|++... .....+.+.+|+.+|+.++||||++++++|.++..+|++||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 688899999999999873 6899999998654 34455778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC--CCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~--~~vkl~Dfg~~~~~~~~~ 307 (447)
||+||+|.+++.+ .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999964 467999999999999999999999999 9999999999999854 89999999999876532
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+...........+..+|+++.+
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 3334567899999999999999999999999999999999999999988877776666443322222334568899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
||.+||+.||.+|||+.++++|
T Consensus 390 li~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=367.83 Aligned_cols=243 Identities=20% Similarity=0.286 Sum_probs=193.0
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceE
Q 013214 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 226 (447)
.|+..+.||+|+||.|+. +++.||+|.+.... . ...+.+|+++++.+ +||||+++++++.+++.+|
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 588899999999999873 36789999886542 2 24567899999988 6999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-CCEEEeeccccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTV 305 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~-~~vkl~Dfg~~~~~~~ 305 (447)
+||||+++|+|.++++ .+++.++..++.|++.||.|||++| |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999984 5999999999999999999999999 9999999999999876 7999999999975432
Q ss_pred CCC---------------------------CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 013214 306 KED---------------------------RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMK 357 (447)
Q Consensus 306 ~~~---------------------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~ 357 (447)
... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 112345699999999998775 5889999999999999999999999654
Q ss_pred CCCc-hHHHHHh-------------------------------------cC---CCC----------CCCChhhhHHHHH
Q 013214 358 HDNE-VPKAYAA-------------------------------------RQ---RPP----------FKAPAKLYARGLK 386 (447)
Q Consensus 358 ~~~~-~~~~~~~-------------------------------------~~---~~~----------~~~~~~~~~~~l~ 386 (447)
.+.. ....+.. .. .+. .......+|+++.
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 4321 1111100 00 000 0011234678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+||++||+.||++|||++|+++|
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHCcCChhHCcCHHHHhcC
Confidence 99999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=351.81 Aligned_cols=247 Identities=27% Similarity=0.461 Sum_probs=214.8
Q ss_pred CCcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|+..+.||+|+||.|+ .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 34478999999999999887 3789999999976543 44566778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||||+++|+|.+++.+.+++++..+..++.|++.||.|||+.+ ++||||||+||+++.++++||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 9999999999999998889999999999999999999999999 999999999999999999999999999765432
Q ss_pred CCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.......||+.|+|||.+.+..+. .++|||||||++|+|++|+.||.+.+..+....+... ...+ +..+++.+.
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~ 242 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-KYRI---PFYMSTDCE 242 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTSCHHHH
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCC---CCCCCHHHH
Confidence 233456789999999999887765 6899999999999999999999988776666655333 2222 234678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|++||+.||.+|||+.+++++
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=347.98 Aligned_cols=261 Identities=24% Similarity=0.384 Sum_probs=216.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +++.||+|.+...........+.+.+|+.++++++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 3688899999999998873 58899999987665566777888999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++++|.+++.+.+++++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999999999998889999999999999999999999999 999999999999999999999999999876543333
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCC-CCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF-KAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 388 (447)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+..........+.. ......+++.+.++
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence 33445689999999999998999999999999999999999999987765544433323332222 11234577899999
Q ss_pred HHHHcccCCCCCC-CHHHHHHHHHHHHhhhh
Q 013214 389 IEECWNEKPAKRP-TFRQIITRLESINNSIN 418 (447)
Q Consensus 389 i~~cl~~dp~~Rp-s~~~~l~~l~~~~~~~~ 418 (447)
|.+||+.||.+|| +++++.+.|+.+.....
T Consensus 248 i~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 248 ILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred HHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 9999999999998 89999998888655543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=346.46 Aligned_cols=259 Identities=36% Similarity=0.593 Sum_probs=211.1
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
..+|+..+.||+|+||.|+ ++|+.||+|++..... .....+.+.+|+.++++++||||+++++++......++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 4478888999999999876 5899999999976543 45566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~---l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|+++|+|.+++.+.+. +++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999987553 999999999999999999999986 349999999999999999999999999997543321
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 386 (447)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.... ... .+..+++.+.
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 269 (309)
T 3p86_A 194 -LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE---IPRNLNPQVA 269 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC---CCTTSCHHHH
T ss_pred -cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCccCCHHHH
Confidence 22234568999999999999899999999999999999999999999877665554443222 222 2456788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
++|.+||+.||.+|||+.++++.|+.+.+...
T Consensus 270 ~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999877543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=354.10 Aligned_cols=258 Identities=28% Similarity=0.525 Sum_probs=220.9
Q ss_pred CcCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 220 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 220 (447)
..+|...+.||+|+||.|+. ++..||+|++... ......+.+.+|+.+++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 34788889999999998873 2457999999765 3556677899999999999 8999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Ni 284 (447)
..+.+++||||+++|+|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence 9999999999999999999998653 3788999999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCch
Q 013214 285 LRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 362 (447)
Q Consensus 285 ll~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~ 362 (447)
|++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+.
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999986543322 22234456789999999988899999999999999999999 9999998887777
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
...+....++.. +..++..+.++|.+||+.||.+||++.++++.|+++.+....
T Consensus 315 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 315 FKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp HHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 766655544443 345778999999999999999999999999999998876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=341.63 Aligned_cols=247 Identities=22% Similarity=0.435 Sum_probs=212.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|+..+.||+|+||.|+. +|+.||+|++....... .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 45788899999999999873 58899999987554333 35678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++|+|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999999764 6899999999999999999999999 99999999999999999999999999886654322
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.....+.+. .+..+++.+.++
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 249 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAIFRDF 249 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-CGGGSCHHHHHH
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-CccccCHHHHHH
Confidence 234456899999999999999999999999999999999999999877765555555444444432 356688999999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.||++|||+.+++++
T Consensus 250 i~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHccCChhHCcCHHHHhhC
Confidence 999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=358.10 Aligned_cols=250 Identities=19% Similarity=0.324 Sum_probs=214.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|+.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 3688889999999999873 689999999876543 3445677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc---CCCCEEEeecccccccccC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~---~~~~vkl~Dfg~~~~~~~~ 306 (447)
||+++|+|.+.+...+.+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999999999889999999999999999999999999 99999999999998 4678999999999866533
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..............+++++.
T Consensus 167 ~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 167 Q-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245 (444)
T ss_dssp C-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred C-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 2 223446789999999999988999999999999999999999999998877766666644433222233456789999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||+.||.+|||+.+++++
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=349.83 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=214.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 688889999999998873 589999999976543 44556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC---CEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~ 307 (447)
|+++|+|.+++.....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||++......
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 9999999999988888999999999999999999999999 99999999999998654 5999999999876532
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..............+++++.+
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred -cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2234467899999999999889999999999999999999999999987766666555443322222334567899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.||.+||++.+++++
T Consensus 264 li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999976
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=352.01 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=212.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
...|...+.||+|+||.|+. +|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 34688899999999998873 589999999876543211 1246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC----CEEEeeccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSK 301 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~----~vkl~Dfg~~~ 301 (447)
++||||++||+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 999999999999999988888999999999999999999999999 99999999999998777 79999999998
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCC-CChhh
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK-APAKL 380 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 380 (447)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+... ...++ ..+..
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 244 (361)
T 2yab_A 168 EIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-SYDFDEEFFSQ 244 (361)
T ss_dssp ECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-CCCCCHHHHTT
T ss_pred EcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCchhccC
Confidence 76532 2234456899999999999889999999999999999999999999987766665555332 22222 12345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+.++|.+||..||.+|||+.+++++
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 78899999999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=349.21 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=211.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++.+...........+.+|..+++.++||||+++++++...+.+++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 688889999999999873 689999999975432222334677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|++||+|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+|||++.+|++||+|||++....... ..
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~ 161 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Cc
Confidence 9999999999998889999999999999999999999999 9999999999999999999999999997543221 22
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+.. ....+ +..+++++.++|.
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~~li~ 237 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-EEIRF---PRTLSPEAKSLLA 237 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCC---CTTSCHHHHHHHH
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCHHHHHHHH
Confidence 3445689999999999998999999999999999999999999988776665555533 23333 3457889999999
Q ss_pred HHcccCCCCCC-----CHHHHHHH
Q 013214 391 ECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
+||+.||.+|| ++.+++++
T Consensus 238 ~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 238 GLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHhhcCHHHhcCCCCCCHHHHHcC
Confidence 99999999999 89999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=345.81 Aligned_cols=260 Identities=28% Similarity=0.481 Sum_probs=218.7
Q ss_pred CCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
...+|...+.||+|+||.|+. .+..||+|++... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 345788899999999998863 3446999999754 245566789999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.++||||+++|+|.+++... +.+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999765 57999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhh
Q 013214 304 TVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 304 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
....... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+......+. +..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 278 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA---PMG 278 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTT
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC---CCC
Confidence 5432221 123345778999999988889999999999999999999 9999998877776666655444443 346
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
+++.+.++|.+||+.||.+|||+.++++.|+.+.......
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 7889999999999999999999999999999988766543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=337.07 Aligned_cols=252 Identities=29% Similarity=0.559 Sum_probs=215.8
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+|+..+.||+|+||.|+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.++...+++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3688888999999998873 6789999999765432 2568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++++|.+++... +.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999999764 45899999999999999999999999 999999999999999999999999999865433222
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.....+.. +..+++.+.++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 239 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQI 239 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHH
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCCHHHHHH
Confidence 2334456788999999988889999999999999999999 9999998777666666644433332 34567899999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 389 IEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+.+||+.||.+|||+.+++++|+.+.++
T Consensus 240 i~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 240 MNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 9999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=335.96 Aligned_cols=254 Identities=30% Similarity=0.543 Sum_probs=215.2
Q ss_pred CCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
...+|+..+.||+|+||.|+. ++..||+|++...... .+++.+|+.++++++||||+++++++......++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 445788899999999998873 4568999999765432 24678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|||+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999998754 4999999999999999999999999 9999999999999999999999999998665433
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+........ +..+++.+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 235 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR---PHLASDTIY 235 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTSCHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC---CCcChHHHH
Confidence 223334456778999999988889999999999999999999 9999988776666555544333322 344678899
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+++.+||+.||.+|||+.+++++|+.+...
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 236 QIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 999999999999999999999999887654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=341.30 Aligned_cols=255 Identities=30% Similarity=0.487 Sum_probs=213.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +++.||+|++.. ......+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 4788889999999998873 588999998854 25566788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++|+|.+++.. ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999987 467999999999999999999999999 99999999999999999999999999986543221
Q ss_pred CC-------------cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-----HHHHHhcC
Q 013214 309 RP-------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-----PKAYAARQ 370 (447)
Q Consensus 309 ~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-----~~~~~~~~ 370 (447)
.. .....||+.|+|||.+.+..++.++||||||+++|+|++|..||........ ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 11 1145689999999999999999999999999999999999999876543221 11111111
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhccc
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 421 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 421 (447)
.+..+++.+.++|.+||+.||++|||+.++++.|+.+........
T Consensus 244 ------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 244 ------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288 (310)
T ss_dssp ------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence 123456789999999999999999999999999999998876443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=335.88 Aligned_cols=256 Identities=23% Similarity=0.462 Sum_probs=207.1
Q ss_pred CCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
...+|+..+.||+|+||.|+. .+..||+|..... ......+.+.+|+.++++++||||+++++++. ++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 345788899999999998863 2457999998754 34566778999999999999999999999984 567
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 899999999999999998654 6999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......+. +..++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~ 243 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PPNCP 243 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTTCC
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC---CCCCC
Confidence 5433222334456788999999988889999999999999999997 9999998887777666655444443 45678
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+.+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 89999999999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=353.60 Aligned_cols=254 Identities=31% Similarity=0.519 Sum_probs=216.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +++.||+|.+... ...+..+.+.+|+.++++++||||+++++++..++..++||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4778888999999998873 5889999998754 24555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999998654 5999999999999999999999999 99999999999999999999999999975432111
Q ss_pred CCc-ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 309 RPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 309 ~~~-~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....+.+. +..+++.+.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 345 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC---PELCPDAVF 345 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC---CTTCCHHHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHH
Confidence 111 11224678999999988889999999999999999998 9999998877666666655444443 345678999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
++|.+||+.||++|||+.++++.|+++.+.
T Consensus 346 ~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 346 RLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 999999999999999999999999998765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=336.59 Aligned_cols=254 Identities=26% Similarity=0.495 Sum_probs=213.7
Q ss_pred CcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..+|+..+.||+|+||.|+. ++..||+|++...... .+++.+|+.+++.++||||+++++++......+++|
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34788889999999998863 4678999999865432 256788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999976 467999999999999999999999999 99999999999999999999999999986543222
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+........ +..+++.+.+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~ 252 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYT 252 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHH
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCCHHHHH
Confidence 22233456788999999988889999999999999999998 9999998877666666644433332 3456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+|.+||+.||.+|||+.+++++|+++....
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 253 IMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 999999999999999999999999987653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=343.82 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=210.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
..|...+.||+|+||.|+. +|+.||+|++........ ...+.+.+|+.+++.++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3688889999999998873 589999999875432211 12467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC----CEEEeecccccc
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKL 302 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~----~vkl~Dfg~~~~ 302 (447)
+||||+++++|.+++.+.+.+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 99999999999999988888999999999999999999999999 99999999999999877 899999999987
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+....+....+..............++
T Consensus 168 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 168 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp CCTT--SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred CCCC--CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 6432 22234568999999999988899999999999999999999999998776655555543322211111234567
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+.++|.+||+.||.+|||+.+++++
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 889999999999999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=351.63 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=208.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|+..+.||+|+||.|+. +|+.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.+|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 3688889999999998873 5889999999764333334456678899999988 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++++||+|||++...... .
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~ 178 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-G 178 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC-C
Confidence 999999999999999889999999999999999999999999 999999999999999999999999999754322 1
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. ....+ +..+++.+.++
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~~~~~~~l 254 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-DEVVY---PTWLHEDATGI 254 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCC---CTTSCHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCHHHHHH
Confidence 223445789999999999888899999999999999999999999998877766666633 33333 33467889999
Q ss_pred HHHHcccCCCCCCCH------HHHHHH
Q 013214 389 IEECWNEKPAKRPTF------RQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~------~~~l~~ 409 (447)
|++||+.||.+||++ .+++++
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 999999999999998 677653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=338.48 Aligned_cols=257 Identities=28% Similarity=0.493 Sum_probs=219.7
Q ss_pred CCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe
Q 013214 152 PHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 221 (447)
....+|...+.||+|+||.|+. ++..||+|++... ......+.+.+|+.+++.++||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3455788899999999998863 2378999999754 345667889999999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRKGA------------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~ 277 (447)
.+..+++|||+++++|.+++.+... +++.+++.++.|++.||.|||+++ ++|+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence 9999999999999999999987543 889999999999999999999999 9999
Q ss_pred CCCCCCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 013214 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT 355 (447)
Q Consensus 278 Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~ 355 (447)
||||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986543221 12233456788999999988889999999999999999999 999999
Q ss_pred CCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
.....+....+.....+.. +..+++.+.++|.+||+.||.+|||+.+++++|+++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMER---PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHHhhcCCcCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 8887777666644443333 346788999999999999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=342.55 Aligned_cols=244 Identities=24% Similarity=0.452 Sum_probs=210.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|+.||+|++...........+.+.+|..+++.++||||+++++++.+...+++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 3688889999999998873 68999999987543222233466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.+|++||+|||++.....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 99999999999999888999999999999999999999999 99999999999999999999999999986542
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+... ...+ +..+++++.++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~~~~li 234 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRF---PPFFNEDVKDLL 234 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-CCCC---CTTSCHHHHHHH
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCC---CCCCCHHHHHHH
Confidence 223456899999999999989999999999999999999999999887765555555332 3333 345778999999
Q ss_pred HHHcccCCCCCC-----CHHHHHHH
Q 013214 390 EECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
.+||+.||.+|| ++.+++++
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcC
Confidence 999999999999 88888864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=353.41 Aligned_cols=247 Identities=30% Similarity=0.550 Sum_probs=214.1
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-ceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-PMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e 230 (447)
.+|+..+.||+|+||.|+ ++|+.||||+++... ..+.+.+|+.++++++||||+++++++.... ..++|||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 467788899999999876 589999999997543 2367889999999999999999999987665 7999999
Q ss_pred ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++|+|.+++.+.+. +++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999987654 799999999999999999999999 999999999999999999999999999854322
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+....+++. +..+++.+.+
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~ 417 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDGCPPAVYD 417 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC---CTTCCHHHHH
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHH
Confidence 122356889999999998899999999999999999998 9999999888887777755545443 3467889999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+|.+||+.||.+|||+.++++.|+.+.+.
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999998765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=343.57 Aligned_cols=246 Identities=16% Similarity=0.295 Sum_probs=209.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 3688889999999999874 5899999998643 234466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC--CCCEEEeecccccccccC
Q 013214 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~--~~~vkl~Dfg~~~~~~~~ 306 (447)
||+++|+|.+++...+ .+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999997654 6999999999999999999999999 999999999999997 789999999999876432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..............+|+++.
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 222345679999999999888889999999999999999999999998776666555533332221122346788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||..||.+|||+.+++++
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=346.41 Aligned_cols=259 Identities=28% Similarity=0.519 Sum_probs=221.8
Q ss_pred CcCcccceeeecceEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEE
Q 013214 154 ELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 220 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 220 (447)
..+|...+.||+|+||.|+.. +..||+|++... ......+.+.+|+.+++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 347888899999999998731 257999999755 3556678889999999999 9999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Ni 284 (447)
..+..++||||+++|+|.+++.... .+++.+++.++.|++.||.|||+.+ ++||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 9999999999999999999998754 4899999999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCch
Q 013214 285 LRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 362 (447)
Q Consensus 285 ll~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~ 362 (447)
+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999986653322 22234456889999999999899999999999999999999 9999998877666
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
...+.....+.. +..+++++.++|.+||+.||++|||+.+++++|+++.......
T Consensus 303 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 303 FKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 666644444443 3457789999999999999999999999999999998766433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=348.57 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=202.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|...+.||+|+||.|+. +++.||+|++++.........+.+.+|..+++++ +||||+++++++.+...+++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 4688889999999999873 5889999999876655555666788899999887 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++++||+|||+++..... .
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 207 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 207 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC-C
Confidence 999999999999998889999999999999999999999999 999999999999999999999999999753322 2
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC--------chHHHHHhcCCCCCCCChhh
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--------EVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 380 (447)
.......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...... +............+ +..
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---p~~ 284 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---PRS 284 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC---CTT
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC---CCc
Confidence 2334567899999999999999999999999999999999999999754321 11112223333333 345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCH
Q 013214 381 YARGLKELIEECWNEKPAKRPTF 403 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~ 403 (447)
+++++.++|++||+.||.+||++
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCHHHHHHHHHHhcCCHhHcCCC
Confidence 78899999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=340.72 Aligned_cols=268 Identities=28% Similarity=0.531 Sum_probs=221.9
Q ss_pred CCCCcccCCCCcCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCC
Q 013214 144 EVPEYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHP 210 (447)
Q Consensus 144 ~~~~~~i~~~~~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 210 (447)
+.+.+++. ..+|...+.||+|+||.|+. ++..||+|++... ......+.+.+|+.+++++ +||
T Consensus 26 ~~~~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp 101 (334)
T 2pvf_A 26 EDPKWEFP--RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHK 101 (334)
T ss_dssp CCTTTBCC--GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCT
T ss_pred CCccccCC--HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCC
Confidence 34444443 34788889999999998872 3578999999754 2456677889999999999 899
Q ss_pred cccceeEEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 013214 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPI 274 (447)
Q Consensus 211 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i 274 (447)
||+++++++...+..++||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ +
T Consensus 102 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 178 (334)
T 2pvf_A 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---C 178 (334)
T ss_dssp TBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 99999999999999999999999999999998654 3889999999999999999999999 9
Q ss_pred EeCCCCCCCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 013214 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352 (447)
Q Consensus 275 ~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~ 352 (447)
+|+||||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.
T Consensus 179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258 (334)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred eCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986543221 11233456788999999988889999999999999999999 999
Q ss_pred CCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhccc
Q 013214 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 421 (447)
Q Consensus 353 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 421 (447)
||.+....+....+.....+.. +..++..+.++|.+||+.||.+|||+.++++.|+++.+......
T Consensus 259 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~ 324 (334)
T 2pvf_A 259 PYPGIPVEELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324 (334)
T ss_dssp SSTTCCHHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred CcCcCCHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCc
Confidence 9998776666555544443333 34577899999999999999999999999999999988765543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=335.89 Aligned_cols=265 Identities=25% Similarity=0.397 Sum_probs=218.4
Q ss_pred cccCCCCcCcccce-eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEE
Q 013214 148 YEIDPHELDFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (447)
Q Consensus 148 ~~i~~~~~~~~~~~-~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 219 (447)
.++.....+|.... .||+|+||.|+. .++.||+|++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 33444455777777 899999998873 268899999976532 334567899999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 220 ~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
..+..+++|||+++++|.+++.+.+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCc
Confidence 56788999999999999999999888999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 300 SKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 300 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
+......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 241 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-- 241 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC--
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence 9866433221 1123345788999999988888999999999999999999 9999998777666666544444443
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
+..+++.+.++|.+||+.||.+|||+.++++.|+++.......
T Consensus 242 -~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 242 -PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp -CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 3467889999999999999999999999999999998876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=341.09 Aligned_cols=247 Identities=24% Similarity=0.408 Sum_probs=209.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|...+.||+|+||.|+. +|+.||+|++.+.........+.+.+|..+++++ +||||+++++++.+...+++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 3688889999999998873 5899999999877666777778889999999988 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++|+|.+++.+.+.+++..++.++.|++.||.|||+.+ |+||||||+||+++.++++||+|||++.......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 999999999999998889999999999999999999999999 9999999999999999999999999997543221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC---------chHHHHHhcCCCCCCCChh
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------EVPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~ 379 (447)
.......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...... .....+ ......+ +.
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~---p~ 240 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRI---PR 240 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH-HHCCCCC---CT
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH-HcCCCCC---CC
Confidence 2234567899999999999989999999999999999999999999753221 112222 2333333 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCH------HHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTF------RQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~------~~~l~~ 409 (447)
.++..+.++|.+||+.||.+||++ .+++++
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 578899999999999999999995 566543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=348.67 Aligned_cols=249 Identities=28% Similarity=0.440 Sum_probs=209.8
Q ss_pred CCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCce
Q 013214 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 225 (447)
....+|...+.||+|+||.|+. +|+.||+|+++.......+..+.+..|..+++.+ +||||+++++++.+...+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3445788899999999998873 5899999999754321222345677899999877 999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
|+||||++||+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.+|++||+|||++.....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
.. .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+.. ..+.+ +..+++++
T Consensus 171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~s~~~ 245 (345)
T 1xjd_A 171 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-DNPFY---PRWLEKEA 245 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCC---CTTSCHHH
T ss_pred CC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-CCCCC---CcccCHHH
Confidence 22 223456789999999999998999999999999999999999999998776666655533 33333 34578899
Q ss_pred HHHHHHHcccCCCCCCCHH-HHHH
Q 013214 386 KELIEECWNEKPAKRPTFR-QIIT 408 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~-~~l~ 408 (447)
.++|.+||+.||.+||++. ++++
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHhcCCHhHcCCChHHHHc
Confidence 9999999999999999997 6654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=347.06 Aligned_cols=245 Identities=27% Similarity=0.437 Sum_probs=206.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++........+....+.+|+.+++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3688899999999998872 68899999986432222222356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+ +|+|.+++.+.+.+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... .
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--N 162 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--B
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC--c
Confidence 999 7899999988889999999999999999999999999 999999999999999999999999999865432 2
Q ss_pred CcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......||+.|+|||.+.+..+ ++++||||||+++|+|++|+.||......+....+ .... ...+..+++.+.++
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-~~~~---~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-NSCV---YVMPDFLSPGAQSL 238 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-CSSC---CCCCTTSCHHHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-HcCC---CCCcccCCHHHHHH
Confidence 2344568999999999988765 67999999999999999999999876655443222 1111 12244578899999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|++||+.||.+|||+.+++++
T Consensus 239 i~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHHhC
Confidence 999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=346.34 Aligned_cols=244 Identities=24% Similarity=0.403 Sum_probs=210.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 3788889999999998873 58999999986543222233467888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 99999999999998889999999999999999999999999 999999999999999999999999999865432
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+... ...+ +..+++.+.++|
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~~~~li 269 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRF---PSHFSSDLKDLL 269 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTCCHHHHHHH
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-CCCC---CCCCCHHHHHHH
Confidence 23346899999999999989999999999999999999999999987766665555333 3333 345788999999
Q ss_pred HHHcccCCCCCCC-----HHHHHHH
Q 013214 390 EECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
.+||+.||.+||+ +.+++++
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhhcCHHhccCCccCCHHHHHhC
Confidence 9999999999998 7887764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=345.61 Aligned_cols=258 Identities=28% Similarity=0.494 Sum_probs=208.6
Q ss_pred CCCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 152 PHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
....+|...+.||+|+||.|+. ++..||+|.+.... .....+.+.+|+.++++++||||+++++++....
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 3345788899999999999974 35679999997542 4566778999999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
..++||||+++|+|.+++.+.+ .+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999998754 6999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChh
Q 013214 303 LTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 303 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (447)
........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+....+.+. +.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~---~~ 273 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP---PM 273 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---CT
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---Cc
Confidence 65332211 122334678999999988899999999999999999998 9999988776666655544433332 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
.++..+.++|.+||+.||.+||++.++++.|+.+....
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 56788999999999999999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=342.74 Aligned_cols=260 Identities=29% Similarity=0.454 Sum_probs=217.8
Q ss_pred CCCCcCcccceeeecceEEEEEE---c-------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE
Q 013214 151 DPHELDFTNSVEITKGTFILAFW---R-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (447)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~~~~---~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 220 (447)
.....+|...+.||+|+||.|+. . ++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34455788899999999998863 2 2789999997542 4556778999999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H 276 (447)
..+..++||||+++|+|.+++... ..+++.+++.++.|++.||.|||+.+ ++|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 999999999999999999999764 56899999999999999999999999 999
Q ss_pred CCCCCCCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 013214 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 354 (447)
Q Consensus 277 ~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~ 354 (447)
|||||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999976543211 12233456889999999988889999999999999999999 99999
Q ss_pred CCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
......+....+.....+.. +..+++.+.++|.+||+.||.+|||+.++++.|+++.....
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 98777666665544443333 44678899999999999999999999999999999876553
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.76 Aligned_cols=246 Identities=24% Similarity=0.440 Sum_probs=206.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 3688899999999998863 57899999986543222333567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+.||+|.+++.+.+.+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++...... .
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999865432 2
Q ss_pred CcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh--cCCCCCCCChhhhHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLYARG 384 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 384 (447)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............. .....+ +..+++.
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---p~~~s~~ 246 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---PSAWSQE 246 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC---CTTSCHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC---CCcCCHH
Confidence 3345678999999999864 3588999999999999999999999987665544333222 222222 3457889
Q ss_pred HHHHHHHHcccCCCCCCC-HHHHHH
Q 013214 385 LKELIEECWNEKPAKRPT-FRQIIT 408 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps-~~~~l~ 408 (447)
+.++|.+||+.||.+||+ +.++++
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHc
Confidence 999999999999999998 666654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=340.25 Aligned_cols=262 Identities=24% Similarity=0.384 Sum_probs=208.3
Q ss_pred cccCCCCcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 148 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 148 ~~i~~~~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
-++.....+|+..+.||+|+||.|+ +.++.||||++... .........|+.++++++||||+++++++.....
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 3444555689999999999998876 57999999998643 2333455669999999999999999999987543
Q ss_pred ----eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEeCCCCCCCEEEcCCC
Q 013214 225 ----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN----------KPVPIIHRDLEPSNILRDDSG 290 (447)
Q Consensus 225 ----~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~----------~~~~i~H~Dikp~Nill~~~~ 290 (447)
+++||||+++|+|.++++. ..+++..++.++.|++.||.|||+. + ++||||||+||+++.++
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTC
T ss_pred CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCC
Confidence 6999999999999999976 4599999999999999999999998 8 99999999999999999
Q ss_pred CEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc---
Q 013214 291 NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE--- 361 (447)
Q Consensus 291 ~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~--- 361 (447)
.+||+|||++........ .......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.....
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 999999999976553322 122345689999999998763 45568899999999999999999998654321
Q ss_pred -------------hHHHHHhcC-CCCCCCC--hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 362 -------------VPKAYAARQ-RPPFKAP--AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 362 -------------~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
......... ++.+... ....++.+.++|.+||+.||++|||+.++++.|+.+.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111111111 2222221 1234677999999999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=342.32 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=207.8
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce----
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM---- 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~---- 225 (447)
.+|+..+.||+|+||.|+ .+++.||+|++.............+.+|+.++++++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 478889999999999887 36899999999877666677778899999999999999999999998766543
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++||||+++++|.+++...+.+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999999999998889999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 306 KED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 306 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+...........+.......+++
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCH
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCH
Confidence 221 122334579999999999988999999999999999999999999987766555444433332221112234778
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHH-HHHHHHHhh
Q 013214 384 GLKELIEECWNEKPAKRPTFRQII-TRLESINNS 416 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l-~~l~~~~~~ 416 (447)
.+.++|.+||+.||++||+..+++ +.+.+....
T Consensus 249 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 999999999999999999665544 555555443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=335.68 Aligned_cols=257 Identities=26% Similarity=0.515 Sum_probs=207.3
Q ss_pred CCcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--
Q 013214 153 HELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-- 221 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 221 (447)
...+|+..+.||+|+||.|+. +++.||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 345788899999999998862 5789999998743 45666789999999999999999999999864
Q ss_pred CCceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
....++||||+++|+|.+++...+ .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 356899999999999999998754 4999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC----------------ch
Q 013214 301 KLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN----------------EV 362 (447)
Q Consensus 301 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~----------------~~ 362 (447)
........ .......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87643321 1123345677899999998889999999999999999999999998643211 11
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
...+....+.+ .+..+++++.++|.+||+.||++|||+.++++.|+++.+.+.
T Consensus 242 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 242 IELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 11222222222 245678899999999999999999999999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.80 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=214.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|+.||+|++..... .....+.+.+|+.++++++||||+++++++......+++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4788889999999998874 488999999976543 4455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC---EEEeecccccccccC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVK 306 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~---vkl~Dfg~~~~~~~~ 306 (447)
||+++++|.+.+.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999999998888999999999999999999999999 999999999999986655 999999999765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+..............+++.+.
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 162 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp --CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred --ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 222345689999999999998999999999999999999999999988777666666544433222223456788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||+.||++|||+.+++++
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHcccChhhCCCHHHHhcC
Confidence 99999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=358.54 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=212.7
Q ss_pred CCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
....+|...+.||+|+||.|+. +++.||+|++.+...........+.+|..++..++||||+++++++.+.+.++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 3345788899999999999873 57899999986432111112234788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 227 IVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+||||+++|+|.+++.+ .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++++||+|||++.....
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999987 467999999999999999999999999 99999999999999999999999999976554
Q ss_pred CCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChh
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAK 379 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 379 (447)
..........||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....+.... ...++....
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 3333334467899999999986 4578999999999999999999999999877766665553322 344444445
Q ss_pred hhHHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
.+++++.+||++||..+|++ ||++.+++++
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 67899999999999888888 9999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=336.70 Aligned_cols=261 Identities=20% Similarity=0.267 Sum_probs=208.4
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
-.+|...+.||+|+||.|+. +++.||+|++...........+.+.+|+.++++++||||+++++++..++..+++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 34788999999999998763 5889999999876555666678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++++|.+++.+.+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 999999999999998888999999999999999999999999 99999999999999999999999999876554332
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+ ....+.....+..+++.+.++
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCTHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCHHHHHH
Confidence 3334456899999999999888999999999999999999999999876544333332 222222222345678899999
Q ss_pred HHHHcccCCCCCC-CHHHHHHHHHHHHhhhh
Q 013214 389 IEECWNEKPAKRP-TFRQIITRLESINNSIN 418 (447)
Q Consensus 389 i~~cl~~dp~~Rp-s~~~~l~~l~~~~~~~~ 418 (447)
|.+||+.||++|| ++.++++.|+.......
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 9999999999999 99999999988665554
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=344.45 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=209.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|...+.||+|+||.|+. +|+.||+|++...........+.+..|..++..+ +||||+++++++.+.+.+|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 3788889999999998873 4788999998754322223346678899999988 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.+|++||+|||++...... .
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 175 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-G 175 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC-C
Confidence 999999999999998888999999999999999999999999 999999999999999999999999999854322 1
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+.. ....+ +..+++++.++
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~~l 251 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HNVAY---PKSMSKEAVAI 251 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCC---CTTSCHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh-CCCCC---CCCCCHHHHHH
Confidence 223456789999999999998999999999999999999999999998776666655533 33333 34578899999
Q ss_pred HHHHcccCCCCCCC-----HHHHHHH
Q 013214 389 IEECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
|.+||+.||.+||+ +.+++++
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999995 5777654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=346.26 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=215.6
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|...+.||+|+||.|+. +++.||+|+++.. ........+.+|+.++++++||||+++++++.....
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4688889999999998762 3568999999743 345556678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC---CEEE
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKV 294 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~---~vkl 294 (447)
.++||||+++|+|.+++...+ .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999998653 4889999999999999999999999 99999999999999555 5999
Q ss_pred eecccccccccCC-CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCC
Q 013214 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 295 ~Dfg~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
+|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.....+
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999997543221 122233456889999999988899999999999999999998 99999988777766666554444
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
.. +..++..+.++|.+||+.||.+|||+.+++++|+.+....
T Consensus 306 ~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 306 DP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 33 3456788999999999999999999999999999887654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=336.29 Aligned_cols=267 Identities=25% Similarity=0.413 Sum_probs=218.0
Q ss_pred CCCCcccCCCCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEE
Q 013214 144 EVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (447)
Q Consensus 144 ~~~~~~i~~~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 219 (447)
..+..++.....+|...+.||+|+||.|+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 445556666777899999999999998874 58999999987542 23456788999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEe
Q 013214 220 TQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (447)
Q Consensus 220 ~~~~~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~ 295 (447)
...+..++||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEEC
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999986543 4899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH------Hh
Q 013214 296 DFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY------AA 368 (447)
Q Consensus 296 Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~------~~ 368 (447)
|||++........ .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+..... ..
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 9999976543221 1223345789999999998888999999999999999999999999876554322111 00
Q ss_pred cC------CCCC-CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 369 RQ------RPPF-KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 369 ~~------~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
.. .+.. ....+.++..+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 10 0111 123456788999999999999999999999999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=329.36 Aligned_cols=254 Identities=31% Similarity=0.531 Sum_probs=200.2
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCC-HHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISD-DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..+|+..+.||+|+||.|+ .+|+.||+|++....... ....+.+.+|+.+++.++||||+++++++..++..+++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 3478888999999999876 579999999987543222 233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC--------CCCEEEeeccccc
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--------SGNLKVADFGVSK 301 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~--------~~~vkl~Dfg~~~ 301 (447)
||+++++|.+++. ...+++..++.++.|++.||.|||+.+..+++||||||+||+++. ++.+||+|||++.
T Consensus 86 e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 86 EFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp ECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9999999999885 457999999999999999999999998545889999999999986 6789999999998
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhh
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (447)
...... .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...+.............. ...+..+
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 239 (271)
T 3dtc_A 165 EWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--LPIPSTC 239 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC--CCCCTTC
T ss_pred cccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC--CCCCccc
Confidence 654322 22346799999999998888999999999999999999999999977655544444333211 1124567
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
++.+.++|.+||+.||.+|||+.+++++|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 88999999999999999999999999999754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=327.96 Aligned_cols=252 Identities=30% Similarity=0.566 Sum_probs=214.7
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+|+..+.||+|+||.|+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++..++..+++||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 4678888999999998873 6789999999765432 2568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999999875 45899999999999999999999999 999999999999999999999999999865432212
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.....+.. +..+++.+.++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~l 237 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQI 237 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHH
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHHHHH
Confidence 2233456788999999988889999999999999999999 8999998776666655544433332 34567899999
Q ss_pred HHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 389 IEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+.+||+.||.+|||+.+++++|+.+.++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999998753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=328.62 Aligned_cols=257 Identities=26% Similarity=0.480 Sum_probs=213.5
Q ss_pred CCCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 152 PHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
....+|...+.||+|+||.|+. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+ +
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence 3445788899999999998863 12359999997652 45566789999999999999999999999865 4
Q ss_pred ceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
..+++|||+++++|.+++.+.+ .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 6799999999999999997654 5999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhh
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (447)
.............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+......+. +..+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 239 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDLC 239 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTTC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCCC
Confidence 65433223344556889999999988889999999999999999998 9999988777776666644444433 3456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
++.+.++|.+||+.||.+|||+.+++++|+++....
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 788999999999999999999999999999986643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.92 Aligned_cols=270 Identities=29% Similarity=0.519 Sum_probs=223.2
Q ss_pred CCCcccCCCCcCcccceeeecceEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccccee
Q 013214 145 VPEYEIDPHELDFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216 (447)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~lg~G~~~~~~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 216 (447)
..+..+......|...+.||+|+||.|+. ++ ..||+|.+... ......+.+.+|+.+++.++||||++++
T Consensus 11 ~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 88 (298)
T 3pls_A 11 VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALI 88 (298)
T ss_dssp TGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 34556667777888889999999998873 22 37999998753 4556678899999999999999999999
Q ss_pred EEEEeCCce-EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 217 GAVTQSSPM-MIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 217 ~~~~~~~~~-~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
+++.+.+.. +++|||+.+|+|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp EEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred EEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEe
Confidence 999876655 999999999999999986 456899999999999999999999999 999999999999999999999
Q ss_pred eecccccccccCC---CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC
Q 013214 295 ADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 295 ~Dfg~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~ 370 (447)
+|||++....... ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+....
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC
Confidence 9999997653321 122234567889999999999899999999999999999999 555666666666555554444
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccc
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 422 (447)
..+. +..+++.+.+++.+||+.||.+|||+.++++.|+++.++......
T Consensus 246 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~ 294 (298)
T 3pls_A 246 RLPQ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294 (298)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred CCCC---CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence 3332 345678999999999999999999999999999999988765543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=342.50 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=214.4
Q ss_pred CCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEE
Q 013214 152 PHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 220 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 220 (447)
....+|...+.||+|+||.|+. +++.||+|++... ......+.+.+|+.+++++ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 3445788899999999998874 2378999999754 3455567889999999999 7999999999998
Q ss_pred eCCc-eEEEEeccCCCCHHHHHHhcCC-----------------------------------------------------
Q 013214 221 QSSP-MMIVTEYLPKGDLRAFLKRKGA----------------------------------------------------- 246 (447)
Q Consensus 221 ~~~~-~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 246 (447)
..+. .+++|||+++|+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 7654 8999999999999999976533
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-CCcc
Q 013214 247 -------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLT 312 (447)
Q Consensus 247 -------------l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~ 312 (447)
+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 889999999999999999999999 99999999999999999999999999986543222 1223
Q ss_pred cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHH
Q 013214 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 313 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 390 (447)
...+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+......... .... +..+++++.++|.
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~ 330 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTML 330 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHH
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC---CCCCCHHHHHHHH
Confidence 3456889999999988889999999999999999998 999998877655443333333 3332 3457789999999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 391 ECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+||+.||.+|||+.+++++|+.+.++-
T Consensus 331 ~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 999999999999999999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=337.34 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=200.1
Q ss_pred cCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
.+|+..+.||+|+||.|+. +|+.||+|++...... .......+.+|+.+++.++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4788899999999998872 6889999999765322 223445678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
.. .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.. ....+ +..+++.+
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-~~~~~---p~~~~~~~ 248 (327)
T 3a62_A 174 DG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK-CKLNL---PPYLTQEA 248 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCC---CTTSCHHH
T ss_pred CC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-CCCCC---CCCCCHHH
Confidence 21 122345689999999999988899999999999999999999999998776555555433 23332 34567899
Q ss_pred HHHHHHHcccCCCCCC-----CHHHHHHH
Q 013214 386 KELIEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
.++|.+||+.||.+|| ++.+++++
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 9999999999999999 77788764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.76 Aligned_cols=257 Identities=27% Similarity=0.487 Sum_probs=203.8
Q ss_pred CcCcccceeeecceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 154 ELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
..+|+..+.||+|+||.|+. ....||+|++.... ......+.+.+|+.++++++||||+++++++ .....+++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 44788899999999999873 55679999997654 3556678899999999999999999999965 55678999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC-CC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DR 309 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~-~~ 309 (447)
+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999999999654 56999999999999999999999999 9999999999999999999999999997654321 12
Q ss_pred CcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC--CCCCCCChhhhHHH
Q 013214 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARG 384 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 384 (447)
......+|+.|+|||.+. +..++.++||||||+++|+|++|+.||......+......... .+........+++.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence 223456899999999986 5567889999999999999999999998766554433332332 33334445578899
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
+.++|.+||+.||.+|||+.++++.|+++.+
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 9999999999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=354.81 Aligned_cols=253 Identities=28% Similarity=0.498 Sum_probs=215.1
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+|...+.||+|+||.|+. ++..||||+++.... ..+.+.+|+.++++++||||+++++++. ....++|||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 4677888999999998873 478899999976432 2467889999999999999999999986 567899999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999754 36889999999999999999999999 99999999999999999999999999986543211
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......+|+.|+|||.+....++.++||||||+++|+|++ |+.||.+....+....+....+.+. +..+++.+.+
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~ 416 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---PENCPEELYN 416 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC---CTTSCHHHHH
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHH
Confidence 12233446788999999988889999999999999999999 9999998887777666655444443 3467889999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
+|.+||+.||++|||+.++++.|+++.+...
T Consensus 417 li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred HHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999876544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=353.51 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=208.3
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|...+.||+|+||.|+. +|+.||+|++.+.........+.+.+|..++..++||||+++++++.+.+.+|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 345788889999999998863 689999999865322222233457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
||||++||+|.+++.+.+ .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++++||+|||++......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999999999998754 7999999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcccCCCCCcccCCcccC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCCh
Q 013214 307 EDRPLTCQDTSCRYVAPEVFK-------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPA 378 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 378 (447)
.........||+.|+|||++. +..++.++|+|||||++|+|++|+.||...+..+....+.... ...++...
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 222233457899999999986 3568999999999999999999999999877666655553322 23333334
Q ss_pred hhhHHHHHHHHHHHcccCCCCC---CCHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKR---PTFRQIITR 409 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~R---ps~~~~l~~ 409 (447)
..+|++++++|++||. +|.+| |++.+++++
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 5678999999999999 99998 589988764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=327.81 Aligned_cols=259 Identities=24% Similarity=0.415 Sum_probs=218.5
Q ss_pred cCcccce-eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 155 LDFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 155 ~~~~~~~-~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
.+|.... .||+|+||.|+. ++..||+|++... ......+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 3455554 899999998862 5788999999764 3456678899999999999999999999999 556799
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++|||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999999754 45999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 306 KED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 306 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+....++.+ +..++
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~ 239 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPECP 239 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTTCC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC---CCCcC
Confidence 222 11223446889999999988889999999999999999998 9999998877766666655444443 34678
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccc
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 422 (447)
+.+.++|.+||+.||.+||++.+++++|+.+..+.....+
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 8999999999999999999999999999999888765443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=354.68 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=208.9
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|...+.||+|+||.|+. +++.||+|++.+.........+.+.+|..+++.++||||+++++++.+...+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 345788899999999999873 588999999864221111112347789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||||++||+|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++++||+|||++.......
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999999875 46999999999999999999999999 9999999999999999999999999998655332
Q ss_pred CCCcccCCCCCcccCCcccCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYA 382 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 382 (447)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+.... ...++ ....++
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s 301 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP-DDNDIS 301 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-TTCCCC
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC-Cccccc
Confidence 22234567899999999987654 7889999999999999999999999877766666654332 22222 133578
Q ss_pred HHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAK--RPTFRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~--Rps~~~~l~~ 409 (447)
++++++|.+||+.+|.+ ||++.+++++
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 89999999999999988 9999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=339.08 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=206.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc--ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3788899999999998873 68999999986543 2233466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~- 308 (447)
||+++|+|.+++.....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999988888999999999999999999999999 99999999999999999999999999976543221
Q ss_pred CCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||................ .........+++.+.+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 240 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSAPLA 240 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-CTTSTTGGGSCHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-cccCCccccCCHHHHH
Confidence 22234578999999999987765 678999999999999999999998776654333322222 2222234667899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.||.+|||+.+++++
T Consensus 241 li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHccCChhhCcCHHHHhhC
Confidence 9999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=342.73 Aligned_cols=271 Identities=28% Similarity=0.488 Sum_probs=217.0
Q ss_pred CCCcccCCCCcCcccceeeecceEEEEEE-----c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccccee
Q 013214 145 VPEYEIDPHELDFTNSVEITKGTFILAFW-----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216 (447)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~lg~G~~~~~~~-----~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 216 (447)
+....+.+....|...+.||+|+||.|+. + +..||+|.+... ......+.+.+|+.++++++||||++++
T Consensus 79 ~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~ 156 (373)
T 3c1x_A 79 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLL 156 (373)
T ss_dssp TTTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCC
T ss_pred ccccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 44556667777888889999999998872 1 246899998753 3445667899999999999999999999
Q ss_pred EEEEe-CCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 217 GAVTQ-SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 217 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
+++.. ++..++||||+++|+|.+++.+. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp EEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred EEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEE
Confidence 98754 56789999999999999999765 45889999999999999999999999 999999999999999999999
Q ss_pred eecccccccccCCC---CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC
Q 013214 295 ADFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~ 370 (447)
+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+....
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~ 313 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC
Confidence 99999986543211 11233456788999999988899999999999999999999 788998888777766664444
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccch
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRW 423 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~ 423 (447)
+... +..+++.+.++|.+||+.||++|||+.++++.|+.+..........
T Consensus 314 ~~~~---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~ 363 (373)
T 3c1x_A 314 RLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 363 (373)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBC
T ss_pred CCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccccee
Confidence 3332 3457789999999999999999999999999999999988766543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=340.96 Aligned_cols=257 Identities=17% Similarity=0.339 Sum_probs=209.3
Q ss_pred ccCCCCcCcccceeeecc--eEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe
Q 013214 149 EIDPHELDFTNSVEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G--~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 221 (447)
.+.+...+|+..+.||+| +||.|+. +|+.||+|++..... ..+..+.+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 344556689999999999 9988863 589999999976543 45667888999999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGG
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccc
Confidence 99999999999999999999875 66999999999999999999999999 99999999999999999999999998
Q ss_pred ccccccCC------CCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC
Q 013214 300 SKLLTVKE------DRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (447)
Q Consensus 300 ~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~ 371 (447)
+....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 76442211 011123467899999999987 5789999999999999999999999988766554433221111
Q ss_pred CC------------------------------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 PP------------------------------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ~~------------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+. ....+..+++.+.+||++||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 001234567889999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=334.64 Aligned_cols=258 Identities=28% Similarity=0.484 Sum_probs=203.0
Q ss_pred CcCcccceeeecceEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
..+|+..+.||+|+||.|+. ++ ..||+|++...... ....+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 44788899999999998873 22 27999999765433 34467889999999999999999999999877654
Q ss_pred ------EEEEeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEE
Q 013214 226 ------MIVTEYLPKGDLRAFLKRKG------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (447)
Q Consensus 226 ------~lv~e~~~~g~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vk 293 (447)
+++|||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999996532 5899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCC
Q 013214 294 VADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 371 (447)
|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 999999986543221 12223456788999999988889999999999999999999 9999998888777766655444
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 372 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
... +..+++.+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 258 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 258 LKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp CCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred CCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 333 34577899999999999999999999999999999877653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=328.98 Aligned_cols=267 Identities=28% Similarity=0.502 Sum_probs=220.9
Q ss_pred CCcccCCCCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeE
Q 013214 146 PEYEIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (447)
Q Consensus 146 ~~~~i~~~~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 217 (447)
+...+++...+|+..+.||+|+||.|+. ++..||+|.+... ......+.+.+|+.++++++||||+++++
T Consensus 16 ~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 93 (298)
T 3f66_A 16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLG 93 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred hheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence 4556777788899999999999998872 1235899998753 45566788999999999999999999999
Q ss_pred EEE-eCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEe
Q 013214 218 AVT-QSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (447)
Q Consensus 218 ~~~-~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~ 295 (447)
++. .++..+++|||+++|+|.+++.+. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 94 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 170 (298)
T 3f66_A 94 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVA 170 (298)
T ss_dssp EECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEEC
Confidence 864 556789999999999999999764 45899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCC---CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCC
Q 013214 296 DFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (447)
Q Consensus 296 Dfg~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 371 (447)
|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+.....
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 250 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence 9999986543221 12234456788999999988889999999999999999999 6778887777776666644443
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 372 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
... +..+++.+.+++.+||+.||.+|||+.++++.|+.+...+..+
T Consensus 251 ~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 251 LLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred CCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 332 3456788999999999999999999999999999998876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=333.25 Aligned_cols=245 Identities=22% Similarity=0.391 Sum_probs=208.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|...+.||+|+||.|+. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..+++||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 355667899999998873 689999999875432 234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 197 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-c
Confidence 9999999998864 56999999999999999999999999 99999999999999999999999999886553221 2
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.....+.+ .....+++.+.++|.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLRDFLE 276 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHHHHHH
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHHHHHH
Confidence 2345689999999999988999999999999999999999999987766555555533333333 234567889999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.||++|||+.+++++
T Consensus 277 ~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 277 RMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHSCSSTTTSCCHHHHHTS
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=331.36 Aligned_cols=256 Identities=29% Similarity=0.492 Sum_probs=219.9
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|+..+.||+|+||.|+. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 345788889999999987763 48899999987532 345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 228 VTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999874 34899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
..........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+........ +..+++.
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 240 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---PEGCPEK 240 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC---CTTCCHH
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC---CCCCCHH
Confidence 33323333445788999999988889999999999999999999 9999998887777666654444333 3467889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 241 l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999999887654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=327.50 Aligned_cols=258 Identities=24% Similarity=0.469 Sum_probs=205.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|+.||+|++...........+.+.+|+.+++.++||||+++++++...+..+++|
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 3788999999999998873 68999999998655556677788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 230 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999864 456899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc--hHHHHHhcCCCCCCCChhhhHH
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE--VPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+.....++. ....+++
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 265 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSE 265 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC--CTTTSCH
T ss_pred CC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC--cccccCH
Confidence 22 12233457899999999998889999999999999999999999998654432 2222322222222 2345788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
.+.++|.+||+.||.+|||+.++++.|+++.....
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 99999999999999999999999999999877653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=331.22 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=202.6
Q ss_pred CcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..+|+..+.||+|+||.|+. +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34799999999999998873 688999999975432 3334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||++ ++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 9996 5888888765 45999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCC-----------
Q 013214 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA----------- 376 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 376 (447)
.......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+......+.+.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 22334567999999999876 468999999999999999999999999887776655543221111000
Q ss_pred ---------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 ---------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ---------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.+++++.++|.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 012356789999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=330.92 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=217.5
Q ss_pred CCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEE
Q 013214 152 PHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 220 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 220 (447)
....+|...+.||+|+||.|+. +++.||+|++... ......+.+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc--hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 3345788899999999998863 3578999999754 2445567889999999999 9999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~ 282 (447)
..+..+++|||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 9999999999999999999998654 3899999999999999999999999 999999999
Q ss_pred CEEEcCCCCEEEeecccccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 013214 283 NILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 360 (447)
Q Consensus 283 Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~ 360 (447)
||+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 9999999999999999998765432211 123345788999999988889999999999999999999 99999887765
Q ss_pred chHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
.............. .+..+++.+.++|.+||+.||.+|||+.+++++|+++..+..
T Consensus 255 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 255 SKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred hHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 54444433332221 234577899999999999999999999999999999876543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=354.08 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=202.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|+.||+|++.............+.+|+.+++.++||||+++++++...+.+++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 3688889999999999873 68899999997654444455567788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++|+|.+++...+.+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||++.......
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 303 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 303 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence 999999999999988899999999999999999999998 88 9999999999999999999999999997543221
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ...+ +..+++++.++
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~~~~l 379 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRF---PRTLGPEAKSL 379 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTSCHHHHHH
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-CCCC---CccCCHHHHHH
Confidence 2234467899999999999989999999999999999999999999887766665555333 2332 34577899999
Q ss_pred HHHHcccCCCCCC-----CHHHHHHH
Q 013214 389 IEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
|.+||+.||.+|| ++.+++++
T Consensus 380 i~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 380 LSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 9999999999999 99999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=342.72 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=202.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+|+..+.||+|+||.|+. +|+.||+|++..... ......+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 688889999999999873 589999999854221 1111246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC---EEEeeccccc
Q 013214 229 TEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSK 301 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~---vkl~Dfg~~~ 301 (447)
|||+++++|.+++.+. ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++.
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999888643 34899999999999999999999999 999999999999986654 9999999998
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhh
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (447)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... +....+........+.....+
T Consensus 182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 182 QLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp ECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTTS
T ss_pred EecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCccccccC
Confidence 765322 222345689999999999988899999999999999999999999987432 233333222221111122457
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+.++|.+||+.||++|||+.+++++
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 8899999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=327.98 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=219.1
Q ss_pred CCCCcccCCC-CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeE
Q 013214 144 EVPEYEIDPH-ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (447)
Q Consensus 144 ~~~~~~i~~~-~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 217 (447)
++|+..+++. ..+|...+.||+|+||.|+. +++.||+|++...........+.+.+|+.+++.++||||+++++
T Consensus 3 ~~p~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 82 (294)
T 2rku_A 3 EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82 (294)
T ss_dssp CCCSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCcceeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence 4455545433 34789999999999998873 57899999998766566677788999999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 218 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
++.+.+..+++|||+++++|.+++...+.+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred eeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEec
Confidence 99999999999999999999999988888999999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCC
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 377 (447)
|++....... .......+|+.|+|||.+.+..++.++|+||||+++|+|++|+.||......+....+... ...+
T Consensus 160 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~--- 234 (294)
T 2rku_A 160 GLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSI--- 234 (294)
T ss_dssp TTCEECCSTT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCC---
T ss_pred cCceecccCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-cCCC---
Confidence 9998654322 2223456799999999998888999999999999999999999999876655544444222 2222
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 34567889999999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=342.88 Aligned_cols=243 Identities=26% Similarity=0.410 Sum_probs=199.4
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHH-HhcCCCCcccceeEEEEeCCceEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
..+|...+.||+|+||.|+. +++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 34788999999999998873 578999999987665555555667777776 567899999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||||++||+|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+|||++.+|++||+|||++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 9999999999999998888999999999999999999999999 999999999999999999999999999864322
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+... ...+ +..++..+.+
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~---~~~~~~~~~~ 268 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQL---KPNITNSARH 268 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-CCCC---CSSSCHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-ccCC---CCCCCHHHHH
Confidence 22234567899999999999989999999999999999999999999987766666555333 2222 3457789999
Q ss_pred HHHHHcccCCCCCCCHH
Q 013214 388 LIEECWNEKPAKRPTFR 404 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~ 404 (447)
+|.+||+.||.+||++.
T Consensus 269 li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHTCSSGGGSTTTT
T ss_pred HHHHHcccCHHhCCCCC
Confidence 99999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.40 Aligned_cols=247 Identities=18% Similarity=0.347 Sum_probs=209.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 4688899999999999873 6889999998654 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC--CCCEEEeecccccccccC
Q 013214 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~--~~~vkl~Dfg~~~~~~~~ 306 (447)
||+++|+|.+++...+ .+++..++.++.|++.||.|||+.+ ++||||||+||+++. .+.+||+|||++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999997654 6999999999999999999999999 999999999999984 577999999999876432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..............+++++.
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 205 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred --cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 222344689999999999988899999999999999999999999998766555555533332222223456789999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||+.||.+|||+.+++++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=326.12 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=213.9
Q ss_pred CcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..+|+..+.||+|+||.|+. ++..||+|.+...... .+.+.+|+.+++.++||||+++++++.. +..+++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 34788889999999998873 4678999998754322 3568899999999999999999998864 5689999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 230 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999997543 6999999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+........ +..+++.+.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 240 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCPEELY 240 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHH
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC---cccccHHHH
Confidence 222334456788999999988888999999999999999999 9999998776666555544333332 346788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
+++.+||+.||++|||+.++++.|+.+.+.....
T Consensus 241 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred HHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 9999999999999999999999999998776543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=353.81 Aligned_cols=246 Identities=28% Similarity=0.443 Sum_probs=210.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++........+....+.+|+.+++.++||||+++++++......++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3688889999999998863 68999999986543222233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++.+++.+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--E 170 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT--C
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc--c
Confidence 99999999999988888999999999999999999999999 999999999999999999999999999875432 2
Q ss_pred CcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.......+.... .. .+..+++++.++
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~---~p~~~s~~~~~L 246 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-FY---TPQYLNPSVISL 246 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-CC---CCTTCCHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-cC---CCccCCHHHHHH
Confidence 2344568999999999988765 679999999999999999999999877666655553332 22 234567899999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.||.+|||+.+++++
T Consensus 247 i~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHcCCCchhCcCHHHHHhC
Confidence 999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.92 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=210.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
..+|...+.||+|+||.|+. +|+.||+|.+........ ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34688899999999998873 588999999875432211 1246788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC----CEEEeeccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSK 301 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~----~vkl~Dfg~~~ 301 (447)
+++|||+++++|.+++...+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999999998888999999999999999999999999 99999999999999887 79999999998
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCC-CChhh
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK-APAKL 380 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 380 (447)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.... ..++ .....
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 244 (321)
T 2a2a_A 168 EIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS-YDFDEEFFSH 244 (321)
T ss_dssp ECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC-CCCCHHHHTT
T ss_pred ecCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-cccChhhhcc
Confidence 65532 22234568999999999998899999999999999999999999998776655555543322 2221 11245
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+.++|.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 67889999999999999999999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=354.95 Aligned_cols=254 Identities=28% Similarity=0.498 Sum_probs=217.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|...+.||+|+||.|+. ++..||||.+..... ..+.+.+|+.++++++||||+++++++......++|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 34677888999999987763 378999999976432 246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 229 TEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|||+++|+|.+++.+. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999864 35899999999999999999999999 999999999999999999999999999876433
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
.........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+....+... +..+++.+
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l 448 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---PEGCPEKV 448 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC---CTTCCHHH
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHH
Confidence 2222233456788999999988889999999999999999999 9999998887777766654444433 34678899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 386 KELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
.++|.+||+.||.+|||+.++++.|+.+....
T Consensus 449 ~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 449 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred HHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 99999999999999999999999998875443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=337.83 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=194.0
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|...+.||+|+||.|+. +++.||+|++.... ..+.+.+|+.++++++||||+++++++......++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 34688899999999998873 57889999987432 235678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeeccccccccc
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV 305 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg~~~~~~~ 305 (447)
|||+++|+|.+++.+.+.+++.+++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||++.....
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999988888999999999999999999999999 999999999999975 88999999999986543
Q ss_pred CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHhcCCCCCCCChhhhHHH
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
. .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......+ ....+..............++..
T Consensus 204 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 204 Q--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred c--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 2 22234568999999999998899999999999999999999999998766554 33333222222222334567889
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.++|++||+.||++|||+.+++++
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=329.98 Aligned_cols=259 Identities=26% Similarity=0.439 Sum_probs=208.1
Q ss_pred CCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-
Q 013214 153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 223 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 223 (447)
...+|...+.||+|+||.|+. ++..||+|.+..... .....+.+.+|+.++++++||||+++++++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345788889999999998762 345899999976543 4556678899999999999999999999997654
Q ss_pred ----ceEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEE
Q 013214 224 ----PMMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (447)
Q Consensus 224 ----~~~lv~e~~~~g~L~~~l~~------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vk 293 (447)
..+++|||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 35999999999999999953 345999999999999999999999999 99999999999999999999
Q ss_pred EeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCC
Q 013214 294 VADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 371 (447)
|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 999999976543221 12233456889999999988889999999999999999999 9999998887777666644444
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 372 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
+.. +..+++.+.++|.+||+.||.+|||+.+++++|+++.+++.
T Consensus 268 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 268 LKQ---PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp CCC---BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCC---CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 433 45678899999999999999999999999999999987764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.70 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=212.7
Q ss_pred CCCCcccCCCCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEE
Q 013214 144 EVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (447)
Q Consensus 144 ~~~~~~i~~~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 219 (447)
..+..++.....+|...+.||+|+||.|+. +|+.||+|++..... ......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC--chHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 344445566667899999999999999874 588999999975432 12223688899999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCCeEeCCCCCCCEEEcCCCCE
Q 013214 220 TQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHEN---KPVPIIHRDLEPSNILRDDSGNL 292 (447)
Q Consensus 220 ~~~~~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~lH~~---~~~~i~H~Dikp~Nill~~~~~v 292 (447)
......++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCE
Confidence 99999999999999999999998643 389999999999999999999999 7 9999999999999999999
Q ss_pred EEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-----CCCCchHHHHH
Q 013214 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-----KHDNEVPKAYA 367 (447)
Q Consensus 293 kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~-----~~~~~~~~~~~ 367 (447)
||+|||++...............||+.|+|||.+.+..++.++||||||+++|+|++|+.||.. ...........
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999999987654433334455689999999999888899999999999999999999999962 11111111111
Q ss_pred hcCC---------CC-CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 368 ARQR---------PP-FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 368 ~~~~---------~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
.... .. ........+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1000 00 012245567899999999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.68 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=211.4
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--CceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 229 (447)
.+|...+.||+|+||.|+ .+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+. ...+++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 368888999999998776 5799999999986543 445567899999999999999999999999877 7889999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 230 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||+++|+|.+++.+.. .+++..++.++.|++.||.|||+.+ .+++|+||||+||+++.++.++++|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 9999999999998765 4899999999999999999999976 3599999999999999999999999988754221
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCC---chhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCChhhhHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR 383 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~---~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 383 (447)
....+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||......+......... .+.+ +..+++
T Consensus 166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 238 (271)
T 3kmu_A 166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI---PPGISP 238 (271)
T ss_dssp ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC---CTTCCH
T ss_pred ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC---CCCCCH
Confidence 2345689999999998765554 7999999999999999999999877665544443333 3333 446788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
.+.++|.+||+.||++|||+.++++.|+.+.+
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=336.80 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=210.5
Q ss_pred CCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe
Q 013214 153 HELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 221 (447)
...+|...+.||+|+||.|+. ++..||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 345788889999999998863 34689999997542 334457788999999999 89999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~D 278 (447)
.+..++||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 999999999999999999997643 2789999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCCEEEeecccccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 013214 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM 356 (447)
Q Consensus 279 ikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~ 356 (447)
|||+||+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999998665432211 223345788999999988889999999999999999998 9999998
Q ss_pred CCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 357 KHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 357 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
.............. .+.. +..+++.+.++|.+||+.||.+|||+.+++++|+.+.....
T Consensus 278 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCcHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 77665444433333 3222 34567899999999999999999999999999999876654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.08 Aligned_cols=247 Identities=25% Similarity=0.468 Sum_probs=207.6
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|+..+.||+|+||.|+. +++.||+|++.............+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 344788899999999998873 467899999865432222334678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
+|||+++++|.+++.+...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 9999999999999998888999999999999999999999999 999999999999999999999999998654322
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.. ....+ +..+++.+.+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~ 236 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTF---PDFVTEGARD 236 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-TCCCC---CTTSCHHHHH
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-CCCCC---CCcCCHHHHH
Confidence 22345679999999999988899999999999999999999999997766555554422 22222 3446788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.||.+|||+.+++++
T Consensus 237 li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHhccChhhCCCHHHHhhC
Confidence 9999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.30 Aligned_cols=244 Identities=21% Similarity=0.338 Sum_probs=201.9
Q ss_pred ccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 158 ~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
...+.||+|+||.|+. +|+.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 3356799999998873 5889999998754 3345678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE--cCCCCEEEeecccccccccCCCC
Q 013214 233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--DDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 233 ~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill--~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...... .
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~ 243 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--E 243 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--C
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--c
Confidence 999999988754 46999999999999999999999999 9999999999999 56778999999999876532 2
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..............+++++.++|
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 22345689999999999888899999999999999999999999998776666555533332222223456789999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+||+.||.+|||+.+++++
T Consensus 324 ~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHS
T ss_pred HHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.01 Aligned_cols=254 Identities=31% Similarity=0.502 Sum_probs=210.3
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+|+..+.||+|+||.|+. .+..||||+++..... .+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 4677888999999998863 3468999999865422 3568899999999999999999999876 67899999
Q ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++........
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999974 356999999999999999999999999 99999999999999999999999999987653322
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+....+....+.+. +..+++.+.+
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~ 412 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPESLHD 412 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHH
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHH
Confidence 22334456788999999988889999999999999999999 9999998877777666655444443 3467889999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
+|.+||+.||++|||+.++++.|+.+.+....
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 99999999999999999999999998766544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=331.73 Aligned_cols=260 Identities=28% Similarity=0.497 Sum_probs=213.2
Q ss_pred CCcCcccceeeecceEEEEEE---c------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 153 HELDFTNSVEITKGTFILAFW---R------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~---~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
...+|...+.||+|+||.|+. . +..||+|.+.... .......+.+|+.++++++||||+++++++...+
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 344677888999999998863 1 2359999997542 4556677899999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999865 56999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChh
Q 013214 303 LTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379 (447)
Q Consensus 303 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (447)
....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+....+.+. +.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~---~~ 273 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---PM 273 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC---cc
Confidence 6433211 1122345788999999988889999999999999999999 9999988776666666544434333 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
.+++.+.++|.+||+.||.+||++.++++.|+.+.......
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 57789999999999999999999999999999988766544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=334.67 Aligned_cols=255 Identities=24% Similarity=0.487 Sum_probs=209.0
Q ss_pred CcCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
..+|+..+.||+|+||.|+. +|+ .||+|.+.... .....+.+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-S
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-C
Confidence 44788899999999998873 343 46888876432 334457788999999999999999999999875 4
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.++++||+.+|+|.+++.+. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++++||+|||++...
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 78999999999999999874 56999999999999999999999999 999999999999999999999999999866
Q ss_pred ccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhh
Q 013214 304 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 304 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (447)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+......+. +..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 244 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPIC 244 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTTB
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC---CccC
Confidence 433222 2233456889999999999899999999999999999999 9999998887777666655444433 3456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+..+.+++.+||+.||.+||++.+++++|+.+....
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 788999999999999999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=338.38 Aligned_cols=248 Identities=27% Similarity=0.373 Sum_probs=196.0
Q ss_pred CCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
....+|...+.||+|+||.|+. +|+.||+|++....... +.+.+|+.+++.++||||+++++++......+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 3445799999999999997762 68999999997544322 45778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC--EEEeecccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFGVSKLLT 304 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~--vkl~Dfg~~~~~~ 304 (447)
+||||+++|+|.+++...+++++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999999988889999999999999999999999999 999999999999987665 9999999987433
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc---CCCCCCCChhh
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QRPPFKAPAKL 380 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 380 (447)
.. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............... ....++ ....
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 246 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP-DDIR 246 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC-TTSC
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC-CcCC
Confidence 22 22234568999999999988777665 89999999999999999999876654433222111 122221 2234
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+.++|.+||+.||.+|||+.+++++
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 67899999999999999999999999976
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=323.76 Aligned_cols=246 Identities=23% Similarity=0.370 Sum_probs=208.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. ++..||+|++....... .+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 3688889999999998873 46789999987654333 457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE---cCCCCEEEeecccccccccC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill---~~~~~vkl~Dfg~~~~~~~~ 306 (447)
||+++++|.+++...+.+++..++.++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999999998888999999999999999999999999 9999999999999 78889999999999865532
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.......+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+....+..............+++.+.
T Consensus 163 --~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 163 --KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp --SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred --cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 22344568999999999866 489999999999999999999999998776666555533332221111235788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||+.||.+|||+.+++++
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=326.92 Aligned_cols=257 Identities=16% Similarity=0.251 Sum_probs=212.8
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|...+.||+|+||.|+ .+|+.||+|++..... .+.+.+|+.+++.+ +|||++++++++......+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 468889999999999886 3689999998864432 13577899999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC-----EEEeecccccc
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSKL 302 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~-----vkl~Dfg~~~~ 302 (447)
|||+ +++|.+++...+ ++++..++.++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||++..
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999 999999998754 5999999999999999999999999 999999999999987776 99999999987
Q ss_pred cccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH---HhcC-CC
Q 013214 303 LTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQ-RP 372 (447)
Q Consensus 303 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~~~~-~~ 372 (447)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||............ .... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 654322 1224456899999999999988999999999999999999999999986654332222 1111 12
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
+.......+++.+.+++.+||+.||++||++.++++.|+++.+.....
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 221122356789999999999999999999999999999998877543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=325.60 Aligned_cols=249 Identities=30% Similarity=0.538 Sum_probs=206.4
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-CceEEEE
Q 013214 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVT 229 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~ 229 (447)
..+|+..+.||+|+||.|+ .+|+.||+|.+.... ..+.+.+|+.++++++||||+++++++... +..+++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 4578889999999998776 589999999987542 346788999999999999999999987554 5789999
Q ss_pred eccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 230 EYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||+++++|.+++.+.+. +++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999999999986543 899999999999999999999999 999999999999999999999999998764432
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.....+.. +..+++.+.
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 244 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDGCPPAVY 244 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC---CTTCCHHHH
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---cccCCHHHH
Confidence 122346888999999988889999999999999999998 9999998877766666544333332 356788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
++|.+||+.||.+|||+.++++.|+.+.+..
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 9999999999999999999999999987653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=355.21 Aligned_cols=248 Identities=25% Similarity=0.456 Sum_probs=213.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 688889999999999873 689999999876544444455778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE---cCCCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill---~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|+.+|+|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++......
T Consensus 107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 182 (484)
T 3nyv_A 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS- 182 (484)
T ss_dssp CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-
Confidence 9999999999998889999999999999999999999999 9999999999999 46789999999999865432
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.+..+....+.........+.+..+|+.+.+
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 183 -KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp -CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred -cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 22334568999999999876 6899999999999999999999999988777666666444322222334578899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.||.+|||+.+++++
T Consensus 261 li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHCCCChhHCcCHHHHhhC
Confidence 9999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=327.86 Aligned_cols=252 Identities=25% Similarity=0.514 Sum_probs=204.3
Q ss_pred cCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--C
Q 013214 155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--S 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 223 (447)
..|+..+.||+|+||.|+. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 3588889999999998862 68999999997543 223456788999999999999999999999876 6
Q ss_pred ceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
..+++|||+++++|.+++.+ ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 68999999999999999955 456999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----------CC----chHHH
Q 013214 303 LTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH-----------DN----EVPKA 365 (447)
Q Consensus 303 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~-----------~~----~~~~~ 365 (447)
...... .......+|..|+|||.+.+..++.++||||||+++|+|++|+.|+.... .. .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 654322 12234557888999999988888999999999999999999999864221 11 11111
Q ss_pred HHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 366 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
+......+ .+..+++.+.++|.+||+.||.+|||+.++++.|+.+.
T Consensus 256 ~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 21222222 34567889999999999999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=323.45 Aligned_cols=254 Identities=30% Similarity=0.491 Sum_probs=205.4
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHH----HHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRV----RAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
...+|+..+.||+|+||.|+. +++.||+|++........... +.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 345788899999999998762 688999999876443332222 67889999999999999999999987654
Q ss_pred ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC-----EEEeec
Q 013214 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADF 297 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~-----vkl~Df 297 (447)
+++|||+++|+|.+++.+. ..+++..++.++.|++.||.|||+.+ .+++|+||||+||+++.++. +||+||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 7999999999999988654 46999999999999999999999986 34999999999999988776 999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCC
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 375 (447)
|++..... ......+|+.|+|||.+. ...++.++||||||+++|+|++|+.||.....................
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 99875332 233456899999999984 446788999999999999999999999877766542222111111112
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 376 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
..+..+++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 23456788999999999999999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=351.28 Aligned_cols=249 Identities=25% Similarity=0.428 Sum_probs=208.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH----------HHHHHHHHHHHHHhcCCCCcccceeEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD----------DRVRAFRDELALLQKIRHPNVVQFLGA 218 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~ 218 (447)
..+|...+.||+|+||.|+. +++.||+|++........ ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34788999999999999873 578999999876543211 234678899999999999999999999
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC---CEEEe
Q 013214 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVA 295 (447)
Q Consensus 219 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~---~vkl~ 295 (447)
+.+....++||||+++|+|.+++...+.+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999999998889999999999999999999999999 99999999999999776 69999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCC
Q 013214 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375 (447)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 375 (447)
|||++...... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.... ..++
T Consensus 192 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~ 267 (504)
T 3q5i_A 192 DFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK-YYFD 267 (504)
T ss_dssp CCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCC
T ss_pred ECCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCC
Confidence 99999876532 23344568999999999864 68999999999999999999999999887776666664433 2221
Q ss_pred -CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 376 -APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 376 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+..+|+++.++|++||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2234678899999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=328.53 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=206.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC--ceE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~ 226 (447)
..+|...+.||+|+||.|+. +|+.||+|++..... ....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 45788999999999998873 489999999875432 222456778999999999999999999998765 789
Q ss_pred EEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE----cCCCCEEEeeccc
Q 013214 227 IVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGV 299 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill----~~~~~vkl~Dfg~ 299 (447)
+||||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999986433 999999999999999999999999 9999999999999 7778899999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc----hHHHHH
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFK--------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYA 367 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~----~~~~~~ 367 (447)
+....... ......+|+.|+|||++. +..++.++|||||||++|+|++|+.||....... ....+.
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred ceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 98765332 223456899999999875 4678899999999999999999999997654432 222221
Q ss_pred hcCC---------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 368 ARQR---------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 368 ~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
.... +........++..+.++|++||+.||++|||+.+++++..+...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 1111 11112345678899999999999999999999999999886443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=332.05 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=215.5
Q ss_pred CCCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE
Q 013214 151 DPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (447)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 220 (447)
.....+|...+.||+|+||.|+. +++.||+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34445788999999999998863 3678999999754 34455677889999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~ 290 (447)
+....+++|||+++|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 999999999999999999999753 35689999999999999999999999 99999999999999999
Q ss_pred CEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHh
Q 013214 291 NLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 368 (447)
Q Consensus 291 ~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~ 368 (447)
.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 9999999999765432211 1123345788999999988889999999999999999999 8999988776666555544
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
...+. .+..+++.+.++|.+||+.||.+|||+.+++++|+++..
T Consensus 256 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 GGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 43333 245678899999999999999999999999999987644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=330.83 Aligned_cols=255 Identities=26% Similarity=0.509 Sum_probs=211.2
Q ss_pred CcccceeeecceEEEEE---E------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC--Cc
Q 013214 156 DFTNSVEITKGTFILAF---W------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 224 (447)
.|+..+.||+|+||.|+ + +|+.||+|++... ......+.+.+|+.++++++||||+++++++.+. ..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 34888999999999984 2 6899999999765 3456677899999999999999999999999874 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.++||||+++|+|.+++.+. .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 89999999999999999764 4999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC---------------chHHHHH
Q 013214 305 VKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------------EVPKAYA 367 (447)
Q Consensus 305 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~---------------~~~~~~~ 367 (447)
.... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 4321 1123445788899999998888899999999999999999999998754221 0111111
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
.....+ .+..+++.+.++|.+||+.||.+|||+.++++.|+.+.+.+..
T Consensus 266 ~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 266 RGERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred cccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 122222 3456788999999999999999999999999999999887764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=326.84 Aligned_cols=248 Identities=21% Similarity=0.414 Sum_probs=199.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++..... .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 688889999999998863 588999999976543 33445678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|+++ +|.+.+.. ++.+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VR 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-cc
Confidence 9965 66655554 677999999999999999999999999 999999999999999999999999999866432 22
Q ss_pred CcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCC-CCCCCchHHHHHhc-CCCC-------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAAR-QRPP------------- 373 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~-~~~~~~~~~~~~~~-~~~~------------- 373 (447)
......+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||. ..+..+....+... ..+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 234456799999999987765 7999999999999999999877754 33333322222111 1100
Q ss_pred -----------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 -----------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 -----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....+.+++.+.++|++||+.||++|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 011123467899999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=323.38 Aligned_cols=255 Identities=26% Similarity=0.446 Sum_probs=209.3
Q ss_pred cccceeeecceEEEEEE---cCeEEEEEEcCccc-CCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 157 FTNSVEITKGTFILAFW---RGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~---~g~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
|...+.||+|+||.|+. +++.||+|++.... .......+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 33447899999998874 78999999986532 233455678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 233 PKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 233 ~~g~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
++++|.+++.. ..++++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99999999974 345999999999999999999999999 999999999999999999999999998765432221
Q ss_pred -CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh---c--------CCCCCCCC
Q 013214 310 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---R--------QRPPFKAP 377 (447)
Q Consensus 310 -~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---~--------~~~~~~~~ 377 (447)
......+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........+.. . ....+...
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 1233468999999998865 588999999999999999999999987665443222111 0 11223334
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
+..++..+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 56678899999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=333.78 Aligned_cols=254 Identities=16% Similarity=0.238 Sum_probs=210.0
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|...+.||+|+||.|+ .+|+.||+|++...... +.+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 468888999999998776 36899999998654321 3577899999999 999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC-----EEEeecccccc
Q 013214 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSKL 302 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~-----vkl~Dfg~~~~ 302 (447)
|||+ +++|.+++... +.+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999 99999999874 67999999999999999999999999 999999999999998887 99999999986
Q ss_pred cccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc---CC-C
Q 013214 303 LTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QR-P 372 (447)
Q Consensus 303 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---~~-~ 372 (447)
....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+........ .. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 5433221 123567899999999999989999999999999999999999999987665543333211 11 1
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
+.......++ ++.+++..||+.||.+||++.++.+.|+++.+...
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 1100112245 89999999999999999999999999999887763
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=349.81 Aligned_cols=247 Identities=23% Similarity=0.423 Sum_probs=206.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. ++..||+|++...... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999873 6889999998764322 2224668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC---CCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~---~~vkl~Dfg~~~~~~~~~ 307 (447)
|+++|+|.+++.....+++..++.++.|++.||.|||+.+ |+||||||+||+++.. +.+||+|||++......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 9999999999998889999999999999999999999999 9999999999999764 45999999999876532
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+..............+|+.+.+
T Consensus 193 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred -ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 2334456899999999986 46899999999999999999999999988877766666444333222334567899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|++||+.||.+|||+.+++++
T Consensus 271 li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHCCCChhhCccHHHHhcC
Confidence 9999999999999999999965
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=335.82 Aligned_cols=244 Identities=26% Similarity=0.461 Sum_probs=208.0
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..|...+.||+|+||.|+ .+|+.||+|++...........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 357888899999999887 368999999997655455666778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9996 688888854 567999999999999999999999999 999999999999999999999999999765422
Q ss_pred CCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 385 (447)
....+|+.|+|||++. +..++.++||||||+++|+|++|+.||...+.......+.....+.. ....+++.+
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 282 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYF 282 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHHH
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCHHH
Confidence 3356899999999984 45788999999999999999999999987765555444444443333 234578899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHH
Q 013214 386 KELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++|.+||+.||++|||+.+++++
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHcccChhhCcCHHHHhhC
Confidence 999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=326.94 Aligned_cols=250 Identities=31% Similarity=0.588 Sum_probs=201.2
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
.+|...+.||+|+||.|+ +.++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 367788899999998775 67899999998632 345678899999999999999999998763 57999999
Q ss_pred cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC-EEEeecccccccccCC
Q 013214 232 LPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKE 307 (447)
Q Consensus 232 ~~~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~-vkl~Dfg~~~~~~~~~ 307 (447)
+++|+|.+++.... .++...++.++.|+++||.|||+.++.+++||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999998655 3788999999999999999999932122999999999999998887 799999998754422
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHH--HHHhcCCCCCCCChhhhHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGL 385 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l 385 (447)
.....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .......++ ....+++.+
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l 233 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP---LIKNLPKPI 233 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC---CBTTCCHHH
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC---cccccCHHH
Confidence 223457999999999998899999999999999999999999998665443222 222222333 345678899
Q ss_pred HHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 386 KELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 386 ~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus 234 ~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999887664
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=330.93 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=214.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|...+.||+|+||.|+. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 34789999999999998873 5789999999876656667778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++++|.+++.....+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 195 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence 999999999999988888999999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+... ...+ +..+++.+.++
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~l 271 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSI---PKHINPVAASL 271 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCC---CTTSCHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-CCCC---CccCCHHHHHH
Confidence 2223456899999999998888999999999999999999999999876655544444222 2222 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.||++|||+.+++++
T Consensus 272 i~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.59 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=207.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|...+.||+|+||.|+. +|+.||+|++.............+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 34688889999999999873 6899999998654322222345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 229 TEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|||++||+|.+++...+. +++..++.++.|++.||.|||+++ |+||||||+|||++.+|++||+|||++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999987544 999999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH---HhcCCCCCCCChhhhHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQRPPFKAPAKLYAR 383 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 383 (447)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ .......+ +..+++
T Consensus 340 --~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~---p~~~s~ 414 (576)
T 2acx_A 340 --QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY---SERFSP 414 (576)
T ss_dssp --CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC---CTTSCH
T ss_pred --ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC---CccCCH
Confidence 2234457899999999999988999999999999999999999999876543222211 12223333 356789
Q ss_pred HHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
++.++|.+||+.||.+|| ++.+++++
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 999999999999999999 78888865
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=326.88 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=198.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC-----------------------HHHHHHHHHHHHHHhc
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-----------------------DDRVRAFRDELALLQK 206 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~ 206 (447)
.+|+..+.||+|+||.|+. +|+.||+|++....... ....+.+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 3788889999999998873 58999999986543211 1224568899999999
Q ss_pred CCCCcccceeEEEEe--CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 013214 207 IRHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284 (447)
Q Consensus 207 l~hp~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Ni 284 (447)
++||||+++++++.+ ....++||||+++++|.+++ ...++++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 168 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL 168 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence 999999999999986 56789999999999998865 3457999999999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 013214 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (447)
Q Consensus 285 ll~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~ 361 (447)
+++.++.+||+|||++....... .......+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.......
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 99999999999999998654322 1223456899999999997754 3678999999999999999999998766544
Q ss_pred hHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 362 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+... ...++ ....+++.+.++|.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~-~~~~~-~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 248 LHSKIKSQ-ALEFP-DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHC-CCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHhcc-cCCCC-CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 44444222 22222 234577899999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=325.61 Aligned_cols=248 Identities=23% Similarity=0.422 Sum_probs=185.3
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|...+.||+|+||.|+. +|+.||+|++...........+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 34788889999999998862 6889999998643221222346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999875 56999999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
. ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+... .. ..+..++.++.+
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~ 241 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DY---EMPSFLSIEAKD 241 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CC---CCCTTSCHHHHH
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-cc---CCccccCHHHHH
Confidence 2 122346789999999998888899999999999999999999999877655443332111 11 123457789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.||++|||+.+++++
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHcccCHhhCCCHHHHhcC
Confidence 9999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.18 Aligned_cols=256 Identities=25% Similarity=0.487 Sum_probs=210.6
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeE----EEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
...+|+..+.||+|+||.|+. +++. ||+|.+.... .....+.+.+|+.+++.++||||+++++++. ..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 345788899999999998873 3443 7888775432 1122345677999999999999999999886 46
Q ss_pred ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
..++||||+.+|+|.+++... +.+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 789999999999999999764 56999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhh
Q 013214 303 LTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 303 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+........ +..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---PQI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---CTT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---CCc
Confidence 654322 22344567889999999988889999999999999999999 9999998887777766655444333 334
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
++..+.++|.+||+.||.+|||+.+++++|+.+....
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 6678899999999999999999999999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=350.78 Aligned_cols=248 Identities=26% Similarity=0.432 Sum_probs=209.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++....... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 4688899999999998873 58999999986432211 22467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc---CCCCEEEeecccccccccC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~---~~~~vkl~Dfg~~~~~~~~ 306 (447)
||+.+|+|.+.+...+.+++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||++......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999999999988889999999999999999999999999 99999999999995 4567999999999865432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.........+.+..+|+.+.
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred --CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 22344568999999999876 589999999999999999999999998877666666644433222233467889999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||+.||.+|||+.+++++
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=325.05 Aligned_cols=245 Identities=25% Similarity=0.463 Sum_probs=208.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688889999999998873 57899999986432212222467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++++|.+++.+.+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence 99999999999998888999999999999999999999999 999999999999999999999999998754422
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......+....+.. ....+ +..++..+.++|
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~li 243 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-VDLKF---PPFLSDGSKDLI 243 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-TCCCC---CTTSCHHHHHHH
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc-cccCC---CCcCCHHHHHHH
Confidence 22345679999999999988899999999999999999999999987765555444422 22222 345678999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+||+.||.+|||+.+++++
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTC
T ss_pred HHHhhcCHhhCCCHHHHhhC
Confidence 99999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=331.53 Aligned_cols=254 Identities=31% Similarity=0.531 Sum_probs=210.1
Q ss_pred cCcccceeeecceEEEEE-----EcCeE--EEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 226 (447)
.+|...+.||+|+||.|+ .+|.. +|+|.+... ......+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 378888999999999886 35664 499988643 2344556788999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC
Q 013214 227 IVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~ 290 (447)
++|||+++|+|.+++.+.+ .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence 9999999999999997654 6899999999999999999999999 99999999999999999
Q ss_pred CEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhc
Q 013214 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (447)
Q Consensus 291 ~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~ 369 (447)
.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+...
T Consensus 180 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred eEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 99999999987543221 2233456788999999988888999999999999999998 99999987766655555333
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 370 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
..... +..+++.+.++|.+||+.||.+|||+.+++++|+.+.....
T Consensus 258 ~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 258 YRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp CCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 33332 34678899999999999999999999999999999887654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=329.97 Aligned_cols=248 Identities=25% Similarity=0.490 Sum_probs=189.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|+.||+|++.... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3688888999999998873 58999999987543 2222356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 230 EYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 230 e~~~~g~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
||++ |+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9996 6999998754 35899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCC--------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP-------- 373 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~-------- 373 (447)
.... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.... .+.
T Consensus 159 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 4322 222345679999999998764 68999999999999999999999998776655444432211 100
Q ss_pred ----C----C-------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 ----F----K-------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ----~----~-------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ . .....++..+.++|.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0 0011457789999999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=331.05 Aligned_cols=260 Identities=26% Similarity=0.450 Sum_probs=216.2
Q ss_pred CCCcCcccceeeecceEEEEEE-----cC-----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEE
Q 013214 152 PHELDFTNSVEITKGTFILAFW-----RG-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 220 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-----~g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 220 (447)
....+|...+.||+|+||.|+. ++ ..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3345788889999999998873 12 479999997542 455667889999999999 8999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~--------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill 286 (447)
..+..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 999999999999999999999753 35799999999999999999999999 9999999999999
Q ss_pred cCCCCEEEeecccccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHH
Q 013214 287 DDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK 364 (447)
Q Consensus 287 ~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~ 364 (447)
+.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 999999999999998654332211 123345778999999988889999999999999999998 999999877665544
Q ss_pred HHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 365 AYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 365 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
...... .... +..+++.+.++|.+||+.||.+|||+.++++.|+.+.....+
T Consensus 278 ~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 330 (333)
T 2i1m_A 278 KLVKDGYQMAQ---PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330 (333)
T ss_dssp HHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence 443333 2222 344678899999999999999999999999999998776543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=326.02 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=207.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....+++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 3688889999999998873 68999999987542 223356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE---cCCCCEEEeecccccccccC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill---~~~~~vkl~Dfg~~~~~~~~ 306 (447)
||+++++|.+++.+.+.+++..++.++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999999988888999999999999999999999999 9999999999999 77889999999998754322
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+..............+++.+.
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 12233578999999999988899999999999999999999999988776655555533332222223456788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||+.||.+|||+.+++++
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=333.31 Aligned_cols=239 Identities=25% Similarity=0.415 Sum_probs=180.5
Q ss_pred ceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEeccC
Q 013214 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 160 ~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
.+.||+|+||.|+. +|+.||+|++... ....+.+|+.+++.+. ||||+++++++.+....++||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 36799999998873 5899999998643 2356678999999996 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC---CEEEeecccccccccCCCCC
Q 013214 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 234 ~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~---~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+|+|.+++.+.+.+++.++..++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||++....... ..
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~ 165 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QP 165 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cc
Confidence 9999999999889999999999999999999999999 99999999999998765 79999999998654322 22
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-------chHHHHHhcCCCCCC-CChhhhH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------EVPKAYAARQRPPFK-APAKLYA 382 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~ 382 (447)
.....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...+.. +....+ ..+...+. .....++
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDFSFEGEAWKNVS 244 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCCCCCSHHHHTSC
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCCCCCcccccCCC
Confidence 23455799999999999889999999999999999999999999865532 122222 22222222 1234578
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.++|.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 999999999999999999999998864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=324.02 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=206.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|...+.||+|+||.|+. +|+.||+|.+........ ...+.+.+|+.++++++||||+++++++......++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 578889999999998873 589999999875433211 124678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC----CEEEeeccccccc
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLL 303 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~----~vkl~Dfg~~~~~ 303 (447)
+|||+++++|.+++.+...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999988888999999999999999999999999 99999999999999877 8999999999865
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+..............+++
T Consensus 163 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 163 EAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 4322 22344679999999999888999999999999999999999999987766555444422221111112345678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 89999999999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=325.84 Aligned_cols=248 Identities=27% Similarity=0.469 Sum_probs=198.6
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.|+. +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 678889999999998873 488999999865432 222235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
++ ++|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (288)
T 1ob3_A 82 LD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (288)
T ss_dssp CS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-cc
Confidence 96 5999998764 66999999999999999999999999 9999999999999999999999999997654321 12
Q ss_pred cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC----------------
Q 013214 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP---------------- 372 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~---------------- 372 (447)
.....+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+... +.+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 2344679999999998764 5899999999999999999999999876654443333211 110
Q ss_pred CCC--------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 PFK--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+. .....+++.+.++|.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0113467889999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=333.31 Aligned_cols=243 Identities=24% Similarity=0.434 Sum_probs=201.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|...+.||+|+||.|+. +|+.||+|++...... ..+|+.++.++ +||||+++++++.+....|+||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 588889999999998873 5899999999765322 34578888887 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-C---CEEEeeccccccccc
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-G---NLKVADFGVSKLLTV 305 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~-~---~vkl~Dfg~~~~~~~ 305 (447)
||++||+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+||++... + .+||+|||++.....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999999998888999999999999999999999999 9999999999998543 3 499999999986543
Q ss_pred CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC---chHHHHHhcCCCCCCCChhhhH
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---EVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...... ++...+...........+..++
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 322 223456799999999998877889999999999999999999999864432 2333332222222222345688
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.++|++||..||++|||+.+++++
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 999999999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=324.25 Aligned_cols=246 Identities=23% Similarity=0.434 Sum_probs=201.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|..||+|++...... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4688899999999998873 5889999998765322 23467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE---cCCCCEEEeecccccc
Q 013214 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKL 302 (447)
Q Consensus 230 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill---~~~~~vkl~Dfg~~~~ 302 (447)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999999854 367999999999999999999999999 9999999999999 4567899999999976
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
.... .......+|+.|+|||.+. ..++.++||||||+++|+|++|+.||......+..... ....+.+......++
T Consensus 177 ~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 177 FKSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-TYKEPNYAVECRPLT 252 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCCCCCC--CCCC
T ss_pred cCCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh-ccCCcccccccCcCC
Confidence 5432 2223456899999999986 46889999999999999999999999887665554444 223333333334467
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+.++|.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 899999999999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.46 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=203.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
.+|...+.||+|+||.|+. ++..||+|++..... ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 4688899999999998873 578999999865321 123445778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 013214 228 VTEYLPKGDLRAFLKR----------------------------------------KGALKPSTAVRFALDIARGMNYLH 267 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~----------------------------------------~~~l~~~~~~~i~~ql~~~l~~lH 267 (447)
||||+++|+|.+++.. ...+++..++.++.|++.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998852 011356778899999999999999
Q ss_pred hCCCCCeEeCCCCCCCEEEcCCC--CEEEeecccccccccCCC---CCcccCCCCCcccCCcccCC--CCCCCchhHHHH
Q 013214 268 ENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSF 340 (447)
Q Consensus 268 ~~~~~~i~H~Dikp~Nill~~~~--~vkl~Dfg~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~sl 340 (447)
+.+ ++||||||+||+++.++ .+||+|||++........ .......+|+.|+|||.+.+ ..++.++|||||
T Consensus 186 ~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 NQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 999 99999999999998776 899999999986543221 12245568999999999865 578899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 341 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 341 G~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
|+++|+|++|+.||......+....+..............+++.+.++|.+||+.||.+||++.+++++
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999877766665554443322223344578999999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=357.76 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=211.0
Q ss_pred eeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccC
Q 013214 161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 161 ~~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
+.||+|+||.|+. .++.||||+++.... .....+++.+|+.++++++||||+++++++.. +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999873 357899999976532 33445788999999999999999999999864 56899999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC--CCc
Q 013214 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPL 311 (447)
Q Consensus 234 ~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~--~~~ 311 (447)
+|+|.+++..++.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999998888999999999999999999999999 99999999999999999999999999986643321 122
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+....+....+....++.. +..+++++.++|.
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~ 606 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDLMN 606 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHH
Confidence 33446788999999988899999999999999999998 9999998888777777655555544 3457889999999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 391 ECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+||+.||++||++.++++.|+++...+
T Consensus 607 ~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999987665
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.88 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=209.8
Q ss_pred eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccCC
Q 013214 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 162 ~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
.||+|+||.|+. ++..||||+++... .....+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 799999998862 35679999997652 23345778999999999999999999999976 569999999999
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC--Cc
Q 013214 235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PL 311 (447)
Q Consensus 235 g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~ 311 (447)
|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999999754 45999999999999999999999999 999999999999999999999999999876432211 11
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+....+... +..+++++.++|.
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~ 573 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPECPPELYALMS 573 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHHHHH
Confidence 22345688999999988899999999999999999998 9999999888777777755555444 3457889999999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 391 ECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
+||+.||++||++.++++.|+.+..+....
T Consensus 574 ~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 574 DCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp HTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred HHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 999999999999999999999988777543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=330.30 Aligned_cols=255 Identities=24% Similarity=0.493 Sum_probs=207.9
Q ss_pred CcCcccceeeecceEEEEEE-----cCeE----EEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
..+|+..+.||+|+||.|+. +++. ||+|.+.... .....+.+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-S
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-C
Confidence 45788999999999998873 3444 5777775432 223446788999999999999999999999875 4
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.++++||+.+|+|.+++... +.+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 88999999999999999874 56999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhh
Q 013214 304 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 304 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (447)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+......+. +..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 244 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPIC 244 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTTB
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CccC
Confidence 433221 2233456788999999998899999999999999999999 9999998888777766655544443 3457
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+..+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus 245 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 789999999999999999999999999999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.86 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=207.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC-C----HHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCc
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-D----DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~-~----~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 224 (447)
+|...+.||+|+||.|+. +|+.||||++...... . ....+.+.+|+.+++++ +||||+++++++.....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 578888999999998873 5899999988654311 1 22356678999999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.++||||+++++|.+++.....+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.+||+|||++....
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999998888999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCcccCCCCCcccCCcccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCCh
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 378 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (447)
.. .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+............
T Consensus 252 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 252 PG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 32 22344568999999998853 35788999999999999999999999876655554444333222111122
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..++..+.++|.+||+.||.+|||+.+++++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3567889999999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=326.84 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=201.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++.... ......+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 688889999999998873 48999999887653 344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y 158 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999986553222 2
Q ss_pred cccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC-----------------
Q 013214 311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP----------------- 372 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~----------------- 372 (447)
.....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 234467999999999876 56799999999999999999999999877655443332111000
Q ss_pred -CCCC---------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 -PFKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 -~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+. ..+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 013467889999999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.12 Aligned_cols=244 Identities=23% Similarity=0.378 Sum_probs=196.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC-------
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 223 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------- 223 (447)
+|+..+.||+|+||.|+. +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 577888999999998872 68999999987543 3345577899999999999999999999986543
Q ss_pred --------------------------------------------------ceEEEEeccCCCCHHHHHHhcCC---CCHH
Q 013214 224 --------------------------------------------------PMMIVTEYLPKGDLRAFLKRKGA---LKPS 250 (447)
Q Consensus 224 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~---l~~~ 250 (447)
..+++|||+++++|.+++.+... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27999999999999999987654 4556
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-----------CCcccCCCCCc
Q 013214 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-----------RPLTCQDTSCR 319 (447)
Q Consensus 251 ~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-----------~~~~~~~~t~~ 319 (447)
.++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999999 99999999999999999999999999987654321 12234568999
Q ss_pred ccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCC
Q 013214 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399 (447)
Q Consensus 320 y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 399 (447)
|+|||.+.+..++.++||||||+++|+|++|..|+.. ............++......++.+.++|.+||+.||.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence 9999999998999999999999999999998776431 11111111222333334566788899999999999999
Q ss_pred CCCHHHHHHH
Q 013214 400 RPTFRQIITR 409 (447)
Q Consensus 400 Rps~~~~l~~ 409 (447)
|||+.+++++
T Consensus 317 Rps~~~~l~~ 326 (332)
T 3qd2_B 317 RPEATDIIEN 326 (332)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhhc
Confidence 9999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=326.93 Aligned_cols=260 Identities=27% Similarity=0.460 Sum_probs=214.8
Q ss_pred CCCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEE
Q 013214 151 DPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAV 219 (447)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 219 (447)
.....+|...+.||+|+||.|+. +++.||+|++... ......+.+.+|+.+++++ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 34455788999999999998863 3478999999754 2455567889999999999 799999999998
Q ss_pred EeCC-ceEEEEeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 013214 220 TQSS-PMMIVTEYLPKGDLRAFLKRKGA----------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (447)
Q Consensus 220 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~ 282 (447)
...+ ..+++|||+++|+|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~ 177 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 177 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccc
Confidence 7754 48999999999999999987543 789999999999999999999999 999999999
Q ss_pred CEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 013214 283 NILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 360 (447)
Q Consensus 283 Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~ 360 (447)
||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 999999999999999999865433221 1123346788999999988889999999999999999998 99999887755
Q ss_pred chHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 361 EVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 361 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
+......... .... +..+++.+.++|.+||+.||.+|||+.+++++|+.+.++-.
T Consensus 258 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 258 EEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHhccCccCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 4433332222 3332 34567899999999999999999999999999999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.09 Aligned_cols=249 Identities=29% Similarity=0.486 Sum_probs=196.6
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc--CCCCcccceeEEEEeC----Cce
Q 013214 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQS----SPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~~~~~~~----~~~ 225 (447)
.+|+..+.||+|+||.|+ .+|+.||+|++.... ...+..|.+++.. ++||||+++++++... ...
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 478889999999999876 589999999986431 2344556666655 7999999999987543 458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH--------~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
+++|||+++|+|.++++. ..+++..++.++.|++.||.||| +.+ ++||||||+||+++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeC
Confidence 999999999999999954 57999999999999999999999 877 999999999999999999999999
Q ss_pred ccccccccCCCC---CcccCCCCCcccCCcccCCC------CCCCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 013214 298 GVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEG----------CPPFTMKH 358 (447)
Q Consensus 298 g~~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~tg----------~~p~~~~~ 358 (447)
|++......... ......||+.|+|||.+.+. .++.++||||||+++|+|++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999765433221 12334689999999999776 345689999999999999999 88887554
Q ss_pred CCch-----HHHHHhcC-CCCCCC--ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 359 DNEV-----PKAYAARQ-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 359 ~~~~-----~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
.... ........ ++..+. ....+++.+.++|.+||+.||++|||+.++++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3221 11111111 222221 1234678999999999999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=350.92 Aligned_cols=246 Identities=25% Similarity=0.395 Sum_probs=205.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++.+.........+.+.+|..+++.++||||+++++++.....+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 4688889999999998873 68999999997543222233467888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 230 EYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 230 e~~~~g~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
||++||+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.+|++||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999763 35999999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc----hHHHHHhcCCCCCCCChhhh
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 381 (447)
.. .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||....... +...+ ......+ +..+
T Consensus 342 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i-~~~~~~~---p~~~ 416 (543)
T 3c4z_A 342 GQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVTY---PDKF 416 (543)
T ss_dssp TC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH-HHCCCCC---CTTS
T ss_pred CC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH-hhcccCC---Cccc
Confidence 32 12234578999999999999899999999999999999999999998765432 22222 2223333 3567
Q ss_pred HHHHHHHHHHHcccCCCCCCCH-----HHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTF-----RQIIT 408 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~-----~~~l~ 408 (447)
++.+.++|.+||+.||.+||++ .++++
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 8899999999999999999965 66664
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=335.65 Aligned_cols=241 Identities=26% Similarity=0.381 Sum_probs=191.5
Q ss_pred Ccccc-eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHh-cCCCCcccceeEEEEe----CCc
Q 013214 156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQ----SSP 224 (447)
Q Consensus 156 ~~~~~-~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~----~~~ 224 (447)
+|... +.||+|+||.|+. +|+.||+|++... ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 45554 6799999999873 5889999998632 34567888874 4589999999999875 567
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeeccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg~ 299 (447)
+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999998754 5999999999999999999999999 999999999999997 78999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc----hHHHHHhcCCCCCC
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFK 375 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~ 375 (447)
+...... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.........
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 211 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred ccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 9865432 22234567999999999998899999999999999999999999998765433 33333222221111
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 376 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....+++++.++|++||+.||.+|||+.+++++
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2235678999999999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.58 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=193.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCC--ceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS--PMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~--~~~l 227 (447)
+|+..+.||+|+||.|+. +|+.||+|++.... ......+.+.+|+.+++.+. ||||+++++++...+ .+|+
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 688889999999998873 58999999987543 34556677888999999996 999999999997544 6899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999996 699999876 57999999999999999999999999 9999999999999999999999999997653211
Q ss_pred --------------------CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH
Q 013214 308 --------------------DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (447)
Q Consensus 308 --------------------~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~ 366 (447)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111234578999999999876 57899999999999999999999999987755544443
Q ss_pred HhcC-CCC-----------------------------CCCC-------------hhhhHHHHHHHHHHHcccCCCCCCCH
Q 013214 367 AARQ-RPP-----------------------------FKAP-------------AKLYARGLKELIEECWNEKPAKRPTF 403 (447)
Q Consensus 367 ~~~~-~~~-----------------------------~~~~-------------~~~~~~~l~~li~~cl~~dp~~Rps~ 403 (447)
.... .|. .... ...+++.+.+||++||+.||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 2111 110 0000 11456789999999999999999999
Q ss_pred HHHHHH
Q 013214 404 RQIITR 409 (447)
Q Consensus 404 ~~~l~~ 409 (447)
.+++++
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=322.68 Aligned_cols=242 Identities=21% Similarity=0.257 Sum_probs=191.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc-CCCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|+..+.||+|+||.|+. +|+.||||++.......... .....|+..+.. .+||||+++++++.+.+..++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 3688889999999999874 68999999987654433333 344445555544 4999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|||+ +++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence 9999 77999988765 45999999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..|+.... ....+.....+ ...+..+++.+.+
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 211 -GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLP--PEFTAGLSSELRS 283 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCC--HHHHTTSCHHHHH
T ss_pred -CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCC--cccccCCCHHHHH
Confidence 22334568999999999876 78999999999999999999976655321 12222111111 1123456789999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.||++|||+.+++++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCChhhCcCHHHHHhC
Confidence 9999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=317.16 Aligned_cols=252 Identities=25% Similarity=0.463 Sum_probs=206.1
Q ss_pred CCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe----
Q 013214 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ---- 221 (447)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 221 (447)
......|...+.||+|+||.|+. ++..||+|.+..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 34444578888999999998873 578899999876544 45567888999999999999999999999875
Q ss_pred CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeecccc
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVS 300 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~~ 300 (447)
....++||||+++++|.+++.+.+.+++..++.++.|++.||.|||+.+ .+++|+||||+||+++ .++.+||+|||++
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 3458999999999999999998888999999999999999999999986 2499999999999998 7899999999999
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhh
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
..... .......+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||..................+ ......
T Consensus 180 ~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 254 (290)
T 1t4h_A 180 TLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFDKV 254 (290)
T ss_dssp GGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-GGGGGC
T ss_pred ccccc---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-cccCCC
Confidence 75432 22234568999999998864 68999999999999999999999998755543332222222111 122344
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++.+.++|.+||+.||.+|||+.+++++
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 56789999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=338.66 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=204.0
Q ss_pred cCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 224 (447)
.+|...+.||+|+||.|+. +|+.||+|++...... .....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4788999999999998872 6899999998753211 111224566799999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.++||||+++|+|.+++.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999998888999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH---hcCCCCCCCChh
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---ARQRPPFKAPAK 379 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~ 379 (447)
...........||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+. ....+++ +.
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~ 287 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---PQ 287 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC---CT
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC---Cc
Confidence 3322223345689999999999863 47889999999999999999999998665443322221 2223333 34
Q ss_pred hhHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
.++..+.++|.+||+.||.+|| ++.+++++
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 5778899999999999999999 99999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.57 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=196.7
Q ss_pred Cccc-ceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 156 DFTN-SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~-~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.|.. .+.||+|+||.|+. +++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 4555 36799999999874 689999999865432 2345678899999885 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC---EEEeeccccccccc
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV 305 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~---vkl~Dfg~~~~~~~ 305 (447)
|||+++|+|.+++...+.+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999998888999999999999999999999999 999999999999998776 99999999876532
Q ss_pred CCC------CCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-------------
Q 013214 306 KED------RPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE------------- 361 (447)
Q Consensus 306 ~~~------~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~------------- 361 (447)
... .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 11123458999999999865 457899999999999999999999998765432
Q ss_pred --hHHHHHhcCCCCCCC-ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 362 --VPKAYAARQRPPFKA-PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 362 --~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+ ......++. ....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 247 ~~~~~~i-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESI-QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHH-HHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHH-hccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 22222 222222221 123467899999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=335.70 Aligned_cols=265 Identities=15% Similarity=0.213 Sum_probs=205.1
Q ss_pred CCCcCcccceeeecceEEEEEEc----------CeEEEEEEcCcccCCCHHH--------HHHHHHHHHHHhcCCCCccc
Q 013214 152 PHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDR--------VRAFRDELALLQKIRHPNVV 213 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~~----------g~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv 213 (447)
....+|+..+.||+|+||.|+.. ++.||+|++.......... ...+..|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 34457999999999999988732 5789999986542100000 01233456667788899999
Q ss_pred ceeEEEEeC----CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-
Q 013214 214 QFLGAVTQS----SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD- 287 (447)
Q Consensus 214 ~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~- 287 (447)
++++++... ...++||||+ +++|.+++... +.+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 999998765 4589999999 99999999876 57999999999999999999999999 99999999999999
Q ss_pred -CCCCEEEeecccccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 013214 288 -DSGNLKVADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (447)
Q Consensus 288 -~~~~vkl~Dfg~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 360 (447)
.++.+||+|||++..+..... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999976543211 1113345899999999999988999999999999999999999999865443
Q ss_pred chHHH-HHhcCCCCCCC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 361 EVPKA-YAARQRPPFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 361 ~~~~~-~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
..... ......+.+.. ....+++++.+++..||+.||.+||++.++++.|+++.+.....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 32211 11111111100 01345788999999999999999999999999999998876443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=320.89 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=200.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++........+..+.+.+|+.+++.++||||+++++++......+++|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 4788889999999998873 58999999986432222233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++++|.+++.+.+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 99999999999998888999999999999999999999999 9999999999999999999999999998654321
Q ss_pred CcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+++.|+|||.+.+..+ +.++|+||||+++|+|++|+.||......+....+.. ....+ +..++..+.++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~l~~l 241 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG-GVFYI---PEYLNRSVATL 241 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCC---CTTSCHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-CcccC---chhcCHHHHHH
Confidence 2233457899999999987655 5799999999999999999999987665555444422 22222 34567889999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.||.+|||+.+++++
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.93 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=206.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 678888999999998873 589999999865432 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-C
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~ 309 (447)
|+++++|.+++.....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999987778999999999999999999999999 99999999999999999999999999976543211 1
Q ss_pred CcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......+|+.|+|||.+.+..+ +.++||||||+++|+|++|+.||................. ........+++.+.++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-TTSTTGGGSCHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-cccCchhhcCHHHHHH
Confidence 2234567999999999987665 6789999999999999999999987765543222212222 2222345678899999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.||.+|||+.+++++
T Consensus 242 i~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHCCCCchhCCCHHHHhcC
Confidence 999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=320.64 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=210.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC------CHHHHHHHHHHHHHHhcCC-CCcccceeEEEEe
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS------DDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ 221 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 221 (447)
..+|...+.||+|+||.|+. +|+.||+|++...... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 34788899999999998873 6899999998654211 1233567789999999995 9999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
....++||||+++++|.+++.+...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchh
Confidence 9999999999999999999998888999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCcccCCCCCcccCCcccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCC
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 375 (447)
..... .......+++.|+|||.+. ...++.++||||||+++|+|++|+.||......+....+.........
T Consensus 173 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 173 QLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp ECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 65432 2233456799999999874 456788999999999999999999999877665555555333322222
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 376 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....++..+.++|.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 3345788999999999999999999999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.39 Aligned_cols=249 Identities=22% Similarity=0.387 Sum_probs=199.7
Q ss_pred CCCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC--CcccceeEEEEeCCce
Q 013214 152 PHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPM 225 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~ 225 (447)
....+|+..+.||+|+||.|+. +++.||+|++.... ......+.+.+|+.+++.++| |||+++++++......
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3455789999999999999873 57899999987654 345566788999999999976 9999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
++|||+ .+++|.+++.+.+.+++.++..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||++.....
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999995 48899999999889999999999999999999999999 99999999999997 57899999999987643
Q ss_pred CCCC-CcccCCCCCcccCCcccCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHHh-cCC
Q 013214 306 KEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAA-RQR 371 (447)
Q Consensus 306 ~~~~-~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-~~~~~~-~~~ 371 (447)
.... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ...+.. ...
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 3221 2234568999999999854 5688899999999999999999999986543221 111111 112
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+ +...+..+.++|.+||+.||.+|||+.+++++
T Consensus 240 ~~~---~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 240 IEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCC---cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 222 33446789999999999999999999999976
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.72 Aligned_cols=246 Identities=25% Similarity=0.353 Sum_probs=195.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 223 (447)
.+|+..+.||+|+||.|+. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4788899999999998863 58999999997653 34556677889999999999999999999997553
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 46999999964 67776643 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------- 370 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 370 (447)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 215 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 215 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp --C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred CCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 432 23345678999999999999999999999999999999999999998876544433332211
Q ss_pred --------CCCCCC-----------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 --------RPPFKA-----------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 --------~~~~~~-----------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+.. .....++++.+||.+||+.||++|||+.+++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111100 001126789999999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=325.50 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=200.9
Q ss_pred CcCcccceeeecceEEEEEE-----cC-------eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RG-------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 221 (447)
..+|...+.||+|+||.|+. ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 34788889999999998863 23 579999986542 3345678899999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC--------E
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------L 292 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~--------v 292 (447)
.+..++||||+++|+|.+++.+.+. +++..++.++.|++.||.|||+++ ++||||||+||+++.++. +
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999987654 999999999999999999999999 999999999999998887 9
Q ss_pred EEeecccccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHHhcC
Q 013214 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 293 kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~ 370 (447)
||+|||++...... ....+|+.|+|||.+.+ ..++.++||||||+++|+|++| .+||............ ..
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~--~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY--ED 233 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--HT
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh--hc
Confidence 99999998754321 22346788999999987 6788999999999999999995 4555544433322222 12
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
...+ +...++.+.++|.+||+.||.+|||+.+++++|+++.+.-
T Consensus 234 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 234 RHQL---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp TCCC---CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred cCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 2222 2234567899999999999999999999999999887654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.22 Aligned_cols=258 Identities=28% Similarity=0.505 Sum_probs=209.5
Q ss_pred CCCcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE--
Q 013214 152 PHELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-- 220 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 220 (447)
....+|+..+.||+|+||.|+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 3445788899999999998862 5789999998754 4556678999999999999999999999886
Q ss_pred eCCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
+....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccc
Confidence 44568999999999999999986 456999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC---------------ch
Q 013214 300 SKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------------EV 362 (447)
Q Consensus 300 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~---------------~~ 362 (447)
+......... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 9876433221 223345788899999998888899999999999999999999998643321 11
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
...+......+ .+..+++.+.++|.+||+.||.+|||+.+++++|+.+.....
T Consensus 254 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11221222222 245678899999999999999999999999999999876554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=352.39 Aligned_cols=254 Identities=31% Similarity=0.505 Sum_probs=214.6
Q ss_pred cCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.+|+..+.||+|+||.|+. .+..||||++...... .+.+.+|+.++++++||||+++++++.+ ...++|||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 4677888999999998873 3478999999765432 3568899999999999999999999876 67899999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+++|+|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999753 56999999999999999999999999 99999999999999999999999999986543211
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+....+....+.+. +..++..+.+
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~ 495 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPESLHD 495 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHH
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHH
Confidence 12233446788999999988889999999999999999999 9999998877777666654444443 3457889999
Q ss_pred HHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 388 LIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
+|.+||+.||++|||+.++++.|+.+.+....
T Consensus 496 li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 99999999999999999999999988765543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=329.72 Aligned_cols=249 Identities=21% Similarity=0.381 Sum_probs=195.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 4799999999999998873 689999999976532 3334566778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-----CCCCEEEeecccccccc
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-----DSGNLKVADFGVSKLLT 304 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-----~~~~vkl~Dfg~~~~~~ 304 (447)
||++ |+|.+++...+.+++..++.++.|++.||.|||+.+ |+||||||+||+++ ..+.+||+|||++....
T Consensus 113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9996 699999999889999999999999999999999999 99999999999995 44559999999998654
Q ss_pred cCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCC------
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKA------ 376 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~------ 376 (447)
... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.... .+.-..
T Consensus 189 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Ccc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 322 222344579999999999774 58999999999999999999999998776554444332211 111000
Q ss_pred -------------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 -------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 -------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+++++.++|.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 011256889999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.94 Aligned_cols=250 Identities=28% Similarity=0.401 Sum_probs=198.8
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHhcC---CCCcccceeEEEEeCC
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSS 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~ 223 (447)
..+|+..+.||+|+||.|+ .+|+.||+|++....... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 3478899999999999887 368899999986432111 11113445566666666 5999999999998765
Q ss_pred -----ceEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 224 -----PMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 224 -----~~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
..+++|||+. ++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEee
Confidence 4799999995 699999987654 999999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCC
Q 013214 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK 375 (447)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~ 375 (447)
||++...... .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.... .++..
T Consensus 164 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 164 FGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp CSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9999865432 22344567999999999988899999999999999999999999998877655544442221 11100
Q ss_pred ----------------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 376 ----------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 376 ----------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+.+++.+.++|.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0012467889999999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=328.76 Aligned_cols=245 Identities=25% Similarity=0.362 Sum_probs=198.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 223 (447)
.+|...+.||+|+||.|+. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4788999999999998863 58999999996543 34556677889999999999999999999997653
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 8899999876 57999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CC----------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QR---------- 371 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~---------- 371 (447)
.. ......+|+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+....+... +.
T Consensus 179 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 179 DS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp CS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred cc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 42 2344567999999999877 67899999999999999999999999877654433332111 11
Q ss_pred ----------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ----------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+....+..++.+.++|.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 11111234567899999999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=327.19 Aligned_cols=256 Identities=29% Similarity=0.470 Sum_probs=211.0
Q ss_pred CcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
..+|...+.||+|+||.|+. +++.||+|.+... ........+.+|+.++++++||||+++++++....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34788899999999987762 3568999999743 34556678889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEE
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLK 293 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vk 293 (447)
..+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999998753 3889999999999999999999999 999999999999994 44699
Q ss_pred EeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCC
Q 013214 294 VADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 371 (447)
|+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 999999875432211 11223456889999999988889999999999999999998 9999988776666555544444
Q ss_pred CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 372 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+.. +..+++.+.++|.+||+.||.+||++.+++++|+.+....
T Consensus 264 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 264 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 333 3457789999999999999999999999999999877654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=331.23 Aligned_cols=239 Identities=23% Similarity=0.399 Sum_probs=201.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|+..+.||+|+||.|+. +|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 688889999999998763 689999999876543221 1234567799999999999999999999999999
Q ss_pred EEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
+++|||+.+| +|.+++...+.+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999766 99999998888999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.. .......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... . .. ....+..+++
T Consensus 182 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~--~~---~~~~~~~~~~ 249 (335)
T 3dls_A 182 RG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----V--EA---AIHPPYLVSK 249 (335)
T ss_dssp TT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----T--TT---CCCCSSCCCH
T ss_pred CC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----H--hh---ccCCCcccCH
Confidence 33 22234568999999999988776 77899999999999999999999753211 0 11 1112334678
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.++|.+||+.||++|||+.+++++
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=322.98 Aligned_cols=260 Identities=26% Similarity=0.462 Sum_probs=202.9
Q ss_pred CCcCcccceeeecceEEEEEE------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 153 HELDFTNSVEITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
...+|+..+.||+|+||.|+. ++ ..||+|++........+..+.+.+|+.++++++||||+++++++..+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 345788899999999987752 12 369999997665545566788999999999999999999999998754
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.++++||+++++|.+++... +.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999999764 56999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhh
Q 013214 304 TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 304 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+..... .. ..+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-RL-PRPED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-CC-CCCTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC-CC-CCCcC
Confidence 433221 1223456788999999988888999999999999999999 9999998776665555533321 11 12446
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
+++.+.++|.+||+.||.+|||+.++++.|+++.....
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 78899999999999999999999999999998766544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=340.56 Aligned_cols=248 Identities=13% Similarity=0.151 Sum_probs=195.9
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH---HHhcCCCCccccee-------E
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA---LLQKIRHPNVVQFL-------G 217 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~hp~iv~~~-------~ 217 (447)
...+|...+.||+|+||.|+. +|+.||||++...........+.+.+|+. .++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 345788899999999998873 58999999997654445556678899994 55555899999998 6
Q ss_pred EEEeCC-----------------ceEEEEeccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCC
Q 013214 218 AVTQSS-----------------PMMIVTEYLPKGDLRAFLKRKGALKP-------STAVRFALDIARGMNYLHENKPVP 273 (447)
Q Consensus 218 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~l~~-------~~~~~i~~ql~~~l~~lH~~~~~~ 273 (447)
++...+ ..+++|||+ +|+|.+++.+.+.+++ ..++.++.|++.||.|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 666553 279999999 6899999987655555 778889999999999999999
Q ss_pred eEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCC-----------CCCCchhHHHHHH
Q 013214 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFAL 342 (447)
Q Consensus 274 i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~Di~slG~ 342 (447)
|+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999985332 2234456 899999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH--HHHHHHhhh
Q 013214 343 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT--RLESINNSI 417 (447)
Q Consensus 343 ~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~--~l~~~~~~~ 417 (447)
++|+|++|+.||...........+.. ....+++.+.++|.+||+.||.+|||+.++++ .++.+....
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 370 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 370 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence 99999999999987665443322211 12346788999999999999999999999996 444444443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=358.94 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=210.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|...+.||+|+||.|+. +++.||||++.+.........+.+..|..++..+ +||+|+++++++.+.+.+|+|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 4688889999999998873 5788999998754322223346677899999988 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|||+++|+|.+++.+.+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++++||+|||++.......
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 496 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 496 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence 999999999999999889999999999999999999999999 9999999999999999999999999998543222
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..++...+.. ....+ +..+++++.+|
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~~l 572 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HNVAY---PKSMSKEAVAI 572 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS-SCCCC---CTTSCHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh-CCCCC---CccCCHHHHHH
Confidence 233456789999999999999999999999999999999999999998877766666633 33333 34678999999
Q ss_pred HHHHcccCCCCCCCH-----HHHHH
Q 013214 389 IEECWNEKPAKRPTF-----RQIIT 408 (447)
Q Consensus 389 i~~cl~~dp~~Rps~-----~~~l~ 408 (447)
|++||+.||.+||++ .++++
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhc
Confidence 999999999999997 66665
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=340.11 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=196.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
.+|...+.||+|+||.|+. +++.||+|++...... .......+.+|+.++++++||||+++++++.. ..
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 3688889999999998873 5789999998754321 22223457889999999999999999999864 45
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC---CEEEeeccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSK 301 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~---~vkl~Dfg~~~ 301 (447)
.++||||+++|+|.+++...+.+++..++.++.|++.||.|||+.+ ++||||||+|||++.++ .+||+|||++.
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccce
Confidence 8999999999999999988888999999999999999999999999 99999999999997544 59999999998
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHHhcCCCCCCCC
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAP 377 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 377 (447)
..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ...+........+..
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 76532 22234568999999999854 5677899999999999999999999987655443 333323222222222
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+++.+.++|.+||+.||.+|||+.+++++
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 34578899999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=318.12 Aligned_cols=257 Identities=16% Similarity=0.222 Sum_probs=207.5
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEE-EeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv 228 (447)
.+|+..+.||+|+||.|+ .+|+.||+|++...... +.+.+|+.+++.++|++++..+..+ ......+++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 478889999999999887 36899999998654322 3578899999999988866666555 566778999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc---CCCCEEEeecccccccc
Q 013214 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLT 304 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~---~~~~vkl~Dfg~~~~~~ 304 (447)
|||+ +++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999 8999999974 456999999999999999999999999 99999999999994 78899999999998765
Q ss_pred cCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC---chHHHHHhcC-CCCC
Q 013214 305 VKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---EVPKAYAARQ-RPPF 374 (447)
Q Consensus 305 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~---~~~~~~~~~~-~~~~ 374 (447)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...... +....+.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 43221 124456899999999999989999999999999999999999999875432 2222222211 1111
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
......+|+.+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 1112456789999999999999999999999999999998876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.32 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=187.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cc
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 224 (447)
.+|...+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4688899999999998863 68999999987543 3555667889999999999999999999998443 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
+|+||||+ +++|.+++.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 89999998 6799999998888999999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCC--------------------------CCcccCCCCCcccCCccc-CCCCCCCchhHHHHHHHHHHHHh--------
Q 013214 305 VKED--------------------------RPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIE-------- 349 (447)
Q Consensus 305 ~~~~--------------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~t-------- 349 (447)
.... .......||+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 3211 112345679999999976 45679999999999999999998
Q ss_pred ---CCCCCCCCCCCc--------------------hHHHH-HhcCC--------------------------CCCCCChh
Q 013214 350 ---GCPPFTMKHDNE--------------------VPKAY-AARQR--------------------------PPFKAPAK 379 (447)
Q Consensus 350 ---g~~p~~~~~~~~--------------------~~~~~-~~~~~--------------------------~~~~~~~~ 379 (447)
|+++|.+..... ....+ ...+. ..+....+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 677776543210 00000 00000 01111123
Q ss_pred hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 380 LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 380 ~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..++.+.+||++||..||.+|||+.+++++
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 457889999999999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=324.81 Aligned_cols=257 Identities=26% Similarity=0.513 Sum_probs=210.3
Q ss_pred CCcCcccceeeecceEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 013214 153 HELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 223 (447)
...+|+..+.||+|+||.|+. +|+.||+|++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 345688889999999998862 5889999998753 3456678999999999999999999999987643
Q ss_pred --ceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 224 --PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 224 --~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
..++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 789999999999999999876 45999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----------CC-c-----h
Q 013214 301 KLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH----------DN-E-----V 362 (447)
Q Consensus 301 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~----------~~-~-----~ 362 (447)
......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.... .. . .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 876543221 1223456778999999988888999999999999999999999986431 11 1 1
Q ss_pred HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
...+....+.+ .+..+++.+.++|.+||+.||.+|||+.++++.|+.+..++.
T Consensus 273 ~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 273 IELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11222222222 245678899999999999999999999999999999988754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=327.28 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=200.9
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----CCcccceeEEEEeCC
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPNVVQFLGAVTQSS 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~~~~ 223 (447)
..+|...+.||+|+||.|+. +++.||+|++.. .....+.+..|..+++.+. ||||+++++++...+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 34789999999999998873 688999999863 3445566788999999996 999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-------------
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD------------- 288 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~------------- 288 (447)
..++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence 999999999 899999998754 4999999999999999999999999 999999999999975
Q ss_pred ------------CCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 013214 289 ------------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (447)
Q Consensus 289 ------------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 356 (447)
++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 789999999999864422 2345679999999999999999999999999999999999999987
Q ss_pred CCCCchHHHHHhcCCCC-------------------------CCC-----------------ChhhhHHHHHHHHHHHcc
Q 013214 357 KHDNEVPKAYAARQRPP-------------------------FKA-----------------PAKLYARGLKELIEECWN 394 (447)
Q Consensus 357 ~~~~~~~~~~~~~~~~~-------------------------~~~-----------------~~~~~~~~l~~li~~cl~ 394 (447)
.+..+....+.....+. ++. .....++.+.++|.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 66544433332211110 000 001122678899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013214 395 EKPAKRPTFRQIITR 409 (447)
Q Consensus 395 ~dp~~Rps~~~~l~~ 409 (447)
.||.+|||+.+++++
T Consensus 342 ~dP~~Rpta~elL~h 356 (360)
T 3llt_A 342 IDPTLRPSPAELLKH 356 (360)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=330.27 Aligned_cols=245 Identities=27% Similarity=0.475 Sum_probs=205.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|...+.||+|+||.|+. +|+.||+|++... ......+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 4788889999999998873 5889999998754 24566678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++++|.+++.+.+.+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++......
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999999888899999999999999999999996 7 999999999999999999999999998754322
Q ss_pred CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH----------------------
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---------------------- 366 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---------------------- 366 (447)
......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+.....
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 123346799999999999989999999999999999999999999865543321111
Q ss_pred --------------------HhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 367 --------------------AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 367 --------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....+. .....++.++.++|.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0111111 1223467899999999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.44 Aligned_cols=254 Identities=27% Similarity=0.482 Sum_probs=200.0
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCcccceeEEEEeC----Cce
Q 013214 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQS----SPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~~~~~~~~~----~~~ 225 (447)
.+|+..+.||+|+||.|+ .+|+.||+|++.... ...+..|..++... +||||+++++++... ...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 478899999999999876 589999999985331 12344455555554 899999999999877 678
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN--------KPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~--------~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
++||||+++|+|.++++.. .+++..++.++.|++.||.|||+. + ++||||||+||+++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeC
Confidence 9999999999999999664 699999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccccCCCC---CcccCCCCCcccCCcccCCCCCCCc------hhHHHHHHHHHHHHhC----------CCCCCCCC
Q 013214 298 GVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTK------VDVFSFALILQEMIEG----------CPPFTMKH 358 (447)
Q Consensus 298 g~~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~------~Di~slG~~l~~l~tg----------~~p~~~~~ 358 (447)
|++......... ......||+.|+|||.+.+...... +||||||+++|+|++| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 999765432221 1124568999999999987766655 9999999999999999 67776543
Q ss_pred CCc-----hHHHHHhcC-CCCCCC--ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 359 DNE-----VPKAYAARQ-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 359 ~~~-----~~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
... ......... ++.++. ....+++.+.++|.+||+.||.+|||+.+++++|+.+.++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 322 111111111 233321 123678899999999999999999999999999999887654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.02 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=196.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cc
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 224 (447)
.+|...+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.+++.++||||+++++++... ..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 3789999999999998873 58899999997543 4556667889999999999999999999999766 57
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.|+||||++ ++|.+++.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 899999995 699999998888999999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCC---------------------CCcccCCCCCcccCCccc-CCCCCCCchhHHHHHHHHHHHHhCCCC---------
Q 013214 305 VKED---------------------RPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPP--------- 353 (447)
Q Consensus 305 ~~~~---------------------~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~tg~~p--------- 353 (447)
.... .......+|+.|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 3221 112456789999999986 455799999999999999999985444
Q ss_pred --CCCCCCC-----------------chHHH-HHhcCCC----------------------CCCC----ChhhhHHHHHH
Q 013214 354 --FTMKHDN-----------------EVPKA-YAARQRP----------------------PFKA----PAKLYARGLKE 387 (447)
Q Consensus 354 --~~~~~~~-----------------~~~~~-~~~~~~~----------------------~~~~----~~~~~~~~l~~ 387 (447)
|.+.+.. ..... ....+.+ ..+. ..+.+++.+.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 4333210 00000 0000000 0000 11346889999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
||++||+.||.+|||+.+++++
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.36 Aligned_cols=247 Identities=23% Similarity=0.411 Sum_probs=194.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +++.||+|++.... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc--ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 688889999999998873 58899999986542 11222234579999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|++ |+|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 996 69999987754 5899999999999999999999999 9999999999999999999999999997654322 2
Q ss_pred CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCC------------
Q 013214 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA------------ 376 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 376 (447)
......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+......+...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2234467999999999876 568999999999999999999999998877655444432221111000
Q ss_pred --------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 --------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 --------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 012456789999999999999999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=319.63 Aligned_cols=256 Identities=16% Similarity=0.224 Sum_probs=204.9
Q ss_pred cCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEE-EeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv 228 (447)
.+|+..+.||+|+||.|+ .+++.||+|++..... .+.+.+|+.+++.++|++++..+..+ ......+++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 468889999999999886 3689999998654322 23577899999999888877666655 667778999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE---cCCCCEEEeecccccccc
Q 013214 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill---~~~~~vkl~Dfg~~~~~~ 304 (447)
|||+ +++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 9999999985 456999999999999999999999999 9999999999999 788999999999998765
Q ss_pred cCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc---hHHHHHhcC-CCCC
Q 013214 305 VKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---VPKAYAARQ-RPPF 374 (447)
Q Consensus 305 ~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~---~~~~~~~~~-~~~~ 374 (447)
.... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 4322 12234568999999999999899999999999999999999999998765432 222221111 1111
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
......+|+.+.++|.+||+.||++|||+.++++.|+++.++...
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 111234678999999999999999999999999999999887753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=330.62 Aligned_cols=247 Identities=22% Similarity=0.384 Sum_probs=199.5
Q ss_pred CcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CCcccceeEEEEeCCceEE
Q 013214 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~l 227 (447)
..+|...+.||+|+||.|+. +++.||||++..... .....+.+.+|+.+++.+. ||||+++++++..++.+++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34688999999999999874 488999999876543 4566788999999999996 5999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|||+ .+++|.+++.+...+++.++..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||++.......
T Consensus 134 v~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9994 58899999998888999999999999999999999999 99999999999996 5899999999998764332
Q ss_pred CC-CcccCCCCCcccCCcccCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHhc-CCCC
Q 013214 308 DR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAAR-QRPP 373 (447)
Q Consensus 308 ~~-~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~~-~~~~ 373 (447)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+... ....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 11 2234568999999999864 368889999999999999999999998654321 12222111 1222
Q ss_pred CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ +...+..+.++|.+||+.||.+|||+.+++++
T Consensus 289 ~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 289 F---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp C---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C---CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 2 22346789999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=326.93 Aligned_cols=248 Identities=22% Similarity=0.363 Sum_probs=204.6
Q ss_pred Ccccc-eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 156 ~~~~~-~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.|... +.||+|+||.|+. +|+.||+|++...... ......+.+|+.+++.+ +||||+++++++......++|
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 34444 7899999998873 5899999998765432 23346788899999999 579999999999999999999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeeccccccc
Q 013214 229 TEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLL 303 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg~~~~~ 303 (447)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||++...
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999998653 56999999999999999999999999 999999999999997 789999999999876
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+..............+++
T Consensus 185 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 262 (327)
T 3lm5_A 185 GHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262 (327)
T ss_dssp -----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred CCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence 5322 22345689999999999988999999999999999999999999988776665555533333322333456788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.++|.+||+.||.+|||+.+++++
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 99999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=323.15 Aligned_cols=257 Identities=21% Similarity=0.371 Sum_probs=205.3
Q ss_pred CcCcccceeeecceEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe----CCc
Q 013214 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSP 224 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~ 224 (447)
..+|+..+.||+|+||.|+ .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 3478999999999999886 36899999988643 45566788999999999999999999999873 346
Q ss_pred eEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 225 MMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
.+++|||+++|+|.+++.. ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999999976 466999999999999999999999999 999999999999999999999999988
Q ss_pred cccccCCCCC--------cccCCCCCcccCCcccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCC--CCchHHHHH
Q 013214 301 KLLTVKEDRP--------LTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKH--DNEVPKAYA 367 (447)
Q Consensus 301 ~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~tg~~p~~~~~--~~~~~~~~~ 367 (447)
.......... .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.... .........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 7543211100 11234689999999987653 6889999999999999999999996422 222222222
Q ss_pred hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 368 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
.....+ ....+++.+.++|.+||+.||.+|||+.+++++|+.+......
T Consensus 262 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 262 NQLSIP---QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp CC--CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred ccCCCC---ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 211111 2345778999999999999999999999999999988765543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=320.00 Aligned_cols=246 Identities=30% Similarity=0.514 Sum_probs=209.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
..|...+.||+|+||.|+. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3588889999999998873 588999999875432 234577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++++|.+++.. +++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 99999999999864 57999999999999999999999999 9999999999999999999999999997654322 1
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.....+.+ ...++..+.++|
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li 251 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL---EGNYSKPLKEFV 251 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---CSSCCHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC---ccccCHHHHHHH
Confidence 22345679999999999988999999999999999999999999987766555444433333332 345778999999
Q ss_pred HHHcccCCCCCCCHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRL 410 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l 410 (447)
.+||+.||.+|||+.+++++.
T Consensus 252 ~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 252 EACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HHHCCSSGGGSCCHHHHTTCH
T ss_pred HHHcCCChhhCcCHHHHhhCh
Confidence 999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=316.82 Aligned_cols=246 Identities=25% Similarity=0.449 Sum_probs=203.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|...+.||+|+||.|+. +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++......+++
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34688889999999998873 48999999987542 135678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999999974 567999999999999999999999999 9999999999999999999999999997654321
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+.....+.+ ..+..++..+.+
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 257 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF-RKPELWSDNFTD 257 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGGSCHHHHH
T ss_pred -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc-CCcccCCHHHHH
Confidence 122345679999999999988899999999999999999999999987665444333322222222 235567899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.||.+|||+.+++++
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHccCChhhCcCHHHHHhC
Confidence 9999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=321.51 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=207.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCceE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMM 226 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 226 (447)
..+|+..+.||+|+||.|+. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 34788889999999998763 689999999976543 45567789999999999999999999998754 56789
Q ss_pred EEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 227 IVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENK--PVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~--~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
++|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ..+++|+||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999753 34999999999999999999999976 123999999999999999999999999998
Q ss_pred cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhh
Q 013214 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 301 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.....+.+ +..
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~ 239 (279)
T 2w5a_A 164 RILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---PYR 239 (279)
T ss_dssp HHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---CTT
T ss_pred eeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---Ccc
Confidence 76543211 11233578999999999888899999999999999999999999998776655555544444333 346
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITRLE 411 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~ 411 (447)
+++.+.++|.+||+.||.+|||+.++++++.
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 7889999999999999999999999998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=326.15 Aligned_cols=253 Identities=28% Similarity=0.408 Sum_probs=198.2
Q ss_pred CCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
....+|...+.||+|+||.|+. +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3445788999999999998873 58899999997543221 1123467789999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.++||||+++ +|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999964 899888765 35899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCC-------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPF------- 374 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~------- 374 (447)
.... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|.+||.+....+....+.... .+..
T Consensus 163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 4322 223445679999999998654 57889999999999999999999998876655444432221 1110
Q ss_pred -----------CC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 375 -----------KA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 375 -----------~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+. ....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 013456889999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=329.66 Aligned_cols=256 Identities=14% Similarity=0.213 Sum_probs=207.0
Q ss_pred CCCcCcccceeeecceEEEEEE-------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccc----
Q 013214 152 PHELDFTNSVEITKGTFILAFW-------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ---- 214 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~---- 214 (447)
....+|...+.||+|+||.|+. .++.||+|.+... +.+.+|+.++++++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhh
Confidence 3346899999999999998873 3789999998643 35778999999999999887
Q ss_pred -----------eeEEEEe-CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 013214 215 -----------FLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280 (447)
Q Consensus 215 -----------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dik 280 (447)
+++++.. +...++||||+ +++|.+++... ..+++.+++.++.|++.||.|||+++ ++|||||
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dik 186 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVT 186 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCC
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCC
Confidence 6777765 67889999999 99999999876 67999999999999999999999999 9999999
Q ss_pred CCCEEEcCCC--CEEEeecccccccccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 013214 281 PSNILRDDSG--NLKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352 (447)
Q Consensus 281 p~Nill~~~~--~vkl~Dfg~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~ 352 (447)
|+||+++.++ .+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999988 8999999999765432211 1133468999999999998889999999999999999999999
Q ss_pred CCCCCCCCc--hHHHHH--hcCCCCCCC---ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 353 PFTMKHDNE--VPKAYA--ARQRPPFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 353 p~~~~~~~~--~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
||....... ...... ......+.. ....+++.+.++|.+||+.||.+|||+.++++.|+.+.+....
T Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 267 PWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 998765322 111111 111121111 1234678999999999999999999999999999999887653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=323.39 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=198.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
+|...+.||+|+||.|+. +++.||+|++...... .......+.+|+.+++.++||||+++++++..+. .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 688889999999998873 5789999998754321 2223455788999999999999999999987654 8
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC---EEEeecccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKL 302 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~---vkl~Dfg~~~~ 302 (447)
++||||+++++|.+++.....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||++..
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 999999999999999988888999999999999999999999999 999999999999987664 99999999986
Q ss_pred cccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHhcCCCCCCCCh
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAPA 378 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 378 (447)
.... .......+|+.|+|||.+. ...++.++||||||+++|+|++|+.||....... ....+........+...
T Consensus 167 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 167 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp CCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred cccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 5421 1122345789999999873 4578899999999999999999999998766543 33333222222222223
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 4568899999999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=324.93 Aligned_cols=258 Identities=27% Similarity=0.445 Sum_probs=196.5
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHH--HhcCCCCcccceeEEEEe-----CC
Q 013214 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELAL--LQKIRHPNVVQFLGAVTQ-----SS 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~hp~iv~~~~~~~~-----~~ 223 (447)
..+|+..+.||+|+||.|+ .+++.||+|++.... ...+..|..+ +..++||||+++++.+.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3478889999999999876 579999999986432 1233334444 445899999999986543 23
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN---------KPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~---------~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
..++||||+++|+|.+++.... .++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 5689999999999999997644 58899999999999999999999 8 999999999999999999999
Q ss_pred eecccccccccCC-------CCCcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-
Q 013214 295 ADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIEGCPPFTMKHD- 359 (447)
Q Consensus 295 ~Dfg~~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~- 359 (447)
+|||++....... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998654321 111234468999999999976 3556789999999999999999776543221
Q ss_pred Cch-----------------HHHHH-hcCCCCCCC---ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 360 NEV-----------------PKAYA-ARQRPPFKA---PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 360 ~~~-----------------~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
.+. ..... ...++.++. ....+++.+.++|.+||+.||++|||+.++++.|+.+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 110 01111 111333322 233477889999999999999999999999999999998876
Q ss_pred ccc
Q 013214 419 HKR 421 (447)
Q Consensus 419 ~~~ 421 (447)
+.+
T Consensus 322 ~~~ 324 (336)
T 3g2f_A 322 RNK 324 (336)
T ss_dssp C--
T ss_pred hcc
Confidence 554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.66 Aligned_cols=261 Identities=15% Similarity=0.216 Sum_probs=201.2
Q ss_pred CCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHH--------HHHHHHHHHHHHhcCCCCccccee
Q 013214 153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDD--------RVRAFRDELALLQKIRHPNVVQFL 216 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~ 216 (447)
...+|...+.||+|+||.|+. ++..||+|+.......... ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 345799999999999998762 5688999998754211000 112356788899999999999999
Q ss_pred EEEEe----CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC--
Q 013214 217 GAVTQ----SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-- 290 (447)
Q Consensus 217 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-- 290 (447)
+++.. ....++||||+ +++|.+++.+.+.+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 99987 67899999999 9999999988778999999999999999999999999 99999999999999877
Q ss_pred CEEEeecccccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchH-
Q 013214 291 NLKVADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP- 363 (447)
Q Consensus 291 ~vkl~Dfg~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~- 363 (447)
.+||+|||++..+..... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999976543211 1124457899999999999888999999999999999999999999754333221
Q ss_pred HHHHhcCCCCCCCC------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 364 KAYAARQRPPFKAP------AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 364 ~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
..........++.. ...+++++.++|.+||+.||++|||+.++++.|+.+....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 11111111121110 1156789999999999999999999999999998865443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=313.61 Aligned_cols=248 Identities=23% Similarity=0.411 Sum_probs=190.1
Q ss_pred CCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
...+|+..+.||+|+||.|+. +|+.||+|++.... ......+.+.++...++.++||||+++++++...+..++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 345788899999999998863 68999999997543 233444555666667888899999999999999999999
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 228 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
||||++ |+|.+++.. ...+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++..
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999996 588877754 46799999999999999999999998 8 99999999999999999999999999976
Q ss_pred cccCCCCCcccCCCCCcccCCccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHHhcCCCCCCCC
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAP 377 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 377 (447)
.... .......+|+.|+|||.+ .+..++.++||||||+++|+|++|+.||....... ..........+.. .
T Consensus 160 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 235 (290)
T 3fme_A 160 LVDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL--P 235 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC--C
T ss_pred cccc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc--c
Confidence 5432 222334689999999996 45578889999999999999999999998644332 2222222222222 2
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+++.+.++|.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 34578899999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.36 Aligned_cols=254 Identities=24% Similarity=0.467 Sum_probs=212.7
Q ss_pred CcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
..+|...+.||+|+||.|+. .+..||+|.+... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34688889999999998863 2467999998753 35566678999999999999999999999985 4678
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
++||||+++|+|.+++...+ .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 99999999999999998654 6899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 305 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
...........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+....+++. +..+++
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~ 619 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PPNCPP 619 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC---CTTCCH
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---CccccH
Confidence 433222234456789999999988889999999999999999997 9999998877766666655544443 346788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=326.89 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=193.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 223 (447)
.+|...+.||+|+||.|+. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4788999999999998863 58999999987543 34556677889999999999999999999997665
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..++||||++ ++|.+.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 104 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 6899999996 58888885 45899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------- 370 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 370 (447)
... .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 178 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 178 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 432 22234568999999999999899999999999999999999999998776544333332211
Q ss_pred --------CCCCCC-----------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 --------RPPFKA-----------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 --------~~~~~~-----------------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+.. .....++.+.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 111100 012237789999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=327.23 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=202.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|+.||+|++.... ......+.+.+|+.++++++||||+++++++...+..++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3788999999999987763 48899999986543 34555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++++|.+++...+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 179 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-c
Confidence 99999999998877788999999999999999999999999 9999999999999999999999999997654322 2
Q ss_pred CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC------------------
Q 013214 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------ 370 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------------ 370 (447)
......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+....
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 22345679999999998775 78899999999999999999999998776544333221110
Q ss_pred ---CCCCCC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ---RPPFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ---~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.... ..+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 012467889999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=313.06 Aligned_cols=240 Identities=21% Similarity=0.358 Sum_probs=198.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
.+|+..+.||+|+||.|+. +++.||+|++....... .....+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 3678889999999998874 68999999987654333 3456677899999998 999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC---------------
Q 013214 229 TEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--------------- 289 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~--------------- 289 (447)
|||+++++|.+++.+. ..+++..++.++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999764 66999999999999999999999999 9999999999999844
Q ss_pred ----CCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHH
Q 013214 290 ----GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364 (447)
Q Consensus 290 ----~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~ 364 (447)
..+||+|||++...... ....+|+.|+|||.+.+. .++.++||||||+++|+|++|.+|+... ....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~ 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWH 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHH
T ss_pred cCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHH
Confidence 47999999999865432 223479999999999775 5567999999999999999998876533 2233
Q ss_pred HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.....+.+ +..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 EIRQGRLPRI---PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHTTCCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHcCCCCCC---CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 3333333333 45678899999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=321.01 Aligned_cols=253 Identities=26% Similarity=0.460 Sum_probs=190.0
Q ss_pred CCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
....+|...+.||+|+||.|+. +++.||+|++.... .....+.+.+|+.++++++||||+++++++...+..+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3345788899999999998762 68999999987543 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 227 IVTEYLPKGDLRAFLKR--------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~--------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999974 355899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCC----CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCC
Q 013214 299 VSKLLTVKED----RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (447)
Q Consensus 299 ~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 373 (447)
++........ .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.................+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 9876543211 11234468999999999865 468899999999999999999999999877665544443333222
Q ss_pred CC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 FK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.. .....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 21 1124567889999999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=326.14 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=199.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-------
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------- 221 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------- 221 (447)
..+|+..+.||+|+||.|+. +|+.||+|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 34789999999999987762 6889999998655432 2223456789999999999999999999887
Q ss_pred -CCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 222 -SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 222 -~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
.+..++||||++ ++|.+.+... ..+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 346899999996 5777777654 56999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCC---CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC---C
Q 013214 300 SKLLTVKE---DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---P 372 (447)
Q Consensus 300 ~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~---~ 372 (447)
+....... ........+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+..... +
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98654321 122234567999999999876 4579999999999999999999999998766554444422211 1
Q ss_pred CCCCChh-------------------------hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 PFKAPAK-------------------------LYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ~~~~~~~-------------------------~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....... ..++.+.++|.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1110000 125678999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=331.72 Aligned_cols=257 Identities=21% Similarity=0.326 Sum_probs=207.0
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC--ceE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~ 226 (447)
..+|...+.||+|+||.|+. +|+.||+|++..... ....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 44788999999999998873 489999999875432 222456778999999999999999999998765 689
Q ss_pred EEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE----cCCCCEEEeeccc
Q 013214 227 IVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGV 299 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill----~~~~~vkl~Dfg~ 299 (447)
+||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999999997643 3999999999999999999999999 9999999999999 7777899999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCC--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc----hHHHHH
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN--------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYA 367 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~----~~~~~~ 367 (447)
+...... .......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....+.
T Consensus 163 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 163 ARELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp CEECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred ceEccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 9865432 22234568999999999864 466789999999999999999999997544322 222221
Q ss_pred hcCCC---------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 368 ARQRP---------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 368 ~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
....+ ........++..+.++|++||+.||++||++.++++.++++....
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 21111 111123567889999999999999999999999999998876643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=323.96 Aligned_cols=255 Identities=16% Similarity=0.209 Sum_probs=208.7
Q ss_pred CcccCCCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCccc
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVV 213 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv 213 (447)
..++.....+|...+.||+|+||.|+. +++.||+|++.... ..++..|..+++.++ |+||+
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhh
Confidence 344455566899999999999998873 47899999997542 245667888888886 99999
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC
Q 013214 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288 (447)
Q Consensus 214 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~ 288 (447)
++++++...+..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGN 207 (365)
T ss_dssp CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECG
T ss_pred hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecc
Confidence 999999999999999999999999999974 456999999999999999999999999 999999999999998
Q ss_pred -----------CCCEEEeecccccccccCC-CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 013214 289 -----------SGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (447)
Q Consensus 289 -----------~~~vkl~Dfg~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 356 (447)
++.+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 8999999999997654221 2233456789999999999998999999999999999999999999975
Q ss_pred CCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCC-CCHHHHHHHHHHHHhhhh
Q 013214 357 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR-PTFRQIITRLESINNSIN 418 (447)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-ps~~~~l~~l~~~~~~~~ 418 (447)
....... ....+... ..++.+.+++..|++.+|.+| |++.++.+.|+++.....
T Consensus 288 ~~~~~~~------~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 288 NEGGECK------PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp EETTEEE------ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred CCCCcee------echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 5432211 11111111 236788999999999999999 788999999998877644
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=316.04 Aligned_cols=248 Identities=26% Similarity=0.431 Sum_probs=206.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +++.||+|++...... ....+.+.+|+.++++++||||+++++++......+++|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 3688889999999998873 5889999998654332 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC---CCEEEeecccccccccC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVK 306 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~---~~vkl~Dfg~~~~~~~~ 306 (447)
||+++++|.+++.+...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+ +.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999999988888999999999999999999999999 9999999999999754 46999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
. ......+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||...+..+....+..............+++.+.
T Consensus 178 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp S--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred C--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 2 1222346888999999876 588999999999999999999999998776655555533332221122346788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++|.+||+.||.+|||+.+++++
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHcccChhhCcCHHHHhcC
Confidence 99999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=320.20 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=204.3
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhc--CCCCcccceeEEEEeCC----ce
Q 013214 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQSS----PM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~~~~~~~~----~~ 225 (447)
.+|...+.||+|+||.|+ .+|+.||+|++... ....+.+|.++++. ++||||+++++++.... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 368888999999998876 58999999998643 12456778888887 68999999999998776 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeCCCCCCCEEEcCCCCEEEeec
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH--------~~~~~~i~H~Dikp~Nill~~~~~vkl~Df 297 (447)
+++|||+++|+|.+++.+ ..+++..++.++.|++.||.||| +.+ ++||||||+||+++.++.+||+||
T Consensus 116 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEEC
Confidence 999999999999999976 46899999999999999999999 777 999999999999999999999999
Q ss_pred ccccccccCCCC---CcccCCCCCcccCCcccCCCC------CCCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 013214 298 GVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEG----------CPPFTMKH 358 (447)
Q Consensus 298 g~~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~tg----------~~p~~~~~ 358 (447)
|++......... ......+|+.|+|||.+.+.. ++.++||||||+++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999765543221 123456899999999987652 33689999999999999999 78887654
Q ss_pred CCc-----hHHHHHhcC-CCCCCCC--hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 359 DNE-----VPKAYAARQ-RPPFKAP--AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 359 ~~~-----~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
... ....+.... ++.++.. ....++.+.++|.+||+.||.+|||+.+++++|+++.++..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 322 122221111 3333221 23566789999999999999999999999999999887643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.98 Aligned_cols=246 Identities=26% Similarity=0.458 Sum_probs=200.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe---------
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 221 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--------- 221 (447)
+|+..+.||+|+||.|+. +|+.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 678889999999987762 58999999987542 246789999999999999999998864
Q ss_pred -------CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCE
Q 013214 222 -------SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292 (447)
Q Consensus 222 -------~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~v 292 (447)
....+++|||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 34589999999999999999754 57999999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCC
Q 013214 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (447)
Q Consensus 293 kl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 372 (447)
||+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.... .....+. ..
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~---~~ 234 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR---DG 234 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH---TT
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh---cc
Confidence 999999988665332 2234468999999999988889999999999999999999998875321 1111221 11
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhccc
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR 421 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 421 (447)
.+ +..++..+.++|.+||+.||.+|||+.+++++|+.+.++..+..
T Consensus 235 ~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 235 II---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred cc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 11 23467889999999999999999999999999999987766544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=319.24 Aligned_cols=247 Identities=24% Similarity=0.405 Sum_probs=201.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..+++|
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3688899999999987763 48899999986542 233567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
||+++++|.+++.+ ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999999876 456999999999999999999999999 9999999999999999999999999875432111
Q ss_pred CCcccCCCCCcccCCccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 309 RPLTCQDTSCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.......+|+.|+|||.+ .+..++.++||||||+++|+|++|+.||...+.......+..... +....+..++.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 250 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-PTLLTPSKWSV 250 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSSGGGSCH
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-cccCCccccCH
Confidence 111234578999999988 356788999999999999999999999987766555444433332 22234567889
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.++|.+||+.||.+|||+.+++++
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 99999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=322.71 Aligned_cols=248 Identities=26% Similarity=0.414 Sum_probs=203.6
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cc
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 224 (447)
.+|+..+.||+|+||.|+. +++.||+|++... ......+.+.+|+.++++++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4799999999999998873 5889999998743 3455667889999999999999999999999755 46
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
.+++|||++ |+|.+++.. +.+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 899999996 699998865 46999999999999999999999999 9999999999999999999999999998665
Q ss_pred cCCCC--CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCC-------
Q 013214 305 VKEDR--PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP------- 373 (447)
Q Consensus 305 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~------- 373 (447)
..... ......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+....+.... .+.
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 33221 12345789999999986544 58999999999999999999999999887666554442211 110
Q ss_pred -------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 -------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 -------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+....+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000113457889999999999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=328.91 Aligned_cols=247 Identities=12% Similarity=0.108 Sum_probs=184.2
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC--CCCccccee-------EEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFL-------GAV 219 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~~~-------~~~ 219 (447)
..+|...+.||+|+||.|+. +|+.||+|++...........+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34588899999999998873 6899999999876655566677788885444444 699977755 555
Q ss_pred EeCC-----------------ceEEEEeccCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 013214 220 TQSS-----------------PMMIVTEYLPKGDLRAFLKRK-GALKPSTA------VRFALDIARGMNYLHENKPVPII 275 (447)
Q Consensus 220 ~~~~-----------------~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~------~~i~~ql~~~l~~lH~~~~~~i~ 275 (447)
..++ ..++||||++ |+|.+++... ..+++..+ ..++.|++.||.|||+++ |+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 4433 3799999997 8999999864 33555555 677899999999999999 99
Q ss_pred eCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCC
Q 013214 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPP 353 (447)
Q Consensus 276 H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p 353 (447)
||||||+|||++.++.+||+|||++...... .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999865421 113345699999999987 6789999999999999999999999
Q ss_pred CCCCCCCchHHHH----Hhc-CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 013214 354 FTMKHDNEVPKAY----AAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408 (447)
Q Consensus 354 ~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~ 408 (447)
|............ ... ...........+++.+.++|.+||+.||++|||+.++++
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9877543211000 000 111111123467899999999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=319.26 Aligned_cols=260 Identities=26% Similarity=0.445 Sum_probs=191.6
Q ss_pred ccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEE--
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVT-- 220 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~-- 220 (447)
.+.....+|+..+.||+|+||.|+. +|+.||+|++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 4445556899999999999998873 6889999988543 4555677889999999995 999999999984
Q ss_pred ------eCCceEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 221 ------QSSPMMIVTEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 221 ------~~~~~~lv~e~~~~g~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
.....+++|||+. |+|.+++.. .+.+++.+++.++.|++.||.|||+.+ .+++|+||||+||+++.++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSC
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCC
Confidence 3344899999995 799998865 456999999999999999999999986 24999999999999999999
Q ss_pred EEEeecccccccccCCCCC-----------cccCCCCCcccCCccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 013214 292 LKVADFGVSKLLTVKEDRP-----------LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~~~-----------~~~~~~t~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 357 (447)
+||+|||++.......... .....+|+.|+|||.+ .+..++.++||||||+++|+|++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998765332211 1134579999999998 4567888999999999999999999999865
Q ss_pred CCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 358 HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
......... ...+ .....+..+.++|.+||+.||.+|||+.+++++|+.+......
T Consensus 257 ~~~~~~~~~---~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 257 AKLRIVNGK---YSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp ------------CCCC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred hHHHhhcCc---ccCC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 543322211 1111 1233456788999999999999999999999999999876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=317.20 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=199.9
Q ss_pred ccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe-
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ- 221 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~- 221 (447)
++.....+|+..+.||+|+||.|+. +|+.||+|++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3334455789999999999998873 688999999865432 235678899999999 89999999999976
Q ss_pred -----CCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 222 -----SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 222 -----~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence 46789999999999999999864 56999999999999999999999999 999999999999999999999
Q ss_pred eecccccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc
Q 013214 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~ 369 (447)
+|||++....... .......+|+.|+|||.+. +..++.++||||||+++|+|++|+.||...........+...
T Consensus 171 ~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 171 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred eeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 9999987654321 1223446799999999986 456889999999999999999999999876654444443333
Q ss_pred CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.. ....+++.+.++|.+||..||.+||++.+++++
T Consensus 250 ~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 250 PAPRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 33222 234578899999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=328.74 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=199.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC------CCCcccceeEEEEeCC
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI------RHPNVVQFLGAVTQSS 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~~ 223 (447)
.+|+..+.||+|+||.|+. +++.||||++... ....+.+.+|+.+++.+ +|+||+++++++....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 4688999999999999873 5799999998643 34456677788888777 5789999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC--EEEeeccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFGV 299 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~--vkl~Dfg~ 299 (447)
..+++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999995 79999998754 4999999999999999999999999 999999999999999887 99999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCC-----
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP----- 373 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~----- 373 (447)
+..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... .++
T Consensus 249 a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 249 SCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp CEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 976432 2234567999999999999899999999999999999999999998776544433322110 000
Q ss_pred --------------------------------------------CCCC-----hhhhHHHHHHHHHHHcccCCCCCCCHH
Q 013214 374 --------------------------------------------FKAP-----AKLYARGLKELIEECWNEKPAKRPTFR 404 (447)
Q Consensus 374 --------------------------------------------~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~ 404 (447)
.... ....++.+.+||++||+.||++|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 0000 012357799999999999999999999
Q ss_pred HHHHH
Q 013214 405 QIITR 409 (447)
Q Consensus 405 ~~l~~ 409 (447)
+++++
T Consensus 405 e~L~H 409 (429)
T 3kvw_A 405 QALRH 409 (429)
T ss_dssp HHHTS
T ss_pred HHhCC
Confidence 99974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=326.24 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=185.2
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------C
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 223 (447)
.+|+..+.||+|+||.|+. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4788999999999998863 58999999997543 3455667788999999999999999999998654 5
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..++++||+ +++|.+++.. ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 679999999 7899998865 57999999999999999999999999 999999999999999999999999999864
Q ss_pred ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC---------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP--------- 372 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~--------- 372 (447)
.. ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+... +.+
T Consensus 183 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 183 AD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred cc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 42 2234568999999999877 57899999999999999999999999877654433333211 110
Q ss_pred ------------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ------------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ------------~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+ ......++.+.+||.+||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0112356789999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=313.53 Aligned_cols=244 Identities=28% Similarity=0.500 Sum_probs=197.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
++.....||+|+||.|+. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..+++||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 455566899999998863 5789999998754 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeecccccccccC
Q 013214 231 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~~~~~~ 306 (447)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999998652 4678889999999999999999999 999999999999997 899999999999865432
Q ss_pred CCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH--HhcCCCCCCCChhhhH
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYA 382 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 382 (447)
. .......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||............ .....+.+ +..++
T Consensus 177 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 252 (295)
T 2clq_A 177 N-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI---PESMS 252 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCC---CTTSC
T ss_pred C-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccc---cccCC
Confidence 1 122345679999999998764 3788999999999999999999999865443321111 11222332 45678
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+.++|.+||+.||++||++.+++++
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 899999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=325.72 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=197.2
Q ss_pred CCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-----
Q 013214 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----- 221 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 221 (447)
....+|+..+.||+|+||.|+. +|+.||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3455799999999999999873 689999998865421 22369999999999999999999844
Q ss_pred ---------------------------------CCceEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 013214 222 ---------------------------------SSPMMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMN 264 (447)
Q Consensus 222 ---------------------------------~~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~ 264 (447)
....++||||++ |+|.+.+. ....+++..++.++.|++.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 334889999997 58777765 3567999999999999999999
Q ss_pred HHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHH
Q 013214 265 YLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFAL 342 (447)
Q Consensus 265 ~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~ 342 (447)
|||+.| |+||||||+||+++ .++.+||+|||++...... .......+|+.|+|||.+.+. .++.++||||+||
T Consensus 156 ~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999 99999999999998 6889999999999865432 233445679999999998765 5899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHHhc-CCC---------------CCC---C------ChhhhHHHHHHHHHHHcccCC
Q 013214 343 ILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP---------------PFK---A------PAKLYARGLKELIEECWNEKP 397 (447)
Q Consensus 343 ~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~---------------~~~---~------~~~~~~~~l~~li~~cl~~dp 397 (447)
++|+|++|+.||.+.+..+....+... +.+ .++ . .+..+++.+.++|.+||+.||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999999999987655544333221 111 000 0 123467889999999999999
Q ss_pred CCCCCHHHHHHH--HHHHHh
Q 013214 398 AKRPTFRQIITR--LESINN 415 (447)
Q Consensus 398 ~~Rps~~~~l~~--l~~~~~ 415 (447)
.+|||+.+++++ ++.+..
T Consensus 311 ~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHHH
T ss_pred hhCCCHHHHhcCHHHHHHHh
Confidence 999999999954 444443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=325.75 Aligned_cols=248 Identities=23% Similarity=0.412 Sum_probs=205.0
Q ss_pred cCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHH--------------HHHHHHHHHHHHhcCCCCcccceeE
Q 013214 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDD--------------RVRAFRDELALLQKIRHPNVVQFLG 217 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~hp~iv~~~~ 217 (447)
.+|...+.||+|+||.|+ .+|+.||+|.+......... ..+.+.+|+.++++++||||+++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred CceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 378899999999998765 58999999998653322111 1267889999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcC
Q 013214 218 AVTQSSPMMIVTEYLPKGDLRAF------LKR--KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDD 288 (447)
Q Consensus 218 ~~~~~~~~~lv~e~~~~g~L~~~------l~~--~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~ 288 (447)
++.+.+..++||||+++++|.++ +.+ ...+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence 99999999999999999999998 655 5679999999999999999999999 88 999999999999999
Q ss_pred CCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCC-CCCC-chhHHHHHHHHHHHHhCCCCCCCCCC-CchHHH
Q 013214 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDT-KVDVFSFALILQEMIEGCPPFTMKHD-NEVPKA 365 (447)
Q Consensus 289 ~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~~Di~slG~~l~~l~tg~~p~~~~~~-~~~~~~ 365 (447)
++.+||+|||++...... ......+|+.|+|||.+.+. .++. ++||||||+++|+|++|+.||..... .+....
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 999999999999865432 23445689999999999877 5666 99999999999999999999997776 334334
Q ss_pred HHhcCCCCCCCC----------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 366 YAARQRPPFKAP----------------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 366 ~~~~~~~~~~~~----------------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ ......++.. ...+++.+.++|.+||+.||.+|||+.+++++
T Consensus 265 i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 265 I-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp H-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred H-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3 2232222210 14578899999999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=313.33 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=199.8
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCCCcccceeEEEE--eCCceE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~ 226 (447)
.+|...+.||+|+||.|+. +++.||+|++...... .....+.+.+|+.+++.++||||+++++++. +....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 3688889999999998873 6789999998753211 1234567899999999999999999999984 456789
Q ss_pred EEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 227 IVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
++|||++++ |.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999765 8787765 356999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCC-CCCcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhh
Q 013214 305 VKE-DRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 305 ~~~-~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (447)
... ........+|+.|+|||.+.+.. .+.++||||||+++|+|++|+.||...+..+....+... ...+ +..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~---~~~~ 236 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-SYAI---PGDC 236 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-CCCC---CSSS
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-CCCC---CCcc
Confidence 321 12223456899999999987643 367999999999999999999999977655555544332 2222 3456
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
++.+.++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 7899999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=324.02 Aligned_cols=259 Identities=24% Similarity=0.418 Sum_probs=205.3
Q ss_pred CCcCcccceeeecceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 153 HELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
...+|+..+.||+|+||.|+. .+..||+|.+..... .....+.+.+|+.++++++||||+++++++.+....+++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 344788889999999998862 345699999875432 22233456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC--
Q 013214 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-- 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~-- 307 (447)
|+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++|+||||+||+++ ++.+||+|||++.......
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999999998754 6999999999999999999999999 99999999999998 6899999999987543211
Q ss_pred --CCCcccCCCCCcccCCcccCC---------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 308 --DRPLTCQDTSCRYVAPEVFKN---------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 308 --~~~~~~~~~t~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.....+...
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 264 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS- 264 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC-
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC-
Confidence 112233457899999999864 34788999999999999999999999987766665555444444332
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
...++..+.++|.+||+.||.+|||+.++++.|+.+.+...
T Consensus 265 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 265 -QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp -CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred -cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 23467789999999999999999999999999998877643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=316.13 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=199.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----C
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----S 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~ 223 (447)
..+|...+.||+|+||.|+. +|+.||+|++... ........+.+|+.+++.++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 45788999999999998873 4899999998643 3455667788999999999999999999987654 6
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..+++|||+. ++|.+++.. +.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7899999996 699998876 57999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCC---------CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC
Q 013214 304 TVKEDR---------PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP 372 (447)
Q Consensus 304 ~~~~~~---------~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~ 372 (447)
...... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+... +.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 432111 1123467999999998754 67889999999999999999999999876643322222110 010
Q ss_pred ----------------------CCCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ----------------------PFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ----------------------~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+. ..+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0100 113567889999999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=320.94 Aligned_cols=244 Identities=24% Similarity=0.388 Sum_probs=198.0
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce----
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM---- 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~---- 225 (447)
.+|...+.||+|+||.|+. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3788899999999999873 58999999997654 3455667888999999999999999999999877655
Q ss_pred --EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 226 --MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 226 --~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
+++|||+. ++|.+++. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999996 68888773 45999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC---------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP--------- 372 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~--------- 372 (447)
... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.... .+
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 422 234567999999999877 678999999999999999999999998776544433332211 00
Q ss_pred -----------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 -----------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 -----------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+....+.+++.+.++|.+||+.||++|||+.+++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000123457899999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=313.21 Aligned_cols=243 Identities=27% Similarity=0.368 Sum_probs=200.3
Q ss_pred cCcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC------cccceeEEEEeC
Q 013214 155 LDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP------NVVQFLGAVTQS 222 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------~iv~~~~~~~~~ 222 (447)
.+|+..+.||+|+||.|+. +|+.||+|++.. .....+.+.+|+.+++.++|+ +++++++++...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3788999999999998873 578999999863 234557788899999988665 499999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC------------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD------------ 288 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~------------ 288 (447)
+..++||||+ +++|.+++...+ ++++..+..++.|++.||.|||+++ ++||||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999 899999998765 5889999999999999999999999 999999999999987
Q ss_pred -------CCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 013214 289 -------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (447)
Q Consensus 289 -------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~ 361 (447)
++.+||+|||++..... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 66899999999976432 2234567999999999998899999999999999999999999998776544
Q ss_pred hHHHHHhcCCC----------------------------------------CCCCChhhhHHHHHHHHHHHcccCCCCCC
Q 013214 362 VPKAYAARQRP----------------------------------------PFKAPAKLYARGLKELIEECWNEKPAKRP 401 (447)
Q Consensus 362 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 401 (447)
....+.....+ .+.......++.+.++|.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 33322111100 00111234578899999999999999999
Q ss_pred CHHHHHHH
Q 013214 402 TFRQIITR 409 (447)
Q Consensus 402 s~~~~l~~ 409 (447)
|+.+++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=325.49 Aligned_cols=256 Identities=15% Similarity=0.225 Sum_probs=208.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-CcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 228 (447)
.+|...+.||+|+||.|+. +++.||||++...... ..+.+|+.+++.+.| +++..+..++......++|
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 3688889999999998873 4899999987654322 246789999999976 5666666777778889999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE---cCCCCEEEeecccccccc
Q 013214 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill---~~~~~vkl~Dfg~~~~~~ 304 (447)
|||+ +++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999 8999999985 467999999999999999999999999 9999999999999 588999999999998765
Q ss_pred cCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc---C-CCCC
Q 013214 305 VKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---Q-RPPF 374 (447)
Q Consensus 305 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---~-~~~~ 374 (447)
..... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+... . ....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43221 122556899999999999999999999999999999999999999987665433332111 1 1111
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
......+++++.++|..||+.||++||++.++++.|+.+......
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF 282 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence 112245678999999999999999999999999999998876643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=315.89 Aligned_cols=244 Identities=24% Similarity=0.382 Sum_probs=198.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc-----
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----- 224 (447)
.+|...+.||+|+||.|+. +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3688889999999998873 58999999997643 345566788899999999999999999999987654
Q ss_pred -eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 -~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.+++|||+. ++|.+++. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999996 68888764 35899999999999999999999999 999999999999999999999999999764
Q ss_pred ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR------------- 369 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~------------- 369 (447)
... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 422 234567999999999877 57889999999999999999999999876644333222110
Q ss_pred --------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 --------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 --------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+....+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0122233345678899999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=312.70 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=183.4
Q ss_pred CCcccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHhcCCCCcccceeEEE
Q 013214 146 PEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAV 219 (447)
Q Consensus 146 ~~~~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~ 219 (447)
+.........+|...+.||+|+||.|+. +|+.||+|++.... .......+..|.. +++.++||||+++++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~ 90 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 90 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence 3444455566888999999999998873 58999999997542 3334445555555 77778999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEE
Q 013214 220 TQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLK 293 (447)
Q Consensus 220 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vk 293 (447)
...+..+++|||++ ++|.+++.. ...+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+|
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 91 FREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp ECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEE
T ss_pred EeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEE
Confidence 99999999999996 588888763 56799999999999999999999998 8 99999999999999999999
Q ss_pred EeecccccccccCCCCCcccCCCCCcccCCccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHh
Q 013214 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAA 368 (447)
Q Consensus 294 l~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~ 368 (447)
|+|||++....... ......+|+.|+|||.+ .+..++.++||||||+++|+|++|+.||...... +....+..
T Consensus 167 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (327)
T 3aln_A 167 LCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244 (327)
T ss_dssp ECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC
T ss_pred EccCCCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc
Confidence 99999997654321 22234678999999998 4557889999999999999999999999865432 11111111
Q ss_pred cCCCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 RQRPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+.+. .....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1122222 1224578899999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.21 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=199.7
Q ss_pred CCCcCcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeEEEE--
Q 013214 152 PHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT-- 220 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~-- 220 (447)
....+|+..+.||+|+||.|+. +|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 3446799999999999998863 47899999886543211 1112345677666666 8999999999987
Q ss_pred ---eCCceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEe
Q 013214 221 ---QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (447)
Q Consensus 221 ---~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~ 295 (447)
.....+++|||++ |+|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999996 69999998754 4899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC--
Q 013214 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP-- 372 (447)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~-- 372 (447)
|||++...... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.... .+
T Consensus 163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99999765432 12334567999999999998899999999999999999999999998776554443332211 00
Q ss_pred --------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.......++..+.++|.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0111124577889999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=322.28 Aligned_cols=241 Identities=24% Similarity=0.384 Sum_probs=176.7
Q ss_pred ceeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCceEEEEe
Q 013214 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (447)
Q Consensus 160 ~~~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e 230 (447)
.+.||+|+||.|+. +++.||+|++...... ..+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 45799999998873 3678999999755332 357789999999999999999999954 667999999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE----cCCCCEEEeec
Q 013214 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 297 (447)
Q Consensus 231 ~~~~g~L~~~l~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill----~~~~~vkl~Df 297 (447)
|++ ++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 995 6888888532 24899999999999999999999999 9999999999999 67789999999
Q ss_pred ccccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCC---------chHHH
Q 013214 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------EVPKA 365 (447)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~---------~~~~~ 365 (447)
|++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... +....
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 99987643211 222345689999999998774 5889999999999999999999999765432 11111
Q ss_pred H-HhcCCCCCCCC---------------------------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 366 Y-AARQRPPFKAP---------------------------------AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 366 ~-~~~~~~~~~~~---------------------------------~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ ...+.+..... ....++.+.+||.+||+.||.+|||+.+++++
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1 11111111000 00115678899999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=309.44 Aligned_cols=252 Identities=22% Similarity=0.388 Sum_probs=199.8
Q ss_pred ccCCCCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CCcccceeEEEEeC
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQS 222 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~ 222 (447)
.+.....+|...+.||+|+||.|+. +++.||+|++..... .....+.+.+|+.++++++ ||||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 3344455799999999999999874 588999999876543 4566788899999999996 59999999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
...+++||+ .+++|.+++.+...+++..++.++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||++..
T Consensus 101 ~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 101 QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp SEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred CEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999999995 58899999999888999999999999999999999999 999999999999964 8899999999986
Q ss_pred cccCCCC-CcccCCCCCcccCCcccCC-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch-HHHHHh-
Q 013214 303 LTVKEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAA- 368 (447)
Q Consensus 303 ~~~~~~~-~~~~~~~t~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-~~~~~~- 368 (447)
....... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ......
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence 5432211 1234467999999999865 4678899999999999999999999986543221 111111
Q ss_pred cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 369 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....+ +...++.+.++|.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 256 NHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCC---cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 112222 23456789999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=308.24 Aligned_cols=243 Identities=28% Similarity=0.441 Sum_probs=190.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe---------
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 221 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--------- 221 (447)
+|+..+.||+|+||.|+. +|+.||+|++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 578888999999998863 689999999863 34556788999999999999999999998865
Q ss_pred ----CCceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 222 ----SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 222 ----~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
....+++|||+++|+|.+++...+ .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 356899999999999999998654 5788999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCC-------------CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC-CCc
Q 013214 297 FGVSKLLTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKH-DNE 361 (447)
Q Consensus 297 fg~~~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~-~~~ 361 (447)
||++....... ........+|+.|+|||.+.+. .++.++||||||+++|+|++ ||.... ..+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99997654221 1112344578999999998764 68899999999999999998 554221 112
Q ss_pred hHHHHHhcCCCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 362 VPKAYAARQRPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 362 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+. .....++ ......++.+.++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 ILKKLR-SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHH-STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHhcc-ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 222222 2222221 2234567789999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=308.72 Aligned_cols=248 Identities=25% Similarity=0.448 Sum_probs=185.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|...+.||+|+||.|+. +|+.||+|++.... ......+.+.++..+++.++||||+++++++...+..+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 34788889999999998763 58999999997543 2333344555666678888999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|||+ ++.+..+... ...+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999 5666666654 46799999999999999999999995 8 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-chHHHHHhcCCCCCCCChhh
Q 013214 307 EDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 380 (447)
.......+|+.|+|||.+. ...++.++||||||+++|+|++|+.||...... +....+.....+.+ .....
T Consensus 179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 255 (318)
T 2dyl_A 179 --KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGHMG 255 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSSSC
T ss_pred --ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-CccCC
Confidence 1223345789999999984 456888999999999999999999999875433 23333322223222 22345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.+.++|.+||+.||.+||++.+++++
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 78899999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=325.79 Aligned_cols=245 Identities=25% Similarity=0.357 Sum_probs=193.0
Q ss_pred CCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC----
Q 013214 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS---- 222 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 222 (447)
+...+|...+.||+|+||.|+. +|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 3445788999999999998873 589999999865321 234699999999999999999988542
Q ss_pred --CceEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-CCEEEe
Q 013214 223 --SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVA 295 (447)
Q Consensus 223 --~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~-~~vkl~ 295 (447)
..+++||||++ ++|.+.+.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 124 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 124 DEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp TEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred cceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEec
Confidence 23679999996 477666642 467999999999999999999999999 9999999999999965 568999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CC--
Q 013214 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QR-- 371 (447)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~-- 371 (447)
|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+... +.
T Consensus 200 DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 200 DFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp CCTTCEECCTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred cchhhhhcccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999865432 223345679999999998764 7899999999999999999999999887654433332211 00
Q ss_pred --------C-----CCCC---------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 --------P-----PFKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 --------~-----~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ .++. .....++++.+||.+||+.||.+||++.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 1110 123457899999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=309.99 Aligned_cols=241 Identities=21% Similarity=0.365 Sum_probs=195.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEe--CCceE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~ 226 (447)
.+|+..+.||+|+||.|+. +++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 3688899999999998873 68999999986432 256888999999996 9999999999987 66789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeeccccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTV 305 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~~~~ 305 (447)
++|||+++++|.+++.. +++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||++.....
T Consensus 110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999998753 889999999999999999999999 99999999999999776 899999999986543
Q ss_pred CCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-hHHHHH------------hcCC
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYA------------ARQR 371 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~-~~~~~~------------~~~~ 371 (447)
.. ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ....+. ....
T Consensus 184 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 32 2334567899999999877 578999999999999999999999996443321 111000 0000
Q ss_pred CCC---------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 PPF---------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ~~~---------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+ ......+++++.++|.+||+.||.+|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 11123368899999999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.13 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=192.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE---------
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--------- 220 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--------- 220 (447)
.+|...+.||+|+||.|+. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 3688899999999998873 4899999988643 4566778899999999999999999999874
Q ss_pred -----eCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEE
Q 013214 221 -----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKV 294 (447)
Q Consensus 221 -----~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl 294 (447)
.....+++|||++ |+|.+++.+ +++++..++.++.|++.||.|||+.+ ++|+||||+||+++ +++.+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999996 699999864 57999999999999999999999999 99999999999997 5678999
Q ss_pred eecccccccccCCC--CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC
Q 013214 295 ADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~ 371 (447)
+|||++........ .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999986543211 11233456889999998765 5788899999999999999999999987765443333321110
Q ss_pred --------------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 --------------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 --------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.....+.++..+.++|.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00001123467899999999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=315.87 Aligned_cols=245 Identities=26% Similarity=0.363 Sum_probs=184.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc-----
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----- 224 (447)
.+|+..+.||+|+||.|+. +|+.||+|++....... ....+|+..++.++||||+++++++.....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 3788889999999998872 58899999886543222 345567888888999999999999976443
Q ss_pred --eEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeCCCCCCCEEEcC-CCCEEEe
Q 013214 225 --MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDD-SGNLKVA 295 (447)
Q Consensus 225 --~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~lH--~~~~~~i~H~Dikp~Nill~~-~~~vkl~ 295 (447)
.+++|||+++ +|.+.+. ....+++..+..++.|++.||.||| +.+ |+||||||+||+++. ++.+||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEEC
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEe
Confidence 7899999975 5554443 4566899999999999999999999 888 999999999999996 8999999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCC
Q 013214 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP 373 (447)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~ 373 (447)
|||++...... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||...+.......+.... .++
T Consensus 175 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 175 DFGSAKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCTTCBCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eCCCceecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 99999876532 223345679999999998665 48999999999999999999999999876654444432211 100
Q ss_pred ---------------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 ---------------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ---------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+......+++.+.++|.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011122367899999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=319.39 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=192.1
Q ss_pred CcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc-----
Q 013214 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----- 224 (447)
..+|...+.||+|+||.|+. .+..||+|++..... ...+|+.+++.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 44799999999999999873 456699998864321 12369999999999999999999865443
Q ss_pred -eEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeecc
Q 013214 225 -MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFG 298 (447)
Q Consensus 225 -~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg 298 (447)
+++||||+++ ++.+.+. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 7899999975 4444433 2567999999999999999999999999 99999999999999 79999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CC-----
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QR----- 371 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~----- 371 (447)
++...... .......+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+... +.
T Consensus 188 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 188 SAKILIAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp TCEECCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CcccccCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99875432 223445679999999998764 5899999999999999999999999987654443333221 01
Q ss_pred -------------CCCCC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 -------------PPFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 -------------~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.... ....+++++.++|.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 11100 112367899999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=312.64 Aligned_cols=243 Identities=25% Similarity=0.374 Sum_probs=170.3
Q ss_pred CcCcccce-eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe----CC
Q 013214 154 ELDFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SS 223 (447)
Q Consensus 154 ~~~~~~~~-~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~ 223 (447)
..+|...+ .||+|+||.|+. +|+.||+|++... .... .+....++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 34677744 699999999873 5899999998642 2222 223334667799999999999876 44
Q ss_pred ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeecc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFG 298 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg 298 (447)
..++||||+++|+|.+++.+.+ .+++.+++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 5899999999999999998754 5999999999999999999999999 999999999999986 4559999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHH---hcCCCCC-
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---ARQRPPF- 374 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~---~~~~~~~- 374 (447)
++...... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||............. ......+
T Consensus 177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3fhr_A 177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence 99765422 2234457999999999988888999999999999999999999998766543321111 1111111
Q ss_pred CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 375 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
......+++.+.++|.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12234678899999999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=319.42 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=194.3
Q ss_pred CCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccC--------CCHHHHHHHHHHHHHHhcCCCCcccceeEEEE
Q 013214 153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVI--------SDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (447)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 220 (447)
...+|...+.||+|+||.|+. +|+.||+|++..... ......+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 345788899999999999874 588999998865322 23344578899999999999999999999985
Q ss_pred eC-----CceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEE
Q 013214 221 QS-----SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (447)
Q Consensus 221 ~~-----~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl 294 (447)
.. ...++||||++ |+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEE
Confidence 42 35799999996 6888888754 46999999999999999999999999 999999999999999999999
Q ss_pred eecccccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC
Q 013214 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP 372 (447)
Q Consensus 295 ~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~ 372 (447)
+|||++...... .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+.... .+
T Consensus 176 ~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 176 CDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp CCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999999754332 22234567899999999877 578999999999999999999999998776544433332111 11
Q ss_pred ----------------------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ----------------------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ----------------------~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+ ...+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000 0112456789999999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=318.90 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=196.4
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--------CCcccceeEEEE-
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--------HPNVVQFLGAVT- 220 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hp~iv~~~~~~~- 220 (447)
.+|...+.||+|+||.|+. +++.||+|++.. .....+.+.+|+.+++.+. ||||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4789999999999999874 489999999863 3445677888999999985 788999999987
Q ss_pred ---eCCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCC----
Q 013214 221 ---QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSG---- 290 (447)
Q Consensus 221 ---~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~---- 290 (447)
.....++||||+ +++|.+.+... ..+++..++.++.|++.||.|||++ + |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 456789999999 66777777554 4699999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------CEEEeecccccccccCCCCCcccCCCCCcccCCcc
Q 013214 291 ---------------------------------------------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325 (447)
Q Consensus 291 ---------------------------------------------~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~ 325 (447)
.+||+|||++...... .....+|+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 8999999999865432 234467999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchH------HHH-HhcCCCC-------------------------
Q 013214 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP------KAY-AARQRPP------------------------- 373 (447)
Q Consensus 326 ~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~-~~~~~~~------------------------- 373 (447)
+.+..++.++|||||||++|+|++|+.||......+.. ..+ ...+.++
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99988999999999999999999999999876643321 011 0000000
Q ss_pred ------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 ------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 ------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+...++.+.+||.+||+.||++|||+.+++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 001134567889999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=323.97 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=190.6
Q ss_pred CcCcccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 228 (447)
..+|...+.||+|+||.|+ .+|+.||||++..... ..+.+|+.+++.+ +||||+++++++.+....+++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3468888999999998753 4789999999865432 2345799999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-----CCCEEEeecccccc
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----SGNLKVADFGVSKL 302 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-----~~~vkl~Dfg~~~~ 302 (447)
|||+. |+|.+++.... ..++..++.++.|++.||.|||+.+ |+||||||+||+++. ...+||+|||++..
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99995 69999997654 4666678899999999999999999 999999999999953 23588999999987
Q ss_pred cccCCC--CCcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 303 LTVKED--RPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 303 ~~~~~~--~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||............ .........
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~-~~~~~~~~~ 251 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-GACSLDCLH 251 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT-TCCCCTTSC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh-ccCCccccC
Confidence 653321 12234568999999999973 567789999999999999999 99999765443332222 222222222
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.....+..+.++|.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 344567789999999999999999999999853
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=324.07 Aligned_cols=241 Identities=25% Similarity=0.363 Sum_probs=184.7
Q ss_pred cccceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEec
Q 013214 157 FTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
|...+.||+|+||.|+ .+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.+.+..++||||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4556789999999774 468999999986432 24567899999876 899999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC-------------CC
Q 013214 232 LPKGDLRAFLKRKGAL-------KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-------------GN 291 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l-------~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~-------------~~ 291 (447)
++ |+|.+++...... ++..++.++.|++.||.|||+.+ |+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 6999999865432 23346789999999999999999 9999999999999754 47
Q ss_pred EEEeecccccccccCCCC---CcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 013214 292 LKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 360 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~ 360 (447)
+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999876543211 1234568999999999865 568899999999999999999 99999765443
Q ss_pred chHHHHHhcC--CCCC-CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 361 EVPKAYAARQ--RPPF-KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 361 ~~~~~~~~~~--~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+. .+.... .+.. ......+++++.++|.+||+.||.+|||+.+++++
T Consensus 247 ~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 32 221111 1111 11234678899999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=309.20 Aligned_cols=243 Identities=26% Similarity=0.319 Sum_probs=197.6
Q ss_pred cCcccceeeecceEEEEEE-----cC-eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc------ccceeEEEEeC
Q 013214 155 LDFTNSVEITKGTFILAFW-----RG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN------VVQFLGAVTQS 222 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~------iv~~~~~~~~~ 222 (447)
.+|...+.||+|+||.|+. ++ +.||+|++.. .....+.+.+|+.+++.++|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 4789999999999998873 33 7899999863 2345577888999999997665 89999999999
Q ss_pred CceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE--------------
Q 013214 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-------------- 286 (447)
Q Consensus 223 ~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill-------------- 286 (447)
+..+++|||+ +++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 678888777653 6999999999999999999999999 9999999999999
Q ss_pred -----cCCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 013214 287 -----DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (447)
Q Consensus 287 -----~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~ 361 (447)
+.++.+||+|||++..... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||......+
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5678999999999976432 2234568999999999998899999999999999999999999998766544
Q ss_pred hHHHHHhcCCCC----------------------------------------CCCChhhhHHHHHHHHHHHcccCCCCCC
Q 013214 362 VPKAYAARQRPP----------------------------------------FKAPAKLYARGLKELIEECWNEKPAKRP 401 (447)
Q Consensus 362 ~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rp 401 (447)
....+.....+. ........+..+.++|.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 333221111000 0011223467899999999999999999
Q ss_pred CHHHHHHH
Q 013214 402 TFRQIITR 409 (447)
Q Consensus 402 s~~~~l~~ 409 (447)
|+.+++++
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.44 Aligned_cols=243 Identities=24% Similarity=0.303 Sum_probs=195.9
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CC-----cccceeEEEEeCC
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HP-----NVVQFLGAVTQSS 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~iv~~~~~~~~~~ 223 (447)
.+|...+.||+|+||.|+. +++.||||++.. .......+..|+.+++.++ |+ +|+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4788899999999999873 588999999873 3344567778898888884 55 4999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeCCCCCCCEEEc--CCCCEEEeec
Q 013214 224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHE--NKPVPIIHRDLEPSNILRD--DSGNLKVADF 297 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~--~~~~~i~H~Dikp~Nill~--~~~~vkl~Df 297 (447)
..++||||++ ++|.+++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999995 6999999875 459999999999999999999995 55 99999999999995 4778999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCC-CC---
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PP--- 373 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~--- 373 (447)
|++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..... ++
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999875422 2345679999999999998999999999999999999999999997765544433322110 00
Q ss_pred ------------------------------CCC--------------------------ChhhhHHHHHHHHHHHcccCC
Q 013214 374 ------------------------------FKA--------------------------PAKLYARGLKELIEECWNEKP 397 (447)
Q Consensus 374 ------------------------------~~~--------------------------~~~~~~~~l~~li~~cl~~dp 397 (447)
+.. .....++.+.+||.+||+.||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 000 000123578999999999999
Q ss_pred CCCCCHHHHHHH
Q 013214 398 AKRPTFRQIITR 409 (447)
Q Consensus 398 ~~Rps~~~~l~~ 409 (447)
++|||+.+++++
T Consensus 362 ~~Rpta~e~L~h 373 (382)
T 2vx3_A 362 KTRIQPYYALQH 373 (382)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=310.67 Aligned_cols=245 Identities=27% Similarity=0.429 Sum_probs=200.1
Q ss_pred ccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcCC--CCcccceeEE
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIR--HPNVVQFLGA 218 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hp~iv~~~~~ 218 (447)
+......+|+..+.||+|+||.|+. +|+.||+|++........ ...+.+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3344556899999999999998873 689999999875433211 11234667999999995 5999999999
Q ss_pred EEeCCceEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEee
Q 013214 219 VTQSSPMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVAD 296 (447)
Q Consensus 219 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~D 296 (447)
+...+..++++|++.+ ++|.+++.+.+.+++..++.++.|++.||.|||+.+ ++||||||+||+++ +++.+||+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999999976 899999998889999999999999999999999999 99999999999999 788999999
Q ss_pred cccccccccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCC
Q 013214 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375 (447)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 375 (447)
||++...... ......+|+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... .+ ......+
T Consensus 194 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~-~~~~~~~- 262 (320)
T 3a99_A 194 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI-IRGQVFF- 262 (320)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH-HHCCCCC-
T ss_pred Cccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hh-hcccccc-
Confidence 9999865432 2234568999999999877665 578999999999999999999997432 11 1111222
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 376 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+++.+.++|.+||+.||.+|||+.+++++
T Consensus 263 --~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 34567899999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=311.88 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=193.6
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----------CCcccceeE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLG 217 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv~~~~ 217 (447)
..+|...+.||+|+||.|+. +|+.||+|++.. .....+.+.+|+.++++++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 34789999999999998873 689999999864 3344567788999999886 899999999
Q ss_pred EEEeCC----ceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEc---
Q 013214 218 AVTQSS----PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRD--- 287 (447)
Q Consensus 218 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~--- 287 (447)
++...+ ..+++|||+ +++|.+++.+. ..+++..++.++.|++.||.|||++ + |+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccC
Confidence 988654 689999999 89999999864 4599999999999999999999998 8 99999999999995
Q ss_pred ---CCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch--
Q 013214 288 ---DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-- 362 (447)
Q Consensus 288 ---~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-- 362 (447)
..+.+||+|||++...... .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 3447999999999865432 2334679999999999998899999999999999999999999986553211
Q ss_pred ----HHHH-HhcCCCC-------------------------------------CCCChhhhHHHHHHHHHHHcccCCCCC
Q 013214 363 ----PKAY-AARQRPP-------------------------------------FKAPAKLYARGLKELIEECWNEKPAKR 400 (447)
Q Consensus 363 ----~~~~-~~~~~~~-------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~R 400 (447)
...+ ...+..+ ....+..+++.+.++|.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 1111 0000000 001234678899999999999999999
Q ss_pred CCHHHHHHH
Q 013214 401 PTFRQIITR 409 (447)
Q Consensus 401 ps~~~~l~~ 409 (447)
||+.+++++
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=304.47 Aligned_cols=240 Identities=28% Similarity=0.431 Sum_probs=192.4
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHhcC----CCCcccceeEEEEe
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKI----RHPNVVQFLGAVTQ 221 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~hp~iv~~~~~~~~ 221 (447)
..+|+..+.||+|+||.|+. +|+.||+|++........ .....+.+|+.+++++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 44799999999999998873 578999999976543221 1223456789999888 89999999999999
Q ss_pred CCceEEEEec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeeccc
Q 013214 222 SSPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGV 299 (447)
Q Consensus 222 ~~~~~lv~e~-~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~ 299 (447)
.+..++++|| +.+++|.+++.+.+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++ .++.+||+|||+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999 789999999998888999999999999999999999999 99999999999999 889999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCCh
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 378 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (447)
+...... ......+++.|+|||.+.+..+. .++||||||+++|+|++|+.||.... .+ ......+ +
T Consensus 187 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~-~~~~~~~---~ 253 (312)
T 2iwi_A 187 GALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EI-LEAELHF---P 253 (312)
T ss_dssp CEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH-HHTCCCC---C
T ss_pred hhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HH-hhhccCC---c
Confidence 9866532 22345689999999998776654 48999999999999999999997431 11 1122222 3
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..++..+.++|.+||+.||++|||+.+++++
T Consensus 254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4567899999999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=299.26 Aligned_cols=232 Identities=13% Similarity=0.100 Sum_probs=188.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|+.||+|++........+..+.+.+|+..++.++||||+++++++..++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 4689999999999998873 48999999998776666777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||++|++|.++++++ ....++..++.|++.||.|||++| |+||||||+||+++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999543 466678899999999999999999 9999999999999999999998443
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH---HhcCCCCCCCChhhhHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~ 386 (447)
|++ .++.++||||||+++|+|++|+.||...+..+..... .....+........+++.+.
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 233 3688999999999999999999999977654321100 01111111111245778999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 387 ELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
++|.+||+.||.+| |+.++++.|+.+.......
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~ 270 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLNLMQQATAVADRT 270 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHHHHHHHHC-----
T ss_pred HHHHHHcccCCccC-CHHHHHHHHHHHhccCCcc
Confidence 99999999999999 9999999999987665543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=323.04 Aligned_cols=246 Identities=27% Similarity=0.364 Sum_probs=195.1
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe------CC
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SS 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 223 (447)
.+|...+.||+|+||.|+. +|+.||+|++... ......+.+.+|+.++++++||||+++++++.. .+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 4688889999999998863 6889999998754 245667789999999999999999999998765 66
Q ss_pred ceEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC---EEEeec
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADF 297 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~---vkl~Df 297 (447)
..++||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 7899999999999999998644 5899999999999999999999999 999999999999997765 999999
Q ss_pred ccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch---------HHHHH-
Q 013214 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---------PKAYA- 367 (447)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~---------~~~~~- 367 (447)
|++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .....
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9998765332 22445689999999999988999999999999999999999999975321100 00000
Q ss_pred ---hcC-------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHH
Q 013214 368 ---ARQ-------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407 (447)
Q Consensus 368 ---~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l 407 (447)
..+ .+........+++.+.++|.+||..||.+|||+.+++
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000 0111123445889999999999999999999998843
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=291.42 Aligned_cols=221 Identities=25% Similarity=0.412 Sum_probs=175.6
Q ss_pred cCcccc-eeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH-hcCCCCcccceeEEEEe----CC
Q 013214 155 LDFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQ----SS 223 (447)
Q Consensus 155 ~~~~~~-~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~----~~ 223 (447)
.+|... +.||+|+||.|+. +|+.||+|++... ..+.+|+.++ +..+||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 356665 6799999998873 6889999998632 3456788887 55699999999999876 67
Q ss_pred ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeecc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFG 298 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg 298 (447)
..++||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 7899999999999999998764 5999999999999999999999999 999999999999998 7889999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCCCCCC
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAP 377 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 377 (447)
++.... +..++.++||||||+++|+|++|+.||................ .......
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 222 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence 986432 2356789999999999999999999998665433211111111 1111111
Q ss_pred ---hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 378 ---AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 378 ---~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+++++.++|.+||+.||.+|||+.+++++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 13578899999999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.01 Aligned_cols=247 Identities=13% Similarity=0.118 Sum_probs=185.4
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-Ccc---------ccee--
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNV---------VQFL-- 216 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i---------v~~~-- 216 (447)
..+|...+.||+|+||.|+. +|+.||||++...........+.+.+|+.+++.+.| +|. +...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577888999999999873 489999999875444444446778999999999976 221 1111
Q ss_pred ----------EEEEe-----CCceEEEEeccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 013214 217 ----------GAVTQ-----SSPMMIVTEYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARGMNYLHENKPVPI 274 (447)
Q Consensus 217 ----------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i 274 (447)
.++.. ....+++|+++ +++|.++++. ...+++..++.++.|++.||.|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111 12467788877 6899998852 233778889999999999999999999 9
Q ss_pred EeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCCccc----------CCCCCCCchhHHHHHHHH
Q 013214 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF----------KNEEYDTKVDVFSFALIL 344 (447)
Q Consensus 275 ~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~~Di~slG~~l 344 (447)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999998765432 233456 899999998 555688899999999999
Q ss_pred HHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHhhh
Q 013214 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINNSI 417 (447)
Q Consensus 345 ~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~--l~~~~~~~ 417 (447)
|+|++|+.||......+....+.. . ...+|+.+.++|.+||+.||++||++.+++++ ++.+...+
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~~~~-~-------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEWIFR-S-------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGGGGS-S-------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred HHHHHCCCCCCCcchhhhHHHHHh-h-------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence 999999999987665443332211 1 12456889999999999999999999888764 45544443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=324.62 Aligned_cols=238 Identities=20% Similarity=0.305 Sum_probs=193.9
Q ss_pred cCcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc----
Q 013214 155 LDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---- 224 (447)
.+|+..+.||+|+||.|+. +|+.||||++... ........+.+|+.++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4799999999999998873 4789999998753 345666788999999999999999999999987766
Q ss_pred -eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 -~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.|+||||++|++|.+++.. .+++.+++.++.|++.||.|||+++ |+||||||+||+++.+ .+||+|||++...
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999988754 7999999999999999999999999 9999999999999975 8999999999865
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||........ + ........++
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------~-~~~~~~~~~~ 295 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------P-EDDPVLKTYD 295 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------C-TTCHHHHHCH
T ss_pred ccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------c-ccccccccCH
Confidence 432 345689999999998764 48899999999999999999998875322111 1 1111233567
Q ss_pred HHHHHHHHHcccCCCCCC-CHHHHHHHHHHHHhh
Q 013214 384 GLKELIEECWNEKPAKRP-TFRQIITRLESINNS 416 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rp-s~~~~l~~l~~~~~~ 416 (447)
.+.++|.+||+.||.+|| +++++.+.|..+...
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 899999999999999999 566677777765433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=302.07 Aligned_cols=240 Identities=13% Similarity=0.147 Sum_probs=182.5
Q ss_pred CcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHhcCC---------CCccccee
Q 013214 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIR---------HPNVVQFL 216 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------hp~iv~~~ 216 (447)
..+|+..+.||+|+||.|+ .+|+.||+|++...... .....+.+.+|+.+++.++ ||||+++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 3468889999999999876 58999999999765321 2223466788999888885 66666666
Q ss_pred EEE-----------------Ee-------------CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 013214 217 GAV-----------------TQ-------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266 (447)
Q Consensus 217 ~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~l 266 (447)
+.+ .+ ....++||||+++|++.+.+.+ +.+++..++.++.|++.||.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence 653 32 6789999999999976666643 5689999999999999999999
Q ss_pred H-hCCCCCeEeCCCCCCCEEEcCCC--------------------CEEEeecccccccccCCCCCcccCCCCCcccCCcc
Q 013214 267 H-ENKPVPIIHRDLEPSNILRDDSG--------------------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325 (447)
Q Consensus 267 H-~~~~~~i~H~Dikp~Nill~~~~--------------------~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~ 325 (447)
| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||+
T Consensus 178 H~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 178 EASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred HHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence 9 898 99999999999999887 8999999999865421 2357999999999
Q ss_pred cCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCC-CchHHHHHhc-C--CCCCCCChhhhHHHHHHHHHHHcccCCCCC
Q 013214 326 FKNEEYDTKVDVFSFALI-LQEMIEGCPPFTMKHD-NEVPKAYAAR-Q--RPPFKAPAKLYARGLKELIEECWNEKPAKR 400 (447)
Q Consensus 326 ~~~~~~~~~~Di~slG~~-l~~l~tg~~p~~~~~~-~~~~~~~~~~-~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 400 (447)
+.+.. +.++||||++++ .+++++|..||..... ......+... . .......+..+++++.+||++||+.|
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 98765 889999998777 7778889999853211 0111122111 1 11112234578999999999999976
Q ss_pred CCHHHHH-HH
Q 013214 401 PTFRQII-TR 409 (447)
Q Consensus 401 ps~~~~l-~~ 409 (447)
|+.+++ ++
T Consensus 324 -sa~e~l~~H 332 (336)
T 2vuw_A 324 -SATDLLCQH 332 (336)
T ss_dssp -SHHHHHHHC
T ss_pred -CHHHHHhcC
Confidence 888888 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=273.24 Aligned_cols=172 Identities=15% Similarity=0.117 Sum_probs=130.9
Q ss_pred EEcCeEEEEEEcCcccCC-------CHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEeccCCCCHHHHHHh
Q 013214 172 FWRGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243 (447)
Q Consensus 172 ~~~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 243 (447)
++.|+.+|+|.+.+.... .+...+++.+|+++|+++ +|+||+++++++++++..||||||++|++|.+++.+
T Consensus 256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~ 335 (569)
T 4azs_A 256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA 335 (569)
T ss_dssp EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence 568999999998754321 223456799999999999 799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccCCCCCcccCC
Q 013214 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323 (447)
Q Consensus 244 ~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aP 323 (447)
.+++++. .++.||+.||.|+|++| |+||||||+|||++.+|++||+|||+++....... ......||+.|+||
T Consensus 336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAP 408 (569)
T 4azs_A 336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVN 408 (569)
T ss_dssp TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhccH
Confidence 8888765 47899999999999999 99999999999999999999999999986654322 22345689999999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHhCC
Q 013214 324 EVFKNEEYDTKVDVFSFALILQEMIEGC 351 (447)
Q Consensus 324 E~~~~~~~~~~~Di~slG~~l~~l~tg~ 351 (447)
|++.+ .+..++|+||+|++++++.++.
T Consensus 409 E~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 409 ELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHC------------------CCCCTTH
T ss_pred HHhCC-CCCCcccccccccchhhhcccc
Confidence 99976 5677899999999988776553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=236.92 Aligned_cols=184 Identities=20% Similarity=0.244 Sum_probs=144.4
Q ss_pred cceeeecceEEEEE---EcCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 159 NSVEITKGTFILAF---WRGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 159 ~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
..+.||+|+||.|+ +.+..+++|+......... ...+.+.+|++++++++||||+++..++......++|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 35589999999887 4788999998654433222 224568999999999999999966666667778899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+++++|.+++.+ +..++.|+++||.|||+++ |+||||||+|||++. ++||+|||+++.........
T Consensus 420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999865 5689999999999999999 999999999999998 99999999998765322111
Q ss_pred ------cccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 013214 311 ------LTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFT 355 (447)
Q Consensus 311 ------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~ 355 (447)
.....||+.|+|||++.. ..|+..+|+||..+-..+-..++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 124568999999999976 567778899999998888888777764
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=186.38 Aligned_cols=99 Identities=41% Similarity=0.497 Sum_probs=49.4
Q ss_pred cchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccc
Q 013214 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (447)
Q Consensus 38 ~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~ 117 (447)
.+|+||||+|+..++.++++.|++.|+|+|.+|.+|+||||+|+..|+.+++++|+++|+++|.+|.+|+||||+|+..|
T Consensus 35 ~~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g 114 (169)
T 4gpm_A 35 SDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENG 114 (169)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcC
Confidence 33444455555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred hHHHHHHHHHhCCCCCCCc
Q 013214 118 NHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 118 ~~~~~~~L~~~~a~~~~~~ 136 (447)
+.+++++|+++|++++..+
T Consensus 115 ~~~~v~~Ll~~gad~~~~d 133 (169)
T 4gpm_A 115 HKEVVKLLISKGADVNTSD 133 (169)
T ss_dssp CHHHHHHHHHTTCCTTCCC
T ss_pred CHHHHHHHHHcCCCccccC
Confidence 5555555555555444433
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=181.40 Aligned_cols=104 Identities=41% Similarity=0.485 Sum_probs=93.9
Q ss_pred CCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcc
Q 013214 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl 110 (447)
.|.+.++.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.++|++|+++|++++.+|..|+|||
T Consensus 61 ad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL 140 (169)
T 4gpm_A 61 ADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSDSDGRTPL 140 (169)
T ss_dssp CCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred cchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHH
Confidence 34555677899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHHhCCCCCC
Q 013214 111 GDAIYYKNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~a~~~~ 134 (447)
|+|+..|+.+++++|+++||++..
T Consensus 141 ~~A~~~g~~~iv~~Ll~~GA~ie~ 164 (169)
T 4gpm_A 141 DLAREHGNEEVVKLLEKQGGWLEH 164 (169)
T ss_dssp HHHHHTTCHHHHHHHHTC------
T ss_pred HHHHHcCCHHHHHHHHHCCCCcCC
Confidence 999999999999999999999754
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=162.95 Aligned_cols=93 Identities=46% Similarity=0.578 Sum_probs=89.6
Q ss_pred chhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccch
Q 013214 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118 (447)
Q Consensus 39 ~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~ 118 (447)
+|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~ 80 (93)
T 1n0q_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (93)
T ss_dssp --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence 48899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCC
Q 013214 119 HEVIKLLEKHGAK 131 (447)
Q Consensus 119 ~~~~~~L~~~~a~ 131 (447)
.+++++|+++|++
T Consensus 81 ~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 81 LEVVKLLLEAGAY 93 (93)
T ss_dssp HHHHHHHHHTTCC
T ss_pred HHHHHHHHHcCCC
Confidence 9999999999975
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=3.4e-22 Score=166.82 Aligned_cols=113 Identities=28% Similarity=0.327 Sum_probs=103.6
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
|.|+ .++.+|+||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 1 G~d~-~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~ 79 (137)
T 3c5r_A 1 GIDP-FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSP 79 (137)
T ss_dssp ---C-CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCH
T ss_pred CCCC-CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCH
Confidence 4566 577889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCcccccccC
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~~ 143 (447)
||+|+..|+.+++++|+++|++++..+..+.++.
T Consensus 80 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl 113 (137)
T 3c5r_A 80 LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPV 113 (137)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCGG
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHH
Confidence 9999999999999999999999988776665553
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.4e-22 Score=187.14 Aligned_cols=144 Identities=17% Similarity=0.091 Sum_probs=112.1
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCH---------------HHHHHHHHHHHHHhcCCCCccccee
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD---------------DRVRAFRDELALLQKIRHPNVVQFL 216 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~hp~iv~~~ 216 (447)
.|...+.||+|+||.|+. +|+.||+|.++....... .....+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 345668999999998873 589999999865321110 24567889999999998 4 5666
Q ss_pred EEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEee
Q 013214 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (447)
Q Consensus 217 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~D 296 (447)
+++.. +..++||||++|++|.+ +. ......++.|++.||.|||+.| ++||||||+|||++ ++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEE
Confidence 65543 56799999999999988 42 2345579999999999999999 99999999999999 99999999
Q ss_pred cccccccccCCCCCcccCCCCCcccCCcccCC
Q 013214 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328 (447)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 328 (447)
||++.. +..++|||.+.+
T Consensus 236 FG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHHH
Confidence 999863 234678887743
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.4e-22 Score=160.85 Aligned_cols=106 Identities=36% Similarity=0.445 Sum_probs=99.3
Q ss_pred CCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 013214 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (447)
Q Consensus 35 ~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~ 114 (447)
-+|.+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 4 ~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~ 83 (115)
T 2l6b_A 4 WGSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAK 83 (115)
T ss_dssp CCSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHH
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHHhCCCCCCCccccc
Q 013214 115 YYKNHEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 115 ~~~~~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
..++.+++++|+++|++++.......
T Consensus 84 ~~~~~~~~~~Ll~~ga~~n~~~~~~~ 109 (115)
T 2l6b_A 84 KNGHHEIVKLLDAKGADVNARSWGSS 109 (115)
T ss_dssp TTTCHHHHHHHHTTSSSHHHHSCCCC
T ss_pred HCCCHHHHHHHHHcCCCCCcCCcccc
Confidence 99999999999999999876544433
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=6.5e-22 Score=164.98 Aligned_cols=108 Identities=23% Similarity=0.208 Sum_probs=89.6
Q ss_pred CCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCC-CCCc
Q 013214 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-GSTP 109 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~-g~tp 109 (447)
.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+. |+.+++++|+++|++++.+|.. |.||
T Consensus 3 ~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~ 81 (136)
T 1d9s_A 3 PGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRP 81 (136)
T ss_dssp CCCSCCCCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCH
T ss_pred CCccCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCH
Confidence 4556666677788888888888888888888888888888888888888888 8888888888888888888888 8888
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCcccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
||+|+..|+.+++++|+++|++++..+...
T Consensus 82 L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g 111 (136)
T 1d9s_A 82 VHDAAREGFLDTLVVLHRAGARLDVCDAWG 111 (136)
T ss_dssp HHHHHHHTCHHHHHHHHHTCCCCCCCSSSS
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCccCCCC
Confidence 888888888888888888888877655443
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=158.47 Aligned_cols=106 Identities=29% Similarity=0.366 Sum_probs=97.4
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~ 116 (447)
+..|.||||+|+..|+.++++.|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..
T Consensus 4 ~~~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~ 83 (123)
T 3aaa_C 4 GSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE 83 (123)
T ss_dssp ---CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHH
T ss_pred ccccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence 34688999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred chHHHHHHHHHhCCCCCCCccccccc
Q 013214 117 KNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 117 ~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
++.+++++|+++|+++...+....++
T Consensus 84 ~~~~~v~~Ll~~ga~~~~~~~~g~t~ 109 (123)
T 3aaa_C 84 GHVSCVKLLLSKGADKTVKGPDGLTA 109 (123)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 99999999999999988766554443
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=161.51 Aligned_cols=101 Identities=32% Similarity=0.395 Sum_probs=64.4
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~ 116 (447)
...+.||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..
T Consensus 11 ~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~ 90 (136)
T 2jab_A 11 GSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFI 90 (136)
T ss_dssp -CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHH
T ss_pred cccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence 34566666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred chHHHHHHHHHhCCCCCCCcc
Q 013214 117 KNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 117 ~~~~~~~~L~~~~a~~~~~~~ 137 (447)
|+.+++++|+++|++++..+.
T Consensus 91 ~~~~~v~~Ll~~g~~~~~~~~ 111 (136)
T 2jab_A 91 GHLEIAEVLLKHGADVNAQDK 111 (136)
T ss_dssp TCHHHHHHHHHTTCCTTCCCT
T ss_pred CCHHHHHHHHHcCCCCcCcCC
Confidence 666666666666666655443
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=6e-22 Score=165.20 Aligned_cols=101 Identities=22% Similarity=0.276 Sum_probs=94.8
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCC-CCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~-g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
+.|.+..+..|+||||+|+. |+.+++++|+++|+|+|.+|.. |+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 35 g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t 113 (136)
T 1d9s_A 35 GADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRL 113 (136)
T ss_dssp TCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHHHTCHHHHHHHHHTCCCCCCCSSSSSC
T ss_pred CCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCC
Confidence 34455556678889999999 9999999999999999999999 999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHHhCCC
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAK 131 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~ 131 (447)
|||+|+..++.+++++|+++|++
T Consensus 114 pl~~A~~~~~~~~~~~Ll~~Gad 136 (136)
T 1d9s_A 114 PVDLAEEQGHRDIARYLHAATGD 136 (136)
T ss_dssp HHHHHHHHTCHHHHHHHHHHHCC
T ss_pred HHHHHHHcCCHHHHHHHHHcCCC
Confidence 99999999999999999999985
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.85 E-value=5.8e-21 Score=166.97 Aligned_cols=113 Identities=22% Similarity=0.273 Sum_probs=101.3
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.+.+..+..|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 29 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~ 108 (179)
T 3f6q_A 29 ENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVP 108 (179)
T ss_dssp TSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred cccccccCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCH
Confidence 44566677788899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
||+|+..|+.+++++|+++|+++...+..+.++
T Consensus 109 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 141 (179)
T 3f6q_A 109 LHYACFWGQDQVAEDLVANGALVSICNKYGEMP 141 (179)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCCG
T ss_pred HHHHHHcCCHHHHHHHHHCCCCcchhccCCCCc
Confidence 999999999999999999999987766555444
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.9e-21 Score=164.05 Aligned_cols=114 Identities=32% Similarity=0.371 Sum_probs=104.9
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.+.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 32 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 111 (165)
T 3twr_A 32 SVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTP 111 (165)
T ss_dssp TTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCH
T ss_pred CCCccccccCCCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCH
Confidence 34556666778899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCcccccccC
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~~ 143 (447)
||+|+..|+.+++++|+++|++++..+....++.
T Consensus 112 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l 145 (165)
T 3twr_A 112 LHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPL 145 (165)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTG
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCcccCCCCCChh
Confidence 9999999999999999999999988766655553
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=6e-21 Score=165.27 Aligned_cols=111 Identities=34% Similarity=0.398 Sum_probs=101.6
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 37 g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~ 116 (169)
T 2y1l_E 37 GADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTP 116 (169)
T ss_dssp TCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence 44555566678899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCccccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
||+|+..|+.+++++|+++|++++..+....
T Consensus 117 L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 147 (169)
T 2y1l_E 117 LHLAAMFGHLEIVEVLLKNGADVNAQDKFGK 147 (169)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCcCCCCC
Confidence 9999999999999999999999876654433
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.84 E-value=8.6e-22 Score=168.31 Aligned_cols=113 Identities=21% Similarity=0.255 Sum_probs=89.7
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCC-HHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t-~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
+.|.+..+..|+||||+|+ .|+.+++++|+++|+++|.+|..|+| |||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 35 g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t 113 (156)
T 1bi7_B 35 GANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRL 113 (156)
T ss_dssp TCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTCCC
T ss_pred CCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCCCHHHHHHHHHcCCCCcccCCCCCC
Confidence 3445555667778899986 89999999999999999999999999 999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHHhCCCCCCCcccccccC
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~~ 143 (447)
|||+|+..|+.+++++|+++|+++........++.
T Consensus 114 pl~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~~ 148 (156)
T 1bi7_B 114 PVDLAEELGHRDVARYLRAAAGGTRGSNHARIDAA 148 (156)
T ss_dssp HHHHHHHHTCHHHHHHHSSCC--------------
T ss_pred HHHHHHHhCHHHHHHHHHHcCCCCCccCcCcCccc
Confidence 99999999999999999999999887765555443
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=7e-21 Score=161.99 Aligned_cols=105 Identities=31% Similarity=0.360 Sum_probs=98.9
Q ss_pred CccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 013214 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~ 115 (447)
.+..|+||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 30 ~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~ 109 (153)
T 1awc_B 30 TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATE 109 (153)
T ss_dssp CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHH
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHH
Confidence 46678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHHhCCCCCCCccccc
Q 013214 116 YKNHEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 116 ~~~~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
.|+.+++++|+++|++++..+..+.
T Consensus 110 ~~~~~~v~~Ll~~ga~~~~~~~~g~ 134 (153)
T 1awc_B 110 HNHQEVVELLIKYGADVHTQSKFCK 134 (153)
T ss_dssp TTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cCCHHHHHHHHHcCCCccccCCCCC
Confidence 9999999999999999877654443
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.84 E-value=8.8e-21 Score=158.09 Aligned_cols=100 Identities=31% Similarity=0.427 Sum_probs=93.2
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|.+..+..|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 37 g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tp 116 (136)
T 2jab_A 37 GADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTA 116 (136)
T ss_dssp TCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcCcCCCCCCH
Confidence 44455556678899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhC
Q 013214 110 LGDAIYYKNHEVIKLLEKHG 129 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~ 129 (447)
||+|+..|+.+++++|+++|
T Consensus 117 l~~A~~~~~~~~~~~Ll~~G 136 (136)
T 2jab_A 117 FDISIGNGNEDLAEILQKLN 136 (136)
T ss_dssp HHHHHHTTCHHHHHHHHHC-
T ss_pred HHHHHHCCCHHHHHHHHHcC
Confidence 99999999999999999876
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=177.27 Aligned_cols=112 Identities=19% Similarity=0.158 Sum_probs=102.1
Q ss_pred cchhcccCCC-CCCCccchhhHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCC
Q 013214 23 RKEAELNGLD-DDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98 (447)
Q Consensus 23 ~~~a~~n~~d-~~~~~~~g~t~lh~a~~~---~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~ 98 (447)
..|++++... .+..+..|+||||+||.. |+.+++++|+++|+|+|.+|.+|+||||+|+..|+.++|++|+++||+
T Consensus 151 ~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gad 230 (278)
T 1dcq_A 151 ADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKAS 230 (278)
T ss_dssp HTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCC
T ss_pred HhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 3455555544 555678899999999999 899999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccccccchHHHHHHHHHhCCCCCC
Q 013214 99 VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 99 ~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~ 134 (447)
++.+|..|.||||+|+..|+.+++++|+++|++...
T Consensus 231 ~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~ 266 (278)
T 1dcq_A 231 IEIANESGETPLDIAKRLKHEHCEELLTQALSGRFN 266 (278)
T ss_dssp TTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTTCCC
T ss_pred CCCccCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCC
Confidence 999999999999999999999999999999997543
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=162.69 Aligned_cols=111 Identities=26% Similarity=0.338 Sum_probs=101.4
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.+.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 26 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 105 (167)
T 3v31_A 26 ENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTP 105 (167)
T ss_dssp SSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCH
T ss_pred CCCcCCCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCH
Confidence 34455666678899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCccccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
||+|+..|+.+++++|+++|+++...+....
T Consensus 106 L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 136 (167)
T 3v31_A 106 LLYAVHGNHVKCVKMLLESGADPTIETDSGY 136 (167)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCcCCCCC
Confidence 9999999999999999999999877654433
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=1.6e-20 Score=153.60 Aligned_cols=102 Identities=44% Similarity=0.565 Sum_probs=88.2
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.+.+..+..|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 25 ~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~ 104 (126)
T 1n0r_A 25 GADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTP 104 (126)
T ss_dssp TCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCcccCCCCCCH
Confidence 34444555667788999999999999999999999999999899999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCC
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAK 131 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~ 131 (447)
+++|+..++.+++++|+++|++
T Consensus 105 l~~A~~~~~~~~~~~Ll~~Gad 126 (126)
T 1n0r_A 105 LHLAARNGHLEVVKLLLEAGAY 126 (126)
T ss_dssp HHHHHHTTCHHHHHHHHHHTCC
T ss_pred HHHHHHcCcHHHHHHHHHcCCC
Confidence 9999999999999999998875
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=166.88 Aligned_cols=111 Identities=26% Similarity=0.347 Sum_probs=98.7
Q ss_pred CCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcc
Q 013214 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl 110 (447)
.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 59 ~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L 138 (192)
T 2rfm_A 59 DKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPL 138 (192)
T ss_dssp CCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCHH
T ss_pred cccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHH
Confidence 34445566688899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHHhCCCCCCCcccccc
Q 013214 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~ 141 (447)
|+|+..|+.+++++|+++|+++...+....+
T Consensus 139 ~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 169 (192)
T 2rfm_A 139 IVASKYGRSEIVKKLLELGADISARDLTGLT 169 (192)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCTTCBCTTSCB
T ss_pred HHHHHcCCHHHHHHHHHCCCCCCCcCCCCCC
Confidence 9999999999999999999998776544433
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=161.50 Aligned_cols=107 Identities=25% Similarity=0.250 Sum_probs=80.8
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.+.+..+..|+||||+|+. |+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 28 ~~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 106 (162)
T 1ihb_A 28 NVNVNAQNGFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLP 106 (162)
T ss_dssp CCCTTCCCTTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCccccCccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 33444455566777888777 88888888888888888888888888888888888888888888888888888888888
Q ss_pred cccccccchHHHHHHHHHhCCCC-CCCcc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKP-LMAPM 137 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~-~~~~~ 137 (447)
||+|+..|+.+++++|+++|+++ +..+.
T Consensus 107 L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 135 (162)
T 1ihb_A 107 LHLAAKEGHLRVVEFLVKHTASNVGHRNH 135 (162)
T ss_dssp HHHHHHTTCHHHHHHHHHHSCCCTTCCCT
T ss_pred HHHHHHcCCHHHHHHHHHccCCCCCCcCC
Confidence 88888888888888888887763 44443
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.9e-20 Score=162.41 Aligned_cols=107 Identities=25% Similarity=0.322 Sum_probs=96.6
Q ss_pred CCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 013214 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 112 (447)
.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 29 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~ 108 (172)
T 3v30_A 29 VNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLY 108 (172)
T ss_dssp GGCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHH
T ss_pred ccCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHH
Confidence 44556678889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHHhCCCCCCCcccc
Q 013214 113 AIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 113 a~~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
|+..|+.+++++|+++|++++..+...
T Consensus 109 A~~~~~~~~v~~Ll~~ga~~~~~~~~g 135 (172)
T 3v30_A 109 AVRGNHVKCVEALLARGADLTTEADSG 135 (172)
T ss_dssp HHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred HHHcCCHHHHHHHHHcCCCccccCCCC
Confidence 999999999999999999987655433
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=175.68 Aligned_cols=104 Identities=30% Similarity=0.387 Sum_probs=81.2
Q ss_pred hhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchH
Q 013214 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119 (447)
Q Consensus 40 g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~ 119 (447)
|.||+|+|+..++.+++++|++.|+|+|.+|..|+||||+||..|+.++|++|+++|+++|.+|..|.||||+|+..|+.
T Consensus 119 g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~ 198 (269)
T 4b93_B 119 QAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHV 198 (269)
T ss_dssp CCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCH
T ss_pred CCCccccccccChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCH
Confidence 33444444444444555555566677778888899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCcccccccC
Q 013214 120 EVIKLLEKHGAKPLMAPMHVKHAR 143 (447)
Q Consensus 120 ~~~~~L~~~~a~~~~~~~~~~~~~ 143 (447)
+++++|+++|++++..+..+.++.
T Consensus 199 ~~v~~Ll~~Gad~~~~d~~G~TpL 222 (269)
T 4b93_B 199 FVVELLLLHGASVQVLNKRQRTAV 222 (269)
T ss_dssp HHHHHHHHTTCCSCCCCTTSCCSG
T ss_pred HHHHHHHHCCCCCCCcCCCCCCHH
Confidence 999999999999887766665553
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=165.62 Aligned_cols=110 Identities=19% Similarity=0.175 Sum_probs=97.1
Q ss_pred CCCCc-cchhhHHHHHHHcCCH----HHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCc------HHHHHHHHHcCCCCCC
Q 013214 33 DDGEE-IKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGF------TEVVSLLLERGADVDP 101 (447)
Q Consensus 33 ~~~~~-~~g~t~lh~a~~~~~~----~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~------~~~v~~Ll~~ga~~~~ 101 (447)
.+..+ ..|+||||+|+..|+. +++++|+++|+|+|.+|.+|+||||+|+..|+ .+++++|+++||++|.
T Consensus 30 ~~~~~~~~g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~ 109 (186)
T 3t8k_A 30 YEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITA 109 (186)
T ss_dssp SSCHHHHHTTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSS
T ss_pred cccccccCCCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCc
Confidence 33444 6799999999999975 58999999999999999999999999999987 6889999999999999
Q ss_pred CCCCCC-Ccccccccc-----chHHHHHHHHH-hCCCCCCCccccccc
Q 013214 102 KDRWGS-TPLGDAIYY-----KNHEVIKLLEK-HGAKPLMAPMHVKHA 142 (447)
Q Consensus 102 ~d~~g~-tpl~~a~~~-----~~~~~~~~L~~-~~a~~~~~~~~~~~~ 142 (447)
+|..|. ||||+|+.. ++.+++++|++ +|++++..+..+.++
T Consensus 110 ~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~Tp 157 (186)
T 3t8k_A 110 LYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTA 157 (186)
T ss_dssp CBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCH
T ss_pred cCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCH
Confidence 999999 999999994 45679999999 999998887665554
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.9e-20 Score=161.64 Aligned_cols=108 Identities=21% Similarity=0.203 Sum_probs=100.4
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|.+..+..|+||||+|+..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 62 g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 141 (179)
T 3f6q_A 62 GARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMP 141 (179)
T ss_dssp TCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCCG
T ss_pred CCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhccCCCCc
Confidence 44555566678899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCcc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
+++|+..++.+++++|+++|++++..+.
T Consensus 142 l~~A~~~~~~~~~~~L~~~g~~~~~~~~ 169 (179)
T 3f6q_A 142 VDKAKAPLRELLRERAEKMGQNLNRIPY 169 (179)
T ss_dssp GGGSCHHHHHHHHHHHHHTTCCCSCBCC
T ss_pred HHHHHHHHHHHHHHHHHHhhcCcccCCc
Confidence 9999999999999999999999876543
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-20 Score=170.27 Aligned_cols=110 Identities=17% Similarity=0.073 Sum_probs=96.9
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCC-CCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGST 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d-~~g~t 108 (447)
+.|.+..+..|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.++ ..|.|
T Consensus 44 g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t 123 (229)
T 2vge_A 44 MNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGAT 123 (229)
T ss_dssp SSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSSTTCC
T ss_pred CCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCCC
Confidence 44555666778889999999999999999999999999999999999999999999999999999999999986 69999
Q ss_pred ccccc--cccchHHHHHHHHHhCCCCCCCcccc
Q 013214 109 PLGDA--IYYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 109 pl~~a--~~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
|||+| +..|+.+++++|+++|++++..+...
T Consensus 124 pL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~~~~ 156 (229)
T 2vge_A 124 AFEKCDPYREGYADCATYLADVEQSMGLMNSGA 156 (229)
T ss_dssp TGGGCCTTSTTHHHHHHHHHHHHHHTTTSGGGE
T ss_pred HHHHHHHHhcChHHHHHHHHHcCCCcccccCCc
Confidence 99999 89999999999999999987765433
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=160.16 Aligned_cols=122 Identities=24% Similarity=0.287 Sum_probs=102.1
Q ss_pred ccceeeeecccCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC
Q 013214 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG 84 (447)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g 84 (447)
+|+..+..+...+.....+.| .|.+..+..|+||||+|+..|+.+++++|+++|+|+|.+|.+|+||||+|+..|
T Consensus 40 t~L~~A~~~~~~~v~~Ll~~g-----~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 114 (162)
T 1ihb_A 40 TALQVMKLGNPEIARRLLLRG-----ANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEG 114 (162)
T ss_dssp CHHHHCCSSCHHHHHHHHHTT-----CCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred cHHHHHHcCcHHHHHHHHHcC-----CCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcC
Confidence 444444443333333344444 455556667889999999999999999999999999999999999999999999
Q ss_pred cHHHHHHHHHcCCC-CCCCCCCCCCccccccccchHHHHHHHHHhCCC
Q 013214 85 FTEVVSLLLERGAD-VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (447)
Q Consensus 85 ~~~~v~~Ll~~ga~-~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~ 131 (447)
+.+++++|+++|++ ++.+|..|.||||+|+..|+.+++++|+++||+
T Consensus 115 ~~~~v~~Ll~~g~~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~GAd 162 (162)
T 1ihb_A 115 HLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGAG 162 (162)
T ss_dssp CHHHHHHHHHHSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC--
T ss_pred CHHHHHHHHHccCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHhCCC
Confidence 99999999999998 699999999999999999999999999999985
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=163.59 Aligned_cols=110 Identities=25% Similarity=0.274 Sum_probs=98.8
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 59 g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 138 (172)
T 3v30_A 59 GADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEADSGYTP 138 (172)
T ss_dssp TCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCH
Confidence 44455556678899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCcccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
||+|+..|+.+++++|+++|+++...+...
T Consensus 139 l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~ 168 (172)
T 3v30_A 139 MDLAVALGYRKVQQVIENHILKLFQSNLVP 168 (172)
T ss_dssp HHHHHHHTCHHHHHHHHHHHHHHSCC----
T ss_pred HHHHHHhCcHHHHHHHHHHHHHHhcccCCC
Confidence 999999999999999999999876655443
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.7e-20 Score=158.26 Aligned_cols=101 Identities=31% Similarity=0.328 Sum_probs=92.5
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
++.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 64 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 143 (165)
T 3twr_A 64 HGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNT 143 (165)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCC
Confidence 34555666677889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHHhCC
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGA 130 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a 130 (447)
|+|+|.. ++.+++++|++.|+
T Consensus 144 ~l~~a~~-~~~~i~~~L~~~gA 164 (165)
T 3twr_A 144 PLDLVKD-GDTDIQDLLRGDAA 164 (165)
T ss_dssp TGGGSCT-TCHHHHHHHHTC--
T ss_pred hhHhHhc-CChHHHHHHhhccc
Confidence 9999877 88999999999876
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.8e-20 Score=148.34 Aligned_cols=93 Identities=32% Similarity=0.455 Sum_probs=86.2
Q ss_pred CCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 013214 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 112 (447)
....+.+|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 17 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 96 (110)
T 2zgd_A 17 GSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDI 96 (110)
T ss_dssp -----CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred ccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHH
Confidence 34567789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHH
Q 013214 113 AIYYKNHEVIKLL 125 (447)
Q Consensus 113 a~~~~~~~~~~~L 125 (447)
|+..|+.+++++|
T Consensus 97 A~~~~~~~~~~~L 109 (110)
T 2zgd_A 97 SIDNGNEDLAEIL 109 (110)
T ss_dssp HHHHTCHHHHHHH
T ss_pred HHHcCCHHHHHHh
Confidence 9999999999887
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=171.26 Aligned_cols=127 Identities=24% Similarity=0.269 Sum_probs=92.9
Q ss_pred ccceeeeec-ccCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc
Q 013214 5 VPVRTTLLK-QSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (447)
Q Consensus 5 ~~~~~~~~~-~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~ 83 (447)
+|+..+... .......+.+.|+++|. +..|.||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..
T Consensus 7 t~L~~a~~~~~~~~~~~ll~~g~~~~~------~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~ 80 (239)
T 1ycs_B 7 VSLPPGKRTNLRKTGSERIAHGMRVKF------NPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCA 80 (239)
T ss_dssp ------------------------------------CHHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHH
T ss_pred ccCchhhhhhhHHHHHHHhccCCCccc------CchhhHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHc
Confidence 444444332 33344555677777763 35689999999999999999999999999999999999999999999
Q ss_pred CcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCcc
Q 013214 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 84 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++....
T Consensus 81 g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~ 134 (239)
T 1ycs_B 81 GHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTY 134 (239)
T ss_dssp TCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCS
T ss_pred CCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecC
Confidence 999999999999999999999999999999999999999999999999876553
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.8e-20 Score=167.38 Aligned_cols=113 Identities=25% Similarity=0.292 Sum_probs=101.0
Q ss_pred ccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCC
Q 013214 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP 101 (447)
Q Consensus 22 ~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~ 101 (447)
.+++++.+..+ ..+.+|.||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.
T Consensus 5 l~~~~~~~~~~--~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~ 82 (229)
T 2vge_A 5 LRKAGSPRKAR--RARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNS 82 (229)
T ss_dssp -----CCCCCC--CTTSCHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred hccCCCCcccc--ccccchhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCC
Confidence 34566666665 3456789999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccccccchHHHHHHHHHhCCCCCCCc
Q 013214 102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 102 ~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
+|..|.||||+|+..|+.+++++|+++|++++...
T Consensus 83 ~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~ 117 (229)
T 2vge_A 83 PDSHGWTPLHCAASCNDTVICMALVQHGAAIFATT 117 (229)
T ss_dssp CCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCC
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccc
Confidence 99999999999999999999999999999987653
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.82 E-value=4.1e-20 Score=157.53 Aligned_cols=109 Identities=23% Similarity=0.234 Sum_probs=97.3
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.+.+..+..|+||||+ |..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 26 ~~~~~~~~~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 104 (156)
T 1bd8_A 26 LVHPDALNRFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALP 104 (156)
T ss_dssp CCCTTCCCTTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCH
T ss_pred CcCccccCCCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcH
Confidence 34666677778899999 99999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCccccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
||+|+..|+.+++++|++. ++++..+..+.
T Consensus 105 L~~A~~~~~~~~v~~Ll~~-~~~~~~~~~g~ 134 (156)
T 1bd8_A 105 IHLAVQEGHTAVVSFLAAE-SDLHRRDARGL 134 (156)
T ss_dssp HHHHHHHTCHHHHHHHHTT-SCTTCCCTTSC
T ss_pred HHHHHHhChHHHHHHHHhc-cCCCCcCCCCC
Confidence 9999999999999999998 87766554433
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.81 E-value=4.4e-20 Score=172.87 Aligned_cols=115 Identities=30% Similarity=0.323 Sum_probs=99.6
Q ss_pred CCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCC-CCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~-~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
.+.+..+..|+||||+||..|+.+++++|+++|+++|.++. .|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 149 ~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tp 228 (282)
T 1oy3_D 149 LQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTP 228 (282)
T ss_dssp GGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred hcCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccccCCCCH
Confidence 34556667788999999999999999999999999999985 49999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCcccccccCCC
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREV 145 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~~~~ 145 (447)
||+|+..|+.+++++|+++|++++.....+.++...
T Consensus 229 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~ 264 (282)
T 1oy3_D 229 LGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSS 264 (282)
T ss_dssp HHHHHTSSCHHHHHHHHHTTCCCCCCC---------
T ss_pred HHHHHHcCCcHHHHHHHHcCCCcCcCCCcccccccc
Confidence 999999999999999999999998887776666443
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.81 E-value=6.6e-20 Score=149.87 Aligned_cols=102 Identities=42% Similarity=0.512 Sum_probs=96.5
Q ss_pred chhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccch
Q 013214 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118 (447)
Q Consensus 39 ~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~ 118 (447)
+|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~ 80 (126)
T 1n0r_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (126)
T ss_dssp CCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCh
Confidence 58899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCccccc
Q 013214 119 HEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 119 ~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
.+++++|+++|+++...+....
T Consensus 81 ~~~~~~Ll~~g~~~~~~~~~g~ 102 (126)
T 1n0r_A 81 LEVVKLLLEAGADVNAKDKNGR 102 (126)
T ss_dssp HHHHHHHHHTTCCTTCCCTTSC
T ss_pred HHHHHHHHHcCCCCcccCCCCC
Confidence 9999999999999876654433
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.2e-20 Score=161.59 Aligned_cols=105 Identities=33% Similarity=0.316 Sum_probs=98.4
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCC-CCCCCccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIY 115 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d-~~g~tpl~~a~~ 115 (447)
+..|+||||+||..|+.++++.|++ |+++|.+|..|+||||+|+..|+.+++++|+++|++++.+| ..|.||||+|+.
T Consensus 41 ~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~ 119 (183)
T 3deo_A 41 VSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 119 (183)
T ss_dssp HHHHHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHh
Confidence 4689999999999999999999999 99999999999999999999999999999999999999998 899999999999
Q ss_pred cchHHHHHHHHHhCCCCCCCccccccc
Q 013214 116 YKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 116 ~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
.|+.+++++|+++|++++..+..+.++
T Consensus 120 ~~~~~~v~~Ll~~ga~~~~~d~~g~tp 146 (183)
T 3deo_A 120 YVRPEVVEALVELGADIEVEDERGLTA 146 (183)
T ss_dssp TTCHHHHHHHHHHTCCTTCCCTTSCCH
T ss_pred cCcHHHHHHHHHcCCCCcCCCCCCCCH
Confidence 999999999999999998766554443
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.5e-20 Score=172.32 Aligned_cols=117 Identities=28% Similarity=0.268 Sum_probs=102.5
Q ss_pred CccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCC
Q 013214 19 PDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98 (447)
Q Consensus 19 ~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~ 98 (447)
....+.|+|+| ..|.+|+||||+||..|+.+++++|++.|+|++.++.+|.||+|+|+..++.+++++|+++|++
T Consensus 70 ~~Ll~~Gadvn-----~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~ 144 (269)
T 4b93_B 70 AKVPASGLGVN-----VTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAK 144 (269)
T ss_dssp -----CCCCTT-----CCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCC
T ss_pred HHHHHCCCCCC-----CcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCC
Confidence 33445555555 4556788999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCccccc
Q 013214 99 VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 99 ~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
+|.+|..|.||||+|+..|+.+++++|+++|++++.....+.
T Consensus 145 ~n~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~ 186 (269)
T 4b93_B 145 PNKKDLSGNTPLIYACSGGHHELVALLLQHGASINASNNKGN 186 (269)
T ss_dssp SCCCCTTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSC
T ss_pred CCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCC
Confidence 999999999999999999999999999999999877654433
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.2e-20 Score=172.87 Aligned_cols=129 Identities=22% Similarity=0.270 Sum_probs=112.5
Q ss_pred cccceeeee----cccCCCCccccchhcccCCC------CCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCC-
Q 013214 4 KVPVRTTLL----KQSSLAPDRERKEAELNGLD------DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID- 72 (447)
Q Consensus 4 ~~~~~~~~~----~~~~~~~~~~~~~a~~n~~d------~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~- 72 (447)
.+|+..|.. +...+.....+.|++++..+ ....+..|+||||+||..|+.+++++|+++|+|+|.+|..
T Consensus 44 ~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~ 123 (256)
T 2etb_A 44 KTCLMKAVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGR 123 (256)
T ss_dssp BCHHHHHHHTCBTTBCTTHHHHHHHHHHTTCSSCGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSG
T ss_pred CCHHHHHHHccccchHHHHHHHHhcCCcccchhhhcccccccccccCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccccc
Confidence 456666654 45556666678888887655 2234567999999999999999999999999999999986
Q ss_pred ------------CCCHHHHHHHcCcHHHHHHHHH---cCCCCCCCCCCCCCccccccc--cchHH-------HHHHHHHh
Q 013214 73 ------------NRTALHVAACQGFTEVVSLLLE---RGADVDPKDRWGSTPLGDAIY--YKNHE-------VIKLLEKH 128 (447)
Q Consensus 73 ------------g~t~Lh~A~~~g~~~~v~~Ll~---~ga~~~~~d~~g~tpl~~a~~--~~~~~-------~~~~L~~~ 128 (447)
|+||||+|+..|+.+++++|++ +|+++|.+|..|+||||+|+. .++.+ ++++|+++
T Consensus 124 ~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ 203 (256)
T 2etb_A 124 FFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQM 203 (256)
T ss_dssp GGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHc
Confidence 9999999999999999999999 999999999999999999998 78888 99999999
Q ss_pred CCCC
Q 013214 129 GAKP 132 (447)
Q Consensus 129 ~a~~ 132 (447)
|+++
T Consensus 204 ga~~ 207 (256)
T 2etb_A 204 GARL 207 (256)
T ss_dssp HHHH
T ss_pred CCCc
Confidence 9998
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=4.5e-20 Score=153.85 Aligned_cols=101 Identities=25% Similarity=0.256 Sum_probs=90.3
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 33 g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 112 (137)
T 3c5r_A 33 GSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRP 112 (137)
T ss_dssp TCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred CCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence 44555666778899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCC
Q 013214 110 LGDAIYYKNHEVIKLLEKHGA 130 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a 130 (447)
+++|+..+..+++++|.+.+.
T Consensus 113 l~~A~~~~~~~~l~~l~~~~~ 133 (137)
T 3c5r_A 113 VDYTDDESMKSLLLLPEKNES 133 (137)
T ss_dssp GGGCCCHHHHHHHSCC-----
T ss_pred HHHHhhccHHHHHhhcccccc
Confidence 999999999999988877654
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.80 E-value=9.9e-20 Score=157.57 Aligned_cols=101 Identities=34% Similarity=0.477 Sum_probs=94.0
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
++.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 69 ~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 148 (169)
T 2y1l_E 69 NGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKT 148 (169)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 34455566677889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHHhC
Q 013214 109 PLGDAIYYKNHEVIKLLEKHG 129 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~ 129 (447)
|+++|+..|+.+++++|+++|
T Consensus 149 ~l~~A~~~~~~~~~~~L~~~G 169 (169)
T 2y1l_E 149 AFDISIDNGNEDLAEILQKLN 169 (169)
T ss_dssp HHHHHHHTTCHHHHHHHHTC-
T ss_pred HHHHHHHhCCHHHHHHHHHcC
Confidence 999999999999999999876
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.80 E-value=6.6e-20 Score=149.87 Aligned_cols=94 Identities=27% Similarity=0.245 Sum_probs=84.7
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
++.|.+..+..|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 29 ~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 108 (123)
T 3aaa_C 29 KGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLT 108 (123)
T ss_dssp TTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 34455566667889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHH
Q 013214 109 PLGDAIYYKNHEVI 122 (447)
Q Consensus 109 pl~~a~~~~~~~~~ 122 (447)
|+|+|...+..+++
T Consensus 109 ~l~~A~~~~~~~ll 122 (123)
T 3aaa_C 109 AFEATDNQAIKALL 122 (123)
T ss_dssp HHHHCCCHHHHHHH
T ss_pred HHHHhCCHHHHHHh
Confidence 99999666555544
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=9.8e-20 Score=154.84 Aligned_cols=96 Identities=31% Similarity=0.415 Sum_probs=90.7
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|.+..+..|+||||+|+..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 57 g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 136 (153)
T 1awc_B 57 GVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTA 136 (153)
T ss_dssp TCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCH
Confidence 44556666778899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHH
Q 013214 110 LGDAIYYKNHEVIKLL 125 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L 125 (447)
+++|+..|+.+++++|
T Consensus 137 l~~A~~~~~~~i~~~L 152 (153)
T 1awc_B 137 FDISIDNGNEDLAEIL 152 (153)
T ss_dssp HHHHHHTTCHHHHHHH
T ss_pred HHHHHHcCCHHHHHHh
Confidence 9999999999999987
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=155.05 Aligned_cols=98 Identities=27% Similarity=0.379 Sum_probs=91.3
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
|.|.+..+..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++ ++++.+|..|.||
T Consensus 58 g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-~~~~~~~~~g~t~ 136 (156)
T 1bd8_A 58 GASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLTP 136 (156)
T ss_dssp TCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTT-SCTTCCCTTSCCH
T ss_pred CCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChHHHHHHHHhc-cCCCCcCCCCCCH
Confidence 344455566788999999999999999999999999999999999999999999999999999999 9999999999999
Q ss_pred cccccccchHHHHHHHHHh
Q 013214 110 LGDAIYYKNHEVIKLLEKH 128 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~ 128 (447)
||+|+..|+.+++++|+++
T Consensus 137 l~~A~~~~~~~~v~~Ll~~ 155 (156)
T 1bd8_A 137 LELALQRGAQDLVDILQGH 155 (156)
T ss_dssp HHHHHHSCCHHHHHHHHTT
T ss_pred HHHHHHcCcHHHHHHHHhh
Confidence 9999999999999999864
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.5e-20 Score=173.59 Aligned_cols=104 Identities=26% Similarity=0.294 Sum_probs=97.6
Q ss_pred CccchhhHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 013214 36 EEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~---~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 112 (447)
.+..|+||||+||.. |+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++||+++.+|..|.||||+
T Consensus 186 ~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~ 265 (301)
T 2b0o_E 186 AQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDI 265 (301)
T ss_dssp SCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCCHHHH
T ss_pred cCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHH
Confidence 578899999999997 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHHhCCCCCCCcccc
Q 013214 113 AIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 113 a~~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
|+..|+.+++++|+++|++....+.+.
T Consensus 266 A~~~~~~~iv~~Ll~~ga~~g~tpLh~ 292 (301)
T 2b0o_E 266 ARKKHHKECEELLEQAQAGTFAFPLHV 292 (301)
T ss_dssp HHHHTCHHHHHHHHHHHHHTTSSCCC-
T ss_pred HHHcCCHHHHHHHHHhcCCCCCChhHH
Confidence 999999999999999999866555443
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-20 Score=172.80 Aligned_cols=130 Identities=20% Similarity=0.191 Sum_probs=111.4
Q ss_pred cccceeee----ecccCCCCccccchhcccC------CCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCC---
Q 013214 4 KVPVRTTL----LKQSSLAPDRERKEAELNG------LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD--- 70 (447)
Q Consensus 4 ~~~~~~~~----~~~~~~~~~~~~~~a~~n~------~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d--- 70 (447)
.+|+..|+ .+...+.....+.+++.+. .+.+..+..|+||||+||..|+.+++++|+++|+|+|.+|
T Consensus 47 ~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~ 126 (260)
T 3jxi_A 47 KTCLPKALLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGR 126 (260)
T ss_dssp CCHHHHHHTSCBTTBCTHHHHHHHHHHHTTCHHHHHTCCBCCSSEESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEEC
T ss_pred CcHHHHHHHHhhcCCHHHHHHHHHhcccccchHhhhcccccccccCCCCHHHHHHHcCCHHHHHHHHhCCCCcCcccccc
Confidence 45666554 2445555556677777544 4455667789999999999999999999999999999999
Q ss_pred -----------CCCCCHHHHHHHcCcHHHHHHHHH---cCCCCCCCCCCCCCccccccccch---------HHHHHHHHH
Q 013214 71 -----------IDNRTALHVAACQGFTEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKN---------HEVIKLLEK 127 (447)
Q Consensus 71 -----------~~g~t~Lh~A~~~g~~~~v~~Ll~---~ga~~~~~d~~g~tpl~~a~~~~~---------~~~~~~L~~ 127 (447)
..|+||||+|+..|+.+++++|++ +|++++.+|..|+||||+|+..++ .+++++|++
T Consensus 127 ~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~ 206 (260)
T 3jxi_A 127 FFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLI 206 (260)
T ss_dssp CCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHH
T ss_pred ccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHH
Confidence 689999999999999999999999 999999999999999999998776 799999999
Q ss_pred hCCCCC
Q 013214 128 HGAKPL 133 (447)
Q Consensus 128 ~~a~~~ 133 (447)
+|++++
T Consensus 207 ~ga~~~ 212 (260)
T 3jxi_A 207 KCAKLF 212 (260)
T ss_dssp HHHHHC
T ss_pred hCcccc
Confidence 999884
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.5e-20 Score=157.60 Aligned_cols=106 Identities=24% Similarity=0.231 Sum_probs=96.6
Q ss_pred CCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC-ccccc
Q 013214 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST-PLGDA 113 (447)
Q Consensus 35 ~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t-pl~~a 113 (447)
..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+ .|+.+++++|+++|++++.+|..|.| |||+|
T Consensus 7 ~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A 85 (156)
T 1bi7_B 7 SSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDA 85 (156)
T ss_dssp ---CCSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHH
T ss_pred CCCccchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHH
Confidence 34567889999999999999999999999999999999999999995 99999999999999999999999999 99999
Q ss_pred cccchHHHHHHHHHhCCCCCCCcccccc
Q 013214 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (447)
Q Consensus 114 ~~~~~~~~~~~L~~~~a~~~~~~~~~~~ 141 (447)
+..|+.+++++|+++|++++..+..+.+
T Consensus 86 ~~~~~~~~v~~Ll~~ga~~~~~d~~g~t 113 (156)
T 1bi7_B 86 AREGFLDTLVVLHRAGARLDVRDAWGRL 113 (156)
T ss_dssp HHHTCHHHHHHHHHHTCCSSCCCTTCCC
T ss_pred HHCCCHHHHHHHHHcCCCCcccCCCCCC
Confidence 9999999999999999999876554433
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=164.62 Aligned_cols=106 Identities=24% Similarity=0.318 Sum_probs=99.2
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHc-CCCCCCCCCCCCCccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIY 115 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~-ga~~~~~d~~g~tpl~~a~~ 115 (447)
+..|+||||+||..|+.++++.|++.|+++|.+|..|+||||+||..|+.+++++|+++ |++++.+|..|.||||+|+.
T Consensus 70 ~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~ 149 (222)
T 3ehr_A 70 AESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAW 149 (222)
T ss_dssp EEEESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHH
T ss_pred ccccccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHH
Confidence 44678999999999999999999999999999999999999999999999999999998 99999999999999999999
Q ss_pred cchHHHHHHHHHhCCCCCCCccccccc
Q 013214 116 YKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 116 ~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
.|+.+++++|+++|++++..+..+.++
T Consensus 150 ~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 176 (222)
T 3ehr_A 150 KGYADIVQLLLAKGARTDLRNIEKKLA 176 (222)
T ss_dssp HTCHHHHHHHHHHTCCSCCCCTTSCCH
T ss_pred cCCHHHHHHHHHcCCCCccccCCCCCH
Confidence 999999999999999998776655444
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-19 Score=162.36 Aligned_cols=113 Identities=26% Similarity=0.220 Sum_probs=99.7
Q ss_pred CCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcC-CCCCCCCCCCCCc
Q 013214 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTP 109 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g-a~~~~~d~~g~tp 109 (447)
.|.+..+..|+||||+|+..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|++.| ++++.+|..|.||
T Consensus 98 ~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~g~t~ 177 (228)
T 2dzn_A 98 PDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTP 177 (228)
T ss_dssp CCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTTSCCH
T ss_pred cccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCCCCCCH
Confidence 455666677888999999999999999999999999999999999999999999999999999998 9999999999999
Q ss_pred cccccccchHHHHHHHH-HhCCCCCCCcccccccC
Q 013214 110 LGDAIYYKNHEVIKLLE-KHGAKPLMAPMHVKHAR 143 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~-~~~a~~~~~~~~~~~~~ 143 (447)
||+|+..|+.+++++|+ ++|++++..+..+.++.
T Consensus 178 L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~l 212 (228)
T 2dzn_A 178 LFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAE 212 (228)
T ss_dssp HHHHHHTTCHHHHHHHHHHHCCCSCCBCTTSCBGG
T ss_pred HHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCcHH
Confidence 99999999999999999 88999887766665554
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.7e-19 Score=162.81 Aligned_cols=111 Identities=28% Similarity=0.308 Sum_probs=65.4
Q ss_pred ccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCC-------------CCCCHHHHHHHcCcHHH
Q 013214 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-------------DNRTALHVAACQGFTEV 88 (447)
Q Consensus 22 ~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~-------------~g~t~Lh~A~~~g~~~~ 88 (447)
.+.++++...+.+..+..|+||||+||..|+.+++++|+++|++++.++. .|+||||+|+..|+.++
T Consensus 57 l~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~ 136 (232)
T 2rfa_A 57 MEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEI 136 (232)
T ss_dssp HHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHH
T ss_pred HHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCCHHH
Confidence 34445544444455555566666666666666666666666666655543 46666666666666666
Q ss_pred HHHHHHcCCCCCCCCCCCCCccccccccchHHHH----HHHHHhCCCC
Q 013214 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI----KLLEKHGAKP 132 (447)
Q Consensus 89 v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~----~~L~~~~a~~ 132 (447)
+++|+++|++++.+|..|.||||+|+..++.+++ ++|+++|+++
T Consensus 137 v~~Ll~~ga~~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~ 184 (232)
T 2rfa_A 137 VRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD 184 (232)
T ss_dssp HHHHHHTTCCTTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSC
T ss_pred HHHHHHCCCCCCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCch
Confidence 6666666666666666666666666666665555 6666666554
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=159.39 Aligned_cols=100 Identities=31% Similarity=0.357 Sum_probs=94.2
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 91 g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 170 (192)
T 2rfm_A 91 GSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLTA 170 (192)
T ss_dssp TCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBH
T ss_pred CCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 44555666778899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhC
Q 013214 110 LGDAIYYKNHEVIKLLEKHG 129 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~ 129 (447)
+++|+..|+.+++++|+++|
T Consensus 171 l~~A~~~~~~~~v~~Ll~~~ 190 (192)
T 2rfm_A 171 EASARIFGRQEVIKIFTEVR 190 (192)
T ss_dssp HHHHHHTTCHHHHHHHHHHH
T ss_pred HHHHHHhCcHHHHHHHHhcc
Confidence 99999999999999999875
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.2e-19 Score=162.16 Aligned_cols=100 Identities=28% Similarity=0.279 Sum_probs=54.9
Q ss_pred CccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 013214 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~ 115 (447)
.+..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 69 ~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~ 148 (231)
T 3aji_A 69 KDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAA 148 (231)
T ss_dssp CCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHH
T ss_pred cCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHH
Confidence 33444555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred cchHHHHHHHHHhCCCCCCC
Q 013214 116 YKNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 116 ~~~~~~~~~L~~~~a~~~~~ 135 (447)
.|+.+++++|+++|++++..
T Consensus 149 ~~~~~~v~~Ll~~g~~~~~~ 168 (231)
T 3aji_A 149 KGNLKMVHILLFYKASTNIQ 168 (231)
T ss_dssp HTCHHHHHHHHHTTCCSCCC
T ss_pred cCCHHHHHHHHhcCCCcccc
Confidence 55555555555555555443
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=166.77 Aligned_cols=107 Identities=22% Similarity=0.101 Sum_probs=98.8
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCC-C
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS-T 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~-t 108 (447)
+.|.+..+..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|. |
T Consensus 60 g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~~~t 139 (239)
T 1ycs_B 60 VDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQT 139 (239)
T ss_dssp TSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSCCC
T ss_pred CCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCCCCcc
Confidence 445566667788999999999999999999999999999999999999999999999999999999999999998887 9
Q ss_pred ccccc--cccchHHHHHHHHHhCCCCCCCc
Q 013214 109 PLGDA--IYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 109 pl~~a--~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
|+|+| +..|+.+++++|+++|+++....
T Consensus 140 ~l~~a~~~~~g~~~~~~~Ll~~~a~~~~~~ 169 (239)
T 1ycs_B 140 AADKCEEMEEGYTQCSQFLYGVQEKMGIMN 169 (239)
T ss_dssp HHHHCCSSSTTCCCHHHHHHHHHHHTTTTG
T ss_pred hHHHHHHhhhccHHHHHHHHHhhhcccccc
Confidence 99999 78899999999999999987654
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=155.89 Aligned_cols=104 Identities=29% Similarity=0.287 Sum_probs=97.0
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 59 g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 138 (167)
T 3v31_A 59 GADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDSGYNS 138 (167)
T ss_dssp TCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 44555566778899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCC
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~ 133 (447)
+++|+..|+.+++++|++++++..
T Consensus 139 l~~A~~~~~~~~~~~L~~~~~~~~ 162 (167)
T 3v31_A 139 MDLAVALGYRSVQQVIESHLLKLL 162 (167)
T ss_dssp HHHHHHHTCHHHHHHHHHHHHHHC
T ss_pred HHHHHHcCcHHHHHHHHHHHHHHH
Confidence 999999999999999999987653
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=166.48 Aligned_cols=107 Identities=27% Similarity=0.207 Sum_probs=69.0
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~ 111 (447)
+.+..+..|+||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 116 ~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpL~ 195 (253)
T 1yyh_A 116 DLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLF 195 (253)
T ss_dssp CTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred CccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHH
Confidence 34444455666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccchHHHHHHHHHhCCCCCCCccc
Q 013214 112 DAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (447)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~a~~~~~~~~ 138 (447)
+|+..|+.+++++|+++|+++...+..
T Consensus 196 ~A~~~~~~~~v~~Ll~~ga~~~~~d~~ 222 (253)
T 1yyh_A 196 LAAREGSYETAKVLLDHFANRDITDHM 222 (253)
T ss_dssp HHHHHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HHHHCCCHHHHHHHHHcCCCccccccC
Confidence 666666666666666666666554433
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.79 E-value=4.7e-19 Score=161.83 Aligned_cols=100 Identities=25% Similarity=0.245 Sum_probs=75.6
Q ss_pred CCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCC-CCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 013214 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (447)
Q Consensus 34 ~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~-~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 112 (447)
+..+..|+||||+|+..|+.+++++|+++|+++|.+|. .|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 111 ~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~ 190 (236)
T 1ikn_D 111 KATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQL 190 (236)
T ss_dssp GCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGG
T ss_pred hccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCHHHH
Confidence 34445677777777777777777777777777777776 77777777777777777777777777777777777777777
Q ss_pred ccccchHHHHHHHHHhCCCCC
Q 013214 113 AIYYKNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 113 a~~~~~~~~~~~L~~~~a~~~ 133 (447)
|+..|+.+++++|+++|+++.
T Consensus 191 A~~~~~~~~~~~Ll~~ga~~~ 211 (236)
T 1ikn_D 191 TWGRPSTRIQQQLGQLTLENL 211 (236)
T ss_dssp CTTSSCHHHHHHHHTTSCGGG
T ss_pred HHccCchHHHHHHHHcchhhh
Confidence 777777777777777777654
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=165.68 Aligned_cols=104 Identities=34% Similarity=0.326 Sum_probs=97.7
Q ss_pred cchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCC-CCCCCcccccccc
Q 013214 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYY 116 (447)
Q Consensus 38 ~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d-~~g~tpl~~a~~~ 116 (447)
..|+||||+||..|+.++++.|++ |+|+|.+|..|+||||+||..|+.++|++|+++|+++|.+| ..|.||||+|+..
T Consensus 43 ~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~ 121 (244)
T 3ui2_A 43 SEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGY 121 (244)
T ss_dssp HHHHHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHT
T ss_pred cCCCCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHc
Confidence 579999999999999999999999 99999999999999999999999999999999999999998 8899999999999
Q ss_pred chHHHHHHHHHhCCCCCCCccccccc
Q 013214 117 KNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 117 ~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|+.+++++|+++|++++..+..+.++
T Consensus 122 g~~~~v~~Ll~~ga~~~~~d~~g~t~ 147 (244)
T 3ui2_A 122 VRPEVVEALVELGADIEVEDERGLTA 147 (244)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTCCCH
T ss_pred CCHHHHHHHHHCCCCCCCCCCCCCcH
Confidence 99999999999999998766554443
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-19 Score=164.11 Aligned_cols=108 Identities=21% Similarity=0.270 Sum_probs=90.0
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHc-CCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~-g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~ 107 (447)
++.|.+.++..|+||||+||..|+.+++++|++. |+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 95 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 174 (222)
T 3ehr_A 95 NRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLRNIEKK 174 (222)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCTTSC
T ss_pred CCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCC
Confidence 4555666677789999999999999999999998 999999999999999999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHHHHhCCCCCCCc
Q 013214 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
|||++|+..++.++++.|++.|+.....+
T Consensus 175 t~l~~A~~~~~~~~l~~l~~~~~~~~~~~ 203 (222)
T 3ehr_A 175 LAFDMATNAACASLLKKKQGTDAVRTLSN 203 (222)
T ss_dssp CHHHHCCSHHHHHHHC-------------
T ss_pred CHHHHhcchhHHHHHHHHhccchhhhccc
Confidence 99999999999999999999999876544
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.1e-19 Score=162.45 Aligned_cols=111 Identities=25% Similarity=0.316 Sum_probs=99.8
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCC-----CCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~-----n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~ 104 (447)
+.|.+..+..|+||||+||..|+.+++++|+++|+++ +.+|..|+||||+|+..|+.+++++|+++|++++..+.
T Consensus 27 g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~ 106 (232)
T 2rfa_A 27 GCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARAT 106 (232)
T ss_dssp CSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCC
T ss_pred CCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccC
Confidence 5556666777889999999999999999999999987 77888999999999999999999999999999999876
Q ss_pred -------------CCCCccccccccchHHHHHHHHHhCCCCCCCccccc
Q 013214 105 -------------WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 105 -------------~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
.|.||||+|+..|+.+++++|+++|++++..+..+.
T Consensus 107 ~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 155 (232)
T 2rfa_A 107 GSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGN 155 (232)
T ss_dssp SGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Confidence 799999999999999999999999999877654443
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.9e-20 Score=162.84 Aligned_cols=127 Identities=16% Similarity=0.111 Sum_probs=102.4
Q ss_pred cccceeeeecccC-----CCCccccchhcccCCCCCCCccchhhHHHHHHHcCC------HHHHHHHHHcCCCCCCCCCC
Q 013214 4 KVPVRTTLLKQSS-----LAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERD------VEGIKELLDSGIDVNFRDID 72 (447)
Q Consensus 4 ~~~~~~~~~~~~~-----~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~------~~~~~~Ll~~g~d~n~~d~~ 72 (447)
.+|+..++.+... +...+.+.|||+|.. +..|+||||+|+..|+ .+++++|+++|+|+|.+|..
T Consensus 39 ~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~-----d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~ 113 (186)
T 3t8k_A 39 SNILYDVLRNNNDEARYKISMFLINKGADIKSR-----TKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKP 113 (186)
T ss_dssp TTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCC-----CTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGG
T ss_pred CCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCC-----CCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCC
Confidence 3555555543321 334445556665555 4567788999999987 68899999999999999999
Q ss_pred CC-CHHHHHHHcC-----cHHHHHHHHH-cCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCC
Q 013214 73 NR-TALHVAACQG-----FTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 73 g~-t~Lh~A~~~g-----~~~~v~~Ll~-~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~ 135 (447)
|+ ||||+|+..+ +.+++++|++ +|++++.+|..|.||||+|+..|+.+++++|.++..+.+++
T Consensus 114 g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~~~~~~~ 183 (186)
T 3t8k_A 114 YKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKYNLK 183 (186)
T ss_dssp GTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHHHHHTCC
T ss_pred cCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHHHHHhcc
Confidence 99 9999999944 5679999999 99999999999999999999999999999999886555443
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7e-19 Score=160.79 Aligned_cols=112 Identities=24% Similarity=0.255 Sum_probs=99.0
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl 110 (447)
+.+..+..|+||||+|+..|+.+++++|++.|++++..| ..|.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 108 ~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L 187 (241)
T 1k1a_A 108 DLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSAL 187 (241)
T ss_dssp CTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHH
T ss_pred cccccCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHH
Confidence 556667778899999999999999999999999999988 8899999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHHhCCCCCCCcccccccC
Q 013214 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~~ 143 (447)
|+|+..|+.+++++|+++|++++..+..+.++.
T Consensus 188 ~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl 220 (241)
T 1k1a_A 188 HSASGRGLLPLVRTLVRSGADSSLKNCHNDTPL 220 (241)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTT
T ss_pred HHHHHcCCHHHHHHHHhcCCCCCCcCCCCCCHH
Confidence 999999999999999999999887766555554
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.6e-19 Score=158.78 Aligned_cols=104 Identities=28% Similarity=0.223 Sum_probs=63.6
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~ 111 (447)
+.+..+..|+||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 84 ~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~ 163 (223)
T 2f8y_A 84 DLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLF 163 (223)
T ss_dssp CTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHH
T ss_pred CcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCHHH
Confidence 33444445556666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccchHHHHHHHHHhCCCCCCC
Q 013214 112 DAIYYKNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~a~~~~~ 135 (447)
+|+..|+.+++++|+++|++++..
T Consensus 164 ~A~~~~~~~~v~~Ll~~ga~~~~~ 187 (223)
T 2f8y_A 164 LAAREGSYETAKVLLDHFANRDIT 187 (223)
T ss_dssp HHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred HHHHcCCHHHHHHHHHcCCCCccc
Confidence 666666666666666666655443
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.8e-19 Score=166.07 Aligned_cols=98 Identities=31% Similarity=0.331 Sum_probs=74.5
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHH-cCCCCCCCCCCCCCcc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPL 110 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~-~ga~~~~~d~~g~tpl 110 (447)
+.+..+..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|++ .|++++.+|..|.|||
T Consensus 175 ~~~~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~TpL 254 (276)
T 4hbd_A 175 INAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGSTAL 254 (276)
T ss_dssp TTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSCCHH
T ss_pred CccccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCCCHH
Confidence 344445567777777777777777777777777777777777777777777777777777777 6777777777777777
Q ss_pred ccccccchHHHHHHHHHhC
Q 013214 111 GDAIYYKNHEVIKLLEKHG 129 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~ 129 (447)
|+|+..|+.+++++|+++.
T Consensus 255 ~~A~~~g~~~iv~~Ll~~~ 273 (276)
T 4hbd_A 255 MVALDAGQSEIASMLYSRM 273 (276)
T ss_dssp HHHHHHTCHHHHHHHHHHC
T ss_pred HHHHHcCCHHHHHHHHhcc
Confidence 7777777777777777654
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.8e-19 Score=158.69 Aligned_cols=104 Identities=22% Similarity=0.261 Sum_probs=97.6
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
++.+.+..+..|+||||+|+..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 114 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 193 (223)
T 2f8y_A 114 SHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRL 193 (223)
T ss_dssp TTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred cCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCccccccCCC
Confidence 34555666677889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHHhCCCC
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~ 132 (447)
|+++|+..++.+++++|+++|+..
T Consensus 194 ~l~~A~~~~~~~i~~~L~~~g~~~ 217 (223)
T 2f8y_A 194 PRDIAQERMHHDIVRLLDEYNLVR 217 (223)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCSS
T ss_pred HHHHHHHhcchHHHHHHHHcCCCc
Confidence 999999999999999999999864
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.78 E-value=7e-19 Score=160.66 Aligned_cols=108 Identities=24% Similarity=0.342 Sum_probs=70.0
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCC------CCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCC-
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR- 104 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d------~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~- 104 (447)
|++..+..|+||||+|+..|+.+++++|++.|++ ++..|..|+||||+|+..|+.+++++|+++|++++.+|.
T Consensus 70 ~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 149 (236)
T 1ikn_D 70 DPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPC 149 (236)
T ss_dssp CSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTT
T ss_pred CCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCC
Confidence 3344444556666666666666666666666654 355566666777777777777777777777777776665
Q ss_pred CCCCccccccccchHHHHHHHHHhCCCCCCCcccc
Q 013214 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
.|.||||+|+..|+.+++++|+++|++++..+..+
T Consensus 150 ~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 184 (236)
T 1ikn_D 150 NGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQG 184 (236)
T ss_dssp TCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTC
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCC
Confidence 67777777777777777777777776665554433
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=154.81 Aligned_cols=106 Identities=24% Similarity=0.319 Sum_probs=97.4
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHH-HcCCCCCCCCCCCCCcc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPL 110 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll-~~ga~~~~~d~~g~tpl 110 (447)
|.+..+.+|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+ ..+++++.+|..|.|||
T Consensus 31 ~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L 110 (201)
T 3hra_A 31 QVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNAL 110 (201)
T ss_dssp CTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSH
T ss_pred CCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHH
Confidence 56666677889999999999999999999999999999999999999999999999999999 56889999999999999
Q ss_pred ccccccchHHHHHHHHHhC-CCCCCCcc
Q 013214 111 GDAIYYKNHEVIKLLEKHG-AKPLMAPM 137 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~-a~~~~~~~ 137 (447)
|+|+..|+.+++++|+++| ++++..+.
T Consensus 111 ~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 138 (201)
T 3hra_A 111 IPAAEKGHIDNVKLLLEDGREDIDFQND 138 (201)
T ss_dssp HHHHHTTCHHHHHHHHHHCCCCTTCCCT
T ss_pred HHHHHcCCHHHHHHHHHcCCCCcCCCCC
Confidence 9999999999999999999 77765544
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=158.86 Aligned_cols=106 Identities=29% Similarity=0.376 Sum_probs=92.2
Q ss_pred CCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 013214 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 112 (447)
.+..+.+|+||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 33 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~ 112 (231)
T 3aji_A 33 ATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHY 112 (231)
T ss_dssp GGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred hhcCCCCCCCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHH
Confidence 34456677888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHHhCCCCCCCccc
Q 013214 113 AIYYKNHEVIKLLEKHGAKPLMAPMH 138 (447)
Q Consensus 113 a~~~~~~~~~~~L~~~~a~~~~~~~~ 138 (447)
|+..++.+++++|+++|++++.....
T Consensus 113 A~~~~~~~~~~~Ll~~g~~~~~~~~~ 138 (231)
T 3aji_A 113 AASKNRHEIAVMLLEGGANPDAKDHY 138 (231)
T ss_dssp HHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence 99999999999999999888765543
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=164.55 Aligned_cols=71 Identities=35% Similarity=0.379 Sum_probs=44.2
Q ss_pred CCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCcccccccC
Q 013214 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (447)
Q Consensus 73 g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~~ 143 (447)
|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+..+.++.
T Consensus 199 g~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t~l 269 (299)
T 1s70_B 199 GGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAF 269 (299)
T ss_dssp CCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTT
T ss_pred CCCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHhcCCHHHHHHHHHcCCCCCCcCCCCCCHH
Confidence 44555566666666666666666666666666666666666666666666666666666665554444443
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=9.7e-19 Score=159.62 Aligned_cols=108 Identities=21% Similarity=0.298 Sum_probs=69.7
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~ 111 (447)
+.+..+..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 103 ~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~ 182 (237)
T 3b7b_A 103 DVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLH 182 (237)
T ss_dssp CTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCCCTTCCCHHH
T ss_pred CcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCCHHH
Confidence 34444455666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccchHHHHHHHHHhCCCCCCCcccc
Q 013214 112 DAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
+|+..++.+++++|+++|+++...+..+
T Consensus 183 ~A~~~~~~~~v~~Ll~~gad~~~~d~~g 210 (237)
T 3b7b_A 183 IAARENRYDCVVLFLSRDSDVTLKNKEG 210 (237)
T ss_dssp HHHHTTCHHHHHHHHTTTCCTTCCCTTS
T ss_pred HHHHhCCHhHHHHHHHcCCCCCccCCCC
Confidence 6666666666666666666665544333
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=9.5e-19 Score=168.93 Aligned_cols=110 Identities=33% Similarity=0.415 Sum_probs=101.9
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.+.+..+..|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++..|..|.||
T Consensus 48 ~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~iv~~Ll~~g~~~~~~~~~g~t~ 127 (351)
T 3utm_A 48 NVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTP 127 (351)
T ss_dssp TTTCCCSSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCH
T ss_pred CCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 45556667778899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCcccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
||+|+..|+.+++++|+++|+++.......
T Consensus 128 L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g 157 (351)
T 3utm_A 128 LHEAASKNRVEVCSLLLSHGADPTLVNCHG 157 (351)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCccccCCC
Confidence 999999999999999999999987655433
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-19 Score=168.88 Aligned_cols=131 Identities=20% Similarity=0.198 Sum_probs=109.5
Q ss_pred cccceeeee----cccCCCCccccchhcccC------CCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCC--
Q 013214 4 KVPVRTTLL----KQSSLAPDRERKEAELNG------LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-- 71 (447)
Q Consensus 4 ~~~~~~~~~----~~~~~~~~~~~~~a~~n~------~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~-- 71 (447)
.+|+..+.. +...+.....+.|++.+. .+....+..|+||||+||..|+.+++++|+++|+|+|.+|.
T Consensus 55 ~tpL~~A~~~~~~g~~~~v~~Ll~~ga~~~~~~~~i~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~ 134 (273)
T 2pnn_A 55 KTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGD 134 (273)
T ss_dssp CCHHHHHHHSCBTTBCHHHHHHHHHHHHTTCHHHHHTCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCSG
T ss_pred CCHHHHHHHHHhcCChHHHHHHHHhhccccchhHHhhcccccccCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCcccccc
Confidence 455555553 344445555667776432 12233556899999999999999999999999999999997
Q ss_pred ------------CCCCHHHHHHHcCcHHHHHHHHH---cCCCCCCCCCCCCCccccccccch---------HHHHHHHHH
Q 013214 72 ------------DNRTALHVAACQGFTEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKN---------HEVIKLLEK 127 (447)
Q Consensus 72 ------------~g~t~Lh~A~~~g~~~~v~~Ll~---~ga~~~~~d~~g~tpl~~a~~~~~---------~~~~~~L~~ 127 (447)
.|+||||+|+..|+.+++++|++ +|++++.+|..|+||||+|+..|+ .+++++|++
T Consensus 135 ~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~ 214 (273)
T 2pnn_A 135 FFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILI 214 (273)
T ss_dssp GGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHH
Confidence 79999999999999999999999 999999999999999999999887 799999999
Q ss_pred hCCCCCC
Q 013214 128 HGAKPLM 134 (447)
Q Consensus 128 ~~a~~~~ 134 (447)
+|++++.
T Consensus 215 ~ga~~n~ 221 (273)
T 2pnn_A 215 LGAKLHP 221 (273)
T ss_dssp HHHHHCT
T ss_pred hhhhccc
Confidence 9998863
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.5e-19 Score=166.50 Aligned_cols=119 Identities=21% Similarity=0.157 Sum_probs=100.6
Q ss_pred CCccccchhcccCCCC---------CCCccchhhHHHHHHHcCCHHHHHHHHH---cCCCCCCCCCCCCCHHHHHHHcCc
Q 013214 18 APDRERKEAELNGLDD---------DGEEIKPEFRLMFLANERDVEGIKELLD---SGIDVNFRDIDNRTALHVAACQGF 85 (447)
Q Consensus 18 ~~~~~~~~a~~n~~d~---------~~~~~~g~t~lh~a~~~~~~~~~~~Ll~---~g~d~n~~d~~g~t~Lh~A~~~g~ 85 (447)
...+.+.|+++|..|. ...+..|+||||+||..|+.+++++|++ .|+|+|.+|.+|+||||+|+..|+
T Consensus 117 v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~ 196 (273)
T 2pnn_A 117 VTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVAD 196 (273)
T ss_dssp HHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCC
T ss_pred HHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccC
Confidence 3344556777776664 2333479999999999999999999999 999999999999999999999998
Q ss_pred ---------HHHHHHHHHcCCCCC-------CCCCCCCCccccccccchHHHHHHHHHhCC-CCCCCc
Q 013214 86 ---------TEVVSLLLERGADVD-------PKDRWGSTPLGDAIYYKNHEVIKLLEKHGA-KPLMAP 136 (447)
Q Consensus 86 ---------~~~v~~Ll~~ga~~~-------~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a-~~~~~~ 136 (447)
.+++++|+++|++++ .+|..|.||||+|+..|+.+++++|+++|+ ++...+
T Consensus 197 ~~~~~~~~~~~~v~~Ll~~ga~~n~~~~~~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~dp~~~~ 264 (273)
T 2pnn_A 197 NTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRH 264 (273)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTC------
T ss_pred cchhHHHHHHHHHHHHHHhhhhcccccccccccCCCCCCHHHHHHHhChHHHHHHHHHCCCCCchhhh
Confidence 899999999999997 489999999999999999999999999999 665443
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-19 Score=167.07 Aligned_cols=116 Identities=18% Similarity=0.112 Sum_probs=101.9
Q ss_pred CccccchhcccCCCC---------CCCccchhhHHHHHHHcCCHHHHHHHHH---cCCCCCCCCCCCCCHHHHHHHcCc-
Q 013214 19 PDRERKEAELNGLDD---------DGEEIKPEFRLMFLANERDVEGIKELLD---SGIDVNFRDIDNRTALHVAACQGF- 85 (447)
Q Consensus 19 ~~~~~~~a~~n~~d~---------~~~~~~g~t~lh~a~~~~~~~~~~~Ll~---~g~d~n~~d~~g~t~Lh~A~~~g~- 85 (447)
....+.|+++|..|. +..+..|+||||+||..|+.+++++|++ .|+|+|.+|..|+||||+|+..|+
T Consensus 110 ~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~ 189 (260)
T 3jxi_A 110 ELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADN 189 (260)
T ss_dssp HHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCS
T ss_pred HHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccC
Confidence 334556777776652 2333679999999999999999999999 999999999999999999999887
Q ss_pred --------HHHHHHHHHcCCCC-------CCCCCCCCCccccccccchHHHHHHHHHhCCCCCC
Q 013214 86 --------TEVVSLLLERGADV-------DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 86 --------~~~v~~Ll~~ga~~-------~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~ 134 (447)
.+++++|+++|+++ +.+|..|.||||+|+..|+.+++++|+++|+++..
T Consensus 190 ~~~~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~ 253 (260)
T 3jxi_A 190 TRENTKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADAA 253 (260)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHHHC
T ss_pred chhHHHHHHHHHHHHHHhCcccccccchhhcccCCCCCHHHHHHHcCCHHHHHHHHHhCCCccc
Confidence 79999999999999 67999999999999999999999999999987643
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.76 E-value=5e-19 Score=166.74 Aligned_cols=104 Identities=25% Similarity=0.246 Sum_probs=98.1
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~ 111 (447)
+.+.+|..|+||||+||..|+.+++++|+++|+|+|.+| |+||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 23 ~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~ 100 (285)
T 3kea_A 23 DTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALY 100 (285)
T ss_dssp TTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred CCCccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHH
Confidence 677888899999999999999999999999999999984 999999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHHHHhCCCCCCCcc
Q 013214 112 DAIYYKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
+|+..|+.+++++|+++|++++....
T Consensus 101 ~A~~~g~~~~v~~Ll~~ga~~~~~~~ 126 (285)
T 3kea_A 101 YAVDSGNMQTVKLFVKKNWRLMFYGK 126 (285)
T ss_dssp HHHHTTCHHHHHHHHHHCGGGGGCSS
T ss_pred HHHHcCCHHHHHHHHhcCCCCCccCC
Confidence 99999999999999999999875543
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=153.11 Aligned_cols=88 Identities=33% Similarity=0.349 Sum_probs=82.7
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
+.|.+..+..|+||||+||..|+.+++++|+++|+|+|.+| .+|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 66 ~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t 145 (183)
T 3deo_A 66 DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLT 145 (183)
T ss_dssp TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCC
T ss_pred cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcHHHHHHHHHcCCCCcCCCCCCCC
Confidence 56677777889999999999999999999999999999998 89999999999999999999999999999999999999
Q ss_pred ccccccccc
Q 013214 109 PLGDAIYYK 117 (447)
Q Consensus 109 pl~~a~~~~ 117 (447)
|||+|+..+
T Consensus 146 pl~~A~~~~ 154 (183)
T 3deo_A 146 ALELAREIL 154 (183)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhc
Confidence 999998764
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1e-18 Score=161.49 Aligned_cols=123 Identities=24% Similarity=0.219 Sum_probs=90.7
Q ss_pred ccCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHH
Q 013214 14 QSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93 (447)
Q Consensus 14 ~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll 93 (447)
...+.......|++++. ..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+
T Consensus 35 ~~~~v~~Ll~~g~~~~~----~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll 110 (253)
T 1yyh_A 35 APAVISDFIYQGASLHN----QTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILI 110 (253)
T ss_dssp ---------------------CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHH
T ss_pred ChHHHHHHHHccCCccc----ccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHH
Confidence 34444445555665543 23556788899999999999999999999999999999999999999999999999999
Q ss_pred HcCC-CCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCccccc
Q 013214 94 ERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 94 ~~ga-~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
+.|+ +++.+|..|.||||+|+..|+.+++++|+++|++++..+..+.
T Consensus 111 ~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~ 158 (253)
T 1yyh_A 111 RNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGK 158 (253)
T ss_dssp HSTTSCTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSC
T ss_pred HcCCCCccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCC
Confidence 8876 8888888899999999988888899999998888876654433
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=160.57 Aligned_cols=102 Identities=32% Similarity=0.346 Sum_probs=94.1
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
+.|.+..+..|+||||+||..|+.+++++|+++|+|+|.+| ..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 67 ~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 146 (244)
T 3ui2_A 67 DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLT 146 (244)
T ss_dssp TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCc
Confidence 56667777789999999999999999999999999999998 88999999999999999999999999999999999999
Q ss_pred cccccc----------------ccchHHHHHHHHHhCCC
Q 013214 109 PLGDAI----------------YYKNHEVIKLLEKHGAK 131 (447)
Q Consensus 109 pl~~a~----------------~~~~~~~~~~L~~~~a~ 131 (447)
|||+|+ ..|+.+++++|.+++.+
T Consensus 147 ~l~~A~~~~~~~~~~~~l~~a~~~g~~~iv~~L~~~~~~ 185 (244)
T 3ui2_A 147 ALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVFE 185 (244)
T ss_dssp HHHHHHHHHTTCCCSSHHHHHHHHHHHHHHHHHHHHHEE
T ss_pred HHHHHHHHHhccCCCCHHHHHHHcChHHHHHHHHHhccc
Confidence 999887 66889999999987654
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-18 Score=153.07 Aligned_cols=111 Identities=25% Similarity=0.340 Sum_probs=99.8
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHH-HcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcC-CCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGS 107 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll-~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g-a~~~~~d~~g~ 107 (447)
|.|.+..+..|+||||+|+..|+.+++++|+ ..+++++.+|..|.||||+|+..|+.+++++|+++| ++++.+|..|.
T Consensus 62 g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~ 141 (201)
T 3hra_A 62 GADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGY 141 (201)
T ss_dssp TCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTTCCCTTSC
T ss_pred CCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcCCCCCCCC
Confidence 4455556667889999999999999999999 567899999999999999999999999999999998 99999999999
Q ss_pred Cccccccccch-----HHHHHHHHHhCCCCCCCccccc
Q 013214 108 TPLGDAIYYKN-----HEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 108 tpl~~a~~~~~-----~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
||||+|+..++ .+++++|+++|++++..+..+.
T Consensus 142 t~L~~A~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 179 (201)
T 3hra_A 142 TALIEAVGLREGNQLYQDIVKLLMENGADQSIKDNSGR 179 (201)
T ss_dssp CHHHHHHHSSCCSHHHHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CHHHHHHHhccchhhHHHHHHHHHHCCCCCCccCCCCC
Confidence 99999998887 9999999999999987655443
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=167.05 Aligned_cols=114 Identities=19% Similarity=0.162 Sum_probs=94.6
Q ss_pred cCCCCCC-CccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCc----------------------
Q 013214 29 NGLDDDG-EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---------------------- 85 (447)
Q Consensus 29 n~~d~~~-~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~---------------------- 85 (447)
.+.|.+. ++..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+
T Consensus 119 ~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~~~~d 198 (327)
T 1sw6_A 119 TQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILED 198 (327)
T ss_dssp SCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEEC
T ss_pred cCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhccccCCC
Confidence 4566666 77888999999999999999999999999999999999999999998665
Q ss_pred -------------------HHHHHHHHHcCC---------------------------------------------CCCC
Q 013214 86 -------------------TEVVSLLLERGA---------------------------------------------DVDP 101 (447)
Q Consensus 86 -------------------~~~v~~Ll~~ga---------------------------------------------~~~~ 101 (447)
.+++++|++.++ ++|.
T Consensus 199 ~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~~n~ 278 (327)
T 1sw6_A 199 SMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNA 278 (327)
T ss_dssp TTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTC
T ss_pred CCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhCCCC
Confidence 344555554422 5788
Q ss_pred CCCCCCCccccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 102 ~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
+|..|+||||+|+..|+.+++++|+++|++++..+..+.++
T Consensus 279 ~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~Tp 319 (327)
T 1sw6_A 279 QDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP 319 (327)
T ss_dssp CCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence 88899999999999999999999999999998776665554
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.76 E-value=6.2e-19 Score=163.12 Aligned_cols=106 Identities=25% Similarity=0.171 Sum_probs=95.6
Q ss_pred CccchhhHHHHHHHc---CCHHHHHHHHHcCCCCCCC-----------CCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCC
Q 013214 36 EEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFR-----------DIDNRTALHVAACQGFTEVVSLLLERGADVDP 101 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~---~~~~~~~~Ll~~g~d~n~~-----------d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~ 101 (447)
.+..|+||||+||.. |+.+++++|++.|++++.. |..|+||||+|+..|+.+++++|+++|++++.
T Consensus 39 ~d~~g~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~ 118 (256)
T 2etb_A 39 EGSTGKTCLMKAVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHL 118 (256)
T ss_dssp BTTTTBCHHHHHHHTCBTTBCTTHHHHHHHHHHTTCSSCGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred CCCCCCCHHHHHHHccccchHHHHHHHHhcCCcccchhhhcccccccccccCCCHHHHHHHcCCHHHHHHHHHcCCCCCc
Confidence 577788999999999 9999999999999887743 47899999999999999999999999999999
Q ss_pred CCCC-------------CCCccccccccchHHHHHHHHH---hCCCCCCCcccccc
Q 013214 102 KDRW-------------GSTPLGDAIYYKNHEVIKLLEK---HGAKPLMAPMHVKH 141 (447)
Q Consensus 102 ~d~~-------------g~tpl~~a~~~~~~~~~~~L~~---~~a~~~~~~~~~~~ 141 (447)
+|.. |.||||+|+..|+.+++++|++ +|++++..+..+.+
T Consensus 119 ~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~T 174 (256)
T 2etb_A 119 RACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNT 174 (256)
T ss_dssp CCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCC
T ss_pred ccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCCC
Confidence 9986 9999999999999999999999 99998776544433
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.6e-18 Score=173.17 Aligned_cols=112 Identities=27% Similarity=0.316 Sum_probs=89.7
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.++|++|+++|+++|.+|..|.||
T Consensus 268 ~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~n~~~~~g~t~ 347 (437)
T 1n11_A 268 QANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSP 347 (437)
T ss_dssp TCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHHcCcHHHHHHHHhcCCCCCCCCCCCCCH
Confidence 34445556667788888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCcccccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~ 141 (447)
||+|+..|+.+++++|+++|++++..+..+.+
T Consensus 348 L~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t 379 (437)
T 1n11_A 348 LHQAAQQGHTDIVTLLLKNGASPNEVSSDGTT 379 (437)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCC
T ss_pred HHHHHHCChHHHHHHHHHCcCCCCCCCCCCCC
Confidence 88888888888888888888888766554443
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=170.02 Aligned_cols=109 Identities=19% Similarity=0.152 Sum_probs=91.2
Q ss_pred CCCCCCccchhhHHHHHHHcC--CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCC-----CCCCC
Q 013214 31 LDDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-----VDPKD 103 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~--~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~-----~~~~d 103 (447)
.+.+..+..|+||||+||..| +.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++ +|.+|
T Consensus 129 ~~~~~~~~~g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~ 208 (364)
T 3ljn_A 129 IGSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYAN 208 (364)
T ss_dssp ETTEEEEESCCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCC
T ss_pred hccccCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccC
Confidence 344446777888888888888 88888888888888888888888888888888888888888888888 88888
Q ss_pred CCCCCccccccccchHHHHHHHHHhCCCCCCCcccc
Q 013214 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (447)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~ 139 (447)
..|.||||+|+..|+.+++++|+++|++++..+..+
T Consensus 209 ~~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d~~g 244 (364)
T 3ljn_A 209 KQGNSHLHWAILINWEDVAMRFVEMGIDVNMEDNEH 244 (364)
T ss_dssp TTCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCCTTS
T ss_pred CCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCC
Confidence 888888888888888888888888888887655433
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-18 Score=166.87 Aligned_cols=101 Identities=27% Similarity=0.348 Sum_probs=75.7
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHc-CCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~-g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
|.|++.++..|+||||+||..|+.++++.|++. |+|+|.+|.+|+||||+|+..|+.++|++|+++||++|.+ |
T Consensus 229 gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~-----~ 303 (337)
T 4g8k_A 229 GADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG-----D 303 (337)
T ss_dssp TCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC-----C
T ss_pred CCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC-----C
Confidence 344455566677788888888888888888764 7888888888888888888888888888888888877654 4
Q ss_pred ccccccccchHHHHHHHHHhCCCCCCC
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~~~~ 135 (447)
|||+|+.+|+.+++++|+++||++++.
T Consensus 304 ~L~~A~~~~~~~iv~~Ll~~GA~~d~~ 330 (337)
T 4g8k_A 304 LVMTARRNYDHSLVKVLLSHGAKEDFH 330 (337)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCC---
T ss_pred HHHHHHHcCCHHHHHHHHHCcCCCCCC
Confidence 788888888888888888888877653
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.9e-18 Score=167.99 Aligned_cols=93 Identities=29% Similarity=0.377 Sum_probs=72.0
Q ss_pred cchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccc
Q 013214 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (447)
Q Consensus 38 ~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~ 117 (447)
..|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..+
T Consensus 233 ~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~LL~~Gad~~~~d~~G~TpL~~A~~~g 312 (368)
T 3jue_A 233 QDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGADLGARDSEGRDPLTIAMETA 312 (368)
T ss_dssp TTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred cCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHCcCCCCCcCCCCCCHHHHHHHCC
Confidence 56677777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred hHHHHHHHHHhCC
Q 013214 118 NHEVIKLLEKHGA 130 (447)
Q Consensus 118 ~~~~~~~L~~~~a 130 (447)
+.+++++|+.++.
T Consensus 313 ~~~iv~lLl~~~~ 325 (368)
T 3jue_A 313 NADIVTLLRLAKM 325 (368)
T ss_dssp CHHHHHHHHHHHC
T ss_pred CHHHHHHHHHcCC
Confidence 7777777777664
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-18 Score=173.03 Aligned_cols=108 Identities=29% Similarity=0.337 Sum_probs=88.7
Q ss_pred CCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcc
Q 013214 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl 110 (447)
.+.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 5 ~~~~~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L 84 (437)
T 1n11_A 5 ISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPL 84 (437)
T ss_dssp ----------CCHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHH
T ss_pred CCccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHH
Confidence 34445556677889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHHhCCCCCCCccc
Q 013214 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~a~~~~~~~~ 138 (447)
|+|+..|+.+++++|+++|++++.....
T Consensus 85 ~~A~~~g~~~~v~~Ll~~ga~~~~~~~~ 112 (437)
T 1n11_A 85 HCAARIGHTNMVKLLLENNANPNLATTA 112 (437)
T ss_dssp HHHHHHTCHHHHHHHHHHTCCTTCCCTT
T ss_pred HHHHHCCCHHHHHHHHhCCCCCCCCCCC
Confidence 9999999999999999999988765543
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.75 E-value=2e-18 Score=161.60 Aligned_cols=60 Identities=20% Similarity=0.185 Sum_probs=30.9
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcC
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG 96 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g 96 (447)
+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|
T Consensus 42 ~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~ 101 (282)
T 1oy3_D 42 NDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPR 101 (282)
T ss_dssp CTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHHHTTTTCHHHHHHHSSSC
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCcchhHhhhccC
Confidence 334445555555555555555555555555555555555555555444444444444443
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.75 E-value=3.9e-18 Score=159.52 Aligned_cols=107 Identities=28% Similarity=0.258 Sum_probs=92.8
Q ss_pred CCCCCCCccchhhHHHHHHHcCC----HHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHH-cCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDR 104 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~----~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~-~ga~~~~~d~ 104 (447)
+.+.+..+..|+||||+|+..++ .+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|++ .|++++.+|.
T Consensus 172 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~~~ 251 (285)
T 1wdy_A 172 GADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDS 251 (285)
T ss_dssp CCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCT
T ss_pred CCCCCccCCCCCCHHHHHHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhccCCCccccCC
Confidence 55566666778888999999888 888999999999999999899999999999999999999998 7899999999
Q ss_pred CCCCccccccccchHHHHHHHHHhCCCCCCCc
Q 013214 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
.|.||||+|+..|+.+++++|+++|+++...+
T Consensus 252 ~g~t~l~~A~~~~~~~i~~~Ll~~Ga~~~~~d 283 (285)
T 1wdy_A 252 DGKTALLLAVELKLKKIAELLCKRGASTDCGD 283 (285)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred CCCcHHHHHHHcCcHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999999999887654
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=161.49 Aligned_cols=103 Identities=25% Similarity=0.262 Sum_probs=98.3
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~ 111 (447)
..+.++.+|+||||+||..|+.+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 51 ~~~~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~ 130 (285)
T 3d9h_A 51 PLMGDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLF 130 (285)
T ss_dssp TTCSSSCCSCCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHH
T ss_pred cccCCCccCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHH
Confidence 35678888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHHHHhCCCCCC
Q 013214 112 DAIYYKNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~a~~~~ 134 (447)
+|+..|+.+++++|+++|+++..
T Consensus 131 ~A~~~~~~~~v~~Ll~~g~~~~~ 153 (285)
T 3d9h_A 131 NACVSGSWDCVNLLLQHGASVQP 153 (285)
T ss_dssp HHHHHTCHHHHHHHHHTTCCSSC
T ss_pred HHHHcCHHHHHHHHHHCCCCCCC
Confidence 99999999999999999988753
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=169.37 Aligned_cols=105 Identities=20% Similarity=0.219 Sum_probs=97.9
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCC-----CCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID-----VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d-----~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~ 104 (447)
+.|++..+..|+||||+||..|+.+++++|+++|++ +|.+|..|+||||+|+..|+.++|++|+++|++++.+|.
T Consensus 163 ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d~ 242 (364)
T 3ljn_A 163 GASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNMEDN 242 (364)
T ss_dssp TCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCCT
T ss_pred CCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCC
Confidence 445556666788999999999999999999999999 999999999999999999999999999999999999999
Q ss_pred CCCCccccccccchHHHHHHHHHhCCCCCC
Q 013214 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~ 134 (447)
.|.||||+|+..|+.+++++|+++|+++..
T Consensus 243 ~g~tpL~~A~~~g~~~~v~~Ll~~~~~~~~ 272 (364)
T 3ljn_A 243 EHTVPLYLSVRAAMVLLTKELLQKTDVFLI 272 (364)
T ss_dssp TSCCHHHHHHHTCCHHHHHHHHHHSCHHHH
T ss_pred CCCCHHHHHHHhChHHHHHHHHHcCCchhh
Confidence 999999999999999999999999988643
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.75 E-value=3.6e-18 Score=161.48 Aligned_cols=104 Identities=25% Similarity=0.358 Sum_probs=98.1
Q ss_pred CCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 013214 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (447)
Q Consensus 35 ~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~ 114 (447)
..+.+|.||||.||..|+.+++++|++.|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 35 ~~~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~ 114 (299)
T 1s70_B 35 KVKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAA 114 (299)
T ss_dssp CCEECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccccCCccHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHH
Confidence 34567999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHHhCCCCCCCccc
Q 013214 115 YYKNHEVIKLLEKHGAKPLMAPMH 138 (447)
Q Consensus 115 ~~~~~~~~~~L~~~~a~~~~~~~~ 138 (447)
..|+.+++++|+++|+++...+..
T Consensus 115 ~~g~~~~v~~Ll~~g~~~~~~~~~ 138 (299)
T 1s70_B 115 SCGYLDIAEYLISQGAHVGAVNSE 138 (299)
T ss_dssp HHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HcCCHHHHHHHHhCCCCCCCcCCC
Confidence 999999999999999998765443
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4.1e-18 Score=154.38 Aligned_cols=97 Identities=27% Similarity=0.279 Sum_probs=50.5
Q ss_pred cchhhHHHHHHHcCCHHHHHHHHHcC--CCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 013214 38 IKPEFRLMFLANERDVEGIKELLDSG--IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (447)
Q Consensus 38 ~~g~t~lh~a~~~~~~~~~~~Ll~~g--~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~ 115 (447)
..|+||||+|+..|+.+++++|+++| ++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 70 ~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~ 149 (228)
T 2dzn_A 70 DSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAAS 149 (228)
T ss_dssp TTSCCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHH
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHH
Confidence 34445555555555555555555554 4555555555555555555555555555555555555555555555555555
Q ss_pred cchHHHHHHHHHhC-CCCCC
Q 013214 116 YKNHEVIKLLEKHG-AKPLM 134 (447)
Q Consensus 116 ~~~~~~~~~L~~~~-a~~~~ 134 (447)
.|+.+++++|++.| ++++.
T Consensus 150 ~~~~~~v~~Ll~~g~~~~~~ 169 (228)
T 2dzn_A 150 VGSLKLIELLCGLGKSAVNW 169 (228)
T ss_dssp TTCHHHHHHHHTTTCCCSCC
T ss_pred cCCHHHHHHHHhcCcccccC
Confidence 55555555555555 44433
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.3e-18 Score=161.34 Aligned_cols=107 Identities=26% Similarity=0.266 Sum_probs=82.0
Q ss_pred CCccchhhHHHHHHHcCCHHHHHHHHHcCC-CCCCC--------------------------------------CCCCCC
Q 013214 35 GEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFR--------------------------------------DIDNRT 75 (447)
Q Consensus 35 ~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~-d~n~~--------------------------------------d~~g~t 75 (447)
..|.+|+||||+||..|+.+++++|++.|+ ++|.+ |..|+|
T Consensus 106 ~~d~~g~T~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 185 (276)
T 4hbd_A 106 IADSNGNTALHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQT 185 (276)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCC
T ss_pred CCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCcCCCCCCCCCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCC
Confidence 334456666777777777777777777776 55544 445778
Q ss_pred HHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHH-hCCCCCCCcccccc
Q 013214 76 ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKH 141 (447)
Q Consensus 76 ~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~-~~a~~~~~~~~~~~ 141 (447)
|||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|++ .|++++..+..+.+
T Consensus 186 pLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~T 252 (276)
T 4hbd_A 186 ALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGST 252 (276)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSCC
T ss_pred HHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCCC
Confidence 8888888888888888888888888888888888888888888888888888 78888766554433
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.4e-18 Score=159.61 Aligned_cols=108 Identities=24% Similarity=0.179 Sum_probs=98.2
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
++.|.+..+.+|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..+ .|.|
T Consensus 81 ~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~-~g~t 159 (285)
T 3d9h_A 81 QGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPES-DLAS 159 (285)
T ss_dssp TTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCSC-TTSC
T ss_pred CCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCHHHHHHHHHHCCCCCCCCC-CCCC
Confidence 345566667778999999999999999999999999999999999999999999999999999999999998755 4999
Q ss_pred ccccccccchHHHHHHHHHhCCCCCCCcc
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
|||+|+..|+.+++++|+++|++++..+.
T Consensus 160 ~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~ 188 (285)
T 3d9h_A 160 PIHEAARRGHVECVNSLIAYGGNIDHKIS 188 (285)
T ss_dssp HHHHHHHHTCHHHHHHHHHTTCCTTCCBT
T ss_pred HHHHHHHcCCHHHHHHHHHCCCCCCCcCC
Confidence 99999999999999999999998866543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=6.5e-18 Score=156.64 Aligned_cols=135 Identities=21% Similarity=0.195 Sum_probs=102.2
Q ss_pred cccceeeecceEEEEE---E--cCeE--EEEEEcCcccCCC---------------------HHHHHHHHHHHHHHhcCC
Q 013214 157 FTNSVEITKGTFILAF---W--RGIQ--VAVKKLGEEVISD---------------------DDRVRAFRDELALLQKIR 208 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~---~--~g~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 208 (447)
|.....||+|+||.|+ . +|+. ||||+++...... ......+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 4556789999999876 2 7888 9999875432110 112246788999999998
Q ss_pred CCcc--cceeEEEEeCCceEEEEeccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCC
Q 013214 209 HPNV--VQFLGAVTQSSPMMIVTEYLPK-G----DLRAFLKRKGALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLE 280 (447)
Q Consensus 209 hp~i--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH-~~~~~~i~H~Dik 280 (447)
|+++ +.+++. ...++||||+.+ | +|.+.... .++..+..++.|++.+|.||| +.| ++|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence 8764 444442 356899999942 3 67765432 335678899999999999999 888 9999999
Q ss_pred CCCEEEcCCCCEEEeeccccccc
Q 013214 281 PSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 281 p~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
|+|||++. .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999998753
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-18 Score=163.10 Aligned_cols=106 Identities=24% Similarity=0.175 Sum_probs=98.4
Q ss_pred ccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCC
Q 013214 20 DRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99 (447)
Q Consensus 20 ~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~ 99 (447)
...+.|+++|..| |+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|+++
T Consensus 49 ~Ll~~g~~~~~~~-------g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~ 121 (285)
T 3kea_A 49 TLLNAGALKNLLE-------NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRL 121 (285)
T ss_dssp HHHHTTGGGSCCT-------TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGG
T ss_pred HHHhCCCCCCCCC-------CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCC
Confidence 3455677777663 789999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCC-CCccccccccchHHHHHHHHHhCCCC
Q 013214 100 DPKDRWG-STPLGDAIYYKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 100 ~~~d~~g-~tpl~~a~~~~~~~~~~~L~~~~a~~ 132 (447)
+.+|..| .||||+|+..|+.+++++|+++|+++
T Consensus 122 ~~~~~~g~~t~L~~A~~~~~~~~v~~Ll~~g~~~ 155 (285)
T 3kea_A 122 MFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST 155 (285)
T ss_dssp GGCSSSGGGSHHHHHHHTTCHHHHHHHHTTSCTT
T ss_pred CccCCCCCCCHHHHHHHcCCHHHHHHHHhCCCcc
Confidence 9999999 79999999999999999999998765
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.8e-18 Score=162.89 Aligned_cols=107 Identities=26% Similarity=0.309 Sum_probs=99.8
Q ss_pred CccchhhHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 013214 36 EEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~---~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 112 (447)
.+..|+||||+|+.. ++.+++++|++.|+|+|.+|.+|+||||+|+..|+.+++++|+++|+++|.+|..|.||||+
T Consensus 207 ~~~~~~t~L~~A~~~~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~t~L~~ 286 (351)
T 3utm_A 207 QPQSHETALHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHR 286 (351)
T ss_dssp CTTTCCCHHHHHHHCCSTTHHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHhCccHHHHHHHHHHcCCCcCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHH
Confidence 346788999999999 56899999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 113 AIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 113 a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|+..|+.+++++|+++|+++...+..+.++
T Consensus 287 A~~~~~~~~v~~Ll~~gad~~~~~~~g~ta 316 (351)
T 3utm_A 287 AALAGHLQTCRLLLSYGSDPSIISLQGFTA 316 (351)
T ss_dssp HHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred HHHcCcHHHHHHHHHcCCCCCCcCCCCCCh
Confidence 999999999999999999998877665554
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=9.8e-18 Score=152.91 Aligned_cols=96 Identities=35% Similarity=0.439 Sum_probs=51.5
Q ss_pred cchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcC-CCCCCCCCCCCCcccccccc
Q 013214 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPLGDAIYY 116 (447)
Q Consensus 38 ~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g-a~~~~~d~~g~tpl~~a~~~ 116 (447)
..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|++.| ++++..|..|.||||+|+..
T Consensus 42 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~ 121 (237)
T 3b7b_A 42 EDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEY 121 (237)
T ss_dssp TTCCCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCTTCCCTTSCCHHHHHHHT
T ss_pred CCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCcccCCCCCCCHHHHHHHc
Confidence 33445555555555555555555555555555555555555555555555555555554 45555555555555555555
Q ss_pred chHHHHHHHHHhCCCCC
Q 013214 117 KNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 117 ~~~~~~~~L~~~~a~~~ 133 (447)
++.+++++|+++|++++
T Consensus 122 ~~~~~~~~Ll~~g~~~~ 138 (237)
T 3b7b_A 122 KHVDLVKLLLSKGSDIN 138 (237)
T ss_dssp TCHHHHHHHHHTTCCTT
T ss_pred CCHHHHHHHHHCCCCCC
Confidence 55555555555555443
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.73 E-value=5.4e-18 Score=165.91 Aligned_cols=113 Identities=23% Similarity=0.270 Sum_probs=100.6
Q ss_pred CccccchhcccCCC---CCCCccchhhHHHHHHHcCCHHHHHHHHHcC-CCCCCCCCCCCCHHHHHHHcCcHHHHHHHHH
Q 013214 19 PDRERKEAELNGLD---DDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94 (447)
Q Consensus 19 ~~~~~~~a~~n~~d---~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g-~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~ 94 (447)
....+.|+++|..+ .+..+..|+||||+||..|+.+++++|+++| +|+|.+|.+|+||||+|+..|+.++|++|++
T Consensus 255 ~~Ll~~g~~~~~~~~~~~~~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~ 334 (373)
T 2fo1_E 255 KLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQ 334 (373)
T ss_dssp HHHHHHTCCSSCCSGGGTSSSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHH
T ss_pred HHHHHCCCCcccccccccCcccccCCCHHHHHHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHH
Confidence 34456677776543 3446778999999999999999999999876 9999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCC
Q 013214 95 RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (447)
Q Consensus 95 ~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~ 131 (447)
+|++++.+|..|.|||++|+.+|+.+++++|++++++
T Consensus 335 ~gad~~~~d~~g~t~l~~A~~~g~~~iv~~Ll~~~a~ 371 (373)
T 2fo1_E 335 QGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPE 371 (373)
T ss_dssp TTCCSSCCCSSSCCHHHHHHHTTCHHHHHHHHTTC--
T ss_pred cCCCccCCCCCCCCHHHHHHHcCCHHHHHHHHhcCcc
Confidence 9999999999999999999999999999999999875
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.7e-17 Score=151.61 Aligned_cols=107 Identities=21% Similarity=0.173 Sum_probs=85.4
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCC----CCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA----DVDPKDRW 105 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga----~~~~~d~~ 105 (447)
+.+.+..+..|+||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+.+++++|++.|+ +++..|..
T Consensus 36 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~~~~ 115 (241)
T 1k1a_A 36 GRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYD 115 (241)
T ss_dssp TCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCTTSCCTTCCCTT
T ss_pred CCCCCcccccCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccccCcC
Confidence 44455555667778888888888888888888888888888888888888888888888888888776 77888888
Q ss_pred CCCccccccccchHHHHHHHHHhCCCCCCCc
Q 013214 106 GSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 106 g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
|.||||+|+..|+.+++++|+++|++++...
T Consensus 116 g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~ 146 (241)
T 1k1a_A 116 GLTALHVAVNTECQETVQLLLERGADIDAVD 146 (241)
T ss_dssp SCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred CCcHHHHHHHcCCHHHHHHHHHcCCCccccc
Confidence 8888888888888888888888888776544
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=155.34 Aligned_cols=109 Identities=27% Similarity=0.297 Sum_probs=98.3
Q ss_pred cchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCC
Q 013214 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102 (447)
Q Consensus 23 ~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~ 102 (447)
+.++++|..+ +..|+||||+|+..|+.+++++|+++|++++.+|.+|.||||+|+..|+.+++++|+++|++++.+
T Consensus 26 ~~g~~~~~~~----~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 101 (285)
T 1wdy_A 26 EGGANVNFQE----EEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNEC 101 (285)
T ss_dssp HTTCCTTCCC----TTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCB
T ss_pred HcCCCccccc----CCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcc
Confidence 3445544431 556889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccccchHHHHHHHHHhCCCCCCC
Q 013214 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 103 d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~ 135 (447)
|..|.||||+|+..|+.+++++|+++|+++...
T Consensus 102 ~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~ 134 (285)
T 1wdy_A 102 DFYGFTAFMEAAVYGKVKALKFLYKRGANVNLR 134 (285)
T ss_dssp CTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred CcccCCHHHHHHHhCCHHHHHHHHHhCCCcccc
Confidence 999999999999999999999999999988654
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3.8e-17 Score=158.76 Aligned_cols=107 Identities=24% Similarity=0.291 Sum_probs=98.4
Q ss_pred CccchhhHHHHHHHc-CCHHHHHHHHHcCCCCCCCC--CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 013214 36 EEIKPEFRLMFLANE-RDVEGIKELLDSGIDVNFRD--IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~-~~~~~~~~Ll~~g~d~n~~d--~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 112 (447)
....+.|+||+|+.. |+.++++.|+++|+|+|..| ..|+||||+|+..|+.+++++|+++|+++|.+|..|.||||+
T Consensus 195 ~~~~~~t~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~ 274 (368)
T 3jue_A 195 GSLHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHH 274 (368)
T ss_dssp --CCHHHHHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred ccCCCCcHHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHH
Confidence 344678999999999 99999999999999999998 899999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 113 AIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 113 a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|+..|+.+++++|+++|++++..+....++
T Consensus 275 A~~~g~~~~v~~LL~~Gad~~~~d~~G~Tp 304 (368)
T 3jue_A 275 ATILGHTGLACLFLKRGADLGARDSEGRDP 304 (368)
T ss_dssp HHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred HHHcCcHHHHHHHHHCcCCCCCcCCCCCCH
Confidence 999999999999999999998776554443
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=7.2e-17 Score=146.92 Aligned_cols=109 Identities=23% Similarity=0.205 Sum_probs=94.8
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~ 107 (447)
++.|.+..+..|.||||+|+..|+.+++++|++.|++++..+ ..|+||||+|+..|+.+++++|++.|++++.+|..|.
T Consensus 31 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 110 (240)
T 3eu9_A 31 AGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGC 110 (240)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cCCCcCCCCCCCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCCHHHHHHHHHcCCCCcccCCCCC
Confidence 344555556678888999999999999999999999988665 5599999999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHHHHhCCCCCCCcc
Q 013214 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
||||+|+..|+.+++++|+++|+++...+.
T Consensus 111 t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~ 140 (240)
T 3eu9_A 111 SCIHLAAQFGHTSIVAYLIAKGQDVDMMDQ 140 (240)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred CHHHHHHHcCHHHHHHHHHhcCCCccccCC
Confidence 999999999999999999999988765543
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.69 E-value=4e-17 Score=159.74 Aligned_cols=107 Identities=25% Similarity=0.260 Sum_probs=98.7
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcC---CCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG---ADVDPKDRW 105 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g---a~~~~~d~~ 105 (447)
+|.|.+..|.+|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++| ++++..|..
T Consensus 155 ~ga~vn~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~d~~ 234 (373)
T 2fo1_E 155 AGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRN 234 (373)
T ss_dssp TCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTSHHHHHTTSCCCTT
T ss_pred cCCCCcCCCCCCCCHHHHHHHcChHHHHHHHHHCCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHhcCccccChhhcCCC
Confidence 34455556677889999999999999999999999999999999999999999999999999999998 899999999
Q ss_pred CCCccccccccc---hHHHHHHHHHhCCCCCCC
Q 013214 106 GSTPLGDAIYYK---NHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 106 g~tpl~~a~~~~---~~~~~~~L~~~~a~~~~~ 135 (447)
|.||||+|+..+ +.+++++|+++|++++..
T Consensus 235 g~t~L~~A~~~~~~~~~~~v~~Ll~~g~~~~~~ 267 (373)
T 2fo1_E 235 GMTALMIVAHNEGRDQVASAKLLVEKGAKVDYD 267 (373)
T ss_dssp SCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSCC
T ss_pred CCCHHHHHHHhCCcchHHHHHHHHHCCCCcccc
Confidence 999999999988 899999999999998763
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=6.4e-17 Score=155.82 Aligned_cols=105 Identities=28% Similarity=0.248 Sum_probs=79.8
Q ss_pred CCCCCCccchhhHHHHHHHcCC----HHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHc-CCCCCCCCCC
Q 013214 31 LDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRW 105 (447)
Q Consensus 31 ~d~~~~~~~g~t~lh~a~~~~~----~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~-ga~~~~~d~~ 105 (447)
.|++..+..|+|++|+++..+. .+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|++. |+++|.+|.+
T Consensus 193 ad~n~~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~~ 272 (337)
T 4g8k_A 193 ADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSD 272 (337)
T ss_dssp CCTTCCCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCTT
T ss_pred CCcCccCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCCC
Confidence 3344444445555665554332 2355666677777778888888899999999999999988875 8899999999
Q ss_pred CCCccccccccchHHHHHHHHHhCCCCCCC
Q 013214 106 GSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 106 g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~ 135 (447)
|+||||+|+..|+.+++++|+++|++++..
T Consensus 273 G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~ 302 (337)
T 4g8k_A 273 GKTALLLAVELKLKKIAELLCKRGASTDCG 302 (337)
T ss_dssp SCBHHHHHHHTTCHHHHHHHHTTSCSSTTC
T ss_pred CCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999999888654
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=8.3e-17 Score=146.51 Aligned_cols=103 Identities=24% Similarity=0.172 Sum_probs=59.2
Q ss_pred CCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCc-HHHHHHHHHcCCCCCCCCC-CCCCccc
Q 013214 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDR-WGSTPLG 111 (447)
Q Consensus 34 ~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~-~~~v~~Ll~~ga~~~~~d~-~g~tpl~ 111 (447)
+..+..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++ .+++++|++.|++++..+. .|.||||
T Consensus 103 ~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~~~~~~~~g~t~L~ 182 (240)
T 3eu9_A 103 SLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALH 182 (240)
T ss_dssp TCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCTTCCCTTTCCCHHH
T ss_pred cccCCCCCCHHHHHHHcCHHHHHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCcchhhccCCCcHHH
Confidence 3334445555566555555555555555555555555555555555554444 5555555555555555554 5666666
Q ss_pred cccccchHHHHHHHHHhCCCCCCCc
Q 013214 112 DAIYYKNHEVIKLLEKHGAKPLMAP 136 (447)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~a~~~~~~ 136 (447)
+|+..|+.+++++|+++|++++..+
T Consensus 183 ~A~~~~~~~~v~~Ll~~g~~~~~~~ 207 (240)
T 3eu9_A 183 WAVLAGNTTVISLLLEAGANVDAQN 207 (240)
T ss_dssp HHHHHTCHHHHHHHHHHTCCTTCBC
T ss_pred HHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 6666666666666666666655443
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.2e-16 Score=160.40 Aligned_cols=104 Identities=25% Similarity=0.259 Sum_probs=96.0
Q ss_pred chhhHHHHHHHcCCHHHHHHHHHcCCCCCCC------CCCCCCHHHHHHH---cCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAAC---QGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 39 ~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~------d~~g~t~Lh~A~~---~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
...+.||.|+..|+.+.++.|++.|+|+|.+ |..|+||||+||. .|+.+++++|+++||++|.+|..|+||
T Consensus 131 ~~~~~L~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~Tp 210 (497)
T 3lvq_E 131 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTA 210 (497)
T ss_dssp -CHHHHHHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCH
T ss_pred ccHHHHHHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcH
Confidence 3447899999999999999999999999988 8999999999966 999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
||+|+..|+.+++++|+++|++++..+..+.++
T Consensus 211 Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 243 (497)
T 3lvq_E 211 LHYAALYNQPDCLKLLLKGRALVGTVNEAGETA 243 (497)
T ss_dssp HHHHTTTTCHHHHHHHHHTCCCCSCCCTTCCCH
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 999999999999999999999998877655544
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=3e-16 Score=148.76 Aligned_cols=105 Identities=24% Similarity=0.243 Sum_probs=96.1
Q ss_pred cchhhHHHHHHHcCCHHHHHHHHHcCCCCCC------CCCCCCCHHHHHHHc---CcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 38 ~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~------~d~~g~t~Lh~A~~~---g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
..+.++||.|+..|+.+.++.|++.|+|+|. .|..|+||||+|+.. |+.+++++|+++|+++|.+|..|.|
T Consensus 149 ~~~~~~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~T 228 (301)
T 2b0o_E 149 TPEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNT 228 (301)
T ss_dssp C-CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCC
T ss_pred CchHHHHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCC
Confidence 3456889999999999999999999999998 699999999999997 8999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|||+|+..|+.+++++|+++|++++..+..+.++
T Consensus 229 pLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~Tp 262 (301)
T 2b0o_E 229 ALHYAALYNQPDCLKLLLKGRALVGTVNEAGETA 262 (301)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCCH
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 9999999999999999999999998776554443
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.65 E-value=4.1e-16 Score=146.11 Aligned_cols=106 Identities=24% Similarity=0.260 Sum_probs=96.1
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCC------CCCCCCCCHHHHHHHc---CcHHHHHHHHHcCCCCCCCCCCCC
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVN------FRDIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGS 107 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n------~~d~~g~t~Lh~A~~~---g~~~~v~~Ll~~ga~~~~~d~~g~ 107 (447)
+....++|+.|+..|+.+.++.+++.|++++ ..|..|+||||+|+.. |+.+++++|+++|+++|.+|..|.
T Consensus 127 ~~~~l~~l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~ 206 (278)
T 1dcq_A 127 TAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGS 206 (278)
T ss_dssp HHHHHHHHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCC
T ss_pred cchhhhhhhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCC
Confidence 3456789999999999999999999999954 4589999999999999 899999999999999999999999
Q ss_pred CccccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
||||+|+..|+.+++++|+++|++++..+..+.++
T Consensus 207 TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tp 241 (278)
T 1dcq_A 207 TALHYCCLTDNAECLKLLLRGKASIEIANESGETP 241 (278)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CHHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCCH
Confidence 99999999999999999999999998876554443
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=117.94 Aligned_cols=69 Identities=42% Similarity=0.556 Sum_probs=63.2
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~ 98 (447)
+.|.+.++..|+||||+|+..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++||+
T Consensus 25 g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 25 GADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAY 93 (93)
T ss_dssp TCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCC
T ss_pred CCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 444555566788999999999999999999999999999999999999999999999999999999985
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.9e-16 Score=126.36 Aligned_cols=81 Identities=33% Similarity=0.387 Sum_probs=72.2
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.++..|.||
T Consensus 32 g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~ga~~n~~~~~~~~~ 111 (115)
T 2l6b_A 32 GADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWGSSHH 111 (115)
T ss_dssp TCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTSSSHHHHSCCCC--
T ss_pred CCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCcccccc
Confidence 34455556678888999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred c
Q 013214 110 L 110 (447)
Q Consensus 110 l 110 (447)
-
T Consensus 112 ~ 112 (115)
T 2l6b_A 112 H 112 (115)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.59 E-value=9.5e-16 Score=147.16 Aligned_cols=85 Identities=24% Similarity=0.146 Sum_probs=75.7
Q ss_pred CCCCccchhhHHHHHHH----cCCHHHHHHHHHcCC--------------------------------------------
Q 013214 33 DDGEEIKPEFRLMFLAN----ERDVEGIKELLDSGI-------------------------------------------- 64 (447)
Q Consensus 33 ~~~~~~~g~t~lh~a~~----~~~~~~~~~Ll~~g~-------------------------------------------- 64 (447)
.+..+..|+||||+||. .|+.+++++|++.++
T Consensus 194 ~~~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~ 273 (327)
T 1sw6_A 194 LILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIA 273 (327)
T ss_dssp GGEECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHH
T ss_pred ccCCCCCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHH
Confidence 44555678899999999 899999999998743
Q ss_pred -CCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccc
Q 013214 65 -DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (447)
Q Consensus 65 -d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~ 117 (447)
++|.+|.+|+||||+|+..|+.++|++|+++||+++.+|..|+||||+|+..|
T Consensus 274 ~~~n~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~~~g 327 (327)
T 1sw6_A 274 NMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGAGLE 327 (327)
T ss_dssp HTTTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTCC--
T ss_pred hCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHhcC
Confidence 68889999999999999999999999999999999999999999999998865
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.56 E-value=5.7e-15 Score=142.73 Aligned_cols=133 Identities=17% Similarity=0.134 Sum_probs=96.0
Q ss_pred cccceeeecceEEEEEE----cCeEEEEEEcCcccCC---------------CHHH----HHHHHHHHHHHhcCCCCccc
Q 013214 157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---------------DDDR----VRAFRDELALLQKIRHPNVV 213 (447)
Q Consensus 157 ~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~---------------~~~~----~~~~~~E~~~l~~l~hp~iv 213 (447)
|.+...||.|++|.||. +|+.||||+++..... .... .-...+|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 66778999999999884 6899999987542111 0011 11124577777777555443
Q ss_pred --ceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 214 --QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 214 --~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
..++. ...++||||++|++|.++. .......++.|++.+|.+||+.| ++||||||.|||+++++.
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCeeeec----cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 23332 2348999999988886532 22345678899999999999999 999999999999998763
Q ss_pred ----------EEEeecccccc
Q 013214 292 ----------LKVADFGVSKL 302 (447)
Q Consensus 292 ----------vkl~Dfg~~~~ 302 (447)
+.|+||+.+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 89999998764
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.51 E-value=5.7e-16 Score=151.01 Aligned_cols=90 Identities=16% Similarity=0.070 Sum_probs=44.8
Q ss_pred chhhHHHHHHHcCCHHHHHHHHHcCCCC---CCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCC--CCCCCCCccccc
Q 013214 39 KPEFRLMFLANERDVEGIKELLDSGIDV---NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP--KDRWGSTPLGDA 113 (447)
Q Consensus 39 ~g~t~lh~a~~~~~~~~~~~Ll~~g~d~---n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~--~d~~g~tpl~~a 113 (447)
.|.||||+||..|+.+++++|+++|+|+ +..+.+ +||||+||..|+.++|++|+++|++++. .|..|.||||+|
T Consensus 127 ~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~A 205 (376)
T 2aja_A 127 ENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWA 205 (376)
T ss_dssp HHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCCCHHHHH
Confidence 4455555555555555555555555431 111111 4555555555555555555555555444 445555555555
Q ss_pred c-ccchHHHHHHHHHhC
Q 013214 114 I-YYKNHEVIKLLEKHG 129 (447)
Q Consensus 114 ~-~~~~~~~~~~L~~~~ 129 (447)
+ ..|+.+++++|+++|
T Consensus 206 a~~~G~~eiv~~Ll~~g 222 (376)
T 2aja_A 206 AVGRGHHNVINFLLDCP 222 (376)
T ss_dssp HSTTCCHHHHHHHTTSH
T ss_pred HHHCCCHHHHHHHHhCC
Confidence 5 555555555555443
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.45 E-value=7.1e-15 Score=143.24 Aligned_cols=97 Identities=16% Similarity=0.025 Sum_probs=80.0
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCC---CCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCC---CCCCCCCCCcc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDV---NFRDIDNRTALHVAACQGFTEVVSLLLERGADV---DPKDRWGSTPL 110 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~---n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~---~~~d~~g~tpl 110 (447)
+.+++||||+||..|+.+++++|++.|+.. +..|..|.||||+||.+|+.++|++|+++|+++ +..+.+ .|||
T Consensus 89 g~~~~T~Lh~Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpL 167 (376)
T 2aja_A 89 GIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAF 167 (376)
T ss_dssp TCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHH
T ss_pred CCCcCCHHHHHHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHH
Confidence 456789999999999999999999999832 234456889999999999999999999999863 333333 8999
Q ss_pred ccccccchHHHHHHHHHhCCCCCC
Q 013214 111 GDAIYYKNHEVIKLLEKHGAKPLM 134 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~a~~~~ 134 (447)
|+|+..|+.+++++|+++|+++..
T Consensus 168 h~Aa~~G~~eiv~~Ll~~ga~~~~ 191 (376)
T 2aja_A 168 RLAAENGHLHVLNRLCELAPTEAT 191 (376)
T ss_dssp HHHHHTTCHHHHHHHHHSCGGGHH
T ss_pred HHHHHCCCHHHHHHHHHcCCccch
Confidence 999999999999999999998653
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.36 E-value=4.5e-13 Score=106.72 Aligned_cols=75 Identities=36% Similarity=0.340 Sum_probs=65.6
Q ss_pred CCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCccccc
Q 013214 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140 (447)
Q Consensus 66 ~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~ 140 (447)
++..|.+|+||||+|+..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++..+..+.
T Consensus 17 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 91 (110)
T 2zgd_A 17 GSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGK 91 (110)
T ss_dssp -----CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred ccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCC
Confidence 456788999999999999999999999999999999999999999999999999999999999999877654443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=1.6e-10 Score=106.86 Aligned_cols=137 Identities=12% Similarity=0.011 Sum_probs=99.3
Q ss_pred cccceeeecceEE---EEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEEEEecc
Q 013214 157 FTNSVEITKGTFI---LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 157 ~~~~~~lg~G~~~---~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
|.....++.|+.. .+...|+.+++|......... ...+.+|+.+++.+ .+..++++++++...+..|++|||+
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 3333344444433 334457899999987532111 13577899999988 4678899999999888999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 013214 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK------------------------------------------ 270 (447)
Q Consensus 233 ~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~------------------------------------------ 270 (447)
+|.+|.+.+. +......++.++..++..||+..
T Consensus 93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 9999887531 22334578889999999999811
Q ss_pred --------------CCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 271 --------------PVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 271 --------------~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
+..++|+|++|.||+++.++.+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1238999999999999875556799999765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=4.8e-09 Score=101.58 Aligned_cols=137 Identities=14% Similarity=0.194 Sum_probs=97.8
Q ss_pred eeecceEE---EEEEcCeEEEEEEcC--cccCCCHHHHHHHHHHHHHHhcCC--CCcccceeEEEEeC---CceEEEEec
Q 013214 162 EITKGTFI---LAFWRGIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQS---SPMMIVTEY 231 (447)
Q Consensus 162 ~lg~G~~~---~~~~~g~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~---~~~~lv~e~ 231 (447)
.++.|.+. .+...+..+++|+.. .... ......+.+|..+++.+. +..+++++.++.+. +..++||||
T Consensus 45 ~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 45 QFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp ECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EcCCcccceEEEEEECCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 45556553 333456788999876 3221 112346778999999996 45688899988776 458999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK----------------------------------------- 270 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~----------------------------------------- 270 (447)
++|..+.+. ....++..+...++.++...|..||+..
T Consensus 123 v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 123 VSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp CCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred cCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 998777541 1234678888899999999999999831
Q ss_pred --------------CCCeEeCCCCCCCEEEcCCCC--EEEeecccccc
Q 013214 271 --------------PVPIIHRDLEPSNILRDDSGN--LKVADFGVSKL 302 (447)
Q Consensus 271 --------------~~~i~H~Dikp~Nill~~~~~--vkl~Dfg~~~~ 302 (447)
+..++|+|++|.||+++.++. +.|+||+.+..
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 234899999999999997653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=3.6e-09 Score=99.98 Aligned_cols=185 Identities=18% Similarity=0.138 Sum_probs=121.5
Q ss_pred eeecceEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCc--ccceeEEEEeCC---ceEEEEeccCCC
Q 013214 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN--VVQFLGAVTQSS---PMMIVTEYLPKG 235 (447)
Q Consensus 162 ~lg~G~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~--iv~~~~~~~~~~---~~~lv~e~~~~g 235 (447)
.++.|....++.-+..+++|+... ......+.+|..+++.+ .+.. +++++....... ..|+||++++|.
T Consensus 27 ~~~~G~~n~v~~v~~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 27 ISGEGNDCIAYEINRDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp EEEECSSEEEEESTTSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred ecCCCCcceEEEECCEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 478888888887678899998652 24456788999999887 3333 455555443332 348899999998
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 013214 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK--------------------------------------------- 270 (447)
Q Consensus 236 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~--------------------------------------------- 270 (447)
+|.+... ..++.++...++.+++..+..||+..
T Consensus 102 ~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 102 PLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp ECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred ECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 8875432 34677788888889998888888621
Q ss_pred ----------CCCeEeCCCCCCCEEEcC--CCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCC-----CCC--
Q 013214 271 ----------PVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEY-- 331 (447)
Q Consensus 271 ----------~~~i~H~Dikp~Nill~~--~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~-- 331 (447)
+..++|+|++|.||+++. ...+.++||+.+.......+....... . .-..|+.... +..
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~-~-~~~~~~~~~~~l~~Y~~~~~ 257 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED-D-EEYGMEFVSKILNHYKHKDI 257 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT-T-TSCCHHHHHHHHHHHTCSCH
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh-c-cccCHHHHHHHHHHcCCCCc
Confidence 123799999999999998 456789999988654321110000000 0 0012221100 011
Q ss_pred -------CCchhHHHHHHHHHHHHhCCCCCC
Q 013214 332 -------DTKVDVFSFALILQEMIEGCPPFT 355 (447)
Q Consensus 332 -------~~~~Di~slG~~l~~l~tg~~p~~ 355 (447)
....+.|+++.++|.+.+|..+|.
T Consensus 258 ~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 258 PTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 112689999999999999987753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.83 E-value=5.5e-09 Score=95.97 Aligned_cols=114 Identities=20% Similarity=0.159 Sum_probs=83.5
Q ss_pred cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc--ccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHH
Q 013214 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251 (447)
Q Consensus 174 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~ 251 (447)
+|..+++|...... ...+..|+.+++.+.+.+ +++++++....+..+++|||++|.+|. .. ..+
T Consensus 43 ~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~--- 108 (264)
T 1nd4_A 43 GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLA--- 108 (264)
T ss_dssp TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCC---
T ss_pred CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCC---
Confidence 35789999876431 134677999998885433 667899888888899999999988874 21 112
Q ss_pred HHHHHHHHHHHHHHHHhCC-------------------------------------------------------CCCeEe
Q 013214 252 AVRFALDIARGMNYLHENK-------------------------------------------------------PVPIIH 276 (447)
Q Consensus 252 ~~~i~~ql~~~l~~lH~~~-------------------------------------------------------~~~i~H 276 (447)
...++.+++..+..||+.. +..++|
T Consensus 109 ~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H 188 (264)
T 1nd4_A 109 PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTH 188 (264)
T ss_dssp HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEEC
T ss_pred HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEEC
Confidence 2356677777788888643 112899
Q ss_pred CCCCCCCEEEcCCCCEEEeeccccc
Q 013214 277 RDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 277 ~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
+|++|.||+++.++.+.|+||+.+.
T Consensus 189 gDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 189 GDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp SSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999876656799999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=3.4e-06 Score=79.48 Aligned_cols=134 Identities=19% Similarity=0.174 Sum_probs=92.7
Q ss_pred eeecceEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCC---cccceeEEEE-eCCceEEEEeccCCCCH
Q 013214 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP---NVVQFLGAVT-QSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 162 ~lg~G~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~~~~~~~-~~~~~~lv~e~~~~g~L 237 (447)
.++.|....++.-|..+++|+.. .......+..|..+++.+.+. .+++++.+.. ..+..+++|||++|.++
T Consensus 26 ~l~~G~~n~v~~vg~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 26 SLGEGFRNYAILVNGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEECSSEEEEEETTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred ecCCCcceeEEEECCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 46666666666557889999853 234456788999999999642 3677777764 44567899999998888
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------
Q 013214 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENK----------------------------------------------- 270 (447)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~----------------------------------------------- 270 (447)
.+..- ..++..+...++.++...|..||+..
T Consensus 101 ~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 101 GEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp HHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred chhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 76321 22445555555555555555555422
Q ss_pred ----------CCCeEeCCCCCCCEEEcC---CCCE-EEeecccccc
Q 013214 271 ----------PVPIIHRDLEPSNILRDD---SGNL-KVADFGVSKL 302 (447)
Q Consensus 271 ----------~~~i~H~Dikp~Nill~~---~~~v-kl~Dfg~~~~ 302 (447)
+..++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 223699999999999997 4665 7999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=2.2e-05 Score=72.26 Aligned_cols=119 Identities=14% Similarity=0.160 Sum_probs=86.8
Q ss_pred cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHH
Q 013214 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA 252 (447)
Q Consensus 174 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~ 252 (447)
.+..+.+|+.+.. ....+..|...|+.+. +-.+.++++++.+.+..+++||+++|.++.+..... ....
T Consensus 49 ~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~ 118 (272)
T 4gkh_A 49 NAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSG 118 (272)
T ss_dssp TCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGH
T ss_pred CCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHH
Confidence 3567899986532 3456788999998884 334788999999989999999999998887765431 2333
Q ss_pred HHHHHHHHHHHHHHHhCC-------------------------------------------------------CCCeEeC
Q 013214 253 VRFALDIARGMNYLHENK-------------------------------------------------------PVPIIHR 277 (447)
Q Consensus 253 ~~i~~ql~~~l~~lH~~~-------------------------------------------------------~~~i~H~ 277 (447)
..+..++...|..||+.. +..++|+
T Consensus 119 ~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HG 198 (272)
T 4gkh_A 119 ENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHG 198 (272)
T ss_dssp HHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECS
T ss_pred HHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcC
Confidence 455666666666676311 1127899
Q ss_pred CCCCCCEEEcCCCCEEEeecccccc
Q 013214 278 DLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 278 Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
|+.+.||+++..+.+-|+||+.+..
T Consensus 199 Dl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 199 DFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCeEEEECCeEEEEEECccccc
Confidence 9999999999876667999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=3.1e-05 Score=74.47 Aligned_cols=61 Identities=5% Similarity=0.012 Sum_probs=40.9
Q ss_pred CeEEEEEEcCccc---CCCHHHHHHHHHHHHHHhcCC-C--CcccceeEEEEeC---CceEEEEeccCCCCHH
Q 013214 175 GIQVAVKKLGEEV---ISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQS---SPMMIVTEYLPKGDLR 238 (447)
Q Consensus 175 g~~vavK~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h--p~iv~~~~~~~~~---~~~~lv~e~~~~g~L~ 238 (447)
+..+++|...... ... ...+.+|..+++.+. + -.+++++.++.+. +..+++|||++|..+.
T Consensus 52 ~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp EEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred CceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 6789999876432 100 134567888888873 3 3578888887655 3568999999876543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00053 Score=59.99 Aligned_cols=139 Identities=13% Similarity=0.110 Sum_probs=91.9
Q ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcccC
Q 013214 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (447)
Q Consensus 236 ~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 314 (447)
+|.+.|+. +.+++++++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|+|.+.+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-------------
Confidence 79999975 4679999999999999999887632110 11233457899999999887663 1110
Q ss_pred CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 013214 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394 (447)
Q Consensus 315 ~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 394 (447)
.....+.|||... ...+.+.=|||||+++|.-+--..|- ..++.+|+.+.+||..|..
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e---------------------~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE---------------------NEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT---------------------TEEECCCHHHHHHHHHHTT
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc---------------------ccchhhCHHHHHHHHHHHh
Confidence 1123467888764 34567889999999999888532221 1244578889999998875
Q ss_pred c-------------------------CCCCCCCHHHHHHHHHH
Q 013214 395 E-------------------------KPAKRPTFRQIITRLES 412 (447)
Q Consensus 395 ~-------------------------dp~~Rps~~~~l~~l~~ 412 (447)
. .+..|+++++|++.-..
T Consensus 156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp CCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 5 24678999998865544
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00025 Score=69.17 Aligned_cols=73 Identities=19% Similarity=0.144 Sum_probs=41.9
Q ss_pred eeeecceEEEEE-----EcCeEEEEEEcCcccC-CCH---HHHHHHHHHHHHHhcCC-C-C-cccceeEEEEeCCceEEE
Q 013214 161 VEITKGTFILAF-----WRGIQVAVKKLGEEVI-SDD---DRVRAFRDELALLQKIR-H-P-NVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 161 ~~lg~G~~~~~~-----~~g~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~-h-p-~iv~~~~~~~~~~~~~lv 228 (447)
+.+|.|..+.++ ..++.+++|....... ... .....+..|..+++.+. + | .+++++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 357777776554 2457899997653211 000 01234567888888773 2 3 45566654 34456899
Q ss_pred EeccCCC
Q 013214 229 TEYLPKG 235 (447)
Q Consensus 229 ~e~~~~g 235 (447)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0045 Score=58.49 Aligned_cols=30 Identities=20% Similarity=0.305 Sum_probs=26.7
Q ss_pred CCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 272 ~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
..++|+|+.+.||+++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 349999999999999878889999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.002 Score=60.40 Aligned_cols=71 Identities=21% Similarity=0.106 Sum_probs=51.5
Q ss_pred eeeecceEE---EEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC---CCcccceeEEEEeCCceEEEEeccCC
Q 013214 161 VEITKGTFI---LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIVTEYLPK 234 (447)
Q Consensus 161 ~~lg~G~~~---~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~~~lv~e~~~~ 234 (447)
+.|+.|... .+..++..+++|+.... ....+..|...|+.+. ...+++++.+....+..+++|||++|
T Consensus 42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346666543 33345678999987532 1356788999888883 36788999988888889999999988
Q ss_pred CCH
Q 013214 235 GDL 237 (447)
Q Consensus 235 g~L 237 (447)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0025 Score=62.49 Aligned_cols=30 Identities=23% Similarity=0.288 Sum_probs=26.5
Q ss_pred CeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 273 ~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.++|+|++|.||+++.++ +.++||+.+...
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 499999999999999776 999999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0058 Score=57.76 Aligned_cols=32 Identities=31% Similarity=0.444 Sum_probs=27.2
Q ss_pred CCeEeCCCCCCCEEEcCC----CCEEEeeccccccc
Q 013214 272 VPIIHRDLEPSNILRDDS----GNLKVADFGVSKLL 303 (447)
Q Consensus 272 ~~i~H~Dikp~Nill~~~----~~vkl~Dfg~~~~~ 303 (447)
..++|+|+.+.||+++.+ +.+.++||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 358999999999999874 67999999988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0058 Score=56.90 Aligned_cols=29 Identities=24% Similarity=0.290 Sum_probs=24.8
Q ss_pred CeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 273 ~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
.++|+|+.|.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4799999999999 5667899999997753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.72 E-value=0.11 Score=47.59 Aligned_cols=71 Identities=18% Similarity=0.101 Sum_probs=45.2
Q ss_pred ceeeecceEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-C--CcccceeEEEEeCCceEEEEecc
Q 013214 160 SVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 160 ~~~lg~G~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--p~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
...+|.|..+.++ .+|+.|.+|+.+...... ...+..|...|+.+. . -.++++++.. .-+++|||+
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 3456777665544 368999999876443221 134677999888884 2 2356666542 237899999
Q ss_pred CCCCH
Q 013214 233 PKGDL 237 (447)
Q Consensus 233 ~~g~L 237 (447)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 77653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.67 E-value=0.021 Score=53.48 Aligned_cols=43 Identities=26% Similarity=0.332 Sum_probs=30.5
Q ss_pred HHHHHHHHHhC----CCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 259 IARGMNYLHEN----KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 259 l~~~l~~lH~~----~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
+...+..+... .+..++|+|+.+.||+++.++.+.++||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 33445555432 12348999999999999876555799999765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.60 E-value=0.015 Score=56.05 Aligned_cols=119 Identities=21% Similarity=0.283 Sum_probs=70.2
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEeccCCCCHH--------------H
Q 013214 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLR--------------A 239 (447)
Q Consensus 175 g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~--------------~ 239 (447)
+..+.+|+..... . ......+|..+++.+. +.-.+++++.+.+ .+|+||++|..|. +
T Consensus 82 ~~~~vlR~~g~~~-~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~ 153 (379)
T 3feg_A 82 PREVLLRLYGAIL-Q---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIAT 153 (379)
T ss_dssp CSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHH
T ss_pred CCeEEEEECCCcc-c---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHH
Confidence 4688999864321 1 1234557889888883 3334677776643 3899999875542 1
Q ss_pred HH---HhcC-C----CC--HHHHHHHHHHHHH-------------------HHHHH----HhC-CCCCeEeCCCCCCCEE
Q 013214 240 FL---KRKG-A----LK--PSTAVRFALDIAR-------------------GMNYL----HEN-KPVPIIHRDLEPSNIL 285 (447)
Q Consensus 240 ~l---~~~~-~----l~--~~~~~~i~~ql~~-------------------~l~~l----H~~-~~~~i~H~Dikp~Nil 285 (447)
.+ +... + .. ..++.++..++.. .+..| ... .+..++|+|+.+.||+
T Consensus 154 ~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil 233 (379)
T 3feg_A 154 KMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNIL 233 (379)
T ss_dssp HHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEE
T ss_pred HHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEE
Confidence 11 1111 1 11 2344445444322 12222 222 2234899999999999
Q ss_pred EcCC----CCEEEeeccccc
Q 013214 286 RDDS----GNLKVADFGVSK 301 (447)
Q Consensus 286 l~~~----~~vkl~Dfg~~~ 301 (447)
++.+ +.+.++||..+.
T Consensus 234 ~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 234 LLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EESCC---CCEEECCCTTCE
T ss_pred EcCCCCccCcEEEEecccCC
Confidence 9876 789999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.51 E-value=0.059 Score=50.43 Aligned_cols=29 Identities=24% Similarity=0.264 Sum_probs=24.8
Q ss_pred CCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 272 ~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3479999999999999 4 899999987754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.24 E-value=0.097 Score=49.47 Aligned_cols=30 Identities=20% Similarity=0.427 Sum_probs=26.9
Q ss_pred CeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 273 ~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
.++|+|+.+.||+++.++.+.++||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 489999999999999888899999987764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.52 E-value=0.089 Score=51.53 Aligned_cols=53 Identities=11% Similarity=0.118 Sum_probs=33.4
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEeccCCCC
Q 013214 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (447)
Q Consensus 175 g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 236 (447)
+..+.+|+.... .. ...+..|..+++.+. +.-.+++++.+.+ .+++||++|.+
T Consensus 105 ~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 105 PNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp CSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred CceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence 478999987432 11 123446888888884 3334677776542 38999997633
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.79 E-value=1.6 Score=37.96 Aligned_cols=114 Identities=11% Similarity=0.158 Sum_probs=76.9
Q ss_pred CCCcccceeEEEEeCCceEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE
Q 013214 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (447)
Q Consensus 208 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill 286 (447)
.||+++.. ..-..++.+.+.++.-+.+ +... + ..++....++++.+++....++++ -+|--+.|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 68888876 4555556555555554322 2222 2 347888999999999998755543 4788899999999
Q ss_pred cCCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHH-HHHHHHHHHHhCCCCCC
Q 013214 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF-SFALILQEMIEGCPPFT 355 (447)
Q Consensus 287 ~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~-slG~~l~~l~tg~~p~~ 355 (447)
+.++.+++.-.|.... ++|. ..+ ..|.| .+=+++..+++++..|.
T Consensus 113 ~~~~~p~i~~RGik~~------------------l~P~-----~~~-ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV------------------VDPL-----PVS-EAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTT------------------BSCC-----CCC-HHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccC------------------CCCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999987775432 1221 111 22333 57888899999988876
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.48 E-value=2.6 Score=36.72 Aligned_cols=114 Identities=11% Similarity=0.104 Sum_probs=76.6
Q ss_pred CCCcccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEeCCCCCCCEEE
Q 013214 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN-YLHENKPVPIIHRDLEPSNILR 286 (447)
Q Consensus 208 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~-~lH~~~~~~i~H~Dikp~Nill 286 (447)
.||++ -...-.+++.+.+.++.-+++.=+..++ .++....++++.+++.... ++++ -+|--+.|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEE
Confidence 67888 3344466676666666654443333343 4788899999999888766 4443 5788899999999
Q ss_pred cCCCCEEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHH-HHHHHHHHHHhCCCCCC
Q 013214 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF-SFALILQEMIEGCPPFT 355 (447)
Q Consensus 287 ~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~-slG~~l~~l~tg~~p~~ 355 (447)
+.++.+++.-.|.-.. ++|.-+ ...|.| .+=+++..++.++..|.
T Consensus 118 ~~~~~p~i~hRGi~~~------------------lpP~e~------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 NRALEPFFLHVGVKES------------------LPPDEW------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CTTCCEEESCCEETTT------------------BSSCSC------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eCCCcEEEEEcCCccc------------------CCCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999997776432 222211 123443 57788888888877765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=82.59 E-value=0.57 Score=44.54 Aligned_cols=28 Identities=32% Similarity=0.536 Sum_probs=23.7
Q ss_pred CeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 273 PIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 273 ~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
.++|+|+.+.||+++.++ +.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 489999999999998654 8999998765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 447 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-26 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 4e-22 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 5e-16 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-14 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-13 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-12 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 5e-12 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-11 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 9e-20 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 9e-14 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-09 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 3e-08 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 3e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-18 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 2e-16 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 6e-11 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 3e-09 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 7e-06 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 0.004 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 2e-14 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 4e-11 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 2e-09 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 4e-06 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 3e-05 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 5e-14 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 2e-10 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 2e-09 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 8e-07 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 4e-13 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 1e-11 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 5e-10 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 5e-08 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 7e-13 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 1e-10 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 4e-08 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 6e-08 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 2e-04 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 2e-12 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 8e-07 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 1e-06 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 3e-06 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-12 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 5e-12 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 7e-11 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-07 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 0.001 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 9e-12 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 1e-05 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 1e-11 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 1e-08 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 5e-05 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 0.004 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-11 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 3e-10 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 2e-08 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 5e-08 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-09 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 8e-09 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-07 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 6e-06 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 6e-06 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 1e-07 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 4e-06 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 2e-04 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 4e-07 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 5e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 2e-04 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 5e-07 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 2e-04 | |
| d1ycsb1 | 130 | d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) | 2e-04 | |
| d1bi7b_ | 125 | d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-62
Identities = 75/281 (26%), Positives = 134/281 (47%), Gaps = 18/281 (6%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++EI ++ I G+F W G VAVK L + +AF++E+ +
Sbjct: 2 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQL-QAFKNEVGV 57
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L+K RH N++ F+G T + IVT++ L L + + + A A+G
Sbjct: 58 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYV 321
M+YLH IIHRDL+ +NI + +K+ DFG++ + + Q + S ++
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 322 APEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKA 376
APEV + ++ Y + DV++F ++L E++ G P++ ++ + R P
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
+ +K L+ EC +K +RP F QI+ +E + S+
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 7e-62
Identities = 80/275 (29%), Positives = 134/275 (48%), Gaps = 24/275 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+ ++ EL I KG F +L +RG +VAVK I +D +AF E +++
Sbjct: 2 WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVM 54
Query: 205 QKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIAR 261
++RH N+VQ LG + + + IVTEY+ KG L +L+ +G L ++F+LD+
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
M YL N +HRDL N+L + KV+DFG++K + + ++
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWT 167
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
APE + +++ TK DV+SF ++L E+ G P+ +V +
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDG 224
Query: 381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
+ E+++ CW+ A RP+F Q+ +LE I
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 9e-59
Identities = 66/266 (24%), Positives = 119/266 (44%), Gaps = 19/266 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDEL 201
++ ++ DF + KG F LA + +A+K L + + R E+
Sbjct: 2 QWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
+ +RHPN+++ G ++ + ++ EY P G + L++ + ++A
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
++Y H + +IHRD++P N+L +G LK+ADFG S T + Y+
Sbjct: 118 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYL 171
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381
PE+ + +D KVD++S ++ E + G PPF E Y R F P
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRISRVEFTFP-DFV 227
Query: 382 ARGLKELIEECWNEKPAKRPTFRQII 407
G ++LI P++RP R+++
Sbjct: 228 TEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-58
Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 18/270 (6%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP +L F E+ G F WR VA+K + E +S+D+ F +E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
+ H +VQ G T+ P+ I+TEY+ G L +L+ + + + D+ M
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL +HRDL N L +D G +KV+DFG+S+ + E R+ PE
Sbjct: 115 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
V ++ +K D+++F +++ E+ G P+ ++E + A R L +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASE 228
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ ++ CW+EK +RPTF+ +++ + +
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-58
Identities = 82/273 (30%), Positives = 141/273 (51%), Gaps = 18/273 (6%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP EL F EI G F L +W +VA+K + E +S++D F +E ++
Sbjct: 2 IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 55
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIARGMN 264
K+ HP +VQ G + +P+ +V E++ G L +L+ + L T + LD+ GM
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL E +IHRDL N L ++ +KV+DFG+++ + + T ++ +PE
Sbjct: 116 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
VF Y +K DV+SF +++ E+ EG P+ + ++EV + + R +L +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLAST 229
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
+ +++ CW E+P RP F +++ +L I S
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-58
Identities = 80/278 (28%), Positives = 129/278 (46%), Gaps = 20/278 (7%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDEL 201
E+E+ L + G F + ++ +VAVK L + +S D F E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS--TAVRFALDI 259
L+++++H +V+ VTQ P+ I+TEY+ G L FLK +K + + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
A GM ++ E IHRDL +NIL D+ + K+ADFG+++L+ E +
Sbjct: 119 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPA 378
+ APE + K DV+SF ++L E++ G P+ + EV + R
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP--- 232
Query: 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
L +L+ CW E+P RPTF + + LE +
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 2e-57
Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 24/290 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
++ DP +L F++ EI G+F A VA+KK+ +++ + E+
Sbjct: 9 FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQK+RHPN +Q+ G + +V EY K L+ +G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+ YLH + +IHRD++ NIL + G +K+ DFG + ++ P + ++A
Sbjct: 128 LAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMA 179
Query: 323 PEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
PEV +YD KVDV+S + E+ E PP + A + P +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSG 237
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQI-----ITRLESINNSINHKRRWK 424
++ + ++ C + P RPT + + R ++ +R K
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK 287
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-57
Identities = 60/265 (22%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
D+ I G++ + G + K+L +++ ++ + E+ LL++++HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 63
Query: 211 NVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMN 264
N+V++ + ++ + IV EY GDL + + + + L +R + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 265 YLHENKPV--PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
H ++HRDL+P+N+ D N+K+ DFG++++L T Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT-PYYMS 182
Query: 323 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382
PE Y+ K D++S +L E+ PPFT E+ + Y+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR---YS 239
Query: 383 RGLKELIEECWNEKPAKRPTFRQII 407
L E+I N K RP+ +I+
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-56
Identities = 71/270 (26%), Positives = 124/270 (45%), Gaps = 20/270 (7%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+++P + + E+ G F A + + A K + + ++ + + E+ +
Sbjct: 7 DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDI 62
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L HPN+V+ L A + + I+ E+ G + A + + + L S
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+NYLH+NK IIHRDL+ NIL G++K+ADFGVS T + + + ++A
Sbjct: 123 LNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMA 178
Query: 323 PEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
PEV K+ YD K DV+S + L EM E PP + V A + P P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 378 AKLYARGLKELIEECWNEKPAKRPTFRQII 407
++ ++ K+ +++C + R T Q++
Sbjct: 239 SR-WSSNFKDFLKKCLEKNVDARWTTSQLL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 8e-56
Identities = 67/256 (26%), Positives = 126/256 (49%), Gaps = 17/256 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
EI +G+F ++VA +L + ++ +R R F++E +L+ ++HPN+V+F
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIVRFY 74
Query: 217 GA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
+ V +++VTE + G L+ +LKR +K + I +G+ +LH P
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 273 PIIHRDLEPSNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY 331
PIIHRDL+ NI +G++K+ D G++ L K + ++APE+++ +Y
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYEE-KY 189
Query: 332 DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391
D VDV++F + + EM P++ + P K+ +KE+IE
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-KVAIPEVKEIIEG 248
Query: 392 CWNEKPAKRPTFRQII 407
C + +R + + ++
Sbjct: 249 CIRQNKDERYSIKDLL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-55
Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 19/278 (6%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+D L + E+ G F +++ VAVK L E +D E
Sbjct: 3 LDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEAN 60
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
++Q++ +P +V+ +G + ++ M+V E G L +L++ +K + ++ G
Sbjct: 61 VMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRY 320
M YL E+ +HRDL N+L K++DFG+SK L E+ ++
Sbjct: 120 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
APE ++ +K DV+SF +++ E G P+ +EV +R A
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG-- 234
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
R + +L+ CW RP F + RL + +
Sbjct: 235 -CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 3e-55
Identities = 64/282 (22%), Positives = 117/282 (41%), Gaps = 21/282 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRD 199
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 2 KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 58
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
E ++ ++ +P +V+ +G V Q+ +M+V E G L FL ++ + S
Sbjct: 59 EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDT 316
++ GM YL E +HRDL N+L + K++DFG+SK L + +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFK 375
++ APE ++ ++ DV+S+ + + E + G P+ EV +R
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC- 233
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
L L+ +CW K RP F + R+ + S+
Sbjct: 234 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-54
Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 20/283 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+EI L ++ +G F + W +VA+K L +S + F E
Sbjct: 11 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 64
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIA 260
+++K+RH +VQ V++ P+ IVTEY+ KG L FLK + L+ V A IA
Sbjct: 65 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
GM Y+ +HRDL +NIL ++ KVADFG+++L+ E ++
Sbjct: 124 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
APE + K DV+SF ++L E+ +G P+ + EV R P
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-- 238
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422
L +L+ +CW ++P +RPTF + LE S + +
Sbjct: 239 -CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-54
Identities = 57/251 (22%), Positives = 118/251 (47%), Gaps = 14/251 (5%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +G A G +VA++++ + + +E+ ++++ ++PN+V +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V EYL G L + + + + +LH N+ +IH
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RD++ NIL G++K+ DFG +T ++ + + + ++APEV + Y KVD
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 337 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396
++S ++ EMIEG PP+ ++ A P + P KL + ++ + C +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL-SAIFRDFLNRCLDMD 257
Query: 397 PAKRPTFRQII 407
KR + ++++
Sbjct: 258 VEKRGSAKELL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-54
Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 52/296 (17%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF E+ G + G+ +A K + E EL +L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+V F GA + I E++ G L LK+ G + + ++ + +G+ YL E
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
I+HRD++PSNIL + G +K+ DFGVS L D + Y++PE +
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTH 179
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------------------- 371
Y + D++S L L EM G P E+ + +
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 372 ---------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
PP K P+ +++ ++ + +C + PA+R +Q+
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 9e-54
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 44/298 (14%)
Query: 162 EITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
I KG F WRG +VAVK S ++R E+ +RH N++ F+ A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV-- 272
+ + + +V++Y G L +L R + ++ AL A G+ +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 273 ---PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF 326
I HRDL+ NIL +G +AD G++ D + RY+APEV
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 327 ------KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP----------------- 363
K+ E + D+++ L+ E+ C + D ++P
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 364 -KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
R P + + R + +++ ECW A R T +I L ++ K
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (453), Expect = 1e-53
Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
++E++ ++ + ++ G + W+ + VAVK L E D V F
Sbjct: 8 NYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFL 61
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFA 256
E A++++I+HPN+VQ LG T+ P I+TE++ G+L +L + + + A
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
I+ M YL + IHRDL N L ++ +KVADFG+S+L+T
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFK 375
++ APE ++ K DV++F ++L E+ G P+ ++V + R
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ + EL+ CW P+ RP+F +I E++
Sbjct: 239 ---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 5e-53
Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 13/262 (4%)
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
P D+ + +G + LA R VAVK + + D + E+ + +
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKM 59
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
+ H NVV+F G + + + EY G+L ++ + A RF + G+ YL
Sbjct: 60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEV 325
H I HRD++P N+L D+ NLK++DFG++ + +R L + YVAPE+
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 326 FKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
K E+ VDV+S ++L M+ G P+ D+ + +++ + P K
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTYLNPWKKIDSA 235
Query: 385 LKELIEECWNEKPAKRPTFRQI 406
L+ + E P+ R T I
Sbjct: 236 PLALLHKILVENPSARITIPDI 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 6e-53
Identities = 65/277 (23%), Positives = 128/277 (46%), Gaps = 21/277 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFR 198
+YEI ++ I +G F + + VA+K + + D F
Sbjct: 1 DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFL 56
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL RK +L ++ + +A
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
++ + YL + +HRD+ N+L + +K+ DFG+S+ + +
Sbjct: 116 QLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKA 376
+++APE + + DV+ F + + E++ G PF +N+V +R P
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP- 231
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
L L+ +CW P++RP F ++ +L +I
Sbjct: 232 --PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 9e-53
Identities = 73/304 (24%), Positives = 122/304 (40%), Gaps = 47/304 (15%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-------IQVAVKKLGEEVISDDDRVR 195
++E L+F + G F + A G IQVAVK L E+ +D
Sbjct: 30 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 85
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL ++ ++ H N+V LGA T S P+ ++ EY GDL +L+ K
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L + FA +A+GM +L +HRDL N+L
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKV 202
Query: 292 LKVADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-E 349
+K+ DFG+++ + + + +++APE Y K DV+S+ ++L E+
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262
Query: 350 GCPPFT-MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
G P+ + D K + + +++ CW KRP+F + +
Sbjct: 263 GVNPYPGIPVDANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 409 RLES 412
L
Sbjct: 320 FLGC 323
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (446), Expect = 2e-52
Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 24/279 (8%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDE 200
EID + I G F + I VA+K L + + R F E
Sbjct: 22 EIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSE 77
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDI 259
+++ + HPNV+ G VT+S+P+MI+TE++ G L +FL++ G V I
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
A GM YL + +HRDL NIL + + KV+DFG+S+ L P
Sbjct: 138 AAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 319 ---RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
R+ APE + ++ + DV+S+ +++ E++ G P+ + +V A R P
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP- 253
Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
P L +L+ +CW + RP F QI+ L+ +
Sbjct: 254 --PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (449), Expect = 4e-52
Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 25/280 (8%)
Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISD 190
P+ +KH + Y+I E+ G F R G A K + SD
Sbjct: 16 PVEIKHDHVLDHYDIHE---------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKP 249
+ R E+ + +RHP +V A + M+++ E++ G+L + +
Sbjct: 67 KET---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 307
AV + + +G+ ++HEN +H DL+P NI+ S LK+ DFG++ L K+
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180
Query: 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367
+T + APEV + + D++S ++ ++ G PF ++D+E +
Sbjct: 181 SVKVTTGT--AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
+ + + K+ I + P R T Q +
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 7e-52
Identities = 66/253 (26%), Positives = 111/253 (43%), Gaps = 10/253 (3%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
+G + + + VAVK L +V+S + + F E+ + + H N+++ G V + P
Sbjct: 26 RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPP 84
Query: 225 MMIVTEYLPKGDLRAF-LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
M +VTE P G L K +G T R+A+ +A GM YL IHRDL N
Sbjct: 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARN 141
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFA 341
+L +K+ DFG+ + L +D + + + APE K + D + F
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 342 LILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
+ L EM G P+ + +++ ++ P + + ++ +CW KP R
Sbjct: 202 VTLWEMFTYGQEPWIGLNGSQILHKI-DKEGERLPRPEDC-PQDIYNVMVQCWAHKPEDR 259
Query: 401 PTFRQIITRLESI 413
PTF + L
Sbjct: 260 PTFVALRDFLLEA 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-51
Identities = 54/257 (21%), Positives = 116/257 (45%), Gaps = 13/257 (5%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + +G+F +LA + A+K L + I +++V E ++ ++ HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
V+ + Y G+L ++++ G+ + + +I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK- 127
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKNE 329
IIHRDL+P NIL ++ ++++ DFG +K+L+ + + YV+PE+ +
Sbjct: 128 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389
D+++ I+ +++ G PPF ++ + + + + P K + + ++L+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKIIKLEYDFPEKFFPK-ARDLV 241
Query: 390 EECWNEKPAKRPTFRQI 406
E+ KR ++
Sbjct: 242 EKLLVLDATKRLGCEEM 258
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 4e-51
Identities = 77/304 (25%), Positives = 125/304 (41%), Gaps = 39/304 (12%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A + VAVK L +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
A EL +L + H N+V LGA T P +++TEY GDL FL+RK
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
AL + F+ +A+GM +L IHRDL NIL K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 297 FGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
FG+++ + + + +++APE N Y + DV+S+ + L E+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES-IN 414
+ ++ +P + ++++ CW+ P KRPTF+QI+ +E I+
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHA-PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 415 NSIN 418
S N
Sbjct: 308 ESTN 311
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 1e-50
Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 15/254 (5%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G F ILA + VA+K + ++ + + + + +E+A+L KI+HPN+V
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ ++ + + G+L + KG A R + + YLH+ I+H
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVH 130
Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
RDL+P N+L D+ + ++DFG+SK+ L+ + YVAPEV + Y
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
VD +S +I ++ G PPF ++D ++ + + + K+ I
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 248
Query: 394 NEKPAKRPTFRQII 407
+ P KR T Q +
Sbjct: 249 EKDPEKRFTCEQAL 262
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (438), Expect = 1e-50
Identities = 46/254 (18%), Positives = 104/254 (40%), Gaps = 16/254 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ G F + G K + D ++E++++ ++ HP ++
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLH 92
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
A M+++ E+L G+L + + + + + + G+ ++HE+ I+
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IV 149
Query: 276 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
H D++P NI+ + ++K+ DFG++ L D + + + APE+ E
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGF 207
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
D+++ ++ ++ G PF + D E + + + K+ I+
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 267
Query: 394 NEKPAKRPTFRQII 407
++P KR T +
Sbjct: 268 QKEPRKRLTVHDAL 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-50
Identities = 76/288 (26%), Positives = 137/288 (47%), Gaps = 22/288 (7%)
Query: 143 REVPEYEIDPHELDFTNSVEITKGTF---ILAFW-----RGIQVAVKKLGEEVISDDDRV 194
+ V I P L + I +G F + I AVK L I+D V
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEV 72
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLK-RKGALKPSTA 252
F E +++ HPNV+ LG +S ++V Y+ GDLR F++
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
+ F L +A+GM +L K +HRDL N + D+ +KVADFG+++ + KE +
Sbjct: 133 IGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 313 CQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA 368
+ + +++A E + +++ TK DV+SF ++L E++ G PP+ + ++
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
+R + L E++ +CW+ K RP+F ++++R+ +I ++
Sbjct: 250 GRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (430), Expect = 6e-50
Identities = 77/306 (25%), Positives = 127/306 (41%), Gaps = 46/306 (15%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF----------ILAFWRGIQVAVKKLGEEVISDDDR 193
++ E + +++ +I +G F +L + VAVK L EE + D
Sbjct: 4 KLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADM 59
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------- 245
F+ E AL+ + +PN+V+ LG PM ++ EY+ GDL FL+
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
L + + A +A GM YL E K +HRDL N L ++
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN 176
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+K+ADFG+S+ + + D R++ PE Y T+ DV+++ ++L E+
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 349 E-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
G P+ EV + L L+ CW++ PA RP+F I
Sbjct: 237 SYGLQPYYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 408 TRLESI 413
L+ +
Sbjct: 294 RILQRM 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-49
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 23/278 (8%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
EI P + I G F + + VA+K L + + F
Sbjct: 3 EIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLG 58
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD-LRAFLKRKGALKPSTAVRFALD 258
E ++ + H N+++ G +++ PMMI+TEY+ G + ++ G V
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 316
IA GM YL +HRDL NIL + + KV+DFG+S++L + T
Sbjct: 119 IAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFK 375
R+ APE ++ + DV+SF +++ E++ G P+ ++EV KA R P
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ +L+ +CW ++ A+RP F I++ L+ +
Sbjct: 236 MD---CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 8e-49
Identities = 60/269 (22%), Positives = 114/269 (42%), Gaps = 19/269 (7%)
Query: 156 DFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
+F + G F W I VA+K+L E + + DE ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 67
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
+ +P+V + LG S+ +I L + K + + + + IA+GMNYL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEV 325
+ + ++HRDL N+L ++K+ DFG++KLL +E +++A E
Sbjct: 128 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 326 FKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
+ Y + DV+S+ + + E++ G P+ +E+ +R P +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---PICTID 241
Query: 385 LKELIEECWNEKPAKRPTFRQIITRLESI 413
+ ++ +CW RP FR++I +
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-48
Identities = 74/258 (28%), Positives = 122/258 (47%), Gaps = 14/258 (5%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRH 209
DF + KG+F LA ++ A+K L ++V+ DD V E +L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
P + + V EYL GDL ++ S A +A +I G+ +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
I++RDL+ NIL D G++K+ADFG+ K + + + T T Y+APE+ +
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT-PDYIAPEILLGQ 178
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389
+Y+ VD +SF ++L EM+ G PF + + E+ + + + P L + K+L+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSIRMDNPFYPRWL-EKEAKDLL 234
Query: 390 EECWNEKPAKRPTFRQII 407
+ + +P KR R I
Sbjct: 235 VKLFVREPEKRLGVRGDI 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (416), Expect = 3e-48
Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 15/266 (5%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G LA VAVK L ++ D FR E + HP +V
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 217 GAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
+P IV EY+ LR + +G + P A+ D + +N+ H+N
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG-- 131
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEE 330
IIHRD++P+NI+ + +KV DFG+++ + + + +Y++PE + +
Sbjct: 132 -IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
D + DV+S +L E++ G PPFT V + P A + + L ++
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 250
Query: 391 ECWNEKPAKRP-TFRQIITRLESINN 415
+ + P R T ++ L ++N
Sbjct: 251 KALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 4e-48
Identities = 78/299 (26%), Positives = 131/299 (43%), Gaps = 41/299 (13%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR---------GIQVAVKKLGEEVISDDDR 193
P +E+ L + +G F +LA +VAVK L + D
Sbjct: 6 PRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 61
Query: 194 VRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------- 245
+ E+ +++ I +H N++ LGA TQ P+ ++ EY KG+LR +L+ +
Sbjct: 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L V A +ARGM YL IHRDL N+L + +K+AD
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIAD 178
Query: 297 FGVSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPF 354
FG+++ + + T +++APE + Y + DV+SF ++L E+ G P+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
E+ K R L ++ +CW+ P++RPTF+Q++ L+ I
Sbjct: 239 PGVPVEELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-48
Identities = 43/253 (16%), Positives = 100/253 (39%), Gaps = 17/253 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
++ +G F K + + D+V + E+++L RH N++
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVL-VKKEISILNIARHRNILHLH 67
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ ++++ E++ D+ + L V + + + +LH + I
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124
Query: 276 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
H D+ P NI+ S +K+ +FG ++ L K T+ Y APEV +++ T
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
D++S ++ ++ G PF + + ++ + + + K + + ++
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242
Query: 394 NEKPAKRPTFRQI 406
++ R T +
Sbjct: 243 VKERKSRMTASEA 255
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 7e-48
Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRDEL 201
+D +++ F + I +G F + A + + A+K++ + + D R F EL
Sbjct: 6 VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGEL 61
Query: 202 ALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------------- 244
+L K+ HPN++ LGA + + EY P G+L FL++
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 245 GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
L + FA D+ARGM+YL + IHRDL NIL ++ K+ADFG+S+
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-- 176
Query: 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363
+ T R++A E Y T DV+S+ ++L E++ G P+ E+
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236
Query: 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ R + +L+ +CW EKP +RP+F QI+ L +
Sbjct: 237 EKLPQGYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (412), Expect = 1e-47
Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 23/264 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-H 209
+ +G + + AVK + + A E+ +L+K+ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN++Q ++ +V + + KG+L +L K L + + + LH+
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
I+HRDL+P NIL DD N+K+ DFG S L L + Y+APE+ +
Sbjct: 130 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEIIECS 184
Query: 330 E------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
Y +VD++S +I+ ++ G PPF + + + + Y+
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244
Query: 384 GLKELIEECWNEKPAKRPTFRQII 407
+K+L+ +P KR T + +
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEAL 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-46
Identities = 67/289 (23%), Positives = 132/289 (45%), Gaps = 32/289 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
E+E+ ++ + E+ +G+F +G+ +VA+K + E +
Sbjct: 14 EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIE 69
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------A 246
F +E +++++ +VV+ LG V+Q P +++ E + +GDL+++L+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
S ++ A +IA GM YL+ N +HRDL N + + +K+ DFG+++ +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 307 ED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPK 364
+ R R+++PE K+ + T DV+SF ++L E+ P+ + +V +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246
Query: 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
L EL+ CW P RP+F +II+ ++
Sbjct: 247 FVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-45
Identities = 60/258 (23%), Positives = 103/258 (39%), Gaps = 17/258 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDR---VRAFRDELALLQKIRHPNVV 213
E+ G F + G+Q A K + + R E+++L++I+HPNV+
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
+ ++++ E + G+L FL K +L A F I G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---Q 133
Query: 274 IIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
I H DL+P NI+ D +K+ DFG++ + + +VAPE+ E
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389
+ D++S +I ++ G PF E +A + K+ I
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 390 EECWNEKPAKRPTFRQII 407
+ P KR T + +
Sbjct: 252 RRLLVKDPKKRMTIQDSL 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (396), Expect = 2e-44
Identities = 56/259 (21%), Positives = 105/259 (40%), Gaps = 16/259 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF+ I +G F G A+K L ++ I +E L+L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P +V A + + + + GDL L + G + +A +I G+ ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF- 326
+++RDL+P+NIL D+ G+++++D G++ + + Y+APEV
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHGYMAPEVLQ 178
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386
K YD+ D FS +L +++ G PF + + + P ++ L+
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS-FSPELR 237
Query: 387 ELIEECWNEKPAKRPTFRQ 405
L+E +R
Sbjct: 238 SLLEGLLQRDVNRRLGCLG 256
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (386), Expect = 2e-43
Identities = 61/249 (24%), Positives = 113/249 (45%), Gaps = 16/249 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G+F L R G A+K L +E++ +V DE +L + HP +++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
G + + ++ +Y+ G+L + L++ A +A ++ + YLH II+
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIY 127
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+P NIL D +G++K+ DFG +K + + Y+APEV + Y+ +D
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYNKSID 183
Query: 337 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396
+SF +++ EM+ G PF + + Y + P +K+L+
Sbjct: 184 WWSFGILIYEMLAGYTPFYDSNTMKT---YEKILNAELRFPPFF-NEDVKDLLSRLITRD 239
Query: 397 PAKRPTFRQ 405
++R Q
Sbjct: 240 LSQRLGNLQ 248
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-43
Identities = 70/298 (23%), Positives = 125/298 (41%), Gaps = 35/298 (11%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDR 193
+ ++E L + +G F I A GI VAVK L E + R
Sbjct: 4 DASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 61
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRKG------- 245
+ L+ H NVV LGA T+ P+M++ E+ G+L +L+ K
Sbjct: 62 -ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L + ++ +A+GM +L K IHRDL NIL + +K+ D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICD 177
Query: 297 FGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
FG+++ + D +++APE + Y + DV+SF ++L E+
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237
Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
+ ++ +AP + + + +CW+ +P++RPTF +++ L ++
Sbjct: 238 PGVKIDEEFCRRLKEGTRMRAPDY-TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-43
Identities = 64/263 (24%), Positives = 110/263 (41%), Gaps = 30/263 (11%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+ G + F + + A+K L D +A R+ + + P++V+ +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72
Query: 218 A----VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKP 271
++IV E L G+L + ++ +G A A I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 272 VPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
I HRD++P N+L + LK+ DFG +K T LT + YVAPEV
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGP 187
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYAR---G 384
E+YD D++S +I+ ++ G PPF H + P + ++ P ++
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 385 LKELIEECWNEKPAKRPTFRQII 407
+K LI +P +R T + +
Sbjct: 248 VKMLIRNLLKTEPTQRMTITEFM 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 9e-43
Identities = 41/278 (14%), Positives = 85/278 (30%), Gaps = 27/278 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I G+F L G +VA+K + + E + + ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 217 GAV-TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ ++V E L F T + A + + Y+H I
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FI 125
Query: 276 HRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDRPLTCQDT------SCRYVAPEVF 326
HRD++P N L + + DFG++K + RY +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG-- 384
E + D+ S +L G P+ + Y P ++ +G
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 385 --LKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
+ C + + +P + + ++ +
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-41
Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 29/259 (11%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIR--HPN 211
+ G F + VA+K + ++ ISD + E+ LL+K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 212 VVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
V++ L + +++ E P DL F+ +GAL+ A F + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 271 PVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
++HRD++ NIL D + G LK+ DFG LL +D T D + Y PE +
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYH 184
Query: 330 EYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388
Y + V+S ++L +M+ G PF +HD E+ R + F+ + + L
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-----IRGQVFFRQR---VSSECQHL 234
Query: 389 IEECWNEKPAKRPTFRQII 407
I C +P+ RPTF +I
Sbjct: 235 IRWCLALRPSDRPTFEEIQ 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-40
Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 13/255 (5%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + KGTF IL + G A+K L +EVI D V E +LQ RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+ A + V EY G+L L R+ A + +I + YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
+++RD++ N++ D G++K+ DFG+ K + + + Y+APEV ++ +
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDND 181
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
Y VD + +++ EM+ G PF + + + + P L + K L+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILMEEIRFPRTL-SPEAKSLLA 237
Query: 391 ECWNEKPAKRPTFRQ 405
+ P +R
Sbjct: 238 GLLKKDPKQRLGGGP 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-40
Identities = 64/276 (23%), Positives = 107/276 (38%), Gaps = 34/276 (12%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215
+ +G F A + VA+KK+ G + D R E+ LLQ++ HPN++
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
L A S + +V +++ L PS + L +G+ YLH++ I+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WIL 122
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
HRDL+P+N+L D++G LK+ADFG++K T +F Y V
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 336 DVFSFALILQEMIEGCPPFTMKHDNEVPKA------------------------YAARQR 371
D+++ IL E++ P D + + +
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
P L +LI+ + P R T Q +
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (351), Expect = 1e-38
Identities = 42/279 (15%), Positives = 83/279 (29%), Gaps = 27/279 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
I +G+F QVA+K SD ++R LL V +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
G + ++V + L T A + + +HE +++
Sbjct: 70 G--QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 124
Query: 277 RDLEPSNILRDD-----SGNLKVADFGVSKLLTVKEDRPLTCQDT------SCRYVAPEV 325
RD++P N L + + V DFG+ K + + RY++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA----ARQRPPFKAPAKLY 381
E + D+ + + + G P+ + Y +Q P + +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 244
Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
+ + N P + + + +N
Sbjct: 245 PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 3e-38
Identities = 59/249 (23%), Positives = 112/249 (44%), Gaps = 16/249 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G+F +L + G A+K L ++ + ++ +E +LQ + P +V+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ +S + +V EY+ G++ + L+R G A +A I YLH +I+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+P N+L D G ++V DFG +K + + +APE+ ++ Y+ VD
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 337 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396
++ +++ EM G PPF ++ Y + P+ ++ LK+L+
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQI---YEKIVSGKVRFPSH-FSSDLKDLLRNLLQVD 276
Query: 397 PAKRPTFRQ 405
KR +
Sbjct: 277 LTKRFGNLK 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (347), Expect = 3e-38
Identities = 59/275 (21%), Positives = 119/275 (43%), Gaps = 33/275 (12%)
Query: 162 EITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+I +GT+ A G A+KK+ E + R E+++L++++H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYD 67
Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
+ +++V E+L + + +G L+ TA F L + G+ Y H+ + ++HR
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
DL+P N+L + G LK+ADFG+++ + + T + +++Y T +D+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 338 FSFALILQEMIEGCPPFTMKHDNEV-------------------------PKAYAARQRP 372
+S I EM+ G P F + + + +
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244
Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
P+++ K +L+ + P +R T +Q +
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-37
Identities = 55/245 (22%), Positives = 104/245 (42%), Gaps = 7/245 (2%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH-PNVVQFLGAVTQS 222
I G A+K L + I + R E +L+ IR P +V A
Sbjct: 42 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ + ++ +Y+ G+L L ++ + +I + +LH+ II+RD++
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE 158
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSF 340
NIL D +G++ + DFG+SK E + Y+AP++ + + +D VD +S
Sbjct: 159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218
Query: 341 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
+++ E++ G PFT+ + + R + + K+LI+ + P KR
Sbjct: 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 278
Query: 401 PTFRQ 405
Sbjct: 279 LGCGP 283
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-37
Identities = 58/290 (20%), Positives = 109/290 (37%), Gaps = 49/290 (16%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +GTF A R G +VA+KK+ E + + A R E+ +LQ ++H NVV +
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 75
Query: 217 GAVTQSSP--------MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
+ + +V ++ S R + G+ Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEV 325
NK I+HRD++ +N+L G LK+ADFG+++ ++ ++ Y PE+
Sbjct: 136 NK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 326 FKNE-EYDTKVDVFSFALILQEMIEGCPPFT----------------------------M 356
E +Y +D++ I+ EM P
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 357 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
+ ++ +++ + A + +LI++ PA+R
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 3e-36
Identities = 61/300 (20%), Positives = 123/300 (41%), Gaps = 39/300 (13%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
+F +I +GT+ A + G VA+KK+ + ++ A R E++LL+++ HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN 269
N+V+ L + + + +V E+L + + + + + +G+ + H +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
++HRDL+P N+L + G +K+ADFG+++ R T + + Y APE+
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGC 177
Query: 330 EY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEV-------------------------P 363
+Y T VD++S I EM+ F + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINNSINHKR 421
++ R F + L+ + + P KR + + + + + + H R
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-36
Identities = 65/296 (21%), Positives = 112/296 (37%), Gaps = 51/296 (17%)
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
P E+ +T++ I G+F A G VA+KK+ R EL +++K
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFAL 257
+ H N+V+ S + +V +Y+P+ R + + K L +
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+ R + Y+H I HRD++P N+ L D+ LK+ DFG +K L V+ + ++ +
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICS 185
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF-------------------TMK 357
+F +Y + +DV+S +L E++ G P F T +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 358 HDNEVPKAYAARQRPPFKAPAKLYARG------LKELIEECWNEKPAKRPTFRQII 407
E+ Y + P KA L P R T +
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-35
Identities = 66/283 (23%), Positives = 113/283 (39%), Gaps = 42/283 (14%)
Query: 162 EITKGTF---ILAFWR---GIQVAVKKLGEEVISDDDRVRAFR--DELALLQKIRHPNVV 213
EI +G + A G VA+K++ + + + R L L+ HPNVV
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 214 QFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLH 267
+ T S + +V E++ + K + T + RG+++LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
++ ++HRDL+P NIL SG +K+ADFG++++ + + + Y APEV
Sbjct: 134 SHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL 188
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-----------------------PK 364
Y T VD++S I EM P F D + +
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
A+ ++ P + K+L+ +C PAKR + +
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-35
Identities = 63/299 (21%), Positives = 118/299 (39%), Gaps = 48/299 (16%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+++ P +TN I +G + A+ ++VA+KK+ + E+
Sbjct: 4 FDVGPR---YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIK 58
Query: 203 LLQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
+L + RH N++ + + + + +L DL LK + L F
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--T 316
I RG+ Y+H ++HRDL+PSN+L + + +LK+ DFG++++ D +
Sbjct: 118 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 317 SCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV------------- 362
+ Y APE+ N + T +D++S IL EM+ P F KH +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 363 --------------PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
+ + + P+ +L+++ P KR Q +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-34
Identities = 55/276 (19%), Positives = 110/276 (39%), Gaps = 35/276 (12%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +GT+ A R VA+K++ + + A R E+ LL++++H N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLH 67
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V E+ + + F G L P F + +G+ + H ++H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+P N+L + +G LK+A+FG+++ + T +F + Y T +D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 337 VFSFALILQEMIEGCPPFTMKHDNE--------------------VPKAYAARQRPPFKA 376
++S I E+ P +D + + K + P + A
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 377 PAKLYARG------LKELIEECWNEKPAKRPTFRQI 406
L ++L++ P +R + +
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-31
Identities = 66/302 (21%), Positives = 109/302 (36%), Gaps = 53/302 (17%)
Query: 148 YEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
E+ + + G + A G +VA+KKL S+ RA+R
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEYLPKGDLRAFLKRKGALKPSTA 252
EL LL+ +RH NV+ L T + +V ++ G L + L
Sbjct: 67 -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRI 123
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
+ +G+ Y+H IHRDL+P N+ ++ LK+ DFG+++ + D +T
Sbjct: 124 QFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMT 176
Query: 313 CQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-------- 363
+ Y APEV N Y VD++S I+ EMI G F +
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 364 -------------------KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
K ++ F + + L+E+ +R T
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 405 QI 406
+
Sbjct: 297 EA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (294), Expect = 3e-30
Identities = 53/319 (16%), Positives = 113/319 (35%), Gaps = 62/319 (19%)
Query: 137 MHVKHAREVPEYEIDPHELDFTNS------VEITKGTF---ILAFWR--GIQVAVKKLGE 185
V R ++ + H +++ N ++ +G + A +V VK L
Sbjct: 11 TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-- 68
Query: 186 EVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLK 242
+ + + E+ +L+ +R PN++ V S +V E++ D + +
Sbjct: 69 ----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSK 301
L + +I + ++Y H I+HRD++P N++ D + L++ D+G+++
Sbjct: 125 T---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178
Query: 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN- 360
++ + + + + YD +D++S +L MI PF HDN
Sbjct: 179 FYHPGQEYNVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
Query: 361 ----------------EVPKAYAARQRPPFKAPAKLYARG-----------------LKE 387
+ Y P F ++R +
Sbjct: 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297
Query: 388 LIEECWNEKPAKRPTFRQI 406
+++ R T R+
Sbjct: 298 FLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 6e-27
Identities = 62/281 (22%), Positives = 99/281 (35%), Gaps = 43/281 (15%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G + AF G++VAVKKL S R +R EL LL+ ++H NV+ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 217 GAVTQSSPMMIVTEYL----PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
T + + + G + + L I RG+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 141
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
IIHRDL+PSN+ ++ LK+ DFG+++ +D T + Y+
Sbjct: 142 -IIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYN 197
Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG-------- 384
VD++S I+ E++ G F + K P K +
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257
Query: 385 -------------------LKELIEECWNEKPAKRPTFRQI 406
+L+E+ KR T Q
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-26
Identities = 64/295 (21%), Positives = 101/295 (34%), Gaps = 58/295 (19%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
I G A+ VA+KKL + RA+R EL L++ + H N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLL 82
Query: 217 GAVTQSSPMM------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
T + +V E + + + G+ +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSA- 138
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
IIHRDL+PSNI+ LK+ DFG+++ T +T + Y APEV
Sbjct: 139 --GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---------------------------- 362
Y VD++S I+ EM+ F + +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 363 ----------PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
PK + P KL A ++L+ + PAKR + +
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.4 bits (236), Expect = 4e-22
Identities = 36/145 (24%), Positives = 57/145 (39%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + +K LL G N ++ T LH+AA G TEV LL+ A V+ K
Sbjct: 4 LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 63
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEI 163
+ TPL A + ++KLL ++ A P +A + E + E
Sbjct: 64 KDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEA 123
Query: 164 TKGTFILAFWRGIQVAVKKLGEEVI 188
++ + + VA K V
Sbjct: 124 SQACMTKKGFTPLHVAAKYGKVRVA 148
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.3 bits (189), Expect = 5e-16
Identities = 33/119 (27%), Positives = 53/119 (44%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
+G+ D L ++ +++ +K LL DVN + + LH AA QG T++
Sbjct: 286 HGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDI 345
Query: 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPE 147
V+LLL+ GA + G+TPL A V +L+ + + KH PE
Sbjct: 346 VTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHRMSFPE 404
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.3 bits (176), Expect = 2e-14
Identities = 35/152 (23%), Positives = 56/152 (36%), Gaps = 12/152 (7%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK--- 131
T LHVA+ G +V LL+RGA + + TPL A + EV K L ++ AK
Sbjct: 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNA 61
Query: 132 -------PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
PL + H + + ++ + + + +A G V L
Sbjct: 62 KAKDDQTPLHCAARIGH-TNMVKLLLE-NNANPNLATTAGHTPLHIAAREGHVETVLALL 119
Query: 185 EEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ S + L + K V + L
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELL 151
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.6 bits (169), Expect = 2e-13
Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 17/217 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ + +G L A + VE + LL G N + T LH+AA +
Sbjct: 187 RGGSPHSPAWNGY-----TPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQE 241
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PL 133
G E+V+LLL + A+ + ++ G TPL + V +L KHG PL
Sbjct: 242 GHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPL 301
Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 193
H + + V +++ + + A +G V L + S ++
Sbjct: 302 HVASHYGNIKLVKFLLQHQADVNAKTKLGYS--PLHQAAQQGHTDIVTLLLKNGASPNEV 359
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
LA+ +++ + +V L VT + ++V++
Sbjct: 360 SSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 396
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.2 bits (160), Expect = 2e-12
Identities = 41/182 (22%), Positives = 55/182 (30%), Gaps = 12/182 (6%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V + LL+ N + T LHVA ++V LLL RG
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 195
Query: 104 RWGSTPLGDAIYYKNHEVIKLL----------EKHGAKPLMAPMHVKHAREVPEYEIDPH 153
G TPL A EV + L G PL HA V
Sbjct: 196 WNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQA 255
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
+ N +T L G L + + D R L + + +V
Sbjct: 256 NGNLGNKSGLT--PLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLV 313
Query: 214 QF 215
+F
Sbjct: 314 KF 315
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.0 bits (157), Expect = 5e-12
Identities = 36/143 (25%), Positives = 47/143 (32%), Gaps = 38/143 (26%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
++ A N + E L A E K LL + VN + D++T LH AA
Sbjct: 21 QRGASPNVSNVKVETP-----LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAAR 75
Query: 83 QGFTEVVSLLLER---------------------------------GADVDPKDRWGSTP 109
G T +V LLLE A + G TP
Sbjct: 76 IGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTP 135
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A Y V +LL + A P
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHP 158
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.7 bits (151), Expect = 2e-11
Identities = 40/164 (24%), Positives = 63/164 (38%), Gaps = 8/164 (4%)
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ T LHVAA G V LLLER A + + G TPL A+++ N +
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLD 179
Query: 121 VIKLLEKHGAKPL------MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGT--FILAF 172
++KLL G P P+H+ + E + + + E +G LA
Sbjct: 180 IVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAA 239
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
G V L + + + ++ L L+ + H V L
Sbjct: 240 QEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVL 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 9e-20
Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 2/112 (1%)
Query: 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
+ A++N D+ G + + LLD G DVN R +T L +A
Sbjct: 169 DEMGADVNACDNMGRNALIHAL-LSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227
Query: 82 CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +V LLE+ +++ D G T L A+ K ++ +LL K GA
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.2 bits (168), Expect = 9e-14
Identities = 21/79 (26%), Positives = 39/79 (49%), Gaps = 6/79 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A++N + G+ L+ ++ + ++ LL+ I++N D D +TAL +A
Sbjct: 210 ADVNVRGERGKTP-----LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264
Query: 85 FTEVVSLLLERGADVDPKD 103
++ LL +RGA D D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (134), Expect = 2e-09
Identities = 20/72 (27%), Positives = 39/72 (54%), Gaps = 1/72 (1%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYYKNHEVIKLLEKHG 129
+++ L A ++V LLE GA+V+ ++ G TPL +A+ ++++LL +HG
Sbjct: 3 VEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHG 62
Query: 130 AKPLMAPMHVKH 141
A P++ +
Sbjct: 63 ADPVLRKKNGAT 74
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (124), Expect = 3e-08
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 1/96 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ DV+ +++LL+ G +VNF++ + T LH A ++V LLL GAD +
Sbjct: 9 LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
+ G+TP A + +++KL GA +
Sbjct: 69 KKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFY 104
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (117), Expect = 3e-07
Identities = 24/72 (33%), Positives = 31/72 (43%), Gaps = 5/72 (6%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----E 120
TAL AA +G EV+ +LL E GADV+ D G L A+ +
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200
Query: 121 VIKLLEKHGAKP 132
+ LL HGA
Sbjct: 201 ITHLLLDHGADV 212
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.2 bits (204), Expect = 4e-18
Identities = 54/291 (18%), Positives = 95/291 (32%), Gaps = 45/291 (15%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
++ G F LA VA+K + D A DE+ LLQ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 217 GAVTQ---------------SSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIA 260
+++V E L + L K + P + + +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSG------NLKVADFGVSKLLTVKEDRPLTCQ 314
G++Y+H IIH D++P N+L + +K+AD G + D T
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEHYTNS 189
Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR--- 371
+ Y +PEV + D++S A ++ E+I G F + K +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 372 -----PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
P + Y R N K ++T +
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 77.1 bits (188), Expect = 2e-16
Identities = 18/65 (27%), Positives = 35/65 (53%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G + + +D D +T + +AA +G EVV L+++GA V+ D T A +H ++
Sbjct: 211 GSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIV 270
Query: 123 KLLEK 127
+ ++
Sbjct: 271 DIFDR 275
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 60.5 bits (145), Expect = 6e-11
Identities = 28/110 (25%), Positives = 39/110 (35%), Gaps = 10/110 (9%)
Query: 41 EFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLL------ 93
E + I E + VN D NRT LH A E L+
Sbjct: 1 ESPIKLHTEAAGSYAITEPITR-ESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKE 59
Query: 94 --ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
GADV+ D +TPL A+ + ++ L K GA P + +
Sbjct: 60 CIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERS 109
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 55.5 bits (132), Expect = 3e-09
Identities = 12/51 (23%), Positives = 20/51 (39%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
+M A E +E + L+ G V D + TA +A +V +
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDR 275
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 45.1 bits (105), Expect = 7e-06
Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 1/71 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+ RTALH AA V L+ E+G++ D +D G TP+ A EV
Sbjct: 177 AARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEV 236
Query: 122 IKLLEKHGAKP 132
+ L + GA
Sbjct: 237 VMYLIQQGASV 247
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 36.6 bits (83), Expect = 0.004
Identities = 18/88 (20%), Positives = 35/88 (39%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
KE + +G DVN D D T L +A +V+ L++ GAD ++ + L A
Sbjct: 55 HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 114
Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
++ ++ + ++
Sbjct: 115 AANRDFGMMVYMLNSTKLKGDIEELDRN 142
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 71.5 bits (174), Expect = 2e-14
Identities = 15/82 (18%), Positives = 25/82 (30%), Gaps = 2/82 (2%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR--WGSTPL 110
++ + LL S V +N A +AA G V++ L E
Sbjct: 106 LDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAF 165
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
A + V+ L +
Sbjct: 166 RLAAENGHLHVLNRLCELAPTE 187
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 61.8 bits (149), Expect = 4e-11
Identities = 13/83 (15%), Positives = 22/83 (26%), Gaps = 3/83 (3%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADVDPKDRWGS 107
+ D + + I + VAA G + + LLL V
Sbjct: 68 YYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENY 127
Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
A + V+ L +
Sbjct: 128 QAFRLAAENGHLHVLNRLCELAP 150
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 56.4 bits (135), Expect = 2e-09
Identities = 27/166 (16%), Positives = 48/166 (28%), Gaps = 13/166 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID--NRTALHVAA 81
+ + + + + A + + L + I N A +AA
Sbjct: 115 SDEIVKVIQAENYQA-----FRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAA 169
Query: 82 CQGFTEVVSLLLERGADVD---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
G V++ L E + A+ +H VI L A +
Sbjct: 170 ENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEI- 228
Query: 139 VKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
H E E ++P N ++ F L+ G+ V K
Sbjct: 229 --HEFEYGEKYVNPFIARHVNRLKEMHDAFKLSNPDGVFDLVTKSE 272
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 46.4 bits (109), Expect = 4e-06
Identities = 10/77 (12%), Positives = 20/77 (25%), Gaps = 7/77 (9%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-----GST 108
+G+ +L+ + L + + + LL +
Sbjct: 262 DGVFDLVTK--SECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 319
Query: 109 PLGDAIYYKNHEVIKLL 125
L A+ N LL
Sbjct: 320 LLRLALRLGNQGACALL 336
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 43.3 bits (101), Expect = 3e-05
Identities = 12/56 (21%), Positives = 19/56 (33%), Gaps = 5/56 (8%)
Query: 44 LMFLANERDVEGIKELLDSG-----IDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
L+ +E ++ I+ LL D L +A G +LLL
Sbjct: 283 LIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQGACALLLS 338
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 70.1 bits (170), Expect = 5e-14
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + E +K L+ + DVN +D D T LH AA G E +L+E D++ +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ G T + +++ LE+ K
Sbjct: 263 KVGQTAF----DVADEDILGYLEELQKK 286
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 59.3 bits (142), Expect = 2e-10
Identities = 27/115 (23%), Positives = 41/115 (35%), Gaps = 9/115 (7%)
Query: 48 ANERDVEGIKELLDSGIDVNFR---------DIDNRTALHVAACQGFTEVVSLLLERGAD 98
A ++ E +K + S D+ D+ A G TE V LLERGAD
Sbjct: 6 AKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGAD 65
Query: 99 VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPH 153
++ + G T L A N +++K L ++GA
Sbjct: 66 INYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLD 120
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 56.7 bits (135), Expect = 2e-09
Identities = 26/74 (35%), Positives = 39/74 (52%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
L I+ TALHVAA +G+TEV+ LL++ DV+ KD G TPL A ++
Sbjct: 185 LNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGK 244
Query: 119 HEVIKLLEKHGAKP 132
E ++L ++
Sbjct: 245 EEACRILVENLCDM 258
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 48.2 bits (113), Expect = 8e-07
Identities = 34/175 (19%), Positives = 65/175 (37%), Gaps = 2/175 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + D E + LL+ G D+N+ ++D TALH A ++V L+E GA+++ D
Sbjct: 44 FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPD 103
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM--HVKHAREVPEYEIDPHELDFTNSV 161
G PL A ++ + L GA E + + +
Sbjct: 104 NEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQG 163
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ ++ A + L I+D ++ L + + V++ L
Sbjct: 164 VDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLL 218
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 66.7 bits (161), Expect = 4e-13
Identities = 24/65 (36%), Positives = 31/65 (47%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
RT LH+A V+ LLL+ GAD + G TPLG A+ N + +LL
Sbjct: 186 KPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLR 245
Query: 127 KHGAK 131
HGA
Sbjct: 246 AHGAP 250
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 62.4 bits (150), Expect = 1e-11
Identities = 15/59 (25%), Positives = 23/59 (38%), Gaps = 1/59 (1%)
Query: 45 MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ ++ LL +G D R RT L A + + LL GA +P+D
Sbjct: 197 HLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP-EPED 254
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 57.4 bits (137), Expect = 5e-10
Identities = 19/78 (24%), Positives = 28/78 (35%), Gaps = 3/78 (3%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGAD---VDPKDRWGSTPLGDAIYYKNHEVIK 123
+ D TALH+A + LL A +D ++ G T L A ++
Sbjct: 3 GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVE 62
Query: 124 LLEKHGAKPLMAPMHVKH 141
L GA L+A
Sbjct: 63 KLYAAGAGVLVAERGGHT 80
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 51.6 bits (122), Expect = 5e-08
Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)
Query: 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
+ +DG+ L + + LL ++ ++ +TALH+AA G
Sbjct: 2 FGYVTEDGDTA-----LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V L GA V +R G T L A + H +L +
Sbjct: 57 EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 66.6 bits (161), Expect = 7e-13
Identities = 16/58 (27%), Positives = 28/58 (48%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+E + +N +D + T L++AA G +V LL+ GAD ++ G P+
Sbjct: 239 LENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 296
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.1 bits (144), Expect = 1e-10
Identities = 19/129 (14%), Positives = 45/129 (34%), Gaps = 2/129 (1%)
Query: 2 ETKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD 61
E K+ + L + + + + E + ++ + ++ + +
Sbjct: 34 EQKMKLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFP 93
Query: 62 -SGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
+ +++N D T LH E+V L++ G++ D G + L A+ N+
Sbjct: 94 NTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNN 153
Query: 120 EVIKLLEKH 128
E
Sbjct: 154 YDSGTFEAL 162
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 52.0 bits (123), Expect = 4e-08
Identities = 11/77 (14%), Positives = 26/77 (33%), Gaps = 3/77 (3%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER---GADVDPKDRWGSTPLGDAIY 115
+ + + + + + ++ L + ++ +D G T L A
Sbjct: 209 VKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAAR 268
Query: 116 YKNHEVIKLLEKHGAKP 132
N ++ L +GA P
Sbjct: 269 LGNISIVDALLDYGADP 285
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.6 bits (122), Expect = 6e-08
Identities = 28/132 (21%), Positives = 48/132 (36%), Gaps = 5/132 (3%)
Query: 6 PVRTT---LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS 62
P+ T L +P + K ++D+ +++K E L L E L +
Sbjct: 2 PIITFTHDLTSDFLSSPLKIMKALPSPVVNDNEQKMKLEAFLQRLLFPEIQEMPTSLNND 61
Query: 63 GIDVNFRDIDNRTALHVAACQGFT-EVVSLLLERGADVD-PKDRWGSTPLGDAIYYKNHE 120
+ N + + EV +++ P D G+TPL N E
Sbjct: 62 SSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLE 121
Query: 121 VIKLLEKHGAKP 132
++K L KHG+
Sbjct: 122 LVKHLVKHGSNR 133
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 12/57 (21%), Positives = 19/57 (33%), Gaps = 5/57 (8%)
Query: 25 EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
LN D +G+ L A ++ + LLD G D + + A
Sbjct: 249 ANMLNAQDSNGDTC-----LNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 64.0 bits (154), Expect = 2e-12
Identities = 25/104 (24%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
+A++N D+ G+ L + A + E + LL + + +D + T L +AA
Sbjct: 111 TADADINAADNSGKTA-----LHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAR 165
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+G E LL+ A+ + D P A +H++++LL+
Sbjct: 166 EGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLLD 209
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.5 bits (111), Expect = 8e-07
Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 1/56 (1%)
Query: 87 EVVSLLLERGADVDPK-DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
+V+S LL +GA+++ D+ G T L A + + K L GA +
Sbjct: 3 QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRT 58
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.7 bits (109), Expect = 1e-06
Identities = 26/76 (34%), Positives = 39/76 (51%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
++L+ + D+N D +TALH AA TE V++LL A+ D +D TPL A
Sbjct: 107 EDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAARE 166
Query: 117 KNHEVIKLLEKHGAKP 132
++E K L + A
Sbjct: 167 GSYEASKALLDNFANR 182
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.9 bits (107), Expect = 3e-06
Identities = 12/40 (30%), Positives = 19/40 (47%), Gaps = 1/40 (2%)
Query: 54 EGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLL 92
+ I +LL G ++N D T+LH+AA + L
Sbjct: 3 QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.4 bits (153), Expect = 3e-12
Identities = 32/123 (26%), Positives = 46/123 (37%), Gaps = 34/123 (27%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG------------------ 84
+ LA +E +KE + + D D+RTALH A G
Sbjct: 7 VCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 66
Query: 85 ---------------FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
E+V LL +GA V+ ++ G TPL A HE+ +L + G
Sbjct: 67 DDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGG 126
Query: 130 AKP 132
A P
Sbjct: 127 ANP 129
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.1 bits (152), Expect = 5e-12
Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N ++ +G L + A++ E LL+ G + + +D TA+H AA +G
Sbjct: 94 AQVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+++ +LL A + +D G+TPL A + E KLL GA
Sbjct: 149 LKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASI 195
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (143), Expect = 7e-11
Identities = 24/70 (34%), Positives = 37/70 (52%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
LL G VN + + T LH AA + E+ +LLE GA+ D KD + +T + A N
Sbjct: 89 LLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148
Query: 119 HEVIKLLEKH 128
++I +L +
Sbjct: 149 LKMIHILLYY 158
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (118), Expect = 1e-07
Identities = 13/52 (25%), Positives = 23/52 (44%), Gaps = 1/52 (1%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
L +E VE K L+ G + + + +T L VA G ++ ++E
Sbjct: 172 PLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMVE 222
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.001
Identities = 8/48 (16%), Positives = 15/48 (31%), Gaps = 1/48 (2%)
Query: 73 NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
+ + A G E+ +L + D+ T L A +
Sbjct: 3 SNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHT 50
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 60.8 bits (146), Expect = 9e-12
Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 42/140 (30%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAA---CQGFTEVVSLLL 93
L RD+ G+ + G+D+ + + TALH+A + +V L+
Sbjct: 9 SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLV 68
Query: 94 ERGADVDPK---------------------------------DRWGSTPLGDAIYYKNHE 120
+ ++D + + G TPL A K+
Sbjct: 69 QNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEH 128
Query: 121 VIKLLEKHGAKPLMAPMHVK 140
+LL + + + +HV+
Sbjct: 129 CEELLTQALSGRFNSHVHVE 148
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 43.0 bits (100), Expect = 1e-05
Identities = 15/129 (11%), Positives = 30/129 (23%), Gaps = 12/129 (9%)
Query: 72 DNRTALHV---AACQGFTEVVSLLLERGADVDPK------DRWGSTPLGDAIYYKNH--- 119
D LH A + G D+ K T L A+ +
Sbjct: 2 DTAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSL 61
Query: 120 EVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVA 179
++ L ++ A + L + + + + +A
Sbjct: 62 HIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA 121
Query: 180 VKKLGEEVI 188
+ E
Sbjct: 122 KRLKHEHCE 130
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (148), Expect = 1e-11
Identities = 21/82 (25%), Positives = 38/82 (46%)
Query: 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP 101
L+ + ++ LL G +VN + +ALH A+ +G +V L+ GAD
Sbjct: 146 SPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSL 205
Query: 102 KDRWGSTPLGDAIYYKNHEVIK 123
K+ TPL A + ++++
Sbjct: 206 KNCHNDTPLMVARSRRVIDILR 227
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (125), Expect = 1e-08
Identities = 15/52 (28%), Positives = 22/52 (42%), Gaps = 4/52 (7%)
Query: 72 DNRTALHVAACQGFTEVVSLLL----ERGADVDPKDRWGSTPLGDAIYYKNH 119
D T LH+A QG V L+ + G ++D + TPL A+
Sbjct: 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLP 53
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 5e-05
Identities = 20/102 (19%), Positives = 40/102 (39%), Gaps = 4/102 (3%)
Query: 44 LMFLANERDVEGIKELLD----SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
L + ++ + L++ G +++ + +T LH+A VV LL+ GA
Sbjct: 7 LHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP 66
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
DR G T A +++ ++ L A + +
Sbjct: 67 MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNY 108
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.4 bits (82), Expect = 0.004
Identities = 17/66 (25%), Positives = 28/66 (42%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
R+ L A +V LLL+ GA+V+ + GS+ L A +++ L
Sbjct: 138 AVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLV 197
Query: 127 KHGAKP 132
+ GA
Sbjct: 198 RSGADS 203
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 58.6 bits (141), Expect = 8e-11
Identities = 29/191 (15%), Positives = 61/191 (31%), Gaps = 37/191 (19%)
Query: 174 RGIQVAVKKLGEEVISDDD---------------RVRAFRDELALLQKIRHPNVVQFLGA 218
+ + VK S +R+ R+E LQK++ V +
Sbjct: 23 KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
++ E + +L + I + + I+H D
Sbjct: 83 ----EGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHR---GIVHGD 128
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L N+L + G + + DF S + + R + +D + + Y T+ D+
Sbjct: 129 LSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN----IITYFSRTYRTEKDIN 183
Query: 339 SFALILQEMIE 349
S + +++
Sbjct: 184 S---AIDRILQ 191
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.0 bits (138), Expect = 3e-10
Identities = 19/67 (28%), Positives = 31/67 (46%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+ RTALH+A ++VSLLL+ GADV+ G +P + + + L
Sbjct: 139 AQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLG 198
Query: 127 KHGAKPL 133
+ + L
Sbjct: 199 QLTLENL 205
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.6 bits (124), Expect = 2e-08
Identities = 9/55 (16%), Positives = 20/55 (36%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
L + ++ + + LL G DVN + + + T + L + +
Sbjct: 149 LHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (121), Expect = 5e-08
Identities = 11/52 (21%), Positives = 20/52 (38%), Gaps = 4/52 (7%)
Query: 72 DNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
D + LH+A EV+ + A ++ ++ TPL A+
Sbjct: 1 DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQP 52
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 54.8 bits (130), Expect = 3e-09
Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKL 124
VN++D T L A +G + LL+E+ GA+ D D G+ A+ N +V K
Sbjct: 165 VNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKF 221
Query: 125 LEKHGA 130
+
Sbjct: 222 FLNNVV 227
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 53.7 bits (127), Expect = 8e-09
Identities = 14/68 (20%), Positives = 25/68 (36%), Gaps = 1/68 (1%)
Query: 75 TALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
LH A + V LL + + + KD+ G PL ++ ++ HE+ L
Sbjct: 2 YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVN 61
Query: 134 MAPMHVKH 141
+
Sbjct: 62 LDDYPDDS 69
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 49.8 bits (117), Expect = 1e-07
Identities = 10/55 (18%), Positives = 17/55 (30%), Gaps = 4/55 (7%)
Query: 45 MFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
E + L++ G + + D A VA + +V L D
Sbjct: 177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNE---QVKKFFLNNVVD 228
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 45.2 bits (105), Expect = 6e-06
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 45 MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-VDPKD 103
++ E + L+++G V +D N+ LH AA G +++ LL G V+ +D
Sbjct: 110 HLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQD 169
Query: 104 RWGSTPLGDAIYYKNHEVIK-LLEKHGAKP 132
+ G TPL A+ + + L+EK+GA+
Sbjct: 170 KQGWTPLFHALAEGHGDAAVLLVEKYGAEY 199
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 44.8 bits (104), Expect = 6e-06
Identities = 19/99 (19%), Positives = 39/99 (39%), Gaps = 1/99 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L E + ++ELL S + +D D R LH + E+ S LL + +V+
Sbjct: 4 LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 63
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
D + + +++++ +PL ++
Sbjct: 64 DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKIT 102
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (114), Expect = 1e-07
Identities = 9/32 (28%), Positives = 18/32 (56%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
L AA +G E ++ LL+ +V+ ++ +G
Sbjct: 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFG 34
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 4e-06
Identities = 12/31 (38%), Positives = 15/31 (48%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERG 96
V R+ TA +A G EVVSL+ G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 2e-04
Identities = 9/31 (29%), Positives = 16/31 (51%)
Query: 99 VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
V ++ G T A Y +EV+ L++ +G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 47.5 bits (111), Expect = 4e-07
Identities = 23/64 (35%), Positives = 36/64 (56%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVN +D+ TALH A EVV LL++ GADV + ++ T +I N ++
Sbjct: 90 GADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLA 149
Query: 123 KLLE 126
++L+
Sbjct: 150 EILQ 153
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.0 bits (94), Expect = 5e-05
Identities = 12/64 (18%), Positives = 29/64 (45%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
+G D + +++ L + E ++ L+ G DV+ + +TA ++ G ++
Sbjct: 89 HGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDL 148
Query: 89 VSLL 92
+L
Sbjct: 149 AEIL 152
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.5 bits (90), Expect = 2e-04
Identities = 15/48 (31%), Positives = 21/48 (43%), Gaps = 1/48 (2%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
D L AA G + V +L+ GA D G++PL A Y +
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHF 47
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.1 bits (110), Expect = 5e-07
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 1/66 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVN D +H+A +G T VVS L +D+ +D G TPL A+ +++
Sbjct: 91 GADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLV 149
Query: 123 KLLEKH 128
+L+ H
Sbjct: 150 DILQGH 155
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 2e-04
Identities = 13/46 (28%), Positives = 19/46 (41%), Gaps = 1/46 (2%)
Query: 75 TALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNH 119
L AA +G + V LL R D +R+G T L ++
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSTA 49
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 2e-04
Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 3/47 (6%)
Query: 56 IKELLDSGIDVNFRDI-DNRTA--LHVAACQGFTEVVSLLLERGADV 99
K L++SG V D +TA +G+T+ L +
Sbjct: 83 CKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 129
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (82), Expect = 0.001
Identities = 20/114 (17%), Positives = 33/114 (28%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
L AA +G E V LLE GA+ + + +G P+ + LL
Sbjct: 5 DWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMMGSARVAELLLLHGAEPNCA 64
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVI 188
P + E L + + +A + +V
Sbjct: 65 DPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVA 118
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 447 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.88 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.86 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.82 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.82 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.8 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.79 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.79 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.79 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.74 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.73 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.73 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.73 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.73 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.72 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.72 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.72 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.71 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.71 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.71 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.69 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.69 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.68 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.67 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.67 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.66 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.66 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.65 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.64 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.63 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.63 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.63 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.62 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.59 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.59 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.57 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.51 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.47 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.94 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 89.06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=396.63 Aligned_cols=265 Identities=28% Similarity=0.470 Sum_probs=215.3
Q ss_pred CcccCCCCcCcccceeeecceEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
+|||++. +|...+.||+|+||.|+. .+..||||+++.... .....+.+.+|+.++++++||||+++++++.+ +.
T Consensus 2 dwei~~~--~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~ 77 (276)
T d1uwha_ 2 DWEIPDG--QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ 77 (276)
T ss_dssp CCBCCTT--CCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred Ccccccc--cEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence 3455544 566778999999999873 445799999976543 34556789999999999999999999998754 57
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
+++|||||++|+|.+++... .++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence 89999999999999999764 56999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCC-CCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC--CCCCCCC
Q 013214 304 TVKED-RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKAP 377 (447)
Q Consensus 304 ~~~~~-~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 377 (447)
..... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.+............ .+.....
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 53322 223456789999999998643 57889999999999999999999999877655443333333 3333444
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
+..+|+++.++|.+||+.||.+|||+++++++|+.+.+++.
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 56788999999999999999999999999999999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=397.11 Aligned_cols=244 Identities=26% Similarity=0.494 Sum_probs=212.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 688889999999999873 688999999875433233345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
||++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---C
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC---c
Confidence 9999999999999889999999999999999999999999 999999999999999999999999999865432 2
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. ...+.+ +..+|+++.++|.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-~~~~~~---p~~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-RVEFTF---PDFVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-TTCCCC---CTTSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCC---CccCCHHHHHHHH
Confidence 344578999999999999999999999999999999999999998877666555552 333333 3457889999999
Q ss_pred HHcccCCCCCCCHHHHHHH
Q 013214 391 ECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~ 409 (447)
+||+.||++|||+++++++
T Consensus 237 ~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTC
T ss_pred HHccCCHhHCcCHHHHHcC
Confidence 9999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=394.38 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=208.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||+|++.... ..+..+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh--cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 688889999999999873 58999999987543 22334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-C
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~ 309 (447)
||++|+|.+++.+++.+++.++..++.|++.||.|||+++ |+||||||+|||+++++++||+|||+|+....... .
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999987653322 2
Q ss_pred CcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 388 (447)
......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............ .............+|+++.+|
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HHTTCTTSTTGGGSCHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-HhcCCCCCCccccCCHHHHHH
Confidence 2345678999999999988776 56899999999999999999999876655443333 222333334456788999999
Q ss_pred HHHHcccCCCCCCCHHHHHHH
Q 013214 389 IEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 389 i~~cl~~dp~~Rps~~~~l~~ 409 (447)
|.+||+.||++|||+++++++
T Consensus 240 i~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=391.14 Aligned_cols=246 Identities=22% Similarity=0.432 Sum_probs=213.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
.+|+..+.||+|+||.|+. +|+.||+|++....... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 3688889999999999873 58999999987654322 356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
|||+||+|.+++.+ +.+++.++..++.|++.||.|||++| |+||||||+|||++.++++||+|||++....... .
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 99999999998765 56999999999999999999999999 9999999999999999999999999998765332 2
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....+.+ ..+..+|++++++|
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li 250 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAIFRDFL 250 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSGGGSCHHHHHHH
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCcccCCHHHHHHH
Confidence 33456789999999999999999999999999999999999999988776665555545544444 33567899999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+||+.||.+|||+.+++++
T Consensus 251 ~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 251 NRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHTCSSTTTSCCHHHHTTC
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=389.31 Aligned_cols=251 Identities=29% Similarity=0.565 Sum_probs=205.3
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.|+. +++.||||+++..... .+++.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 567778999999998863 5788999999765432 25688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999998765 55889999999999999999999999 9999999999999999999999999998765443333
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....||+.|+|||++.+..++.++|||||||++|||+| |++||...+..+....+....++.. +..+++++.++|
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li 235 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIM 235 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHHHHH
Confidence 344568999999999999999999999999999999999 5777776666666666655444443 345678999999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 390 EECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
.+||+.||++|||+++++++|+++.++
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-52 Score=391.02 Aligned_cols=255 Identities=30% Similarity=0.522 Sum_probs=208.9
Q ss_pred CcccceeeecceEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.|+. +| ..||||.+... ......+.|.+|+.++++++||||+++++++..++..++
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 577778999999998873 22 35899988754 345666789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|||||++|+|.+++... +.+++.++..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999988774 56999999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCC----cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhh
Q 013214 307 EDRP----LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (447)
Q Consensus 307 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (447)
.... .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....++...+....+++. +..+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~ 258 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP---PMDC 258 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---Cccc
Confidence 2211 123457899999999999899999999999999999998 8999998887777776655555554 3457
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
++++.++|.+||+.||++|||+.++++.|+++.+..+
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 8899999999999999999999999999999876544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=387.86 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=210.7
Q ss_pred eeeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEeccC
Q 013214 161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (447)
Q Consensus 161 ~~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 233 (447)
++||+|+||.|+. .++.||||+++.... +....+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 5799999999873 246899999976543 44556789999999999999999999999865 46799999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC--Cc
Q 013214 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PL 311 (447)
Q Consensus 234 ~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~--~~ 311 (447)
+|+|.+++.+...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999999999899999999999999999999999999 999999999999999999999999999865433221 12
Q ss_pred ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..++...+....+++. +..+|+++.++|.
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~ 244 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDLMN 244 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHHHH
Confidence 34568999999999998899999999999999999998 8999998887777777655555554 3467899999999
Q ss_pred HHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 391 ECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 391 ~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+||+.||++|||++++.+.|+.+....
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 999999999999999999998865543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-52 Score=385.81 Aligned_cols=259 Identities=30% Similarity=0.495 Sum_probs=216.2
Q ss_pred CCCcccCCCCcCcccceeeecceEEEEE---E-cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE
Q 013214 145 VPEYEIDPHELDFTNSVEITKGTFILAF---W-RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (447)
Q Consensus 145 ~~~~~i~~~~~~~~~~~~lg~G~~~~~~---~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 220 (447)
..+|+|... +|+..+.||+|+||.|+ + +++.||||++...... .+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~wei~~~--~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 5 EDEWEVPRE--TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TCTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCeecCHH--HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 345666554 67778899999999887 3 4678999999764322 356889999999999999999999875
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
+ +..++||||+++|+|.+++... .++++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecccc
Confidence 4 5679999999999999987543 35999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHHhcCCCCCCCC
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQRPPFKAP 377 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 377 (447)
+|+..............+|+.|+|||++.+..++.++|||||||++|||+|| .+||...+..+....+....++..
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~--- 231 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR--- 231 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---
T ss_pred ceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---
Confidence 9987654433334456689999999999888899999999999999999995 556666655556566544444443
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+..+++++.++|.+||+.||++|||++++++.|+++.++
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 346788999999999999999999999999999998765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=386.85 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=201.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe--CCceEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 228 (447)
+|+..+.||+|+||.|+. +|+.||+|++..... .+...+.+.+|++++++++||||+++++++.+ ++.+|+|
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 688889999999999873 588999999987654 45556788999999999999999999999864 4668999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP--VPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~--~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
||||++|+|.+++.+ +..+++..++.++.|++.||.|||+.++ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 4579999999999999999999998641 2399999999999999999999999999987
Q ss_pred cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 303 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+.....+.+ +..+|
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s 239 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---PYRYS 239 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---CcccC
Confidence 654322 22446789999999999998999999999999999999999999998777666666644443333 45688
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+++.++|.+||+.||.+|||+.+++++
T Consensus 240 ~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 240 DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-52 Score=393.19 Aligned_cols=244 Identities=25% Similarity=0.447 Sum_probs=213.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||+|+||.|+. +|+.||||++...........+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488889999999999873 689999999987666666777889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
||.+|+|..++..++++++.+++.++.|++.||.|||+++ |+||||||+|||++.++++||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 9999999888888888999999999999999999999999 99999999999999999999999999986543
Q ss_pred cccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....+.+. ...+|+++.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~ 245 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFRN 245 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHHHH
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHHHH
Confidence 234568999999999864 35889999999999999999999999887766655555444444432 3467899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
||.+||+.||.+|||+.+++++
T Consensus 246 li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHCcCChhHCcCHHHHHhC
Confidence 9999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=390.35 Aligned_cols=246 Identities=28% Similarity=0.406 Sum_probs=211.1
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||+|+||.|+. +|+.||+|++.... .+..+.+.+|++++++++||||+++++++.+++.+++|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 478888999999999873 68899999987542 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||++|+|.+++.+ .+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++++||+|||+|....... .
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 9999999999765 456999999999999999999999999 9999999999999999999999999997654321 1
Q ss_pred CcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+..+....+.....+. ...+..+|++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~ 244 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSN 244 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-CSSGGGSCHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCccccCCHH
Confidence 123456899999999984 4468899999999999999999999999888877777664444333 3345678999
Q ss_pred HHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+.+||.+||+.||++|||+.+++++
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-52 Score=390.83 Aligned_cols=259 Identities=28% Similarity=0.471 Sum_probs=216.4
Q ss_pred CCcccCCCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEE
Q 013214 146 PEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (447)
Q Consensus 146 ~~~~i~~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 220 (447)
..|||++. +|+..+.||+|+||.|+. +|+.||||+++.+.. ..+++.+|++++++++||||+++++++.
T Consensus 10 ~~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 10 DKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp CTTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 35677664 577778999999998863 588999999976532 2356889999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 221 QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 221 ~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
+.+..+++||||++|+|.+++.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccc
Confidence 999999999999999999999764 45899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCCCchHHHHHhcCCCCCCCC
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRPPFKAP 377 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~ 377 (447)
+++..............+++.|+|||.+.+..++.++|||||||++|||++|..|| ...+..+....+....+++.
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~--- 237 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER--- 237 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC---
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCC---
Confidence 99876544333333445788999999999999999999999999999999966554 44444444444434434443
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+..+|+++.+||.+||+.||++|||+.++++.|+.+.+.
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 346788999999999999999999999999999887543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=385.53 Aligned_cols=255 Identities=24% Similarity=0.419 Sum_probs=217.2
Q ss_pred Ccccce-eeecceEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~-~lg~G~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
++.... +||+|+||.|+. ++..||||+++.. ......+++.+|++++++++||||+++++++.+ +.+++
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 344444 599999999873 3457999999754 355667889999999999999999999999865 56899
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
|||||++|+|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999998654 56999999999999999999999999 999999999999999999999999999876533
Q ss_pred CC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 307 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
.. .......+|+.|+|||++.++.++.++|||||||++|||+| |+.||...+..++...+....+++. +..+|+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~ 239 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPECPP 239 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTTCCH
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCH
Confidence 22 12234567899999999998899999999999999999998 9999998888777777765556554 356789
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
++.++|.+||+.||++|||+.++.+.|+....+...
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999987766543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-53 Score=394.87 Aligned_cols=247 Identities=21% Similarity=0.406 Sum_probs=211.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||||++...........+.+.+|++++++++||||+++++++.+++.+|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 588889999999998873 589999999875433233345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC-C
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 309 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~-~ 309 (447)
||+||+|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999999999999999999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. .....+ +..+++++++||
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-~~~~~~---p~~~s~~~~~li 241 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDF---PEKFFPKARDLV 241 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-TTCCCC---CTTCCHHHHHHH
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH-cCCCCC---CccCCHHHHHHH
Confidence 2344678999999999999999999999999999999999999999877666655553 333333 345788999999
Q ss_pred HHHcccCCCCCCCHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+||+.||.+|||++|++++
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCH
T ss_pred HHHccCCHhHCcCHHHHcCC
Confidence 99999999999999998664
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-52 Score=393.04 Aligned_cols=247 Identities=24% Similarity=0.397 Sum_probs=198.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
.|+..+.||+|+||.|+. +|+.||||++...... .....+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 488889999999998863 5899999999765432 233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc---CCCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~---~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||+||+|.+++.+.+.+++.++..++.|++.||.|||+++ |+||||||+||++. +++.+||+|||++......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 9999999999998889999999999999999999999999 99999999999995 5789999999999865432
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+..............+|+++.+
T Consensus 164 -~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 164 -SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred -CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 2233456899999999999999999999999999999999999999987776666666444433223345678899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.||++|||+.|++++
T Consensus 243 li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCHhHCcCHHHHhcC
Confidence 9999999999999999999885
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=379.91 Aligned_cols=245 Identities=25% Similarity=0.484 Sum_probs=203.1
Q ss_pred ccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe----CCceEEE
Q 013214 158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMIV 228 (447)
Q Consensus 158 ~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~lv 228 (447)
+..++||+|+||.|+. +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+ +..+++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 5566899999999873 578999999876544 44556789999999999999999999999875 3458999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc-CCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~-~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|||+++|+|.+++.+.+.+++.++..++.|++.||.|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence 999999999999999889999999999999999999999986 3599999999999997 578999999999975432
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..................+ ...+...++++.+
T Consensus 168 -~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 168 -SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFDKVAIPEVKE 244 (270)
T ss_dssp -TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-GGGGGCCCHHHHH
T ss_pred -CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC-cccCccCCHHHHH
Confidence 22345678999999999865 69999999999999999999999998665443332222222211 1223456788999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|.+||+.||++|||+.|++++
T Consensus 245 li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCCHhHCcCHHHHhCC
Confidence 9999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=380.20 Aligned_cols=247 Identities=27% Similarity=0.512 Sum_probs=216.1
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.|+. +++.||||+++..... .+++.+|+.++++++||||+++++++.+++.+++||||
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 566778999999999874 5779999999865432 25788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 232 ~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
+++|+|.+++.. ...+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999999765 456899999999999999999999999 9999999999999999999999999998765444334
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
.....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...+..++...+....+++. +...++++.++|
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li 234 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYTIM 234 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccHHHHHHH
Confidence 445668999999999998899999999999999999998 8999999988887777755445443 346778999999
Q ss_pred HHHcccCCCCCCCHHHHHHHHHH
Q 013214 390 EECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
.+||+.||++|||+++++++|.+
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999999999865
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=380.26 Aligned_cols=259 Identities=24% Similarity=0.475 Sum_probs=211.1
Q ss_pred cccCCCCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEE
Q 013214 148 YEIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (447)
Q Consensus 148 ~~i~~~~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 219 (447)
|||+.. +|...+.||+|+||.|+. .+..||+|.++.. ......+.+.+|+.++++++||||+++++++
T Consensus 2 ~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 2 YEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 556554 678888999999998863 2356899988643 3566678899999999999999999999998
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 220 TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 220 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
. ++.+++||||+++|+|.+++... ..+++..++.++.|+++||.|||+++ ++||||||+||++++++.+||+|||
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred e-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccch
Confidence 6 56789999999999999987654 56999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCC
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 377 (447)
+++..............+|+.|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+....++++
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~--- 230 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM--- 230 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---
T ss_pred hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 998765443334445667999999999998899999999999999999998 8999999988888877766555554
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
++.+|+++.++|.+||+.||++|||+.+++++|+++.+..
T Consensus 231 ~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 4567899999999999999999999999999999886653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=391.93 Aligned_cols=248 Identities=27% Similarity=0.495 Sum_probs=206.5
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEE
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 228 (447)
+-+|+..+.||+|+||.|+. +|+.||+|+++... .....+.+.+|+.++++++||||++++++|.++..+|+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34788889999999998873 68999999987653 234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|||++||+|.+++.+.+.+++..+..++.|++.||.|||++ + |+||||||+|||++.++++||+|||+|......
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 99999999999999988999999999999999999999974 7 999999999999999999999999999865432
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc------------------
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR------------------ 369 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~------------------ 369 (447)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..+........
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 223457899999999999999999999999999999999999999876543321110000
Q ss_pred ----------------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 ----------------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 ----------------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..++.......+|.++.++|.+||+.||.+|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000011123467889999999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.1e-51 Score=391.71 Aligned_cols=246 Identities=22% Similarity=0.380 Sum_probs=213.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|++.+.||+|+||.|+. +|+.||||++... .....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 688999999999999873 5899999999754 34456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc--CCCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~--~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||+||+|.+++.+ .+++++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999999999954 467999999999999999999999999 99999999999996 4678999999999876532
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..............+|+++.+
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 3334567899999999999999999999999999999999999999988777666666444322222334568899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
||.+||+.||.+|||+++++++
T Consensus 259 li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999885
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-51 Score=384.02 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=213.2
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC---HHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
.|+..+.||+|+||.|+. +|+.||||++.+..... ....+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 588899999999999873 58999999986543322 1235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC----CEEEeeccccccc
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLL 303 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~----~vkl~Dfg~~~~~ 303 (447)
|||||++|+|.+++.+.+.+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+|++|||++...
T Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999998889999999999999999999999999 99999999999999776 5999999999876
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...........+..+|+
T Consensus 168 ~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 168 DFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp TTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred CCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 533 223445689999999999998999999999999999999999999998777666655533332222223356788
Q ss_pred HHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.+||++||+.||.+|||+++++++
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=390.27 Aligned_cols=246 Identities=25% Similarity=0.401 Sum_probs=214.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|++.+......+..+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 588889999999999873 689999999976543333345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
||+||+|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+|||++.+|++||+|||+|+...... ..
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~ 161 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC-cc
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999998654322 22
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. ...+.+ +..+|+++.+||.
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~-~~~~~~---p~~~s~~~~dli~ 237 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-MEEIRF---PRTLSPEAKSLLA 237 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCCCC---CTTSCHHHHHHHH
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh-cCCCCC---CccCCHHHHHHHH
Confidence 344668999999999999999999999999999999999999999888766666553 333443 4567899999999
Q ss_pred HHcccCCCCCCC-----HHHHHHH
Q 013214 391 ECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rps-----~~~~l~~ 409 (447)
+||+.||.+||+ +.++++|
T Consensus 238 ~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 238 GLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hhccCCchhhcccccccHHHHHcC
Confidence 999999999995 7888874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-50 Score=379.11 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=214.0
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc----eE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----MM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~ 226 (447)
+|+..+.||+|+||.|+. +|+.||||+++.....+....+.+.+|+.+++.++||||+++++++..+.. .|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 588889999999999873 589999999988776677777889999999999999999999999976543 79
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
+||||++|++|.+++...+++++.++..++.|++.||.|||+++ |+||||||+|||++.++.++++|||.+......
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccc
Confidence 99999999999999999999999999999999999999999999 999999999999999999999999998755432
Q ss_pred CC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHH
Q 013214 307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (447)
Q Consensus 307 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (447)
.. .......||+.|+|||++.+..+++++|||||||++|+|++|+.||.+.+..+....+......+.......+|++
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 22 2234456899999999999989999999999999999999999999987766655555444332222234567899
Q ss_pred HHHHHHHHcccCCCCCC-CHHHHHHHHHHHH
Q 013214 385 LKELIEECWNEKPAKRP-TFRQIITRLESIN 414 (447)
Q Consensus 385 l~~li~~cl~~dp~~Rp-s~~~~l~~l~~~~ 414 (447)
+.++|.+||+.||.+|| |++++++.|.++.
T Consensus 245 l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 99999999999999999 8999999988875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=377.62 Aligned_cols=262 Identities=29% Similarity=0.497 Sum_probs=211.4
Q ss_pred ccCCCCcCcccceeeecceEEEEEE---c--C----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEE
Q 013214 149 EIDPHELDFTNSVEITKGTFILAFW---R--G----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (447)
Q Consensus 149 ~i~~~~~~~~~~~~lg~G~~~~~~~---~--g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 219 (447)
||++. .|+..+.||+|+||.|+. . + ..||||++.... ......++.+|+.++++++||||+++++++
T Consensus 3 ei~~~--~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 3 EIHPS--CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp BCCTT--TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHH--HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence 45554 477788999999998873 1 1 469999987543 445567789999999999999999999999
Q ss_pred EeCCceEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 220 TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 220 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
.+.+..+++|||+.++++.+++.+. +.+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred ecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence 9999999999999999999988765 56999999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHHhcCCCCCC
Q 013214 299 VSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQRPPFK 375 (447)
Q Consensus 299 ~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~ 375 (447)
+++........ ......||+.|+|||.+.++.++.++|||||||++|||++| .+|+...+..++...+....+++.
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~- 234 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT- 234 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC-
Confidence 99876433221 22334679999999999999999999999999999999995 555555555556666655555554
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 013214 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420 (447)
Q Consensus 376 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~ 420 (447)
+..+++.+.++|.+||+.||++|||+.++++.|+.+.+..+..
T Consensus 235 --~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l 277 (283)
T d1mqba_ 235 --PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277 (283)
T ss_dssp --CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred --chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcccc
Confidence 3457789999999999999999999999999999988765433
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-50 Score=389.25 Aligned_cols=246 Identities=18% Similarity=0.349 Sum_probs=212.7
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||||++... .......+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc---chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 588999999999999873 6899999998754 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEc--CCCCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~--~~~~vkl~Dfg~~~~~~~~~ 307 (447)
||+||+|.+++.+. .++++.+++.++.|++.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 99999999887654 46999999999999999999999999 99999999999998 6789999999999876532
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 387 (447)
.......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..............+|+++.+
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2334456899999999999999999999999999999999999999987776666666443322222334578899999
Q ss_pred HHHHHcccCCCCCCCHHHHHHH
Q 013214 388 LIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 388 li~~cl~~dp~~Rps~~~~l~~ 409 (447)
||.+||+.||.+|||+.+++++
T Consensus 262 li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=386.33 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=209.6
Q ss_pred cccCCCCcCcccceeeecceEEEEEE---c--C-----eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCccccee
Q 013214 148 YEIDPHELDFTNSVEITKGTFILAFW---R--G-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFL 216 (447)
Q Consensus 148 ~~i~~~~~~~~~~~~lg~G~~~~~~~---~--g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~ 216 (447)
||+++. +|...+.||+|+||.|+. . + ..||+|.+.... .......+.+|+.+++++ +||||++++
T Consensus 32 wei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 32 WEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GBCCGG--GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHH--HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 445443 577788999999999873 1 1 369999986542 334456788999999998 899999999
Q ss_pred EEEEeCCceEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 013214 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPVP 273 (447)
Q Consensus 217 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~ 273 (447)
+++.+.+.+++|||||++|+|.+++++.. .+++..++.++.|++.||.|||+++
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--- 184 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--- 184 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 99999999999999999999999997542 4788999999999999999999999
Q ss_pred eEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CC
Q 013214 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GC 351 (447)
Q Consensus 274 i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~ 351 (447)
|+||||||+||+++.++++||+|||+|+......... .....+|+.|+|||.+.++.++.++|||||||++|||+| |+
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 9999999999999999999999999998765433222 223456999999999999999999999999999999998 89
Q ss_pred CCCCCCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 013214 352 PPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412 (447)
Q Consensus 352 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~ 412 (447)
.||.+.+..+....+.... +++. +..+|+++.+||.+||+.||++|||+++|+++|..
T Consensus 265 ~Pf~~~~~~~~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 265 NPYPGIPVDANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSSTTCCCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 9999877766554443333 4443 44678899999999999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=373.76 Aligned_cols=252 Identities=30% Similarity=0.550 Sum_probs=210.2
Q ss_pred cccCCCCcCcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-CC
Q 013214 148 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SS 223 (447)
Q Consensus 148 ~~i~~~~~~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 223 (447)
|+|+.. +|+..+.||+|+||.|+ ++|..||||+++.+. ..+.+.+|++++++++||||+++++++.+ ++
T Consensus 2 w~i~~~--~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMK--ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGG--GEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHH--HeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 455555 45667889999999876 789999999997542 23678899999999999999999999854 46
Q ss_pred ceEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
.+++||||+++|+|.+++.+.+ .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|++|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccce
Confidence 7899999999999999997643 4899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhh
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
..... .....+|+.|+|||.+.+..+++++||||||+++|||+| |++||...+..++...+....+++++ ..
T Consensus 152 ~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~---~~ 224 (262)
T d1byga_ 152 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP---DG 224 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC---TT
T ss_pred ecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC---cc
Confidence 65432 223456889999999988899999999999999999998 79999988888887777555566653 45
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
+++++.++|.+||+.||.+|||+.+++++|+++++.
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 678999999999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-49 Score=371.21 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=213.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCC------HHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCC
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS 223 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 223 (447)
+|+..+.||+|+||.|+. +|+.||||+++...... ....+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 688889999999999873 68999999987654321 223456888999999996 999999999999999
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
..|+|||||++|+|.++++.++.+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999999999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccCCcccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCC
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 377 (447)
... .......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+....+...........
T Consensus 161 ~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 161 DPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred cCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 543 23345678999999998753 3578899999999999999999999998877666666544433322334
Q ss_pred hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 378 ~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+|+++.++|.+||+.||++|||+.+++++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 56789999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-50 Score=382.84 Aligned_cols=243 Identities=24% Similarity=0.456 Sum_probs=212.5
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||||++++.........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 688889999999998873 589999999875433233345778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
||+||+|..++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.+|++||+|||+++.....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999875432
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... ...+ ++.+|+++.++|.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRF---PPFFNEDVKDLLS 233 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-CCCC---CTTSCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC-CCCC---CCCCCHHHHHHHH
Confidence 23467899999999999989999999999999999999999999987776666665333 3333 3457789999999
Q ss_pred HHcccCCCCCC-----CHHHHHHH
Q 013214 391 ECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
+||+.||.+|+ |+++++++
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhhCHHhccccchhhHHHHHcC
Confidence 99999999996 89999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=374.57 Aligned_cols=261 Identities=31% Similarity=0.493 Sum_probs=210.9
Q ss_pred CCcccCCCCcCcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe
Q 013214 146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (447)
Q Consensus 146 ~~~~i~~~~~~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 221 (447)
.+++|++. +|+..+.||+|+||.|+. +++.||||++...... .+.|.+|+.++++++||||+++++++.
T Consensus 10 ~~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~- 82 (285)
T d1fmka3 10 DAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS- 82 (285)
T ss_dssp TCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe-
Confidence 35667654 688888999999998873 4568999999765432 256889999999999999999999985
Q ss_pred CCceEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccc
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~ 299 (447)
++..++||||+++|+|.+++.. .+.+++.++..++.|++.||.|||+++ |+||||||+|||+++++++||+|||+
T Consensus 83 ~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccch
Confidence 4568999999999999998864 356999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCCCchHHHHHhcCCCCCCCCh
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPKAYAARQRPPFKAPA 378 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (447)
++..............+|+.|+|||.+..+.++.++||||||+++|||++|. +|+......+....+....+++. +
T Consensus 160 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~---~ 236 (285)
T d1fmka3 160 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---P 236 (285)
T ss_dssp TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---C
T ss_pred hhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---C
Confidence 9876543333334456899999999999999999999999999999999954 55555555555555544445444 4
Q ss_pred hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 379 ~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
..+|+++.++|.+||+.||++|||++++++.|+.+.++..+
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 56788999999999999999999999999999987766543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-49 Score=383.69 Aligned_cols=243 Identities=24% Similarity=0.410 Sum_probs=211.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||||++.+.........+.+.+|+.+++.++||||+++++++......++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 688899999999998873 589999999865433233345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|++||+|||+++.....
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 9999999999999899999999999999999999999999 999999999999999999999999999876432
Q ss_pred cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 013214 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 390 (447)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+... .+.+ +..+|+++.++|+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRF---PSHFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTCCHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC-CCCC---CccCCHHHHHHHH
Confidence 23456899999999999999999999999999999999999999887766655555333 3332 3467889999999
Q ss_pred HHcccCCCCCC-----CHHHHHHH
Q 013214 391 ECWNEKPAKRP-----TFRQIITR 409 (447)
Q Consensus 391 ~cl~~dp~~Rp-----s~~~~l~~ 409 (447)
+||+.||.+|+ |++++++|
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhhCHHhccccccccHHHHHcC
Confidence 99999999994 89998864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.3e-49 Score=382.22 Aligned_cols=247 Identities=22% Similarity=0.352 Sum_probs=205.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 227 (447)
+|...+.||+|+||.|+. +|+.||||++.+.... .........+|+.+++.++||||+++++++.+++.+|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 688889999999999873 6899999998643321 12222333445778888899999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~ 307 (447)
|||||+||+|.+++.+...+++..++.++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||+|......
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999999899999999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 386 (447)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+...........+ ...+..+|+++.
T Consensus 161 --~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~ 237 (364)
T d1omwa3 161 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-VELPDSFSPELR 237 (364)
T ss_dssp --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC-CCCCSSSCHHHH
T ss_pred --cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-CCCCCCCCHHHH
Confidence 2234578999999999865 468999999999999999999999998877665544332222222 223456789999
Q ss_pred HHHHHHcccCCCCCCC-----HHHHHHH
Q 013214 387 ELIEECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
+||.+||+.||.+||| +++++++
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 9999999999999999 6888764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=372.66 Aligned_cols=260 Identities=27% Similarity=0.469 Sum_probs=204.1
Q ss_pred CcccCCCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccce
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 215 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~ 215 (447)
.|++... +|+..+.||+|+||.|+. +++.||||+++... .....+.+.+|...+.++ +||||+++
T Consensus 7 ~wei~~~--~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCGG--GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHH--HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 3455543 678888999999999873 24689999987543 344556777788887777 78999999
Q ss_pred eEEEEeC-CceEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 013214 216 LGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278 (447)
Q Consensus 216 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~D 278 (447)
++++..+ ..++++||||++|+|.++++.. ..+++.++..++.|++.||.|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9988764 4689999999999999999753 23889999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCC
Q 013214 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTM 356 (447)
Q Consensus 279 ikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg-~~p~~~ 356 (447)
|||+|||+++++++||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||++| .+||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999865443222 23445789999999999999999999999999999999986 568887
Q ss_pred CCCCchHHH-HHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 357 KHDNEVPKA-YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 357 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
....+.... +....+++. +..+++++.++|.+||+.||++|||+.+++++|+++.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 240 VKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 766554433 333334443 345778999999999999999999999999999987643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=369.66 Aligned_cols=262 Identities=29% Similarity=0.539 Sum_probs=217.4
Q ss_pred CCCCcccCCCCcCcccceeeecceEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCC
Q 013214 144 EVPEYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHP 210 (447)
Q Consensus 144 ~~~~~~i~~~~~~~~~~~~lg~G~~~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 210 (447)
..|.|+|+.. +|...+.||+|+||.|+. ++..||||+++.+. ......++.+|...+.++ +||
T Consensus 4 ~~~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 4 EDPRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHK 79 (299)
T ss_dssp CCTTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCT
T ss_pred cCCcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCC
Confidence 4556776665 677778999999998863 12479999997653 445567788899998888 799
Q ss_pred cccceeEEEEeCCceEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 013214 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPI 274 (447)
Q Consensus 211 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i 274 (447)
||+++++++.+++.+++||||+++|+|.+++.... .+++.+++.++.|++.||+|||+.+ +
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---i 156 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---C 156 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---E
Confidence 99999999999999999999999999999997542 4899999999999999999999999 9
Q ss_pred EeCCCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCC
Q 013214 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352 (447)
Q Consensus 275 ~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~ 352 (447)
+||||||+|||++.++.+||+|||++......... ......+|+.|+|||.+.++.++.++||||||+++|+|++ |.+
T Consensus 157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~ 236 (299)
T d1fgka_ 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236 (299)
T ss_dssp CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred EeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCC
Confidence 99999999999999999999999999876543322 2344568899999999999999999999999999999998 799
Q ss_pred CCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 353 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
||.+.+..++...+....+++. +..+++.+.++|.+||+.||.+|||+.++++.|+++..
T Consensus 237 p~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 237 PYPGVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 9988887776666655545554 34578899999999999999999999999999988753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=369.93 Aligned_cols=252 Identities=27% Similarity=0.490 Sum_probs=202.6
Q ss_pred cCcccceeeecceEEEEEE---c-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceE
Q 013214 155 LDFTNSVEITKGTFILAFW---R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~---~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 226 (447)
.+|+..+.||+|+||.|+. . +..||||++........+..+++.+|+.++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 4678888999999998763 1 24799999987665566677889999999999999999999999965 5789
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+||||+++|++.+++..+ +.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999887654 56999999999999999999999999 99999999999999999999999999987644
Q ss_pred CCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcC-CCCCCCChhhh
Q 013214 306 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLY 381 (447)
Q Consensus 306 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 381 (447)
.... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.+.+..+....+.... +++ .+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~ 240 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---RPEDC 240 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---CCTTC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC---Ccccc
Confidence 3221 1233457889999999999899999999999999999998 899999888777766664443 333 24567
Q ss_pred HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 013214 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESI 413 (447)
Q Consensus 382 ~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~ 413 (447)
|+++.++|.+||+.||++|||+.++++.|++.
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 88999999999999999999999999988764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=378.78 Aligned_cols=245 Identities=29% Similarity=0.456 Sum_probs=208.9
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHh-cCCCCcccceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~ 229 (447)
+|...+.||+|+||.|+. +|+.||||++++......+..+.+..|..++. .++||||+++++++.+++.+|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 578889999999998873 68999999997543222223345556666654 689999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCC
Q 013214 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (447)
Q Consensus 230 e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~ 309 (447)
||+++|+|.+++...+.+++.++..++.|++.||.|||+++ ++||||||+|||+++++++||+|||+++...... .
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 99999999999999999999999999999999999999999 9999999999999999999999999998654332 2
Q ss_pred CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 013214 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389 (447)
Q Consensus 310 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 389 (447)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. ...+.+ +..+|+++.+||
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-~~~~~~---p~~~s~~~~dli 234 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-MDNPFY---PRWLEKEAKDLL 234 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCCCC---CTTSCHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCC---CccCCHHHHHHH
Confidence 3345678999999999999999999999999999999999999999887776666663 334444 345789999999
Q ss_pred HHHcccCCCCCCCHH-HHHH
Q 013214 390 EECWNEKPAKRPTFR-QIIT 408 (447)
Q Consensus 390 ~~cl~~dp~~Rps~~-~~l~ 408 (447)
.+||+.||.+|||+. ++++
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGG
T ss_pred HHhcccCCCCCcCHHHHHHh
Confidence 999999999999995 6764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=375.80 Aligned_cols=244 Identities=16% Similarity=0.312 Sum_probs=209.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|...+.||+|+||.|+. +|+.||+|+++... .....+.+|+++|++++||||+++++++.+++.+|+|||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 588889999999999873 68999999997542 233567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCC--CCEEEeecccccccccCC
Q 013214 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 307 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~--~~vkl~Dfg~~~~~~~~~ 307 (447)
||+||+|.+++.+.+ ++++.+++.++.|++.||.|||+++ |+||||||+|||++.+ ..+||+|||++......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 999999999998765 6999999999999999999999999 9999999999999854 48999999999865432
Q ss_pred CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCC-CChhhhHHHHH
Q 013214 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK-APAKLYARGLK 386 (447)
Q Consensus 308 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 386 (447)
.......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.... ..++ ...+.+|+++.
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-YTFDEEAFKEISIEAM 235 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCHHHHTTSCHHHH
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCChhhccCCCHHHH
Confidence 22234567899999999999999999999999999999999999999888776666663333 2222 22345788999
Q ss_pred HHHHHHcccCCCCCCCHHHHHHH
Q 013214 387 ELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 387 ~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+||.+||+.||.+|||+.+++++
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-48 Score=370.96 Aligned_cols=252 Identities=29% Similarity=0.458 Sum_probs=215.1
Q ss_pred cCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCc
Q 013214 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 224 (447)
-+|+..+.||+|+||.|+. +++.||||++... ...+..+++.+|+.++++++||||+++++++.....
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3688888999999998873 2478999999754 345567789999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 013214 225 MMIVTEYLPKGDLRAFLKRKG------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~~------------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dik 280 (447)
.+++|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999997532 3788899999999999999999999 9999999
Q ss_pred CCCEEEcCCCCEEEeecccccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCC
Q 013214 281 PSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PPFTMKH 358 (447)
Q Consensus 281 p~Nill~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~-~p~~~~~ 358 (447)
|+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++|. +||.+.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999976543222 2223456789999999999999999999999999999999984 6888888
Q ss_pred CCchHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 013214 359 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414 (447)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~ 414 (447)
..++...+....+++. +..+++++.++|.+||+.||++|||+.++++.|+++.
T Consensus 248 ~~e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 7777777655555544 4467789999999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=373.31 Aligned_cols=254 Identities=24% Similarity=0.482 Sum_probs=211.2
Q ss_pred cCcccceeeecceEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCce
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 225 (447)
.+|+..+.||+|+||.|+. +|+ .||+|.+.... ..+..+++.+|+.++++++||||+++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 3688899999999999873 233 68999886432 333457789999999999999999999999864 67
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~ 304 (447)
++++||+.+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8889999999999988764 56999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCchHHHHHhcCCCCCCCChhhhH
Q 013214 305 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (447)
Q Consensus 305 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (447)
...... .....||+.|+|||.+.++.++.++|||||||++|||+| |++||.+.+..++...+....+++. +..++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---p~~~~ 239 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPICT 239 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC---CTTBC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccC
Confidence 433222 233457999999999999999999999999999999998 8999998888887777755555554 35678
Q ss_pred HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 383 ~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+.+.++|.+||+.||.+|||+.+++++|+.+.+..
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 89999999999999999999999999999886543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=367.07 Aligned_cols=264 Identities=27% Similarity=0.466 Sum_probs=213.4
Q ss_pred CCCCcCcccceeeecceEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-
Q 013214 151 DPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ- 221 (447)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 221 (447)
.+....+...+.||+|+||.||. +...||||+++.. ......+++.+|++++++++||||++++|++..
T Consensus 23 ~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 100 (311)
T d1r0pa_ 23 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100 (311)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET
T ss_pred ChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec
Confidence 33444444457899999999873 1236999998743 456677889999999999999999999999875
Q ss_pred CCceEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 222 SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 222 ~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
++..++|||||++|+|.+++.... .+++..+..++.|++.||.|+|+.+ |+||||||+|||+++++.+||+|||++
T Consensus 101 ~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 101 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA 177 (311)
T ss_dssp TTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred CCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccch
Confidence 457899999999999999987543 4778889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC---CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCCCchHHHHHhcCCCCCCC
Q 013214 301 KLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 301 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~ 376 (447)
+....... .......+|+.|+|||.+.+..++.++||||||+++|||++|..||.. .+..+....+....++..
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~-- 255 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-- 255 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC--
T ss_pred hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence 87643322 122345689999999999989999999999999999999997666654 344445555544444443
Q ss_pred ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccc
Q 013214 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422 (447)
Q Consensus 377 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 422 (447)
+..+++++.++|.+||+.||++|||+.+++++|+++.+++..+..
T Consensus 256 -p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~ 300 (311)
T d1r0pa_ 256 -PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300 (311)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred -cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhc
Confidence 345778999999999999999999999999999999988776543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=369.23 Aligned_cols=252 Identities=31% Similarity=0.526 Sum_probs=209.2
Q ss_pred CcccceeeecceEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEeCCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 227 (447)
+|+..+.||+|+||.|+. +|. .||||++... ...+..+.+.+|+++++++ +||||+++++++.+++.+++
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 556678999999998862 344 5788887533 2344567899999999998 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCC
Q 013214 228 VTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~ 291 (447)
||||+++|+|.++++++ ..+++..+..++.|++.||.|+|+.+ ++||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999999754 45899999999999999999999999 999999999999999999
Q ss_pred EEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCchHHHHHhcC
Q 013214 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQ 370 (447)
Q Consensus 292 vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg-~~p~~~~~~~~~~~~~~~~~ 370 (447)
+||+|||+++....... .....+|+.|+|||.+.+..++.++|||||||++|||++| .+||...+..++...+....
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999986543322 2344579999999999999999999999999999999996 46788877777766665554
Q ss_pred CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 013214 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417 (447)
Q Consensus 371 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~ 417 (447)
+++. +..+++++.+||.+||+.||++|||+++++++|+++.+..
T Consensus 244 ~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 244 RLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp CCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 5554 4467899999999999999999999999999999987643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=362.10 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=217.4
Q ss_pred CcccCCCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccce
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 215 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~ 215 (447)
.|+++.. +|+..+.||+|+||.|+. +++.||||+++... .......+.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 17 KWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 4566554 666678999999999873 34689999997653 455667889999999999 69999999
Q ss_pred eEEEEeCCceEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 013214 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (447)
Q Consensus 216 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~ 277 (447)
++++.+.+..+++||||++|+|.+++++.. .+++..+..++.|++.||.|||+++ ++||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHr 169 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR 169 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 999999999999999999999999997543 4889999999999999999999999 9999
Q ss_pred CCCCCCEEEcCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 013214 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT 355 (447)
Q Consensus 278 Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~ 355 (447)
||||+||+++.++.+|++|||.++........ ......+|+.|+|||.+.++.++.++||||||+++|+|+| |.+||.
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876543222 2234567999999999998899999999999999999998 677777
Q ss_pred CCCCCchHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 356 MKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 356 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
..+..+....+...+ ++.. +..+|+.+.+||.+||+.||++|||+.++++.|+++...
T Consensus 250 ~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFRMLS---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp TCCSSHHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCC---cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 777665544443443 4433 345678999999999999999999999999999876544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=367.68 Aligned_cols=241 Identities=26% Similarity=0.403 Sum_probs=196.4
Q ss_pred Ccccce-eeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC-CCCcccceeEEEEe----CCc
Q 013214 156 DFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----SSP 224 (447)
Q Consensus 156 ~~~~~~-~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~----~~~ 224 (447)
+|.+.. .||+|+||.|+. +|+.||||+++.. ..+.+|+.++.++ +||||++++++|.+ +..
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 676654 599999999873 5899999998632 3466799886554 89999999999875 456
Q ss_pred eEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeeccc
Q 013214 225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (447)
Q Consensus 225 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg~ 299 (447)
+|+|||||+||+|.+++.+. ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 89999999999999999874 36999999999999999999999999 999999999999985 56799999999
Q ss_pred ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC---CCCCCC
Q 013214 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---RPPFKA 376 (447)
Q Consensus 300 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~ 376 (447)
++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... ...++.
T Consensus 161 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 161 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp CEECCCC--CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred eeeccCC--CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 9876543 23345678999999999999899999999999999999999999998776655443332221 222222
Q ss_pred -ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 -PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 -~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
....+|+++.+||.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 234678999999999999999999999999885
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=365.29 Aligned_cols=246 Identities=28% Similarity=0.386 Sum_probs=197.3
Q ss_pred ceeeecceEEEEEE-----cCeEEEEEEcCcccCCCH--HHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEecc
Q 013214 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (447)
Q Consensus 160 ~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 232 (447)
.+.||+|+||.|+. +|+.||||+++....... ...+.+.+|+.++++++||||+++++++..++.+|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 35799999999973 689999999976433221 22356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCcc
Q 013214 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (447)
Q Consensus 233 ~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~~ 312 (447)
.++++......+..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....... ....
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-cccc
Confidence 88877777666777999999999999999999999999 9999999999999999999999999998665432 2233
Q ss_pred cCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CCC-----------------
Q 013214 313 CQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP----------------- 373 (447)
Q Consensus 313 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~----------------- 373 (447)
...+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.... .+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 45689999999998654 57899999999999999999999998777655544432211 100
Q ss_pred -CCCC-----hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 -FKAP-----AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 -~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.. .+..++++.+||.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000 12457889999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=363.15 Aligned_cols=259 Identities=26% Similarity=0.447 Sum_probs=218.4
Q ss_pred CcccCCCCcCcccceeeecceEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCccccee
Q 013214 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216 (447)
Q Consensus 147 ~~~i~~~~~~~~~~~~lg~G~~~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 216 (447)
.++|++. +|...+.||+|+||.|+. +++.||||+++.. ........+.+|+.++++++||||++++
T Consensus 14 ~~ei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 14 EWEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TTBCCGG--GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ceeecHH--HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 4667764 667788999999998862 2578999999754 3455567789999999999999999999
Q ss_pred EEEEeCCceEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEE
Q 013214 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (447)
Q Consensus 217 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill 286 (447)
+++..+...++||||+++|+|.+++... ..+++..+..++.|+++||.|||+++ |+||||||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence 9999999999999999999999998642 23688899999999999999999998 9999999999999
Q ss_pred cCCCCEEEeecccccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCchHH
Q 013214 287 DDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPK 364 (447)
Q Consensus 287 ~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg-~~p~~~~~~~~~~~ 364 (447)
+.++++||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+|| +.||.+.+..+...
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999866433221 12334578999999999999999999999999999999997 58888887777777
Q ss_pred HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 013214 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415 (447)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~ 415 (447)
.+....+++. +..+++.+.++|.+||+.||++|||+.+++++|++..+
T Consensus 247 ~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 FVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 6655555443 45677899999999999999999999999998876543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=356.70 Aligned_cols=240 Identities=27% Similarity=0.417 Sum_probs=199.1
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHH---HHHHHHHHHHHHhcCC--CCcccceeEEEEeCC
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD---RVRAFRDELALLQKIR--HPNVVQFLGAVTQSS 223 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~ 223 (447)
+.+|++.+.||+|+||.|+. +|+.||||++......... ....+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 45789999999999999873 6899999998754432211 1233567999999986 899999999999999
Q ss_pred ceEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-CCCEEEeeccccc
Q 013214 224 PMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSK 301 (447)
Q Consensus 224 ~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-~~~vkl~Dfg~~~ 301 (447)
..++||||+.+ +++.+++.++..+++.+++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++.
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 99999999975 688899988889999999999999999999999999 999999999999985 5789999999998
Q ss_pred ccccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhh
Q 013214 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380 (447)
Q Consensus 302 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (447)
.... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+ .+ ......+ +..
T Consensus 160 ~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i-~~~~~~~---~~~ 226 (273)
T d1xwsa_ 160 LLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI-IRGQVFF---RQR 226 (273)
T ss_dssp ECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH-HHCCCCC---SSC
T ss_pred eccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HH-hhcccCC---CCC
Confidence 6543 23345678999999999977665 567999999999999999999997532 12 1222222 345
Q ss_pred hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 381 YARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 381 ~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+|+++.++|++||+.||++|||+++++++
T Consensus 227 ~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 227 VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 78899999999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=355.45 Aligned_cols=248 Identities=24% Similarity=0.449 Sum_probs=197.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||||+++.... .+...+.+.+|++++++++||||+++++++.++..+|+|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 688889999999998873 589999999975432 23335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCC
Q 013214 231 YLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (447)
Q Consensus 231 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~ 308 (447)
|+.+ ++.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9965 55555543 356999999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-CCC--------------
Q 013214 309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP-------------- 372 (447)
Q Consensus 309 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~~~-------------- 372 (447)
.......||+.|+|||.+.... ++.++|+||+||++|+|++|+.||.+.+..+....+... +.+
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 2334456899999999876654 578999999999999999999999876654433332111 000
Q ss_pred --CCCC--------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 --PFKA--------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 --~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.++. ....+++++.+||++||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 112456889999999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=350.39 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=196.8
Q ss_pred CcccceeeecceEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC----ceEEE
Q 013214 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV 228 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~lv 228 (447)
+|...+.||+|+||.|+ ++|+.||||++.... ......+.|+..+.+++||||+++++++.+++ .+++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 46667889999998775 689999999986431 22222334666666789999999999998654 57999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-----PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-----~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
|||+++|+|.+++++. ++++..++.++.|++.||.|+|+.. ..+|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999999764 6899999999999999999999741 113999999999999999999999999999876
Q ss_pred ccCCCC---CcccCCCCCcccCCcccCCCC------CCCchhHHHHHHHHHHHHhCCCCCCCCCCCc-------------
Q 013214 304 TVKEDR---PLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTMKHDNE------------- 361 (447)
Q Consensus 304 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~------------- 361 (447)
...... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||......+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 543221 223467899999999986642 5668999999999999999988875332111
Q ss_pred --hHHHHHhc-CCCCCCCCh--hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 013214 362 --VPKAYAAR-QRPPFKAPA--KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418 (447)
Q Consensus 362 --~~~~~~~~-~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~ 418 (447)
........ .+|+++... ...+..+.+++.+||+.||.+|||+.++++.|+++..+..
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 11111111 134443322 2345679999999999999999999999999999886543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-46 Score=351.98 Aligned_cols=249 Identities=25% Similarity=0.431 Sum_probs=201.1
Q ss_pred CcccceeeecceEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEec
Q 013214 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 231 (447)
+|+..+.||+|+||.|+. +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+++..++++||
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 688889999999999873 578999999976532 233356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCCc
Q 013214 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (447)
Q Consensus 232 ~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~~ 311 (447)
+.++.+..+....+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||.+........ ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence 987777777777788999999999999999999999999 99999999999999999999999999987553322 22
Q ss_pred ccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHh-cCCCC----------------
Q 013214 312 TCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP---------------- 373 (447)
Q Consensus 312 ~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~---------------- 373 (447)
....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+.. .+.+.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 344578999999998765 568999999999999999999999987665444333211 11110
Q ss_pred --------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 374 --------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 374 --------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.......+++.+.+||++||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001123467889999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=354.77 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=198.5
Q ss_pred CCCCcCcccceeeecceEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcC---CCCcccceeEEEEe
Q 013214 151 DPHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ 221 (447)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~ 221 (447)
...+.+|++.+.||+|+||.|+. +++.||||+++...... .....+.+|+.+++.+ +||||++++++|..
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 34556899999999999999873 25779999986543221 1122345567666655 79999999999853
Q ss_pred -----CCceEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEe
Q 013214 222 -----SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (447)
Q Consensus 222 -----~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~ 295 (447)
....+++|||++++++...... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeec
Confidence 3468999999987766554443 356899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C---
Q 013214 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R--- 371 (447)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~--- 371 (447)
|||++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+.... .
T Consensus 159 dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 159 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred chhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99998765432 23345678999999999999999999999999999999999999998876655444432210 0
Q ss_pred -------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 -------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 -------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+.......+++.+.+||++||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 01111223467889999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=357.30 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=208.4
Q ss_pred CcccceeeecceEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHhcCCC-CcccceeEEEEeCCce
Q 013214 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 225 (447)
+|+..+.||+|+||.|+. +|+.||||+++..... +....+.+.+|+.++++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 588999999999999874 4789999998754321 12223567789999999966 8999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+++|||+.+|+|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+..
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999999999999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCCChhhhHH
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (447)
..........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||......+....+...........+..+|+
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 261 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence 433334456689999999998764 467899999999999999999999998877766555533321111223456889
Q ss_pred HHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 013214 384 GLKELIEECWNEKPAKRPT-----FRQIITR 409 (447)
Q Consensus 384 ~l~~li~~cl~~dp~~Rps-----~~~~l~~ 409 (447)
++.++|++||+.||++||| ++|++++
T Consensus 262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 9999999999999999995 7888763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=344.82 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=196.7
Q ss_pred CcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEe-------
Q 013214 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------- 221 (447)
Q Consensus 154 ~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------- 221 (447)
..+|+..+.||+|+||.|+. +|+.||||++..... .+.....+.+|+.+++.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 35899999999999998873 589999999876543 22334567889999999999999999998855
Q ss_pred -CCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccc
Q 013214 222 -SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (447)
Q Consensus 222 -~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~ 300 (447)
++.++++|||+.++.+.........+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 3568999999987776666556677999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCC---CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcCCCCCCC
Q 013214 301 KLLTVKE---DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376 (447)
Q Consensus 301 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 376 (447)
....... ........||+.|+|||.+.+. .+++++||||+||++|+|++|+.||.+.+..+....+..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 7655322 1222345689999999998765 68899999999999999999999998766544433332211000000
Q ss_pred -----------------------C-----hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 377 -----------------------P-----AKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 377 -----------------------~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
. ....++.+.+||.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 01125678899999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=345.26 Aligned_cols=245 Identities=25% Similarity=0.364 Sum_probs=196.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC------
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 223 (447)
.+|+..+.||+|+||.|+. +|+.||||+++... ......+.+.+|+.+|++++||||++++++|...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4789999999999998873 58999999998654 35556678889999999999999999999997654
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.+|+||||+ +++|..+.+ ++++++..++.++.|++.||.|||++| |+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence 479999999 677877665 467999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------ 370 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------------ 370 (447)
.. ..+...+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+............
T Consensus 172 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 172 DS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp CS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred CC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 43 23456789999999998764 56889999999999999999999998765443322221110
Q ss_pred ---------------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 ---------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 ---------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...+.......++.+.+||.+||..||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111111224567889999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=345.55 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=194.8
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCC----ceE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMM 226 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~ 226 (447)
+|+..+.||+|+||.|+. +|+.||||++... ......+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 588999999999998873 6899999999754 24555678889999999999999999999997653 234
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccC
Q 013214 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (447)
Q Consensus 227 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~ 306 (447)
++++|+.+|+|.+++.. ..+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 87 ~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 44556669999999975 46999999999999999999999999 999999999999999999999999999865433
Q ss_pred CC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-C-----------
Q 013214 307 ED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R----------- 371 (447)
Q Consensus 307 ~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~----------- 371 (447)
.. .......+|+.|+|||.+... .++.++||||+||++|+|++|+.||...+..+......... .
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 22 122445689999999998554 67889999999999999999999998765433222211100 0
Q ss_pred ----------C-----CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 ----------P-----PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 ----------~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
+ ++....+..++++.+||.+||+.||++|||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0001122456789999999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=347.33 Aligned_cols=246 Identities=25% Similarity=0.338 Sum_probs=194.0
Q ss_pred CCCcCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC----
Q 013214 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS---- 222 (447)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 222 (447)
+.+.+|+..+.||+|+||.|+. +|+.||||++..... ...+|++++++++||||++++++|...
T Consensus 17 ~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp CEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred cccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence 3455788999999999999873 689999999875432 234699999999999999999998543
Q ss_pred --CceEEEEeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEee
Q 013214 223 --SPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVAD 296 (447)
Q Consensus 223 --~~~~lv~e~~~~g~L~~~l---~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~D 296 (447)
.++++|||||+++.+.... .....+++.++..++.|++.||+|||++| |+||||||+|||++.++ .+||+|
T Consensus 90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECC
T ss_pred CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEec
Confidence 3478999999765333322 34557999999999999999999999999 99999999999999765 899999
Q ss_pred cccccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc-C----
Q 013214 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-Q---- 370 (447)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-~---- 370 (447)
||++...... .......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+... +
T Consensus 167 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 167 FGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CTTCEECCTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccchhhccCC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 9999876432 23344578999999998765 47899999999999999999999999876654433332110 0
Q ss_pred -----------CCCCC---------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 -----------RPPFK---------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 -----------~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
...++ ......++++.+||.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00010 1123467889999999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-43 Score=333.02 Aligned_cols=256 Identities=16% Similarity=0.246 Sum_probs=208.7
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCC-CcccceeEEEEeCCceEEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIV 228 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 228 (447)
.+|++.+.||+|+||.|+. +|+.||||++...... ..+.+|++.++.+.| +|++.+++++......++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 3688899999999999873 5899999988654321 346778899999964 8999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC-----CCCEEEeecccccc
Q 013214 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----SGNLKVADFGVSKL 302 (447)
Q Consensus 229 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~-----~~~vkl~Dfg~~~~ 302 (447)
|||+ +++|.+++...+ .++..++..++.|++.||.|||+.| |+||||||+|||++. ++.+||+|||+++.
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999 789999997654 6999999999999999999999999 999999999999974 57899999999987
Q ss_pred cccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHH---HhcC-CC
Q 013214 303 LTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQ-RP 372 (447)
Q Consensus 303 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~~~~-~~ 372 (447)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.......... .... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 643221 1223456899999999999999999999999999999999999999877665433222 1111 11
Q ss_pred CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 013214 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419 (447)
Q Consensus 373 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~~~~ 419 (447)
+.......+|+++.+++..|+..+|++||+++.+.+.|+++.++...
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 21112245678999999999999999999999999999988766543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=334.55 Aligned_cols=249 Identities=21% Similarity=0.382 Sum_probs=205.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeCCceEEEEe
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 230 (447)
+|+..+.||+|+||.|+. +|+.||||+++.... .......+.+|+.+++.++||||+++++++.+....++++|
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 688889999999999873 688999999976543 44566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecccccccccCCCCC
Q 013214 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (447)
Q Consensus 231 ~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~~~~~~ 310 (447)
++.+++|..++...+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+....... ..
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RC 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-cc
Confidence 9999999998888888999999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred cccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCC-CchHHHHHhcC-C----------------
Q 013214 311 LTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQ-R---------------- 371 (447)
Q Consensus 311 ~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~-~~~~~~~~~~~-~---------------- 371 (447)
.....+++.|+|||.+.... ++.++|||||||++|+|++|+.||..... .+....+.... .
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 33455688899999987664 68899999999999999999998754433 22222221110 0
Q ss_pred --------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 372 --------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 372 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..........++.+.+||++||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111234567889999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-44 Score=336.61 Aligned_cols=252 Identities=17% Similarity=0.224 Sum_probs=197.4
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcc-cceeEEEEeCCceEEEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV-VQFLGAVTQSSPMMIVT 229 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~ 229 (447)
+|+..+.||+|+||.|+. +|+.||||++...... .++..|+++++.++|+++ +.+.+++...+..++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 588899999999998873 5899999988654322 346789999999977665 55556667778889999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcC---CCCEEEeeccccccccc
Q 013214 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV 305 (447)
Q Consensus 230 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~---~~~vkl~Dfg~~~~~~~ 305 (447)
||+ +++|.+.+.. .+.+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999 5677666654 567999999999999999999999999 999999999999864 45799999999987653
Q ss_pred CCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc----CCCCCC
Q 013214 306 KED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR----QRPPFK 375 (447)
Q Consensus 306 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~~~ 375 (447)
... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+... ...+.+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 321 1223456899999999999989999999999999999999999999876654433222111 112221
Q ss_pred CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 013214 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416 (447)
Q Consensus 376 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~l~~~~~~ 416 (447)
.....+|+++.++|..||+.||++||+++++.+.|+++...
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 12345778999999999999999999999999999887554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-42 Score=333.49 Aligned_cols=240 Identities=22% Similarity=0.373 Sum_probs=193.6
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEe--CCceEE
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMMI 227 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~l 227 (447)
+|+..+.||+|+||.|+. +|+.||||+++... .+.+.+|+.+|+.++ ||||+++++++.. ...+++
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 688999999999999874 58999999987432 256788999999995 9999999999974 456999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCC-CEEEeecccccccccC
Q 013214 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK 306 (447)
Q Consensus 228 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~-~vkl~Dfg~~~~~~~~ 306 (447)
||||+.+++|.++. +.+++..+..++.|++.||.|||++| |+||||||+|||++.++ .+||+|||++......
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999997753 46999999999999999999999999 99999999999999665 5999999999876533
Q ss_pred CCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchH-HHHHh------------cC--
Q 013214 307 EDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAYAA------------RQ-- 370 (447)
Q Consensus 307 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~-~~~~~------------~~-- 370 (447)
.......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||......... ..+.. ..
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred --CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 233455689999999998765 5789999999999999999999999865542211 00000 00
Q ss_pred --CC-----------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 371 --RP-----------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 371 --~~-----------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.+ ........+++++.+||++||..||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0011234567899999999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=336.94 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=190.5
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC------C
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 223 (447)
.+|++.+.||+|+||.|+. +|+.||||+++.... +......+.+|+.++++++||||++++++|... .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3689999999999999873 589999999976553 455667788999999999999999999999643 5
Q ss_pred ceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccc
Q 013214 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (447)
Q Consensus 224 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~ 303 (447)
.+|+||||+.+ ++.+.+ ...+++..++.++.|++.||.|||+.| |+||||||+|||++.++.+|++|||++...
T Consensus 96 ~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcc
Confidence 78999999965 455444 356899999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhc--------------
Q 013214 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------- 369 (447)
Q Consensus 304 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~-------------- 369 (447)
... .......+|+.|+|||.+.+..+++++||||+||++|+|++|+.||.+.+.......+...
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 432 2334556899999999999999999999999999999999999999866543332222110
Q ss_pred -------CCCCC-----------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 370 -------QRPPF-----------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 370 -------~~~~~-----------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
..+.. .......++++.+||++||..||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 00123467889999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-43 Score=337.33 Aligned_cols=245 Identities=26% Similarity=0.348 Sum_probs=195.3
Q ss_pred CcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCcccceeEEEEeC-----Cce
Q 013214 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 225 (447)
Q Consensus 156 ~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 225 (447)
+|+..+.||+|+||.|+. +|+.||||++..... +....+.+.+|+.++++++||||+++++++... ...
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 588899999999998863 689999999986543 445556788999999999999999999998643 334
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeeccccccccc
Q 013214 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (447)
Q Consensus 226 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~~~~ 305 (447)
+++++|+.+|+|.+++.. +++++.++..++.|++.||.|||++| |+||||||+|||++.++.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence 666777789999998854 57999999999999999999999999 99999999999999999999999999876432
Q ss_pred CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCchHHHHHhcC-CC-----------
Q 013214 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP----------- 372 (447)
Q Consensus 306 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-~~----------- 372 (447)
......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+.... .+
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 23445678999999987665 46789999999999999999999998766544333331111 10
Q ss_pred ----------CCCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 013214 373 ----------PFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409 (447)
Q Consensus 373 ----------~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~~l~~ 409 (447)
.... .....++++.+||++||..||.+|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000 112467889999999999999999999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-36 Score=295.11 Aligned_cols=244 Identities=20% Similarity=0.310 Sum_probs=182.3
Q ss_pred cCcccceeeecceEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-----------CCcccceeEE
Q 013214 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLGA 218 (447)
Q Consensus 155 ~~~~~~~~lg~G~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv~~~~~ 218 (447)
.+|+..+.||+|+||.|+. +|+.||||+++.. ....+.+.+|+++++.++ ||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 3589999999999999873 6899999999753 233456778998888875 5789999988
Q ss_pred EEeC--CceEEEEeccCCCC-HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEEcCCCC-
Q 013214 219 VTQS--SPMMIVTEYLPKGD-LRAFLK--RKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN- 291 (447)
Q Consensus 219 ~~~~--~~~~lv~e~~~~g~-L~~~l~--~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~~i~H~Dikp~Nill~~~~~- 291 (447)
+... ...+++++++..+. ...... ....+++..+..++.|++.||.|||+ .| |+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcc
Confidence 7643 45566666654443 333332 23568999999999999999999998 77 999999999999986654
Q ss_pred -----EEEeecccccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCch----
Q 013214 292 -----LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---- 362 (447)
Q Consensus 292 -----vkl~Dfg~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~---- 362 (447)
++++|||.+...... .....+|+.|+|||++.+..++.++|+||+||++++|++|+.||........
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 999999998764432 2345689999999999998999999999999999999999999975543210
Q ss_pred ---HHHHHhcCC-------------------------CC------------CCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 013214 363 ---PKAYAARQR-------------------------PP------------FKAPAKLYARGLKELIEECWNEKPAKRPT 402 (447)
Q Consensus 363 ---~~~~~~~~~-------------------------~~------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps 402 (447)
.......+. .. ........++++.+||.+||..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 000000000 00 00113456789999999999999999999
Q ss_pred HHHHHHH
Q 013214 403 FRQIITR 409 (447)
Q Consensus 403 ~~~~l~~ 409 (447)
++|++++
T Consensus 322 a~e~L~H 328 (362)
T d1q8ya_ 322 AGGLVNH 328 (362)
T ss_dssp HHHHHTC
T ss_pred HHHHhcC
Confidence 9999875
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.88 E-value=3.5e-23 Score=166.34 Aligned_cols=105 Identities=30% Similarity=0.396 Sum_probs=99.6
Q ss_pred hhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHH
Q 013214 41 EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120 (447)
Q Consensus 41 ~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~ 120 (447)
.|||++||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+.+|+.+
T Consensus 3 ~tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~ 82 (118)
T d1myoa_ 3 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS 82 (118)
T ss_dssp HHHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCH
T ss_pred ChHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchh
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCcccccccCCC
Q 013214 121 VIKLLEKHGAKPLMAPMHVKHAREV 145 (447)
Q Consensus 121 ~~~~L~~~~a~~~~~~~~~~~~~~~ 145 (447)
++++|+++|++++..+..+.++...
T Consensus 83 ~v~~Ll~~Gad~~~~d~~G~t~l~~ 107 (118)
T d1myoa_ 83 CVKLLLSKGADKTVKGPDGLTALEA 107 (118)
T ss_dssp HHHHHHTTCCCSSSSSSSTCCCCCT
T ss_pred hhhhhhcccccceeeCCCCCCHHHH
Confidence 9999999999999887777666443
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.86 E-value=4.2e-22 Score=167.41 Aligned_cols=112 Identities=19% Similarity=0.172 Sum_probs=98.8
Q ss_pred chhcccCCCC-CCCccchhhHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCC
Q 013214 24 KEAELNGLDD-DGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99 (447)
Q Consensus 24 ~~a~~n~~d~-~~~~~~g~t~lh~a~~~---~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~ 99 (447)
.|+|++.... ...+..|+||||+|+.. |+.+++++|+++|+|+|.+|.+|+||||+||..|+.+++++|+++|+++
T Consensus 28 ~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~ 107 (154)
T d1dcqa1 28 DGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASI 107 (154)
T ss_dssp TTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCT
T ss_pred cCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccccccccccccccccCccc
Confidence 4556554432 33466799999999975 6789999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccccchHHHHHHHHHhCCCCCCC
Q 013214 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 100 ~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~ 135 (447)
+.+|..|.||||+|+..|+.+++++|++.++.....
T Consensus 108 ~~~d~~g~tpL~~A~~~~~~~i~~~L~~~~~~~~~~ 143 (154)
T d1dcqa1 108 EIANESGETPLDIAKRLKHEHCEELLTQALSGRFNS 143 (154)
T ss_dssp TCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTTCCCS
T ss_pred cccCCCCCCHHHHHHHcCCHHHHHHHHHhCCCCCCc
Confidence 999999999999999999999999999988765443
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=8.9e-22 Score=160.87 Aligned_cols=96 Identities=29% Similarity=0.348 Sum_probs=90.8
Q ss_pred hhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHH
Q 013214 41 EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120 (447)
Q Consensus 41 ~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~ 120 (447)
.++||.||..|+.++++.|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|.+|+||||+|+.+|+.+
T Consensus 2 l~lL~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~ 81 (130)
T d1ycsb1 2 LALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQ 81 (130)
T ss_dssp HHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred hHHHHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHH
Confidence 46799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCc
Q 013214 121 VIKLLEKHGAKPLMAP 136 (447)
Q Consensus 121 ~~~~L~~~~a~~~~~~ 136 (447)
++++|+++|++++...
T Consensus 82 ~v~~Ll~~ga~v~~~~ 97 (130)
T d1ycsb1 82 VCKFLVESGAAVFAMT 97 (130)
T ss_dssp HHHHHHHTTCCTTCCC
T ss_pred HHHHHHHcCCCccccc
Confidence 9999999999987543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=8.3e-22 Score=172.35 Aligned_cols=162 Identities=19% Similarity=0.141 Sum_probs=117.1
Q ss_pred ccceeeecceEEEEEE----cCeEEEEEEcCcccCC---------------CHHHHHHHHHHHHHHhcCCCCcccceeEE
Q 013214 158 TNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---------------DDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (447)
Q Consensus 158 ~~~~~lg~G~~~~~~~----~g~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 218 (447)
.+.+.||+|+||.|+. +|+.||||+++..... .........+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 3567899999999873 6899999987532111 01122345678999999999999998876
Q ss_pred EEeCCceEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEEcCCCCEEEeecc
Q 013214 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (447)
Q Consensus 219 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~~i~H~Dikp~Nill~~~~~vkl~Dfg 298 (447)
. ..+++|||+++..+. .++......++.|++.++.|||+.| |+||||||+|||+++++ ++|+|||
T Consensus 83 ~----~~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCT
T ss_pred c----CCEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECC
Confidence 3 237999999875543 2566677889999999999999999 99999999999999655 9999999
Q ss_pred cccccccCCCCCcccCCCCCcccCC------cccCCCCCCCchhHHHHHHHH
Q 013214 299 VSKLLTVKEDRPLTCQDTSCRYVAP------EVFKNEEYDTKVDVFSFALIL 344 (447)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~t~~y~aP------E~~~~~~~~~~~Di~slG~~l 344 (447)
+|........ ..|... +.+ ...|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~---------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGW---------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTH---------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCc---------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9875432110 011111 112 34678899999976443
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=8.7e-21 Score=154.91 Aligned_cols=101 Identities=23% Similarity=0.108 Sum_probs=88.9
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCC-CCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WGST 108 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~-~g~t 108 (447)
|.|++.+|.+|+||||+||..|+.+++++|++.|+|+|.+|.+|+||||+|+.+|+.+++++|+++|++++..+. .|.|
T Consensus 24 g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~v~~~~~~~~~~ 103 (130)
T d1ycsb1 24 VDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQT 103 (130)
T ss_dssp TSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSCCC
T ss_pred CCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHHHHHHHHcCCCcccccCCCCCC
Confidence 445556667788999999999999999999999999999999999999999999999999999999999998875 5888
Q ss_pred ccc--cccccchHHHHHHHHHhCC
Q 013214 109 PLG--DAIYYKNHEVIKLLEKHGA 130 (447)
Q Consensus 109 pl~--~a~~~~~~~~~~~L~~~~a 130 (447)
|++ .|...|+.+++++|+..+.
T Consensus 104 ~~~~~~a~~~g~~eiv~~L~~~~~ 127 (130)
T d1ycsb1 104 AADKCEEMEEGYTQCSQFLYGVQE 127 (130)
T ss_dssp HHHHCCSSSTTCCCHHHHHHHHHH
T ss_pred HHHHHHHHHcChHHHHHHHHhHHH
Confidence 755 5567888999999987643
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.82 E-value=3e-21 Score=154.90 Aligned_cols=86 Identities=30% Similarity=0.271 Sum_probs=79.0
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
|.|++.++.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+.+|+.+++++|+++|+|++.+|.+|.||
T Consensus 25 g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~~Ll~~Gad~~~~d~~G~t~ 104 (118)
T d1myoa_ 25 GEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTA 104 (118)
T ss_dssp TCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHHHHHTTCCCSSSSSSSTCCC
T ss_pred hhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchhhhhhhhcccccceeeCCCCCCH
Confidence 34445556667888999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccc
Q 013214 110 LGDAIY 115 (447)
Q Consensus 110 l~~a~~ 115 (447)
||+|..
T Consensus 105 l~~a~~ 110 (118)
T d1myoa_ 105 LEATDN 110 (118)
T ss_dssp CCTCSS
T ss_pred HHHHhH
Confidence 999954
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.1e-20 Score=153.27 Aligned_cols=90 Identities=23% Similarity=0.314 Sum_probs=55.5
Q ss_pred CccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCC-CHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 013214 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~-t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~ 114 (447)
.+..|+||+|+|+ .|+.+++++|+++|+|+|.+|..|. ||||+|+..|+.+++++|+++|++++.+|..|+||||+|+
T Consensus 32 ~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~G~T~l~~A~ 110 (125)
T d1bi7b_ 32 PNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAE 110 (125)
T ss_dssp CCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTCCCHHHHHH
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCCHHHHHH
Confidence 3334445566443 4666666666666666666665544 4666666666666666666666666666666666666666
Q ss_pred ccchHHHHHHHH
Q 013214 115 YYKNHEVIKLLE 126 (447)
Q Consensus 115 ~~~~~~~~~~L~ 126 (447)
.+|+.+++++|+
T Consensus 111 ~~g~~~~v~~Ll 122 (125)
T d1bi7b_ 111 ELGHRDVARYLR 122 (125)
T ss_dssp HHTCHHHHHHHS
T ss_pred HcCCHHHHHHHH
Confidence 666666666654
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.9e-19 Score=161.02 Aligned_cols=114 Identities=26% Similarity=0.259 Sum_probs=104.9
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
++.|.+..|.+|+||||+|+..|+.+++++|+++|+|+|.+|.+|.||||+|+..|+.+++++|++.|++++.+|.+|+|
T Consensus 92 ~~~d~~~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~T 171 (223)
T d1uoha_ 92 KGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNT 171 (223)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCC
T ss_pred cCceeEeeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCc
Confidence 34556667778889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|||+|+..|+.+++++|+++|++++..+..+.++
T Consensus 172 pL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~tp 205 (223)
T d1uoha_ 172 PLHLACDEERVEEAKLLVSQGASIYIENKEEKTP 205 (223)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCH
T ss_pred eeccccccCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 9999999999999999999999998876655444
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.79 E-value=1.2e-19 Score=165.38 Aligned_cols=100 Identities=33% Similarity=0.408 Sum_probs=93.2
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCC-CCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~-d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl 110 (447)
+.+.++..|+||||+||..|+.+++++|++.|++.+.. +..|.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 150 ~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~d~~g~t~L 229 (255)
T d1oy3d_ 150 QLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPL 229 (255)
T ss_dssp GTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred ccccccccCcccccccccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCCCCCCCCHH
Confidence 34456677889999999999999999999999998865 57899999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHHhCCC
Q 013214 111 GDAIYYKNHEVIKLLEKHGAK 131 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~~a~ 131 (447)
|+|+..++.+++++|+++||+
T Consensus 230 ~~A~~~~~~~i~~~Ll~~Ga~ 250 (255)
T d1oy3d_ 230 GSALLRPNPILARLLRAHGAP 250 (255)
T ss_dssp HHHHTSSCHHHHHHHHHTTCC
T ss_pred HHHHHCCCHHHHHHHHHcCCC
Confidence 999999999999999999996
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=5.1e-20 Score=149.18 Aligned_cols=102 Identities=24% Similarity=0.247 Sum_probs=92.9
Q ss_pred hhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCC-Cccccccccch
Q 013214 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS-TPLGDAIYYKN 118 (447)
Q Consensus 40 g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~-tpl~~a~~~~~ 118 (447)
+.++||+||..|+.+++++|+++|+|+|.+|.+|.||||+|+ .|+.+++++|+++|++++.+|..|. ||||+|+..|+
T Consensus 3 ~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~ 81 (125)
T d1bi7b_ 3 SADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF 81 (125)
T ss_dssp STTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTC
T ss_pred ChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence 346799999999999999999999999999999999999775 7999999999999999999999877 69999999999
Q ss_pred HHHHHHHHHhCCCCCCCccccccc
Q 013214 119 HEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 119 ~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
.+++++|+++|++++..+..+.++
T Consensus 82 ~~~v~~Ll~~ga~~~~~d~~G~T~ 105 (125)
T d1bi7b_ 82 LDTLVVLHRAGARLDVRDAWGRLP 105 (125)
T ss_dssp HHHHHHHHHHTCCSSCCCTTCCCH
T ss_pred ccccccccccccccccccCCCCCH
Confidence 999999999999998776555443
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=8.9e-19 Score=147.48 Aligned_cols=105 Identities=24% Similarity=0.281 Sum_probs=56.6
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~ 111 (447)
|++..|..|+||||+|+. |+.+++++|++.++|+|..+..|.+|++.|+..++.+++++++++|+++|.+|..|.||||
T Consensus 28 ~~n~~d~~g~t~L~~A~~-~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~ 106 (156)
T d1bd8a_ 28 HPDALNRFGKTALQVMMF-GSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIH 106 (156)
T ss_dssp CTTCCCTTSCCHHHHSCT-TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHH
T ss_pred CCCccCCCCCcccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCeeec
Confidence 334444445555555543 4555555555555555555555555555555555555555555555555555555555555
Q ss_pred cccccchHHHHHHHHHhCCCCCCCccc
Q 013214 112 DAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (447)
Q Consensus 112 ~a~~~~~~~~~~~L~~~~a~~~~~~~~ 138 (447)
+|+..|+.+++++|+ .|++++..+..
T Consensus 107 ~A~~~~~~~i~~~L~-~~~~~~~~d~~ 132 (156)
T d1bd8a_ 107 LAVQEGHTAVVSFLA-AESDLHRRDAR 132 (156)
T ss_dssp HHHHHTCHHHHHHHH-TTSCTTCCCTT
T ss_pred ccccccccccccccc-ccccccccCCC
Confidence 555555555555444 34555444433
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.73 E-value=1.7e-18 Score=157.52 Aligned_cols=96 Identities=23% Similarity=0.170 Sum_probs=90.1
Q ss_pred CccchhhHHHHHHHcCCHHHHHHHHHcCCC---CCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 013214 36 EEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (447)
Q Consensus 36 ~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d---~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 112 (447)
.+.+|+||||+||..|+.+++++|+++|++ +|.+|..|+||||+|+..|+.+++++|+++|++++.+|.+|.||||+
T Consensus 5 i~~~G~t~Lh~A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~~ 84 (255)
T d1oy3d_ 5 VTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHL 84 (255)
T ss_dssp CCTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHH
T ss_pred CCcCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhhhh
Confidence 467899999999999999999999999988 77888999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHHhCCC
Q 013214 113 AIYYKNHEVIKLLEKHGAK 131 (447)
Q Consensus 113 a~~~~~~~~~~~L~~~~a~ 131 (447)
|+..++.++++.|++.+..
T Consensus 85 A~~~~~~~~~~~Ll~~~~~ 103 (255)
T d1oy3d_ 85 ACRVRAHTCACVLLQPRPS 103 (255)
T ss_dssp HTTTTCHHHHHHHSSSCCS
T ss_pred hhccCchHHHHHHHhhccc
Confidence 9999999999999876543
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=4.1e-18 Score=150.17 Aligned_cols=97 Identities=23% Similarity=0.247 Sum_probs=91.1
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
.+.+.+..+..|+||||+|+..+..++++.+++.++++|.+|.+|.||||+||..|+.++|++|+++|||++.+|..|+|
T Consensus 112 ~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~~g~T 191 (209)
T d1ot8a_ 112 ADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDHMDRL 191 (209)
T ss_dssp TTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred hcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCCCcCCCCCC
Confidence 44555666777889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHH
Q 013214 109 PLGDAIYYKNHEVIKLL 125 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L 125 (447)
|||+|+++|+.+++++|
T Consensus 192 pl~~A~~~~~~~iv~lL 208 (209)
T d1ot8a_ 192 PRDVASERLHHDIVRLL 208 (209)
T ss_dssp HHHHHHHTTCHHHHHHH
T ss_pred HHHHHHHcCCHHHHhhc
Confidence 99999999999999986
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.73 E-value=5.6e-18 Score=141.71 Aligned_cols=100 Identities=30% Similarity=0.351 Sum_probs=64.5
Q ss_pred hhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcC---------------------------------cHH
Q 013214 41 EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---------------------------------FTE 87 (447)
Q Consensus 41 ~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g---------------------------------~~~ 87 (447)
.||||.||+.|+.+++++||++|++++ .|..|+||||+|+..+ +.+
T Consensus 3 ~t~L~~Aa~~g~~~~v~~LL~~ga~~~-~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (153)
T d1awcb_ 3 GKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHAN 81 (153)
T ss_dssp HHHHHHHHHHTCHHHHHHHHHHTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHH
T ss_pred CHHHHHHHHCCCHHHHHHHHHcCCCcc-cccCCCccccccccccccccccccccccccccccccccccccccccccccce
Confidence 355555555555555555555555554 3555555555555444 335
Q ss_pred HHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCcccccc
Q 013214 88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (447)
Q Consensus 88 ~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~ 141 (447)
++++|+.+|++++.+|..|.||||+|+..|+.+++++|+++|++++..+..+.+
T Consensus 82 ~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~T 135 (153)
T d1awcb_ 82 IVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKT 135 (153)
T ss_dssp HHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred eeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCC
Confidence 667777777777777788888888888888888888888888777665544433
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.73 E-value=4.4e-18 Score=159.24 Aligned_cols=113 Identities=19% Similarity=0.201 Sum_probs=93.4
Q ss_pred CCCCCCC-ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcH-------HHHHHH---------
Q 013214 30 GLDDDGE-EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT-------EVVSLL--------- 92 (447)
Q Consensus 30 ~~d~~~~-~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~-------~~v~~L--------- 92 (447)
+.|.|.. |.+|+||||+||..|+.+++++|+++|+|++.+|..|+||||.||..++. +++++|
T Consensus 96 ~~dvn~~~D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d~ 175 (301)
T d1sw6a_ 96 QLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDS 175 (301)
T ss_dssp CCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECT
T ss_pred CCCcCcCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhccc
Confidence 4455544 77899999999999999999999999999999999999999999986642 333322
Q ss_pred ---------------------------------HHcCC-------------------------------------CCCCC
Q 013214 93 ---------------------------------LERGA-------------------------------------DVDPK 102 (447)
Q Consensus 93 ---------------------------------l~~ga-------------------------------------~~~~~ 102 (447)
++.+. .+|.+
T Consensus 176 ~g~t~lh~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~ 255 (301)
T d1sw6a_ 176 MNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQ 255 (301)
T ss_dssp TCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCC
T ss_pred ccCCHHHHHHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccCC
Confidence 22221 17889
Q ss_pred CCCCCCccccccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 103 d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|..|+||||+|++.|+.+++++|+++||++++.+..+.+|
T Consensus 256 D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tp 295 (301)
T d1sw6a_ 256 DSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP 295 (301)
T ss_dssp CTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 9999999999999999999999999999999877666554
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.72 E-value=9.8e-18 Score=149.89 Aligned_cols=100 Identities=25% Similarity=0.250 Sum_probs=83.9
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcC-CCCCCCCCCCCCHHHHHHHcCcHHHHHHHHH-cCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWG 106 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g-~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~-~ga~~~~~d~~g 106 (447)
.+.+.+..+..|+||||+|+..|+.++++.|++.| .++|.+|.+|+||||+|+.+|+.++|++|++ .|+|++.+|.+|
T Consensus 127 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~~g 206 (229)
T d1ixva_ 127 NGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKG 206 (229)
T ss_dssp TTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCTTS
T ss_pred hcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCCCC
Confidence 44555666777888899999999999999998876 6788888899999999999999999999886 489999999999
Q ss_pred CCccccccccchHHHHHHHHHhCCC
Q 013214 107 STPLGDAIYYKNHEVIKLLEKHGAK 131 (447)
Q Consensus 107 ~tpl~~a~~~~~~~~~~~L~~~~a~ 131 (447)
+||||+|+. .+++++|++.|+|
T Consensus 207 ~t~l~~A~~---~~~~~~Ll~~g~d 228 (229)
T d1ixva_ 207 AKAEDVALN---EQVKKFFLNNVVD 228 (229)
T ss_dssp CCTGGGCSC---HHHHHHHHHHCCC
T ss_pred CCHHHHHhh---HHHHHHHHHcCCC
Confidence 999998874 4788899988886
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.72 E-value=8e-19 Score=161.59 Aligned_cols=112 Identities=21% Similarity=0.264 Sum_probs=93.7
Q ss_pred ecccCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHH--------HHcCCCCCCCCCCCCCHHHHHHHc
Q 013214 12 LKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKEL--------LDSGIDVNFRDIDNRTALHVAACQ 83 (447)
Q Consensus 12 ~~~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~L--------l~~g~d~n~~d~~g~t~Lh~A~~~ 83 (447)
.+...+.....+.+ +|..|. ..|+||||+||..|+.++++.| +++|||||.+|.+|+||||+|+.+
T Consensus 11 ~~~~~~~~~l~~~~--~n~~~~----~~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~ 84 (277)
T d2fo1e1 11 AGSYAITEPITRES--VNIIDP----RHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLA 84 (277)
T ss_dssp HSSSCCCSCCSTTT--TTTCCC----SSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHH
T ss_pred CCCHHHHHHHHhcC--CCcCCC----CCCccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeecccccc
Confidence 34444554444444 344442 3588999999999999888776 567999999999999999999999
Q ss_pred CcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHhC
Q 013214 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (447)
Q Consensus 84 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~ 129 (447)
|+.+++++|+++|||++.+|..|.||+++|...++.++...+...+
T Consensus 85 g~~~iv~~Ll~~Gad~n~~~~~g~t~l~~a~~~~~~~~~~~l~~~~ 130 (277)
T d2fo1e1 85 RRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNST 130 (277)
T ss_dssp TCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTSH
T ss_pred ccccccccccccccccccccccccccccchhhhcchhhhhhhhhcc
Confidence 9999999999999999999999999999999999999998886543
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=8.5e-18 Score=150.13 Aligned_cols=98 Identities=22% Similarity=0.234 Sum_probs=90.9
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 108 (447)
+|.|++..+.+|.||||+|+..++.+.+++|++.|+|+|.+|.+|+||||+|+..|+.++|++|++.|||++.+|.+|+|
T Consensus 125 ~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~t 204 (223)
T d1uoha_ 125 GGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKT 204 (223)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCC
T ss_pred CCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCceeccccccCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence 35556667778889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHH
Q 013214 109 PLGDAIYYKNHEVIKLLEK 127 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~ 127 (447)
|||+|. .|+.++++.|++
T Consensus 205 pl~~A~-~~~~~i~~~Ll~ 222 (223)
T d1uoha_ 205 PLQVAK-GGLGLILKRMVE 222 (223)
T ss_dssp HHHHCC-TTHHHHHHHHHC
T ss_pred HHHHHH-CCCHHHHhcccC
Confidence 999984 699999999885
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=1.1e-17 Score=140.59 Aligned_cols=119 Identities=24% Similarity=0.356 Sum_probs=100.2
Q ss_pred cccceeeeecccCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc
Q 013214 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (447)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~ 83 (447)
.+|+..|+.+.........+. +.|.+..+..|.+|+++++..++.++++.+++.|+++|.+|.+|+||||+||..
T Consensus 37 ~t~L~~A~~~~~~~v~~Ll~~-----~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~ 111 (156)
T d1bd8a_ 37 KTALQVMMFGSTAIALELLKQ-----GASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQE 111 (156)
T ss_dssp CCHHHHSCTTCHHHHHHHHHT-----TCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHH
T ss_pred Ccccccccccccccccccccc-----cccccccccccccccccccccccccccccccccccccccccCCCCeeecccccc
Confidence 456666654443333333344 445555566778889999999999999999999999999999999999999999
Q ss_pred CcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHHHHh
Q 013214 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128 (447)
Q Consensus 84 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L~~~ 128 (447)
|+.+++++|+ .|++++.+|.+|+||||+|+..|+.+++++|+++
T Consensus 112 ~~~~i~~~L~-~~~~~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~h 155 (156)
T d1bd8a_ 112 GHTAVVSFLA-AESDLHRRDARGLTPLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp TCHHHHHHHH-TTSCTTCCCTTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred cccccccccc-ccccccccCCCCCCHHHHHHHcCCHHHHHHHHhh
Confidence 9999999888 7899999999999999999999999999999875
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=7e-18 Score=164.01 Aligned_cols=94 Identities=32% Similarity=0.386 Sum_probs=90.4
Q ss_pred hHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHH
Q 013214 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (447)
Q Consensus 42 t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~ 121 (447)
||||+||..|+.+++++|+++|+|+|.+|..|+||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.++
T Consensus 2 TpL~~Aa~~g~~~~v~~Ll~~g~~in~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gadi~~~~~~g~t~L~~A~~~g~~~~ 81 (408)
T d1n11a_ 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNM 81 (408)
T ss_dssp CHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCHHH
T ss_pred ChHHHHHHCcCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHH
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCC
Q 013214 122 IKLLEKHGAKPLMA 135 (447)
Q Consensus 122 ~~~L~~~~a~~~~~ 135 (447)
+++|+..++++...
T Consensus 82 ~~~Ll~~~~~~~~~ 95 (408)
T d1n11a_ 82 VKLLLENNANPNLA 95 (408)
T ss_dssp HHHHHHHTCCTTCC
T ss_pred HHHHHHhhhccccc
Confidence 99999988776443
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=6.8e-18 Score=150.47 Aligned_cols=140 Identities=22% Similarity=0.208 Sum_probs=101.0
Q ss_pred cccceeeeecccCCCCccccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc
Q 013214 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83 (447)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~ 83 (447)
.|||..|+...........-+...-++.+.|.+|.+|+||||+||..|+.+++++|+++|+|++.+|..|+||||+|+..
T Consensus 3 ~t~Lh~A~~~g~~~~~~~li~~~~~~~~~in~~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~ 82 (221)
T d1iknd_ 3 DSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQ 82 (221)
T ss_dssp CCTTHHHHHTTCSSSSSCCCC-----CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHH
T ss_pred ChHHHHHHHcCCHHHHHHHHHHHHhCCCCcccCCCCCCcccccccccccccccccccccccccccccccccccccccccc
Confidence 46666665443321111111112224455566677788999999999999999999999999999999999998888877
Q ss_pred CcHHHHH---------------------------------------HHHHcCCCCCCCC-CCCCCccccccccchHHHHH
Q 013214 84 GFTEVVS---------------------------------------LLLERGADVDPKD-RWGSTPLGDAIYYKNHEVIK 123 (447)
Q Consensus 84 g~~~~v~---------------------------------------~Ll~~ga~~~~~d-~~g~tpl~~a~~~~~~~~~~ 123 (447)
|+.++++ +|+..|++++..+ .+|.||||+|++.|+.++++
T Consensus 83 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~ 162 (221)
T d1iknd_ 83 GCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVS 162 (221)
T ss_dssp TCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHH
T ss_pred ccccccchhhhhcccccccccccccccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHH
Confidence 7665554 4455566776654 57999999999999999999
Q ss_pred HHHHhCCCCCCCcccccccC
Q 013214 124 LLEKHGAKPLMAPMHVKHAR 143 (447)
Q Consensus 124 ~L~~~~a~~~~~~~~~~~~~ 143 (447)
+|+++|++++..+..+.++.
T Consensus 163 ~Ll~~gad~~~~~~~G~tpl 182 (221)
T d1iknd_ 163 LLLKCGADVNRVTYQGYSPY 182 (221)
T ss_dssp HHHTTTCCSCCCCTTCCCGG
T ss_pred HHHhcCCcccccCCCCCCHH
Confidence 99999999987766655553
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=3e-17 Score=159.48 Aligned_cols=98 Identities=30% Similarity=0.293 Sum_probs=85.4
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
+.|.+..+..+.||||.|+..++.+.++.+++.|+|+|.+|.+|.||||+|+.+|+.++|++|+++|||+|.+|.+|+||
T Consensus 287 g~~~~~~~~~~~t~L~~~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G~t~ 366 (408)
T d1n11a_ 287 GVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTP 366 (408)
T ss_dssp TCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCCH
T ss_pred CCccccccccccccchhhcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 45555555667788999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHH
Q 013214 110 LGDAIYYKNHEVIKLLEK 127 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~ 127 (447)
||+|+.+|+.+++++|..
T Consensus 367 L~~A~~~~~~~iv~~L~~ 384 (408)
T d1n11a_ 367 LAIAKRLGYISVTDVLKV 384 (408)
T ss_dssp HHHHHHTTCHHHHHHHHH
T ss_pred HHHHHHcCCHHHHHHHHH
Confidence 999999999888876644
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.9e-17 Score=138.96 Aligned_cols=93 Identities=31% Similarity=0.317 Sum_probs=66.5
Q ss_pred hHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHH
Q 013214 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (447)
Q Consensus 42 t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~ 121 (447)
+|||+||..|+.++++.|+++|+|+|.+|.+|+||||+|+ .|+.+++++|+++|++++.++..|.+|++.++..++.++
T Consensus 3 ~~Lh~Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~ 81 (156)
T d1ihba_ 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDT 81 (156)
T ss_dssp HHHHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHH
T ss_pred HHHHHHHHcCCHHHHHHHHHCCCCcCccCCcccccccccc-cccccccccccccccccccccccCccccccccccccccc
Confidence 5677777777777777777777777777777777777664 567777777777777777777777777777777777777
Q ss_pred HHHHHHhCCCCCCC
Q 013214 122 IKLLEKHGAKPLMA 135 (447)
Q Consensus 122 ~~~L~~~~a~~~~~ 135 (447)
++.|++.+.++...
T Consensus 82 ~~~l~~~~~~~~~~ 95 (156)
T d1ihba_ 82 LQTLLEFQADVNIE 95 (156)
T ss_dssp HHHHHHTTCCTTCC
T ss_pred cccccccccccccc
Confidence 77777766655443
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=2.7e-17 Score=151.80 Aligned_cols=108 Identities=28% Similarity=0.288 Sum_probs=90.1
Q ss_pred hhcccCCCCCCCccchhhHHHHHH----HcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHc-CCCC
Q 013214 25 EAELNGLDDDGEEIKPEFRLMFLA----NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADV 99 (447)
Q Consensus 25 ~a~~n~~d~~~~~~~g~t~lh~a~----~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~-ga~~ 99 (447)
++++|..|. .|.++++.+. ..+..+++++|+++|+|+|.+|.+|.||||+|+..|+.+++++|++. |+++
T Consensus 172 ~~~i~~~~~-----~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~di 246 (285)
T d1wdya_ 172 GADVNACDN-----MGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEI 246 (285)
T ss_dssp CCCTTCCCT-----TSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCT
T ss_pred CCCcccccC-----CCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCC
Confidence 444444444 4444454433 23335688899999999999999999999999999999999999985 9999
Q ss_pred CCCCCCCCCccccccccchHHHHHHHHHhCCCCCCCcc
Q 013214 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (447)
Q Consensus 100 ~~~d~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~~~~~ 137 (447)
|.+|.+|.||||+|+.+|+.+++++|+++||+++.++.
T Consensus 247 n~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d~ 284 (285)
T d1wdya_ 247 NDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDL 284 (285)
T ss_dssp TCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSSC
T ss_pred cCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence 99999999999999999999999999999999988753
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.67 E-value=3.3e-17 Score=151.97 Aligned_cols=95 Identities=27% Similarity=0.319 Sum_probs=85.0
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
..+....+..|.||||+|+..|+.++++.|++.|+|+|.+|.+|+||||+|+..|+.++|++|+++|||++.+|..|+||
T Consensus 189 ~~~~~~~~~~g~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~Ta 268 (291)
T d1s70b_ 189 HINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTA 268 (291)
T ss_dssp CCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred ccccccccCCCCChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 34455667789999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHh
Q 013214 110 LGDAIYYKNHEVIKLLEKH 128 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~ 128 (447)
||+|+. +++++|.+.
T Consensus 269 L~~A~e----~~~~~L~~~ 283 (291)
T d1s70b_ 269 FDVADE----DILGYLEEL 283 (291)
T ss_dssp TTSCCS----GGGHHHHHH
T ss_pred HHHHHH----HHHHHHHHH
Confidence 999986 355555443
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.67 E-value=8.3e-17 Score=134.59 Aligned_cols=101 Identities=25% Similarity=0.297 Sum_probs=90.1
Q ss_pred hHHHHHHHcCCHHHHHHHHHcCCCCCCC------CCCCCCHHHHHHHc---CcHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 013214 42 FRLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (447)
Q Consensus 42 t~lh~a~~~~~~~~~~~Ll~~g~d~n~~------d~~g~t~Lh~A~~~---g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 112 (447)
..|+.|++.+++..+..++..|+|++.+ +..|+||||+|+.. |+.+++++|+++|+++|.+|..|+||||+
T Consensus 8 ~~L~~Av~~~dl~~l~~~~~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~ 87 (154)
T d1dcqa1 8 HSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHY 87 (154)
T ss_dssp HHHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHH
T ss_pred HHHHHHHHhCCHHHHHHHHHcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhcccccc
Confidence 3456788999999999999999998865 77899999999974 67899999999999999999999999999
Q ss_pred ccccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 113 AIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 113 a~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
|+..|+.+++++|+++|++++..+..+.+|
T Consensus 88 A~~~~~~~~v~~Ll~~gad~~~~d~~g~tp 117 (154)
T d1dcqa1 88 CCLTDNAECLKLLLRGKASIEIANESGETP 117 (154)
T ss_dssp HHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred ccccccccccccccccCccccccCCCCCCH
Confidence 999999999999999999998876655444
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.66 E-value=5.4e-17 Score=142.82 Aligned_cols=118 Identities=31% Similarity=0.242 Sum_probs=99.7
Q ss_pred cccchhcccCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCC--------------------------------
Q 013214 21 RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNF-------------------------------- 68 (447)
Q Consensus 21 ~~~~~a~~n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~-------------------------------- 68 (447)
+.++|+|+|.. .|.+|+||||+||..|+.+++++|++.|+++|.
T Consensus 8 Ll~~g~din~~----~d~~G~t~L~~A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (209)
T d1ot8a_ 8 LLAQGAELNAT----MDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRATNL 83 (209)
T ss_dssp HHHHHHHHHHH----HHHHCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTTCCT
T ss_pred HHHCCCCcCcC----cCCCCCCHHHHHHHcCCHHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 34567777653 245677889999999999999999999988764
Q ss_pred -----------------------------------CCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 013214 69 -----------------------------------RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (447)
Q Consensus 69 -----------------------------------~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a 113 (447)
+|..|+||||+|+..|..++++.|++.+++++.+|..|.||||+|
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A 163 (209)
T d1ot8a_ 84 NARMHDGTTPLILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLA 163 (209)
T ss_dssp TCCCTTCCCHHHHHHHTTCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHH
T ss_pred ccccccccccccccccccchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchh
Confidence 455667778888888899999999999999999999999999999
Q ss_pred cccchHHHHHHHHHhCCCCCCCccccccc
Q 013214 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (447)
Q Consensus 114 ~~~~~~~~~~~L~~~~a~~~~~~~~~~~~ 142 (447)
+..|+.+++++|+++|++++..+..+.+|
T Consensus 164 ~~~g~~~~v~~Ll~~gad~n~~d~~g~Tp 192 (209)
T d1ot8a_ 164 AREGSYEASKALLDNFANREITDHMDRLP 192 (209)
T ss_dssp HHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred ccccHHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 99999999999999999998766544433
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.66 E-value=2.6e-18 Score=164.01 Aligned_cols=99 Identities=19% Similarity=0.071 Sum_probs=86.6
Q ss_pred CCCccchhhHHHHHHHcCCHHHHHH---HHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCC--CCCCC
Q 013214 34 DGEEIKPEFRLMFLANERDVEGIKE---LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGST 108 (447)
Q Consensus 34 ~~~~~~g~t~lh~a~~~~~~~~~~~---Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d--~~g~t 108 (447)
+.++..|.||||+||.+|+.+++++ |++.|+++|.+|.+|+||||+||.+|+.++|++|+++|++++..+ .+|.|
T Consensus 84 ~~~~~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t 163 (346)
T d2ajaa1 84 HKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYH 163 (346)
T ss_dssp HHHTCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHH
T ss_pred HhccCCCCcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCC
Confidence 3566789999999999999877765 688999999999999999999999999999999999999999876 46999
Q ss_pred ccccccccchHHHHHHHHHhCCCC
Q 013214 109 PLGDAIYYKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~~a~~ 132 (447)
|||+|+.+|+.+++++|++.|++.
T Consensus 164 ~L~~Aa~~g~~~iv~~Ll~~~~~~ 187 (346)
T d2ajaa1 164 AFRLAAENGHLHVLNRLCELAPTE 187 (346)
T ss_dssp HHHHHHHTTCHHHHHHHHHSCGGG
T ss_pred hhHHHHHHhhHHHHHHHHHcCCcc
Confidence 999999999999999999988764
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.65 E-value=1.8e-16 Score=132.30 Aligned_cols=74 Identities=34% Similarity=0.467 Sum_probs=69.0
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccchHHHHHHH
Q 013214 52 DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125 (447)
Q Consensus 52 ~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~~~~~~~~L 125 (447)
+.+.++.+++.|++++.+|.+|+||||+|+..|+.+++++|+++|++++.+|.+|.||||+|+.+|+.+++++|
T Consensus 79 ~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~~~g~~eiv~lL 152 (153)
T d1awcb_ 79 HANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152 (153)
T ss_dssp CHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred cceeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHHHHcCCHHHHHhC
Confidence 44667777788889999999999999999999999999999999999999999999999999999999999976
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=2.6e-16 Score=131.80 Aligned_cols=109 Identities=25% Similarity=0.237 Sum_probs=94.9
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCc
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 109 (447)
|.|++.+|.+|+||||+|+ .|+.+++++|+++|+|++.++..|.|||+.++..++.++++.|++.+.+++..|..|.+|
T Consensus 24 g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 102 (156)
T d1ihba_ 24 NVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLP 102 (156)
T ss_dssp CCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCcCccCCcccccccccc-cccccccccccccccccccccccCcccccccccccccccccccccccccccccccccccc
Confidence 4455556677889999886 689999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHHhCC-CCCCCcccc
Q 013214 110 LGDAIYYKNHEVIKLLEKHGA-KPLMAPMHV 139 (447)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~~a-~~~~~~~~~ 139 (447)
+++|+..++.+++++|+++++ ++..++..+
T Consensus 103 l~~a~~~~~~~~~~~Ll~~~~~~~~~~d~~g 133 (156)
T d1ihba_ 103 LHLAAKEGHLRVVEFLVKHTASNVGHRNHKG 133 (156)
T ss_dssp HHHHHHTTCHHHHHHHHHHSCCCTTCCCTTS
T ss_pred cccccccccccccccccccccccccccCCCC
Confidence 999999999999999999887 555544433
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=3.9e-16 Score=138.80 Aligned_cols=96 Identities=25% Similarity=0.243 Sum_probs=88.0
Q ss_pred ccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 013214 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (447)
Q Consensus 37 ~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d-~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~ 115 (447)
..+|.||||+|+..++.+.+++|++.|++++..+ .+|+||||+|++.|+.+++++|+++|+|++.+|..|.||||+|+.
T Consensus 108 ~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A~~ 187 (221)
T d1iknd_ 108 NYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWG 187 (221)
T ss_dssp CTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCTT
T ss_pred ccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHHHHHH
Confidence 3347788999999999999999999999998775 679999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHHhCCCC
Q 013214 116 YKNHEVIKLLEKHGAKP 132 (447)
Q Consensus 116 ~~~~~~~~~L~~~~a~~ 132 (447)
.++.+++++|.+.+.+.
T Consensus 188 ~~~~~~~~~l~~~~~~~ 204 (221)
T d1iknd_ 188 RPSTRIQQQLGQLTLEN 204 (221)
T ss_dssp SSCHHHHHHHHTTSCGG
T ss_pred CCCHHHHHHHHHcCCcc
Confidence 99999999999987653
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.63 E-value=3.6e-18 Score=163.03 Aligned_cols=105 Identities=14% Similarity=-0.001 Sum_probs=90.6
Q ss_pred cCCCCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCC--CCCCCHHHHHHHcCcHHHHHHHHHcCCCCC---CCC
Q 013214 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD--IDNRTALHVAACQGFTEVVSLLLERGADVD---PKD 103 (447)
Q Consensus 29 n~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d--~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~---~~d 103 (447)
++.+.+..+.+|+||||+||.+|+.+++++|+++|+++|..| .+|+||||+||.+|+.++|++|++.|++.. ..+
T Consensus 115 ~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~~~~~~~~ 194 (346)
T d2ajaa1 115 SDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQA 194 (346)
T ss_dssp CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHH
T ss_pred CCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHHHhhHHHHHHHHHcCCccccccccc
Confidence 455666677889999999999999999999999999999876 469999999999999999999999998654 344
Q ss_pred CCCCCccccccccchHHHHHHHHHhCCCCC
Q 013214 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133 (447)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~~~~a~~~ 133 (447)
..|.||++.|+.+|+.+++++|++.|+++.
T Consensus 195 ~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~~ 224 (346)
T d2ajaa1 195 ENYYAFRWAAVGRGHHNVINFLLDCPVMLA 224 (346)
T ss_dssp HHHHHHHHHHSTTCCHHHHHHHTTSHHHHH
T ss_pred CCCcchhhHHhhcCHHHHHHHHHhCCCCcc
Confidence 567788889999999999999999988764
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.63 E-value=3.8e-16 Score=144.66 Aligned_cols=98 Identities=27% Similarity=0.393 Sum_probs=93.4
Q ss_pred cchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCccccccccc
Q 013214 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (447)
Q Consensus 38 ~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~~~~ 117 (447)
.+|.|+||.||..|+.+++++||++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++.+..+..+.||+++|+..+
T Consensus 38 ~~~~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~ 117 (291)
T d1s70b_ 38 FDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCG 117 (291)
T ss_dssp ECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred CCCchHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeeccccccccccccccccccccccccc
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCC
Q 013214 118 NHEVIKLLEKHGAKPLMA 135 (447)
Q Consensus 118 ~~~~~~~L~~~~a~~~~~ 135 (447)
+.++++.|+++|+.....
T Consensus 118 ~~~~~~~l~~~~~~~~~~ 135 (291)
T d1s70b_ 118 YLDIAEYLISQGAHVGAV 135 (291)
T ss_dssp CHHHHHHHHHTTCCTTCC
T ss_pred ccchhhcccccCcccccc
Confidence 999999999999876544
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.62 E-value=3.1e-16 Score=143.93 Aligned_cols=96 Identities=26% Similarity=0.375 Sum_probs=89.4
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHH-HcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll-~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl 110 (447)
..+..+..|+||||+++..++.+.++.++ ..+.+++.+|..|+||||+|+..|+.++|++|+++|+|+|.+|.+|.|||
T Consensus 179 ~~~~~~~~g~t~L~~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T~L 258 (277)
T d2fo1e1 179 RKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTAR 258 (277)
T ss_dssp GTSSSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHH
T ss_pred cccccccCCCCccccccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCCCHH
Confidence 34556778899999999999999999866 57899999999999999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHH
Q 013214 111 GDAIYYKNHEVIKLLEK 127 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~ 127 (447)
|+|+..|+.+++++|++
T Consensus 259 ~~A~~~~~~~iv~lL~~ 275 (277)
T d2fo1e1 259 QLAQANNHHNIVDIFDR 275 (277)
T ss_dssp HHHHHTTCHHHHHHHHT
T ss_pred HHHHHcCCHHHHHHHHH
Confidence 99999999999999986
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=1.4e-15 Score=133.81 Aligned_cols=93 Identities=22% Similarity=0.280 Sum_probs=87.0
Q ss_pred chhhHHHHHHHcCCHHHHHHHHH----cCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 013214 39 KPEFRLMFLANERDVEGIKELLD----SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (447)
Q Consensus 39 ~g~t~lh~a~~~~~~~~~~~Ll~----~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~ 114 (447)
+|+||||+||..|+.++++.|++ .|+|+|.+|.+|+||||+|+..|+.+++++|+++|++.+..+..|.++++.|.
T Consensus 2 dG~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~a~ 81 (228)
T d1k1aa_ 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLAC 81 (228)
T ss_dssp TTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred CCccHHHHHHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhccccccccccccccccccccccccccccccccc
Confidence 59999999999999999999874 79999999999999999999999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHHhCCC
Q 013214 115 YYKNHEVIKLLEKHGAK 131 (447)
Q Consensus 115 ~~~~~~~~~~L~~~~a~ 131 (447)
..++.++++.+......
T Consensus 82 ~~~~~~~~~~~~~~~~~ 98 (228)
T d1k1aa_ 82 EHRSPTCLRALLDSAAP 98 (228)
T ss_dssp HTTCHHHHHHHHHHSCT
T ss_pred ccccccchhhhhhcccc
Confidence 99999999888776543
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=1.7e-15 Score=133.32 Aligned_cols=89 Identities=24% Similarity=0.295 Sum_probs=84.6
Q ss_pred CCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 013214 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (447)
Q Consensus 35 ~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~ 114 (447)
.....|.++|+.|+..+..++++.+++.|.+++.+|..|.||||+|+..|+.+++++|+++|||++.+|.+|+||||+|+
T Consensus 139 ~~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~A~ 218 (228)
T d1k1aa_ 139 VDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVAR 218 (228)
T ss_dssp CCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTCS
T ss_pred ccccchhhHHHHHHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence 44557889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccchHHHHH
Q 013214 115 YYKNHEVIK 123 (447)
Q Consensus 115 ~~~~~~~~~ 123 (447)
.+|+.++++
T Consensus 219 ~~~~~divk 227 (228)
T d1k1aa_ 219 SRRVIDILR 227 (228)
T ss_dssp SHHHHHHHT
T ss_pred hCCCccccC
Confidence 999998874
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.57 E-value=5e-15 Score=131.87 Aligned_cols=112 Identities=25% Similarity=0.223 Sum_probs=101.0
Q ss_pred CCCCCccchhhHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcC-CCCCCCCCCCCCcc
Q 013214 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPL 110 (447)
Q Consensus 32 d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~g-a~~~~~d~~g~tpl 110 (447)
+....+..+.|+++.++..++.++++.|++.|.+.+.+|.+|+||||+|+..|+.+++++|++.| .+++.+|.+|+|||
T Consensus 97 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpL 176 (229)
T d1ixva_ 97 DLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPL 176 (229)
T ss_dssp CTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHH
T ss_pred cccccccccccccccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCch
Confidence 34556667889999999999999999999999999999999999999999999999999999986 78999999999999
Q ss_pred ccccccchHHHHHHHHH-hCCCCCCCcccccccC
Q 013214 111 GDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKHAR 143 (447)
Q Consensus 111 ~~a~~~~~~~~~~~L~~-~~a~~~~~~~~~~~~~ 143 (447)
|+|+..|+.+++++|++ .|++++..+..+.++.
T Consensus 177 h~A~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~l 210 (229)
T d1ixva_ 177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAE 210 (229)
T ss_dssp HHHHHTTCHHHHHHHHHHHCCCSCCCCTTSCCTG
T ss_pred hhhcccccHHHHHHHHHhcCCCCCCcCCCCCCHH
Confidence 99999999999999996 6999988766555553
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.2e-14 Score=133.57 Aligned_cols=75 Identities=27% Similarity=0.369 Sum_probs=68.5
Q ss_pred CCCCCCCccchhhHHHHHHHcCCHHHHHHHHHc-CCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCC
Q 013214 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (447)
Q Consensus 30 ~~d~~~~~~~g~t~lh~a~~~~~~~~~~~Ll~~-g~d~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~ 104 (447)
|.|.+.++..|+||||+||..|+.+++++|+++ |+|+|.+|.+|.||||+|+..|+.++|++|+++|||+|++|.
T Consensus 209 ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d~ 284 (285)
T d1wdya_ 209 GADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDL 284 (285)
T ss_dssp TCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSSC
T ss_pred CCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence 445556667788999999999999999999985 999999999999999999999999999999999999999984
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.47 E-value=3.1e-14 Score=132.62 Aligned_cols=49 Identities=31% Similarity=0.376 Sum_probs=47.8
Q ss_pred CCCCCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 013214 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (447)
Q Consensus 66 ~n~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~a~ 114 (447)
+|.+|.+|+||||+||+.|+.++|++|+++|||++.+|+.|.|||+||+
T Consensus 252 in~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~ 300 (301)
T d1sw6a_ 252 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300 (301)
T ss_dssp TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred ccCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence 7889999999999999999999999999999999999999999999996
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.02 E-value=1.8e-05 Score=70.15 Aligned_cols=127 Identities=13% Similarity=0.020 Sum_probs=84.1
Q ss_pred EEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEeccCCCCHHHHHHhcCC
Q 013214 168 FILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246 (447)
Q Consensus 168 ~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 246 (447)
++.+..+++.+.+|+........ ...+.+|...++.+. +-.+++++.+...++..++||++++|.++.+....
T Consensus 30 v~rv~~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~--- 103 (263)
T d1j7la_ 30 VYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--- 103 (263)
T ss_dssp EEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT---
T ss_pred EEEEEeCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc---
Confidence 45566678888999886543222 224567888887773 44478888888888889999999988877654311
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------------------
Q 013214 247 LKPSTAVRFALDIARGMNYLHENK-------------------------------------------------------- 270 (447)
Q Consensus 247 l~~~~~~~i~~ql~~~l~~lH~~~-------------------------------------------------------- 270 (447)
......++.++...+..||+..
T Consensus 104 --~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 181 (263)
T d1j7la_ 104 --EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEE 181 (263)
T ss_dssp --CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCC
T ss_pred --cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcC
Confidence 1122233444444445555211
Q ss_pred CCCeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 271 ~~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
+..++|+|+.|.||++++++..-|+||+.+..
T Consensus 182 ~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11278999999999999766567999997753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.41 E-value=0.00025 Score=66.73 Aligned_cols=29 Identities=28% Similarity=0.375 Sum_probs=25.2
Q ss_pred CeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 273 ~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
.++|+|+.|.|||+++++ ++++||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 489999999999998764 89999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.34 E-value=0.00022 Score=62.50 Aligned_cols=63 Identities=19% Similarity=0.104 Sum_probs=43.4
Q ss_pred EEEEE-cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC--CCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 169 ILAFW-RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 169 ~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
+.+.. .+..+.+|....... ..+..|...++.+. .-.+++++.+..+++..+++|++++|.++
T Consensus 28 ~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 28 FRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp EEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 44443 455688898764432 23566777777763 23477888888888889999999987665
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.28 E-value=0.019 Score=51.72 Aligned_cols=130 Identities=12% Similarity=0.076 Sum_probs=69.1
Q ss_pred eEEEEE-EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCCCCc--ccceeE-----EEEeCCceEEEEeccCCCCH-
Q 013214 167 TFILAF-WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLG-----AVTQSSPMMIVTEYLPKGDL- 237 (447)
Q Consensus 167 ~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~-----~~~~~~~~~lv~e~~~~g~L- 237 (447)
..+.+. .+|+.+++|+......+ .+++..|...+..+.... ++.... .+...+..+.++++++|..+
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred eeEEEEcCCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 334443 36788999998654332 245667888877773222 111111 22345667889999865432
Q ss_pred ----HHHH---------Hh---c------C-------------------CCCHHHH---HHHHHHHHHHHHHHH-hCCCC
Q 013214 238 ----RAFL---------KR---K------G-------------------ALKPSTA---VRFALDIARGMNYLH-ENKPV 272 (447)
Q Consensus 238 ----~~~l---------~~---~------~-------------------~l~~~~~---~~i~~ql~~~l~~lH-~~~~~ 272 (447)
..+- +. . . .++.... ...+.++...+.-.- +..+.
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1111 00 0 0 1111111 122233333332221 22234
Q ss_pred CeEeCCCCCCCEEEcCCCCEEEeecccccc
Q 013214 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (447)
Q Consensus 273 ~i~H~Dikp~Nill~~~~~vkl~Dfg~~~~ 302 (447)
.++|+|+.+.|||++.+ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 58999999999999743 56899997763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.94 E-value=0.018 Score=53.45 Aligned_cols=53 Identities=13% Similarity=0.154 Sum_probs=33.7
Q ss_pred eEEEEEEcCcccCCCHHHHHHHHHHHHHHhcCC-CCcccceeEEEEeCCceEEEEeccCCCCH
Q 013214 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (447)
Q Consensus 176 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~g~L 237 (447)
..|.+++.... .. .....+|..+++.+. +.-.+++++++.+ .+|+||++|..+
T Consensus 75 ~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 75 NKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp SEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 45677765421 12 123456888888884 4445678887753 689999976544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=89.06 E-value=0.047 Score=48.64 Aligned_cols=30 Identities=23% Similarity=0.207 Sum_probs=26.2
Q ss_pred CCeEeCCCCCCCEEEcCCCCEEEeeccccc
Q 013214 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (447)
Q Consensus 272 ~~i~H~Dikp~Nill~~~~~vkl~Dfg~~~ 301 (447)
.+++|+|+.++|++++.+...-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 359999999999999988767899999875
|